Psyllid ID: psy6346
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1238 | 2.2.26 [Sep-21-2011] | |||||||
| Q8CFH6 | 931 | Serine/threonine-protein | yes | N/A | 0.227 | 0.302 | 0.680 | 1e-117 | |
| Q9H0K1 | 926 | Serine/threonine-protein | yes | N/A | 0.233 | 0.312 | 0.661 | 1e-117 | |
| Q5REX1 | 925 | Serine/threonine-protein | yes | N/A | 0.233 | 0.312 | 0.654 | 1e-114 | |
| Q60670 | 779 | Serine/threonine-protein | no | N/A | 0.222 | 0.354 | 0.636 | 1e-109 | |
| Q9R1U5 | 776 | Serine/threonine-protein | yes | N/A | 0.222 | 0.355 | 0.636 | 1e-108 | |
| Q9IA88 | 798 | Serine/threonine-protein | no | N/A | 0.222 | 0.345 | 0.625 | 1e-106 | |
| P57059 | 783 | Serine/threonine-protein | no | N/A | 0.219 | 0.347 | 0.617 | 1e-105 | |
| Q6P4S6 | 1311 | Serine/threonine-protein | no | N/A | 0.230 | 0.217 | 0.613 | 1e-104 | |
| Q9Y2K2 | 1263 | Serine/threonine-protein | no | N/A | 0.230 | 0.225 | 0.609 | 1e-104 | |
| Q6NSM8 | 1187 | Serine/threonine-protein | no | N/A | 0.227 | 0.237 | 0.596 | 1e-101 |
| >sp|Q8CFH6|SIK2_MOUSE Serine/threonine-protein kinase SIK2 OS=Mus musculus GN=Sik2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 424 bits (1091), Expect = e-117, Method: Compositional matrix adjust.
Identities = 196/288 (68%), Positives = 234/288 (81%), Gaps = 6/288 (2%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETKSM+Y+V+EYA GEIF
Sbjct: 46 VAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLVTEYAKNGEIF 105
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
DY+A +GR+NE+ ARRKFWQILSAV+YCH R+VVHRDLKAENLL+D+N++IK+ADFGF N
Sbjct: 106 DYLANHGRLNESEARRKFWQILSAVDYCHGRKVVHRDLKAENLLLDNNMNIKIADFGFGN 165
Query: 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL 397
++ G+ LATWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGALPFDG TL L
Sbjct: 166 FFKTGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPFDGPTLPIL 225
Query: 398 RDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINIL 457
R RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM E P + PI
Sbjct: 226 RQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLSIAQIKEHKWMLIEVP-VQRPILYP 284
Query: 458 GEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
E +NEP NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 285 QEQENEPSIGEFNEQVLRLMHSLGIDQQKTVESLQNKSYNHFAAIYFL 332
|
Phosphorylates 'Ser-789' of IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing TORCs, the CREB-specific coactivators. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens GN=SIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1086), Expect = e-117, Method: Compositional matrix adjust.
Identities = 197/298 (66%), Positives = 238/298 (79%), Gaps = 9/298 (3%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETKSM+Y+V
Sbjct: 36 LGRHRITKTEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLV 95
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+EYA GEIFDY+A +GR+NE+ ARRKFWQILSAV+YCH R++VHRDLKAENLL+D+N++
Sbjct: 96 TEYAKNGEIFDYLANHGRLNESEARRKFWQILSAVDYCHGRKIVHRDLKAENLLLDNNMN 155
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGF N++ G+ LATWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGAL
Sbjct: 156 IKIADFGFGNFFKSGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGAL 215
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG TL LR RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM E
Sbjct: 216 PFDGPTLPILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLTIAQIKEHKWMLIEV 275
Query: 448 PRLLPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
P + P+ E +NEP NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 276 P-VQRPVLYPQEQENEPSIGEFNEQVLRLMHSLGIDQQKTIESLQNKSYNHFAAIYFL 332
|
Phosphorylates 'Ser-794' of IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing TORCs, the CREB-specific coactivators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5REX1|SIK2_PONAB Serine/threonine-protein kinase SIK2 OS=Pongo abelii GN=SIK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1066), Expect = e-114, Method: Compositional matrix adjust.
Identities = 195/298 (65%), Positives = 236/298 (79%), Gaps = 9/298 (3%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETKSM+Y+V
Sbjct: 36 LGRHRITKTEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLV 95
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+EYA GEIFDY+A +GR+NE+ ARRKFWQILSAV+YCH R++VHRDLKAENLL+D+N++
Sbjct: 96 TEYAKNGEIFDYLANHGRLNESEARRKFWQILSAVDYCHGRKIVHRDLKAENLLLDNNMN 155
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADF F N++ G+ LATW GSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGAL
Sbjct: 156 IKIADFSFGNFFKSGELLATWRGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGAL 215
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG TL LR RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM E
Sbjct: 216 PFDGPTLPILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLTIAQIKEHKWMLIEV 275
Query: 448 PRLLPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
P + P+ E +NEP NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 276 P-VQRPVLYPQEQENEPSIGEFNEQVLRLMHSLGIDQQKTIESLQNKSYNHFAAIYFL 332
|
Phosphorylates 'Ser-794' of IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing TORCs, the CREB-specific coactivators. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60670|SIK1_MOUSE Serine/threonine-protein kinase SIK1 OS=Mus musculus GN=Sik1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 395 bits (1016), Expect = e-109, Method: Compositional matrix adjust.
Identities = 182/286 (63%), Positives = 227/286 (79%), Gaps = 10/286 (3%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH V VAIKIIDK++LD NL+K+YREV++MK L+HP+IIKL+QVMETK M+YIV
Sbjct: 43 LARHRVTKTQVAIKIIDKTRLDSSNLEKIYREVQLMKLLNHPNIIKLYQVMETKDMLYIV 102
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+E+A GE+FDY+ G ++EN AR+KFWQILSAVEYCHN +VHRDLK ENLL+DSN+D
Sbjct: 103 TEFAKNGEMFDYLTSNGHLSENEARQKFWQILSAVEYCHNHHIVHRDLKTENLLLDSNMD 162
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IKLADFGF N+Y PG+ L+TWCGSPPYAAPEVFEGK+Y GP++D+WSLGVVLYVLVCG+L
Sbjct: 163 IKLADFGFGNFYKPGEPLSTWCGSPPYAAPEVFEGKEYEGPQLDVWSLGVVLYVLVCGSL 222
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG L +LR RVL GRFRIP+FMS +CE+LIR+MLV +P KR I QI++HRWM +
Sbjct: 223 PFDGPNLPTLRQRVLEGRFRIPFFMSQDCETLIRRMLVVDPAKRITIAQIRQHRWM-QAD 281
Query: 448 PRLL----PPINILGEVKN--EPNEQILRLMNSLGIDAAKTKEVFE 487
P LL P ++ G N + NEQ+L +M +LGID +T E +
Sbjct: 282 PTLLQQDDPAFDMQGYTSNLGDYNEQVLGIMQALGIDRQRTIESLQ 327
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis regulation, muscle growth and differentiation and tumor suppression. Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, TORC1/CRTC1 and TORC2/CRTC2. Acts as a tumor suppressor and plays a key role in p53/TP53-dependent anoikis, a type of apoptosis triggered by cell detachment: required for phosphorylation of p53/TP53 in response to loss of adhesion and is able to suppress metastasis. Part of a sodium-sensing signaling network, probably by mediating phosphorylation of PPME1: following increases in intracellular sodium, SIK1 is activated by CaMK1 and phosphorylates PPME1 subunit of protein phosphatase 2A (PP2A), leading to dephosphorylation of sodium/potassium-transporting ATPase ATP1A1 and subsequent increase activity of ATP1A1. Acts as a regulator of muscle cells by phosphorylating and inhibiting class II histone deacetylases HDAC4 and HDAC5, leading to promote expression of MEF2 target genes in myocytes. Also required during cardiomyogenesis by regulating the exit of cardiomyoblasts from the cell cycle via down-regulation of CDKN1C/p57Kip2. Acts as a regulator of hepatic gluconeogenesis by phosphorylating and repressing the CREB-specific coactivators TORC1/CRTC1 and TORC2/CRTC2, leading to inhibit CREB activity. Also regulates hepatic lipogenesis by phosphorylating and inhibiting SREBF1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1U5|SIK1_RAT Serine/threonine-protein kinase SIK1 OS=Rattus norvegicus GN=Sik1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 394 bits (1013), Expect = e-108, Method: Compositional matrix adjust.
Identities = 182/286 (63%), Positives = 226/286 (79%), Gaps = 10/286 (3%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH V VAIKIIDK++LD NL+K+YREV++MK L+HP+IIKL+QVMETK M+YIV
Sbjct: 43 LARHRVTKTQVAIKIIDKTRLDSSNLEKIYREVQLMKLLNHPNIIKLYQVMETKDMLYIV 102
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+E+A GE+FDY+ G ++EN AR+KFWQILSAVEYCHN +VHRDLK ENLL+D N+D
Sbjct: 103 TEFAKNGEMFDYLTSNGHLSENEARKKFWQILSAVEYCHNHHIVHRDLKTENLLLDGNMD 162
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IKLADFGF N+Y PG+ L+TWCGSPPYAAPEVFEGK+Y GP++DIWSLGVVLYVLVCG+L
Sbjct: 163 IKLADFGFGNFYKPGEPLSTWCGSPPYAAPEVFEGKEYEGPQLDIWSLGVVLYVLVCGSL 222
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG L +LR RVL GRFRIP+FMS +CE+LIR+MLV +P KR I QI++HRWM +
Sbjct: 223 PFDGPNLPTLRQRVLEGRFRIPFFMSQDCETLIRRMLVVDPAKRITIAQIRQHRWM-QAD 281
Query: 448 PRLL----PPINILGEVKN--EPNEQILRLMNSLGIDAAKTKEVFE 487
P LL P ++ G N + NEQ+L +M +LGID +T E +
Sbjct: 282 PTLLQQDDPAFSMQGYTSNLGDYNEQVLGIMQALGIDRQRTVESLQ 327
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis regulation, muscle growth and differentiation and tumor suppression. Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, TORC1/CRTC1 and TORC2/CRTC2. Acts as a tumor suppressor and plays a key role in p53/TP53-dependent anoikis, a type of apoptosis triggered by cell detachment: required for phosphorylation of p53/TP53 in response to loss of adhesion and is able to suppress metastasis. Part of a sodium-sensing signaling network, probably by mediating phosphorylation of PPME1: following increases in intracellular sodium, SIK1 is activated by CaMK1 and phosphorylates PPME1 subunit of protein phosphatase 2A (PP2A), leading to dephosphorylation of sodium/potassium-transporting ATPase ATP1A1 and subsequent increase activity of ATP1A1. Acts as a regulator of muscle cells by phosphorylating and inhibiting class II histone deacetylases HDAC4 and HDAC5, leading to promote expression of MEF2 target genes in myocytes. Also required during cardiomyogenesis by regulating the exit of cardiomyoblasts from the cell cycle via down-regulation of CDKN1C/p57Kip2. Acts as a regulator of hepatic gluconeogenesis by phosphorylating and repressing the CREB-specific coactivators TORC1/CRTC1 and TORC2/CRTC2, leading to inhibit CREB activity. Also regulates hepatic lipogenesis by phosphorylating and inhibiting SREBF1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9IA88|SIK2_CHICK Serine/threonine-protein kinase SIK2 OS=Gallus gallus GN=SIK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-106, Method: Compositional matrix adjust.
Identities = 179/286 (62%), Positives = 226/286 (79%), Gaps = 10/286 (3%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH V VAIKIIDK++LDP NL+K+YREV+IMK L+HPHIIKL+QVMETK M+YIV
Sbjct: 42 LARHRVTKTQVAIKIIDKTRLDPSNLEKIYREVQIMKLLNHPHIIKLYQVMETKDMLYIV 101
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+E+A GE+FD++ G ++E+ AR+KFWQILSAVEYCH+ +VHRDLK ENLL+D+N++
Sbjct: 102 TEFAKNGEMFDHLTSNGHLSESEARKKFWQILSAVEYCHSHHIVHRDLKTENLLLDANMN 161
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IKLADFGF N+Y G+ L+TWCGSPPYAAPEVFEGK+Y GP +DIWSLGVVLYVLVCG+L
Sbjct: 162 IKLADFGFGNFYKSGEPLSTWCGSPPYAAPEVFEGKEYEGPHLDIWSLGVVLYVLVCGSL 221
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG L +LR RVL GRFRIPYFMS +CE+LIR+MLV +PTKR I QIK+H+WM +
Sbjct: 222 PFDGPNLPTLRQRVLEGRFRIPYFMSEDCETLIRRMLVVDPTKRITISQIKQHKWMQAD- 280
Query: 448 PRLLPPINILGEVKN------EPNEQILRLMNSLGIDAAKTKEVFE 487
P L ++ ++N + NEQ+L +M +LGID +T E +
Sbjct: 281 PSLRQQQSLSFSMQNYNSNLGDYNEQVLGIMQTLGIDRQRTVESLQ 326
|
Phosphorylates IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing the CREB-specific coactivators, CRTC1-3. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P57059|SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 383 bits (983), Expect = e-105, Method: Compositional matrix adjust.
Identities = 179/290 (61%), Positives = 222/290 (76%), Gaps = 18/290 (6%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH V VAIKIIDK++LD NL+K+YREV++MK L+HPHIIKL+QVMETK M+YIV
Sbjct: 43 LARHRVTKTQVAIKIIDKTRLDSSNLEKIYREVQLMKLLNHPHIIKLYQVMETKDMLYIV 102
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+E+A GE+FDY+ G ++EN AR+KFWQILSAVEYCH+ +VHRDLK ENLL+D N+D
Sbjct: 103 TEFAKNGEMFDYLTSNGHLSENEARKKFWQILSAVEYCHDHHIVHRDLKTENLLLDGNMD 162
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IKLADFGF N+Y G+ L+TWCGSPPYAAPEVFEGK+Y GP++DIWSLGVVLYVLVCG+L
Sbjct: 163 IKLADFGFGNFYKSGEPLSTWCGSPPYAAPEVFEGKEYEGPQLDIWSLGVVLYVLVCGSL 222
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG L +LR RVL GRFRIP+FMS +CESLIR+MLV +P +R I QI++HRWM E
Sbjct: 223 PFDGPNLPTLRQRVLEGRFRIPFFMSQDCESLIRRMLVVDPARRITIAQIRQHRWMRAE- 281
Query: 448 PRLLPP----------INILGEVKNEPNEQILRLMNSLGIDAAKTKEVFE 487
P L P + LG+ +EQ L +M +LG+D +T E +
Sbjct: 282 PCLPGPACPAFSAHSYTSNLGDY----DEQALGIMQTLGVDRQRTVESLQ 327
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis regulation, muscle growth and differentiation and tumor suppression. Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, TORC1/CRTC1 and TORC2/CRTC2. Acts as a tumor suppressor and plays a key role in p53/TP53-dependent anoikis, a type of apoptosis triggered by cell detachment: required for phosphorylation of p53/TP53 in response to loss of adhesion and is able to suppress metastasis. Part of a sodium-sensing signaling network, probably by mediating phosphorylation of PPME1: following increases in intracellular sodium, SIK1 is activated by CaMK1 and phosphorylates PPME1 subunit of protein phosphatase 2A (PP2A), leading to dephosphorylation of sodium/potassium-transporting ATPase ATP1A1 and subsequent increase activity of ATP1A1. Acts as a regulator of muscle cells by phosphorylating and inhibiting class II histone deacetylases HDAC4 and HDAC5, leading to promote expression of MEF2 target genes in myocytes. Also required during cardiomyogenesis by regulating the exit of cardiomyoblasts from the cell cycle via down-regulation of CDKN1C/p57Kip2. Acts as a regulator of hepatic gluconeogenesis by phosphorylating and repressing the CREB-specific coactivators TORC1/CRTC1 and TORC2/CRTC2, leading to inhibit CREB activity. Also regulates hepatic lipogenesis by phosphorylating and inhibiting SREBF1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P4S6|SIK3_MOUSE Serine/threonine-protein kinase SIK3 OS=Mus musculus GN=Sik3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 381 bits (979), Expect = e-104, Method: Compositional matrix adjust.
Identities = 179/292 (61%), Positives = 225/292 (77%), Gaps = 7/292 (2%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VAIKIIDKSQLD NL+K++REV+IMK L HPHII+L+QVMET+ MIY+V+EYA+ GE
Sbjct: 32 AKVAIKIIDKSQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 91
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
IFD++ +GRM E ARRKF QI++AV +CH R +VHRDLKAENLL+D+NL+IK+ADFGF
Sbjct: 92 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 151
Query: 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
SN + PGQ L TWCGSPPYAAPE+FEGK+Y GP++DIWSLGVVLYVLVCGALPFDGSTL
Sbjct: 152 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 211
Query: 396 SLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM--AEETP---RL 450
+LR RVLSG+FRIP+FMSTECE LIR MLV +P KR +EQI RH+WM + P RL
Sbjct: 212 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICRHKWMKLGDADPNFDRL 271
Query: 451 LPPINILGEVK-NEP-NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
+ L E + ++P N+ +L M +G+D +T + ++ + Y L
Sbjct: 272 IAECQQLKEERQSDPLNDDVLLAMEDMGLDKERTLQSLRSDAYDHYSAIYSL 323
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2K2|SIK3_HUMAN Serine/threonine-protein kinase SIK3 OS=Homo sapiens GN=SIK3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 380 bits (976), Expect = e-104, Method: Compositional matrix adjust.
Identities = 178/292 (60%), Positives = 224/292 (76%), Gaps = 7/292 (2%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VAIKIIDK+QLD NL+K++REV+IMK L HPHII+L+QVMET+ MIY+V+EYA+ GE
Sbjct: 32 AKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 91
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
IFD++ +GRM E ARRKF QI++AV +CH R +VHRDLKAENLL+D+NL+IK+ADFGF
Sbjct: 92 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 151
Query: 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
SN + PGQ L TWCGSPPYAAPE+FEGK+Y GP++DIWSLGVVLYVLVCGALPFDGSTL
Sbjct: 152 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 211
Query: 396 SLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM--AEETP---RL 450
+LR RVLSG+FRIP+FMSTECE LIR MLV +P KR +EQI +H+WM + P RL
Sbjct: 212 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKLGDADPNFDRL 271
Query: 451 LPPINILGEVKN-EP-NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
+ L E + +P NE +L M +G+D +T + ++ + Y L
Sbjct: 272 IAECQQLKEERQVDPLNEDVLLAMEDMGLDKEQTLQSLRSDAYDHYSAIYSL 323
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NSM8|SIK3_DANRE Serine/threonine-protein kinase SIK3 homolog OS=Danio rerio GN=zgc:66101 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (954), Expect = e-101, Method: Compositional matrix adjust.
Identities = 176/295 (59%), Positives = 223/295 (75%), Gaps = 13/295 (4%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VAIKI+DK+QLD NL+K++REV+IMK L HPHII+L+QVMET+ MIY+V+EYA+ GE
Sbjct: 83 AKVAIKIVDKTQLDDENLKKIFREVQIMKMLRHPHIIRLYQVMETERMIYLVTEYASGGE 142
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
IFD++ +GRM E ARRKF QI++AV +CH R +VHRDLKAENLL+D NL+IK+ADFGF
Sbjct: 143 IFDHLVAHGRMAEKDARRKFKQIVAAVYFCHCRSIVHRDLKAENLLLDHNLNIKIADFGF 202
Query: 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
SN + GQ L TWCGSPPYAAPE+FEGK+Y GP++DIWSLGVVLYVLVCGALPFDGSTL
Sbjct: 203 SNLFSRGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 262
Query: 396 SLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP-----RL 450
+LR RVLSG+FRIP+FMST+CE LIR ML+ EP++R +EQI +++WM + P RL
Sbjct: 263 NLRARVLSGKFRIPFFMSTDCEYLIRHMLILEPSRRLSMEQICKNKWMRQGDPDPEFDRL 322
Query: 451 LPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
I +VK E NEQ+L M +G D +T + A++ + Y L
Sbjct: 323 ---IVECEQVKVERETELINEQVLMAMAEMGFDRERTLQSLHADSYDHYSATYSL 374
|
Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1238 | ||||||
| 357624153 | 1141 | hypothetical protein KGM_19156 [Danaus p | 0.220 | 0.239 | 0.782 | 1e-130 | |
| 328721463 | 922 | PREDICTED: hypothetical protein LOC10016 | 0.226 | 0.304 | 0.742 | 1e-128 | |
| 347969047 | 1422 | AGAP003005-PB [Anopheles gambiae str. PE | 0.233 | 0.203 | 0.721 | 1e-128 | |
| 347969051 | 1328 | AGAP003005-PA [Anopheles gambiae str. PE | 0.233 | 0.217 | 0.721 | 1e-128 | |
| 242012487 | 1349 | hypothetical protein Phum_PHUM287820 [Pe | 0.234 | 0.214 | 0.723 | 1e-126 | |
| 347969058 | 289 | AGAP013439-PA [Anopheles gambiae str. PE | 0.220 | 0.944 | 0.756 | 1e-124 | |
| 270005428 | 831 | hypothetical protein TcasGA2_TC007481 [T | 0.232 | 0.346 | 0.723 | 1e-123 | |
| 189236384 | 856 | PREDICTED: similar to SNF1-like kinase 2 | 0.232 | 0.336 | 0.723 | 1e-123 | |
| 195447720 | 1437 | GK25743 [Drosophila willistoni] gi|19416 | 0.234 | 0.201 | 0.708 | 1e-122 | |
| 194768735 | 1480 | GF21982 [Drosophila ananassae] gi|190617 | 0.234 | 0.195 | 0.708 | 1e-122 |
| >gi|357624153|gb|EHJ75032.1| hypothetical protein KGM_19156 [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1216), Expect = e-130, Method: Compositional matrix adjust.
Identities = 223/285 (78%), Positives = 243/285 (85%), Gaps = 12/285 (4%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDKSQLD NLQKVYREV+IMK+LDHPHIIKL+QVMETK+MIYIV
Sbjct: 33 LARHRITKTEVAIKIIDKSQLDASNLQKVYREVDIMKRLDHPHIIKLYQVMETKNMIYIV 92
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA++GEIFDYIARYGRM E AARRKFWQILSAVEYCH RR+VHRDLKAENLL+D+N++
Sbjct: 93 SEYASKGEIFDYIARYGRMAEQAARRKFWQILSAVEYCHERRIVHRDLKAENLLLDANMN 152
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSNYY G+ LATWCGSPPYAAPEVFEGK+Y GPEIDIWSLGVVLYVLVCGAL
Sbjct: 153 IKIADFGFSNYYATGELLATWCGSPPYAAPEVFEGKRYTGPEIDIWSLGVVLYVLVCGAL 212
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDGSTL SLRDRVLSGRFRIPYFMS ECESLIRKMLV EP KRY IEQIK+HRWM+ E
Sbjct: 213 PFDGSTLQSLRDRVLSGRFRIPYFMSEECESLIRKMLVLEPMKRYTIEQIKKHRWMSTE- 271
Query: 448 PRLLP-----PINILGEVKN---EPNEQILRLMNSLGIDAAKTKE 484
P P P+ V + EPNEQ+LRLM SLGID KTKE
Sbjct: 272 PYTAPSVASDPMRSPAHVAHHSQEPNEQVLRLMQSLGIDPVKTKE 316
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328721463|ref|XP_001945307.2| PREDICTED: hypothetical protein LOC100167523 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 467 bits (1201), Expect = e-128, Method: Compositional matrix adjust.
Identities = 210/283 (74%), Positives = 244/283 (86%), Gaps = 2/283 (0%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK+IDK +LD VNL+KV+REV+IMKQLDHPHIIKL+QVME+K MIYI+SEYA+QGEIF
Sbjct: 38 VAIKMIDKRKLDAVNLEKVHREVDIMKQLDHPHIIKLYQVMESKDMIYIISEYASQGEIF 97
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
DYIA+YGRM E AAR+KFWQILSAVEYCHNR VVHRDLKAENLL+D+N++IK+ADFGFSN
Sbjct: 98 DYIAKYGRMTEAAARKKFWQILSAVEYCHNRHVVHRDLKAENLLLDANMNIKIADFGFSN 157
Query: 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL 397
Y+ PG++LATWCGSPPYAAPEVFEGKKY GPEID+WS+GVVLYVLVCGALPFDGSTL+SL
Sbjct: 158 YFTPGEQLATWCGSPPYAAPEVFEGKKYYGPEIDVWSMGVVLYVLVCGALPFDGSTLHSL 217
Query: 398 RDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINIL 457
RDRVLSGRFRIPYFMST CESLIRKML+ +P KRY +EQIKRH WM EE PRLLP +
Sbjct: 218 RDRVLSGRFRIPYFMSTGCESLIRKMLILDPNKRYTVEQIKRHPWMLEEAPRLLP--GTI 275
Query: 458 GEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
E+ EPN+Q+LR M+SL I+ +T++ T Y L
Sbjct: 276 AEMPAEPNDQVLRFMSSLDINTTRTRQSLRNRTYDHYAAIYYL 318
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347969047|ref|XP_003436351.1| AGAP003005-PB [Anopheles gambiae str. PEST] gi|347969049|ref|XP_003436352.1| AGAP003005-PC [Anopheles gambiae str. PEST] gi|333467721|gb|EGK96661.1| AGAP003005-PB [Anopheles gambiae str. PEST] gi|333467722|gb|EGK96662.1| AGAP003005-PC [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1197), Expect = e-128, Method: Compositional matrix adjust.
Identities = 218/302 (72%), Positives = 253/302 (83%), Gaps = 13/302 (4%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDKSQLDP NLQKVYREVEIMK+LDHPH+IKL+QVMET+SMIYIV
Sbjct: 225 LARHRITKNEVAIKIIDKSQLDPGNLQKVYREVEIMKRLDHPHVIKLYQVMETQSMIYIV 284
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA+QGEIFDYIA+YGR+NE AAR KFWQILSAVEYCHN+ +VHRDLKAENLL+DS +D
Sbjct: 285 SEYASQGEIFDYIAKYGRLNERAARNKFWQILSAVEYCHNKGIVHRDLKAENLLLDSKMD 344
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSN+Y G+ LATWCGSPPYAAPEVFEGK+Y GPEIDIWSLGVVLYVLVCGAL
Sbjct: 345 IKIADFGFSNFYKKGELLATWCGSPPYAAPEVFEGKRYTGPEIDIWSLGVVLYVLVCGAL 404
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE- 446
PFDGS+L SLRDRVLSGRFRIP+FMS++CESLIRKMLV +P++R+ I+QIKRHRWM E
Sbjct: 405 PFDGSSLQSLRDRVLSGRFRIPFFMSSDCESLIRKMLVLDPSRRFSIDQIKRHRWMMVEI 464
Query: 447 --TPRLLPPINILGEV------KNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCY 498
TP+ + I I G V + EPNEQIL++M +LGID KT+E + + T Y
Sbjct: 465 IDTPK-ISSIVINGSVSEVSALETEPNEQILKIMQNLGIDILKTRESLKLHSYDHYTAFY 523
Query: 499 IL 500
+L
Sbjct: 524 LL 525
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347969051|ref|XP_001237399.2| AGAP003005-PA [Anopheles gambiae str. PEST] gi|333467720|gb|EAU77050.2| AGAP003005-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1197), Expect = e-128, Method: Compositional matrix adjust.
Identities = 218/302 (72%), Positives = 253/302 (83%), Gaps = 13/302 (4%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDKSQLDP NLQKVYREVEIMK+LDHPH+IKL+QVMET+SMIYIV
Sbjct: 131 LARHRITKNEVAIKIIDKSQLDPGNLQKVYREVEIMKRLDHPHVIKLYQVMETQSMIYIV 190
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA+QGEIFDYIA+YGR+NE AAR KFWQILSAVEYCHN+ +VHRDLKAENLL+DS +D
Sbjct: 191 SEYASQGEIFDYIAKYGRLNERAARNKFWQILSAVEYCHNKGIVHRDLKAENLLLDSKMD 250
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSN+Y G+ LATWCGSPPYAAPEVFEGK+Y GPEIDIWSLGVVLYVLVCGAL
Sbjct: 251 IKIADFGFSNFYKKGELLATWCGSPPYAAPEVFEGKRYTGPEIDIWSLGVVLYVLVCGAL 310
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE- 446
PFDGS+L SLRDRVLSGRFRIP+FMS++CESLIRKMLV +P++R+ I+QIKRHRWM E
Sbjct: 311 PFDGSSLQSLRDRVLSGRFRIPFFMSSDCESLIRKMLVLDPSRRFSIDQIKRHRWMMVEI 370
Query: 447 --TPRLLPPINILGEV------KNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCY 498
TP+ + I I G V + EPNEQIL++M +LGID KT+E + + T Y
Sbjct: 371 IDTPK-ISSIVINGSVSEVSALETEPNEQILKIMQNLGIDILKTRESLKLHSYDHYTAFY 429
Query: 499 IL 500
+L
Sbjct: 430 LL 431
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242012487|ref|XP_002426964.1| hypothetical protein Phum_PHUM287820 [Pediculus humanus corporis] gi|212511193|gb|EEB14226.1| hypothetical protein Phum_PHUM287820 [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1183), Expect = e-126, Method: Compositional matrix adjust.
Identities = 215/297 (72%), Positives = 246/297 (82%), Gaps = 7/297 (2%)
Query: 211 LLRHTVNV---AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + AIKIIDK+QLD VNL KVYREV+IMKQLDHPHIIKLFQVMETK+MIYIV
Sbjct: 31 LARHRITKTQGAIKIIDKTQLDAVNLLKVYREVDIMKQLDHPHIIKLFQVMETKNMIYIV 90
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA+QGEIFDYIA++GRMNE AR+KFWQILSA+EYCH++++VHRDLKAENLLMD N++
Sbjct: 91 SEYASQGEIFDYIAKFGRMNEKTARKKFWQILSAIEYCHSKQIVHRDLKAENLLMDQNME 150
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSNYY P + L+TWCGSPPYAAPEVF+G KY GPEIDIWSLGVVLYVLVCGAL
Sbjct: 151 IKIADFGFSNYYNPNELLSTWCGSPPYAAPEVFQGLKYVGPEIDIWSLGVVLYVLVCGAL 210
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDGSTL SL+DRVLSGRFRIPYFMS++CESLIRKMLV +P KRY IE IK+HRWM E
Sbjct: 211 PFDGSTLQSLKDRVLSGRFRIPYFMSSDCESLIRKMLVVDPGKRYSIENIKKHRWMQAEI 270
Query: 448 PRLLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCY--ILKR 502
P+L NI +E N+QILRLM SLGID+ KT+E + Y +LKR
Sbjct: 271 PKLPDSTNI--GTTHELNDQILRLMQSLGIDSVKTRESLRCGSYDHHAAIYYLLLKR 325
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347969058|ref|XP_003436354.1| AGAP013439-PA [Anopheles gambiae str. PEST] gi|333467719|gb|EGK96660.1| AGAP013439-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1164), Expect = e-124, Method: Compositional matrix adjust.
Identities = 214/283 (75%), Positives = 245/283 (86%), Gaps = 10/283 (3%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
LL VAIKIIDKSQLDP NLQKVYREVEIMK+LDHPH+IKL+QVMET+SMIYIVSEY
Sbjct: 5 LLFLRFQVAIKIIDKSQLDPGNLQKVYREVEIMKRLDHPHVIKLYQVMETQSMIYIVSEY 64
Query: 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
A+QGEIFDYIA+YGR+NE AAR KFWQILSAVEYCHN+ +VHRDLKAENLL+DS +DIK+
Sbjct: 65 ASQGEIFDYIAKYGRLNERAARNKFWQILSAVEYCHNKGIVHRDLKAENLLLDSKMDIKI 124
Query: 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
ADFGFSN+Y G+ LATWCGSPPYAAPEVFEGK+Y GPEIDIWSLGVVLYVLVCGALPFD
Sbjct: 125 ADFGFSNFYKKGELLATWCGSPPYAAPEVFEGKRYTGPEIDIWSLGVVLYVLVCGALPFD 184
Query: 391 GSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE---T 447
GS+L SLRDRVLSGRFRIP+FMS++CESLIRKMLV +P++R+ I+QIKRHRWM E T
Sbjct: 185 GSSLQSLRDRVLSGRFRIPFFMSSDCESLIRKMLVLDPSRRFSIDQIKRHRWMMVEIIDT 244
Query: 448 PRLLPPINILGEV------KNEPNEQILRLMNSLGIDAAKTKE 484
P+ + I I G V + EPNEQIL++M +LGID KT+E
Sbjct: 245 PK-ISSIVINGSVSEVSALETEPNEQILKIMQNLGIDILKTRE 286
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270005428|gb|EFA01876.1| hypothetical protein TcasGA2_TC007481 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1158), Expect = e-123, Method: Compositional matrix adjust.
Identities = 212/293 (72%), Positives = 239/293 (81%), Gaps = 5/293 (1%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L +H + VAIKIIDKSQLD NLQKVYREV+IMK+LDHPHIIKL+QVMETK+MIY+V
Sbjct: 32 LAKHRITKTEVAIKIIDKSQLDAGNLQKVYREVDIMKRLDHPHIIKLYQVMETKNMIYLV 91
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA+QGEIFDYIARYGRM E+ AR KFWQILSAVEYCHNR +VHRDLKAENLL+DSN +
Sbjct: 92 SEYASQGEIFDYIARYGRMTEDQARTKFWQILSAVEYCHNRNIVHRDLKAENLLLDSNNN 151
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSNYY G L+TWCGSPPYAAPEVFEGKKY GPEIDIWSLGVVLYVLVCGAL
Sbjct: 152 IKIADFGFSNYYTSGGVLSTWCGSPPYAAPEVFEGKKYTGPEIDIWSLGVVLYVLVCGAL 211
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG +L +LRDRVLSGRFRIPYFMS++CESLIRKMLV EP KRY I QIK+HRWM +
Sbjct: 212 PFDGCSLPALRDRVLSGRFRIPYFMSSDCESLIRKMLVLEPNKRYSISQIKKHRWM--QM 269
Query: 448 PRLLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
++ +PNEQILRLM SLGID++KT+E + Y L
Sbjct: 270 AIPPSLPPLIPASPTQPNEQILRLMQSLGIDSSKTRESIRIGSYDHHAAIYFL 322
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189236384|ref|XP_969698.2| PREDICTED: similar to SNF1-like kinase 2 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1155), Expect = e-123, Method: Compositional matrix adjust.
Identities = 212/293 (72%), Positives = 239/293 (81%), Gaps = 5/293 (1%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L +H + VAIKIIDKSQLD NLQKVYREV+IMK+LDHPHIIKL+QVMETK+MIY+V
Sbjct: 32 LAKHRITKTEVAIKIIDKSQLDAGNLQKVYREVDIMKRLDHPHIIKLYQVMETKNMIYLV 91
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA+QGEIFDYIARYGRM E+ AR KFWQILSAVEYCHNR +VHRDLKAENLL+DSN +
Sbjct: 92 SEYASQGEIFDYIARYGRMTEDQARTKFWQILSAVEYCHNRNIVHRDLKAENLLLDSNNN 151
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSNYY G L+TWCGSPPYAAPEVFEGKKY GPEIDIWSLGVVLYVLVCGAL
Sbjct: 152 IKIADFGFSNYYTSGGVLSTWCGSPPYAAPEVFEGKKYTGPEIDIWSLGVVLYVLVCGAL 211
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG +L +LRDRVLSGRFRIPYFMS++CESLIRKMLV EP KRY I QIK+HRWM +
Sbjct: 212 PFDGCSLPALRDRVLSGRFRIPYFMSSDCESLIRKMLVLEPNKRYSISQIKKHRWM--QM 269
Query: 448 PRLLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
++ +PNEQILRLM SLGID++KT+E + Y L
Sbjct: 270 AIPPSLPPLIPASPTQPNEQILRLMQSLGIDSSKTRESIRIGSYDHHAAIYFL 322
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195447720|ref|XP_002071340.1| GK25743 [Drosophila willistoni] gi|194167425|gb|EDW82326.1| GK25743 [Drosophila willistoni] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1150), Expect = e-122, Method: Compositional matrix adjust.
Identities = 211/298 (70%), Positives = 245/298 (82%), Gaps = 8/298 (2%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDKSQLD NLQKVYREVEIMK+L HPHIIKL+QVMETK+MIYIV
Sbjct: 185 LARHRITKNEVAIKIIDKSQLDQTNLQKVYREVEIMKRLKHPHIIKLYQVMETKNMIYIV 244
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA+QGEIFDYIA+YGRM+E+AAR KFWQI+SAVEYCH + +VHRDLKAENLLMD N++
Sbjct: 245 SEYASQGEIFDYIAKYGRMSESAARFKFWQIISAVEYCHKKGIVHRDLKAENLLMDFNMN 304
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSN++ PG+ LATWCGSPPYAAPEVFEGK+Y GPEIDIWSLGVVLYVLVCGAL
Sbjct: 305 IKIADFGFSNHFKPGELLATWCGSPPYAAPEVFEGKQYTGPEIDIWSLGVVLYVLVCGAL 364
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDGSTL SLRDRVLSGRFRIP+FMS+ECE LIR+MLV EPT+RY IEQIKRHRWM E
Sbjct: 365 PFDGSTLQSLRDRVLSGRFRIPFFMSSECEHLIRRMLVLEPTRRYTIEQIKRHRWMCPEL 424
Query: 448 PR--LLPPINILGEVKN--EPNEQILRLMNS-LGIDAAKTKEVFEAETSKRRTFCYIL 500
L+ N+ + ++ EP+E ILR+M+ +GI KT+ + T Y+L
Sbjct: 425 VEHVLIAKYNLNMDRQSVLEPSEDILRIMSEYVGIGPDKTRASLKKNTYDHVAAIYLL 482
|
Source: Drosophila willistoni Species: Drosophila willistoni Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|194768735|ref|XP_001966467.1| GF21982 [Drosophila ananassae] gi|190617231|gb|EDV32755.1| GF21982 [Drosophila ananassae] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-122, Method: Compositional matrix adjust.
Identities = 211/298 (70%), Positives = 244/298 (81%), Gaps = 8/298 (2%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDKSQLD NLQKVYREVEIMK+L HPHIIKL+QVMETK+MIYIV
Sbjct: 156 LARHRITKNEVAIKIIDKSQLDQTNLQKVYREVEIMKRLKHPHIIKLYQVMETKNMIYIV 215
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA+QGEIFDYIA+YGRM+E+AAR KFWQI+SAVEYCH + +VHRDLKAENLL+D N++
Sbjct: 216 SEYASQGEIFDYIAKYGRMSESAARYKFWQIISAVEYCHKKGIVHRDLKAENLLLDMNMN 275
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSN++ PG+ LATWCGSPPYAAPEVFEGK+Y GPEIDIWSLGVVLYVLVCGAL
Sbjct: 276 IKIADFGFSNHFKPGELLATWCGSPPYAAPEVFEGKQYTGPEIDIWSLGVVLYVLVCGAL 335
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDGSTL SLRDRVLSGRFRIP+FMS+ECE LIR+MLV EPT+RY IEQIKRHRWM E
Sbjct: 336 PFDGSTLQSLRDRVLSGRFRIPFFMSSECEHLIRRMLVLEPTRRYTIEQIKRHRWMCPEL 395
Query: 448 PR--LLPPINILGEVKN--EPNEQILRLMNS-LGIDAAKTKEVFEAETSKRRTFCYIL 500
L+ N+ E ++ EP+E ILR+M +GI KT+ + T Y+L
Sbjct: 396 LEHVLIAKYNLGAERQSGLEPSEDILRIMAEYVGIGPDKTRASLKKNTYDHVAAIYLL 453
|
Source: Drosophila ananassae Species: Drosophila ananassae Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1238 | ||||||
| UNIPROTKB|E2RCU0 | 918 | SIK2 "Uncharacterized protein" | 0.231 | 0.312 | 0.665 | 4.3e-131 | |
| MGI|MGI:2445031 | 931 | Sik2 "salt inducible kinase 2" | 0.227 | 0.302 | 0.680 | 9.9e-130 | |
| UNIPROTKB|F1MKW8 | 906 | SIK2 "Uncharacterized protein" | 0.231 | 0.316 | 0.658 | 2.6e-129 | |
| UNIPROTKB|E9PSK5 | 920 | E9PSK5 "Uncharacterized protei | 0.231 | 0.311 | 0.665 | 3.3e-127 | |
| UNIPROTKB|Q9H0K1 | 926 | SIK2 "Serine/threonine-protein | 0.231 | 0.309 | 0.662 | 5.3e-127 | |
| ZFIN|ZDB-GENE-071012-1 | 896 | sik2b "salt-inducible kinase 2 | 0.234 | 0.323 | 0.646 | 8.6e-127 | |
| UNIPROTKB|Q5REX1 | 925 | SIK2 "Serine/threonine-protein | 0.231 | 0.310 | 0.655 | 4.1e-125 | |
| UNIPROTKB|E1C5R4 | 911 | SIK2 "Serine/threonine-protein | 0.233 | 0.317 | 0.653 | 1.5e-123 | |
| FB|FBgn0025625 | 1398 | Sik2 "Salt-inducible kinase 2" | 0.234 | 0.207 | 0.704 | 2.5e-123 | |
| ZFIN|ZDB-GENE-070705-451 | 842 | sik2a "salt-inducible kinase 2 | 0.234 | 0.344 | 0.638 | 4.1e-123 |
| UNIPROTKB|E2RCU0 SIK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 4.3e-131, Sum P(5) = 4.3e-131
Identities = 197/296 (66%), Positives = 237/296 (80%)
Query: 213 RHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
RH + VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETK+M+Y+V+E
Sbjct: 38 RHRITKTEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKNMLYLVTE 97
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
YA GEIFDY+A +GR+NE+ ARRKFWQILSAV+YCH R++VHRDLKAENLL+DSN++IK
Sbjct: 98 YAKNGEIFDYLANHGRLNESEARRKFWQILSAVDYCHGRKIVHRDLKAENLLLDSNMNIK 157
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
LADFGF N++ G+ LATWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGALPF
Sbjct: 158 LADFGFGNFFKSGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPF 217
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
DG TL LR RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM E P
Sbjct: 218 DGPTLPILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLTIAQIKEHKWMLIEVPV 277
Query: 450 LLPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
P + G+ +NEP NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 278 QRPVLYPQGQ-ENEPSIGEFNEQVLRLMHSLGIDQQKTIESLQNKSYNHFAAIYYL 332
|
|
| MGI|MGI:2445031 Sik2 "salt inducible kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 9.9e-130, Sum P(5) = 9.9e-130
Identities = 196/288 (68%), Positives = 234/288 (81%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETKSM+Y+V+EYA GEIF
Sbjct: 46 VAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLVTEYAKNGEIF 105
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
DY+A +GR+NE+ ARRKFWQILSAV+YCH R+VVHRDLKAENLL+D+N++IK+ADFGF N
Sbjct: 106 DYLANHGRLNESEARRKFWQILSAVDYCHGRKVVHRDLKAENLLLDNNMNIKIADFGFGN 165
Query: 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL 397
++ G+ LATWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGALPFDG TL L
Sbjct: 166 FFKTGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPFDGPTLPIL 225
Query: 398 RDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINIL 457
R RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM E P + PI
Sbjct: 226 RQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLSIAQIKEHKWMLIEVP-VQRPILYP 284
Query: 458 GEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
E +NEP NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 285 QEQENEPSIGEFNEQVLRLMHSLGIDQQKTVESLQNKSYNHFAAIYFL 332
|
|
| UNIPROTKB|F1MKW8 SIK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1021 (364.5 bits), Expect = 2.6e-129, Sum P(5) = 2.6e-129
Identities = 195/296 (65%), Positives = 235/296 (79%)
Query: 213 RHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
RH + VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETKSM+Y+V+E
Sbjct: 38 RHRITRTEVAIKIIDKSQLDEVNLEKIYREVKIMKLLDHPHIIKLYQVMETKSMLYLVTE 97
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
YA GEIFDY+A +GR+NE+ ARRKFWQILSAV+YCH R++VHRDLKAENLL+D+N++IK
Sbjct: 98 YAKNGEIFDYLANHGRLNESEARRKFWQILSAVDYCHGRQIVHRDLKAENLLLDNNMNIK 157
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ADFGF N++ G+ LATWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGALPF
Sbjct: 158 IADFGFGNFFKSGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPF 217
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
DG TL LR RVL GRFRIPYFMS +CE LIR+MLV +P KR I QIK H+WM E P
Sbjct: 218 DGPTLPILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPAKRLTIAQIKEHKWMLVEVP- 276
Query: 450 LLPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
+ P+ E +NEP NEQ+LRLM+ LGID KT E + ++ Y L
Sbjct: 277 VQRPVLYPQEQENEPSIGEFNEQVLRLMHGLGIDQQKTIEALQNKSYNHFAAIYYL 332
|
|
| UNIPROTKB|E9PSK5 E9PSK5 "Uncharacterized protein" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 3.3e-127, Sum P(4) = 3.3e-127
Identities = 197/296 (66%), Positives = 238/296 (80%)
Query: 213 RHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
RH + VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETKSM+Y+V+E
Sbjct: 38 RHRITKTEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLVTE 97
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
YA GEIFDY+A +GR+NE+ ARRKFWQILSAV+YCH+R+VVHRDLKAENLL+D++++IK
Sbjct: 98 YAKNGEIFDYLANHGRLNESEARRKFWQILSAVDYCHSRKVVHRDLKAENLLLDNSMNIK 157
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ADFGF N++ G+ LATWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGALPF
Sbjct: 158 IADFGFGNFFKTGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPF 217
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
DG TL LR RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM E P
Sbjct: 218 DGPTLPILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLSIAQIKEHKWMLIEVP- 276
Query: 450 LLPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
+ PI E +NEP NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 277 VQRPILYPQEQENEPSIGEFNEQVLRLMHSLGIDQQKTIESLQNKSYNHFAAIYFL 332
|
|
| UNIPROTKB|Q9H0K1 SIK2 "Serine/threonine-protein kinase SIK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 5.3e-127, Sum P(4) = 5.3e-127
Identities = 196/296 (66%), Positives = 237/296 (80%)
Query: 213 RHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
RH + VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETKSM+Y+V+E
Sbjct: 38 RHRITKTEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLVTE 97
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
YA GEIFDY+A +GR+NE+ ARRKFWQILSAV+YCH R++VHRDLKAENLL+D+N++IK
Sbjct: 98 YAKNGEIFDYLANHGRLNESEARRKFWQILSAVDYCHGRKIVHRDLKAENLLLDNNMNIK 157
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ADFGF N++ G+ LATWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGALPF
Sbjct: 158 IADFGFGNFFKSGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPF 217
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
DG TL LR RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM E P
Sbjct: 218 DGPTLPILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLTIAQIKEHKWMLIEVP- 276
Query: 450 LLPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
+ P+ E +NEP NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 277 VQRPVLYPQEQENEPSIGEFNEQVLRLMHSLGIDQQKTIESLQNKSYNHFAAIYFL 332
|
|
| ZFIN|ZDB-GENE-071012-1 sik2b "salt-inducible kinase 2b" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1004 (358.5 bits), Expect = 8.6e-127, Sum P(4) = 8.6e-127
Identities = 192/297 (64%), Positives = 234/297 (78%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDK+QLD VNL+K+YREV+IMK LDHPHIIKL+QVMETK+M+Y+V
Sbjct: 38 LARHRITKTEVAIKIIDKTQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKNMLYLV 97
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+EYA GEIFDY+A++GR++E ARRKFWQILSAVEYCHNR +VHRDLKAENLL+D +++
Sbjct: 98 TEYAKNGEIFDYLAKHGRLSEPEARRKFWQILSAVEYCHNRNIVHRDLKAENLLLDGHMN 157
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGF N++ G+ LATWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGAL
Sbjct: 158 IKIADFGFGNFFQSGKPLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGAL 217
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG +L LR RVL GRFRIPYFM+ +CE LIR+MLV +P+KR I QIK H+WM E
Sbjct: 218 PFDGPSLPVLRQRVLEGRFRIPYFMTEDCEHLIRRMLVLDPSKRLSIGQIKEHKWMVMEV 277
Query: 448 PRLLPPI---NILGEVK-NEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
P P + GE E NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 278 PVQRPMLYQQTTEGEAGVGEYNEQVLRLMHSLGIDQHKTVESLQNKSYNHFAAIYYL 334
|
|
| UNIPROTKB|Q5REX1 SIK2 "Serine/threonine-protein kinase SIK2" [Pongo abelii (taxid:9601)] | Back alignment and assigned GO terms |
|---|
Score = 1010 (360.6 bits), Expect = 4.1e-125, Sum P(4) = 4.1e-125
Identities = 194/296 (65%), Positives = 235/296 (79%)
Query: 213 RHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
RH + VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+QVMETKSM+Y+V+E
Sbjct: 38 RHRITKTEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLVTE 97
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
YA GEIFDY+A +GR+NE+ ARRKFWQILSAV+YCH R++VHRDLKAENLL+D+N++IK
Sbjct: 98 YAKNGEIFDYLANHGRLNESEARRKFWQILSAVDYCHGRKIVHRDLKAENLLLDNNMNIK 157
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ADF F N++ G+ LATW GSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGALPF
Sbjct: 158 IADFSFGNFFKSGELLATWRGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPF 217
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
DG TL LR RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM E P
Sbjct: 218 DGPTLPILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLTIAQIKEHKWMLIEVP- 276
Query: 450 LLPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
+ P+ E +NEP NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 277 VQRPVLYPQEQENEPSIGEFNEQVLRLMHSLGIDQQKTIESLQNKSYNHFAAIYFL 332
|
|
| UNIPROTKB|E1C5R4 SIK2 "Serine/threonine-protein kinase SIK2" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 1.5e-123, Sum P(4) = 1.5e-123
Identities = 196/300 (65%), Positives = 237/300 (79%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ--VMETKSMIY 265
L RH + VAIKIIDKSQLD VNL+K+YREV+IMK LDHPHIIKL+Q VMETKSM+Y
Sbjct: 40 LARHRIQKTEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQQQVMETKSMLY 99
Query: 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
+V+E+A GEIFDY+A +GR++E+ ARRKFWQILSAVEYCHNR+VVHRDLKAENLL+D+N
Sbjct: 100 LVTEFAKNGEIFDYLASHGRLSESEARRKFWQILSAVEYCHNRKVVHRDLKAENLLLDNN 159
Query: 326 LDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
++IK+ADFGF N+Y G+ L TWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCG
Sbjct: 160 MNIKIADFGFGNFYKSGEPLTTWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCG 219
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
ALPFDG TL LR RVL GRFRIPYFMS +CE LIR+MLV +P+KR I QIK H+WM
Sbjct: 220 ALPFDGPTLPILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLTIAQIKEHKWMLI 279
Query: 446 ETPRLLPPINILGEVKNEP-----NEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
E P + G+ +N+P NEQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 280 EVPAQRSILYAPGQ-ENQPSIGEYNEQVLRLMHSLGIDQQKTIESLQNKSYNHFAAIYYL 338
|
|
| FB|FBgn0025625 Sik2 "Salt-inducible kinase 2" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1070 (381.7 bits), Expect = 2.5e-123, Sum P(4) = 2.5e-123
Identities = 210/298 (70%), Positives = 244/298 (81%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDKSQLD NLQKVYREVEIMK+L HPHIIKL+QVMETK+MIYIV
Sbjct: 157 LARHRITKNEVAIKIIDKSQLDQTNLQKVYREVEIMKRLKHPHIIKLYQVMETKNMIYIV 216
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
SEYA+QGEIFDYIA+YGRM+E+AAR KFWQI+SAVEYCH + +VHRDLKAENLL+D N++
Sbjct: 217 SEYASQGEIFDYIAKYGRMSESAARFKFWQIISAVEYCHKKGIVHRDLKAENLLLDLNMN 276
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
IK+ADFGFSN++ PG+ LATWCGSPPYAAPEVFEGK+Y GPEIDIWSLGVVLYVLVCGAL
Sbjct: 277 IKIADFGFSNHFKPGELLATWCGSPPYAAPEVFEGKQYTGPEIDIWSLGVVLYVLVCGAL 336
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDGSTL SLRDRVLSGRFRIP+FMS+ECE LIR+MLV EPT+RY I+QIKRHRWM E
Sbjct: 337 PFDGSTLQSLRDRVLSGRFRIPFFMSSECEHLIRRMLVLEPTRRYTIDQIKRHRWMCPEL 396
Query: 448 PR--LLPPINILGEVKN--EPNEQILRLMNS-LGIDAAKTKEVFEAETSKRRTFCYIL 500
L+ N+ E + EP+E ILR+M +GI + KT+ + T Y+L
Sbjct: 397 LEHVLIAKYNLGAERQTSVEPSEDILRIMAEYVGIGSDKTRASLKKNTYDHVAAIYLL 454
|
|
| ZFIN|ZDB-GENE-070705-451 sik2a "salt-inducible kinase 2a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 4.1e-123, Sum P(4) = 4.1e-123
Identities = 191/299 (63%), Positives = 234/299 (78%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RH + VAIKIIDK+QLD VNL+K+YREVEIMK LDHPHIIKL+QVMETK+M+Y+V
Sbjct: 37 LARHRITKSEVAIKIIDKTQLDAVNLEKIYREVEIMKLLDHPHIIKLYQVMETKNMLYLV 96
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+EYA GEIFDY+A GR++E AR+KFWQILSAVEYCH R +VHRDLKAENLL+D++++
Sbjct: 97 TEYARNGEIFDYLASRGRLSEVDARKKFWQILSAVEYCHQRNIVHRDLKAENLLLDTHMN 156
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
+K+ADFGF N++ PG+ L TWCGSPPYAAPEVFEG++Y GP++DIWS+GVVLYVLVCGAL
Sbjct: 157 MKIADFGFGNFFRPGEPLTTWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGAL 216
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PFDG +L LR RVL GRFRIPYFMS +CE LIRKMLV +P +R + QIK HRWM +E
Sbjct: 217 PFDGPSLPVLRQRVLEGRFRIPYFMSEDCEHLIRKMLVLDPARRLSLSQIKEHRWMVQEV 276
Query: 448 PRLLPPINILG---EVKN---EPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYIL 500
P P + G E K+ E +EQ+LRLM+SLGID KT E + ++ Y L
Sbjct: 277 PSQRPVLYRQGLPCESKSGLGEHSEQVLRLMHSLGIDQQKTIESLQNKSYNHFAAIYYL 335
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1238 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-87 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-79 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-57 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-54 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-53 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-51 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-48 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-45 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-43 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-43 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-41 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-38 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-38 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-37 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-36 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-36 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-36 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-35 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-35 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-34 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-34 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-34 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-34 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-33 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-33 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-33 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-33 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-33 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-32 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-32 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-32 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-31 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-31 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-31 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-31 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-30 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-30 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-30 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-30 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-30 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-30 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-29 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-29 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-29 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-28 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-27 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-27 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-27 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-27 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-26 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-25 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-24 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-22 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-22 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-21 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-21 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-20 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-20 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-19 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-15 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 283 bits (727), Expect = 1e-87
Identities = 99/230 (43%), Positives = 149/230 (64%), Gaps = 6/230 (2%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK+I K ++ + +++ RE++I+K+L HP+I++L+ V E + +Y+V EY G++F
Sbjct: 27 VAIKVIKKKKIK-KDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLF 85
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + + GR++E+ AR QILSA+EY H++ +VHRDLK EN+L+D + +KLADFG +
Sbjct: 86 DLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR 145
Query: 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-TLNS 396
PG+KL T+ G+P Y APEV GK Y G +DIWSLGV+LY L+ G PF G L
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGKGY-GKAVDIWSLGVILYELLTGKPPFPGDDQLLE 204
Query: 397 LRDRVLSGRFRIPYFM---STECESLIRKMLVREPTKRYCIEQIKRHRWM 443
L ++ + P S E + LIRK+LV++P KR E+ +H +
Sbjct: 205 LFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 7e-79
Identities = 89/234 (38%), Positives = 134/234 (57%), Gaps = 8/234 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+KI+ K Q RE+ I+++L HP+I++L E K +Y+V EY G++F
Sbjct: 27 VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLF 86
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
DY++R G ++E+ A++ QIL +EY H+ ++HRDLK EN+L+D N +K+ADFG +
Sbjct: 87 DYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAK 146
Query: 338 -YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
L T+ G+P Y APEV G GP++D+WSLGV+LY L+ G PF G +
Sbjct: 147 KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD 206
Query: 397 LR---DRVLSGRFRIPYF----MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
R+L S E + LI+K L ++P+KR E+I +H W
Sbjct: 207 QLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 4e-63
Identities = 86/232 (37%), Positives = 137/232 (59%), Gaps = 10/232 (4%)
Query: 219 AIKIIDKSQLDPVNLQK-VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K++ K ++ + E I+ +++HP I+KL +T+ +Y+V EYA GE+F
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 278 DYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
++++ GR +E AR F+ +I+ A+EY H+ +++RDLK EN+L+D++ IKL DFG
Sbjct: 82 SHLSKEGRFSEERAR--FYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGL 139
Query: 336 SNY-YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G + T+CG+P Y APEV GK Y G +D WSLGV+LY ++ G PF
Sbjct: 140 AKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDR 198
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC---IEQIKRHRWM 443
+ +++L R P F+S E LI +L ++PTKR E+IK H +
Sbjct: 199 KEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 8e-62
Identities = 83/236 (35%), Positives = 130/236 (55%), Gaps = 10/236 (4%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L+R + +K ID S + + EV+I+K+L+HP+IIK ++ E K + IV
Sbjct: 18 LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77
Query: 268 SEYANQGEIFDYIARYGRMN----ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD 323
EYA+ G++ I + + E F Q+ A++Y H+R+++HRD+K +N+ +
Sbjct: 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 324 SNLDIKLADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL 382
SN +KL DFG S LA T G+P Y +PE+ + K Y + DIWSLG VLY L
Sbjct: 138 SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYEL 196
Query: 383 VCGALPFDGSTLNSLRDRVLSGRFR-IPYFMSTECESLIRKMLVREPTKRYCIEQI 437
PF+G L L ++L G++ IP S+E +L+ +L ++P +R I QI
Sbjct: 197 CTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 1e-60
Identities = 87/226 (38%), Positives = 123/226 (54%), Gaps = 35/226 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIKII K L+++ RE+EI+K+L+HP+I+KL+ V E ++ +Y+V EY G +
Sbjct: 21 VAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79
Query: 278 DYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGF 335
D + G+++E+ R QIL +EY H+ ++HRDLK EN+L+DS N +KLADFG
Sbjct: 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGL 139
Query: 336 SNYYVPGQKLATW-CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S + L G+P Y APEV GK Y + DIWSLGV+LY L
Sbjct: 140 SKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------ 187
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
E + LIRKML ++P KR ++I H
Sbjct: 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 7e-57
Identities = 81/252 (32%), Positives = 129/252 (51%), Gaps = 28/252 (11%)
Query: 218 VAIKIIDKSQLDPVNLQK-VYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQGE 275
AIKI+DK QL K V E E++ +L+ HP IIKL+ + + +Y V EYA GE
Sbjct: 29 YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGE 88
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG- 334
+ YI +YG ++E R +IL A+EY H++ ++HRDLK EN+L+D ++ IK+ DFG
Sbjct: 89 LLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGT 148
Query: 335 --------------------FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWS 374
S ++ A++ G+ Y +PE+ K G D+W+
Sbjct: 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWA 207
Query: 375 LGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR--- 431
LG ++Y ++ G PF GS ++L + P + + LI K+LV +P R
Sbjct: 208 LGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267
Query: 432 -YCIEQIKRHRW 442
+++K H +
Sbjct: 268 NEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 4e-54
Identities = 85/246 (34%), Positives = 138/246 (56%), Gaps = 22/246 (8%)
Query: 210 VLLRHTVNV-AIKIIDKSQLDPVNLQKV---YREVEIMKQLDHPHIIKLFQVMETKSMIY 265
V + + A+KI+ K+++ V L++V E I++ + HP ++ L+ + S +Y
Sbjct: 20 VRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLY 77
Query: 266 IVSEYANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMD 323
+V EY GE+F ++ + GR E AR F+ Q++ A+EY H+ +V+RDLK ENLL+D
Sbjct: 78 LVMEYVPGGELFSHLRKSGRFPEPVAR--FYAAQVVLALEYLHSLDIVYRDLKPENLLLD 135
Query: 324 SNLDIKLADFGFSNYYVPGQKLATW--CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYV 381
S+ IK+ DFGF+ T+ CG+P Y APE+ K Y G +D W+LG+++Y
Sbjct: 136 SDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYE 190
Query: 382 LVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC-----IEQ 436
++ G PF + +++L G+ R P F S + + LIR +L + TKR +
Sbjct: 191 MLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVND 250
Query: 437 IKRHRW 442
IK H W
Sbjct: 251 IKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 2e-53
Identities = 84/234 (35%), Positives = 135/234 (57%), Gaps = 11/234 (4%)
Query: 219 AIKIIDKSQLDPVNLQK-VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K + K + Q+ ++ E EI+++ +HP I+KL++ + K IY++ EY GE++
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
+ G +E AR ++ A EY HNR +++RDLK ENLL+DSN +KL DFGF+
Sbjct: 82 TILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
Query: 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL 397
GQK T+CG+P Y APE+ K Y +D WSLG++LY L+ G PF + +
Sbjct: 142 KLKSGQKTWTFCGTPEYVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
Query: 398 R--DRVLSGRFRI--PYFMSTECESLIRKMLVREPTKRY-----CIEQIKRHRW 442
+ +L G ++ P ++ + LI+++L R P +R I+ IK+H+W
Sbjct: 201 EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 8e-51
Identities = 82/240 (34%), Positives = 129/240 (53%), Gaps = 16/240 (6%)
Query: 218 VAIKIIDKSQLDPVNLQK-VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
AIK+I K+ + N V E +I+ Q P+++KL+ + K +Y+V EY G++
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ G ++E+ AR +I+ A+EY H+ ++HRDLK +N+L+DSN +KL DFG S
Sbjct: 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLS 140
Query: 337 NYYVPGQKLATW---------CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
+ +++ G+P Y APEV G+ + +D WSLG +LY + G
Sbjct: 141 KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIP 199
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFM--STECESLIRKMLVREPTKR---YCIEQIKRHRW 442
PF G T + +L+G+ P + S E LI K+LV +P KR IE+IK H +
Sbjct: 200 PFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 8e-48
Identities = 71/242 (29%), Positives = 125/242 (51%), Gaps = 25/242 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLF--QVMETKSMIYIVSEYANQGE 275
+A+K ++ S L+ + RE+ I+ L HP+I++ + + E K+ + I EY + G
Sbjct: 28 MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGS 87
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ + ++G++ E R+ QIL + Y H+ +VHRD+K N+L+DS+ +KLADFG
Sbjct: 88 LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147
Query: 336 S-----NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
+ G + G+P + APEV G++Y G DIWSLG + + G P+
Sbjct: 148 AKRLGDIETGEGTG--SVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPW- 203
Query: 391 GSTLNSLRDRVLSGRFRI------PYF---MSTECESLIRKMLVREPTKRYCIEQIKRHR 441
S ++ ++I P +S E + +RK L R+P KR +++ +H
Sbjct: 204 -----SELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258
Query: 442 WM 443
++
Sbjct: 259 FL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 6e-45
Identities = 77/233 (33%), Positives = 129/233 (55%), Gaps = 14/233 (6%)
Query: 234 QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARR 293
Q V+ E ++K++ HP II+LF + +Y++ EY GE+F Y+ GR + +
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF 105
Query: 294 KFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353
+I+ A+EY H++ +V+RDLK EN+L+D IKL DFGF+ + T CG+P
Sbjct: 106 YASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPE 163
Query: 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMS 413
Y APEV + K + +D W+LG+++Y ++ G PF + +++L+G+ P +
Sbjct: 164 YLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLD 222
Query: 414 TECESLIRKMLVREPTKRY-----CIEQIKRHRWMA----EETP--RLLPPIN 455
+ LI+K+LV + T+R + +K HRW ++ P +L PPI
Sbjct: 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIV 275
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 82/251 (32%), Positives = 131/251 (52%), Gaps = 17/251 (6%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A+K++ K Q D V + V + HP + +L +TK ++ V EY N G+
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRV-LALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGD 82
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ +I R GR +E AR +I+ +++ H R +++RDLK +N+L+DS IK+ADFG
Sbjct: 83 LMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGM 142
Query: 336 SNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G +T+CG+P Y APE+ + Y GP +D W+LGV+LY ++ G PF+G
Sbjct: 143 CKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDE 201
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRH------RWM 443
+ L +L R P ++S E +S+++ L + P KR + IK H W
Sbjct: 202 DELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261
Query: 444 AEETPRLLPPI 454
E + PP
Sbjct: 262 KLERKEIKPPF 272
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 73/233 (31%), Positives = 120/233 (51%), Gaps = 15/233 (6%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK+I + +K+ E++I+K+ HP+I+K + K ++IV E+ + G +
Sbjct: 28 VAIKVIKLESKE--KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85
Query: 278 DYI-ARYGRMNEN--AARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
D + + + E+ A K ++L +EY H+ ++HRD+KA N+L+ S+ ++KL DFG
Sbjct: 86 DLLKSTNQTLTESQIAYVCK--ELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFG 143
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S + T G+P + APEV GK Y + DIWSLG+ L G P+ S L
Sbjct: 144 LSAQLSDTKARNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPY--SEL 200
Query: 395 NSLRDRVLSGR-----FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
++ R P S E + ++K L + P KR EQ+ +H +
Sbjct: 201 PPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 75/237 (31%), Positives = 119/237 (50%), Gaps = 14/237 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ--VMETKSMIYIVSEYANQGE 275
+ K ID + Q++ EV I+++L HP+I++ + + + +YIV EY G+
Sbjct: 28 LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGD 87
Query: 276 IFDYIARYGRMN----ENAARRKFWQILSAVEYCHNR-----RVVHRDLKAENLLMDSNL 326
+ I + + E R Q+L A+ CHNR V+HRDLK N+ +D+N
Sbjct: 88 LAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN 147
Query: 327 DIKLADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
++KL DFG + A T+ G+P Y +PE Y + DIWSLG ++Y L
Sbjct: 148 NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCAL 206
Query: 386 ALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441
+ PF L ++ G+F RIPY S+E +I+ ML +P KR E++ +
Sbjct: 207 SPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-43
Identities = 67/243 (27%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 210 VLLRHTVNV-AIKIIDKSQLDPVN-LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
V R T + A+K ++K + ++ V E I+++L+HP ++ L+ + + +Y+V
Sbjct: 19 VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSN 325
+ G++ ++++ + +E KFW +I+ A+EY H++ ++HRD+K +N+L+D
Sbjct: 79 VDLLLGGDLRYHLSQKVKFSEEQV--KFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136
Query: 326 LDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
+ + DF + P + G+P Y APEV + Y +D WSLGV Y + G
Sbjct: 137 GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRG 195
Query: 386 ALPFDGSTL---NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR--YCIEQIKRH 440
P+ G + + +R + + P STE I K+L R+P KR ++ +K H
Sbjct: 196 KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255
Query: 441 RWM 443
+
Sbjct: 256 PYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 86/250 (34%), Positives = 129/250 (51%), Gaps = 18/250 (7%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A+KI+ K D V E +++ HP + L +T + V EYAN GE
Sbjct: 24 AMKILKKEVIIAKDEV--AHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+F +++R +E+ AR +I+SA+ Y H+ VV+RDLK ENL++D + IK+ DFG
Sbjct: 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGL 141
Query: 336 SNYYVP-GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G + T+CG+P Y APEV E Y G +D W LGVV+Y ++CG LPF
Sbjct: 142 CKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC-----IEQIKRHR------WM 443
L + +L R P +S E +SL+ +L ++P +R ++I HR W
Sbjct: 201 EKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260
Query: 444 AEETPRLLPP 453
+L PP
Sbjct: 261 DVVQKKLEPP 270
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 73/234 (31%), Positives = 129/234 (55%), Gaps = 9/234 (3%)
Query: 218 VAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
AIK + K + L +Q V +E I+ +L HP I+ + + ++ +Y + E+ GE+
Sbjct: 46 YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL 105
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
F ++ + GR + A+ +++ A EY H++ +++RDLK ENLL+D+ +K+ DFGF+
Sbjct: 106 FTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA 165
Query: 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
VP + T CG+P Y APEV + K + G +D W++GV+LY + G PF T
Sbjct: 166 K-KVP-DRTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222
Query: 397 LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-----CIEQIKRHRWMAE 445
+ +++L+GR + P + L++ +L + TKR + +K H +
Sbjct: 223 IYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276
|
Length = 329 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 148 bits (373), Expect = 2e-38
Identities = 84/298 (28%), Positives = 141/298 (47%), Gaps = 33/298 (11%)
Query: 211 LLRHTVNVAIKIIDKS-QLDPVNLQKVYREVEIMKQLDHP-HIIKLFQVMETKSMIYIVS 268
L R VA+K++ K + +++ RE++I+ L+HP +I+KL+ + + +Y+V
Sbjct: 18 LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77
Query: 269 EYANQGEIFDYIARYGR---MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
EY + G + D + + GR ++E+ A QILSA+EY H++ ++HRD+K EN+L+D +
Sbjct: 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD 137
Query: 326 LD-IKLADFGFSNYY-------VPGQKLATWCGSPPYAAPEVFEGKK--YCGPEIDIWSL 375
+KL DFG + +T G+P Y APEV G Y DIWSL
Sbjct: 138 GRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197
Query: 376 GVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------RFRIPYFMSTECESLIRK 422
G+ LY L+ G PF+G +S + L P +S L++K
Sbjct: 198 GITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKK 257
Query: 423 MLVREPTKRYCIEQ-----IKRHRWMAEETPRLLPPINILGEVKNEPNEQILRLMNSL 475
+L ++P R + H + E L + ++ + L++SL
Sbjct: 258 LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 71/230 (30%), Positives = 120/230 (52%), Gaps = 7/230 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK I ++ L+ + +E++++K L HP+I+K +ET +YI+ EYA G +
Sbjct: 28 VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR 87
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
I ++G E+ +Q+L + Y H + V+HRD+KA N+L + +KLADFG +
Sbjct: 88 QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVAT 147
Query: 338 YYVP-GQKLATWCGSPPYAAPEVFEGKKYCGPEI--DIWSLGVVLYVLVCGALP-FDGST 393
+ A+ G+P + APEV E G DIWSLG + L+ G P +D +
Sbjct: 148 KLNDVSKDDASVVGTPYWMAPEVIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLNP 204
Query: 394 LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
+ +L V +P +S E + + + ++P R +Q+ +H W+
Sbjct: 205 MAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 5e-38
Identities = 80/239 (33%), Positives = 121/239 (50%), Gaps = 21/239 (8%)
Query: 219 AIKIIDKSQLDPVN-LQKVYREVEIMK-QLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
AIK++ KS + N + V E IM Q + P++ KL+ ++K +Y+V EY N G+
Sbjct: 25 AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC 84
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
I G + E+ A++ +++ VE H R ++HRD+K ENLL+D +KL DFG S
Sbjct: 85 ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144
Query: 337 -NYYVPGQKLATWCGSPPYAAPEVFEGK---KYCGPEIDIWSLGVVLYVLVCGALPFDGS 392
N + + G+P Y APE G K D WSLG V++ + G PF
Sbjct: 145 RNGLENKK----FVGTPDYLAPETILGVGDDKMS----DWWSLGCVIFEFLFGYPPFHAE 196
Query: 393 TLNSLRDRVLSGRFRIP----YFMSTECESLIRKMLVREPTKRY---CIEQIKRHRWMA 444
T +++ D +LS R P F S E LI ++L +P KR ++IK H +
Sbjct: 197 TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 8e-38
Identities = 81/227 (35%), Positives = 122/227 (53%), Gaps = 13/227 (5%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQI 298
E +++ HP + L +T + V EYAN GE+F +++R E AR +I
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 299 LSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPPYAAP 357
+SA+EY H+R VV+RD+K ENL++D + IK+ DFG + G + T+CG+P Y AP
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 164
Query: 358 EVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECE 417
EV E Y G +D W LGVV+Y ++CG LPF L + +L R P +S E +
Sbjct: 165 EVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 223
Query: 418 SLIRKMLVREPTKRYC-----IEQIKRHR------WMAEETPRLLPP 453
SL+ +L ++P +R +++ HR W +LLPP
Sbjct: 224 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 69/246 (28%), Positives = 120/246 (48%), Gaps = 33/246 (13%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A+K I DP ++++ E+++++ L HP+++K + V + +YI EY + G + +
Sbjct: 29 AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE 88
Query: 279 YIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS- 336
+ +GR ++E+ R Q+L + Y H+ +VHRD+K N+ +D N IKL DFG +
Sbjct: 89 -LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147
Query: 337 ----NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPE--IDIWSLGVVLYVLVCGALPFD 390
N G+++ + G+P Y APEV G K G DIWSLG V+ + G P+
Sbjct: 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
Query: 391 GSTLNSLRDRVLSGRFRIPY--------------FMSTECESLIRKMLVREPTKRYCIEQ 436
L F+I + +S E + + + L +P KR +
Sbjct: 208 E----------LDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE 257
Query: 437 IKRHRW 442
+ +H +
Sbjct: 258 LLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-37
Identities = 77/244 (31%), Positives = 126/244 (51%), Gaps = 23/244 (9%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK + L N + + E+ IMK HP+I+ + +++V EY + G +
Sbjct: 47 VAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103
Query: 278 DYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
D I + RMNE ++L +EY H++ V+HRD+K++N+L+ + +KLADFGF+
Sbjct: 104 DIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA 163
Query: 337 -NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
K + G+P + APEV + K Y GP++DIWSLG++ + G P+
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPY------ 216
Query: 396 SLRDRVLSGRFRI----------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
LR+ L F I P S E + + K LV++P KR E++ +H ++ +
Sbjct: 217 -LREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
Query: 446 ETPR 449
P+
Sbjct: 276 ACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 77/227 (33%), Positives = 123/227 (54%), Gaps = 13/227 (5%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQI 298
E ++K HP + L +TK + V EY N GE+F +++R +E+ R +I
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104
Query: 299 LSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPPYAAP 357
+SA++Y H+ ++V+RDLK ENL++D + IK+ DFG + + T+CG+P Y AP
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAP 164
Query: 358 EVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECE 417
EV E Y G +D W LGVV+Y ++CG LPF L + +L + P +S + +
Sbjct: 165 EVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAK 223
Query: 418 SLIRKMLVREPTKRYC-----IEQIKRH------RWMAEETPRLLPP 453
SL+ +L+++P KR ++I RH W +L+PP
Sbjct: 224 SLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPP 270
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 66/273 (24%)
Query: 218 VAIKIIDKSQLD---PVN-LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
VA+K I + P L RE+ ++K+L HP+I+KL V+ T+ +Y+V EY +
Sbjct: 27 VALKKIRLDNEEEGIPSTAL----REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM 82
Query: 274 GEIFDYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
++ Y+ + ++ N + +Q+L + YCH+ R++HRDLK +N+L++ + +KLAD
Sbjct: 83 -DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLAD 141
Query: 333 FGFSNYY-VPGQKLAT-----WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386
FG + + +P + W Y APE+ G K+ +DIWS+G + ++ G
Sbjct: 142 FGLARAFGIPLRTYTHEVVTLW-----YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
Query: 387 LPFDG-STLNSLRDRVLSGRFRIPYFMSTECES--------------------------- 418
F G S ++ L F+I + T E
Sbjct: 197 PLFPGDSEIDQL--------FKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL 248
Query: 419 ---------LIRKMLVREPTKRYCIEQIKRHRW 442
L+ KML P KR ++ +H +
Sbjct: 249 PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 78/217 (35%), Positives = 124/217 (57%), Gaps = 6/217 (2%)
Query: 219 AIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
AIK + K + D V V R V + +HP + LF +TK ++ V EY N G+
Sbjct: 24 AIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHLFCTFQTKEHLFFVMEYLNGGD 82
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ +I GR +E AR +I+ +++ H + +++RDLK +N+L+D + IK+ADFG
Sbjct: 83 LMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGM 142
Query: 336 SNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G+ A T+CG+P Y APE+ +G+KY +D WS GV+LY ++ G PF G
Sbjct: 143 CKENMNGEGKASTFCGTPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDE 201
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR 431
+ L D +L+ R P ++S E + + K+ R+PTKR
Sbjct: 202 DELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 79/228 (34%), Positives = 125/228 (54%), Gaps = 14/228 (6%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQI 298
E +++ HP + L +T + V EYAN GE+F +++R +E+ AR +I
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 299 LSAVEYCHNRR-VVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPPYAA 356
+SA++Y H+ + VV+RDLK ENL++D + IK+ DFG + G + T+CG+P Y A
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164
Query: 357 PEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTEC 416
PEV E Y G +D W LGVV+Y ++CG LPF L + +L R P +S E
Sbjct: 165 PEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 223
Query: 417 ESLIRKMLVREPTKRYC-----IEQIKRHR------WMAEETPRLLPP 453
+SL+ +L ++P +R ++I +H+ W +L+PP
Sbjct: 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPP 271
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 22/239 (9%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
V VA+K + K +++ RE IM++LDHP+I+KL V + + IV EY
Sbjct: 27 KEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPG 85
Query: 274 GEIFDYIARYGRMNENAARRKF---WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G++ DY+ R R E + QI +EY ++ +HRDL A N L+ NL +K+
Sbjct: 86 GDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKI 144
Query: 331 ADFGFS------NYYVPGQKLAT--WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-V 381
+DFG S +YY W APE + K+ + D+WS GV+L+ +
Sbjct: 145 SDFGLSRDLYDDDYYKVKGGKLPIRWM------APESLKEGKF-TSKSDVWSFGVLLWEI 197
Query: 382 LVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
G P+ G + + + + G R P E L+ + +P R ++
Sbjct: 198 FTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 19/235 (8%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
V VA+K + K +++ RE IM++LDHP+++KL V + +YIV EY G+
Sbjct: 29 VEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGD 87
Query: 276 IFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ Y+ + + F QI +EY ++ +HRDL A N L+ NL +K++DFG
Sbjct: 88 LLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG 147
Query: 335 FS------NYYVPGQKLAT--WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCG 385
S +YY W APE + K+ + D+WS GV+L+ + G
Sbjct: 148 LSRDLYDDDYYRKRGGKLPIRWM------APESLKEGKF-TSKSDVWSFGVLLWEIFTLG 200
Query: 386 ALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
P+ G + + + + +G R P E L+ + +P R ++
Sbjct: 201 EQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 71/225 (31%), Positives = 121/225 (53%), Gaps = 9/225 (4%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A+K +D + + E+ I+ ++HP+II + + + IV EYA G++
Sbjct: 29 ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSK 88
Query: 279 YIARYGRMN----ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
I++ + E R F Q+L ++ H ++++HRDLK+ N+L+ +N +K+ D G
Sbjct: 89 AISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLG 148
Query: 335 FSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
S V + +A T G+P Y APEV++G+ Y DIWSLG +LY + A PF+ +
Sbjct: 149 ISK--VLKKNMAKTQIGTPHYMAPEVWKGRPYSYKS-DIWSLGCLLYEMATFAPPFEARS 205
Query: 394 LNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
+ LR +V G++ IP S + ++ IR ML +P R ++I
Sbjct: 206 MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-34
Identities = 68/233 (29%), Positives = 121/233 (51%), Gaps = 18/233 (7%)
Query: 247 DHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH 306
+HP + +L+ +T ++ V E+ N G++ +I + R +E AR +I SA+ + H
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 307 NRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKY 365
++ +++RDLK +N+L+D KLADFG + G+ +T+CG+P Y APE+ + Y
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 366 CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV 425
GP +D W++GV+LY ++CG PF+ + L + +L+ P ++S + +++ +
Sbjct: 174 -GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232
Query: 426 REPTKRY-CIEQ-----IKRHRWMAE----------ETPRLLPPINILGEVKN 462
+ PT R + I RH + E P P I +V N
Sbjct: 233 KNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSN 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VAIK I + RE++++K+L+HP+IIKL V K +Y+V E+ + +
Sbjct: 25 EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83
Query: 276 IFDYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
++ I R + E+ + +Q+L + +CH+ ++HRDLK ENLL+++ +KLADFG
Sbjct: 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFG 143
Query: 335 FSNYYVPGQKLAT------WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
+ + + T W Y APE+ G K +DIWS+G + L+
Sbjct: 144 LARSFGSPVRPYTHYVVTRW-----YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198
Query: 389 FDGS-----------TLNSLRDRVLSGRFRIPYFM-------------------STECES 418
F G TL + V + S +
Sbjct: 199 FPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALD 258
Query: 419 LIRKMLVREPTKRYCIEQIKRH 440
L+ +ML +P KR EQ H
Sbjct: 259 LLSQMLHYDPHKRITAEQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/217 (29%), Positives = 115/217 (52%), Gaps = 5/217 (2%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A+K ID S+++ ++ E ++ +LD +II+ ++ K + IV EYA G++
Sbjct: 29 AMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHK 88
Query: 279 YIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + E+ R F QIL + + H+++++HRD+K+ NL +D+ ++K+ D G +
Sbjct: 89 LLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVA 148
Query: 337 NYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
A T G+P Y +PE+ E K Y + D+W+LGVVLY G PFD +
Sbjct: 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQG 207
Query: 396 SLRDRVLSGRFR-IPYFMSTECESLIRKMLVREPTKR 431
+L +++ G F + S + LI + L ++ +R
Sbjct: 208 ALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 77/227 (33%), Positives = 118/227 (51%), Gaps = 5/227 (2%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
V IK I Q+ E +++K L HP+II+ ++ + IV EYA G +
Sbjct: 28 VIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA 87
Query: 278 DYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI-KLADFG 334
+YI + ++E+ F QIL A+ + H + ++HRDLK +N+L+D + + K+ DFG
Sbjct: 88 EYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFG 147
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S K T G+P Y +PE+ EGK Y + DIW+LG VLY L F+ + L
Sbjct: 148 ISKILSSKSKAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANL 206
Query: 395 NSLRDRVLSGRFR-IPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
+L +++SG F I S + LI ML +P+KR + QI
Sbjct: 207 PALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 9/235 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K I D +++ RE++ ++ + P+++K + + I IV EY + G +
Sbjct: 29 YALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLA 87
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFS 336
D + + G++ E QIL ++Y H R ++HRD+K NLL++S ++K+ADFG S
Sbjct: 88 DLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
Query: 337 NYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
T+ G+ Y +PE +G+ Y DIWSLG+ L G PF
Sbjct: 148 KVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA-DIWSLGLTLLECALGKFPFLPPGQP 206
Query: 396 SLRDRVLSGRFRIPYF-----MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
S + + + P S E I L ++P KR ++ +H ++ +
Sbjct: 207 SFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 79/240 (32%), Positives = 120/240 (50%), Gaps = 18/240 (7%)
Query: 218 VAIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
VA+K + KS +L+ V V E +I+ ++KL + +Y+ EY G
Sbjct: 29 VALKRMKKSLLFKLNEVR--HVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ + G ++E+ AR ++ AV+ H +HRDLK EN L+D++ IKL DFG
Sbjct: 87 DFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFG 146
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S V + GSP Y APEV GK Y +D WSLG +LY +CG PF GST
Sbjct: 147 LSKGIV--TYANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
Query: 395 NSLRDRVLSGR--FRIP------YFMSTECESLIRKMLVREPTKRYC-IEQIKRHRWMAE 445
N + + + + P + +S E LI K++ +P++R+ +E IK H + E
Sbjct: 204 NETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 64/247 (25%), Positives = 111/247 (44%), Gaps = 28/247 (11%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
T VA+K + K + +E +MK+L HP++++L V + +Y+V EY
Sbjct: 22 KTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80
Query: 274 GEIFDYIARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDLKAENLLMDS 324
G++ DY+ + + + + QI +EY +++ VHRDL A N L+
Sbjct: 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE 140
Query: 325 NLDIKLADFGFS------NYYV--PGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
+L +K++DFG S +YY G KL W APE + + + D+WS
Sbjct: 141 DLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM------APESLKDGIF-TSKSDVWSF 193
Query: 376 GVVLY-VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYC 433
GV+L+ + GA P+ G + + + + G R P + E L+ +P R
Sbjct: 194 GVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPT 253
Query: 434 IEQIKRH 440
++
Sbjct: 254 FSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 67/223 (30%), Positives = 113/223 (50%), Gaps = 18/223 (8%)
Query: 249 PHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR 308
P ++ L +T + ++++ +Y N GE+F ++ + E+ R +I+ A+++ H
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 309 RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT--WCGSPPYAAPEVFEGKKYC 366
+++RD+K EN+L+DS + L DFG S ++ ++ +CG+ Y APEV G
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184
Query: 367 -GPEIDIWSLGVVLYVLVCGALPF--DGSTLNSLRD---RVLSGRFRIPYFMSTECESLI 420
+D WSLGV+ + L+ GA PF DG NS + R+L + P MS E I
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPPFPKTMSAEARDFI 243
Query: 421 RKMLVREPTKRYC---IEQIKRHR------WMAEETPRLLPPI 454
+K+L ++P KR ++IK H W R+ P
Sbjct: 244 QKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPF 286
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 68/232 (29%), Positives = 128/232 (55%), Gaps = 7/232 (3%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A+K++ K+ L + + E +I+ +++HP I+KL +T+ +Y++ ++ G++F
Sbjct: 28 AMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 87
Query: 279 YIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338
+++ E + ++ A+++ H+ +++RDLK EN+L+D IKL DFG S
Sbjct: 88 RLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 147
Query: 339 YVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL 397
+ +K A ++CG+ Y APEV + + D WS GV+++ ++ G+LPF G
Sbjct: 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206
Query: 398 RDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-----CIEQIKRHRWMA 444
+L + +P F+S E +SL+R + R P R +E+IKRH + +
Sbjct: 207 MTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFS 258
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 75/252 (29%), Positives = 129/252 (51%), Gaps = 19/252 (7%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
AIK++ K Q D V+ + + + HP + L +TK ++ V EY N G+
Sbjct: 24 AIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTALHCCFQTKDRLFFVMEYVNGGD 82
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ I R + +E +R ++ A+ + H V++RDLK +N+L+D+ KLADFG
Sbjct: 83 LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGM 142
Query: 336 SNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G T+CG+P Y APE+ + +Y GP +D W+LGV++Y ++ G PF+
Sbjct: 143 CKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNE 201
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-CI------EQIKRH------R 441
+ L + +L P ++S E S+++ + + P KR C+ + IK+H
Sbjct: 202 DDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261
Query: 442 WMAEETPRLLPP 453
W+ E ++ PP
Sbjct: 262 WVLLEQRKIKPP 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 86/267 (32%), Positives = 144/267 (53%), Gaps = 27/267 (10%)
Query: 219 AIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+K++ K + D ++ V E + +Q +HP ++ L +T+S ++ V EY N G++
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
++ R ++ E AR +I A+ Y H R +++RDLK +N+L+DS IKL D+G
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 143
Query: 337 NYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD--GST 393
+ PG +T+CG+P Y APE+ G+ Y G +D W+LGV+++ ++ G PFD GS+
Sbjct: 144 KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSS 202
Query: 394 LNS-------LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-CIEQ-----IKRH 440
N L +L + RIP +S + S+++ L ++P +R C Q I+ H
Sbjct: 203 DNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262
Query: 441 ------RWMAEETPRLLPPI--NILGE 459
W E +++PP NI GE
Sbjct: 263 PFFRNVDWDLMEQKQVVPPFKPNISGE 289
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 69/231 (29%), Positives = 119/231 (51%), Gaps = 13/231 (5%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQI 298
E I++ + HP I+ L +T +Y++ EY + GE+F ++ R G E+ A +I
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 299 LSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPPYAAP 357
A+E+ H + +++RDLK EN+L+D+ +KL DFG + G T+CG+ Y AP
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 358 EVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECE 417
E+ + G +D WSLG ++Y ++ GA PF D++L G+ +P +++ E
Sbjct: 170 EILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEAR 228
Query: 418 SLIRKMLVREPTKRYC-----IEQIKRH------RWMAEETPRLLPPINIL 457
L++K+L R P+ R +++ H W ++ PP L
Sbjct: 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPL 279
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 75/255 (29%), Positives = 128/255 (50%), Gaps = 26/255 (10%)
Query: 219 AIK------IIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
AIK II + +++ + +K R E HP ++ LF +T+ + V EYA
Sbjct: 28 AIKALKKGDIIARDEVESLMCEK--RIFETANSERHPFLVNLFACFQTEDHVCFVMEYAA 85
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G++ +I +E R F+ ++ ++Y H ++V+RDLK +NLL+D+ +K+
Sbjct: 86 GGDLMMHIHT-DVFSE--PRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKI 142
Query: 331 ADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
ADFG + G + +T+CG+P + APEV Y +D W LGV++Y ++ G PF
Sbjct: 143 ADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPF 201
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC-----IEQIKRHR--- 441
G + D +++ R P F+S E S++R++L R P +R E +K+
Sbjct: 202 PGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261
Query: 442 ---WMAEETPRLLPP 453
W ++ PP
Sbjct: 262 DINWDDLLARKIKPP 276
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 8/226 (3%)
Query: 220 IKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDY 279
+ + D Q ++++ +E+ ++ +L HP+I++ + +YI E G +
Sbjct: 33 VSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKL 92
Query: 280 IARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY 339
+ +YG E R QIL +EY H+R VHRD+K N+L+D+N +KLADFG +
Sbjct: 93 LKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152
Query: 340 VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD-----GSTL 394
V ++ GSP + APEV + G DIWSLG + + G P+ +
Sbjct: 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
R + L IP +S E + I K L R+P+ R ++ H
Sbjct: 213 KIGRSKELP---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 76/246 (30%), Positives = 129/246 (52%), Gaps = 13/246 (5%)
Query: 219 AIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
AIK + K + D V V + V + +HP + L+ +TK ++ V EY N G+
Sbjct: 24 AIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGD 82
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ +I + + A +I+ +++ H++ +V+RDLK +N+L+D++ IK+ADFG
Sbjct: 83 LMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGM 142
Query: 336 SNYYVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G K T+CG+P Y APE+ G+KY +D WS GV+LY ++ G PF G
Sbjct: 143 CKENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDE 201
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIE-QIKRH------RWMAEET 447
L + P +++ E + ++ K+ VREP +R ++ I++H W A E
Sbjct: 202 EELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEE 261
Query: 448 PRLLPP 453
+ PP
Sbjct: 262 REIEPP 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 81/268 (30%), Positives = 131/268 (48%), Gaps = 21/268 (7%)
Query: 182 TLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVE 241
TL G+ I K + PPV ++ KII + Q+D V+ E +
Sbjct: 37 TLGTGSFGRVILATYKNE------DFPPVAIKRFEKS--KIIKQKQVD-----HVFSERK 83
Query: 242 IMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSA 301
I+ ++HP + L+ + +S +Y+V E+ GE F ++ R R + QI+
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143
Query: 302 VEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFE 361
EY + +V+RDLK ENLL+D + IK+ DFGF+ V + T CG+P Y APE+
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILL 201
Query: 362 GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIR 421
+ G D W+LG+ +Y ++ G PF + + ++L G P F+ C+ L++
Sbjct: 202 NVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK 260
Query: 422 KMLVREPTKRY-----CIEQIKRHRWMA 444
K+L + TKRY + +K H W
Sbjct: 261 KLLSHDLTKRYGNLKKGAQNVKEHPWFG 288
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 40/265 (15%)
Query: 219 AIKIIDKSQLDPVN-LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K++DK ++ N +++V E EI+ LDHP + L+ +T++ + +V +Y GE+F
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 278 DYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ R ++E AR ++L A+EY H +V+RDLK EN+L+ + I L+DF
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149
Query: 336 S---------------------------NYYV---PGQKLATWCGSPPYAAPEVFEGKKY 365
S + P + ++ G+ Y APEV G +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209
Query: 366 CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP--YFMSTECESLIRKM 423
G +D W+LG++LY ++ G PF GS + +L P +S+ LIRK+
Sbjct: 210 -GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKL 268
Query: 424 LVREPTKR----YCIEQIKRHRWMA 444
LV++P+KR +IK+H +
Sbjct: 269 LVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 67/248 (27%), Positives = 114/248 (45%), Gaps = 35/248 (14%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VAIK ID + ++ ++ +EV+ M Q +HP+++K + +++V Y + G +
Sbjct: 28 KVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86
Query: 277 FD---YIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
D G ++E ++L +EY H+ +HRD+KA N+L+ + +K+ADF
Sbjct: 87 LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADF 146
Query: 334 GFS-NYYVPGQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
G S + G T+ G+P + APEV E + DIWS G+ L GA P
Sbjct: 147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
Query: 389 F---------------DGSTLNSLRD-RVLSGRFRIPYFMSTECESLIRKMLVREPTKRY 432
+ D +L + D + S FR +I L ++P+KR
Sbjct: 207 YSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR----------KMISLCLQKDPSKRP 256
Query: 433 CIEQIKRH 440
E++ +H
Sbjct: 257 TAEELLKH 264
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 76/271 (28%), Positives = 125/271 (46%), Gaps = 47/271 (17%)
Query: 213 RHTVNV-AIKIIDKSQLDPVNLQK-----VYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
+ T V A+K++ KS + +++ V E +I+ D P I+KL+ + + +Y+
Sbjct: 23 KDTGQVYAMKVLRKSDM----IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
V EY G++ + + R E AR +++ A++ H +HRD+K +N+L+D++
Sbjct: 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG 138
Query: 327 DIKLADFGFS-------------------NYYVPGQKLATWC-----------GSPPYAA 356
IKLADFG + G+P Y A
Sbjct: 139 HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIA 198
Query: 357 PEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPYF--M 412
PEV G Y G E D WSLGV+LY ++ G PF TL +++++ + R P +
Sbjct: 199 PEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPV 257
Query: 413 STECESLIRKMLVREPTKRYC-IEQIKRHRW 442
S E LI + L+ +P R E+IK H +
Sbjct: 258 SPEAIDLICR-LLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 77/259 (29%), Positives = 138/259 (53%), Gaps = 25/259 (9%)
Query: 219 AIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+K+I K + D ++ V E + + +HP ++ L +T+S ++ V E+ + G++
Sbjct: 24 AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
++ R ++ E AR +I A+ + H R +++RDLK +N+L+D+ IKL D+G
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 143
Query: 337 NYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
+ PG +T+CG+P Y APE+ G+ Y G +D W+LGV+++ ++ G PFD ++
Sbjct: 144 KEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMS 202
Query: 396 SLRDR---------VLSGRFRIPYFMSTECESLIRKMLVREPTKRY-CIEQ-----IKRH 440
D+ +L + RIP +S + S+++ L ++P +R C Q IK H
Sbjct: 203 DNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262
Query: 441 R------WMAEETPRLLPP 453
W E ++LPP
Sbjct: 263 PFFRNIDWDLLEQKQVLPP 281
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 2e-31
Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 57/245 (23%)
Query: 238 REVEIMKQLDHPHIIKLFQVM--ETKSMIYIVSEYANQGEIFDY-----IARYG-RMNEN 289
RE++++++L HP+I++L +++ + K IY+V EY D+ + + E+
Sbjct: 47 REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY------MDHDLTGLLDSPEVKFTES 100
Query: 290 AARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA--- 346
+ Q+L ++Y H+ ++HRD+K N+L++++ +KLADFG + Y
Sbjct: 101 QIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160
Query: 347 ---T-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST--------- 393
T W Y PE+ G GPE+D+WS+G +L L G F GST
Sbjct: 161 RVITLW-----YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF 215
Query: 394 -------------LNSL-------RDRVLSGRFRIPY--FMSTECESLIRKMLVREPTKR 431
++ L + R R + + L+ K+L +P KR
Sbjct: 216 ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275
Query: 432 YCIEQ 436
+Q
Sbjct: 276 ISADQ 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 66/215 (30%), Positives = 118/215 (54%), Gaps = 9/215 (4%)
Query: 247 DHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH 306
++P + L+ +TK ++ V E+ N G++ +I GR + A +I+ +++ H
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 307 NRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWCGSPPYAAPEVFEGKKY 365
++ +++RDLK +N+++D + IK+ADFG V G + +T+CG+P Y APE+ +G KY
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 366 CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV 425
+D WS GV+LY ++ G PF G + L + + P +++ E + ++ K+
Sbjct: 174 TF-SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFE 232
Query: 426 REPTKRYCIE-QIKRH------RWMAEETPRLLPP 453
R+PT+R + I+ H W A E L PP
Sbjct: 233 RDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPP 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 78/251 (31%), Positives = 122/251 (48%), Gaps = 16/251 (6%)
Query: 219 AIKIIDKSQLDPVNLQK---VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A+K++ K + QK R V ++K + HP ++ L +T +Y V +Y N GE
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGE 82
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+F ++ R E AR +I SA+ Y H+ +++RDLK EN+L+DS + L DFG
Sbjct: 83 LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL 142
Query: 336 SNYYVPGQK-LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ K +T+CG+P Y APEV + Y +D W LG VLY ++ G PF
Sbjct: 143 CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDT 201
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC----IEQIKRH------RWMA 444
+ D +L+ R+ +S L+ +L ++ TKR +IK H W
Sbjct: 202 AEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261
Query: 445 EETPRLLPPIN 455
++ PP N
Sbjct: 262 LVNKKITPPFN 272
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 79/257 (30%), Positives = 137/257 (53%), Gaps = 23/257 (8%)
Query: 219 AIKIIDKSQL-DPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+K++ K + D ++ V E + +Q +P ++ L +T S +++V EY N G++
Sbjct: 24 AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
++ R ++ E AR +I A+ + H R +++RDLK +N+L+D++ IKL D+G
Sbjct: 84 MFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMC 143
Query: 337 NYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
+ PG +T+CG+P Y APE+ G++Y G +D W+LGV+++ ++ G PFD T N
Sbjct: 144 KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDN 202
Query: 396 S-------LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-CIEQ-----IKRHR- 441
L +L RIP F+S + +++ L ++P +R C Q IK H
Sbjct: 203 PDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262
Query: 442 -----WMAEETPRLLPP 453
W E ++ PP
Sbjct: 263 FRSIDWDLLEKKQVTPP 279
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-31
Identities = 75/231 (32%), Positives = 123/231 (53%), Gaps = 17/231 (7%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM--------ETKSMIYIVSEY 270
A+K++D + + + EV + D I+K + E MI +V +Y
Sbjct: 61 AVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDY 120
Query: 271 ANQGEIFDYI---ARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
AN G++ I A+ R E+ A F Q+L AV + H++ ++HRD+K+ N+L+ SN
Sbjct: 121 ANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG 180
Query: 327 DIKLADFGFSNYY---VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
+KL DFGFS Y V T+CG+P Y APE++ K Y + D++SLGV+LY L+
Sbjct: 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELL 239
Query: 384 CGALPFDGSTLNSLRDRVLSGRFR-IPYFMSTECESLIRKMLVREPTKRYC 433
PFDG + + + L+GR+ +P +S E + ++ +L +P +R
Sbjct: 240 TLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-31
Identities = 70/228 (30%), Positives = 120/228 (52%), Gaps = 10/228 (4%)
Query: 222 IIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIA 281
I+ +S++ E ++ Q++ P I+ L ++ +Y+V + N GE+F ++
Sbjct: 31 IVSRSEVT-----HTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ 85
Query: 282 RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341
R GR + + AR ++L A+E H V++RDLK EN+L+D I L DFG +
Sbjct: 86 REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145
Query: 342 -GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400
K T+CG+P Y APE+ G Y +D W+LGV+LY ++ G PF +N + +
Sbjct: 146 DDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK 204
Query: 401 VLSGRFRIPYFMSTECESLIRKMLVREPTKRYCI---EQIKRHRWMAE 445
+L R P + + L+ +L R+PT+R ++IK H + ++
Sbjct: 205 ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 72/241 (29%), Positives = 117/241 (48%), Gaps = 32/241 (13%)
Query: 218 VAIKIID-KSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VAIK+ID + D + + +E++ + Q P+I K + S ++I+ EY G
Sbjct: 29 VAIKVIDLEEAEDEIED--IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
D + + G+++E ++L +EY H +HRD+KA N+L+ D+KLADFG
Sbjct: 87 LDLL-KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFG-- 143
Query: 337 NYYVPGQ------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
V GQ K T+ G+P + APEV + Y + DIWSLG+ L G P
Sbjct: 144 ---VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPL- 198
Query: 391 GSTLNSLRDRVLSGRFRIP---------YFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441
S L+ + RVL F IP S + + L ++P +R +++ +H+
Sbjct: 199 -SDLHPM--RVL---FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252
Query: 442 W 442
+
Sbjct: 253 F 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 28/243 (11%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
VA+K + K ++ E IMK+L HP+I++L V +YIV+EY
Sbjct: 27 TETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPG 85
Query: 274 GEIFDYIARYGRMNENA----ARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
G++ D++ R + + QI +EY ++ VHRDL A N L+ NL +
Sbjct: 86 GDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVV 141
Query: 329 KLADFGFS------NYYVPGQKLAT---WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
K++DFG S +YY W APE + K+ + D+WS GV+L
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWM------APESLKDGKF-TSKSDVWSFGVLL 194
Query: 380 YVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
+ + G P+ G + + + + G R P E L+ + +P R ++
Sbjct: 195 WEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSEL 254
Query: 438 KRH 440
Sbjct: 255 VED 257
|
Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 75/240 (31%), Positives = 131/240 (54%), Gaps = 18/240 (7%)
Query: 218 VAIKIID--KSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VA+K +D K Q + ++ EV IM+ HP+I++++ +++V E+ G
Sbjct: 47 VAVKKMDLRKQQ----RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ D I + RMNE +L A+ + H + V+HRD+K++++L+ S+ +KL+DFGF
Sbjct: 103 LTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF 161
Query: 336 SNYY---VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDG 391
VP +K + G+P + APEV Y G E+DIWSLG+++ +V G P F+
Sbjct: 162 CAQVSKEVPRRK--SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNE 218
Query: 392 STLNS---LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
L + +RD L + + + +S S + +MLVR+P +R ++ H ++A+ P
Sbjct: 219 PPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 57/177 (32%), Positives = 96/177 (54%), Gaps = 4/177 (2%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK +S+ D + REV++++QL H +I+ L + K +Y+V EY + +
Sbjct: 29 VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLL 87
Query: 278 DYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + G + +A R WQ+L A+ YCH+ ++HRD+K EN+L+ + +KL DFGF+
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA 147
Query: 337 NYYV--PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
P L + + Y APE+ G G +D+W++G ++ L+ G F G
Sbjct: 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 83/258 (32%), Positives = 131/258 (50%), Gaps = 27/258 (10%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVN-LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
L+RH A+K I+K L N +Q+V+ E +I+ ++P ++ +F ETK + +
Sbjct: 19 LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
V EY G+ + G + + AR F + + A+EY HN +VHRDLK +NLL+ S
Sbjct: 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG 138
Query: 327 DIKLADFGFS---------NYYVPGQKLATW-------CGSPPYAAPEVFEGKKYCGPEI 370
IKL DFG S N Y + T CG+P Y APEV + Y G +
Sbjct: 139 HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPV 197
Query: 371 DIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP---YFMSTECESLIRKMLVRE 427
D W++G++LY + G +PF G T L +V+S P + + + LI ++L +
Sbjct: 198 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQN 257
Query: 428 PTKRYCI---EQIKRHRW 442
P +R ++K+HR+
Sbjct: 258 PLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 6/205 (2%)
Query: 247 DHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH 306
+ P I+ L +T S +Y+V++Y + GE+F ++ + GR +E+ A+ +++ A+E+ H
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH 113
Query: 307 NRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKY 365
+V+RDLK EN+L+D+ I L DFG S + K T+CG+ Y APEV +K
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 366 CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY-FMSTECESLIRKML 424
+D WSLGV+++ + CG PF + + G+ R P +S E ++ +L
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLL 233
Query: 425 VREPTKRYC----IEQIKRHRWMAE 445
R P R ++K H + A+
Sbjct: 234 NRNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-30
Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 8/218 (3%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHP-HIIKLFQVMETKSMIYIVSEYANQG 274
AIKI+ K Q D V V E ++ D P + +L +T +Y V EY N G
Sbjct: 29 AIKILKKDVVIQDDDVECTMV--EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGG 86
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
++ +I + G+ E A +I + + H R +++RDLK +N+++DS IK+ADFG
Sbjct: 87 DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFG 146
Query: 335 F-SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
+ V G T+CG+P Y APE+ + Y G +D W+ GV+LY ++ G PFDG
Sbjct: 147 MCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGED 205
Query: 394 LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR 431
+ L ++ P +S E S+ + ++ + P+KR
Sbjct: 206 EDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 8e-30
Identities = 76/287 (26%), Positives = 117/287 (40%), Gaps = 65/287 (22%)
Query: 218 VAIKIID----KSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN- 272
VAIK I K D +N RE++++++L HP+II L V KS I +V E+
Sbjct: 28 VAIKKIKLGERKEAKDGIN-FTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET 86
Query: 273 --QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
+ I D A K + L +EY H+ ++HRDLK NLL+ S+ +
Sbjct: 87 DLEKVIKDKSIVLT-----PADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVL 141
Query: 329 KLADFGFSNYYVPGQKLATWCGSPP-----------YAAPEVFEGKKYCGPEIDIWSLGV 377
KLADFG LA GSP Y APE+ G ++ G +D+WS+G
Sbjct: 142 KLADFG----------LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGC 191
Query: 378 VLYVLVCGALPFDGS-----------TLNSLRDRVLSGRFRIPYFM-------------- 412
+ L+ G L + + G +P ++
Sbjct: 192 IFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIF 251
Query: 413 ---STECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINI 456
S + L++++L P KR Q H + + + P PP +
Sbjct: 252 PAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND-PAPTPPSQL 297
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-30
Identities = 77/267 (28%), Positives = 138/267 (51%), Gaps = 26/267 (9%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQ-LDH----PHIIKLFQVMETKSMIYIVSEYANQ 273
A+K++ K+ L V K + L+H P ++ L +T++ ++++ +Y +
Sbjct: 32 AMKVLQKAAL--VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSG 89
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
GE+F ++ + +E+ R +I+ A+E+ H +V+RD+K EN+L+DS + L DF
Sbjct: 90 GEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDF 149
Query: 334 GFSNYYVPGQKLATW--CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF-- 389
G S ++ +K T+ CG+ Y APE+ GK G +D WSLG++++ L+ GA PF
Sbjct: 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
Query: 390 --DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRH-- 440
+ +T + + R+L P F+ E + L+ K+L ++P KR +IK H
Sbjct: 210 EGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269
Query: 441 ----RWMAEETPRLLPPINILGEVKNE 463
W A ++ PP ++NE
Sbjct: 270 FKGLDWEALALRKVNPPFR--PSIRNE 294
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 8/235 (3%)
Query: 210 VLLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
L R T + V K ++ ++L + E+ I+ L HP+II + + + I
Sbjct: 17 TLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76
Query: 267 VSEYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS 324
EYAN G ++D I R E +QI+SAV Y H ++HRD+K N+ +
Sbjct: 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK 136
Query: 325 NLDIKLADFGFSNYYVPGQKLATWC-GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
IKL DFG S +A G+P Y +PE+ +G KY + DIW+LG VLY L+
Sbjct: 137 AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELL 195
Query: 384 CGALPFDGSTLNSLRDRVLSGRFR-IPYFMSTECESLIRKMLVREPTKRYCIEQI 437
FD + +L +++ G + + S+E SL+ +L ++P KR +++
Sbjct: 196 TLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 218 VAIKIIDKSQLDP---VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
+A+K + P + + E++++K L H I++ + + + I EY G
Sbjct: 30 LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGG 89
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ D + YG + E R+ QIL VEY H+ +VHRD+K N+L DS ++KL DFG
Sbjct: 90 SVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 149
Query: 335 FSNYYVPGQKLATWC----------GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC 384
S ++L T C G+P + +PEV G+ Y G + D+WS+G + ++
Sbjct: 150 AS------KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLT 202
Query: 385 GALP----------FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCI 434
P F +T + ++P +S + + +R+ V KR
Sbjct: 203 EKPPWAEFEAMAAIFKIATQPT--------NPQLPSHVSPDARNFLRRTFVENAKKRPSA 254
Query: 435 EQIKRH 440
E++ RH
Sbjct: 255 EELLRH 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 8e-29
Identities = 70/225 (31%), Positives = 112/225 (49%), Gaps = 12/225 (5%)
Query: 242 IMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSA 301
++K L HP ++ L +T +Y V +Y N GE+F ++ R E AR ++ SA
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108
Query: 302 VEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPPYAAPEVF 360
+ Y H+ +++RDLK EN+L+DS + L DFG V P + +T+CG+P Y APEV
Sbjct: 109 IGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168
Query: 361 EGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLI 420
+ Y +D W LG VLY ++ G PF ++ + D +L ++P + L+
Sbjct: 169 RKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLL 227
Query: 421 RKMLVREPTKRYC----IEQIKRH------RWMAEETPRLLPPIN 455
+L ++ +R +IK H W R+ PP N
Sbjct: 228 VGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYN 272
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 68/218 (31%), Positives = 113/218 (51%), Gaps = 8/218 (3%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPH-IIKLFQVMETKSMIYIVSEYANQG 274
AIKI+ K Q D V V E ++ P + +L +T +Y V EY N G
Sbjct: 29 AIKILKKDVIIQDDDVECTMV--EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
++ +I + G+ E A +I + + H++ +++RDLK +N+++D+ IK+ADFG
Sbjct: 87 DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFG 146
Query: 335 FSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
+ G+ T+CG+P Y APE+ + Y G +D W+ GV+LY ++ G PFDG
Sbjct: 147 MCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGED 205
Query: 394 LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR 431
+ L ++ P +S E S+ + +L + P KR
Sbjct: 206 EDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 18/232 (7%)
Query: 218 VAIKIIDKSQLDPVN--LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VAIK++ PV LQ++ +E+ I+KQ D P+I+K + + ++IV EY G
Sbjct: 31 VAIKVV------PVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84
Query: 276 IFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ D + + E +Q L +EY H+ + +HRD+KA N+L++ KLADFG
Sbjct: 85 VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG 144
Query: 335 FSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
S T G+P + APEV + Y + DIWSLG+ + G P+ S
Sbjct: 145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPY--SD 201
Query: 394 LNSLRDRVLSGR-----FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
++ +R + P S E ++K LV++P +R Q+ +H
Sbjct: 202 IHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-28
Identities = 86/298 (28%), Positives = 137/298 (45%), Gaps = 75/298 (25%)
Query: 218 VAIK-IIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM--IYIVSEYANQ 273
VA+K I D + + + Q+ +RE+ +++L DHP+I+KL V++ ++ IY+V EY
Sbjct: 35 VALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET 93
Query: 274 GEIFDYIA--RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
D A R + + R +Q+L A++Y H+ V+HRDLK N+L++S+ +KLA
Sbjct: 94 ----DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLA 149
Query: 332 DFG----FSN-----------YYVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
DFG S YV AT W Y APE+ G +D+WS+
Sbjct: 150 DFGLARSLSELEENPENPVLTDYV-----ATRW-----YRAPEILLGSTRYTKGVDMWSV 199
Query: 376 GVVLYVLVCGALPFDG-STLNSLRDRVLSG----------------------------RF 406
G +L ++ G F G STLN L ++++ R
Sbjct: 200 GCILGEMLLGKPLFPGTSTLNQL-EKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRK 258
Query: 407 RIPYFM---STECESLIRKMLVREPTKRYCIEQIKRHRWMA-----EETPRLLPPINI 456
+ + S + L++K+LV P KR E+ H ++A + P L PI I
Sbjct: 259 PLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITI 316
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 71/230 (30%), Positives = 123/230 (53%), Gaps = 8/230 (3%)
Query: 220 IKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDY 279
+K I +L+P + +E +++ +LDHP I+K + I++EY ++
Sbjct: 33 LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCK 92
Query: 280 IARYGR----MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ ++EN F Q+L V Y H RR++HRDLKA+N+ + +NL +K+ DFG
Sbjct: 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGV 151
Query: 336 SNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S + LA T+ G+P Y +PE + + Y + DIWSLG +LY + C A F+G
Sbjct: 152 SRLLMGSCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNF 210
Query: 395 NSLRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
S+ R++ G +P S + S+++ ML ++P+ R +I R+ ++
Sbjct: 211 LSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 68/217 (31%), Positives = 111/217 (51%), Gaps = 6/217 (2%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
AIKI+ K Q D V V + V + P + +L +T +Y V EY N G+
Sbjct: 29 AIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQLHSCFQTMDRLYFVMEYVNGGD 87
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ I + GR E A +I + + H++ +++RDLK +N+++DS IK+ADFG
Sbjct: 88 LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM 147
Query: 336 SNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G T+CG+P Y APE+ + Y G +D W+ GV+LY ++ G PF+G
Sbjct: 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE 206
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR 431
+ L ++ P MS E ++ + ++ + P KR
Sbjct: 207 DELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 11/231 (4%)
Query: 217 NVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VA+K + ++ D Q +E++++KQLDHP++IK + + IV E A+ G+
Sbjct: 29 VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGD 88
Query: 276 IFDYIARYGRMNENAARRKFW----QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
+ I + + R W Q+ SA+E+ H++R++HRD+K N+ + + +KL
Sbjct: 89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLG 148
Query: 332 DFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
D G ++ A + G+P Y +PE Y + DIWSLG +LY + PF
Sbjct: 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFY 207
Query: 391 GSTLN--SLRDRVLSGRFR-IP-YFMSTECESLIRKMLVREPTKRYCIEQI 437
G +N SL ++ + +P S E L+ + + +P KR I +
Sbjct: 208 GDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 64/224 (28%), Positives = 121/224 (54%), Gaps = 5/224 (2%)
Query: 220 IKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDY 279
IK I+ S++ P ++ +EV ++ + HP+I++ + E +YIV +Y G+++
Sbjct: 30 IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKK 89
Query: 280 I-ARYGRM-NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
I A+ G + E+ F QI A+++ H+R+++HRD+K++N+ + + IKL DFG +
Sbjct: 90 INAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
Query: 338 YYVPGQKLATWC-GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
+LA C G+P Y +PE+ E + Y + DIW+LG VLY + F+ + +
Sbjct: 150 VLNSTVELARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
Query: 397 LRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
L +++ G + + S + +L+ ++ R P R + I
Sbjct: 209 LVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 65/204 (31%), Positives = 111/204 (54%), Gaps = 5/204 (2%)
Query: 232 NLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIA-RYGRM-NEN 289
++ +E ++ ++ HP+I+ + E +YIV EY + G++ I + G++ E+
Sbjct: 41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED 100
Query: 290 AARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATW 348
+ F Q+ V++ H +RV+HRD+K++N+ + N +KL DFG + PG T+
Sbjct: 101 TILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160
Query: 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR- 407
G+P Y PE++E Y + DIWSLG +LY L PF ++ +L +V G ++
Sbjct: 161 VGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
Query: 408 IPYFMSTECESLIRKMLVREPTKR 431
+P S E SLI++M R P R
Sbjct: 220 LPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 60/175 (34%), Positives = 95/175 (54%), Gaps = 13/175 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK +S+ DPV + RE+ ++KQL HP+++ L +V K +++V EY + +
Sbjct: 29 VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVL 87
Query: 278 DYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + + R + E+ ++ WQ L AV +CH +HRD+K EN+L+ IKL DFGF+
Sbjct: 88 NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA 147
Query: 337 NYYVPGQK-----LAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
+AT W Y APE+ G GP +D+W++G V L+ G
Sbjct: 148 RILTGPGDDYTDYVATRW-----YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 70/225 (31%), Positives = 111/225 (49%), Gaps = 12/225 (5%)
Query: 242 IMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSA 301
++K + HP ++ L +T +Y V +Y N GE+F ++ R E AR +I SA
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 108
Query: 302 VEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPPYAAPEVF 360
+ Y H+ +V+RDLK EN+L+DS I L DFG + +T+CG+P Y APEV
Sbjct: 109 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 361 EGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLI 420
+ Y +D W LG VLY ++ G PF + D +L+ ++ ++ L+
Sbjct: 169 HKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 227
Query: 421 RKMLVREPTKRYCIE----QIKRH------RWMAEETPRLLPPIN 455
+L ++ TKR + +IK H W ++ PP N
Sbjct: 228 EGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFN 272
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 67/239 (28%), Positives = 130/239 (54%), Gaps = 19/239 (7%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQ-LDH----PHIIKLFQVMETKSMIYIVSEYANQ 273
A+K++ K+ + V K +Q L+H P ++ L +T + ++++ +Y N
Sbjct: 32 AMKVLKKATI--VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYING 89
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
GE+F ++++ R E + +I+ A+E+ H +++RD+K EN+L+DSN + L DF
Sbjct: 90 GELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149
Query: 334 GFSNYYVPG--QKLATWCGSPPYAAPEVFEGKKYCGPE-IDIWSLGVVLYVLVCGALPF- 389
G S + ++ ++CG+ Y AP++ G + +D WS+GV++Y L+ GA PF
Sbjct: 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
Query: 390 ---DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-C----IEQIKRH 440
+ ++ + R+L P MS + +I+++L+++P KR C ++IK+H
Sbjct: 210 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 56/178 (31%), Positives = 102/178 (57%), Gaps = 3/178 (1%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK +S+ D + + RE+ ++KQL H +++ L +V K +Y+V E+ + +
Sbjct: 29 VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH-TVL 87
Query: 278 DYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
D + +Y ++E+ R+ +QIL +E+CH+ ++HRD+K EN+L+ + +KL DFGF+
Sbjct: 88 DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 147
Query: 337 NYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
PG+ + + Y APE+ G G +DIW++G ++ ++ G F G +
Sbjct: 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 67/242 (27%), Positives = 117/242 (48%), Gaps = 43/242 (17%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAAR-RKF- 295
RE+ ++K+L+HP+I++L V+ +++ +Y+V E+ + ++ Y+ + + +
Sbjct: 47 REISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYL 105
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VP----GQKLAT-WC 349
+Q+L + YCH+ RV+HRDLK +NLL+D +KLADFG + + VP ++ T W
Sbjct: 106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW- 164
Query: 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-----------TLNSLR 398
Y APE+ G + +DIWS+G + +V F G TL +
Sbjct: 165 ----YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD 220
Query: 399 DRVLSGRFRIPYFMST------------------ECESLIRKMLVREPTKRYCIEQIKRH 440
+ V G +P + T + L+ KMLV +P KR + +H
Sbjct: 221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280
Query: 441 RW 442
+
Sbjct: 281 PY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 31/225 (13%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG-EIFDYIARYGRMNENAARRKFW 296
RE+ ++K+L+HP+I+KL V+ T++ +Y+V E+ +Q + F + + + +
Sbjct: 48 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLF 107
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLATWCGSPPYA 355
Q+L + +CH+ RV+HRDLK +NLL+++ IKLADFG + + VP + + Y
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167
Query: 356 APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-----------TLNSLRDRVLSG 404
APE+ G KY +DIWSLG + +V F G TL + + V G
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227
Query: 405 RFRIPYFMST------------------ECESLIRKMLVREPTKR 431
+P + + + L+ +ML +P KR
Sbjct: 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 71/226 (31%), Positives = 121/226 (53%), Gaps = 8/226 (3%)
Query: 220 IKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDY 279
IK ID +++ + +EV ++ ++ HP+I+ F + ++IV EY + G++
Sbjct: 30 IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKR 89
Query: 280 IAR-YGRM-NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI-KLADFGFS 336
I R G + +E+ F QI +++ H+R+++HRD+K++N+ + N + KL DFG +
Sbjct: 90 INRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149
Query: 337 NYYVPGQKLATWC-GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
+LA C G+P Y +PE+ + + Y + DIWSLG VLY L PF+G+ L+
Sbjct: 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLH 208
Query: 396 SLRDRVLSGRFR--IPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
L ++ G F P F S + SLI ++ P R I I +
Sbjct: 209 QLVLKICQGYFAPISPNF-SRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 77/310 (24%), Positives = 130/310 (41%), Gaps = 68/310 (21%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-----IYIVSEYA 271
VAIK I D ++ +++ RE+++++ L H +II L ++ S +YIV+E
Sbjct: 27 KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM 86
Query: 272 ----NQGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
++ + + + + + F +QIL ++Y H+ V+HRDLK N+L++SN
Sbjct: 87 ETDLHK------VIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC 140
Query: 327 DIKLADFGFSNYYVPGQKLAT---------WCGSPPYAAPEVFEGKKYCGPEIDIWSLGV 377
D+K+ DFG + P + W Y APE+ IDIWS+G
Sbjct: 141 DLKICDFGLARGVDPDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGC 195
Query: 378 VLYVLVCGALPFDG-STLNSLR--------------DRVLSGRFR--------------- 407
+ L+ F G ++ L + S + R
Sbjct: 196 IFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS 255
Query: 408 --IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMA-----EETPRLLPPINILGEV 460
P S E L+ KMLV +P KR ++ H ++A E+ P PP +
Sbjct: 256 KLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFD 314
Query: 461 KNEPNEQILR 470
+E E+ L+
Sbjct: 315 DDELTEEELK 324
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 7/199 (3%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW-- 296
E +I++++ I+ L ETK + +V N G++ +I G AR F+
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAA 356
QI+ +E+ H RR+V+RDLK EN+L+D + +++++D G + G+K+ G+P Y A
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162
Query: 357 PEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF----DGSTLNSLRDRVLSGRFRIPYFM 412
PEV +G+ Y +D ++LG LY ++ G PF + L+ R L P
Sbjct: 163 PEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF 221
Query: 413 STECESLIRKMLVREPTKR 431
S E + L +L ++P KR
Sbjct: 222 SPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 66/242 (27%), Positives = 118/242 (48%), Gaps = 26/242 (10%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
L ++ V VAIKI+ D + Q +EV+ +K+L H H+I LF V +YI++E
Sbjct: 26 LWKNRVRVAIKIL--KSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83
Query: 271 ANQGEIFDYIAR-YGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
+G + ++ G++ A+ Q+ + Y + +HRDL A N+L+ +L
Sbjct: 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVC 143
Query: 329 KLADFGFS-----NYYVPGQKLATWCGSPPY--AAPEVFEGKKYCGPEIDIWSLGVVLY- 380
K+ADFG + + Y+ K PY APE + + D+WS G++LY
Sbjct: 144 KVADFGLARLIKEDVYLSSDK------KIPYKWTAPEAASHGTF-STKSDVWSFGILLYE 196
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV----REPTKRYCIEQ 436
+ G +P+ G + + D++ +G +R+P +C I K+++ EP R +
Sbjct: 197 MFTYGQVPYPGMNNHEVYDQITAG-YRMP--CPAKCPQEIYKIMLECWAAEPEDRPSFKA 253
Query: 437 IK 438
++
Sbjct: 254 LR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 74/251 (29%), Positives = 121/251 (48%), Gaps = 16/251 (6%)
Query: 219 AIKIIDKSQLDPVNLQK---VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A+K++ K + QK R V ++K + HP ++ L +T +Y V ++ N GE
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGE 82
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+F ++ R E AR +I SA+ Y H+ +V+RDLK EN+L+DS + L DFG
Sbjct: 83 LFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142
Query: 336 SNYYVP-GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ T+CG+P Y APEV + Y +D W LG VLY ++ G PF +
Sbjct: 143 CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDV 201
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIE----QIKRH------RWMA 444
+ D +L + S S++ ++L ++ +R + +I+ H W
Sbjct: 202 AEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTD 261
Query: 445 EETPRLLPPIN 455
E ++ PP N
Sbjct: 262 LEQKKIPPPFN 272
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 74/238 (31%), Positives = 131/238 (55%), Gaps = 14/238 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K +D + L ++ EV IM+ H +++ ++ +++V E+ G +
Sbjct: 50 VAVKKMDLRKQQRREL--LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS- 336
D I + RMNE +L A+ Y HN+ V+HRD+K++++L+ S+ IKL+DFGF
Sbjct: 108 D-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166
Query: 337 --NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGST 393
+ VP +K + G+P + APEV Y G E+DIWSLG+++ ++ G P F+
Sbjct: 167 QVSKEVPKRK--SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPP 223
Query: 394 LNSLRDRV---LSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
L ++R R+ L R + + +S+ + MLVREP++R +++ +H ++ P
Sbjct: 224 LQAMR-RIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 73/231 (31%), Positives = 118/231 (51%), Gaps = 14/231 (6%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+ VA+K K+ P +K +E IM+Q DHPHI+KL V+ ++ ++IV E A GE
Sbjct: 35 IAVAVKTC-KNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGE 92
Query: 276 IFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ Y+ + A+ + +Q+ +A+ Y ++R VHRD+ A N+L+ S +KL DFG
Sbjct: 93 LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG 152
Query: 335 FSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDG 391
S Y G P + APE +++ D+W GV ++ +L+ G PF G
Sbjct: 153 LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSAS-DVWMFGVCMWEILMLGVKPFQG 211
Query: 392 STLNSLRDRVLSGRFRIPYFMSTECE----SLIRKMLVREPTKRYCIEQIK 438
N + R+ +G R+P M C SL+ K +P+KR ++K
Sbjct: 212 VKNNDVIGRIENGE-RLP--MPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 11/183 (6%)
Query: 218 VAIKIIDKSQLDPVNLQKVY----REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
+A+K + + ++V +E+ +M +L+HPHII++ S + E+
Sbjct: 28 MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAG 87
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLAD 332
G + +++YG E Q+L + Y H +++HRD+K NLL+DS +++AD
Sbjct: 88 GSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIAD 147
Query: 333 FGF-----SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
FG + G+ G+ + APEV G++Y G D+WS+G V+ +
Sbjct: 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKP 206
Query: 388 PFD 390
P++
Sbjct: 207 PWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 71/246 (28%), Positives = 109/246 (44%), Gaps = 27/246 (10%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ--VMETKSMIYIVSEYANQGEI 276
A+K I + Q + RE+EI K P+I+K + + E+ S I I EY G +
Sbjct: 30 ALKTITTDPNPDLQKQ-ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL 88
Query: 277 FDYI-----ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
D I R GR+ E + +L + Y H+R+++HRD+K N+L+ +KL
Sbjct: 89 -DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLC 147
Query: 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEI--DIWSLGVVLYVLVCGALPF 389
DFG S V T+ G+ Y APE +GK Y I D+WSLG+ L + PF
Sbjct: 148 DFGVSGELVNSLA-GTFTGTSFYMAPERIQGKPY---SITSDVWSLGLTLLEVAQNRFPF 203
Query: 390 DGSTLNSLRD-RVLSGRFRIPYFMSTECESL-----------IRKMLVREPTKRYCIEQI 437
L +LS +P + I++ L ++PT+R +
Sbjct: 204 PPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM 263
Query: 438 KRHRWM 443
H W+
Sbjct: 264 LEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 69/241 (28%), Positives = 115/241 (47%), Gaps = 44/241 (18%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG--EIFDYIARYGRMNENAARRKF 295
RE+ ++K+L HP+I+ L V+ +S +Y++ E+ + + D + + M+ +
Sbjct: 48 REISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL 107
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-----VPGQKLAT-WC 349
+QIL + +CH+RRV+HRDLK +NLL+D+ IKLADFG + + V ++ T W
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW- 166
Query: 350 GSPPYAAPEVFEG-KKYCGPEIDIWSLGVVLYVLVCGALPFDGS-----------TLNSL 397
Y APEV G +Y P +DIWS+G + + F G L +
Sbjct: 167 ----YRAPEVLLGSPRYSTP-VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP 221
Query: 398 RDRVLSGRFRIPYFMST------------------ECESLIRKMLVREPTKRYCIEQIKR 439
+ V G +P + +T + L+ KML+ +P KR ++
Sbjct: 222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281
Query: 440 H 440
H
Sbjct: 282 H 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 60/224 (26%), Positives = 115/224 (51%), Gaps = 9/224 (4%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
R ++VAIK+I + + + E ++M +L HP++++L+ V + I+IV+EY
Sbjct: 26 RGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82
Query: 273 QGEIFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + +Y+ R G++ + A+EY + +HRDL A N L+ + +K++
Sbjct: 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVS 142
Query: 332 DFGFSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALP 388
DFG + Y + Q ++ P +A PEVF+ ++ D+WS GV+++ V G +P
Sbjct: 143 DFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS-DVWSFGVLMWEVFSEGKMP 201
Query: 389 FDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431
++ + + + + V +G R P TE +++ +P R
Sbjct: 202 YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 48/245 (19%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR---MNENAARRK 294
RE+ +MK+L H +I++L V+ T++ + +V EY ++ ++ Y+ +G ++ N +
Sbjct: 47 REISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSF 105
Query: 295 FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLATWCGSPP 353
+Q+L + +CH RV+HRDLK +NLL++ ++KLADFG + + +P + +
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW 165
Query: 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMS 413
Y AP+V G + IDIWS+G ++ ++ G F G+ ++ FRI M
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI----FRI---MG 218
Query: 414 TECES------------------------------------LIRKMLVREPTKRYCIEQI 437
T ES L+ ++L P R
Sbjct: 219 TPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278
Query: 438 KRHRW 442
+H W
Sbjct: 279 LQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 8e-25
Identities = 66/209 (31%), Positives = 118/209 (56%), Gaps = 13/209 (6%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRK---- 294
E+ + DH I+K F ++ + ++ EY + G++ I + R+ E+ ++
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVG 172
Query: 295 --FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL---ATWC 349
F+QI+ A++ H+R+++HRDLK+ N+ + IKL DFGFS Y L +++C
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR-I 408
G+P Y APE++E K+Y + D+WSLGV+LY L+ PF G + + +VL G++
Sbjct: 233 GTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 409 PYFMSTECESLIRKMLVREPTKRYCIEQI 437
P +S+ ++L+ +L + P R +Q+
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 48/160 (30%), Positives = 86/160 (53%), Gaps = 22/160 (13%)
Query: 238 REVEIMKQLD---HPHIIKLFQV-----METKSMIYIVSEYANQGEIFDYIARYGR--MN 287
RE+ ++KQL+ HP+I++L V + + + +V E+ +Q ++ Y+++ + +
Sbjct: 47 REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLP 105
Query: 288 ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347
+ Q+L V++ H+ R+VHRDLK +N+L+ S+ +K+ADFG + Y L +
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165
Query: 348 -----WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL 382
W Y APEV Y P +D+WS+G + L
Sbjct: 166 VVVTLW-----YRAPEVLLQSSYATP-VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 67/244 (27%), Positives = 131/244 (53%), Gaps = 15/244 (6%)
Query: 215 TVNVAIKIIDKSQLDPVNLQK---VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
TV + K++ ++D Q+ ++ EV IM+ H ++++++ +++V E+
Sbjct: 40 TVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + D I + RMNE +L A+ H + V+HRD+K++++L+ + +KL+
Sbjct: 100 EGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158
Query: 332 DFGFS---NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
DFGF + VP +K + G+P + APE+ Y GPE+DIWSLG+++ +V G P
Sbjct: 159 DFGFCAQVSKEVPRRK--SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPP 215
Query: 389 FDGS----TLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444
+ + +RD L + + + +S + + ++LVR+P +R ++ +H ++A
Sbjct: 216 YFNEPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 274
Query: 445 EETP 448
+ P
Sbjct: 275 KAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 67/236 (28%), Positives = 119/236 (50%), Gaps = 9/236 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIKIID + + ++ + +E+ ++ Q D P++ K + + ++I+ EY G
Sbjct: 32 VAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL 90
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + R G +E +IL ++Y H+ + +HRD+KA N+L+ D+KLADFG +
Sbjct: 91 DLL-RAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 338 YYVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
Q K T+ G+P + APEV + Y + DIWSLG+ L G P S ++
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPP--NSDMHP 206
Query: 397 LRDRVLSGRFRIPYFM---STECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
+R L + P S + I L ++P+ R +++ +H+++ + +
Sbjct: 207 MRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 63/241 (26%), Positives = 114/241 (47%), Gaps = 26/241 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
+A+K I + +++ +++ RE++I+ + + P+I+ + I I EY + G +
Sbjct: 29 MAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87
Query: 278 DYIARY-GRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ GR+ E + +L + Y H +++HRD+K N+L++S IKL DFG
Sbjct: 88 KILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGV 147
Query: 336 SNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S V LA T+ G+ Y APE +G Y + DIWSLG+ L L G P+
Sbjct: 148 SGQLV--NSLAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPEND 204
Query: 395 NS-----LRDRVL--------SGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441
L ++ SG+F S + + + L+++P +R +++ H
Sbjct: 205 PPDGIFELLQYIVNEPPPRLPSGKF------SPDFQDFVNLCLIKDPRERPSYKELLEHP 258
Query: 442 W 442
+
Sbjct: 259 F 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 34/240 (14%)
Query: 236 VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR-MNENAARRK 294
RE++ ++ HP+++KL V S +V EY ++ + + R + E +
Sbjct: 46 ALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSY 104
Query: 295 FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW--CGSP 352
+L V Y H ++HRDLK NLL+ ++ +K+ADFG + + + +
Sbjct: 105 MRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG-----------STLNSLRDRV 401
Y APE+ G + P +D+W++G + L+ G+ F G TL + +
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET 224
Query: 402 LSGRFRIP-----YF--------------MSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
G +P F S E L++ +LV +P+KR + RH +
Sbjct: 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 68/236 (28%), Positives = 118/236 (50%), Gaps = 9/236 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIKIID + + ++ + +E+ ++ Q D P+I + + + ++I+ EY G
Sbjct: 32 VAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL 90
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + + G + E +IL ++Y H+ R +HRD+KA N+L+ D+KLADFG +
Sbjct: 91 DLL-KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 338 YYVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
Q K T+ G+P + APEV + Y + DIWSLG+ L G P S L+
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPN--SDLHP 206
Query: 397 LRDRVLSGRFRIPYFM---STECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
+R L + P S + + L ++P R +++ +H+++ T +
Sbjct: 207 MRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK 262
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 61/242 (25%), Positives = 115/242 (47%), Gaps = 43/242 (17%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG--EIFDYIARYGRMNENAARRKF 295
RE+ ++K+L H +I++L+ V+ + + +V EY +Q + FD + G ++ +
Sbjct: 48 REICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFM 105
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS-NYYVPGQKLATWCGSPPY 354
+Q+L + +CH+ V+HRDLK +NLL++ N ++KLADFG + + +P + + + Y
Sbjct: 106 FQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWY 165
Query: 355 AAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGSTLNSLRDRVLSGRFRI----- 408
P+V G K ID+WS G + L P F G+ ++ R+ FR+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI----FRLLGTPT 221
Query: 409 ----------------PYF------------MSTECESLIRKMLVREPTKRYCIEQIKRH 440
P + +++ L++ +LV P +R E+ +H
Sbjct: 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281
Query: 441 RW 442
+
Sbjct: 282 PY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 71/230 (30%), Positives = 113/230 (49%), Gaps = 12/230 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK ++ Q L + E+ +M++ HP+I+ +++V EY G +
Sbjct: 47 VAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + M+E + L A+E+ H+ +V+HRD+K++N+L+ + +KL DFGF
Sbjct: 105 DVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163
Query: 338 YYVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
P Q K +T G+P + APEV K Y GP++DIWSLG++ +V G P+ N
Sbjct: 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNE--NP 220
Query: 397 LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446
LR L P + E S I + + C+E R A+E
Sbjct: 221 LRALYLIATNGTPELQNPEKLSAIFRDFLNR-----CLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 69/243 (28%), Positives = 121/243 (49%), Gaps = 17/243 (6%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A KII L+ E++I+ + HP+I+ L++ ++ ++I+ E+ + G +
Sbjct: 34 AAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS 91
Query: 279 YIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
+ R + E R Q+L A+ + H+ +V+HRDLKA N+L+ + D+KLADFG S
Sbjct: 92 IMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA 151
Query: 338 YYVPG-QKLATWCGSPPYAAPEV-----FEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
QK T+ G+P + APEV F+ Y + DIWSLG+ L L P
Sbjct: 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY-DYKADIWSLGITLIELAQMEPP--H 208
Query: 392 STLNSLRD--RVLSG---RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446
LN +R ++L P S+ ++ LV++P R ++ +H +++++
Sbjct: 209 HELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268
Query: 447 TPR 449
+
Sbjct: 269 SDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 18/225 (8%)
Query: 237 YREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW 296
+ E +IM + I++L + +Y+V EY G++ + ++ Y + E AR
Sbjct: 91 WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTA 149
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF-----SNYYVPGQKLATWCGS 351
+++ A++ H+ +HRD+K +N+L+D + +KLADFG +N V + T G+
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV---RCDTAVGT 206
Query: 352 PPYAAPEVFE---GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL----SG 404
P Y +PEV + G Y G E D WS+GV LY ++ G PF +L +++ S
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266
Query: 405 RFRIPYFMSTECESLIRKMLVREPTK--RYCIEQIKRHRWMAEET 447
F +S + + LI L + R +++IK H + +
Sbjct: 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 66/236 (27%), Positives = 114/236 (48%), Gaps = 36/236 (15%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
T VA+K + + P + +E +IMK+L H +++L+ V + IYIV+EY ++G
Sbjct: 30 TTKVAVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG 86
Query: 275 EIFDYI----ARYGRMNE---NAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ D++ + R+ + AA QI + Y +R +HRDL A N+L+ NL
Sbjct: 87 SLLDFLKSGEGKKLRLPQLVDMAA-----QIAEGMAYLESRNYIHRDLAARNILVGENLV 141
Query: 328 IKLADFGFS-----NYYVP--GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
K+ADFG + + Y G K +P A F K D+WS G++L
Sbjct: 142 CKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS------DVWSFGILLT 195
Query: 381 VLVC-GALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR----EPTKR 431
+V G +P+ G T + ++V G +R+P C + ++++ +P +R
Sbjct: 196 EIVTYGRVPYPGMTNREVLEQVERG-YRMP--RPPNCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 68/234 (29%), Positives = 118/234 (50%), Gaps = 12/234 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDH---PHIIKLFQVMETKSMIYIVSEYANQG 274
VA+KII+ D ++ + REV ++ QL P+I K + ++I+ EYA G
Sbjct: 29 VALKIINLDTPDD-DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGG 87
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ + + G + E ++L A++Y H V+HRD+KA N+L+ + ++KL DFG
Sbjct: 88 SVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG 146
Query: 335 FSNYYVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
+ K +T+ G+P + APEV KY + DIWSLG+ +Y + G P+ S
Sbjct: 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY--SD 204
Query: 394 LNSLRDRVLSGRFRIPYF----MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
+++ R +L + + P S + L EP +R E++ + +W+
Sbjct: 205 VDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-23
Identities = 77/267 (28%), Positives = 123/267 (46%), Gaps = 39/267 (14%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-IYIVSE 269
L NVAIK I K PV ++ YRE++++K L H +II L + + IY V+E
Sbjct: 32 QLTGQ-NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G + + + + +QIL ++Y H+ VVHRDLK N+L++ N D+K
Sbjct: 91 L--LGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK 148
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEV-FEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
+ DFG + P ++ + + Y APE+ +KY E+DIWS G + ++ G
Sbjct: 149 ICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKY-DVEVDIWSAGCIFAEMLEGKPL 205
Query: 389 FDG-------------------------STLNSLR-DRVLSGRFRIPY---FMSTECE-- 417
F G + N+LR + L R +P+ F + +
Sbjct: 206 FPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAI 265
Query: 418 SLIRKMLVREPTKRYCIEQIKRHRWMA 444
L+ KMLV +P KR + H ++A
Sbjct: 266 DLLEKMLVFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 68/240 (28%), Positives = 114/240 (47%), Gaps = 14/240 (5%)
Query: 219 AIKIIDKSQLDPVNLQKVYREV-EIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K++ KS L + E +I+ + P I +L + K +Y+V EY G++
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 278 DYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ RY + +E+ A+ +++ A+ H VHRD+K EN+L+D IKLADFG +
Sbjct: 90 SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149
Query: 337 -NYYVPGQKLATW-CGSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ G+P Y APEV GK G E D WSLGV+ Y ++ G PF
Sbjct: 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
Query: 390 DGSTLNSLRDRVLSG----RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
T + +++ +F +S++ LI+ +L +R E + H + ++
Sbjct: 210 HEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-22
Identities = 57/166 (34%), Positives = 92/166 (55%), Gaps = 9/166 (5%)
Query: 231 VNLQK------VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYG 284
+NLQK + E+ +MK+L +P+I+ +++V EY G + D +
Sbjct: 52 INLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC 111
Query: 285 RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343
M+E + L A+E+ H +V+HRD+K++N+L+ + +KL DFGF P Q
Sbjct: 112 -MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170
Query: 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
K +T G+P + APEV K Y GP++DIWSLG++ +V G P+
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 6/211 (2%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKS-MIYIVSEYANQGEIFDYIA-RYGRM-NENAARRK 294
+E +++ QL HP+I+ + E + ++YIV + G+++ + + G++ EN
Sbjct: 48 QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 295 FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA-TWCGSPP 353
F QI A++Y H + ++HRDLK +N+ + IK+ D G + +A T G+P
Sbjct: 108 FVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY 167
Query: 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFM 412
Y +PE+F K Y + D+W+LG +Y + F+ +NSL R++ G+ +P
Sbjct: 168 YMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDY 226
Query: 413 STECESLIRKMLVREPTKRYCIEQIKRHRWM 443
S E LI ML + P KR ++ I R ++
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 219 AIKIIDKSQLDPVNLQK---VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A+K + K+ D + + V E +I+ + D+ ++KL+ + K +Y V +Y G+
Sbjct: 30 AMKTLRKA--DVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ + R G E+ AR ++ A+E H +HRD+K +N+L+D + IKL DFG
Sbjct: 88 MMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
Query: 336 ---------SNYYVPGQ-----------------------------KLATWC------GS 351
S YY G + C G+
Sbjct: 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGT 207
Query: 352 PPYAAPEVFEGKKY---CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--F 406
P Y APEV Y C D WS+GV+LY ++ G PF T + +V++
Sbjct: 208 PNYIAPEVLLRTGYTQLC----DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
Query: 407 RIPYF--MSTECESLIRKMLVREPTKR---YCIEQIKRHRWMA 444
IP +S E LI + L R ++IK H +
Sbjct: 264 HIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 64/257 (24%), Positives = 113/257 (43%), Gaps = 60/257 (23%)
Query: 238 REVEIMKQLDHPHIIKLFQVM----------ETKSMIYIVSEYANQGEIFDYIARYGRMN 287
RE++I++QL+H +I+ L +++ + K Y+V EY + + + +
Sbjct: 55 REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS 114
Query: 288 ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--- 344
E+ + Q+L + YCH + +HRD+K N+L+++ IKLADFG + Y +
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 345 ----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL------------------ 382
+ W Y PE+ G++ GP ID+WS G +L L
Sbjct: 175 TNKVITLW-----YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
Query: 383 ---VCGA-----------LPFDGSTLNSLR-DRVLSGRFRIPY-FMSTECESLIRKMLVR 426
+CG+ LP+ N+++ + R R + F+ T L+ ML
Sbjct: 230 ISRLCGSPCPAVWPDVIKLPY----FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285
Query: 427 EPTKRYCIEQIKRHRWM 443
+P+KR E+ W+
Sbjct: 286 DPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-22
Identities = 67/245 (27%), Positives = 132/245 (53%), Gaps = 15/245 (6%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K++D + L ++ EV IM+ H +++++++ ++++ E+ G +
Sbjct: 49 VAVKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS- 336
D +++ R+NE +L A+ Y H++ V+HRD+K++++L+ + +KL+DFGF
Sbjct: 107 DIVSQT-RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165
Query: 337 --NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST- 393
+ VP +K + G+P + APEV Y G E+DIWSLG+++ +V G P+ +
Sbjct: 166 QISKDVPKRK--SLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
Query: 394 ---LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE-ETPR 449
+ LRD + + + +S + +ML REP +R +++ H ++ + P
Sbjct: 223 VQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281
Query: 450 LLPPI 454
L P+
Sbjct: 282 CLVPL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 55/157 (35%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQI 298
E+E +K LDH +I++ T+ + I EY G I + YGR E R Q+
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV 117
Query: 299 LSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS----NYYVPGQKLATWCGSPPY 354
L + Y H++ ++HRDLKA+NLL+D++ K++DFG S + Y Q + + GS +
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM-SMQGSVFW 176
Query: 355 AAPEVFE--GKKYCGPEIDIWSLGVVLYVLVCGALPF 389
APEV + Y ++DIWSLG V+ + G P+
Sbjct: 177 MAPEVIHSYSQGYSA-KVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 6e-22
Identities = 73/248 (29%), Positives = 119/248 (47%), Gaps = 26/248 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIKIID + + ++ + +E+ ++ Q D P++ K + + ++I+ EY G
Sbjct: 32 VAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL 90
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + G ++E +IL ++Y H+ + +HRD+KA N+L+ + ++KLADFG +
Sbjct: 91 DLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG 149
Query: 338 YYVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-------- 388
Q K T+ G+P + APEV + Y + DIWSLG+ L G P
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMK 208
Query: 389 ------------FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTK-RYCIE 435
+G+ L++ V + + P F T E L K +VR K Y E
Sbjct: 209 VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTE 268
Query: 436 QIKRH-RW 442
I R+ RW
Sbjct: 269 LIDRYKRW 276
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-22
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 10/210 (4%)
Query: 239 EVEIMKQLDHPHIIKLFQVME--TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW 296
E++++K L H I++ + + + + I EY G I D + YG + EN RR
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS----NYYVPGQKLATWCGSP 352
QIL V Y H+ +VHRD+K N+L DS ++KL DFG S + G + + G+P
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--GRFRIPY 410
+ +PEV G+ Y G + D+WS+ + ++ P+ + ++ + + +P
Sbjct: 174 YWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
Query: 411 FMSTECESLIRKMLVREPTKRYCIEQIKRH 440
+S C ++++ V E +R E + RH
Sbjct: 233 GVSDACRDFLKQIFVEE-KRRPTAEFLLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 7e-22
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 35/267 (13%)
Query: 213 RHT-VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
R T +A+K I Q D RE+ ++K++ H +I++L V+ ++ +Y+V EY
Sbjct: 24 RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83
Query: 272 NQG--EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD-SNLDI 328
+ + D + + N + +QIL + YCH+ RV+HRDLK +NLL+D +
Sbjct: 84 DLDLKKHMDSSPDFAK-NPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142
Query: 329 KLADFGFSNYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
KLADFG + + +P + + Y APE+ G ++ +DIWS+G + +V
Sbjct: 143 KLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202
Query: 388 PFDGST-----------LNSLRDRVLSGRFRIPYFMST------------------ECES 418
F G + L + + G +P + S
Sbjct: 203 LFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVD 262
Query: 419 LIRKMLVREPTKRYCIEQIKRHRWMAE 445
L+ KML +P+KR H + +
Sbjct: 263 LLSKMLRLDPSKRITARAALEHEYFKD 289
|
Length = 294 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 31/156 (19%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSM--IYIVSEYANQGEIFDYIARYGRMNEN--AARR 293
RE+ I+ +L HP+I+ + +V+ ++ IY+V EY ++ + M + +
Sbjct: 53 REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEV 108
Query: 294 KFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGS 351
K Q+LS V + H+ ++HRDLK NLL+++ +K+ DFG LA GS
Sbjct: 109 KCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFG----------LAREYGS 158
Query: 352 PP-----------YAAPEVFEGKKYCGPEIDIWSLG 376
P Y APE+ G K ID+WS+G
Sbjct: 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 6/194 (3%)
Query: 207 RPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
R LL K+ +D +E++++KQL+HP++IK + + + I
Sbjct: 20 RATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFW----QILSAVEYCHNRRVVHRDLKAENLLM 322
V E A+ G++ I + + + W Q+ SA+E+ H+RRV+HRD+K N+ +
Sbjct: 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139
Query: 323 DSNLDIKLADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYV 381
+ +KL D G ++ A + G+P Y +PE Y + DIWSLG +LY
Sbjct: 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYE 198
Query: 382 LVCGALPFDGSTLN 395
+ PF G +N
Sbjct: 199 MAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 49/193 (25%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
+VAIK+I + + + E ++M +L H +++L+ V + IYIV+EY + G +
Sbjct: 30 DVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 277 FDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+Y+ +G+ + + + + + Y +++ +HRDL A N L+D +K++DFG
Sbjct: 87 LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGL 146
Query: 336 SNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGS 392
S Y + + ++ P ++ PEV K+ D+W+ GV+++ V G +P++
Sbjct: 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS-DVWAFGVLMWEVYSLGKMPYERF 205
Query: 393 TLNSLRDRVLSGR 405
+ ++V G
Sbjct: 206 NNSETVEKVSQGL 218
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 14/167 (8%)
Query: 238 REVEIMKQLDH-PHIIKLFQVMET-----KSMIYIVSEYANQGEIFDYIARYGR-----M 286
RE+ +++ L +I++L V K +Y+V EY + ++ ++ GR +
Sbjct: 49 REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPL 107
Query: 287 NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD-IKLADFGFS-NYYVPGQK 344
+ +Q+L V +CH V+HRDLK +NLL+D +K+AD G + +P +
Sbjct: 108 PAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
+ Y APEV G + +DIWS+G + + F G
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-21
Identities = 67/237 (28%), Positives = 125/237 (52%), Gaps = 15/237 (6%)
Query: 219 AIKIIDKSQLDPVNLQKVYREV-EIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+KI++K ++ +RE +++ D+ I L + ++ +Y+V +Y G++
Sbjct: 30 AMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLL 89
Query: 278 DYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
++++ R+ E+ AR +++ A++ H VHRD+K +N+LMD N I+LADFG
Sbjct: 90 TLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 149
Query: 337 NYYVPGQKL--ATWCGSPPYAAPEVFE----GKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
+ + + G+P Y +PE+ + GK GPE D WSLGV +Y ++ G PF
Sbjct: 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
Query: 391 GSTLNSLRDRVLSG--RFRIPYF---MSTECESLIRKMLVREPTK--RYCIEQIKRH 440
+L ++++ RF+ P +S + + LIR+++ + + IE K+H
Sbjct: 210 AESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 57/276 (20%)
Query: 218 VAIKIIDKSQLDPVNLQK-----VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
A+K + KS++ L+K V E +I+ + D+P ++KL+ + ++ +Y++ EY
Sbjct: 29 YAMKKLRKSEM----LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84
Query: 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
G++ + + E R + + A++ H +HRD+K +NLL+D+ IKL+D
Sbjct: 85 GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSD 144
Query: 333 FGF---------SNYY-------------------VPGQKLATW-----------CGSPP 353
FG + +Y +K TW G+P
Sbjct: 145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPD 204
Query: 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFM- 412
Y APEVF Y E D WSLGV++Y ++ G PF ++++ + + +
Sbjct: 205 YIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDE 263
Query: 413 ---STECESLIRKMLVREPTKRYC---IEQIKRHRW 442
S E + LI++ L E +R + +IK H +
Sbjct: 264 VPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 206 NRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265
+R PV L+ ++I + +D Q +E++++KQL+HP++IK + +
Sbjct: 26 DRKPVALKK-----VQIFE--MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78
Query: 266 IVSEYANQGEIFDYIARYGRMNENAARRKFW----QILSAVEYCHNRRVVHRDLKAENLL 321
IV E A+ G++ I + + R W Q+ SAVE+ H+RRV+HRD+K N+
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138
Query: 322 MDSNLDIKLADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
+ + +KL D G ++ A + G+P Y +PE Y + DIWSLG +LY
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLY 197
Query: 381 VLVCGALPFDGSTLN 395
+ PF G +N
Sbjct: 198 EMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 239 EVEIMKQLDHPHIIKLFQVME--TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW 296
E++++K L H I++ + + + + I E+ G I D + YG + EN R+
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY----VPGQKLATWCGSP 352
QIL V Y H+ +VHRD+K N+L DS ++KL DFG S + G + + G+P
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173
Query: 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI---- 408
+ +PEV G+ Y G + DIWS+G + ++ P+ ++ F+I
Sbjct: 174 YWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPW-------AEFEAMAAIFKIATQP 225
Query: 409 -----PYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
P +S C ++++ V E R +++ RH
Sbjct: 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 22/190 (11%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
V VA+K + + + ++ RE +M QLDHP I++L V + + ++ +V E A G
Sbjct: 24 VEVAVKTLKQEHI-AAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLM-LVMELAPLGP 81
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ Y+ + + + K Q+ + Y ++ VHRDL A N+L+ + K++DF
Sbjct: 82 LLKYLKKRREIPV--SDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
Query: 334 GFS-------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLV 383
G S +YY AT G P + APE K+ D+WS GV L+
Sbjct: 140 GMSRALGAGSDYYR-----ATTAGRWPLKWYAPECINYGKFSSKS-DVWSYGVTLWEAFS 193
Query: 384 CGALPFDGST 393
GA P+
Sbjct: 194 YGAKPYGEMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 73/238 (30%), Positives = 108/238 (45%), Gaps = 32/238 (13%)
Query: 212 LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
L+ VA+K +S L P +K +E EI+KQ DHP+I+KL V K IYIV E
Sbjct: 16 LKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELV 74
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQIL-------SAVEYCHNRRVVHRDLKAENLLMDS 324
G + ++ R +N K ++L + +EY ++ +HRDL A N L+
Sbjct: 75 PGGSLLTFL----RKKKNRLTVK--KLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE 128
Query: 325 NLDIKLADFGFSN------YYVP---GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
N +K++DFG S Y V Q W APE +Y E D+WS
Sbjct: 129 NNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW------TAPEALNYGRYTS-ESDVWSY 181
Query: 376 GVVLY-VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431
G++L+ G P+ G + R+R+ SG R P E L+ + +P R
Sbjct: 182 GILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 57/178 (32%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIYIVSEYANQGE 275
VA+K ++ S + RE+EI++ LDH +I+K V E + ++ EY G
Sbjct: 36 VAVKSLNHSGEEQH-RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94
Query: 276 IFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ DY+ R+ F QI ++Y ++R +HRDL A N+L++S +K++DFG
Sbjct: 95 LRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG 154
Query: 335 FSN--------YYV--PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL 382
+ YYV PG+ W Y APE K+ D+WS GV LY L
Sbjct: 155 LAKVLPEDKDYYYVKEPGESPIFW-----Y-APECLRTSKF-SSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 81/274 (29%), Positives = 122/274 (44%), Gaps = 65/274 (23%)
Query: 218 VAIKIIDK---SQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQ 273
VAIK + K S + +NL REV+ +++L +HP+I+KL +V +Y V EY
Sbjct: 27 VAIKKMKKKFYSWEECMNL----REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYME- 81
Query: 274 GEIFDYI-ARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G ++ + R G+ +E+ R +QIL + + H HRDLK ENLL+ +K+A
Sbjct: 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIA 141
Query: 332 DFG----------FSNYYVPGQKLAT-WCGSPPYAAPEVF-EGKKYCGPEIDIWSLGVV- 378
DFG +++Y ++T W Y APE+ Y P +DIW+LG +
Sbjct: 142 DFGLAREIRSRPPYTDY------VSTRW-----YRAPEILLRSTSYSSP-VDIWALGCIM 189
Query: 379 --LYV---LVCGALPFD---------GSTLNSLRDR--VLSGR--FRIPYFMST------ 414
LY L G+ D G+ L+ + FR P F T
Sbjct: 190 AELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI 249
Query: 415 -----ECESLIRKMLVREPTKRYCIEQIKRHRWM 443
E LI+ ML +P KR Q +H +
Sbjct: 250 PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-20
Identities = 56/173 (32%), Positives = 95/173 (54%), Gaps = 5/173 (2%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK ++ Q L + E+ +M++ +P+I+ +++V EY G +
Sbjct: 47 VAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + M+E + L A+++ H+ +V+HRD+K++N+L+ + +KL DFGF
Sbjct: 105 DVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163
Query: 338 YYVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
P Q K +T G+P + APEV K Y GP++DIWSLG++ +V G P+
Sbjct: 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 50/159 (31%), Positives = 90/159 (56%), Gaps = 3/159 (1%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR-MNENAARRKFW 296
REV ++K L H +I+ L ++ T+ + +V EY ++ ++ Y+ G +N + + +
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLF 111
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY-YVPGQKLATWCGSPPYA 355
Q+L + YCH R+V+HRDLK +NLL++ ++KLADFG + +P + + + Y
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYR 171
Query: 356 APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
P++ G +ID+W +G + Y + G F GST+
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-20
Identities = 52/159 (32%), Positives = 89/159 (55%), Gaps = 3/159 (1%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR-MNENAARRKFW 296
REV ++K L H +I+ L ++ T+ + +V EY + ++ Y+ G M+ + + +
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF 110
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY-YVPGQKLATWCGSPPYA 355
Q+L + YCH R+++HRDLK +NLL++ ++KLADFG + VP + + + Y
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYR 170
Query: 356 APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
P+V G ID+W +G +LY + G F GST+
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 52/185 (28%), Positives = 97/185 (52%), Gaps = 8/185 (4%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
R + VAIK I++ + + E ++M +L HP +++L+ V + +YIV+E+
Sbjct: 26 RAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82
Query: 273 QGEIFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + +Y+ R G+++++ + +EY +HRDL A N L+ S +K++
Sbjct: 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVS 142
Query: 332 DFGFSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALP 388
DFG + Y + + ++ P ++ PEVF KY D+WS GV+++ V G +P
Sbjct: 143 DFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS-DVWSFGVLMWEVFTEGKMP 201
Query: 389 FDGST 393
F+ +
Sbjct: 202 FEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-20
Identities = 52/159 (32%), Positives = 89/159 (55%), Gaps = 3/159 (1%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR-MNENAARRKFW 296
REV ++K L H +I+ L ++ T + +V EY ++ ++ Y+ G M+ + + +
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY-YVPGQKLATWCGSPPYA 355
QIL + YCH R+V+HRDLK +NLL++ ++KLADFG + VP + + + Y
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYR 171
Query: 356 APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
P+V G +ID+W +G + + + G F GST+
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 8/164 (4%)
Query: 233 LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAAR 292
L + RE+ ++K+L H +I++ + I EY G + + YG E R
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR 109
Query: 293 RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS-----NYYVPGQKLA- 346
QIL + Y HNR ++HRD+K N+L+D+ IK++DFG S N A
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 347 -TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ GS + APEV + Y + DIWSLG ++ ++ G PF
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 68/238 (28%), Positives = 120/238 (50%), Gaps = 27/238 (11%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAA----RRK 294
E I+ ++ I+ L +TK+ + +V N G++ +I Y EN R
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHI--YNVDEENPGFPEPRAC 100
Query: 295 FW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWCGS 351
F+ QI+S +E+ H RR+++RDLK EN+L+D++ +++++D G + GQ K + G+
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160
Query: 352 PPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF--DGSTLNS--LRDRVLSGRFR 407
P + APE+ +G++Y +D ++LGV LY ++ PF G + + L+ R+L+
Sbjct: 161 PGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT 219
Query: 408 IPYFMSTECESLIRKMLVREPTKRY------CIEQIKRH------RWMAEETPRLLPP 453
P S +S +L ++P KR C + ++ H W E L PP
Sbjct: 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNC-DGLRTHPLFRDLNWRQLEAGMLPPP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-20
Identities = 64/215 (29%), Positives = 113/215 (52%), Gaps = 12/215 (5%)
Query: 237 YREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW 296
+ E +IM + P +++LF + +Y+V EY G++ + ++ Y + E AR
Sbjct: 91 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA 149
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS-NYYVPGQ-KLATWCGSPPY 354
+++ A++ H+ +HRD+K +N+L+D + +KLADFG G + T G+P Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 355 AAPEVFE---GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY- 410
+PEV + G Y G E D WS+GV LY ++ G PF +L ++++ + + +
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269
Query: 411 ---FMSTECESLIRKMLVREPTK--RYCIEQIKRH 440
+S E ++LI L + R +E+IKRH
Sbjct: 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-20
Identities = 69/248 (27%), Positives = 127/248 (51%), Gaps = 18/248 (7%)
Query: 210 VLLRHTVNV-AIKIIDKSQLDPVNLQKVYREV-EIMKQLDHPHIIKLFQVMETKSMIYIV 267
V ++HT + A+KI++K ++ +RE ++ D I L + ++ +Y+V
Sbjct: 20 VKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79
Query: 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
+Y G++ ++++ R+ E+ AR +++ A+ H VHRD+K +N+L+D N
Sbjct: 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG 139
Query: 327 DIKLADFGFSNYYVPGQKL--ATWCGSPPYAAPEVFEGK-----KYCGPEIDIWSLGVVL 379
I+LADFG + + G+P Y +PE+ + KY GPE D WSLGV +
Sbjct: 140 HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCM 198
Query: 380 YVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFM---STECESLIRKMLVREPTK--RY 432
Y ++ G PF +L ++++ RF+ P + S E + LI++++ + +
Sbjct: 199 YEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQN 258
Query: 433 CIEQIKRH 440
IE K+H
Sbjct: 259 GIEDFKKH 266
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 4e-20
Identities = 66/230 (28%), Positives = 116/230 (50%), Gaps = 16/230 (6%)
Query: 231 VNLQK------VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYG 284
+NLQ+ + E+ +M++ +P+I+ +++V EY G + D +
Sbjct: 53 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 285 RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343
M+E + L A+E+ H+ +V+HRD+K++N+L+ + +KL DFGF P Q
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS 403
K +T G+P + APEV K Y GP++DIWSLG++ ++ G P+ N LR L
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLI 228
Query: 404 GRFRIPYFMSTE-CESLIRKMLVR----EPTKRYCIEQIKRHRWMAEETP 448
P + E ++ R L R + KR +++ +H+++ P
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 23/168 (13%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR-MNENAARRKFW 296
RE ++K L H +I+ L ++ TK + +V EY ++ Y+ G ++ + R +
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLF 110
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG-----------FSNYYVPGQKL 345
Q+L + YCH RRV+HRDLK +NLL+ ++KLADFG +SN V
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----- 165
Query: 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
W Y P+V G +D+W +G + Y + G F GST
Sbjct: 166 TLW-----YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 53/214 (24%), Positives = 103/214 (48%), Gaps = 9/214 (4%)
Query: 232 NLQKVYREVEIMK-QLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENA 290
++ + EV I+K QL HP+I++ ++ +YIV + + ++ +
Sbjct: 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF 110
Query: 291 ARRKFW----QILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL 345
+ W Q++ A+ Y H +R+VHRDL N+++ + + + DFG + P KL
Sbjct: 111 TEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL 170
Query: 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR 405
+ G+ Y+ PE+ + + Y G + D+W+ G +LY + PF + + SL +++
Sbjct: 171 TSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
Query: 406 FR-IPYFM-STECESLIRKMLVREPTKRYCIEQI 437
+ +P M S + +I L + R I Q+
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-20
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 58/278 (20%)
Query: 219 AIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K + KS++ L V E +++ + D P ++ L+ + +Y++ E+ G++
Sbjct: 30 AMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLM 89
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS- 336
+ +Y +E+ R + + A+E H +HRD+K +N+L+D IKL+DFG S
Sbjct: 90 TMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149
Query: 337 --------NYYV----------------------------PGQKLATW-----------C 349
YY ++ATW
Sbjct: 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209
Query: 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
G+P Y APE+F + Y G E D WSLG +++ + G PF + ++++ R +
Sbjct: 210 GTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL- 267
Query: 410 YF-----MSTECESLIRKMLVREPTK--RYCIEQIKRH 440
YF +S E E LIR+++ + R +IK H
Sbjct: 268 YFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSH 305
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 66/233 (28%), Positives = 114/233 (48%), Gaps = 17/233 (7%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
T VAIK + + P + +E ++MK+L H +++L+ V+ ++ IYIV+EY ++G
Sbjct: 30 TTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG 85
Query: 275 EIFDYI-ARYGRMNENAARRKFW-QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
+ D++ G+ QI S + Y VHRDL+A N+L+ NL K+AD
Sbjct: 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 145
Query: 333 FGFSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPF 389
FG + + A P + APE ++ + D+WS G++L L G +P+
Sbjct: 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPY 204
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV----REPTKRYCIEQIK 438
G + D+V G +R+P EC + ++ +EP +R E ++
Sbjct: 205 PGMVNREVLDQVERG-YRMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 71/252 (28%), Positives = 110/252 (43%), Gaps = 56/252 (22%)
Query: 213 RHTVN---VAIKIIDKSQLDPV-NLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268
R VAIK+I +L+P + + + +E+ ++K+ HP+I+ F + ++IV
Sbjct: 23 RDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79
Query: 269 EYANQGEIFD-YIARYGRMNENAARRKFWQI-------LSAVEYCHNRRVVHRDLKAENL 320
EY G + D Y G ++E QI L + Y H +HRD+K N+
Sbjct: 80 EYCGGGSLQDIYQVTRGPLSEL-------QIAYVCRETLKGLAYLHETGKIHRDIKGANI 132
Query: 321 LMDSNLDIKLADFGFSNYYVPGQ------KLATWCGSPPYAAPEVFEGKKYCG--PEIDI 372
L+ + D+KLADFG V Q K ++ G+P + APEV ++ G + DI
Sbjct: 133 LLTEDGDVKLADFG-----VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187
Query: 373 WSLGVVLYVLVCGALP-FDGSTLNSLRDRVLSGRFRIPYFM------------STECESL 419
W+LG+ L P FD + R L F I S
Sbjct: 188 WALGITAIELAELQPPMFDLHPM-----RAL---FLISKSNFPPPKLKDKEKWSPVFHDF 239
Query: 420 IRKMLVREPTKR 431
I+K L ++P KR
Sbjct: 240 IKKCLTKDPKKR 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 62/226 (27%), Positives = 112/226 (49%), Gaps = 12/226 (5%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
++++ VA+K + + D + +++ +E +MK++ HP++++L V + YI++E+
Sbjct: 29 KYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G + DY+ R NA + QI SA+EY + +HRDL A N L+ N +K+
Sbjct: 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 145
Query: 331 ADFGFSNYYVPGQKLATWCGSP---PYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGA 386
ADFG S + G G+ + APE K+ + D+W+ GV+L+ + G
Sbjct: 146 ADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGM 203
Query: 387 LPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431
P+ G L+ + + + G R P + L+R P+ R
Sbjct: 204 SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 72/254 (28%), Positives = 116/254 (45%), Gaps = 48/254 (18%)
Query: 213 RHTVNVAIKII-----DKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
+ ++VAIK + DK +LD E IM Q DHP+II+L V+ + I+
Sbjct: 30 KKEIDVAIKTLKAGSSDKQRLD------FLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQIL-------SAVEYCHNRRVVHRDLKAENL 320
+EY G + D R EN + Q++ S ++Y VHRDL A N+
Sbjct: 84 TEYMENGSL-DKFLR-----ENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137
Query: 321 LMDSNLDIKLADFGFSN--------YYVPGQKL-ATWCGSPPYAAPEVFEGKKYCGPEID 371
L++SNL K++DFG S Y G K+ W APE +K+ D
Sbjct: 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW------TAPEAIAYRKFT-SASD 190
Query: 372 IWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV----R 426
+WS G+V++ V+ G P+ + + V G +R+P M +C S + ++++ +
Sbjct: 191 VWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPM--DCPSALYQLMLDCWQK 247
Query: 427 EPTKRYCIEQIKRH 440
+ +R QI
Sbjct: 248 DRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 33/185 (17%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
+ VA+K + +L + +E IM LDH ++I+L+ V+ T ++ +V+E A
Sbjct: 22 KVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPL 79
Query: 274 GEIFDYIARYGRMNENAAR----RKFW----QILSAVEYCHNRRVVHRDLKAENLLMDSN 325
G + D R+ ++A QI + + Y ++R +HRDL A N+L+ S+
Sbjct: 80 GSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD 133
Query: 326 LDIKLADFGFS-------NYYV--PGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
+K+ DFG ++YV K+ WC APE + + D+W
Sbjct: 134 DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC------APESLRTRTFSHAS-DVWMF 186
Query: 376 GVVLY 380
GV L+
Sbjct: 187 GVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKS--MIYIVSEYANQGEIFDYIARYGRMNENAARRKFW 296
E++++K L H I++ + + ++ + I EY G + D + YG + E+ R+
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY----VPGQKLATWCGSP 352
QIL + Y H+ +VHRD+K N+L DS ++KL DFG S + G + + G+P
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI---- 408
+ +PEV G+ Y G + D+WSLG + ++ P+ ++ F+I
Sbjct: 174 YWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPW-------AEYEAMAAIFKIATQP 225
Query: 409 -----PYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
P +S + + V E R E++ RH
Sbjct: 226 TNPQLPSHISEHARDFLGCIFV-EARHRPSAEELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 76/256 (29%), Positives = 119/256 (46%), Gaps = 28/256 (10%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A+K+I + D V Q + RE+EI++ ++HP+++K + + I ++ E+ + G +
Sbjct: 103 ALKVIYGNHEDTVRRQ-ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 279 YIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338
+ + AR QILS + Y H R +VHRD+K NLL++S ++K+ADFG S
Sbjct: 162 THIADEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR- 216
Query: 339 YVPGQKL---ATWCGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPF-- 389
+ Q + + G+ Y +PE Y G DIWSLGV + G PF
Sbjct: 217 -ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
Query: 390 --DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
G + + +S P S E I L REP KR+ Q+ +H ++
Sbjct: 276 GRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335
Query: 448 PR----------LLPP 453
P LLPP
Sbjct: 336 PGQGQGGPNLHQLLPP 351
|
Length = 353 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 30/238 (12%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW-- 296
E +I+++++ ++ L ETK + +V N G++ +I G + R F+
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAA 356
+I +E H R+V+RDLK EN+L+D I+++D G + G+ + G+ Y A
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMA 169
Query: 357 PEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRV----------LSGRF 406
PEV + ++Y D W LG ++Y ++ G PF R+ V S +F
Sbjct: 170 PEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKF 228
Query: 407 RIPYFMSTECESLIRKMLVREPTKRY-C----IEQIKRH------RWMAEETPRLLPP 453
S S+ R++L ++P R C E++K H + E L PP
Sbjct: 229 ------SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
T VA+K + +DP + E +IMK+L HP +I+L+ V + IYIV+E G
Sbjct: 30 TTPVAVKTLKPGTMDP---KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYG 86
Query: 275 EIFDYIARYG-------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ +Y+ ++ + AA Q+ S + Y + +HRDL A N+L+ N
Sbjct: 87 SLLEYLQGGAGRALKLPQLIDMAA-----QVASGMAYLEAQNYIHRDLAARNVLVGENNI 141
Query: 328 IKLADFGFS-----NYYVP--GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
K+ADFG + + Y G K + APE ++ + D+WS G++L
Sbjct: 142 CKVADFGLARVIKEDIYEAREGAKFPI-----KWTAPEAALYNRF-SIKSDVWSFGILLT 195
Query: 381 VLVC-GALPFDGSTLNSLRDRVLSGRFRIP 409
+V G +P+ G T + +V G +R+P
Sbjct: 196 EIVTYGRMPYPGMTNAEVLQQVDQG-YRMP 224
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 17/241 (7%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A K+I+ + L+ E+EI+ +HP+I+KL ++I+ E+ G +
Sbjct: 41 AAKVIETKSEE--ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98
Query: 279 YIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
+ R + E + Q+L A++Y H+ +++HRDLKA N+L+ + DIKLADFG S
Sbjct: 99 IMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158
Query: 338 YYVPG-QKLATWCGSPPYAAPEV-----FEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
V Q+ ++ G+P + APEV + Y + DIWSLG+ L + P
Sbjct: 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPH-- 215
Query: 392 STLNSLRDRVLSGRFRIPYFM-----STECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446
LN +R + + P S E ++ L + P R Q+ H +++
Sbjct: 216 HELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275
Query: 447 T 447
T
Sbjct: 276 T 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 72/258 (27%), Positives = 130/258 (50%), Gaps = 34/258 (13%)
Query: 210 VLLRHTVNV-AIKIIDKSQLDPVNLQKVYREV-EIMKQLDHPHIIKLFQVMETKSMIYIV 267
V +++T V A+KI++K ++ +RE +++ D I L + ++ +Y+V
Sbjct: 20 VKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79
Query: 268 SEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
+Y G++ ++++ R+ E+ AR +++ A++ H VHRD+K +N+L+D N
Sbjct: 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG 139
Query: 327 DIKLADFG-----------FSNYYVPGQKLATWCGSPPYAAPEVF----EGKKYCGPEID 371
I+LADFG SN V G+P Y +PE+ +GK GPE D
Sbjct: 140 HIRLADFGSCLRLLADGTVQSNVAV---------GTPDYISPEILQAMEDGKGRYGPECD 190
Query: 372 IWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--GRFRIP---YFMSTECESLIRKMLVR 426
WSLGV +Y ++ G PF +L ++++ F+ P +S E + LIR+++
Sbjct: 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS 250
Query: 427 EPTK--RYCIEQIKRHRW 442
T+ R ++ K H +
Sbjct: 251 PETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K + D Q E +M L HP++++L V+ + +YIV+EY +G +
Sbjct: 32 VAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88
Query: 278 DYIARYGR-MNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
DY+ GR + A + F + +EY + VHRDL A N+L+ +L K++DFG
Sbjct: 89 DYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL 148
Query: 336 ---SNYYVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFD 390
++ KL W APE KK+ D+WS G++L+ + G +P+
Sbjct: 149 AKEASQGQDSGKLPVKW------TAPEALREKKFSTKS-DVWSFGILLWEIYSFGRVPYP 201
Query: 391 GSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
L + V G R P E +++ +P KR +Q++
Sbjct: 202 RIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-19
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW-- 296
E +I+++++ ++ L ETK + +V N G++ +I G R F+
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAA 356
+I +E H R+V+RDLK EN+L+D + I+++D G + + GQ + G+ Y A
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169
Query: 357 PEVFEGKKYC-GPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRV----------LSGR 405
PEV + ++Y P D W+LG +LY ++ G PF R+ V S +
Sbjct: 170 PEVVKNERYTFSP--DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227
Query: 406 FRIPYFMSTECESLIRKMLVREPTKR 431
F S + SL + +L ++P +R
Sbjct: 228 F------SPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 7e-19
Identities = 67/243 (27%), Positives = 109/243 (44%), Gaps = 21/243 (8%)
Query: 218 VAIKIIDKSQLDPVNL-------QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
+A+K + +LD N+ +K+ EV+++K L H +I++ + I I E+
Sbjct: 27 IAVKQV---ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83
Query: 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G I + R+G + E + QIL V Y HN VVHRD+K N+++ N IKL
Sbjct: 84 VPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKL 143
Query: 331 ADFG-------FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
DFG + L + G+P + APEV Y G + DIWS+G ++ +
Sbjct: 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMA 202
Query: 384 CGALPFDGSTLNSLRDRVLSGRF---RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
G P + + + R R+P S + L R+ +R Q+ RH
Sbjct: 203 TGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262
Query: 441 RWM 443
++
Sbjct: 263 DFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 39/246 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK ++++ ++ E +MK+ + H+++L V+ T +V E +G++
Sbjct: 39 VAIKTVNENASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLK 97
Query: 278 DYIARYGRMNENAARRKF----------W--QILSAVEYCHNRRVVHRDLKAENLLMDSN 325
Y+ R E +I + Y ++ VHRDL A N ++ +
Sbjct: 98 SYLR--SRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155
Query: 326 LDIKLADFGF------SNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGV 377
L +K+ DFG ++YY G K G P + APE + + + D+WS GV
Sbjct: 156 LTVKIGDFGMTRDIYETDYYRKGGK-----GLLPVRWMAPESLKDGVFT-TKSDVWSFGV 209
Query: 378 VLYVLVC-GALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVR----EPTKR 431
VL+ + P+ G + + V+ G +P C + +++ P R
Sbjct: 210 VLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP----ENCPDKLLELMRMCWQYNPKMR 265
Query: 432 YCIEQI 437
+I
Sbjct: 266 PTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 221 KIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYI 280
KII + + V+ ++MK D+P+ IKL+ + T ++ +Y G++FD +
Sbjct: 47 KIIKAKNFNAIEP-MVH---QLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL 100
Query: 281 ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD-IKLADFGFSNYY 339
+ G+++E ++ Q++ A+ H ++H D+K EN+L D D I L D+G
Sbjct: 101 KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-- 158
Query: 340 VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-----TL 394
+ G + + G+ Y +PE +G Y D W++GV+ Y L+ G PF L
Sbjct: 159 IIGTP-SCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC-IEQIKRHRWM 443
SL R + +S ++ ML R +I +H ++
Sbjct: 217 ESLLKR-QQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-18
Identities = 59/215 (27%), Positives = 111/215 (51%), Gaps = 12/215 (5%)
Query: 237 YREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW 296
+ E +IM + P +++LF + +Y+V EY G++ + ++ Y + E A+
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTA 149
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG--FSNYYVPGQKLATWCGSPPY 354
+++ A++ H+ ++HRD+K +N+L+D + +KLADFG + T G+P Y
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209
Query: 355 AAPEVFE---GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY- 410
+PEV + G Y G E D WS+GV L+ ++ G PF +L +++ + + +
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269
Query: 411 ---FMSTECESLIRKMLVREPTK--RYCIEQIKRH 440
+S ++LI L + R +E+IK+H
Sbjct: 270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-18
Identities = 77/285 (27%), Positives = 139/285 (48%), Gaps = 33/285 (11%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYIVSEY 270
NVAIK + + + + ++ YRE+ +MK ++H +II L V +E +YIV E
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 271 --ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
AN ++ + RM+ +Q+L +++ H+ ++HRDLK N+++ S+ +
Sbjct: 111 MDANLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
K+ DFG + + + + Y APEV G Y +DIWS+G ++ ++ G +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVL 224
Query: 389 FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
F G+ ++V+ + T C ++K+ +PT R +E R ++
Sbjct: 225 FPGTDHIDQWNKVIEQ-------LGTPCPEFMKKL---QPTVRTYVEN--RPKYAGYSFE 272
Query: 449 RLLPPINILGEVKNEPNE----QILRLMNS-LGIDAAKTKEVFEA 488
+L P ++L +E N+ Q L++ L IDA+K V EA
Sbjct: 273 KLFP--DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 53/178 (29%), Positives = 88/178 (49%), Gaps = 23/178 (12%)
Query: 218 VAIKII--DKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM---ETKSMIYIVSEYAN 272
AIK DK Q ++ Q RE+ ++++L H +++ L +V KS +Y++ +YA
Sbjct: 30 YAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVSLVEVFLEHADKS-VYLLFDYAE 87
Query: 273 Q--GEI--FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD- 327
+I F A+ + + + WQIL+ V Y H+ V+HRDLK N+L+
Sbjct: 88 HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPE 147
Query: 328 ---IKLADFGFSN-YYVPGQKLATWCGSPP-----YAAPEVFEGKKYCGPEIDIWSLG 376
+K+ D G + + P + LA P Y APE+ G ++ IDIW++G
Sbjct: 148 RGVVKIGDLGLARLFNAPLKPLAD--LDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 66/245 (26%), Positives = 116/245 (47%), Gaps = 27/245 (11%)
Query: 212 LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
L V +AIK I + D +Q ++ E+ + L H +I++ I E
Sbjct: 30 LSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87
Query: 272 NQGEIFDYI-ARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
G + + +++G + +N F+ QIL ++Y H+ ++VHRD+K +N+L+++ +
Sbjct: 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV 147
Query: 329 -KLADFGFSNYYVPGQKLA-------TWCGSPPYAAPEVFE-GKKYCGPEIDIWSLGVVL 379
K++DFG S ++LA T+ G+ Y APEV + G + G DIWSLG +
Sbjct: 148 VKISDFGTS------KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTI 201
Query: 380 YVLVCGALPFDGSTLNSLRDRVLS-GRFR----IPYFMSTECESLIRKMLVREPTKRYCI 434
+ G PF L + + G F+ IP +S E ++ I + +P KR
Sbjct: 202 VEMATGKPPF--IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASA 259
Query: 435 EQIKR 439
+ +
Sbjct: 260 HDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 4/178 (2%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K+I + V + RE ++K L H +I+ L ++ TK + V EY ++
Sbjct: 33 VALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLA 90
Query: 278 DYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
Y+ ++ G ++ R +Q+L + Y H + ++HRDLK +NLL+ ++KLADFG +
Sbjct: 91 QYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLA 150
Query: 337 NY-YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
+P Q ++ + Y P+V G +DIW G + ++ G F G +
Sbjct: 151 RAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 67/234 (28%), Positives = 112/234 (47%), Gaps = 17/234 (7%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A K+ID + L+ E++I+ DHP+I+KL ++ ++I+ E+ G +
Sbjct: 34 AAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 91
Query: 279 YIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
+ R + E R Q L A+ Y H +++HRDLKA N+L + DIKLADFG S
Sbjct: 92 VMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA 151
Query: 338 YYVPG-QKLATWCGSPPYAAPEVF-----EGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
Q+ ++ G+P + APEV + + Y + D+WSLG+ L + P
Sbjct: 152 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPH-- 208
Query: 392 STLNSLRDRVLSGRFRIPYFM-----STECESLIRKMLVREPTKRYCIEQIKRH 440
LN +R + + P S+E + ++K L + R+ Q+ +H
Sbjct: 209 HELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 57/222 (25%), Positives = 110/222 (49%), Gaps = 33/222 (14%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYIVSE 269
VAIK + + ++ ++ YRE+ ++K +DH ++I L V +E +Y+V+
Sbjct: 41 RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G + I + +++++ + +QIL ++Y H+ ++HRDLK N+ ++ + ++K
Sbjct: 101 LM--GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 158
Query: 330 LADFGFSNY-------YVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYV 381
+ DFG + + YV AT W Y APE+ + +DIWS+G ++
Sbjct: 159 ILDFGLARHTDDEMTGYV-----ATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 382 LVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKM 423
L+ G F GS R+++ + T E L++K+
Sbjct: 209 LLTGKTLFPGSDHIDQLKRIMN-------LVGTPDEELLQKI 243
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 32/229 (13%)
Query: 234 QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIAR-YGRMNENAAR 292
+++ RE++IM + P+I+ + ++ I + E+ + G D I + G +
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS-LDRIYKKGGPIPVEILG 106
Query: 293 RKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA-TWCG 350
+ ++ + Y +N R++HRD+K N+L++S IKL DFG S + +A T+ G
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFVG 164
Query: 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRD----------- 399
+ Y +PE +G KY + D+WSLG+ + L G PF S ++
Sbjct: 165 TSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ 223
Query: 400 --------RVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
R+ S F + + L+++PT+R +Q+
Sbjct: 224 QIVQEPPPRLPSSDF------PEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 57/221 (25%), Positives = 109/221 (49%), Gaps = 9/221 (4%)
Query: 219 AIKIIDKSQLDPVNLQKV-YREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A K +DK +L + +K+ E EI+++++ P I+ L E+K+ + +V N G++
Sbjct: 22 ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK 81
Query: 278 DYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+I G R + QI + + H+ +V+RD+K EN+L+D + +L+D G
Sbjct: 82 YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL 141
Query: 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF----DG 391
+ G+ + G+ Y APE+ + + Y P +D +++G +Y +V G PF +
Sbjct: 142 AVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEK 200
Query: 392 STLNSLRDRVLSGRFRIPYF-MSTECESLIRKMLVREPTKR 431
L+ R L + + + E + + R L ++P R
Sbjct: 201 VAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK + + + P + E +MKQL HP +++L+ V+ T+ IYI++EY G +
Sbjct: 33 VAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLV 88
Query: 278 DYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
D++ ++ N QI + + + +HRDL+A N+L+ L K+ADFG
Sbjct: 89 DFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGL 148
Query: 336 SNYYVPGQKLATWCGSPP--YAAPE-----VFEGKKYCGPEIDIWSLGVVLYVLVC-GAL 387
+ + A P + APE F K D+WS G++L +V G +
Sbjct: 149 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS------DVWSFGILLTEIVTYGRI 202
Query: 388 PFDGSTLNSLRDRVLSGRFRIP 409
P+ G T N + L +R+P
Sbjct: 203 PYPGMT-NPEVIQNLERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 54/174 (31%), Positives = 92/174 (52%), Gaps = 11/174 (6%)
Query: 218 VAIKIIDKSQLD-PVNLQK-VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+A+K+I LD V LQK + E+EI+ + D P+II + ++ I I +E+ + G
Sbjct: 29 LAVKVI---PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ Y ++ E+ R ++ + Y + +++HRD+K N+L+++ +KL DFG
Sbjct: 86 L----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGV 141
Query: 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
S V T+ G+ Y APE G++Y G D+WSLG+ L G P+
Sbjct: 142 STQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 58/269 (21%)
Query: 218 VAIKIIDK--SQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVM--ETKSMIYIVSEYAN 272
AIK + K L+ VN RE++ +++L HP+I++L +V+ + +V E +
Sbjct: 27 YAIKCMKKHFKSLEQVN---NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83
Query: 273 QGEIFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
+++ I R + E + +Q+L ++++ H + HRD+K EN+L+ ++ +KLA
Sbjct: 84 M-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI-LKLA 141
Query: 332 DFGFSNYYVPGQKLATWCGSPPYA---------APEVFEGKKYCGPEIDIWSLGVVLYVL 382
DFG PPY APE Y GP++DIW++G V + +
Sbjct: 142 DFG---------SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEI 192
Query: 383 VC------GALPFD---------GSTLNSLRDRVLSGRFRIPYF--------------MS 413
+ G D G+ + + R F S
Sbjct: 193 LSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNAS 252
Query: 414 TECESLIRKMLVREPTKRYCIEQIKRHRW 442
E L++K+L +P +R +Q RH +
Sbjct: 253 AEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 9e-18
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW-- 296
E +I+++++ ++ L ETK + +V N G++ +I G R F+
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAA 356
+IL +E H V+RDLK EN+L+D I+++D G + G+ + G+ Y A
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169
Query: 357 PEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRD----RVLSGRFRIPYFM 412
PEV ++Y D W LG ++Y ++ G PF G R+ RVL
Sbjct: 170 PEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF 228
Query: 413 STECESLIRKMLVREPTKRY-CIE----QIKRH 440
S E +S+ + +L ++P +R C E ++KRH
Sbjct: 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 60/238 (25%), Positives = 118/238 (49%), Gaps = 27/238 (11%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
VA+K + + P + E +IMK+L H +++L+ V+ ++ IYIV+EY ++G
Sbjct: 30 NTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKG 85
Query: 275 EIFDYI----ARYGRMN---ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ D++ R ++ + AA Q+ + + Y +HRDL++ N+L+ L
Sbjct: 86 SLLDFLKDGEGRALKLPNLVDMAA-----QVAAGMAYIERMNYIHRDLRSANILVGDGLV 140
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC- 384
K+ADFG + + A P + APE ++ + D+WS G++L LV
Sbjct: 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTK 199
Query: 385 GALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV----REPTKRYCIEQIK 438
G +P+ G + ++V G +R+P +C + ++++ ++P +R E ++
Sbjct: 200 GRVPYPGMNNREVLEQVERG-YRMP--CPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 78/289 (26%)
Query: 218 VAIK-IIDKSQLD--PVNLQKVYREVEIMKQLDHPHIIKLF--------QVMETKSMIYI 266
VA+K I+ ++ D P+ RE++I+K+L HP+++ L + + +Y+
Sbjct: 36 VALKKILMHNEKDGFPITAL---REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92
Query: 267 VSEYANQGEIFDYIARYG----RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM 322
V+ Y + D ++ E+ + Q+L + Y H ++HRD+KA N+L+
Sbjct: 93 VTPYMDH----DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI 148
Query: 323 DSNLDIKLADFGFS-NYYVPGQKLATWCGSPP---------------YAAPEVFEGKKYC 366
D+ +K+ADFG + Y P Y PE+ G++
Sbjct: 149 DNQGILKIADFGLARPYDGPPPNP----KGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204
Query: 367 GPEIDIWSLGVVLYVL---------------------VCG-----------ALP-FDGST 393
+DIW +G V + +CG +LP +G
Sbjct: 205 TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVH 264
Query: 394 LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
+ R L RF + E L+ K+L +P KR H +
Sbjct: 265 SFTNYPRTLEERFGK---LGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK I + + + E ++M +L HP +++L+ V +S I +V E+ G +
Sbjct: 31 VAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87
Query: 278 DYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
DY+ A+ G+ ++ + + Y + V+HRDL A N L+ N +K++DFG +
Sbjct: 88 DYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
Query: 337 NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGST 393
+ + Q ++ P +++PEVF KY D+WS GV+++ V G P++ +
Sbjct: 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS-DVWSFGVLMWEVFSEGKTPYENRS 206
Query: 394 LNSLRDRVLSGRFRI 408
NS ++ FR+
Sbjct: 207 -NSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K + L P K +E I+KQ HP+I++L V K IYIV E G+
Sbjct: 23 VAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81
Query: 278 DYIARYG---------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
++ G +M ENAA + +EY ++ +HRDL A N L+ +
Sbjct: 82 TFLRTEGPRLKVKELIQMVENAA--------AGMEYLESKHCIHRDLAARNCLVTEKNVL 133
Query: 329 KLADFGFSNYYVPGQKLATWCGSP---PYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVC 384
K++DFG S G +T + APE +Y E D+WS G++L+
Sbjct: 134 KISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSL 192
Query: 385 GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431
GA+P+ + R+ + G R P L+ + +P +R
Sbjct: 193 GAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 65/243 (26%), Positives = 107/243 (44%), Gaps = 31/243 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K++ K L+ + E ++KQ++HPH+IKL+ + ++ EYA G +
Sbjct: 33 VAVKML-KENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 91
Query: 278 DYI---------------ARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHR 313
++ R +N R WQI ++Y ++VHR
Sbjct: 92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151
Query: 314 DLKAENLLMDSNLDIKLADFGFS-NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEI 370
DL A N+L+ +K++DFG S + Y + G P + A E Y +
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQS 210
Query: 371 DIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREP 428
D+WS GV+L+ +V G P+ G L + + +G R P S E +L+ +EP
Sbjct: 211 DVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEP 270
Query: 429 TKR 431
KR
Sbjct: 271 DKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 71/259 (27%), Positives = 112/259 (43%), Gaps = 39/259 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA--NQGE 275
VAIK S+ + + RE+++++ L +I++L + + +Y+V EY N E
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ + + G E R +Q++ A+ +CH +VHRD+K ENLL+ N +KL DFGF
Sbjct: 89 LLEEMPN-GVPPEKV-RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146
Query: 336 SNYYVPGQ--KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL----------- 382
+ G + + Y +PE+ G Y G +D+WS+G +L L
Sbjct: 147 ARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGES 205
Query: 383 ----------VCGALPFDGSTLNSLRDRVLSGRF-----------RIPYFMSTECESLIR 421
V G LP + L R RF R +S L++
Sbjct: 206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMK 265
Query: 422 KMLVREPTKRYCIEQIKRH 440
+L PT RY EQ H
Sbjct: 266 NLLKLNPTDRYLTEQCLNH 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 50/188 (26%), Positives = 92/188 (48%), Gaps = 22/188 (11%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+ VAIK++ + P +++ E +M +DHPH+++L + + + ++++ G
Sbjct: 37 IPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGC 94
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ DY+ R + N + W QI + Y +R+VHRDL A N+L+ + +K+ DF
Sbjct: 95 LLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDF 153
Query: 334 GF--------SNYYVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLV 383
G Y+ G K+ W A E + Y + D+WS GV ++ ++
Sbjct: 154 GLAKLLDVDEKEYHAEGGKVPIKW------MALESILHRIYTH-KSDVWSYGVTVWELMT 206
Query: 384 CGALPFDG 391
GA P++G
Sbjct: 207 FGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 66/256 (25%), Positives = 110/256 (42%), Gaps = 48/256 (18%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSM--IYIVSEYANQ--GEIFDYIARYGRMNENAARR 293
RE+ ++ L HP+I++L +V+ K + I++V EY Q + D + +E+ +
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKC 112
Query: 294 KFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT------ 347
Q+L ++Y H ++HRDLK NLL+ +K+ADFG + Y K T
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL 172
Query: 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST----LN-------- 395
W Y APE+ G ID+W++G +L L+ G + L+
Sbjct: 173 W-----YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227
Query: 396 -------SLRDRVLSGRFRI---PY--------FMSTECESLIRKMLVREPTKRYCIEQI 437
D L G+F + PY ++S L+ +L+ +P KR E+
Sbjct: 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287
Query: 438 KRHRWMAEETPRLLPP 453
+ +E P P
Sbjct: 288 LESSYF-KEKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 64/235 (27%), Positives = 112/235 (47%), Gaps = 21/235 (8%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
T VAIK + + P + +E +IMK+L H ++ L+ V+ ++ IYIV+E+ +G
Sbjct: 30 TTKVAIKTLKPGTMMP---EAFLQEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKG 85
Query: 275 EIFDYIA-------RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ D++ + ++ + AA QI + Y +HRDL+A N+L+ NL
Sbjct: 86 SLLDFLKEGDGKYLKLPQLVDMAA-----QIADGMAYIERMNYIHRDLRAANILVGDNLV 140
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC- 384
K+ADFG + + A P + APE ++ + D+WS G++L LV
Sbjct: 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTK 199
Query: 385 GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIK 438
G +P+ G + ++V G R P L++ ++P +R E I+
Sbjct: 200 GRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQ 254
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 35/246 (14%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K + K + RE E++ H +I+K + V +V EY G++
Sbjct: 38 VAVKTL-KETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96
Query: 278 DYIARYG--------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD 323
++ +G + + + QI S + Y ++ VHRDL N L+
Sbjct: 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156
Query: 324 SNLDIKLADFGFS------NYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLG 376
+L +K+ DFG S +YY V G + PP + + K E D+WS G
Sbjct: 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPES---IMYRKFTT--ESDVWSFG 211
Query: 377 VVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV----REPTKR 431
VVL+ + G P+ G + + + + GR C S + +++ R+P +R
Sbjct: 212 VVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQR 268
Query: 432 YCIEQI 437
I+ I
Sbjct: 269 INIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-17
Identities = 64/271 (23%), Positives = 121/271 (44%), Gaps = 48/271 (17%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-----IYIVSEYAN 272
VA+K + + V+ ++V+RE++++ H +++ +++ + IY+V+E
Sbjct: 28 VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM- 86
Query: 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
Q ++ I ++ + + +QIL ++Y H+ ++HRD+K NLL++SN +K+ D
Sbjct: 87 QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146
Query: 333 FGFSNYYVPG------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386
FG + P Q++ T Y APE+ G ++ +DIWS+G + L+
Sbjct: 147 FGLARVEEPDESKHMTQEVVT----QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
Query: 387 LPFD-----------------------GSTLNSLRDRVLSGRFRIP-----YFMST---- 414
+ F S R +L G + P Y +S+
Sbjct: 203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATH 262
Query: 415 ECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
E L+ +MLV +P KR H ++ E
Sbjct: 263 EAVHLLCRMLVFDPDKRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 9/234 (3%)
Query: 212 LRHTVNVAIKIIDKSQLDPVNLQ-KVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
L+ VA+K K L P L+ K E I+KQ DHP+I+KL V + IYIV E
Sbjct: 16 LKDKTPVAVKTC-KEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL 73
Query: 271 ANQGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G+ ++ + + KF + + Y ++ +HRDL A N L+ N +K
Sbjct: 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLK 133
Query: 330 LADFGFSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGA 386
++DFG S G ++ P + APE +Y E D+WS G++L+ G
Sbjct: 134 ISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS-ESDVWSYGILLWETFSLGV 192
Query: 387 LPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
P+ G T R++V G R P + ++++ +P R ++++
Sbjct: 193 CPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 64/257 (24%), Positives = 121/257 (47%), Gaps = 23/257 (8%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQL----DHPHIIKLFQVMETKSMIYIVSEYANQG 274
A+K +DK ++ + + IM L D P I+ + T + + + N G
Sbjct: 23 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 82
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
++ +++++G +E R +I+ +E+ HNR VV+RDLK N+L+D + ++++D G
Sbjct: 83 DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ + + A+ G+ Y APEV + D +SLG +L+ L+ G PF
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
Query: 395 ---NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-YCI----EQIKRHR----- 441
+ + L+ +P S E SL+ +L R+ +R C+ +++K H
Sbjct: 202 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261
Query: 442 -----WMAEETPRLLPP 453
++ + P L+PP
Sbjct: 262 DWQMVFLQKYPPPLIPP 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-16
Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 26/244 (10%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYIVSEY 270
NVAIK + + + + ++ YRE+ +MK ++H +II L V +E +Y+V E
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103
Query: 271 --ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
AN ++ + RM+ +Q+L +++ H+ ++HRDLK N+++ S+ +
Sbjct: 104 MDANLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
K+ DFG + + + + Y APEV G Y +DIWS+G ++ +V +
Sbjct: 159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKIL 217
Query: 389 FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
F G ++V+ + T C ++K+ +PT R +E R ++ P
Sbjct: 218 FPGRDYIDQWNKVIEQ-------LGTPCPEFMKKL---QPTVRNYVEN--RPKYAGLTFP 265
Query: 449 RLLP 452
+L P
Sbjct: 266 KLFP 269
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-16
Identities = 66/278 (23%), Positives = 126/278 (45%), Gaps = 56/278 (20%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYIVSE 269
+NVA+K + + + + ++ YRE+ ++K ++H +II L V +E +Y+V E
Sbjct: 47 INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106
Query: 270 Y--ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
AN ++ + RM+ +Q+L +++ H+ ++HRDLK N+++ S+
Sbjct: 107 LMDANLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 161
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
+K+ DFG + + + + Y APEV G Y +DIWS+G ++ LV G++
Sbjct: 162 LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSV 220
Query: 388 PFDGST-------------------LNSLRDRVLSGRFRIPYF----------------- 411
F G+ +N L+ V + P +
Sbjct: 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSE 280
Query: 412 ------MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
+++ L+ KMLV +P KR +++ RH ++
Sbjct: 281 SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 66/247 (26%), Positives = 114/247 (46%), Gaps = 29/247 (11%)
Query: 219 AIKIIDKSQLDPVNL--QKVYREVEIMKQL-DHPHIIKLFQVMETKSM-----IYIVSEY 270
A+KI LDP++ +++ E I+K L DHP+++K + + K + +++V E
Sbjct: 47 AVKI-----LDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101
Query: 271 ANQGEIFD----YIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
N G + D ++ R RM E + L +++ H + +HRD+K N+L+ +
Sbjct: 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG 161
Query: 327 DIKLADFGFSNYYVPGQ-KLATWCGSPPYAAPEVFEGKKYCGP----EIDIWSLGVVLYV 381
+KL DFG S + + T G+P + APEV ++ D+WSLG+
Sbjct: 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
Query: 382 LVCGALPFDGSTLNSLR-----DRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQ 436
L G P + L+ +R R P S E IRK L ++ KR +
Sbjct: 222 LGDGDPPL--ADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSD 279
Query: 437 IKRHRWM 443
+ +H ++
Sbjct: 280 LLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 28/248 (11%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS-------MIYIVS 268
VAIKI+D + +++ E I+++ +HP+I F K +++V
Sbjct: 33 LVAIKIMD---IIEDEEEEIKEEYNILRKYSNHPNIAT-FYGAFIKKNPPGNDDQLWLVM 88
Query: 269 EYANQGEIFDYI----ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS 324
E G + D + + R+ E + L + Y H +V+HRD+K +N+L+
Sbjct: 89 ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK 148
Query: 325 NLDIKLADFGFS-NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGP----EIDIWSLGVVL 379
N ++KL DFG S + T+ G+P + APEV + D+WSLG+
Sbjct: 149 NAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208
Query: 380 YVLVCGALPFDGSTLNSLRD-----RVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCI 434
L G P ++ +R R + P S + I + L++ +R +
Sbjct: 209 IELADGKPPL--CDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM 266
Query: 435 EQIKRHRW 442
E++ H +
Sbjct: 267 EELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 63/268 (23%), Positives = 113/268 (42%), Gaps = 37/268 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K+I + + + RE ++K L H +I+ L ++ TK + +V EY + ++
Sbjct: 33 VALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLC 90
Query: 278 DYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
Y+ ++ G ++ + +Q+L + Y H R ++HRDLK +NLL+ ++KLADFG +
Sbjct: 91 QYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLA 150
Query: 337 NY-YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS--- 392
VP + + Y P+V G +D+W +G + ++ G F G
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
Query: 393 ---------TLNSLRDRVLSGRFRIPYFMS---------------------TECESLIRK 422
L + + G +P+F E L K
Sbjct: 211 QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASK 270
Query: 423 MLVREPTKRYCIEQIKRHRWMAEETPRL 450
+L P R + H + ++ PRL
Sbjct: 271 LLQCFPKNRLSAQAALSHEYFSDLPPRL 298
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 43/269 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM----IYIVSEYANQ 273
VAIK I + P ++ RE++I++ H +II + ++ +Y+V + +
Sbjct: 33 VAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-E 91
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
++ I + E R +Q+L ++Y H+ V+HRDLK NLL++ + ++++ DF
Sbjct: 92 SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDF 151
Query: 334 GFSNYYVPGQK-----LATWCGSPPYAAPEV-FEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
G + + + + Y APE+ +Y ID+WS+G + ++
Sbjct: 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEMLGRRQ 210
Query: 388 PFDGST-------------------LNSLR-DRV------LSGRFRIPY---FMSTECES 418
F G LN + DRV L + +P+ F E+
Sbjct: 211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEA 270
Query: 419 --LIRKMLVREPTKRYCIEQIKRHRWMAE 445
L+ +ML +P +R +EQ +H ++A+
Sbjct: 271 LDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW-- 296
E I+++++ ++ L ETK + +V N G++ +I G + R F+
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAA 356
++ +E R+V+RDLK EN+L+D I+++D G + G+ + G+ Y A
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMA 169
Query: 357 PEVFEGKKYC-GPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRD----RVLSGRFRIPYF 411
PEV +KY P D W LG ++Y ++ G PF R+ RV +
Sbjct: 170 PEVINNEKYTFSP--DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
Query: 412 MSTECESLIRKMLVREPTKR 431
S + +S+ R +L + P +R
Sbjct: 228 FSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-16
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 219 AIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+KI+ K+ L+ + + E +I+ + D ++K+F + K +Y++ E+ G++
Sbjct: 30 AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS- 336
+ + + E + + + A++ H +HRD+K +NLL+DS +KL+DFG
Sbjct: 90 TLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149
Query: 337 --------------NYYVPG----------QKLATW-----------CGSPPYAAPEVFE 361
N+ +P +K TW G+P Y APEVF
Sbjct: 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209
Query: 362 GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR 405
Y D WSLGV++Y ++ G PF T +V++ +
Sbjct: 210 QTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 34/217 (15%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
+VAIK + ++ V Q+ +E E+M L HP+I+ L V + ++ EY
Sbjct: 34 SATSVAIKTLKENAEPKVQ-QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAH 92
Query: 274 GEIFDYIARYGRMNENAARRKF----------------WQILSAVEYCHNRRVVHRDLKA 317
G++ +++ R ++ A QI + +EY + VHRDL A
Sbjct: 93 GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAA 152
Query: 318 ENLLMDSNLDIKLADFGFS------NYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEI 370
N L+ L +K++DFG S +YY V + L PP A + GK E
Sbjct: 153 RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEA---ILYGK--FTTES 207
Query: 371 DIWSLGVVLY-VLVCGALPFDG----STLNSLRDRVL 402
DIWS GVVL+ + G P+ G + +R R L
Sbjct: 208 DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
++ VA+K + + ++Q E +MK L H +++L+ V+ + IYI++EY +
Sbjct: 29 NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85
Query: 274 GEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + D++ G++ QI + Y + +HRDL+A N+L+ +L K+A
Sbjct: 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIA 145
Query: 332 DFGFSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALP 388
DFG + + A P + APE + + D+WS G++LY +V G +P
Sbjct: 146 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIP 204
Query: 389 FDGSTLNSLRDRVLSGRFRIP 409
+ G + NS L +R+P
Sbjct: 205 YPGMS-NSDVMSALQRGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 72/308 (23%), Positives = 132/308 (42%), Gaps = 74/308 (24%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS--------------M 263
VA+K I DP +++ RE++I+++LDH +I+K+++V+
Sbjct: 33 VAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90
Query: 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD 323
+YIV EY + G ++E AR +Q+L ++Y H+ V+HRDLK N+ ++
Sbjct: 91 VYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148
Query: 324 S-NLDIKLADFGFS-----NY----YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIW 373
+ +L +K+ DFG + +Y Y+ + W Y +P + ID+W
Sbjct: 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-----YRSPRLLLSPNNYTKAIDMW 203
Query: 374 SLGVVLYVLVCGALPFDGS--------TLNSL-------RDRVLSGRFRIPYFMS----- 413
+ G + ++ G F G+ L S+ R+ +L+ IP F+
Sbjct: 204 AAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN---VIPSFVRNDGGE 260
Query: 414 -----------TECESL--IRKMLVREPTKRYCIEQIKRHRWMA-----EETPRLLPPIN 455
E+L + ++L P R E+ H +M+ + P L P +
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFH 320
Query: 456 ILGEVKNE 463
I E+ +
Sbjct: 321 IEDELDDI 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 63/234 (26%), Positives = 116/234 (49%), Gaps = 13/234 (5%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQL----DHPHIIKLFQVMETKSMIYIVSEYANQG 274
A+K +DK ++ + + IM L D P I+ + T + + + N G
Sbjct: 23 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGG 82
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
++ +++++G +E R +I+ +E+ HNR VV+RDLK N+L+D + ++++D G
Sbjct: 83 DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ + + A+ G+ Y APEV + D +SLG +L+ L+ G PF
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
Query: 395 NSLR--DRV-LSGRFRIPYFMSTECESLIRKMLVREPTKRY-CI----EQIKRH 440
DR+ L+ +P S E +SL+ +L R+ +KR C+ +++K H
Sbjct: 202 KDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-16
Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 56/273 (20%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-----IYIVSEYAN 272
VAIK I + + ++ ++ RE+++++ LDH ++I + +M +YIV E +
Sbjct: 33 VAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD 92
Query: 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
++ I ++++ + +Q+L ++Y H+ V+HRDLK NLL+++N D+K+ D
Sbjct: 93 T-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 151
Query: 333 FG----------FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL 382
FG F YV + W Y APE+ ID+WS+G + L
Sbjct: 152 FGLARTTSEKGDFMTEYV----VTRW-----YRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
Query: 383 VCGALPFDG-----------STLNSLRDRVL-------SGRF--RIPYF----------- 411
+ F G L S + L + R+ +PY
Sbjct: 203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH 262
Query: 412 MSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444
+ L+ KMLV +P+KR +E+ H ++A
Sbjct: 263 ANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 57/178 (32%), Positives = 88/178 (49%), Gaps = 22/178 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIYIVSEYANQGE 275
VA+K + S + +L+ RE+EI+K L H +I+K V + + + +V EY G
Sbjct: 36 VAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93
Query: 276 IFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ DY+ ++ R++ QI +EY ++R VHRDL N+L++S +K+ DFG
Sbjct: 94 LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153
Query: 335 FS-------NYYV---PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL 382
+ YY PG+ W APE K+ D+WS GVVLY L
Sbjct: 154 LTKVLPQDKEYYKVREPGESPIFW------YAPESLTESKF-SVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 7e-16
Identities = 70/284 (24%), Positives = 131/284 (46%), Gaps = 30/284 (10%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYIVSEY 270
NVAIK + + + + ++ YRE+ +MK ++H +II L V +E +Y+V E
Sbjct: 43 NVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL 102
Query: 271 --ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
AN ++ + RM+ +Q+L +++ H+ ++HRDLK N+++ S+ +
Sbjct: 103 MDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 157
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
K+ DFG + + + + Y APEV G Y +DIWS+G ++ ++ G +
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVL 216
Query: 389 FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
F G D + +I + T + + ++ +PT R +E ++ + E
Sbjct: 217 FPG------TDHIDQWN-KIIEQLGTPSDEFMSRL---QPTVRNYVENRPKYAGYSFE-- 264
Query: 449 RLLPPINILGE----VKNEPNEQILRLMNSLGIDAAKTKEVFEA 488
L P + + K + ++ L L ID K V +A
Sbjct: 265 ELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 56/180 (31%), Positives = 87/180 (48%), Gaps = 8/180 (4%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+ VAIK + + + E IM Q DHP+II L V+ + IV+EY G
Sbjct: 33 IPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGS 91
Query: 276 IFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ ++ ++ G+ I S ++Y + VHRDL A N+L++SNL K++DFG
Sbjct: 92 LDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 335 FSNYYV--PGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPF 389
S P T G P + APE +K+ D+WS G+V++ V+ G P+
Sbjct: 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS-DVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 7e-16
Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 32/181 (17%)
Query: 218 VAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVM-----ETKSMIYIVSEY- 270
VAIK I S + Q+ RE++I+++ H +II + ++ E+ + +YIV E
Sbjct: 33 VAIKKI--SPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM 90
Query: 271 --------ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM 322
Q D+I + +QIL ++Y H+ V+HRDLK NLL+
Sbjct: 91 ETDLYKLIKTQHLSNDHIQYF-----------LYQILRGLKYIHSANVLHRDLKPSNLLL 139
Query: 323 DSNLDIKLADFGFSNYYVP----GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
++N D+K+ DFG + P L + + Y APE+ K IDIWS+G +
Sbjct: 140 NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCI 199
Query: 379 L 379
L
Sbjct: 200 L 200
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM-ETKSMIYIVSEYANQG 274
VA+K I Q E +M QL H ++++L V+ E K +YIV+EY +G
Sbjct: 30 NKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85
Query: 275 EIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
+ DY+ GR + + + + A+EY VHRDL A N+L+ + K++D
Sbjct: 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSD 145
Query: 333 FGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDG 391
FG + Q + APE KK+ + D+WS G++L+ + G +P+
Sbjct: 146 FGLTKEASSTQDTGKL--PVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPR 202
Query: 392 STLNSLRDRVLSG 404
L + RV G
Sbjct: 203 IPLKDVVPRVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 45/186 (24%), Positives = 98/186 (52%), Gaps = 10/186 (5%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYI 266
+ + VA+K + + ++ ++ YRE+ ++K + H ++I L V +E + +Y+
Sbjct: 40 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
V+ G + I + ++ ++ + +QIL ++Y H+ ++HRDLK NL ++ +
Sbjct: 100 VTHL--MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157
Query: 327 DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386
++K+ DFG + + ++ + + Y APE+ + +DIWS+G ++ L+ G
Sbjct: 158 ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
Query: 387 LPFDGS 392
F G+
Sbjct: 216 TLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-15
Identities = 63/189 (33%), Positives = 94/189 (49%), Gaps = 20/189 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKL--------FQVMETKSMIYIVSE 269
VAIK K DP Q RE+ IMK L+H +II L F+ E + +V E
Sbjct: 94 VAIK---KVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 270 YANQGEIFDYIARYGRMNENA----ARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
+ Q + Y+ Y R N + +Q+ A+ Y H++ + HRDLK +NLL+D N
Sbjct: 148 FIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN 206
Query: 326 L-DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC 384
+KL DFG + + GQ+ ++ S Y APE+ G ID+WSLG ++ ++
Sbjct: 207 THTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 385 GALPFDGST 393
G F G +
Sbjct: 267 GYPIFSGQS 275
|
Length = 440 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 47/152 (30%), Positives = 85/152 (55%), Gaps = 12/152 (7%)
Query: 238 REVEIMKQLD---HPHIIKLFQV-----METKSMIYIVSEYANQGEIFDYIARYGR--MN 287
REV +++ L+ HP++++LF V + ++ + +V E+ +Q ++ Y+ + +
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108
Query: 288 ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347
+ +Q+L +++ H+ RVVHRDLK +N+L+ S+ IKLADFG + Y L +
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 168
Query: 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
+ Y APEV Y P +D+WS+G +
Sbjct: 169 VVVTLWYRAPEVLLQSSYATP-VDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K I + D V Q E +M +L H ++++L V+ + YIV E ++G +
Sbjct: 32 VAVKNI---KCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGL-YIVMELMSKGNLV 86
Query: 278 DYIARYGRMNENAAR--RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+++ GR + + + + +EY ++++VHRDL A N+L+ + K++DFG
Sbjct: 87 NFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL 146
Query: 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTL 394
+ V + + APE + KK+ + D+WS GV+L+ V G P+ +L
Sbjct: 147 AR--VGSMGVDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203
Query: 395 NSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431
+++ V G R P + L+ EP KR
Sbjct: 204 KEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-15
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 219 AIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+KI+ K+ L+ + + E +I+ + D ++K+F + K +Y++ E+ G++
Sbjct: 30 AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF-- 335
+ + ++E A + + + A++ H +HRD+K +NLL+D+ +KL+DFG
Sbjct: 90 TLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149
Query: 336 -------SNYYV----------------PGQKLATW-----------CGSPPYAAPEVFE 361
+ +Y +K TW G+P Y APEVF
Sbjct: 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209
Query: 362 GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR 405
Y D WSLGV++Y ++ G PF T +V++ +
Sbjct: 210 QTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 16/184 (8%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEI-MKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
+A+K + ++ + +++ ++++ +K D P+I+K + T S ++I E
Sbjct: 43 MAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL--MSTC 99
Query: 277 FDYIAR--YGRMNENAARRKFWQILSAVEYC---HNRRVVHRDLKAENLLMDSNLDIKLA 331
D + + G + E+ + I+ A+ Y H V+HRD+K N+L+D++ ++KL
Sbjct: 100 LDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLC 157
Query: 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDI----WSLGVVLYVLVCGAL 387
DFG S V + G Y APE + P+ DI WSLG+ L L G
Sbjct: 158 DFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATGQF 216
Query: 388 PFDG 391
P+
Sbjct: 217 PYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-15
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 12/152 (7%)
Query: 238 REVEIMKQL---DHPHIIKLFQVMET-----KSMIYIVSEYANQGEIFDYIARYGR--MN 287
REV ++K+L DHP+I++L V T ++ + +V E+ +Q ++ Y+ + +
Sbjct: 48 REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLP 106
Query: 288 ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347
+ Q L +++ H +VHRDLK EN+L+ S +KLADFG + Y L
Sbjct: 107 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166
Query: 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
+ Y APEV Y P +D+WS+G +
Sbjct: 167 VVVTLWYRAPEVLLQSTYATP-VDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 21/244 (8%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG- 274
V +A+K I + +LD ++ E++I+ + P+I+ + + +Y+ EY + G
Sbjct: 27 VTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85
Query: 275 --EIFDYIARYGRMNENAARRKFWQILSAVEYC---HNRRVVHRDLKAENLLMDSNLDIK 329
+++ + E+ RR + ++ +++ HN ++HRD+K N+L++ N +K
Sbjct: 86 LDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVK 143
Query: 330 LADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGP-----EIDIWSLGVVLYVLV 383
L DFG S V LA T G Y APE + + D+WSLG+ + +
Sbjct: 144 LCDFGVSGNLV--ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201
Query: 384 CGALPFDGSTLNS----LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
G P+ T + L V +P S + + + K L + P +R Q+
Sbjct: 202 LGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261
Query: 440 HRWM 443
H W+
Sbjct: 262 HPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-15
Identities = 71/260 (27%), Positives = 108/260 (41%), Gaps = 57/260 (21%)
Query: 236 VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKF 295
V E +I+ + D+ +++L+ + K +Y V +Y G++ + R G E+ AR
Sbjct: 48 VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYI 107
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF---------SNYYVPGQKLA 346
++ AVE H +HRD+K +N+L+D + IKL DFG S YY G +
Sbjct: 108 AELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167
Query: 347 T--------W-------------------------------CGSPPYAAPEVFEGKKYCG 367
W G+P Y APEV Y
Sbjct: 168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT- 226
Query: 368 PEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIP--YFMSTECESLIRKM 423
D WS+GV+LY ++ G PF T + +V++ + IP +S E LI K
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK- 285
Query: 424 LVREPTKRY---CIEQIKRH 440
L R P R ++IK H
Sbjct: 286 LCRGPEDRLGKNGADEIKAH 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-15
Identities = 69/251 (27%), Positives = 120/251 (47%), Gaps = 34/251 (13%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYAN 272
TV VA+K++ + D +L + E+E+MK + H +II L V + +Y++ EYA
Sbjct: 43 QTVTVAVKMLKDNATDK-DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAA 101
Query: 273 QGEIFDYI-AR----------YGRMNENAARRK-----FWQILSAVEYCHNRRVVHRDLK 316
+G + +++ AR ++ E K +Q+ +EY +RR +HRDL
Sbjct: 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161
Query: 317 AENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGP 368
A N+L+ + +K+ADFG + +YY T G P + APE + Y
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTH- 215
Query: 369 EIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVR 426
+ D+WS G++++ + G P+ G + L + G R P + E L+R+
Sbjct: 216 QSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHA 275
Query: 427 EPTKRYCIEQI 437
PT+R +Q+
Sbjct: 276 VPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 16/235 (6%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD 278
A+KII D +L + +E+ ++K+ H +I+ F ++ ++I EY G + D
Sbjct: 38 AVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD 95
Query: 279 YIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338
G ++E + L + Y H++ +HRD+K N+L+ N D+KLADFG +
Sbjct: 96 IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK 155
Query: 339 YVPG-QKLATWCGSPPYAAPEVFEGKKYCGPE--IDIWSLGVVLYVLVCGALP-FDGSTL 394
K ++ G+P + APEV +K G DIW++G+ L P FD L
Sbjct: 156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD---L 212
Query: 395 NSLRDRVLSGR--FRIPYFM-----STECESLIRKMLVREPTKRYCIEQIKRHRW 442
+ +R L + F+ P S+ + ++ L + P KR E++ H +
Sbjct: 213 HPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 72/252 (28%), Positives = 118/252 (46%), Gaps = 25/252 (9%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
R V VAIK + K Q E IM Q H +II+L V+ I++EY
Sbjct: 31 RKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89
Query: 273 QGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + Y+ + G + I + ++Y + VHRDL A N+L++SNL+ K++
Sbjct: 90 NGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVS 149
Query: 332 DFGFSNYY--VPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGA 386
DFG S P T G P + APE +K+ D+WS G+V++ V+ G
Sbjct: 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS-DVWSFGIVMWEVMSFGE 208
Query: 387 LPF-DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
P+ D S + + ++ FR+P M +C S + +++++ C +Q + R
Sbjct: 209 RPYWDMSNHEVM--KAINDGFRLPAPM--DCPSAVYQLMLQ------CWQQDRARR---- 254
Query: 446 ETPRLLPPINIL 457
PR + +N+L
Sbjct: 255 --PRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 14/223 (6%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+KI+ DP ++ RE +M+QLD+P+I+++ + E +S + +V E A G +
Sbjct: 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLN 83
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS- 336
++ + + E Q+ ++Y VHRDL A N+L+ + K++DFG S
Sbjct: 84 KFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSK 143
Query: 337 ------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPF 389
NYY + W + APE K+ D+WS GV+++ G P+
Sbjct: 144 ALGADENYY-KAKTHGKW--PVKWYAPECMNYYKFSSKS-DVWSFGVLMWEAFSYGQKPY 199
Query: 390 DGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431
G N + + SG R P E L++ +R
Sbjct: 200 KGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274
++ AIK + K + + E+E++ +L HP+II L E + +Y+ EYA G
Sbjct: 23 MDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81
Query: 275 EIFDYIAR---------YGRMNENAARRKFWQIL-------SAVEYCHNRRVVHRDLKAE 318
+ D++ + + N A+ Q+L ++Y ++ +HRDL A
Sbjct: 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 141
Query: 319 NLLMDSNLDIKLADFGFSNYYVPGQK--LATWCGSPP--YAAPEVFEGKKYCGPEIDIWS 374
N+L+ N K+ADFG S GQ+ + G P + A E Y D+WS
Sbjct: 142 NILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWS 196
Query: 375 LGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRY 432
GV+L+ +V G P+ G T L +++ G R P E L+R+ +P +R
Sbjct: 197 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP 256
Query: 433 CIEQI 437
QI
Sbjct: 257 SFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-15
Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMI-YIVSEYANQGEIFDYIARYGRM---NENAARRK 294
E I++ ++HP II+L I+ Y + +++ Y+A + + A R
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICDILAIER- 189
Query: 295 FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP--GQKLATWCGSP 352
+L A++Y H R++HRD+KAEN+ ++ D+ L DFG + + V K W G+
Sbjct: 190 --SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
APE+ Y GP +DIWS G+VL+ +
Sbjct: 248 ATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 18/234 (7%)
Query: 219 AIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
AIK+I +L+P + V +E+ +MK H +I+ F + ++I E+ G +
Sbjct: 38 AIKVI---KLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ 94
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D G ++E+ + L + Y H++ +HRD+K N+L+ N +KLADFG S
Sbjct: 95 DIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA 154
Query: 338 YYVPG-QKLATWCGSPPYAAPEV--FEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGST 393
K ++ G+P + APEV E K DIW++G+ L P FD
Sbjct: 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD--- 211
Query: 394 LNSLRDRVLSGR--FRIPYFM-----STECESLIRKMLVREPTKRYCIEQIKRH 440
L+ +R L + F+ P S ++ L + P KR E++ +H
Sbjct: 212 LHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 67/250 (26%)
Query: 238 REVEIMKQLDHPHIIKLFQVMET--------KSMIYIVSEYANQGEIFDYIAR-----YG 284
RE++I++ L H +++ L ++ T K Y+V E+ +A
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-----LAGLLSNKNV 114
Query: 285 RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344
+ + ++ +L+ + Y H +++HRD+KA N+L+ + +KLADFG + + +
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 345 LATWCGSPP----------YAAPEVFEGKKYCGPEIDIWSLGVV---------------- 378
P Y PE+ G++ GP ID+W G +
Sbjct: 175 -----SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229
Query: 379 -----LYVLVCGALP------------FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIR 421
L +CG++ F L + R + R + PY LI
Sbjct: 230 QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK-PYVKDPHALDLID 288
Query: 422 KMLVREPTKR 431
K+LV +P KR
Sbjct: 289 KLLVLDPAKR 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 234 QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY--ANQGEIFDYIARYGRMNENAA 291
Q + +EV ++QL HP+ I+ + ++V EY + +I + + + E AA
Sbjct: 60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA 119
Query: 292 RRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGS 351
L + Y H+ +HRD+KA N+L+ +KLADFG ++ P ++ G+
Sbjct: 120 ICH--GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGT 174
Query: 352 PPYAAPEVF----EGKKYCGPEIDIWSLGV 377
P + APEV EG +Y G ++D+WSLG+
Sbjct: 175 PYWMAPEVILAMDEG-QYDG-KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 42/212 (19%)
Query: 249 PHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR 308
P+++ L + + ++ +++V ++A G+++ +I+++ + E +R +++ A++ H
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 309 RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGP 368
+V RDL N+L+D I+L F W E E YC P
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFS------------RWSEVEDSCDGEAVE-NMYCAP 151
Query: 369 EI----------DIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-----RFRIPYFMS 413
E+ D WSLG +L+ L+ G +L + SG IP ++S
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK---------TLVECHPSGINTHTTLNIPEWVS 202
Query: 414 TECESLIRKMLVREPTKRY-----CIEQIKRH 440
E SL++++L PT+R +E IK H
Sbjct: 203 EEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 9/164 (5%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQ 297
RE++I+K + H II L KS + +V ++F Y+ R G + A +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 298 ILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS-----NYYVPGQKLATWCGSP 352
+L A+ Y H R ++HRD+K EN+ +D + L DFG + + P + W G+
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP--QCYGWSGTL 251
Query: 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
+PE+ YC + DIWS G+VL+ + + G + S
Sbjct: 252 ETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+ VAIKI++++ N++ E IM +DHPH+++L V + + I +V++ G
Sbjct: 37 IPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGC 94
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ DY+ + + N + W QI + Y RR+VHRDL A N+L+ S +K+ DF
Sbjct: 95 LLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDF 153
Query: 334 GFS--------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC- 384
G + Y G K+ + A E +K+ + D+WS GV ++ L+
Sbjct: 154 GLARLLEGDEKEYNADGGKMPI-----KWMALECIHYRKFTH-QSDVWSYGVTIWELMTF 207
Query: 385 GALPFDGSTLNSLRDRVLSGRFRIP 409
G P+DG + D + G R+P
Sbjct: 208 GGKPYDGIPTREIPDLLEKGE-RLP 231
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 239 EVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIAR---------YGRMNE 288
E+E++ +L HP+II L E + +YI EYA G + D++ + + + +
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111
Query: 289 NAARRKFWQIL-------SAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS---NY 338
A+ Q+L + ++Y ++ +HRDL A N+L+ NL K+ADFG S
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171
Query: 339 YVP---GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTL 394
YV G+ W A E Y + D+WS GV+L+ +V G P+ G T
Sbjct: 172 YVKKTMGRLPVRW------MAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTC 224
Query: 395 NSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
L +++ G R P E L+R+ P +R QI
Sbjct: 225 AELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 67/251 (26%), Positives = 114/251 (45%), Gaps = 36/251 (14%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQ 273
T VA+K++ + +L + E+E+MK + H +II L V + +Y+V EYA
Sbjct: 42 TSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100
Query: 274 GEIFDYIARYGRMNENAARRKF-----------------WQILSAVEYCHNRRVVHRDLK 316
G + D++ R R A +Q+ +E+ +++ +HRDL
Sbjct: 101 GNLRDFL-RARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159
Query: 317 AENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPPYA--APEVFEGKKYCGP 368
A N+L+ + +K+ADFG + +YY +K T G P APE + Y
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYY---RK--TTNGRLPVKWMAPEALFDRVYTH- 213
Query: 369 EIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVR 426
+ D+WS GV+L+ + G P+ G + L + G R P + E L+R
Sbjct: 214 QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHE 273
Query: 427 EPTKRYCIEQI 437
P++R +Q+
Sbjct: 274 VPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 66/280 (23%), Positives = 117/280 (41%), Gaps = 64/280 (22%)
Query: 218 VAIK----IIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYAN 272
VAIK + K L ++ RE+++++ H +I L+ M+ IV
Sbjct: 30 VAIKKITNVFSKKIL----AKRALRELKLLRHFRGHKNITCLYD-MD------IVFPGNF 78
Query: 273 QG-----EIFDY----IARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLM 322
E+ + I R G+ +A + F +QIL ++Y H+ V+HRDLK NLL+
Sbjct: 79 NELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138
Query: 323 DSNLDIKLADFGFSNYYVPGQK-----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGV 377
+++ ++K+ DFG + + + + + Y APE+ + ID+WS+G
Sbjct: 139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 378 VLYVLVCGALPFDGS-----------TLNSLRDRVLSGRF----------------RIPY 410
+L L+ F G L + + LS R + P+
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS-RIGSPKAQNYIRSLPNIPKKPF 257
Query: 411 -----FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
+ L+ K+L +PTKR +E+ H ++A
Sbjct: 258 ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 42/181 (23%), Positives = 95/181 (52%), Gaps = 10/181 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYIVSEYA 271
VA+K + + ++ ++ YRE+ ++K + H ++I L V +E + +Y+V+
Sbjct: 43 VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL- 101
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + I + ++++ + +Q+L ++Y H+ ++HRDLK N+ ++ + ++++
Sbjct: 102 -MGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160
Query: 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
DFG + ++ + + Y APE+ + +DIWS+G ++ L+ G F G
Sbjct: 161 DFGLARQ--ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
Query: 392 S 392
+
Sbjct: 219 N 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 11/164 (6%)
Query: 230 PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNEN 289
P ++ RE++++ + + P+I+ + + I I E+ + G + + + GR+ EN
Sbjct: 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN 99
Query: 290 AARRKFWQILSAVEYCH-NRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---KL 345
+ +L + Y +++HRD+K N+L++S +IKL DFG V GQ +
Sbjct: 100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG-----VSGQLIDSM 154
Query: 346 A-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
A ++ G+ Y +PE +G Y + DIWSLG+ L + G P
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 22/191 (11%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ + VAIK + KS + E IM Q DHP+II L V+ + I++E+
Sbjct: 30 KREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88
Query: 273 QGEIFDYIARYGRMNENAARRKFWQ-------ILSAVEYCHNRRVVHRDLKAENLLMDSN 325
G + ++ R N+ + Q I + ++Y VHRDL A N+L++SN
Sbjct: 89 NGALDSFL----RQND--GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN 142
Query: 326 LDIKLADFGFSNYYVPGQKLATWCGS-----P-PYAAPEVFEGKKYCGPEIDIWSLGVVL 379
L K++DFG S + T+ S P + APE +K+ D+WS G+V+
Sbjct: 143 LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSAS-DVWSYGIVM 201
Query: 380 Y-VLVCGALPF 389
+ V+ G P+
Sbjct: 202 WEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-14
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 24/155 (15%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIV-SEYANQGEIFDYIAR----YGRMNENAARR 293
E ++++L HP ++ L V + +V +Y + +++ Y+ G A R
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 294 KFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353
Q+LSA++Y H ++HRD+K EN+L++ DI L DFG + + G +W
Sbjct: 268 ---QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AACFARG----SWSTPFH 319
Query: 354 YA--------APEVFEGKKYCGPEIDIWSLGVVLY 380
Y APEV G Y P +DIWS G+V++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-14
Identities = 55/222 (24%), Positives = 107/222 (48%), Gaps = 17/222 (7%)
Query: 199 GVKSRSCNRPP--VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ 256
GV ++ ++P ++ R +++ IK P ++ RE++++ + + P+I+ +
Sbjct: 19 GVVTKVQHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 257 VMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDL 315
+ I I E+ + G + + R+ E + +L + Y + +++HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 316 KAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
K N+L++S +IKL DFG S + ++ G+ Y +PE +G Y + DIWS+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHY-SVQSDIWSM 188
Query: 376 GVVLYVLVCGALPF---DGSTLNSLRDR-VLSGRFRIPYFMS 413
G+ L L G P D L ++ R V+ G P+ +S
Sbjct: 189 GLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-14
Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 59/271 (21%)
Query: 210 VLLRHTV----NVAIKIIDKSQLDPVNLQKVY-REVEIMKQLDHPHIIKLFQVMETKSMI 264
V L + VA+K I + + L+K + RE +I L HP I+ ++ + +
Sbjct: 18 VYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPV 77
Query: 265 YIVSEYANQGEIFDYIARYGRMNENAAR------------RKFWQILSAVEYCHNRRVVH 312
Y Y +G + + E+ ++ F +I + +EY H++ V+H
Sbjct: 78 YYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLH 136
Query: 313 RDLKAENLLM---------------------DSNLDIKLADFG--FSNYYVPGQKLATWC 349
RDLK +N+L+ + LDI + + +S+ +PG+ +
Sbjct: 137 RDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIV---- 192
Query: 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF---DGSTLNSLRDRVLS--- 403
G+P Y APE G DI++LGV+LY ++ + P+ G + S RD +LS
Sbjct: 193 GTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKI-SYRDVILSPIE 250
Query: 404 -GRFR-IPYFMSTECESLIRKMLVREPTKRY 432
+R IP F+S + K L +P +RY
Sbjct: 251 VAPYREIPPFLS----QIAMKALAVDPAERY 277
|
Length = 932 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+HT VA+K + + +++ E +MK L H ++KL V+ TK IYI++E+
Sbjct: 29 KHT-KVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMA 83
Query: 273 QGEIFDYIARYGRMNENAARRKF-------WQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
+G + D++ ++ +++ QI + + R +HRDL+A N+L+ ++
Sbjct: 84 KGSLLDFLK-----SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 138
Query: 326 LDIKLADFGFSNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
L K+ADFG + + A P + APE + + D+WS G++L +V
Sbjct: 139 LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIV 197
Query: 384 C-GALPFDGSTLNSLRDRVLSGRFRIP 409
G +P+ G + N R L +R+P
Sbjct: 198 TYGRIPYPGMS-NPEVIRALERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 9e-14
Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L +H VA+K I+ +L+ + +E+ +QL HP+I+ S +Y+V
Sbjct: 18 LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77
Query: 268 SEYANQGEIFDYIARY---GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS 324
S G D + + G + E A +L+A++Y H++ +HR +KA ++L+
Sbjct: 78 SPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG 136
Query: 325 NLDIKLADFGFSNYYVP-GQKLATWCGSP-------PYAAPEVFEG--KKYCGPEIDIWS 374
+ + L+ +S + G++ P P+ +PEV + + Y + DI+S
Sbjct: 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYS 195
Query: 375 LGVVLYVLVCGALPF 389
+G+ L G +PF
Sbjct: 196 VGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 7/168 (4%)
Query: 285 RMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343
+ E+ + I+ A+EY H++ V+HRD+K N+L++ N +KL DFG S Y V
Sbjct: 99 TIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158
Query: 344 KLATWCGSPPYAAPEVFEGK-KYCGPEI--DIWSLGVVLYVLVCGALPFD--GSTLNSLR 398
G PY APE + G ++ D+WSLG+ + L G P+D + L+
Sbjct: 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK 218
Query: 399 DRVLSGRFRIPY-FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
V ++P S E + + K L + +R ++ +H +
Sbjct: 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 30/189 (15%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
V VA+K++ D + +EV+I+ +L P+I +L V + ++ EY
Sbjct: 44 DAPVLVAVKVLRPDASDNA-REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYME 102
Query: 273 QGEIFDYIARY-GRMNENAARRKFW----------QILSAVEYCHNRRVVHRDLKAENLL 321
G++ ++ ++ + A K QI S + Y + VHRDL N L
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162
Query: 322 MDSNLDIKLADFGFSN------YYVPGQKLATWCGSPP----YAAPEVFEGKKYCGPEID 371
+ N IK+ADFG S YY ++ G P + A E K+ D
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYY----RVQ---GRAPLPIRWMAWESVLLGKFTTKS-D 214
Query: 372 IWSLGVVLY 380
+W+ GV L+
Sbjct: 215 VWAFGVTLW 223
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-13
Identities = 47/193 (24%), Positives = 96/193 (49%), Gaps = 13/193 (6%)
Query: 199 GVKSRSCNRPP--VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ 256
GV + ++P ++ R +++ IK P ++ RE++++ + + P+I+ +
Sbjct: 19 GVVFKVSHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 257 VMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDL 315
+ I I E+ + G + + + GR+ E + ++ + Y + +++HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 316 KAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
K N+L++S +IKL DFG S + ++ G+ Y +PE +G Y + DIWS+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHY-SVQSDIWSM 188
Query: 376 GVVLYVLVCGALP 388
G+ L + G P
Sbjct: 189 GLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 49/197 (24%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI------YI 266
R VAIK + + + ++ YRE+ ++K + H ++I L V + Y+
Sbjct: 38 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
V + G + ++ +++E+ + +Q+L ++Y H ++HRDLK NL ++ +
Sbjct: 98 VMPF--MGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC 155
Query: 327 DIKLADFGFSNYY---VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
++K+ DFG + + G + W Y APEV + +DIWS+G ++ ++
Sbjct: 156 ELKILDFGLARQTDSEMTGYVVTRW-----YRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
Query: 384 CGALPFDGST-LNSLRD 399
G F G L+ L +
Sbjct: 211 TGKPLFKGHDHLDQLME 227
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-13
Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 53/251 (21%)
Query: 225 KSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYG 284
K L+ + V E +I+ + D+ ++KL+ + K +Y V +Y G++ + R
Sbjct: 37 KDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME 96
Query: 285 RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF--------- 335
E AR ++ A+E H +HRD+K +N+L+D + IKL DFG
Sbjct: 97 VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156
Query: 336 SNYYVPGQKLAT--------W-------------------------------CGSPPYAA 356
S YY G + W G+P Y A
Sbjct: 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216
Query: 357 PEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--GRFRIP--YFM 412
PEV K Y D WS+GV+L+ ++ G PF T + +V++ IP +
Sbjct: 217 PEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKL 275
Query: 413 STECESLIRKM 423
S E LI K+
Sbjct: 276 SPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 67/248 (27%), Positives = 120/248 (48%), Gaps = 20/248 (8%)
Query: 216 VNVAIKII-DKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
+ VAIK I D+S Q++ + M LDH +I++L + S+ +V++ + G
Sbjct: 37 IPVAIKTIQDRSGRQ--TFQEITDHMLAMGSLDHAYIVRLLGICPGASL-QLVTQLSPLG 93
Query: 275 EIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
+ D++ R R + + R W QI + Y R+VHR+L A N+L+ S+ +++AD
Sbjct: 94 SLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152
Query: 333 FGFSNYYVPGQK--LATWCGSP-PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALP 388
FG ++ P K + +P + A E +Y + D+WS GV ++ ++ GA P
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH-QSDVWSYGVTVWEMMSYGAEP 211
Query: 389 FDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRK-MLVRE---PTKRYCIEQIKRHRWM 443
+ G + + D + G R P + + ++ K ++ E PT + + R M
Sbjct: 212 YAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR---M 268
Query: 444 AEETPRLL 451
A + PR L
Sbjct: 269 ARDPPRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 58/246 (23%), Positives = 108/246 (43%), Gaps = 41/246 (16%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274
+ VA+K++ K + + E++IM L +H +I+ L I +++EY G
Sbjct: 66 MKVAVKML-KPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124
Query: 275 EIFDYIARYGRMNENAARRKF----------WQILSAVEYCHNRRVVHRDLKAENLLMDS 324
++ +++ R R F +Q+ + + ++ +HRDL A N+L+
Sbjct: 125 DLLNFLRR--------KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH 176
Query: 325 NLDIKLADFGF-------SNYYVPGQKL--ATWCGSPPYAAPE-VFEGKKYCGPEIDIWS 374
+K+ DFG SNY V G W APE +F E D+WS
Sbjct: 177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKW------MAPESIFNCVYTF--ESDVWS 228
Query: 375 LGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRI--PYFMSTECESLIRKMLVREPTKR 431
G++L+ + G+ P+ G ++S +++ +R+ P E +++ +P KR
Sbjct: 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKR 288
Query: 432 YCIEQI 437
+QI
Sbjct: 289 PTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIYIVSEYANQGE 275
VA+K + K + N +E+ I+K L H +I+K + + ++ EY G
Sbjct: 36 VAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ DY+ ++ N A+ + QI + Y H++ +HRDL A N+L+D++ +K+ DF
Sbjct: 95 LRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDF 151
Query: 334 GFSNYYVPGQKL--ATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
G + G + G P + A E + K+ D+WS GV LY L+
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-13
Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 227 QLDPVNL---QKVYREVEIM--KQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIA 281
Q DPV L QK +E M + ++HP +I++ + + ++ +V + + +++ Y+
Sbjct: 90 QPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLT 148
Query: 282 -RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340
R + + A QIL + Y H +R++HRD+K EN+ ++ + + D G + + V
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 341 PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
G+ APEV KY + DIWS G+VL+
Sbjct: 209 VAPAFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLF 247
|
Length = 357 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 62/243 (25%), Positives = 113/243 (46%), Gaps = 29/243 (11%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS-------MIYIVSEYA 271
AIK++D + + +++ +E+ ++K+ H I + K +++V E+
Sbjct: 35 AIKVMDVTGDEE---EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91
Query: 272 NQGEIFDYI--ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G + D I + + E +IL + + H +V+HRD+K +N+L+ N ++K
Sbjct: 92 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 151
Query: 330 LADFGFSNYY--VPGQKLATWCGSPPYAAPEVFEGKKYCGPEI------DIWSLGVVLYV 381
L DFG S G++ T+ G+P + APEV + P+ D+WSLG+
Sbjct: 152 LVDFGVSAQLDRTVGRR-NTFIGTPYWMAPEVIACDE--NPDATYDFKSDLWSLGITAIE 208
Query: 382 LVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTEC----ESLIRKMLVREPTKRYCIEQI 437
+ GA P ++ +R L R P S + +S I LV+ ++R EQ+
Sbjct: 209 MAEGAPPL--CDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
Query: 438 KRH 440
+H
Sbjct: 267 MKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 237 YREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYG------------ 284
+RE E++ L H HI+K + V + +V EY G++ ++ +G
Sbjct: 55 HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114
Query: 285 -RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN------ 337
+ ++ QI + + Y ++ VHRDL N L+ NL +K+ DFG S
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174
Query: 338 -YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLN 395
Y V G + P PE +K+ E D+WSLGVVL+ + G P+ + N
Sbjct: 175 YYRVGGHTMLPIRWMP----PESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
Query: 396 SLRDRVLSGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
+ + + GR + P E L+ REP R I++I
Sbjct: 230 EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 49/175 (28%), Positives = 92/175 (52%), Gaps = 18/175 (10%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
++VAIK++ K++ + ++ RE EIM QLD+P+I+++ V E ++++ +V E A+ G
Sbjct: 23 IDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALM-LVMEMASGGP 80
Query: 276 IFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ ++ + + + Q+ ++Y + VHRDL A N+L+ + K++DFG
Sbjct: 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFG 140
Query: 335 FS-------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY 380
S +YY A G P + APE +K+ D+WS G+ ++
Sbjct: 141 LSKALGADDSYYK-----ARSAGKWPLKWYAPECINFRKFSSRS-DVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 239 EVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIAR---------YGRMNE 288
E+E++ +L HP+II L E + +Y+ EYA G + D++ + + N
Sbjct: 57 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116
Query: 289 NAARRKFWQILS-------AVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341
A+ Q+L ++Y ++ +HRDL A N+L+ N K+ADFG S
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---- 172
Query: 342 GQK--LATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNS 396
GQ+ + G P + A E Y D+WS GV+L+ +V G P+ G T
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231
Query: 397 LRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
L +++ G R P E L+R+ +P +R QI
Sbjct: 232 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 20/187 (10%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+ VAIK + ++ N +++ E +M +D+PH+ +L + T S + ++++ G
Sbjct: 37 IPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGC 94
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ DY+ R + N + W QI + Y RR+VHRDL A N+L+ + +K+ DF
Sbjct: 95 LLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDF 153
Query: 334 GFSN--------YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC- 384
G + Y+ G K+ + A E + Y + D+WS GV ++ L+
Sbjct: 154 GLAKLLGADEKEYHAEGGKVPI-----KWMALESILHRIYTH-QSDVWSYGVTVWELMTF 207
Query: 385 GALPFDG 391
G+ P+DG
Sbjct: 208 GSKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 69/261 (26%), Positives = 117/261 (44%), Gaps = 44/261 (16%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYA 271
+ V VA+K++ K +L + E+E+MK + H +II L +Y++ EYA
Sbjct: 45 KEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103
Query: 272 NQGEIFDYI-AR----------YGRMNENAARRK-----FWQILSAVEYCHNRRVVHRDL 315
++G + +Y+ AR R+ + K +Q+ +EY +++ +HRDL
Sbjct: 104 SKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL 163
Query: 316 KAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCG 367
A N+L+ N +K+ADFG + +YY T G P + APE + Y
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTH 218
Query: 368 PEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSG-RFRIP-------YFMSTECES 418
+ D+WS GV+++ + G P+ G + L + G R P Y M +C
Sbjct: 219 -QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWH 277
Query: 419 LIRKMLVREPTKRYCIEQIKR 439
I PT + +E + R
Sbjct: 278 AIPS---HRPTFKQLVEDLDR 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 28/201 (13%)
Query: 218 VAIK---IIDKSQLDPVNLQKV---------YREVEIMKQLDHPHIIKLFQVMETKSMIY 265
VAIK II+ S + Q V RE++IM ++ H +I+ L V I
Sbjct: 37 VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN 96
Query: 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
+V + ++ + R R+ E+ + QIL+ + H +HRDL N+ ++S
Sbjct: 97 LVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155
Query: 326 LDIKLADFGFSNYYV------PGQKLATWCGSPP---------YAAPEVFEGKKYCGPEI 370
K+ADFG + Y K T Y APE+ G + +
Sbjct: 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV 215
Query: 371 DIWSLGVVLYVLVCGALPFDG 391
D+WS+G + L+ G F G
Sbjct: 216 DMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-12
Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 28/174 (16%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENA-------- 290
E+ + +L+H +I+K+ +++ +++ Y++++ + FD Y M + A
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYD----FDL---YSFMYDEAFDWKDRPL 265
Query: 291 ---ARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG----FSNYYVPGQ 343
R Q+L AVEY H+++++HRD+K EN+ ++ + I L DFG F
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 344 KLATWCGSPPYAAPEVFEGKKYCGPEI-DIWSLGVVLYVLVCGAL-PFDGSTLN 395
W G+ +PE+ G YC EI DIWS G++L ++ P
Sbjct: 326 --YGWVGTVATNSPEILAGDGYC--EITDIWSCGLILLDMLSHDFCPIGDGGGK 375
|
Length = 501 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 18/233 (7%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV---METKSMIYI---VSE 269
VA+K++ ++++ RE MK+ DHP++IKL V K + I +
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 270 YANQGEI--FDYIARYGRMNENAARRKFWQ----ILSAVEYCHNRRVVHRDLKAENLLMD 323
+ G++ F ++R G + + I S +EY ++ +HRDL A N +++
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 324 SNLDIKLADFGFSNYYVPGQKLATWCGSP---PYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
N+ + +ADFG S G C S + A E Y D+W+ GV ++
Sbjct: 148 ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMW 206
Query: 381 -VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431
++ G P+ G + + + ++ G R + P + L+ + EP R
Sbjct: 207 EIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 48/184 (26%), Positives = 89/184 (48%), Gaps = 19/184 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM------IYIVSEYA 271
VAIK + + + ++ YRE+ ++K + H ++I L V + Y+V Y
Sbjct: 43 VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM 102
Query: 272 NQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
D G ++E+ + +Q+L ++Y H+ ++HRDLK NL ++ + ++K+
Sbjct: 103 QT----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKI 158
Query: 331 ADFGFSNYY---VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
DFG + + + G + W Y APEV + +DIWS+G ++ ++ G
Sbjct: 159 LDFGLARHADAEMTGYVVTRW-----YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
Query: 388 PFDG 391
F G
Sbjct: 214 LFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 31/194 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-----IYIVSEYAN 272
VAIK I+ + ++ RE+++++ L HP I+++ +M S IY+V E
Sbjct: 28 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM- 86
Query: 273 QGEIFDYIARYGRMNENAARRKF----WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
+ ++ I + N++ +Q+L A++Y H V HRDLK +N+L +++ +
Sbjct: 87 ESDLHQVI----KANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKL 142
Query: 329 KLADFGFSNYY---VPGQKLAT-WCGSPPYAAPEVFEGKKYCG-------PEIDIWSLGV 377
K+ DFG + P T + + Y APE+ CG P IDIWS+G
Sbjct: 143 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL------CGSFFSKYTPAIDIWSIGC 196
Query: 378 VLYVLVCGALPFDG 391
+ ++ G F G
Sbjct: 197 IFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQ 297
E + Q DH +I++L V+ + + IV+EY + G + ++ ++ G++
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 298 ILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK------LATWCGS 351
+ S ++Y VH+ L A +L++S+L K++ F Q+ T G
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGK 169
Query: 352 PP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRI 408
P +AAPE + + D+WS G+V++ V+ G P+ + + V G FR+
Sbjct: 170 SPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRL 227
Query: 409 PYFMSTECESLIRKMLV----REPTKRYCIEQI 437
P C +L+ ++++ +E +R QI
Sbjct: 228 P--APRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-12
Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 35/184 (19%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKS--MIYIVSEYANQGEIFDYIAR----YGRMNENAAR 292
EV +M++L H +I++ K+ +YI+ E+ + G++ I + +G++ E+A
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 293 RKFWQILSAVEYCHN-------RRVVHRDLKAENLLMDS-------------NLD----I 328
Q+L A+ YCHN RV+HRDLK +N+ + + NL+
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 329 KLADFGFSNYYVPGQKLATWC-GSPPYAAPEVF--EGKKYCGPEIDIWSLGVVLYVLVCG 385
K+ DFG S + + +A C G+P Y +PE+ E K Y + D+W+LG ++Y L G
Sbjct: 182 KIGDFGLSKN-IGIESMAHSCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSG 239
Query: 386 ALPF 389
PF
Sbjct: 240 KTPF 243
|
Length = 1021 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 234 QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYG------RMN 287
Q RE E++ L H HI++ + V + +V EY G++ ++ +G
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 288 ENAARRKFW---------QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS-- 336
E+ A + QI S + Y + VHRDL N L+ L +K+ DFG S
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171
Query: 337 ----NYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFD 390
+YY V G+ + P PE +K+ E DIWS GVVL+ + G P+
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMP----PESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWY 226
Query: 391 GSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
+ + + GR P E ++++ REP +R I+ I
Sbjct: 227 QLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 42/276 (15%)
Query: 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-D 247
GQ + E G+ N+P V VA+K++ D +L + E+E+MK +
Sbjct: 26 GQVVMA-EAIGIDKDKPNKP-------VTVAVKMLKDDATDK-DLSDLVSEMEMMKMIGK 76
Query: 248 HPHIIKLFQVMETKSMIYIVSEYANQGEI-----------FDYIARYGRMNENAARRK-- 294
H +II L +Y++ EYA++G + DY ++ E K
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 295 ---FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS------NYYVPGQKL 345
+Q+ +EY +++ +HRDL A N+L+ + +K+ADFG + +YY
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK----- 191
Query: 346 ATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVL 402
T G P + APE + Y + D+WS GV+L+ + G P+ G + L +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
Query: 403 SG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
G R P + E ++R+ P++R +Q+
Sbjct: 251 EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYG------------- 284
RE E++ L H HI+K + V + +V EY G++ ++ +G
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115
Query: 285 ---RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS----- 336
+ + QI S + Y ++ VHRDL N L+ +NL +K+ DFG S
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175
Query: 337 -NYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGST 393
+YY V G + P PE +K+ E D+WS GV+L+ + G P+ +
Sbjct: 176 TDYYRVGGHTMLPIRWMP----PESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLS 230
Query: 394 LNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
+ + + GR P E ++ REP +R I++I +
Sbjct: 231 NTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 34/247 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VA+K++ KS +L + E+E+MK + H +II L +Y++ EYA++G +
Sbjct: 53 VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 277 FDYIA--RYGRM----------NENAARRKF----WQILSAVEYCHNRRVVHRDLKAENL 320
+Y+ R M E + + +Q+ +EY +++ +HRDL A N+
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171
Query: 321 LMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDI 372
L+ + +K+ADFG + +YY T G P + APE + Y + D+
Sbjct: 172 LVTEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTH-QSDV 225
Query: 373 WSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTK 430
WS GV+L+ + G P+ G + L + G R P + E ++R P++
Sbjct: 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 285
Query: 431 RYCIEQI 437
R +Q+
Sbjct: 286 RPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-12
Identities = 57/230 (24%), Positives = 105/230 (45%), Gaps = 18/230 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVY-REVEIMKQLDHPHIIKLFQVMETK-SMIYIVSEYANQGE 275
VAIK++ + + + + RE + +L HP+I+ L E +++ V EY
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLAD 332
+ + +A G + R Q+L A+ HN+ +VHRDLK +N+++ K+ D
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125
Query: 333 FGFSNYYVPGQKLAT---------WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
FG +PG + A G+P Y APE G+ P D+++ G++ +
Sbjct: 126 FGIGT-LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIFLECL 183
Query: 384 CGALPFDGSTLNSLRDRVLSGR-FRIP-YFMSTECESLIRKMLVREPTKR 431
G G+++ + + LS +P + ++RK L ++P +R
Sbjct: 184 TGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVE-IMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K I +S +D +++ +++ +M+ D P+I+K + + + +I E +
Sbjct: 33 AVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDIS--L 89
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYC---------HNRRVVHRDLKAENLLMDSNLDI 328
D +Y +IL + +++HRD+K N+L+D N +I
Sbjct: 90 DKFYKYVYEVLK--SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNI 147
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEI--DIWSLGVVLYVLVCGA 386
KL DFG S V G PY APE + G ++ D+WSLG+ LY + G
Sbjct: 148 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
Query: 387 LPFDGSTLNSLRDRV 401
P+ NS+ D++
Sbjct: 208 FPYPK--WNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-11
Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 1/119 (0%)
Query: 219 AIKIIDKSQLDPVNL-QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K++ K+ + N+ +V E + + P I+ L+ +++ + +Y+V EY G++
Sbjct: 33 AVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVK 92
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ YG +E A + ++ A++Y H ++HRDLK +N+L+ + IKL DFG S
Sbjct: 93 SLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 27/197 (13%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV---METKSMI---YIVSE 269
+ VA+K + +++ E MK DHP+++KL V + I ++
Sbjct: 28 LKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILP 87
Query: 270 YANQGEIFDYI--ARYGRMNENAARRKFWQ----ILSAVEYCHNRRVVHRDLKAENLLMD 323
+ G++ ++ +R G + E + + I +EY NR +HRDL A N ++
Sbjct: 88 FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR 147
Query: 324 SNLDIKLADFGFS------NYYVPGQ--KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
++ + +ADFG S +YY G+ K+ + A E + Y + D+W+
Sbjct: 148 EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV-----KWIAIESLADRVYT-SKSDVWAF 201
Query: 376 GVVLY-VLVCGALPFDG 391
GV ++ + G P+ G
Sbjct: 202 GVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 219 AIKIIDK-SQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS------MIYIVSEY 270
A+KI+D S +D +++ E I++ L +HP+++K F M K+ +++V E
Sbjct: 51 AVKILDPISDVD----EEIEAEYNILQSLPNHPNVVK-FYGMFYKADKLVGGQLWLVLEL 105
Query: 271 ANQGEIFDYIA----RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
N G + + + R++E + L +++ HN R++HRD+K N+L+ +
Sbjct: 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG 165
Query: 327 DIKLADFGFSNYYVPGQ-KLATWCGSPPYAAPEVFEGKKY----CGPEIDIWSLGVVLYV 381
+KL DFG S + + T G+P + APEV ++ D+WSLG+
Sbjct: 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
Query: 382 LVCGALP-FDGSTLNSLRDRVLSGRFRIP 409
L G P FD + +L F+IP
Sbjct: 226 LGDGDPPLFDMHPVKTL--------FKIP 246
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 30/247 (12%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKL----FQVMETKSMI--YIVSE 269
+ VA+K + + ++ E MK+ DHP++++L Q +E++ ++
Sbjct: 27 LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILP 86
Query: 270 YANQGEIFDYIARYGRMNE------NAARRKFW-QILSAVEYCHNRRVVHRDLKAENLLM 322
+ G++ ++ Y R+ + KF I S +EY ++ +HRDL A N ++
Sbjct: 87 FMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML 145
Query: 323 DSNLDIKLADFGFS------NYYVPGQ--KLATWCGSPPYAAPEVFEGKKYCGPEIDIWS 374
+ N+++ +ADFG S +YY G+ K+ + A V+ K D+WS
Sbjct: 146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKS------DVWS 199
Query: 375 LGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRY 432
GV ++ + G P+ G + + D + G R + P SL+ + P R
Sbjct: 200 FGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRP 259
Query: 433 CIEQIKR 439
E ++
Sbjct: 260 SFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 11/149 (7%)
Query: 234 QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR-MNENAAR 292
Q + +EV+ ++QL HP+ I+ + ++V EY G D + + + + E
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 124
Query: 293 RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSP 352
L + Y H+ ++HRD+KA N+L+ +KLADFG ++ P ++ G+P
Sbjct: 125 AITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTP 181
Query: 353 PYAAPEVF----EGKKYCGPEIDIWSLGV 377
+ APEV EG +Y G ++D+WSLG+
Sbjct: 182 YWMAPEVILAMDEG-QYDG-KVDVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 17/224 (7%)
Query: 234 QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR-MNENAAR 292
Q + +EV+ ++++ HP+ I+ + ++V EY G D + + + + E
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 128
Query: 293 RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSP 352
L + Y H+ ++HRD+KA N+L+ +KLADFG ++ P ++ G+P
Sbjct: 129 AITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTP 185
Query: 353 PYAAPEVF----EGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI 408
+ APEV EG +Y G ++D+WSLG+ L P +N++ +
Sbjct: 186 YWMAPEVILAMDEG-QYDG-KVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNES 241
Query: 409 PYFMSTECESLIRKM----LVREPTKRYCIEQIKRHRWMAEETP 448
P S E R L + P R E++ +H ++ E P
Sbjct: 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/246 (25%), Positives = 114/246 (46%), Gaps = 29/246 (11%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVEIMKQLDH-PHIIKLFQVMETKS------MIYIVSEYA 271
AIK++D ++ + +++ E+ ++K+ H +I + KS +++V E+
Sbjct: 45 AIKVMDVTEDEE---EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFC 101
Query: 272 NQGEIFDYI--ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G + D + + + E+ +IL + + H +V+HRD+K +N+L+ N ++K
Sbjct: 102 GAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVK 161
Query: 330 LADFGFSNYY--VPGQKLATWCGSPPYAAPEVFEGKKYCGPEI------DIWSLGVVLYV 381
L DFG S G++ T+ G+P + APEV + P+ DIWSLG+
Sbjct: 162 LVDFGVSAQLDRTVGRR-NTFIGTPYWMAPEVIACDE--NPDATYDYRSDIWSLGITAIE 218
Query: 382 LVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECE----SLIRKMLVREPTKRYCIEQI 437
+ GA P ++ +R L R P S + I LV+ R EQ+
Sbjct: 219 MAEGAPPL--CDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276
Query: 438 KRHRWM 443
+H ++
Sbjct: 277 LKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 236 VYREVEIMKQLDHPHIIKLFQVMETK--SMIYIVSEYANQGEIFDYIAR-YGRMNENAAR 292
+ +E+EI++ L H +I+K + + I ++ E+ G + +Y+ R ++N
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 293 RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN-------YYVPGQKL 345
+ QI ++Y +R+ VHRDL A N+L++S +K+ DFG + YY L
Sbjct: 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 346 ATWCGSPPY-AAPE-VFEGKKYCGPEIDIWSLGVVLYVLV--CGAL------------PF 389
SP + APE + + K Y D+WS GV LY L+ C + P
Sbjct: 173 ----DSPVFWYAPECLIQSKFYIAS--DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT 226
Query: 390 DGSTLNSLRDRVLS--GRFRIPYFMSTECESLIRKMLVREPTKR 431
G + RVL R P E L+RK +P+KR
Sbjct: 227 HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 234 QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGR-MNENAAR 292
Q + +EV +++L HP+ I+ + ++V EY G D + + + + E
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 118
Query: 293 RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSP 352
L + Y H+ ++HRD+KA N+L+ +KL DFG ++ P + G+P
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTP 175
Query: 353 PYAAPEVF----EGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI 408
+ APEV EG +Y G ++D+WSLG+ L P +N++ +
Sbjct: 176 YWMAPEVILAMDEG-QYDG-KVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNES 231
Query: 409 PYFMSTECESLIRKM----LVREPTKRYCIEQIKRHRWMAEETP 448
P S R L + P R E + +HR++ E P
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 49/189 (25%), Positives = 92/189 (48%), Gaps = 24/189 (12%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM-ETKSMIYIVSEYANQG 274
++ A+K +++ D +++ +E IMK HP+++ L + ++ +V Y G
Sbjct: 24 IHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHG 82
Query: 275 EIFDYIARYGRMNENAARRK----F-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
++ ++I R + K F Q+ +EY +++ VHRDL A N ++D + +K
Sbjct: 83 DLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVK 138
Query: 330 LADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGVVLYV 381
+ADFG + YY P + A E + +K+ + D+WS GV+L+
Sbjct: 139 VADFGLARDIYDKEYYSVHNHTG---AKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWE 194
Query: 382 LVC-GALPF 389
L+ GA P+
Sbjct: 195 LMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+ VAIK++ + P +++ E +M + P++ +L + T S + +V++ G
Sbjct: 37 IPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGC 94
Query: 276 IFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ DY+ R+ QI + Y R+VHRDL A N+L+ S +K+ DFG
Sbjct: 95 LLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFG 154
Query: 335 FS--------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-G 385
+ Y+ G K+ + A E +++ + D+WS GV ++ L+ G
Sbjct: 155 LARLLDIDETEYHADGGKVPI-----KWMALESILHRRFTH-QSDVWSYGVTVWELMTFG 208
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIP 409
A P+DG + D + G R+P
Sbjct: 209 AKPYDGIPAREIPDLLEKGE-RLP 231
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKS--MIYIVSEYANQGEIFDYIARYGRMNE------- 288
RE+ ++++L HP++I L +V + S ++++ +YA +I ++ R ++
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD--LWHIIKFHRASKANKKPMQ 104
Query: 289 ---NAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDIKLADFGFSNYY-V 340
+ + +QIL + Y H V+HRDLK N+L+ +K+AD GF+ +
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 341 PGQKLAT--------WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF--- 389
P + LA W Y APE+ G ++ IDIW++G + L+ F
Sbjct: 165 PLKPLADLDPVVVTFW-----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219
Query: 390 --DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKM 423
D T N L F + F + + IRKM
Sbjct: 220 QEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKM 255
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 37/193 (19%)
Query: 218 VAIKII-DKSQLDPVNLQKVY-REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VA+K++ +++ D +Q + RE +M + DHP+I+KL V + ++ EY G+
Sbjct: 38 VAVKMLKEEASAD---MQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGD 94
Query: 276 IFDYI-ARYGRMNENAARRKFW---------------------QILSAVEYCHNRRVVHR 313
+ +++ R R + + Q+ + + Y R+ VHR
Sbjct: 95 LNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR 154
Query: 314 DLKAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCG 367
DL N L+ N+ +K+ADFG S +YY + A P PE +Y
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMP---PESIFYNRYT- 210
Query: 368 PEIDIWSLGVVLY 380
E D+W+ GVVL+
Sbjct: 211 TESDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 31/205 (15%)
Query: 212 LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
+ H VAIK + K +P + +E +M +L HP+I+ L V+ + + ++ EY
Sbjct: 31 MDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89
Query: 272 NQGEIFDY-IARY------------GRMNENAARRKFW----QILSAVEYCHNRRVVHRD 314
NQG++ ++ I R G + + F QI + +EY + VH+D
Sbjct: 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKD 149
Query: 315 LKAENLLMDSNLDIKLADFGFSN-------YYVPGQKLATWCGSPPYAAPEVFEGKKYCG 367
L A N+L+ L +K++D G S Y V + L PP A + GK
Sbjct: 150 LAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEA---IMYGKF--S 204
Query: 368 PEIDIWSLGVVLY-VLVCGALPFDG 391
+ DIWS GVVL+ + G P+ G
Sbjct: 205 SDSDIWSFGVVLWEIFSFGLQPYYG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 62/250 (24%), Positives = 106/250 (42%), Gaps = 43/250 (17%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K + K D ++ +E +M +HP+I+KL V YI+ E G++
Sbjct: 29 VAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLL 87
Query: 278 DYIARYGRMNENAARRKFWQILSAVE-------------YCHNRRVVHRDLKAENLLM-- 322
Y+ R R+ R +L+ E Y +HRDL A N L+
Sbjct: 88 SYL-RDARV-----ERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSE 141
Query: 323 ---DSNLDIKLADFGF------SNYY-VPGQKL--ATWCGSPPYAAPEVFEGKKYCGPEI 370
D++ +K+ DFG S+YY G+ L W APE K+ +
Sbjct: 142 KGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW------MAPESLLDGKFTT-QS 194
Query: 371 DIWSLGVVLY-VLVCGALPFDG-STLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428
D+WS GV+++ +L G P+ + L+ GR + P + L+ ++P
Sbjct: 195 DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDP 254
Query: 429 TKRYCIEQIK 438
++R ++I+
Sbjct: 255 SERPTFDRIQ 264
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-10
Identities = 45/171 (26%), Positives = 83/171 (48%), Gaps = 32/171 (18%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKS--MIYIVSEYANQGEIFDYIARYGRMNE------- 288
RE+ ++++L HP++I L +V + + ++++ +YA +I ++ R ++
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD--LWHIIKFHRASKANKKPVQ 104
Query: 289 ---NAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDIKLADFGFSNYY-V 340
+ +QIL + Y H V+HRDLK N+L+ +K+AD GF+ +
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 341 PGQKLAT--------WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
P + LA W Y APE+ G ++ IDIW++G + L+
Sbjct: 165 PLKPLADLDPVVVTFW-----YRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 55/227 (24%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
V +K + K++ D + RE+++ ++L H ++++L + Y++ EY + G++
Sbjct: 38 VLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96
Query: 278 DYIARYGRMNENAARRK----------FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
++ R + + + QI +++ N R VHRDL A N L+ S +
Sbjct: 97 QFL-RATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE 155
Query: 328 IKLADFGFSN------YYVPGQKLATWCGSPPYAAPE-VFEGKKYCGPEIDIWSLGVVLY 380
+K++ S YY L P A E F K D+WS GV+++
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKS------DVWSFGVLMW 209
Query: 381 -VLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426
V G LPF G + + +R+ +G+ +P + C S + K++ R
Sbjct: 210 EVFTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGCPSRLYKLMTR 254
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 45/186 (24%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARY----GRMNENAARR 293
+EV+I+ +L P+II+L V + + +++EY G++ +++ + N N A
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 294 K---------------FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS-- 336
QI S ++Y + VHRDL N L+ NL IK+ADFG S
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 337 ----NYY-------VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY--VLV 383
+YY +P + +A C + GK D+W+ GV L+ +++
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWEC---------ILMGKFTTAS--DVWAFGVTLWEILML 236
Query: 384 CGALPF 389
C P+
Sbjct: 237 CKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 26/240 (10%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
V+V +K++ + + +M QL H H++KL+ V I +V EY
Sbjct: 29 QEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKF 84
Query: 274 GEIFDYIARYGRMNENAARRKF---WQILSAVEYCHNRRVVHRDLKAENLLM-------D 323
G + ++ R N + K Q+ SA+ Y ++++VH ++ +N+L+
Sbjct: 85 GPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEG 142
Query: 324 SNLDIKLADFGFSNYYVPGQKLATWCGSP-PYAAPEVFEG-KKYCGPEIDIWSLGVVLYV 381
IKL+D G + ++ P+ APE + D WS G L
Sbjct: 143 YVPFIKLSDPGIPITVLSREE----RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLE 198
Query: 382 LVC-GALPFDGSTLNSLR-DRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
+ G P STL+S +R + R+P E +LI + +PTKR I R
Sbjct: 199 ICSNGEEPL--STLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 12/114 (10%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW- 296
+E++IM +L P+II+L V T + +++EY G++ +++R+
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 297 ----------QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS-NYY 339
QI S ++Y + VHRDL N L+ N IK+ADFG S N Y
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 28/242 (11%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
H V +K++DKS + + + +M QL H H++ + V +V EY
Sbjct: 26 HKTEVLLKVLDKSHRN--YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKF 83
Query: 274 GEIFDYIARYGRMNENAARRKFW------QILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
G + Y+ + N+N W Q+ A+ + ++ + H ++ A+N+L+ D
Sbjct: 84 GSLDTYLKK----NKNLIN-ISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREED 138
Query: 328 --------IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
IKL+D G S +P + L P+ PE E + D WS G L
Sbjct: 139 RKTGNPPFIKLSDPGISITVLPKEILLE---RIPWVPPECIENPQNLSLAADKWSFGTTL 195
Query: 380 YVLVCGA-LPFDGSTLNSLRD-RVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
+ + G P S L+S + + R ++P TE +LI + + EP R I
Sbjct: 196 WEIFSGGDKPL--SALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAI 253
Query: 438 KR 439
R
Sbjct: 254 IR 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 31/205 (15%)
Query: 208 PPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
P V VA+K++ ++ + +E++IM +L +P+II+L V + + ++
Sbjct: 37 APEFDGQPVLVAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMI 95
Query: 268 SEYANQGEIFDYIAR------YGRMNE--NAARRKFW----QILSAVEYCHNRRVVHRDL 315
+EY G++ ++++ + N + + QI S ++Y + VHRDL
Sbjct: 96 TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL 155
Query: 316 KAENLLMDSNLDIKLADFGFS------NYY-VPGQKL--ATWCGSPPYAAPEVFEGKKYC 366
N L+ ++ IK+ADFG S +YY + G+ + W A + GK
Sbjct: 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW-----MAWESILLGKFTT 210
Query: 367 GPEIDIWSLGVVLYVL--VCGALPF 389
D+W+ GV L+ + +C P+
Sbjct: 211 AS--DVWAFGVTLWEMFTLCKEQPY 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 36/204 (17%)
Query: 215 TVNVAIKII-DKSQLDPVNLQKVYREVEIMK-QLDHPHIIKLFQVMETKSMIYIVSEYAN 272
T VAIK + DK++ L++ ++ +M+ +L HP+I+ L V+ + + ++ Y +
Sbjct: 35 TQAVAIKTLKDKAE---GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS 91
Query: 273 QGEIFDYI------ARYGRMNENAARRK----------FWQILSAVEYCHNRRVVHRDLK 316
++ +++ + G +++ + QI + +E+ + VVH+DL
Sbjct: 92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLA 151
Query: 317 AENLLMDSNLDIKLADFGF------SNYYVPGQKLATWCGSP-PYAAPE-VFEGKKYCGP 368
N+L+ L++K++D G ++YY KL P + +PE + GK
Sbjct: 152 TRNVLVFDKLNVKISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGK--FSI 205
Query: 369 EIDIWSLGVVLY-VLVCGALPFDG 391
+ DIWS GVVL+ V G P+ G
Sbjct: 206 DSDIWSYGVVLWEVFSYGLQPYCG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 17/103 (16%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG---------QKLAT 347
QI + Y H R V+H+D+ A N ++D L +K+ D S P +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPF 389
W A E K+Y D+WS GV+L+ L+ G P+
Sbjct: 185 W------MALESLVNKEYSSAS-DVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 13/145 (8%)
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN--YYVPGQKLATWCGSP- 352
+Q+ +E+ +R+ +HRDL A N+L+ N +K+ DFG + Y P P
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLNS-----LRDRVLSGRF 406
+ APE K Y + D+WS GV+L+ + GA P+ G +N L+D R
Sbjct: 241 KWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD---GTRM 296
Query: 407 RIPYFMSTECESLIRKMLVREPTKR 431
R P + E ++ +P +R
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 57/234 (24%), Positives = 103/234 (44%), Gaps = 17/234 (7%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+ V +K++D S D ++L + +M+Q+ H HI+ L+ V +V E+ G
Sbjct: 33 IKVILKVLDPSHRD-ISL-AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 276 IFDYIARYGRMNENAARRKFW-QILSAVEYCHNRRVVHRDLKAENLLM-DSNLD------ 327
+ ++ R + + K Q+ SA+ Y ++ +VH ++ +N+L+ +D
Sbjct: 91 LDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC--G 385
IKL+D G + Q+ P+ APE E K D WS G L+ +C G
Sbjct: 151 IKLSDPGIPITVLSRQECVE---RIPWIAPECVEDSKNLSIAADKWSFGTTLWE-ICYNG 206
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
+P TL + ++R G+ + E L+ + +P +R I R
Sbjct: 207 EIPLKDKTL-AEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 7/151 (4%)
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN--YYVPGQKLATWCGSP- 352
+Q+ +E+ +R+ +HRDL A N+L+ N +K+ DFG + Y P P
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLS--GRFRIP 409
+ APE + Y + D+WS GV+L+ + GA P+ G ++ R L R R P
Sbjct: 246 KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 304
Query: 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
+ + E + EP++R ++ H
Sbjct: 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 26/206 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK ++++ ++ E +MK+ + H+++L V+ ++ E +G++
Sbjct: 39 VAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 97
Query: 278 DYIARYGRMNENAAR------RKFWQ----ILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
Y+ EN +K Q I + Y + + VHRDL A N ++ +
Sbjct: 98 SYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157
Query: 328 IKLADFGF------SNYYVPGQK--LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
+K+ DFG ++YY G K L SP VF D+WS GVVL
Sbjct: 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS------DVWSFGVVL 211
Query: 380 Y-VLVCGALPFDGSTLNSLRDRVLSG 404
+ + P+ G + + V+ G
Sbjct: 212 WEIATLAEQPYQGMSNEQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 40/217 (18%)
Query: 243 MKQLDHPHIIKLFQVMETKSMIYIVSEYAN-QGEIFDYIARYGRMNENAARRKF------ 295
MKQ D + + ++ E S+Y++ Q +D A Y N++ +
Sbjct: 180 MKQADTTQYVPMLEIKEA-------SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSE 232
Query: 296 -----------WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF-------SN 337
+Q+ +E+ ++ VHRDL A N+L+ +K+ DFG SN
Sbjct: 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN 292
Query: 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLNS 396
Y G + APE Y D+WS G++L+ + G P+ G ++S
Sbjct: 293 YVSKGSTFL----PVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDS 347
Query: 397 -LRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431
+++ SG R P + E ++ K EP KR
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 25/183 (13%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VA+K +++S ++ E +MK H+++L V+ +V E G+
Sbjct: 37 TRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 95
Query: 276 IFDYIARYGRMNENAARRKF----------WQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
+ Y+ EN R +I + Y + ++ VHRDL A N ++ +
Sbjct: 96 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155
Query: 326 LDIKLADFGF------SNYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLGV 377
+K+ DFG ++YY G K G P + APE + + D+WS GV
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGK-----GLLPVRWMAPESLKDGVFT-TSSDMWSFGV 209
Query: 378 VLY 380
VL+
Sbjct: 210 VLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 38/198 (19%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKF--- 295
E IM + +H +I++L V + +I+ E G++ ++ R N R
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL----RENRPRPERPSSLT 114
Query: 296 --------WQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFGF------SNY 338
+ +Y +HRD+ A N L+ K+ADFG ++Y
Sbjct: 115 MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174
Query: 339 YVPGQKL---ATWCGSPPYAAPE-VFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGST 393
Y G + W PP A + +F K D+WS GV+L+ + G +P+ G T
Sbjct: 175 YRKGGRAMLPIKW--MPPEAFLDGIFTSKT------DVWSFGVLLWEIFSLGYMPYPGRT 226
Query: 394 LNSLRDRVLSG-RFRIPY 410
+ + V G R P
Sbjct: 227 NQEVMEFVTGGGRLDPPK 244
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-06
Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 211 LLRHT---VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L RHT V ++I D +L+ + EV + HP+I+ + V T S ++++
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77
Query: 268 SEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
S + G + Y M+E + L + Y H +HR++KA ++L+ +
Sbjct: 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD 137
Query: 326 LDIKLADFGFSNYYV---PGQKLATWCGSP-------PYAAPEVFEGKKY-CGPEIDIWS 374
+ L+ G S+ Y GQK P P+ +PE+ Y + DI+S
Sbjct: 138 GLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195
Query: 375 LGVVLYVLVCGALPF 389
+G+ L G +PF
Sbjct: 196 VGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 27/241 (11%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
+ V +K++D S D + L + +M Q+ H H+ + V S +V E+
Sbjct: 43 RELRVVLKVLDPSHRD-IAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 274 GEIFDYIARYGRMNENAARRKFW------QILSAVEYCHNRRVVHRDLKAENLLM----- 322
G + D R + A W Q+ SA+ Y ++ +VH ++ A+N+L+
Sbjct: 101 GPL-DVCLRKEKGRVPVA----WKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155
Query: 323 --DSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
++ IKL+D G S + ++ P+ APE G D WS G L
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSREERVE---RIPWIAPECVPGGNSLSTAADKWSFGTTL- 211
Query: 381 VLVC--GALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIK 438
+ +C G +P T S ++R + R+P E +LI + L EPT+R I
Sbjct: 212 LEICFDGEVPLKERT-PSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270
Query: 439 R 439
R
Sbjct: 271 R 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 40/165 (24%), Positives = 80/165 (48%), Gaps = 26/165 (15%)
Query: 238 REVEIMKQLDHPHIIKLF-QVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFW 296
+EV+ ++L+HP++++ Q +E+ + +V E+ G++ +Y+ M A++
Sbjct: 44 QEVQPYRELNHPNVLQCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL 102
Query: 297 Q-----ILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS------NYYVPGQKL 345
Q + S + + H +H DL N + ++L +K+ D+G + +YY+
Sbjct: 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162
Query: 346 ATWCGSPP--YAAPEVFE--GKKYCGPEI----DIWSLGVVLYVL 382
A P + APE+ E G+ + +IWSLGV ++ L
Sbjct: 163 AV-----PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-06
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
G+P Y APE+ GK + GP +D W+LGV L+ + G PF+ T + +L+ IP
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR--DIP 598
Query: 410 Y-----FMSTECESLIRKMLVREPTKRYCIEQIKRHR 441
+ +S ++ I +L +PTKR ++++K+H
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 23/156 (14%)
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF-------SNYYVPGQ-KLAT 347
+Q+ + + ++ +HRDL A N+L+ K+ DFG SNY V G +L
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 348 WCGSPPYAAPE-VFEGKKYC--GPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLS 403
+ APE +F C E D+WS G++L+ + G+ P+ G ++S +++
Sbjct: 281 -----KWMAPESIFN----CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331
Query: 404 GRFRI--PYFMSTECESLIRKMLVREPTKRYCIEQI 437
+R+ P +E +++ +P KR +QI
Sbjct: 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN--YYVPGQKLATWCGSP-P 353
Q+ +E+ +R+ +HRDL A N+L+ N +K+ DFG + Y P P
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 354 YAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLN 395
+ APE K Y + D+WS GV+L+ + GA P+ G ++
Sbjct: 241 WMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQID 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 246 LDHPHIIK-LFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAA----RRKFWQILS 300
L HP+I++ L Q +E + +V EY G++ Y+++ N+ +R +I +
Sbjct: 52 LQHPNILQCLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 301 AVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF--GFSNY---YVPGQKLATWCGSPPYA 355
V + H +H DL N + S+L +K+ D+ G S Y Y+ + C +
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED--DKCVPLRWL 168
Query: 356 APEV---FEGKKYCGPEI---DIWSLGVVLYVLV-CGALPF 389
APE+ F G + ++W+LGV L+ L A P+
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 40/143 (27%), Positives = 54/143 (37%), Gaps = 28/143 (19%)
Query: 309 RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGP 368
R +HR K+ N+L D L G + P Q P + APEV +G+ Y
Sbjct: 31 RELHRQAKSGNIL--LTWDGLLKLDGSVAFKTPEQSRPD----PYFMAPEVIQGQSY-TE 83
Query: 369 EIDIWSLGVVLYVLVCGALP--------------FDGSTLNSLRDRV----LSGRFRIPY 410
+ DI+SLG+ LY + LP +G + RDR +S
Sbjct: 84 KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFED 143
Query: 411 FMSTECESLIRKMLVREPTKRYC 433
FM C S R RE Y
Sbjct: 144 FMRL-CAS--RLPQRREAANHYL 163
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 44/181 (24%), Positives = 76/181 (41%), Gaps = 32/181 (17%)
Query: 225 KSQLDPVNLQKVYREVEIMKQLDHPHIIK-LFQVMETKSMIYIVSEYANQGEIFDYIARY 283
+ K E + + L H ++++ L Q E + +V E+ G++ Y+ R
Sbjct: 31 RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL-LVMEFCPLGDLKGYL-RS 88
Query: 284 GRMNENAA------RRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS- 336
R E +R +I + + H +H DL N L+ ++L +K+ D+G S
Sbjct: 89 CRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148
Query: 337 -----NYYVPGQKLATWCGSPPYAAPE----------VFEGKKYCGPEIDIWSLGVVLYV 381
+YYV +L W + APE V + K E ++WSLGV ++
Sbjct: 149 NKYKEDYYVTPDQL--WV-PLRWIAPELVDEVHGNLLVVDQTK----ESNVWSLGVTIWE 201
Query: 382 L 382
L
Sbjct: 202 L 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-04
Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 17/165 (10%)
Query: 239 EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFW 296
E+ + K +HP+I+ + +++V+ + G D I + M+E A
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL----ADFGFSNYYVPGQKLATWCGSP 352
+L A++Y H+ VHR +KA ++L+ + + L ++ N+ GQ+L P
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH---GQRLRVVHDFP 165
Query: 353 -------PYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPF 389
P+ +PEV + + + DI+S+G+ L G +PF
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-04
Identities = 35/137 (25%), Positives = 60/137 (43%), Gaps = 15/137 (10%)
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF-------SNYYVPGQKLATW 348
+Q+ + +E+ ++ VHRDL A N+L+ +K+ DFG SNY G
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFR 407
+ APE Y D+WS G++L+ + G P+ +N + +R
Sbjct: 306 ----KWMAPESIFNNLYTTLS-DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360
Query: 408 I--PYFMSTECESLIRK 422
+ P S E +++K
Sbjct: 361 MAKPAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 8e-04
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 23/155 (14%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF-------SNYYVPGQ-KLATW 348
Q+ +++ ++ +HRD+ A N+L+ K+ DFG SNY V G +L
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV- 278
Query: 349 CGSPPYAAPE-VFEGKKYC--GPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSG 404
+ APE +F C + D+WS G++L+ + G P+ G +NS +++
Sbjct: 279 ----KWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330
Query: 405 RFRI--PYFMSTECESLIRKMLVREPTKRYCIEQI 437
+++ P F E S+++ EPT+R QI
Sbjct: 331 GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.003
Identities = 11/27 (40%), Positives = 16/27 (59%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
Y+I +G+G+F V LAR + T V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLV 27
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.004
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 58/226 (25%)
Query: 193 RKR-EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHI 251
RKR E C VK N P ++T + I+I ++ V +MK I
Sbjct: 151 RKRKEYCAVKIVR-NVP----KYTRDAKIEI---QFMEKVRQADPADRFPLMK------I 196
Query: 252 IKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR-RV 310
+ FQ ET M ++ +Y + D+I ++G + + +Q A++Y H +
Sbjct: 197 QRYFQ-NETGHMCIVMPKYGPC--LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHL 253
Query: 311 VHRDLKAENLLM---DSNLD-------------IKLADFGFSNYYVPGQKLATWCGSPPY 354
+H DLK EN+LM D+ +D +++ D G C +
Sbjct: 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-------------GCCDERH 300
Query: 355 AAPEVFEGKKYCGPEI----------DIWSLGVVLYVLVCGALPFD 390
+ + + Y PE+ D+WS+G ++Y L G L +D
Sbjct: 301 SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 41/236 (17%), Positives = 99/236 (41%), Gaps = 25/236 (10%)
Query: 218 VAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLF----QVMETKSMIYIVSEYAN 272
V I+ K V + E++ ++++D +I+K++ +++ + ++ EY
Sbjct: 46 VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105
Query: 273 QGEIFDYIARYGRMNENAARRKFWQI-------LSAVEYCHNRRVVHRDLKAENLLMDSN 325
+G Y+ ++ + + + L + N+ +++L + + L+ N
Sbjct: 106 RG----YLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN 159
Query: 326 LDIKLADFGFSNYYV--PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
+K+ G P + + ++F +Y + DI+SLGVVL+ +
Sbjct: 160 YKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS--EYT-IKDDIYSLGVVLWEIF 216
Query: 384 CGALPFDGSTLNSLRDRVL--SGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
G +PF+ T + D ++ + ++P E + ++ + KR I++I
Sbjct: 217 TGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1238 | |||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG0596|consensus | 677 | 100.0 | ||
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0983|consensus | 391 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG4250|consensus | 732 | 99.98 | ||
| KOG1035|consensus | 1351 | 99.97 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669|consensus | 376 | 99.97 | ||
| KOG0670|consensus | 752 | 99.97 | ||
| KOG1151|consensus | 775 | 99.97 | ||
| KOG0665|consensus | 369 | 99.97 | ||
| KOG4257|consensus | 974 | 99.97 | ||
| KOG0587|consensus | 953 | 99.97 | ||
| KOG0199|consensus | 1039 | 99.97 | ||
| KOG1006|consensus | 361 | 99.97 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0196|consensus | 996 | 99.97 | ||
| KOG1290|consensus | 590 | 99.97 | ||
| KOG4278|consensus | 1157 | 99.97 | ||
| KOG1027|consensus | 903 | 99.96 | ||
| KOG0664|consensus | 449 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668|consensus | 338 | 99.96 | ||
| KOG1094|consensus | 807 | 99.96 | ||
| KOG0200|consensus | 609 | 99.96 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152|consensus | 772 | 99.95 | ||
| KOG1167|consensus | 418 | 99.95 | ||
| KOG1025|consensus | 1177 | 99.94 | ||
| KOG0576|consensus | 829 | 99.94 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG3653|consensus | 534 | 99.93 | ||
| KOG0984|consensus | 282 | 99.93 | ||
| KOG2052|consensus | 513 | 99.93 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0590|consensus | 601 | 99.91 | ||
| KOG1345|consensus | 378 | 99.9 | ||
| KOG1164|consensus | 322 | 99.88 | ||
| KOG0603|consensus | 612 | 99.88 | ||
| KOG1024|consensus | 563 | 99.87 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1165|consensus | 449 | 99.84 | ||
| KOG1163|consensus | 341 | 99.82 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG0606|consensus | 1205 | 99.79 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG1033|consensus | 516 | 99.75 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG1240|consensus | 1431 | 99.74 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1166|consensus | 974 | 99.73 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG0590|consensus | 601 | 99.7 | ||
| KOG0195|consensus | 448 | 99.69 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG4158|consensus | 598 | 99.64 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG1023|consensus | 484 | 99.6 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0606|consensus | 1205 | 99.37 | ||
| KOG0601|consensus | 524 | 99.36 | ||
| KOG0601|consensus | 524 | 99.31 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.28 | |
| KOG1243|consensus | 690 | 99.26 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG1266|consensus | 458 | 99.02 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG0576|consensus | 829 | 98.95 | ||
| KOG2137|consensus | 700 | 98.85 | ||
| KOG3741|consensus | 655 | 98.83 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.52 | |
| KOG3087|consensus | 229 | 98.51 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.44 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.03 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.93 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.9 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.9 | |
| KOG1035|consensus | 1351 | 97.9 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.9 | |
| KOG1235|consensus | 538 | 97.85 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.74 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.54 | |
| KOG0595|consensus | 429 | 97.5 | ||
| KOG4717|consensus | 864 | 97.47 | ||
| KOG0588|consensus | 786 | 97.46 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.36 | |
| KOG0583|consensus | 370 | 97.27 | ||
| KOG1826|consensus | 2724 | 97.23 | ||
| KOG0615|consensus | 475 | 97.22 | ||
| KOG0593|consensus | 396 | 97.14 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.07 | |
| KOG0586|consensus | 596 | 97.03 | ||
| KOG0667|consensus | 586 | 97.02 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.01 | |
| KOG0585|consensus | 576 | 96.99 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.97 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.97 | |
| KOG0580|consensus | 281 | 96.95 | ||
| KOG0575|consensus | 592 | 96.94 | ||
| KOG0598|consensus | 357 | 96.88 | ||
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.83 | |
| KOG0605|consensus | 550 | 96.75 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 96.75 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 96.74 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 96.73 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 96.69 | |
| KOG0694|consensus | 694 | 96.63 | ||
| KOG0659|consensus | 318 | 96.62 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 96.62 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 96.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.6 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 96.58 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 96.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.55 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 96.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.53 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 96.51 |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=496.28 Aligned_cols=331 Identities=35% Similarity=0.582 Sum_probs=295.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccC-CCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKS-QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks-~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|+....+|.|+.|.|-.|.+..+|+.+|||++.+. .........+.+||.||+.+.||||++||++|+++.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3688889999999999999999999999999999887 445556678999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||++||.|++++.+.+++++.+++++|+||+.|+.|||..+|+||||||+|+|||..++|||+|||+|..-.++..+.+.
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS 171 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS 171 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998899999999
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
||+|.|.|||++.|.+|.+.++||||+|||||.||+|++||++++...++.++..|.|.+|..++.++++||++||.+||
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp 251 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDP 251 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccccccCCCCC----CCc---c-cccccCCCChHHHHHHHHHcCCC--hhhhHHHH-hhhccchhhHH
Q psy6346 429 TKRYCIEQIKRHRWMAEETPRLL----PPI---N-ILGEVKNEPNEQILRLMNSLGID--AAKTKEVF-EAETSKRRTFC 497 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~~p~~l----ppi---~-~l~elk~~~~eqILelMesLgid--~~kike~l-e~E~~~rkt~~ 497 (1238)
++|+|.+||++|||+........ ++. . ..-.-....++.|++-|..++.. .+++.+.+ ..+...+++++
T Consensus 252 ~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~iLwc~~d~~kl~~kLls~~~n~EK~~Y 331 (786)
T KOG0588|consen 252 STRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLCILWCGRDPEKLVEKLLSPDDNDEKTLY 331 (786)
T ss_pred cccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhhheeecCChHHHHHHHcCCCcchhHHHH
Confidence 99999999999999986532211 111 1 11122357789999999988654 45555544 55667789999
Q ss_pred HHHhhcccCCCCcccccchhhhh
Q psy6346 498 YILKRRADGGQTYEKEDMSAEKR 520 (1238)
Q Consensus 498 YiLkrr~e~~~~~e~ed~~~~kr 520 (1238)
++|.+++...+.-+++.....|.
T Consensus 332 ~LLl~~k~r~~~~~~~~~~~kk~ 354 (786)
T KOG0588|consen 332 FLLLRRKRRDSSQLDDFDENKKD 354 (786)
T ss_pred HHHHHhhccchhhhhhhhhhhhh
Confidence 99999998888877777766655
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=468.42 Aligned_cols=256 Identities=30% Similarity=0.574 Sum_probs=244.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||+|+|.++|+++++.+|..||+|++.+..+ .....+++.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 679999999999999999999999999999999998764 4556789999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t 347 (1238)
|+|..++|.+++++.+.++|.+++.+++||+.||.|||+++|||||||..||||+++.+|||+|||+|+..... ....+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988744 77889
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccC
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kD 427 (1238)
.||||.|.|||++....+ ++.+||||+|||||.||+|++||+..+..+.+.+|....+.+|..++.++++||.+||..|
T Consensus 178 lCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN 256 (592)
T ss_pred ecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence 999999999999997776 9999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHhccccccc
Q psy6346 428 PTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 428 PskRPTaeEILeHPWFke~ 446 (1238)
|.+|||+++||.|+||...
T Consensus 257 P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 257 PSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred cccCCCHHHHhcCHhhhCC
Confidence 9999999999999999554
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=450.00 Aligned_cols=261 Identities=32% Similarity=0.574 Sum_probs=236.7
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-----HhHHHHHHHHHHHHhCCCCCeeEEEEEeee
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-----VNLQKVYREVEIMKQLDHPHIIKLFQVMET 260 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-----e~ikrf~rEIeILkkL~HPNIVrL~dvfed 260 (1238)
..+-..|.....+|.|+||.|-+|...++|+.||||++++..... .....+.+|++||++|.|||||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 345567888899999999999999999999999999999876432 123456799999999999999999999999
Q ss_pred CCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC---CcEEEEecCCcc
Q psy6346 261 KSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN---LDIKLADFGFSN 337 (1238)
Q Consensus 261 ~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n---G~VKLiDFGLS~ 337 (1238)
.+..||||||+.||+|++.+...+.+.+...+.+++||+.||.|||+.||+||||||+|||+..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999765 779999999999
Q ss_pred cccCCCccccccCCCCCCCcccccCCc--cCCCccceehhhHHHHHHhhCCCCCCCCChhH-HHHHHhcCCccCC----C
Q psy6346 338 YYVPGQKLATWCGSPPYAAPEVFEGKK--YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS-LRDRVLSGRFRIP----Y 410 (1238)
Q Consensus 338 ~~~~s~~l~t~~GTp~YmAPEVL~gk~--y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee-L~ekIl~g~~~~P----~ 410 (1238)
.......+.+.||||.|.|||++.++. ++..++||||||||||-+|+|.+||.+..... +.+.|..+.+.+- .
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 988888999999999999999998654 34568999999999999999999998876665 9999999987653 2
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+++++.+||.+||..||++||+++|+|+||||+..
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 389999999999999999999999999999999865
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=432.80 Aligned_cols=297 Identities=36% Similarity=0.657 Sum_probs=269.2
Q ss_pred eeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee
Q psy6346 181 DTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET 260 (1238)
Q Consensus 181 ~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed 260 (1238)
..+..|++...|...+.||.|-|..|..+.+.-+|..||||++++..++......++.|++.|+.+.|||||+||+++.+
T Consensus 9 g~i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 9 GHIYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred ccccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 34567788888999999999999999999999999999999999999988888899999999999999999999999999
Q ss_pred CCEEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc-CCCcEEEEecCCccc
Q psy6346 261 KSMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD-SNLDIKLADFGFSNY 338 (1238)
Q Consensus 261 ~d~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd-~nG~VKLiDFGLS~~ 338 (1238)
...+|||+|+-.+|+|+|||.+. ..+.+..++++|+||+.|+.|||...+|||||||+||++. .-|-+||+|||++..
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence 99999999999999999999766 5799999999999999999999999999999999999875 468999999999999
Q ss_pred ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHH
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECES 418 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkD 418 (1238)
+.+++++.+.||+..|-|||++.|..|+.+++||||||||||.|+||++||...+..+....|+.-++.+|..++.+|++
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrd 248 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRD 248 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccCCCCCCCccc--ccccCCCChHHHHHHHHHcCC
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINI--LGEVKNEPNEQILRLMNSLGI 477 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~~p~~lppi~~--l~elk~~~~eqILelMesLgi 477 (1238)
||..||+.||++|.+.++|..|+|++...+.....++. -..+.++....|++.|....|
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvsr~~L~ee~Ha~IIq~Mv~G~I 309 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVSRHHLPEEAHATIIQQMVAGAI 309 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCCCCccccCceeehhhCChHHHHHHHHHHhcccc
Confidence 99999999999999999999999999876554443322 133444445556666655444
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=440.16 Aligned_cols=257 Identities=45% Similarity=0.788 Sum_probs=241.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC---hHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD---PVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld---~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~ly 265 (1238)
..|.....||.|+||.|+.+.+..++..||||++++.... ....+.+.+|+.++++++ ||||+++++++.....+|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 4588889999999999999999999999999998876322 134567789999999999 999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-CcEEEEecCCcccc-cCCC
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSNYY-VPGQ 343 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~~~-~~s~ 343 (1238)
+|||||.||+|++++.+.+++.+.+++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++... ....
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~ 176 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG 176 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC
Confidence 999999999999999999999999999999999999999999999999999999999999 99999999999987 4677
Q ss_pred ccccccCCCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCC-CHHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFM-STECESLIR 421 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~i-S~eLkDLIr 421 (1238)
...+.|||+.|+|||++.+.. |.+.++|||||||+||.|++|+.||+..+...++.+|..+.+.+|.++ ++++.+||+
T Consensus 177 ~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~ 256 (370)
T KOG0583|consen 177 LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIE 256 (370)
T ss_pred cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHH
Confidence 889999999999999999988 988999999999999999999999999999999999999999999999 999999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||..||.+|+|+.+|++||||+..
T Consensus 257 ~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 257 KMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHcCCCcccCCCHHHHhhChhhccC
Confidence 9999999999999999999999973
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=420.79 Aligned_cols=257 Identities=32% Similarity=0.572 Sum_probs=240.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
+.|.....||+|+||.||.+...++++.+|+|++++..+. ..+.+.+.+|..||.+++||+||+++..|.+.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 5588889999999999999999999999999999988754 346788999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCcccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t 347 (1238)
||+.||+|+.+|.+.+.|++..++-++..|+.||.|||++|||||||||+|||||..|+++|+|||+|+... .+....+
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~t 184 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRT 184 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999998654 4456677
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhccc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~k 426 (1238)
.|||+.|||||++.+.+| +.++|.||||+++|+|++|.+||.+.+...+.++|..++ ...|..++.++++||+++|.+
T Consensus 185 fcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~r 263 (357)
T KOG0598|consen 185 FCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKR 263 (357)
T ss_pred ccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhcc
Confidence 899999999999999988 899999999999999999999999999999999999998 555666999999999999999
Q ss_pred CCCCCC----CHHHHHhcccccccC
Q psy6346 427 EPTKRY----CIEQIKRHRWMAEET 447 (1238)
Q Consensus 427 DPskRP----TaeEILeHPWFke~~ 447 (1238)
||.+|. .+.+|.+||||....
T Consensus 264 dp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 264 DPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred CHHHhcCCCCChHHhhcCcccccCC
Confidence 999996 699999999998753
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=416.77 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=234.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-EEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS-MIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d-~lyLVME 269 (1238)
.+...+.||.|..|+||++.+..+++.+|+|++.. ..++...+++.+|++|++.++||+||.+|+.|..+. .++|+||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34556789999999999999999999999999944 357778899999999999999999999999999998 5999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+||+|.++++..++++|.....++.+|+.||.|||. ++||||||||.|||++..|.|||+|||.+...... ...++
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tf 237 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTF 237 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccc
Confidence 99999999999999999999999999999999999995 89999999999999999999999999999887665 66889
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-----ChhHHHHHHhcC-CccCCCC-CCHHHHHHHH
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-----TLNSLRDRVLSG-RFRIPYF-MSTECESLIR 421 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-----d~eeL~ekIl~g-~~~~P~~-iS~eLkDLIr 421 (1238)
+||..|||||.+.+..| +.++||||||+.++||.+|+.||... +.-++...|+.+ ...+|.. +++++++||.
T Consensus 238 vGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred cccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 99999999999999988 89999999999999999999999774 667888888885 4567876 9999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.||.+||.+|+++.|+++|||+++..
T Consensus 317 ~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999999999999999999998653
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=431.62 Aligned_cols=293 Identities=52% Similarity=0.860 Sum_probs=268.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|.|+.|..+++..++..||||+++++..+......+.+|+++|+.|+|||||+|+.+++....+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 45778889999999999999999999999999999999998888889999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
|+.+|++++++.+.+++.+.+++.+|.|++.|++|||+++|||||||++||||+.+.++||+|||++.++..+....++|
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~c 215 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFC 215 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
|++.|.|||++.+..|.++++|+||+|++||.|++|.+||+|.+..++..+++.+++.+|..++.+|++||++||.++|.
T Consensus 216 gsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Ps 295 (596)
T KOG0586|consen 216 GSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPS 295 (596)
T ss_pred CCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhccCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccccccCCC--CCCCcccccccCCCChHHHHHHHHHcCCChhhhHHH
Q psy6346 430 KRYCIEQIKRHRWMAEETPR--LLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEV 485 (1238)
Q Consensus 430 kRPTaeEILeHPWFke~~p~--~lppi~~l~elk~~~~eqILelMesLgid~~kike~ 485 (1238)
+|++++++++|.|+...... ..+.... ........-+..|..+|+...++.+.
T Consensus 296 kr~~~dqim~~~W~n~~~~~~~l~p~~e~---~~~~~~~~r~~~m~~~G~~~~~i~~s 350 (596)
T KOG0586|consen 296 KRGPCDQIMKDRWRNDLLEARLLAPLIER---STPFILAKRILHMNSIGHRRLKIEES 350 (596)
T ss_pred ccCCHHHhhhhcccchhhhhhhhhccccc---CccchhhHHHHHHHhhccchhhHHHH
Confidence 99999999999999765443 1111111 11222334446788889888887766
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=417.07 Aligned_cols=256 Identities=34% Similarity=0.606 Sum_probs=239.7
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....||.|+|++||+|++.+++..||||.+.+..+.+...+.+..||.||+.++|||||.|++++++++++||||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 46666779999999999999999999999999999988888889999999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC------CcEEEEecCCcccccCCCc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN------LDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n------G~VKLiDFGLS~~~~~s~~ 344 (1238)
|.||+|.+||.+.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+...++..
T Consensus 91 C~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~ 170 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM 170 (429)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH
Confidence 9999999999999999999999999999999999999999999999999999764 5699999999999999888
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc---CCCCCCHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR---IPYFMSTECESLIR 421 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~---~P~~iS~eLkDLIr 421 (1238)
..+.||+|.|||||++....| +.|+|+||+|+|||+|++|+.||+..+..++...+..+... ++..++..+.+|+.
T Consensus 171 a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~ 249 (429)
T KOG0595|consen 171 AETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLI 249 (429)
T ss_pred HHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhh
Confidence 999999999999999998887 89999999999999999999999999999999988877543 45567888899999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..|..+|..|.+..+-+.|+++....
T Consensus 250 ~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 250 SLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHHhcCccccCchHHhhhhhhcccCc
Confidence 99999999999999999999987654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=428.57 Aligned_cols=257 Identities=32% Similarity=0.568 Sum_probs=238.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|+..+.+|+|+|++|++|+..++++.|||||+.+..+- +...+-+.+|-.+|.+| +||.|++||-.|.+...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 4466678999999999999999999999999999988753 33456778999999999 999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC----
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---- 343 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---- 343 (1238)
+||+++|+|.++|++.+.|++..++.++.+|+.||+|||++|||||||||+|||||.+|+++|+|||.+..+.+..
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987664321
Q ss_pred ----------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCC
Q psy6346 344 ----------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMS 413 (1238)
Q Consensus 344 ----------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS 413 (1238)
...+++||-.|.+||++.+... ++.+|||+||||||.|+.|.+||.+.+...++++|+.-.+.||...+
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp 311 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFP 311 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCC
Confidence 1245899999999999998876 89999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+.+.|||+++|..||.+|+|+++|.+||||....
T Consensus 312 ~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 312 EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred HHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 9999999999999999999999999999998753
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=401.55 Aligned_cols=255 Identities=32% Similarity=0.601 Sum_probs=238.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
+.|.....+|.|+||.|..+....+|..+|+|++++..+ .-...+...+|..+|+.+.||++++|++.|.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 446666788999999999999999999999999988764 4456688899999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||++||+|+.++++.++|++..++.++.||+.||+|||+++|++|||||||||||.+|.+||+|||++...... ..+.
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~Tl 201 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTL 201 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876443 6789
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
||||.|+|||++..++| +.++|.|+|||++|||+.|.+||...+...++++|+.++..+|..++.++++||+++|++|-
T Consensus 202 CGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~ 280 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDL 280 (355)
T ss_pred cCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhh
Confidence 99999999999999998 99999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-----CHHHHHhcccccccC
Q psy6346 429 TKRY-----CIEQIKRHRWMAEET 447 (1238)
Q Consensus 429 skRP-----TaeEILeHPWFke~~ 447 (1238)
.+|. ...+|..||||+...
T Consensus 281 t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 281 TKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HhhhcCcCCCccccccCccccccc
Confidence 9994 578999999998643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=391.15 Aligned_cols=249 Identities=33% Similarity=0.534 Sum_probs=227.3
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGS 275 (1238)
.||.|+||.||++....+|+.||||++.+... .......+.+|+.+|++++||||+++++++...+.+|+||||+.|++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 58999999999999999999999999986542 33455778899999999999999999999999999999999999999
Q ss_pred cchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccccCCCCC
Q psy6346 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPPY 354 (1238)
Q Consensus 276 L~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~~GTp~Y 354 (1238)
|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+||+.|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y 161 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccc
Confidence 99999888899999999999999999999999999999999999999999999999999987532 22334556899999
Q ss_pred CCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCC--
Q psy6346 355 AAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-- 432 (1238)
Q Consensus 355 mAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRP-- 432 (1238)
+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+...+|..+++++.+||++||..||++||
T Consensus 162 ~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05571 162 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred cChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence 99999988876 899999999999999999999999998888888888888889999999999999999999999999
Q ss_pred ---CHHHHHhccccccc
Q psy6346 433 ---CIEQIKRHRWMAEE 446 (1238)
Q Consensus 433 ---TaeEILeHPWFke~ 446 (1238)
++.++++||||...
T Consensus 241 ~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 241 GPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCHHHHHcCCCcCCC
Confidence 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=388.97 Aligned_cols=254 Identities=29% Similarity=0.541 Sum_probs=232.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|++|.||++.+..+++.||||++.+... .....+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 457888999999999999999999999999999976532 2344577899999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 175 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFTL 175 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--Cccee
Confidence 9999999999999888999999999999999999999999999999999999999999999999999876533 23456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.....+.+..+...+|..++..+.+||++||..||
T Consensus 176 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP 254 (329)
T PTZ00263 176 CGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDH 254 (329)
T ss_pred cCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCH
Confidence 89999999999988876 89999999999999999999999998888888999999888999999999999999999999
Q ss_pred CCCCC-----HHHHHhccccccc
Q psy6346 429 TKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRPT-----aeEILeHPWFke~ 446 (1238)
.+|++ +++++.||||.+.
T Consensus 255 ~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 255 TKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHcCCCCCCCHHHHhcCCccCCC
Confidence 99996 7999999999763
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=411.37 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=233.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||.|....+|..+|+|++++... ...+++.++.|-.||...++|+||+||..|.+.+++||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 457777899999999999999999999999999998864 4567789999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-------
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP------- 341 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~------- 341 (1238)
||++||++..+|.+.+.|++..++.++.+++.||+-||++|+|||||||+|+|||..|++||+|||+|.-...
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999843210
Q ss_pred ---------------CC-c-------------------------cccccCCCCCCCcccccCCccCCCccceehhhHHHH
Q psy6346 342 ---------------GQ-K-------------------------LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380 (1238)
Q Consensus 342 ---------------s~-~-------------------------l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILY 380 (1238)
.. . ....+|||.|||||++.+..| +..+|+||||||+|
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~Imy 379 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGCIMY 379 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHHHHHH
Confidence 00 0 013479999999999999997 99999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhcCC--ccCCCC--CCHHHHHHHHHhcccCCCCCCC---HHHHHhcccccccCC
Q psy6346 381 VLVCGALPFDGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYC---IEQIKRHRWMAEETP 448 (1238)
Q Consensus 381 ELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~~--iS~eLkDLIrkML~kDPskRPT---aeEILeHPWFke~~p 448 (1238)
|||.|.+||.++++.+.+.+|+.++ +.+|.. +++++.|||.+||. ||.+|.. ++||.+||||+....
T Consensus 380 EmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 380 EMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 9999999999999999999999886 555654 78999999999999 9999984 999999999987544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=382.71 Aligned_cols=253 Identities=30% Similarity=0.556 Sum_probs=230.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||++....+++.||||++..... .....+.+.+|+.+|++++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 36677889999999999999999999999999976533 22345678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
|+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~~~~~~ 159 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWTLC 159 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--Cccccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999876533 233467
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+.+.+..+...+|..++..+.+||++||..||.
T Consensus 160 gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~ 238 (291)
T cd05612 160 GTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT 238 (291)
T ss_pred CChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999999988776 899999999999999999999999999888999999998889999999999999999999999
Q ss_pred CCCC-----HHHHHhccccccc
Q psy6346 430 KRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRPT-----aeEILeHPWFke~ 446 (1238)
+|++ ++++++||||...
T Consensus 239 ~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 239 RRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HccCCccCCHHHHhcCccccCC
Confidence 9995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=401.51 Aligned_cols=254 Identities=46% Similarity=0.782 Sum_probs=237.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.+|+|-+|.|.++...+.|+.||||.|+++.+ ++.++-.+++||+||..|+||||+.+|++|++.+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 34555667777777777787888899999999999876 56778899999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
|..+|+|+||+.+.+.+++.+++.||+||+.|+.|||.++++|||||.+|||||.++++||.|||++..+.....+.++|
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFC 213 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFC 213 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
|+|.|.+||++.|.+|.++.+|-|||||+||.|+.|.+||+|.+...+..+|..|.+.-|.. +.++.-||+.||-+||+
T Consensus 214 GSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLmVNP~ 292 (668)
T KOG0611|consen 214 GSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLMVNPE 292 (668)
T ss_pred CCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHhcCcc
Confidence 99999999999999999999999999999999999999999999999999999999876654 45678899999999999
Q ss_pred CCCCHHHHHhcccccc
Q psy6346 430 KRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 430 kRPTaeEILeHPWFke 445 (1238)
+|.|+++|-.|=|+.=
T Consensus 293 RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 293 RRATIEDIASHWWVNW 308 (668)
T ss_pred cchhHHHHhhhheeec
Confidence 9999999999988753
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=415.86 Aligned_cols=256 Identities=29% Similarity=0.523 Sum_probs=239.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
+.|....++|+|+||.|+.+....+++.+|||+++|..+ ...+.+.++.|.+|+... +||.++.|+..|.+++++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 558888999999999999999999999999999999874 566788999999999988 599999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~ 346 (1238)
|||+.||++ .++...+.|++..++.++..|+.||+|||++||||||||.+|||||.+|.+||+|||+++... .+....
T Consensus 448 mey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~Ts 526 (694)
T KOG0694|consen 448 MEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTS 526 (694)
T ss_pred EEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccc
Confidence 999999994 445556889999999999999999999999999999999999999999999999999998765 566788
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
++||||.|||||++.+..| +.++|.|+|||+|||||.|..||.|++.+++.+.|+..+..+|.+++.++.++|++||.+
T Consensus 527 TfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k 605 (694)
T KOG0694|consen 527 TFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRK 605 (694)
T ss_pred cccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhcc
Confidence 9999999999999999998 999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCC-----HHHHHhcccccccC
Q psy6346 427 EPTKRYC-----IEQIKRHRWMAEET 447 (1238)
Q Consensus 427 DPskRPT-----aeEILeHPWFke~~ 447 (1238)
+|++|+. +++|..||||+...
T Consensus 606 ~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 606 NPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred CcccccCCCCCCchhhhhCCccccCC
Confidence 9999985 68999999998753
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=382.68 Aligned_cols=248 Identities=30% Similarity=0.515 Sum_probs=225.6
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
||.|+||.||++.+..+++.||||++.+... .......+.+|+.+|++++||||+++++++.+.+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 5889999999999999999999999976432 344567888999999999999999999999999999999999999999
Q ss_pred chhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-CccccccCCCCCC
Q psy6346 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWCGSPPYA 355 (1238)
Q Consensus 277 ~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~GTp~Ym 355 (1238)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 999988888999999999999999999999999999999999999999999999999998754322 2334567999999
Q ss_pred CcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCC---
Q psy6346 356 APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY--- 432 (1238)
Q Consensus 356 APEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRP--- 432 (1238)
|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||..||.+||
T Consensus 161 aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 161 APELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred CHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 9999988876 899999999999999999999999998888889999888889999999999999999999999997
Q ss_pred CHHHHHhccccccc
Q psy6346 433 CIEQIKRHRWMAEE 446 (1238)
Q Consensus 433 TaeEILeHPWFke~ 446 (1238)
++.+++.||||.+.
T Consensus 240 ~~~e~l~hp~~~~~ 253 (312)
T cd05585 240 GAQEIKNHPFFSQL 253 (312)
T ss_pred CHHHHHcCCCcCCC
Confidence 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=383.52 Aligned_cols=248 Identities=31% Similarity=0.544 Sum_probs=225.9
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGS 275 (1238)
.||.|+||.||++....++..||||++.+... .......+.+|+.+|+.++||||+++++++...+.+|+||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 58999999999999999999999999986543 33456788899999999999999999999999999999999999999
Q ss_pred cchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCCCC
Q psy6346 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPPY 354 (1238)
Q Consensus 276 L~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp~Y 354 (1238)
|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+||+.|
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y 161 (328)
T cd05593 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161 (328)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCc
Confidence 999998888899999999999999999999999999999999999999999999999999875322 2233456799999
Q ss_pred CCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCC--
Q psy6346 355 AAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-- 432 (1238)
Q Consensus 355 mAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRP-- 432 (1238)
+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++||.+||.+|+
T Consensus 162 ~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 240 (328)
T cd05593 162 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGG 240 (328)
T ss_pred cChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 99999988776 899999999999999999999999988888888888888889999999999999999999999997
Q ss_pred ---CHHHHHhcccccc
Q psy6346 433 ---CIEQIKRHRWMAE 445 (1238)
Q Consensus 433 ---TaeEILeHPWFke 445 (1238)
++.++++||||..
T Consensus 241 ~~~~~~~il~h~~~~~ 256 (328)
T cd05593 241 GPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCHHHHhcCCCcCC
Confidence 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=384.90 Aligned_cols=259 Identities=34% Similarity=0.595 Sum_probs=241.2
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.+.++|...+.||+|.|+.|+++....+|+.+|+|+++...+.....+++.+|+.|-+.|+|||||+|.+.+.+.++.||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 45677888899999999999999999999999999999888877788999999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEEecCCcccccCCC
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLiDFGLS~~~~~s~ 343 (1238)
|+|++.|++|..-|....-+++..+..+++||+++|.|+|.+||||||+||+|++|-. ..-+||+|||++.....+.
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 9999999999888877788899999999999999999999999999999999999953 3459999999998887666
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESL 419 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkDL 419 (1238)
.-....|||.|||||++...+| +..+|||+.|||||-||.|++||.+++...+++.|..+.+.+|. .+++++++|
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred ccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 6667889999999999999888 99999999999999999999999999999999999999888765 389999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|++||..||.+|+|+.|+|+|||+.+.
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999865
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=409.14 Aligned_cols=255 Identities=28% Similarity=0.517 Sum_probs=240.6
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|-+.+.||.|+||+||+|....+...||||.+.+....+.+++.+.+|++|++.|+|||||.++++|++..++|+|.|||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 45567899999999999999999999999999999888888999999999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc-ccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL-ATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l-~t~~G 350 (1238)
.| +|+.++...+.++|+.++.+..+++.||.|||+++|+|||+||.|||++..|.+|++|||+++....+..+ ....|
T Consensus 84 ~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikG 162 (808)
T KOG0597|consen 84 VG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKG 162 (808)
T ss_pred hh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccC
Confidence 86 99999999999999999999999999999999999999999999999999999999999999987766544 34569
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
||.|||||++.+.+| +..+|+||||||+|||+.|++||.......+.+.|.......|...+..+..||..+|.+||.+
T Consensus 163 tPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~ 241 (808)
T KOG0597|consen 163 TPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQ 241 (808)
T ss_pred cccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhh
Confidence 999999999999888 8999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccccccCC
Q psy6346 431 RYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 431 RPTaeEILeHPWFke~~p 448 (1238)
|+|..+++.|||++....
T Consensus 242 RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 242 RLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred cccHHHHhcChHHhhhhh
Confidence 999999999999987543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.81 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=220.9
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|.....||.|+||.||++.+..++..||||++.+..... .....+.+|+.+|++++|+||+++++++.+.+..|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 566788999999999999999999999999997654332 2345678999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++............
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence 9999998887543 36899999999999999999999999999999999999999999999999999875544444556
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh----HHHHHHhcCCccCCCCCCHHHHHHHHHhc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN----SLRDRVLSGRFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e----eL~ekIl~g~~~~P~~iS~eLkDLIrkML 424 (1238)
.|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.... .+...+......++..++.++.+||++||
T Consensus 162 ~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 240 (285)
T cd05631 162 VGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240 (285)
T ss_pred CCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence 79999999999998877 89999999999999999999999876542 33344445555677789999999999999
Q ss_pred ccCCCCCCC-----HHHHHhccccccc
Q psy6346 425 VREPTKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRPT-----aeEILeHPWFke~ 446 (1238)
..||.+||+ ++++++||||.+.
T Consensus 241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 241 TKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred hcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=381.60 Aligned_cols=249 Identities=33% Similarity=0.539 Sum_probs=226.1
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGS 275 (1238)
.||.|+||.||++....+|..||+|++.+... .......+.+|+.+++.++||||+++++++...+.+|+||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 58999999999999999999999999986532 33456778899999999999999999999999999999999999999
Q ss_pred cchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCCCC
Q psy6346 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPPY 354 (1238)
Q Consensus 276 L~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp~Y 354 (1238)
|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+.|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y 161 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCc
Confidence 999998888899999999999999999999999999999999999999999999999999875322 2233456799999
Q ss_pred CCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCC--
Q psy6346 355 AAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-- 432 (1238)
Q Consensus 355 mAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRP-- 432 (1238)
+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||..||++|+
T Consensus 162 ~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05595 162 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred CCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCC
Confidence 99999988776 899999999999999999999999988888888888888888999999999999999999999998
Q ss_pred ---CHHHHHhccccccc
Q psy6346 433 ---CIEQIKRHRWMAEE 446 (1238)
Q Consensus 433 ---TaeEILeHPWFke~ 446 (1238)
++.++++|+||...
T Consensus 241 ~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 241 GPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCHHHHHcCCCcCCC
Confidence 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=387.73 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=221.5
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|+..+++|+|++|+||+|....+|+.||||++..+.-++...+-.+|||++|++|+|+|+|.|+++|.....++||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 55667899999999999999999999999999877666777778899999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~~G 350 (1238)
+.--|.++-.....++...++.+++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+... ++.....++.
T Consensus 84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVA 163 (396)
T KOG0593|consen 84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVA 163 (396)
T ss_pred chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhh
Confidence 855444433344679999999999999999999999999999999999999999999999999999887 6777788899
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--C-----------------ccCCC-
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--R-----------------FRIPY- 410 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~-----------------~~~P~- 410 (1238)
|.+|+|||.+.|...|+..+|||++||++.||++|.+.|+|.+.-+....|... . ..+|.
T Consensus 164 TRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~ 243 (396)
T KOG0593|consen 164 TRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEP 243 (396)
T ss_pred hhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCC
Confidence 999999999999766799999999999999999999999998766555444421 0 01121
Q ss_pred -----------CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 411 -----------FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 411 -----------~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.++..+.||+++||..||.+|++.+|+|.|++|..
T Consensus 244 ~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 244 EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 14667899999999999999999999999999943
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=380.11 Aligned_cols=249 Identities=33% Similarity=0.541 Sum_probs=225.6
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGS 275 (1238)
.||.|+||.||++....++..||||++.+... .......+.+|+++++.++||||+++++++...+.+|+||||+.+++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 58999999999999999999999999987543 23445678899999999999999999999999999999999999999
Q ss_pred cchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccccCCCC
Q psy6346 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPP 353 (1238)
Q Consensus 276 L~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~~GTp~ 353 (1238)
|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.... ........+||+.
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 161 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcc
Confidence 99999888889999999999999999999997 799999999999999999999999999987532 2233445679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCC-
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY- 432 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRP- 432 (1238)
|+|||++.+..+ +.++|||||||+||+|++|..||.+.+.......+......+|..+++++.+||++||..||++|+
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 162 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred cCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCC
Confidence 999999988776 899999999999999999999999988888888888888889999999999999999999999997
Q ss_pred ----CHHHHHhccccccc
Q psy6346 433 ----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 433 ----TaeEILeHPWFke~ 446 (1238)
++.++++||||...
T Consensus 241 ~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 241 GGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 99999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=404.80 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=225.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCC-EEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKS-MIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d-~lyLV 267 (1238)
.+|...+++|.|.||.||++..+.+|..||||.+++.....++.- =.||+..|++|+ |||||+|.+++.+.+ .+|+|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 456666788888889999999999999999999998876544433 358999999998 999999999998887 99999
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||||+ ..|+++++.+ +.|++..++.|++||++||+|+|.+|+.||||||||||+.....+||+|||+|+.........
T Consensus 89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT 167 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT 167 (538)
T ss_pred HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcc
Confidence 99997 7899999865 569999999999999999999999999999999999999988899999999999988888899
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc-------------------CCcc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS-------------------GRFR 407 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~-------------------g~~~ 407 (1238)
.++.|++|+|||+++...+|+.++|||++|||++|+.+-++.|.|.+..+...+|++ -.+.
T Consensus 168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~ 247 (538)
T KOG0661|consen 168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR 247 (538)
T ss_pred hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence 999999999999999999999999999999999999999999999876655555442 1222
Q ss_pred CCCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 408 IPYF-----------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 408 ~P~~-----------iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+|.. .+.++.+||.+||.+||++|||++|+|+||||+...
T Consensus 248 ~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 248 FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 3322 578899999999999999999999999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=366.01 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=213.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....+|.|++|.||++.+..++..||||++..........+.+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 36778899999999999999999999999999987655555567888999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~t~ 348 (1238)
+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccccc
Confidence 9988776665555679999999999999999999999999999999999999999999999999997654322 22345
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccC-
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRI- 408 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~- 408 (1238)
.|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+... ...+
T Consensus 162 ~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 162 VATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred ccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 78999999999988776 88999999999999999999999876543322222110 0001
Q ss_pred ------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 409 ------------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 409 ------------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
...++.++.+||++||.+||++|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 12367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=379.09 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=225.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|++|.||++.+..+++.||||++.+.... ......+.+|+.+|..++|+||+++++++.+++.+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 367788999999999999999999999999999865432 2455778899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC------
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ------ 343 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~------ 343 (1238)
|+.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987654332
Q ss_pred ------------------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHH
Q psy6346 344 ------------------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRD 399 (1238)
Q Consensus 344 ------------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~e 399 (1238)
......||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 2334579999999999998876 899999999999999999999999988877777
Q ss_pred HHhc--CCccCCCC--CCHHHHHHHHHhcccCCCCCCC-HHHHHhccccccc
Q psy6346 400 RVLS--GRFRIPYF--MSTECESLIRKMLVREPTKRYC-IEQIKRHRWMAEE 446 (1238)
Q Consensus 400 kIl~--g~~~~P~~--iS~eLkDLIrkML~kDPskRPT-aeEILeHPWFke~ 446 (1238)
.+.. ....+|.. +++++.+||.+||. ||.+|++ ++++++||||...
T Consensus 241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7776 44445544 59999999999997 9999999 9999999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=383.04 Aligned_cols=254 Identities=30% Similarity=0.542 Sum_probs=229.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCC-cEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHT-VNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG-~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|+||.||++.+...+ ..||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 34777889999999999999876554 7899999976532 334557788999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
|||+.||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...+
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--~~~~ 187 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYT 187 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--Ccce
Confidence 99999999999999888999999999999999999999999999999999999999999999999999976432 2345
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccC
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kD 427 (1238)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...+|..+++.+.+||++||..|
T Consensus 188 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~d 266 (340)
T PTZ00426 188 LCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHD 266 (340)
T ss_pred ecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 689999999999988776 8999999999999999999999999988888899999888889999999999999999999
Q ss_pred CCCCC-----CHHHHHhccccccc
Q psy6346 428 PTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 428 PskRP-----TaeEILeHPWFke~ 446 (1238)
|.+|+ +++++++||||...
T Consensus 267 p~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 267 LTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99995 89999999999763
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=390.99 Aligned_cols=261 Identities=37% Similarity=0.589 Sum_probs=238.9
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCC
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKS 262 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d 262 (1238)
...+...|.....+|.|.||.||.++...+|..+|+|++.+.... ....+.+.+|+.||+++. |||||.++++|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 344556788889999999999999999999999999999887653 335678999999999998 999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC----CcEEEEecCCccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN----LDIKLADFGFSNY 338 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n----G~VKLiDFGLS~~ 338 (1238)
.+++|||+|.||+|++.|... .+++..+..+++||+.++.|||+.||+||||||+|+|+... +.+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999876 49999999999999999999999999999999999999643 5799999999998
Q ss_pred ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCC----CCH
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF----MST 414 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~----iS~ 414 (1238)
...+......|||+.|+|||++.+.+| +..+||||+||++|.|++|..||.+.+......+|..+.+.++.. ++.
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 887778889999999999999998887 999999999999999999999999999999999999998766543 789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.+++||++||..||.+|+|+.++|+|||+....
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 999999999999999999999999999998753
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=394.18 Aligned_cols=260 Identities=31% Similarity=0.562 Sum_probs=230.0
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh------------HhHHHHHHHHHHHHhCCCCCeeEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP------------VNLQKVYREVEIMKQLDHPHIIKLFQ 256 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~------------e~ikrf~rEIeILkkL~HPNIVrL~d 256 (1238)
-..|.....||.|.+|.|.++....+++.||||++.+..+.. ..++++++||.||++|.|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 355778889999999999999999999999999998865321 12468999999999999999999999
Q ss_pred Eeee--CCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecC
Q psy6346 257 VMET--KSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 257 vfed--~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
+..+ .+.+|||+|||..|.+.+.-.....+++.+++.+++.++.||+|||.+|||||||||.|+||+.+|.+||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 9965 56799999999999887654443349999999999999999999999999999999999999999999999999
Q ss_pred CcccccCC------CccccccCCCCCCCcccccC---CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC
Q psy6346 335 FSNYYVPG------QKLATWCGSPPYAAPEVFEG---KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR 405 (1238)
Q Consensus 335 LS~~~~~s------~~l~t~~GTp~YmAPEVL~g---k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~ 405 (1238)
.+..+..+ ..+....|||.|+|||...+ ..+.+.+.||||+||+||.|+.|+.||-++...+++++|.+..
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 98766222 23344689999999999987 5567899999999999999999999999999999999999999
Q ss_pred ccCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 406 FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 406 ~~~P~~--iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
+.||.. +.++++|||.+||.+||.+|+++.+|..|||+.....
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 988876 7999999999999999999999999999999987643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=376.08 Aligned_cols=248 Identities=29% Similarity=0.524 Sum_probs=224.7
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++....++..||||++.+... .....+.+..|++++..+ +||||+++++++.+.+.+|+||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 57999999999999988999999999986532 334556788899999876 8999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp~ 353 (1238)
+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCcc
Confidence 9999998888899999999999999999999999999999999999999999999999999875432 233445679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCC-
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY- 432 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRP- 432 (1238)
|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.....+.+..+...+|..++.++.+||.+||..||++|+
T Consensus 162 y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 162 YIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred ccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 999999988776 889999999999999999999999999999999999988888989999999999999999999999
Q ss_pred ------CHHHHHhcccccc
Q psy6346 433 ------CIEQIKRHRWMAE 445 (1238)
Q Consensus 433 ------TaeEILeHPWFke 445 (1238)
+++++++||||..
T Consensus 241 ~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 241 CVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCCCHHHHhcCCccCC
Confidence 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=378.15 Aligned_cols=249 Identities=29% Similarity=0.544 Sum_probs=225.2
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+..+++.||||++.+... .....+.+..|+.++..+ +||||+++++++.+.+.+|+||||++|+
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 58999999999999999999999999976532 234556778899999877 7999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~~GTp~ 353 (1238)
+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+.
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 161 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD 161 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCcc
Confidence 999999888899999999999999999999999999999999999999999999999999987532 2233445679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+...+..+...+|..++.++.+||++||..||.+|++
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~ 240 (320)
T cd05590 162 YIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG 240 (320)
T ss_pred ccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence 999999988776 8899999999999999999999999999999999998888889999999999999999999999999
Q ss_pred H------HHHHhccccccc
Q psy6346 434 I------EQIKRHRWMAEE 446 (1238)
Q Consensus 434 a------eEILeHPWFke~ 446 (1238)
+ ++++.||||...
T Consensus 241 ~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 241 SLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCHHHHHcCCCcCCC
Confidence 8 999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=387.07 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=220.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC--EEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS--MIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d--~lyLV 267 (1238)
..|.....+|.|+||.||.+...++|...|||.+..... ...+.+.+|+.+|.+|+|||||++++...... .++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 446777899999999999999999999999999987632 22677999999999999999999999754433 79999
Q ss_pred EeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCcccccC----
Q psy6346 268 SEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYVP---- 341 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~~---- 341 (1238)
|||+++|+|.+++.+.+ .+++..++.+.+||++||.|||++|||||||||+|||++. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999999987 7999999999999999999999999999999999999999 79999999999987653
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCC-CChhHHHHHHhcC--CccCCCCCCHHHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG-STLNSLRDRVLSG--RFRIPYFMSTECES 418 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g-~d~eeL~ekIl~g--~~~~P~~iS~eLkD 418 (1238)
........||+.|||||++.......+++|||||||++.||+||..||.. .......-.+... ...+|..+++++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD 254 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 22344578999999999999633334699999999999999999999987 3333333333333 35688899999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
||.+||..||.+|||++++|+|||.....+
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999999987654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=381.10 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=221.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||++....+++.||||++.+... .......+.+|+.++.+++|+||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 46778899999999999999999999999999976532 23445678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC------
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ------ 343 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~------ 343 (1238)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~ 161 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999986542110
Q ss_pred ------------------------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC
Q psy6346 344 ------------------------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393 (1238)
Q Consensus 344 ------------------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d 393 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred cccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 0124579999999999988876 889999999999999999999999988
Q ss_pred hhHHHHHHhcC--CccCCC--CCCHHHHHHHHHhcccCCCC---CCCHHHHHhccccccc
Q psy6346 394 LNSLRDRVLSG--RFRIPY--FMSTECESLIRKMLVREPTK---RYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 394 ~eeL~ekIl~g--~~~~P~--~iS~eLkDLIrkML~kDPsk---RPTaeEILeHPWFke~ 446 (1238)
..+...++... ...+|. .+++++++||.+|+. +|.+ ||+++||++||||...
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 88888888764 334454 368999999999875 4544 5899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=374.50 Aligned_cols=253 Identities=30% Similarity=0.457 Sum_probs=223.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|++|.||++.+..++..||||++.+.... ......+.+|+++|..++||||+++++++...+..|||||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 367788999999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
|++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~ 159 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVV 159 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcc
Confidence 999999999998888899999999999999999999999999999999999999999999999999876433 334567
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC------CCCHHHHHHHH
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY------FMSTECESLIR 421 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~------~iS~eLkDLIr 421 (1238)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.... ...|. .++.++.+||.
T Consensus 160 gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 160 GSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred cCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 9999999999988866 899999999999999999999999988877776665432 12222 35899999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||..+|.+||+++++++||||...
T Consensus 239 ~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=374.37 Aligned_cols=250 Identities=28% Similarity=0.514 Sum_probs=222.5
Q ss_pred EEecCCCCccccCceEc---cCCcEEEEEEeccCCC--ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 196 EKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQL--DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~l--d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
+.||.|+||.||++... .+++.||||++.+... +......+.+|+.+|+.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 46788888888887664 4688999999986532 223345678999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCcccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~ 349 (1238)
+.|++|.+++.+.+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC 161 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence 99999999998888899999999999999999999999999999999999999999999999999875432 22334567
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++++.+||.+||..||.
T Consensus 162 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 240 (323)
T cd05584 162 GTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240 (323)
T ss_pred CCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHh
Confidence 9999999999988776 889999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCC-----CHHHHHhccccccc
Q psy6346 430 KRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRP-----TaeEILeHPWFke~ 446 (1238)
+|| ++++++.||||...
T Consensus 241 ~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 241 SRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcCCCCCCCHHHHhcCCCcCCC
Confidence 999 89999999999763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=378.88 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=221.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||++.+..+++.||||++.+... .......+.+|+.+|+.++||||+++++++.+.+.+|||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 36777899999999999999999999999999986532 23445678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC------
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ------ 343 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~------ 343 (1238)
||.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999986532111
Q ss_pred ---------------------------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCC
Q psy6346 344 ---------------------------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390 (1238)
Q Consensus 344 ---------------------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~ 390 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred cccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCCC
Confidence 1113469999999999988776 899999999999999999999999
Q ss_pred CCChhHHHHHHhcCC--ccCCC--CCCHHHHHHHHHhcccCCCCCCC---HHHHHhccccccc
Q psy6346 391 GSTLNSLRDRVLSGR--FRIPY--FMSTECESLIRKMLVREPTKRYC---IEQIKRHRWMAEE 446 (1238)
Q Consensus 391 g~d~eeL~ekIl~g~--~~~P~--~iS~eLkDLIrkML~kDPskRPT---aeEILeHPWFke~ 446 (1238)
+.+.......+.... +.+|. .+++++.+||.+||. +|.+|++ +++++.||||+..
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 988877777776543 33343 368999999999997 9999997 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=373.04 Aligned_cols=254 Identities=27% Similarity=0.464 Sum_probs=227.9
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCC-CeeEEEEEeeeCCEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHP-HIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HP-NIVrL~dvfed~d~lyLVME 269 (1238)
|.....||.|+||.||++....+++.||||++.+... .....+.+..|++++..++|+ +|+.+++++.+.+.+|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 5667889999999999999999999999999986532 334567788999999999765 58889999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~ 348 (1238)
|++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF 161 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeee
Confidence 99999999999888889999999999999999999999999999999999999999999999999986432 22334456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+...+......+|..++.++.+||++||.+||
T Consensus 162 ~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P 240 (324)
T cd05587 162 CGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP 240 (324)
T ss_pred cCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 79999999999998877 88999999999999999999999999988899999988888899999999999999999999
Q ss_pred CCCCCH-----HHHHhccccccc
Q psy6346 429 TKRYCI-----EQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRPTa-----eEILeHPWFke~ 446 (1238)
.+|++. +++++||||...
T Consensus 241 ~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 241 AKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHcCCCCCCCHHHHhcCCCcCCC
Confidence 999976 899999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=375.98 Aligned_cols=248 Identities=29% Similarity=0.535 Sum_probs=220.2
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+..++..||||++++.... ....+.+.+|+.++.++ +||||+++++++.+.+.+|+|||||+|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 589999999999999999999999999876432 34557788999999998 7999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc-cCCCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~-~~s~~l~t~~GTp~ 353 (1238)
+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .........+||+.
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN 161 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCcc
Confidence 99999988889999999999999999999999999999999999999999999999999998653 22334456789999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC---------ChhHHHHHHhcCCccCCCCCCHHHHHHHHHhc
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS---------TLNSLRDRVLSGRFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~---------d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML 424 (1238)
|+|||++.+..+ +.++|||||||++|+|++|+.||... ....+.+.+......+|..++.++.+||++||
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L 240 (329)
T cd05588 162 YIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL 240 (329)
T ss_pred ccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 999999988776 88999999999999999999999632 12335666777778889999999999999999
Q ss_pred ccCCCCCCC------HHHHHhcccccc
Q psy6346 425 VREPTKRYC------IEQIKRHRWMAE 445 (1238)
Q Consensus 425 ~kDPskRPT------aeEILeHPWFke 445 (1238)
..||.+|++ ++++++||||..
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 241 NKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred ccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999987 799999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=381.75 Aligned_cols=253 Identities=25% Similarity=0.449 Sum_probs=219.6
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|+||.||++....+++.||||++.+... .....+.+.+|+++|+.++||||+++++++.+.+.+|||||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 36677899999999999999999999999999876432 33456788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC------
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ------ 343 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~------ 343 (1238)
|++||+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 161 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999986331100
Q ss_pred ------------------------------------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHH
Q psy6346 344 ------------------------------------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYV 381 (1238)
Q Consensus 344 ------------------------------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYE 381 (1238)
.....+||+.|+|||++.+..+ +.++|||||||+|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~e 240 (377)
T cd05629 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFE 240 (377)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhhh
Confidence 0012479999999999988776 899999999999999
Q ss_pred HhhCCCCCCCCChhHHHHHHhcC--CccCCC--CCCHHHHHHHHHhcccCCCCC---CCHHHHHhcccccc
Q psy6346 382 LVCGALPFDGSTLNSLRDRVLSG--RFRIPY--FMSTECESLIRKMLVREPTKR---YCIEQIKRHRWMAE 445 (1238)
Q Consensus 382 LLTGrlPF~g~d~eeL~ekIl~g--~~~~P~--~iS~eLkDLIrkML~kDPskR---PTaeEILeHPWFke 445 (1238)
|++|..||.+.+.......+... ...+|. .++.++.+||.+||. +|.+| +++.+++.||||..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999999988877777777653 334454 478999999999998 67765 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=374.87 Aligned_cols=249 Identities=28% Similarity=0.513 Sum_probs=222.7
Q ss_pred EEecCCCCccccCceEc---cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 196 EKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
+.||.|+||.||++... .+|..||||++.+..........+.+|+++|++++||||+++++++.+.+.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 35778888888876653 468999999998765444455678899999999999999999999999999999999999
Q ss_pred CCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-CccccccCC
Q psy6346 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWCGS 351 (1238)
Q Consensus 273 GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~GT 351 (1238)
+++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+|+
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~ 161 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 161 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence 9999999988888999999999999999999999999999999999999999999999999998765433 234456799
Q ss_pred CCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCC
Q psy6346 352 PPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR 431 (1238)
Q Consensus 352 p~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskR 431 (1238)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||++||+.||.+|
T Consensus 162 ~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R 240 (318)
T cd05582 162 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANR 240 (318)
T ss_pred hhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHc
Confidence 99999999988776 88999999999999999999999998888888888888888899999999999999999999999
Q ss_pred CC-----HHHHHhcccccc
Q psy6346 432 YC-----IEQIKRHRWMAE 445 (1238)
Q Consensus 432 PT-----aeEILeHPWFke 445 (1238)
|+ +++++.||||..
T Consensus 241 ~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 241 LGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CCCCCCCHHHHhCCCCcCC
Confidence 99 888999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=380.10 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=218.9
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|...+.||.|+||.||++.+..++..||||++.+... .......+.+|+.+|++++|+||+++++++.+.+.+|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 6677899999999999999999999999999987543 344567899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC--------
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-------- 342 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-------- 342 (1238)
|+||+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~ 162 (381)
T cd05626 83 IPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK 162 (381)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccc
Confidence 999999999988888999999999999999999999999999999999999999999999999987532100
Q ss_pred ----------------------------------------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHH
Q psy6346 343 ----------------------------------------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL 382 (1238)
Q Consensus 343 ----------------------------------------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYEL 382 (1238)
....+.+||+.|+|||++.+..+ +.++|||||||++|||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~el 241 (381)
T cd05626 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFEM 241 (381)
T ss_pred cccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHHHH
Confidence 00123579999999999988776 8999999999999999
Q ss_pred hhCCCCCCCCChhHHHHHHhcC--CccCCC--CCCHHHHHHHHHhccc--CCCCCCCHHHHHhccccccc
Q psy6346 383 VCGALPFDGSTLNSLRDRVLSG--RFRIPY--FMSTECESLIRKMLVR--EPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 383 LTGrlPF~g~d~eeL~ekIl~g--~~~~P~--~iS~eLkDLIrkML~k--DPskRPTaeEILeHPWFke~ 446 (1238)
++|..||...+.......+... ...+|. .+++++.+||.+|+.. +|..|+++++++.||||.+.
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999988776666666543 334443 4799999999996654 45559999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=372.07 Aligned_cols=253 Identities=28% Similarity=0.498 Sum_probs=223.9
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHH---hCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMK---QLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILk---kL~HPNIVrL~dvfed~d~lyLV 267 (1238)
|.....||.|++|.||++.+..++..||||++++... .....+.+.+|++++. .++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 4567889999999999999999999999999986532 2334567777877664 56899999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~ 346 (1238)
|||+.|++|..++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999888754 5799999999999999999999999999999999999999999999999999865322 23344
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
..+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..++.++.+||.+||..
T Consensus 160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238 (324)
T ss_pred ccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence 5789999999999988776 889999999999999999999999999888888888888888989999999999999999
Q ss_pred CCCCCC-----CHHHHHhccccccc
Q psy6346 427 EPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRP-----TaeEILeHPWFke~ 446 (1238)
||.+|| +++++++||||...
T Consensus 239 dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 239 NPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999 79999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.66 Aligned_cols=248 Identities=29% Similarity=0.482 Sum_probs=221.1
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHH-HHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVE-IMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIe-ILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+..+|+.||||++.+... .......+..|.. +++.++||||+++++++.+.+.+|+||||+.++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 58999999999999999999999999976532 2233455666665 467899999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp~ 353 (1238)
+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChh
Confidence 9999998888899999999999999999999999999999999999999999999999999875322 233445679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++.+.+......++..++.++.+||.+||..||.+||+
T Consensus 162 y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 240 (323)
T cd05575 162 YLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG 240 (323)
T ss_pred hcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCC
Confidence 999999988776 8899999999999999999999999988888889988888888889999999999999999999998
Q ss_pred H----HHHHhcccccc
Q psy6346 434 I----EQIKRHRWMAE 445 (1238)
Q Consensus 434 a----eEILeHPWFke 445 (1238)
+ .++++||||..
T Consensus 241 ~~~~~~~il~~~~~~~ 256 (323)
T cd05575 241 AKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCHHHHHcCCCcCC
Confidence 7 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.81 Aligned_cols=249 Identities=27% Similarity=0.491 Sum_probs=222.6
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+..+|..||||++++... .......+..|+.++..+ +||||+++++++.+.+.+|+||||+.|+
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 58999999999999999999999999986532 123456677888888765 9999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp~ 353 (1238)
+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+||+.
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (316)
T cd05620 82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPD 161 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcC
Confidence 9999998888899999999999999999999999999999999999999999999999999864322 233455789999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+.+.+......+|..++.++.+||.+||..||.+|++
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~ 240 (316)
T cd05620 162 YIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG 240 (316)
T ss_pred ccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 999999988876 8999999999999999999999999988888888888888888899999999999999999999999
Q ss_pred H-HHHHhccccccc
Q psy6346 434 I-EQIKRHRWMAEE 446 (1238)
Q Consensus 434 a-eEILeHPWFke~ 446 (1238)
+ +++++||||...
T Consensus 241 ~~~~~~~h~~f~~~ 254 (316)
T cd05620 241 VVGNIRGHPFFKTI 254 (316)
T ss_pred ChHHHHcCCCcCCC
Confidence 7 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=370.58 Aligned_cols=255 Identities=26% Similarity=0.476 Sum_probs=220.6
Q ss_pred EEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCC--ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQL--DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~l--d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ly 265 (1238)
|...+.||.|+||.||++... .++..||+|++.+... .....+.+.+|+.+|+.+ +|+||+++++++...+.+|
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 566788999999999987664 4689999999976432 223456788999999999 5999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-- 343 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-- 343 (1238)
+||||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987653322
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC----ChhHHHHHHhcCCccCCCCCCHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS----TLNSLRDRVLSGRFRIPYFMSTECESL 419 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~----d~eeL~ekIl~g~~~~P~~iS~eLkDL 419 (1238)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||... ....+...+......+|..+++.+.+|
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 2334679999999999987654588999999999999999999999643 334555666667777888899999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRP-----TaeEILeHPWFke~ 446 (1238)
|.+||..||++|| +++++++||||.+.
T Consensus 242 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=397.66 Aligned_cols=254 Identities=26% Similarity=0.467 Sum_probs=227.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
-..|....++|.|+.|.||.+....++..||||.+...... ..+-+.+|+.+|+.+.|+|||.+++.|--++.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 35577778899999999999999999999999999887543 3467899999999999999999999998889999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t 347 (1238)
||++||+|.|.+... .++|..+..|++.++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.... +..+
T Consensus 350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 999999999988764 49999999999999999999999999999999999999999999999999998876655 7788
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh-cC--CccCCCCCCHHHHHHHHHhc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL-SG--RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl-~g--~~~~P~~iS~eLkDLIrkML 424 (1238)
.+|||+|||||++..+.| ++++||||||++++||+-|.+||-.++.......|. ++ ++..|..+|+++++||.+||
T Consensus 429 mVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL 507 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL 507 (550)
T ss_pred ccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence 999999999999999998 999999999999999999999998666544444444 34 34567789999999999999
Q ss_pred ccCCCCCCCHHHHHhccccccc
Q psy6346 425 VREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRPTaeEILeHPWFke~ 446 (1238)
+.|+.+|+++.|||+||||+..
T Consensus 508 ~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 508 VVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred hcchhcCCCHHHHhcChhhhhc
Confidence 9999999999999999999544
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=369.53 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=227.4
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVME 269 (1238)
|.....||.|+||.||++.+..++..||||++.+... .....+.+..|..++..+ .|++|+.+++++.+.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 5667889999999999999999999999999987543 233456677888998887 58899999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~ 348 (1238)
|+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~ 161 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccC
Confidence 99999999999888889999999999999999999999999999999999999999999999999987533 22234456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+...+......+|..++.++.+||.+||..||
T Consensus 162 ~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p 240 (323)
T cd05616 162 CGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240 (323)
T ss_pred CCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCH
Confidence 79999999999998877 89999999999999999999999999988999999988888899999999999999999999
Q ss_pred CCCCC-----HHHHHhcccccc
Q psy6346 429 TKRYC-----IEQIKRHRWMAE 445 (1238)
Q Consensus 429 skRPT-----aeEILeHPWFke 445 (1238)
.+|++ ..++++||||+.
T Consensus 241 ~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 241 GKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HhcCCCCCCCHHHHhcCCCcCC
Confidence 99997 589999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.94 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=211.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.||.|+||.||++....++..||+|+++.... ......+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 47788999999999999999999999999999976532 22335678999999999999999999999999999999999
Q ss_pred cCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 271 ANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
+.+ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~ 163 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCc
Confidence 985 8888886544 4789999999999999999999999999999999999999999999999998654322 223445
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRIP 409 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~P 409 (1238)
.|++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+... ...+|
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence 78999999999877554588999999999999999999999887765544433210 00111
Q ss_pred -----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 410 -----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 410 -----------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
..++.++.+||++||..||.+|||++|+++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 2367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=371.57 Aligned_cols=249 Identities=32% Similarity=0.573 Sum_probs=225.3
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+..++..||||++.+... .......+.+|++++..+ +||||+++++++.+.+.+|+||||+.|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 58999999999999989999999999987542 234556788999999988 7999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~~GTp~ 353 (1238)
+|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.... ........+|++.
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~ 161 (318)
T cd05570 82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD 161 (318)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCcc
Confidence 999999888899999999999999999999999999999999999999999999999999986532 2233345679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+......+|..++.++.+||++||..||++||+
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s 240 (318)
T cd05570 162 YIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG 240 (318)
T ss_pred ccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCC
Confidence 999999988877 8899999999999999999999999988888888888888889899999999999999999999999
Q ss_pred H-----HHHHhccccccc
Q psy6346 434 I-----EQIKRHRWMAEE 446 (1238)
Q Consensus 434 a-----eEILeHPWFke~ 446 (1238)
+ .+++.||||...
T Consensus 241 ~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 241 CLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 9 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=370.71 Aligned_cols=249 Identities=32% Similarity=0.572 Sum_probs=221.8
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++....++..||||++++... .....+.+..|..++..+ +||||+++++++...+.+|+||||+.|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 58999999999999999999999999986532 233455667788887755 8999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-CccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~GTp~ 353 (1238)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~ 161 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD 161 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCcc
Confidence 99999988888999999999999999999999999999999999999999999999999998754322 33345679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+......+|..++.++.+||.+||..||.+||+
T Consensus 162 y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~ 240 (316)
T cd05592 162 YIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG 240 (316)
T ss_pred ccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 999999988776 8999999999999999999999999998888888888888888899999999999999999999998
Q ss_pred H-HHHHhccccccc
Q psy6346 434 I-EQIKRHRWMAEE 446 (1238)
Q Consensus 434 a-eEILeHPWFke~ 446 (1238)
+ ++++.||||...
T Consensus 241 ~~~~l~~h~~~~~~ 254 (316)
T cd05592 241 VDGDIRQHPFFRGI 254 (316)
T ss_pred ChHHHHcCcccCCC
Confidence 6 589999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=390.53 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=226.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIYI 266 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~lyL 266 (1238)
...|...+.||.|-||.||++.+..+|+.||+|.+..+..++....-..|||.||++|+||||++|.++..+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3557777889999999999999999999999999999887777778889999999999999999999998766 78999
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-- 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-- 343 (1238)
|+|||+ -+|.-++... -.|++.+++.+++||+.||+|||.+||+|||||..|||||.+|.+||+|||+|+++....
T Consensus 196 VFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 999998 5677777653 479999999999999999999999999999999999999999999999999999776554
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC----------CccCCC---
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG----------RFRIPY--- 410 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g----------~~~~P~--- 410 (1238)
.+...+-|.+|+|||+++|...|+.++|+||+||||.||+.|++.|.|.+..+..++|..- ...+|.
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 5667789999999999999988899999999999999999999999999887777666531 111221
Q ss_pred ----------------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 411 ----------------FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 411 ----------------~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.++..+.+|+..||..||.+|.|+.++|.++||...
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 257889999999999999999999999999999544
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=377.30 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=219.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|.....||.|+||.||++....++..||||++.+... .......+.+|+.+|+.++|+||+++++++.+++.+|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 6677899999999999999999999999999976532 334567889999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC--------
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-------- 342 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-------- 342 (1238)
|+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~ 162 (382)
T cd05625 83 IPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162 (382)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccc
Confidence 999999999988888999999999999999999999999999999999999999999999999997432100
Q ss_pred ----------------------------------------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHH
Q psy6346 343 ----------------------------------------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL 382 (1238)
Q Consensus 343 ----------------------------------------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYEL 382 (1238)
......+||+.|+|||++.+..+ +.++|||||||+||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~el 241 (382)
T cd05625 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEM 241 (382)
T ss_pred ccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHHHH
Confidence 00123579999999999988877 8999999999999999
Q ss_pred hhCCCCCCCCChhHHHHHHhcCC--ccCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHHhccccccc
Q psy6346 383 VCGALPFDGSTLNSLRDRVLSGR--FRIP--YFMSTECESLIRKMLVREPTKRYC---IEQIKRHRWMAEE 446 (1238)
Q Consensus 383 LTGrlPF~g~d~eeL~ekIl~g~--~~~P--~~iS~eLkDLIrkML~kDPskRPT---aeEILeHPWFke~ 446 (1238)
++|+.||.+.+..+....+.... ..+| ..+++++.+||.+|+ .+|.+|++ ++++++||||...
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999888776666665532 3333 357999999999986 59999997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=366.55 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=210.4
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC-----CEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK-----SMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~-----d~lyL 266 (1238)
|...+.||.|++|.||++++..++..||||++...........++.+|+.+|++++||||+++++++... ..+|+
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 6778899999999999999999999999999976544444556789999999999999999999988543 35899
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--- 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--- 343 (1238)
|||||. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 999995 6899999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred -ccccccCCCCCCCcccccCC-ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh---------------cC--
Q psy6346 344 -KLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL---------------SG-- 404 (1238)
Q Consensus 344 -~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl---------------~g-- 404 (1238)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+. ..
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 12345799999999998652 234889999999999999999999998765432221110 00
Q ss_pred ---------CccCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 405 ---------RFRIP-----YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 405 ---------~~~~P-----~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
....+ ..+++++.+||.+||..||++|||++|+++||||.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000 135778999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.79 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=209.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|++|.||++....++..||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4588889999999999999999989999999999765422 223467789999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCcccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t 347 (1238)
|+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 996 5677766543 5689999999999999999999999999999999999999999999999999865332 223345
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhc--CC-------------------
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLS--GR------------------- 405 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~--g~------------------- 405 (1238)
.+|++.|+|||++.+...++.++|||||||++|+|++|..||.+... ....+.+.. +.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 67899999999988765558899999999999999999999987532 122211110 00
Q ss_pred cc--CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 406 FR--IP---------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 406 ~~--~P---------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
+. .+ ...+.++.+||.+||+.||++|||++|+++||||.+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 00 00 013567899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=371.04 Aligned_cols=249 Identities=31% Similarity=0.553 Sum_probs=219.6
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++....++..||+|++.+... .....+.+.+|+.++.++ +||||+++++++.+.+.+|+||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 58999999999999999999999999987643 334557788999998877 8999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~~GTp~ 353 (1238)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.... ........+||+.
T Consensus 82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 161 (329)
T cd05618 82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 161 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCcc
Confidence 999999888899999999999999999999999999999999999999999999999999987532 2333445689999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCC---------CChhHHHHHHhcCCccCCCCCCHHHHHHHHHhc
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG---------STLNSLRDRVLSGRFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g---------~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML 424 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.. .....+.+.+......+|..++.++.+||.+||
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L 240 (329)
T cd05618 162 YIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 240 (329)
T ss_pred ccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence 999999998876 8899999999999999999999953 122335566777778889999999999999999
Q ss_pred ccCCCCCCC------HHHHHhccccccc
Q psy6346 425 VREPTKRYC------IEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRPT------aeEILeHPWFke~ 446 (1238)
..||++|++ ++++++||||...
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 241 NKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred cCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999998 6899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=377.02 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=219.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|+||.||++....+++.||||++.+... .......+.+|+++|+.++|+||+++++.+.+++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 36778899999999999999999999999999976432 22345678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-------
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG------- 342 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s------- 342 (1238)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999997432100
Q ss_pred -------------------------------------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC
Q psy6346 343 -------------------------------------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385 (1238)
Q Consensus 343 -------------------------------------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG 385 (1238)
......+||+.|||||++.+..+ +.++|||||||+||+|++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~G 240 (376)
T cd05598 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-CcceeeeeccceeeehhhC
Confidence 00113479999999999988877 8999999999999999999
Q ss_pred CCCCCCCChhHHHHHHhcCC--ccCCC--CCCHHHHHHHHHhcccCCCCCC---CHHHHHhccccccc
Q psy6346 386 ALPFDGSTLNSLRDRVLSGR--FRIPY--FMSTECESLIRKMLVREPTKRY---CIEQIKRHRWMAEE 446 (1238)
Q Consensus 386 rlPF~g~d~eeL~ekIl~g~--~~~P~--~iS~eLkDLIrkML~kDPskRP---TaeEILeHPWFke~ 446 (1238)
+.||.+.+..+....+.... ..+|. .+++++.+||.+|+ .+|.+|+ +++++++||||...
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 99999888777666665442 23333 57899999999977 5999999 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.03 Aligned_cols=249 Identities=28% Similarity=0.483 Sum_probs=220.0
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC---CCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL---DHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL---~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
||.|+||.||++.+..++..||||++.+... .......+..|..++..+ +||||+++++++.+...+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6899999999999999999999999976432 233445666788887766 799999999999999999999999999
Q ss_pred CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCC
Q psy6346 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSP 352 (1238)
Q Consensus 274 GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp 352 (1238)
++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875432 23345678999
Q ss_pred CCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCC-CCHHHHHHHHHhcccCCCCC
Q psy6346 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF-MSTECESLIRKMLVREPTKR 431 (1238)
Q Consensus 353 ~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~-iS~eLkDLIrkML~kDPskR 431 (1238)
.|+|||++.+...++.++|||||||++|+|++|..||.+.+..++...+..+...+|.. +++++.+||++||..||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 99999999876545899999999999999999999999998888888888887777754 79999999999999999999
Q ss_pred C----CHHHHHhccccccc
Q psy6346 432 Y----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 432 P----TaeEILeHPWFke~ 446 (1238)
| +++++++||||.+.
T Consensus 241 ~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 241 LGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCHHHHhcCccccCC
Confidence 8 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=381.02 Aligned_cols=243 Identities=29% Similarity=0.472 Sum_probs=222.2
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEE-Ee-eeCCEEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ-VM-ETKSMIYIVS 268 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~d-vf-ed~d~lyLVM 268 (1238)
.|.+.++||.|+||.||++..+.+|..||.|.+.-...+....+.+..|+.+|+.|+|||||++++ .| ++..-++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 356667899999999999999999999999999988888888899999999999999999999998 44 4445599999
Q ss_pred eecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhc--cc--eeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 269 EYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHN--RR--VVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHS--kG--IIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
|||.+|+|..+|+.. +.+++..+++++.|++.||..||. .. |+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999999754 469999999999999999999998 44 9999999999999999999999999999876
Q ss_pred CCC-ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc-CC-CCCCHHHH
Q psy6346 341 PGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR-IP-YFMSTECE 417 (1238)
Q Consensus 341 ~s~-~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~-~P-~~iS~eLk 417 (1238)
... ...+.+|||.||+||.+.+.+| ++++||||+||++|||+.-+.||.|++..++..+|.+++++ +| ..+|.++.
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~ 258 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLR 258 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHH
Confidence 654 3456789999999999999998 99999999999999999999999999999999999999876 67 67899999
Q ss_pred HHHHHhcccCCCCCCCH
Q psy6346 418 SLIRKMLVREPTKRYCI 434 (1238)
Q Consensus 418 DLIrkML~kDPskRPTa 434 (1238)
.||..|+.+||..||+.
T Consensus 259 ~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 259 ELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHccCCcccCCCc
Confidence 99999999999999985
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=370.39 Aligned_cols=257 Identities=32% Similarity=0.583 Sum_probs=232.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-----h-HhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-----P-VNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-----~-e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d 262 (1238)
..|...+.+|.|..++|.++++..+|..+|+|++...... . .-.+....|+.||+++ +||+|+.|.|+++++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4466667899999999999999999999999999765421 1 2235567899999998 8999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
++++|+|+|+.|.|+|++...-.+++.++++|++|+++|++|||.++||||||||+|||++++.++||+|||+++...++
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCccccc-----CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC--C--CCC
Q psy6346 343 QKLATWCGSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP--Y--FMS 413 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~-----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P--~--~iS 413 (1238)
.++...||||+|+|||.+. +.+-|+..+|+|++|||||.||.|.+||......-+...|++|.+.|- . .++
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis 256 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADIS 256 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcc
Confidence 9999999999999999975 334458899999999999999999999999888888899999988763 3 378
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...+|||.+||++||.+|+|++|+|.||||...
T Consensus 257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 899999999999999999999999999999653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=367.49 Aligned_cols=248 Identities=29% Similarity=0.478 Sum_probs=219.9
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHH-HHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVE-IMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIe-ILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+..++..||||++.+... .......+..|+. +++.++||||+++++++.+.+..|+||||++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 58999999999999999999999999976543 2233455666665 578899999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~~GTp~ 353 (1238)
+|..++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.... ........+||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPE 161 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcc
Confidence 999999888889999999999999999999999999999999999999999999999999987532 2233345679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+.+.+......+|...+.++.++|.+||..||.+|++
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 240 (321)
T cd05603 162 YLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG 240 (321)
T ss_pred cCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCC
Confidence 999999988776 8899999999999999999999999988888899988888888889999999999999999999986
Q ss_pred H----HHHHhcccccc
Q psy6346 434 I----EQIKRHRWMAE 445 (1238)
Q Consensus 434 a----eEILeHPWFke 445 (1238)
+ .++++|+||..
T Consensus 241 ~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 241 AKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCHHHHhCCCCcCC
Confidence 4 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=368.28 Aligned_cols=249 Identities=29% Similarity=0.507 Sum_probs=221.9
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+..++..||||++++... .......+..|..++..+ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 58999999999999999999999999987532 123445677888888864 9999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp~ 353 (1238)
+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD 161 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCcc
Confidence 9999998878899999999999999999999999999999999999999999999999999865322 223445679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++.+.+......+|..++.++.+||.+||..||.+||+
T Consensus 162 y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 240 (316)
T cd05619 162 YIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG 240 (316)
T ss_pred ccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCC
Confidence 999999988776 8999999999999999999999999888888888887777788889999999999999999999999
Q ss_pred HH-HHHhccccccc
Q psy6346 434 IE-QIKRHRWMAEE 446 (1238)
Q Consensus 434 ae-EILeHPWFke~ 446 (1238)
+. +++.||||...
T Consensus 241 ~~~~l~~h~~~~~~ 254 (316)
T cd05619 241 VKGDIRQHPFFREI 254 (316)
T ss_pred ChHHHHcCcccCCC
Confidence 96 99999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=373.04 Aligned_cols=254 Identities=24% Similarity=0.419 Sum_probs=221.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|+||.||++....++..||||++.+... .......+.+|+.++..++|+||+++++.+.+.+.+|||||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 36677899999999999999999999999999976432 33456788899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC------
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ------ 343 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~------ 343 (1238)
||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~ 161 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999986432110
Q ss_pred ------------------------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC
Q psy6346 344 ------------------------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393 (1238)
Q Consensus 344 ------------------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d 393 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred ccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCCC
Confidence 0124579999999999988877 889999999999999999999999988
Q ss_pred hhHHHHHHhcCC--ccCCCC--CCHHHHHHHHHhcccCCCCCC---CHHHHHhccccccc
Q psy6346 394 LNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRY---CIEQIKRHRWMAEE 446 (1238)
Q Consensus 394 ~eeL~ekIl~g~--~~~P~~--iS~eLkDLIrkML~kDPskRP---TaeEILeHPWFke~ 446 (1238)
.......+.... ..+|.. +++++.+||.+|+. ||.+|+ +++++++||||...
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 888887777543 334443 78999999999874 999998 58999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=368.15 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=220.2
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHH-HHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVE-IMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIe-ILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++....+|..||||++.+... .......+..|.. +++.++||||+++++++...+.+|+||||+.|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 58999999999999999999999999976532 2334456666765 467799999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp~ 353 (1238)
+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 161 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE 161 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChh
Confidence 9999998888999999999999999999999999999999999999999999999999999875322 233445679999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+......++..++..+.++|++||..+|.+||+
T Consensus 162 y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~ 240 (325)
T cd05604 162 YLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG 240 (325)
T ss_pred hCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCC
Confidence 999999988877 8899999999999999999999999988888888888877777789999999999999999999997
Q ss_pred H----HHHHhcccccc
Q psy6346 434 I----EQIKRHRWMAE 445 (1238)
Q Consensus 434 a----eEILeHPWFke 445 (1238)
+ .++++||||..
T Consensus 241 ~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 241 AKEDFLEIQEHPFFES 256 (325)
T ss_pred CCCCHHHHhcCCCcCC
Confidence 5 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=367.20 Aligned_cols=249 Identities=30% Similarity=0.552 Sum_probs=220.6
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++....++..||||++.+... +....+.+.+|+.++.++ +||||+.+++++.+.+.+|+||||++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 58999999999999999999999999987643 334567788999999988 6999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t~~GTp~ 353 (1238)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+||+.
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN 161 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcc
Confidence 999999888889999999999999999999999999999999999999999999999999987532 2334456789999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-------ChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-------TLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-------d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
|+|||++.+..+ +.++|||||||+||+|++|..||... ....+...+......+|..++..+.++|.+||..
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 240 (327)
T cd05617 162 YIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK 240 (327)
T ss_pred cCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999988877 89999999999999999999999642 2334566667777788999999999999999999
Q ss_pred CCCCCCC------HHHHHhccccccc
Q psy6346 427 EPTKRYC------IEQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPT------aeEILeHPWFke~ 446 (1238)
||++|++ ++++++||||...
T Consensus 241 dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 241 DPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred CHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999997 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=367.53 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=221.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|+||.||++....++..||||++++... .....+.+.+|+.+++.++|+||+++++++.+.+.+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 36778899999999999999999999999999987543 33455678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--cc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--LA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l~ 346 (1238)
|+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 161 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK 161 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeee
Confidence 99999999999876 6799999999999999999999999999999999999999999999999999976543322 22
Q ss_pred cccCCCCCCCcccccC-----CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC--CCCHHHH
Q psy6346 347 TWCGSPPYAAPEVFEG-----KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY--FMSTECE 417 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~g-----k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~--~iS~eLk 417 (1238)
...||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+.......+.... ..+|. .++.++.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (330)
T cd05601 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFL 241 (330)
T ss_pred cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHH
Confidence 3479999999999873 2234789999999999999999999999888777777766542 23333 4789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||.+||. +|.+|||+++++.||||...
T Consensus 242 ~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 242 DLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 99999998 99999999999999999763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.47 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=220.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|+....||.|++|.||++.+..++..||||++....... .....+.+|+.+++.++|+||+++++++.+.+.+|+||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 566788999999999999998899999999997654332 2335678899999999999999999999999999999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
+.+++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR 161 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccc
Confidence 9999999887643 45899999999999999999999999999999999999999999999999998765444444456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH----HHHHHhcCCccCCCCCCHHHHHHHHHhc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS----LRDRVLSGRFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee----L~ekIl~g~~~~P~~iS~eLkDLIrkML 424 (1238)
+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... +...+......++..++..+.+||.+||
T Consensus 162 ~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05605 162 VGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240 (285)
T ss_pred cCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence 79999999999988776 889999999999999999999998866533 3333444455566778999999999999
Q ss_pred ccCCCCCC-----CHHHHHhccccccc
Q psy6346 425 VREPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRP-----TaeEILeHPWFke~ 446 (1238)
..||++|| ++++++.||||...
T Consensus 241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 241 TKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred cCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 99999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.34 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=214.3
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
||.|+||.||++.+..+++.||||++.+.... ....+.+..|+++|++++|+||+++++++......|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 58899999999999999999999999765432 23446778999999999999999999999999999999999999999
Q ss_pred chhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccccCC
Q psy6346 277 FDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWCGS 351 (1238)
Q Consensus 277 ~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~GT 351 (1238)
.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 877743 3468999999999999999999999999999999999999999999999999987654332 23345799
Q ss_pred CCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh----hHHHHHHhcCCccCCCCCCHHHHHHHHHhcccC
Q psy6346 352 PPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL----NSLRDRVLSGRFRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 352 p~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~----eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kD 427 (1238)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......+......+|..++.++.+|+.+||..|
T Consensus 161 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 161 PGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred cCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence 99999999998876 7899999999999999999999976532 334444555556667778999999999999999
Q ss_pred CCCCC-----CHHHHHhccccccc
Q psy6346 428 PTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 428 PskRP-----TaeEILeHPWFke~ 446 (1238)
|++|| +++++++||||+..
T Consensus 240 P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 240 PEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=366.28 Aligned_cols=248 Identities=29% Similarity=0.472 Sum_probs=218.4
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHH-HHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVE-IMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIe-ILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+..++..||+|++.+.... ......+..|.. +++.++||||+++++++.+.+.+|+||||+.|+
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 589999999999999999999999999764321 223344555554 567889999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~~GTp~ 353 (1238)
+|.+++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+.
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 161 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCcc
Confidence 9999998888899999999999999999999999999999999999999999999999999875322 233455689999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......++..++..+.+||.+||+.||.+|++
T Consensus 162 y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 240 (325)
T cd05602 162 YLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG 240 (325)
T ss_pred ccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence 999999988776 8899999999999999999999999988888888888877777789999999999999999999998
Q ss_pred HH----HHHhcccccc
Q psy6346 434 IE----QIKRHRWMAE 445 (1238)
Q Consensus 434 ae----EILeHPWFke 445 (1238)
+. ++++|+||..
T Consensus 241 ~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 241 AKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCHHHHhcCcccCC
Confidence 65 8999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=371.98 Aligned_cols=256 Identities=24% Similarity=0.423 Sum_probs=222.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|+||.||++....++..||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 457788899999999999999999999999999976432 2234456789999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 99999999998865 468899999999999999999999999999999999999999999999999987654322 224
Q ss_pred cccCCCCCCCcccccCCc---cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC--CCCHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKK---YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY--FMSTECESL 419 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~---y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~--~iS~eLkDL 419 (1238)
..+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+....+..+.... ..+|. .++.++.+|
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 281 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHH
Confidence 567999999999987543 34789999999999999999999999998888888887643 44454 479999999
Q ss_pred HHHhcccCCCC--CCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTK--RYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPsk--RPTaeEILeHPWFke~ 446 (1238)
|.+||..+|.+ |++++++++||||+..
T Consensus 282 i~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 282 ICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999998 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=363.67 Aligned_cols=252 Identities=31% Similarity=0.556 Sum_probs=232.7
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChH-hHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV-NLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e-~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
.....+|+|.||.||.+...+++-.||+|++.++.+... ...++.+|++|-..|+||||+++|++|.+...+||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 334567777777888888888899999999988765333 3467899999999999999999999999999999999999
Q ss_pred CCCccchhhh--cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 272 NQGEIFDYIA--RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 272 ~GGSL~d~Lk--k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
.+|+|+..+. ..+++++..+..+++|++.||.|+|.++||||||||+|+|++..+.+||+|||.+.... .....+.|
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlc 183 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLC 183 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeee
Confidence 9999999998 67889999999999999999999999999999999999999999999999999987643 67788999
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
||..|.+||+..+..+ +..+|+|++|++.||++.|.+||...+..+.+++|..-++.+|..++.++.|||.+||.++|.
T Consensus 184 gt~dyl~pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~ 262 (281)
T KOG0580|consen 184 GTLDYLPPEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPI 262 (281)
T ss_pred cccccCCHhhcCCCCc-cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCcc
Confidence 9999999999999988 899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccccccc
Q psy6346 430 KRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRPTaeEILeHPWFke~ 446 (1238)
+|.+..|++.|||+...
T Consensus 263 ~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 263 ERLALTEVMDHPWIVAN 279 (281)
T ss_pred ccccHHHHhhhHHHHhc
Confidence 99999999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=362.33 Aligned_cols=254 Identities=21% Similarity=0.405 Sum_probs=218.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|.....||.|++|.||++.+..++..||+|++.... .....+++.+|+++|++++||||+++++++...+.+++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 45778889999999999999999999999999998653 44456789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
|+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..... ......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 162 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSF 162 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-cccccC
Confidence 999999999998888899999999999999999999986 699999999999999999999999999876533 233456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh--------------------------
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL-------------------------- 402 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl-------------------------- 402 (1238)
.|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..++...+.
T Consensus 163 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd06649 163 VGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241 (331)
T ss_pred CCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccc
Confidence 79999999999988776 899999999999999999999997765544332211
Q ss_pred --------------------cC-CccCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 403 --------------------SG-RFRIP-YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 403 --------------------~g-~~~~P-~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.. ....+ ..+++++.+||.+||.+||++|||+++|++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 242 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 10 01111 1367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.45 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=208.4
Q ss_pred EEEEEEEecCCCCccccCceEcc-CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC---CCCCeeEEEEEee-----eC
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLR-HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL---DHPHIIKLFQVME-----TK 261 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lk-tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL---~HPNIVrL~dvfe-----d~ 261 (1238)
.|.....||.|+||.||++.+.. ++..||||++............+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 46677889999999999998865 468899999986654443445667788887776 6999999999885 34
Q ss_pred CEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY 339 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~ 339 (1238)
..+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 56899999997 5888888653 45899999999999999999999999999999999999999999999999999766
Q ss_pred cCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-------------
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF------------- 406 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~------------- 406 (1238)
..........|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred cCCcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 54444556679999999999988776 8899999999999999999999998776555555432100
Q ss_pred --------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 407 --------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 407 --------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.+...+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112367888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=363.99 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=226.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVME 269 (1238)
|.....||.|+||.||++....++..||||++.+... .....+.+..|+.++..+. |++|+++++++.+.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 4556789999999999999999999999999986532 2334567888999999886 5678889999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
|++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~ 161 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF 161 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCc
Confidence 9999999999988889999999999999999999999999999999999999999999999999998754322 233456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+......+|..++.++.+|+.+||.++|
T Consensus 162 ~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p 240 (323)
T cd05615 162 CGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240 (323)
T ss_pred cCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCH
Confidence 79999999999988776 89999999999999999999999999888888899888888899999999999999999999
Q ss_pred CCCCC-----HHHHHhccccccc
Q psy6346 429 TKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRPT-----aeEILeHPWFke~ 446 (1238)
.+|++ .+++++||||...
T Consensus 241 ~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 241 SKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred hhCCCCCCCCHHHHhcCcccCCC
Confidence 99997 5899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=373.74 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=222.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee-----CCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-----KSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-----~d~l 264 (1238)
..|.....+|.|++|.|+.+++..+|..||||.+.....+....++..||+++|+.++|+||+.+++++.. -..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 34444688999999999999999999999999998777677888999999999999999999999999854 4569
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC---
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP--- 341 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~--- 341 (1238)
|+|+|+|+ -+|...|+....+++..+..+++||+.||+|+|+.+|+||||||.|++++.+..+||+|||+|+....
T Consensus 102 YiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 99999994 78888888877899999999999999999999999999999999999999999999999999988753
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-----------------
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG----------------- 404 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g----------------- 404 (1238)
...+..++.|.+|+|||++.....|+.++||||+||||.||++|++.|.|.+.......|..-
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 455677889999999999987777799999999999999999999999997755444333310
Q ss_pred ------CccCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 ------RFRIP--------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 ------~~~~P--------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
-...| ...++.+.+|+++||+.||.+|+|++|+|+|||+..-
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 00111 1468899999999999999999999999999999864
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=374.06 Aligned_cols=261 Identities=27% Similarity=0.434 Sum_probs=229.0
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
....|+..+.||.|..++||.++.+..+..||||+++.+.++.. ++.+.+|+..|+.++||||++++..|..+..+|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 45678999999999999999999999999999999999887655 89999999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cc
Q psy6346 268 SEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QK 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~ 344 (1238)
|.||.+|++.++++.. ..|+|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+... ..
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999999865 45999999999999999999999999999999999999999999999999987554332 21
Q ss_pred ----cccccCCCCCCCccc-ccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC---------
Q psy6346 345 ----LATWCGSPPYAAPEV-FEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY--------- 410 (1238)
Q Consensus 345 ----l~t~~GTp~YmAPEV-L~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~--------- 410 (1238)
..+..||++|||||+ +....-|++|+||||||++..||.+|..||....+..+.-.-+++.++.+.
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~ 262 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDED 262 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHh
Confidence 156789999999999 555455699999999999999999999999887766655555555543221
Q ss_pred -CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy6346 411 -FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449 (1238)
Q Consensus 411 -~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p~ 449 (1238)
.++..++++|..||++||.+|||++++|+|+||+.....
T Consensus 263 k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 263 KKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred hhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 257789999999999999999999999999999986543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.49 Aligned_cols=251 Identities=35% Similarity=0.623 Sum_probs=215.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|+..+.||.|++|+||++....++..||+|++..............+|+.++++++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 66788999999999999999999999999999987655444455567999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc-cCCCccccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~-~~s~~l~t~~G 350 (1238)
.+++|.+++...+.+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||++... ..........+
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999998889999999999999999999999999999999999999999999999999998753 23344556778
Q ss_pred CCCCCCccccc-CCccCCCccceehhhHHHHHHhhCCCCCCCCCh---hHHHHHHhcCCccCCC----CCCHHHHHHHHH
Q psy6346 351 SPPYAAPEVFE-GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL---NSLRDRVLSGRFRIPY----FMSTECESLIRK 422 (1238)
Q Consensus 351 Tp~YmAPEVL~-gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~---eeL~ekIl~g~~~~P~----~iS~eLkDLIrk 422 (1238)
+..|+|||++. +.. .+.++||||||+++|+|++|..||..... ..............+. ....++.+||.+
T Consensus 161 ~~~y~aPE~~~~~~~-~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKK-YTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SGGGSCHHHHTTTSS-BSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 99999999998 444 48999999999999999999999988732 2233333322221111 124889999999
Q ss_pred hcccCCCCCCCHHHHHhcccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWF 443 (1238)
||..||++||++.++++||||
T Consensus 240 ~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HSSSSGGGSTTHHHHHTSGGG
T ss_pred HccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=340.91 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=219.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh---HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP---VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~---e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
.|.....+|.|++|.||.+....++..||||++....... ...+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 4677889999999999999998999999999987654322 2356788999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL-- 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l-- 345 (1238)
|||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT 162 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999998754332111
Q ss_pred --ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHHHH
Q psy6346 346 --ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIR 421 (1238)
Q Consensus 346 --~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDLIr 421 (1238)
....|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+... ...+|..++.++.+||+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (263)
T cd06625 163 GMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241 (263)
T ss_pred cccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence 23568889999999988775 89999999999999999999999876555444443332 34467778999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWF 443 (1238)
+||..+|.+|||+.++++|+||
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 242 RTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=369.70 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=220.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++....+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 457888899999999999999999999999999976432 2334466889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~ 201 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecc
Confidence 999999999998654 68999999999999999999999999999999999999999999999999997654322 224
Q ss_pred cccCCCCCCCcccccCCc---cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC--CCCHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKK---YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY--FMSTECESL 419 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~---y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~--~iS~eLkDL 419 (1238)
+.+||+.|+|||++.+.. +++.++|||||||+||+|++|..||.+.+.......+.... +.+|. .++..+++|
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~l 281 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHH
Confidence 567999999999987643 34789999999999999999999999988877777777643 44454 468999999
Q ss_pred HHHhcccCCCC--CCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTK--RYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPsk--RPTaeEILeHPWFke~ 446 (1238)
|.+||..++.+ |++++|+++||||+..
T Consensus 282 i~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 282 ICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999866654 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=348.86 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=206.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC---CCCCeeEEEEEeee-----CCE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL---DHPHIIKLFQVMET-----KSM 263 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL---~HPNIVrL~dvfed-----~d~ 263 (1238)
|.....||.|++|.||++.+..++..||||+++...........+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 6677889999999999999999999999999986543333334566788877766 79999999998864 356
Q ss_pred EEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 264 IYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 899999998 4788888654 3489999999999999999999999999999999999999999999999999986654
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-----------Cc----
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-----------RF---- 406 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-----------~~---- 406 (1238)
........|+..|+|||++.+..+ +.++|||||||++|+|++|..||.+........++... ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 444445678999999999988776 89999999999999999999999877655444443221 00
Q ss_pred ------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 407 ------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 407 ------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.....++.++.+||.+||..||++|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0112367788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=362.82 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=211.6
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------C
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------S 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d 262 (1238)
...|...+.||.|+||.||++.+..+|..||||++...........++.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4668888999999999999999999999999999987655556667889999999999999999999998644 3
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 57999999975 4655553 35788999999999999999999999999999999999999999999999999765444
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc-------------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS------------------- 403 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~------------------- 403 (1238)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 44455679999999999988877 8899999999999999999999987654332221110
Q ss_pred ---CCcc--------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 404 ---GRFR--------------------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 404 ---g~~~--------------------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.... .+...++++.+||.+||..||++|||+.|+|+||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 0000 111246789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=363.02 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=210.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.||.|+||.||++.+..+++.||||++.... .....+.+.+|+++|+.++|+||+++++++...+.+|+||||+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 445578999999999999999999999999997653 3445578899999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-CccccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~G 350 (1238)
.+++|.+.. ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......|
T Consensus 155 ~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 230 (353)
T PLN00034 155 DGGSLEGTH----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG 230 (353)
T ss_pred CCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccccc
Confidence 999986543 3567788899999999999999999999999999999999999999999998765432 22345679
Q ss_pred CCCCCCcccccC----CccCCCccceehhhHHHHHHhhCCCCCCCCChhH---HHHHHh-cCCccCCCCCCHHHHHHHHH
Q psy6346 351 SPPYAAPEVFEG----KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS---LRDRVL-SGRFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 351 Tp~YmAPEVL~g----k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee---L~ekIl-~g~~~~P~~iS~eLkDLIrk 422 (1238)
|..|+|||++.. ..+.+.++|||||||++|+|++|+.||....... +...+. ......+..++.++.+||.+
T Consensus 231 t~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 310 (353)
T PLN00034 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISC 310 (353)
T ss_pred CccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHH
Confidence 999999998743 2344678999999999999999999997433222 222222 22334566789999999999
Q ss_pred hcccCCCCCCCHHHHHhcccccccCC
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
||..||++|||+.||++||||.....
T Consensus 311 ~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 311 CLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred HccCChhhCcCHHHHhcCcccccCCc
Confidence 99999999999999999999988643
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=375.07 Aligned_cols=257 Identities=31% Similarity=0.494 Sum_probs=227.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|+....+|.|.-|+||.+....++..+|+|++.+..+. ...+.++..|-+||+.++||.++.||..|+++++.|+||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 33445677788888888888888899999999998754 55678899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-------
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP------- 341 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~------- 341 (1238)
|+||+|..++++. +.|++..++.++..++.||+|||-.|||+||||||||||.++|+|-|+||.++.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 9999999988765 5699999999999999999999999999999999999999999999999998732210
Q ss_pred --------------------------C-C-----------------------ccccccCCCCCCCcccccCCccCCCccc
Q psy6346 342 --------------------------G-Q-----------------------KLATWCGSPPYAAPEVFEGKKYCGPEID 371 (1238)
Q Consensus 342 --------------------------s-~-----------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSD 371 (1238)
. . ....++||-.|+|||++.|... +.++|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH-gsAVD 317 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH-GSAVD 317 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC-Cchhh
Confidence 0 0 1124579999999999999987 89999
Q ss_pred eehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCC--CCHHHHHHHHHhcccCCCCCCC----HHHHHhcccccc
Q psy6346 372 IWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF--MSTECESLIRKMLVREPTKRYC----IEQIKRHRWMAE 445 (1238)
Q Consensus 372 IWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~--iS~eLkDLIrkML~kDPskRPT----aeEILeHPWFke 445 (1238)
+|+|||+|||||.|..||.|.+..+....|+.....+|.. ++..++|||+++|.+||.+|+. +.||.+||||..
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 9999999999999999999999999999999998888865 6789999999999999999998 999999999987
Q ss_pred cCCC
Q psy6346 446 ETPR 449 (1238)
Q Consensus 446 ~~p~ 449 (1238)
....
T Consensus 398 VnWa 401 (459)
T KOG0610|consen 398 VNWA 401 (459)
T ss_pred CChh
Confidence 6543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=367.52 Aligned_cols=254 Identities=23% Similarity=0.411 Sum_probs=215.5
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-----EEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS-----MIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d-----~lyL 266 (1238)
|.....||.|+||.||++.+..+++.||||++.....+....+++.+|+++|+.++|+||+++++++...+ ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 34557899999999999999899999999999765545556678999999999999999999999998776 7999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC--Cc
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG--QK 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s--~~ 344 (1238)
||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 v~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~ 160 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH 160 (372)
T ss_pred Eeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence 999997 678888877788999999999999999999999999999999999999999999999999998764322 22
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc---------------------
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--------------------- 403 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~--------------------- 403 (1238)
.....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 240 (372)
T cd07853 161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240 (372)
T ss_pred CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence 33456899999999998866558899999999999999999999988765544433321
Q ss_pred --CCc---------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 404 --GRF---------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 404 --g~~---------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
... .+....++++.+||.+||..||.+|||++|+++||||.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223467889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=370.45 Aligned_cols=240 Identities=27% Similarity=0.462 Sum_probs=212.8
Q ss_pred EecCCCCccccCceEccCCcE-EEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-EEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVN-VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS-MIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~k-VAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d-~lyLVMEy~~GG 274 (1238)
.+|.|+||+||++.+. |.. ||||++.....+....+.|.+|+.+|.+++|||||++++++.+.. .++|||||+++|
T Consensus 48 ~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4888999999988774 555 999999988766666889999999999999999999999999887 799999999999
Q ss_pred ccchhhhc--ccccchhHHHHHHHHHHHHHhHhhccc-eeeccCCcccccccCCC-cEEEEecCCcccccCC-Ccccccc
Q psy6346 275 EIFDYIAR--YGRMNENAARRKFWQILSAVEYCHNRR-VVHRDLKAENLLMDSNL-DIKLADFGFSNYYVPG-QKLATWC 349 (1238)
Q Consensus 275 SL~d~Lkk--~~~Lsesea~kI~~QILsALeYLHSkG-IIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~s-~~l~t~~ 349 (1238)
+|.+++.. .+.++...+..|+.+|+.||.|||+++ |||||||++|||++.++ ++||+|||+++..... .......
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~ 205 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVA 205 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCC
Confidence 99999988 578999999999999999999999999 99999999999999997 9999999999876544 3344468
Q ss_pred CCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHHHHHhcc
Q psy6346 350 GSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 350 GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDLIrkML~ 425 (1238)
||+.|||||++.+ ..| +.++||||||++||||+||..||.+.........+... ...+|..+++.+..||.+||.
T Consensus 206 GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~ 284 (362)
T KOG0192|consen 206 GTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWL 284 (362)
T ss_pred CCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCC
Confidence 9999999999994 465 99999999999999999999999998876666555433 455677899999999999999
Q ss_pred cCCCCCCCHHHHHh
Q psy6346 426 REPTKRYCIEQIKR 439 (1238)
Q Consensus 426 kDPskRPTaeEILe 439 (1238)
.||.+||++.+|+.
T Consensus 285 ~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 285 VDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCcCCCHHHHHH
Confidence 99999999999875
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.21 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=217.5
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC-CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~-ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|+||.||++....+++.||||++.+.. ......+.+.+|+.++..++|+||+++++++.+.+.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 3677889999999999999999999999999997632 233445678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--cc
Q psy6346 270 YANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--LA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l~ 346 (1238)
|+.|++|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence 9999999999976 45799999999999999999999999999999999999999999999999999876543322 22
Q ss_pred cccCCCCCCCcccccC----CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC---CCCHHHH
Q psy6346 347 TWCGSPPYAAPEVFEG----KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY---FMSTECE 417 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~g----k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~---~iS~eLk 417 (1238)
..+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+....+.... +.+|. .++.+++
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd05597 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241 (331)
T ss_pred ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHH
Confidence 3469999999999873 2334789999999999999999999999888777777776532 33333 3789999
Q ss_pred HHHHHhcccCCCC--CCCHHHHHhccccccc
Q psy6346 418 SLIRKMLVREPTK--RYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 418 DLIrkML~kDPsk--RPTaeEILeHPWFke~ 446 (1238)
+||++||..++++ |++++++++||||...
T Consensus 242 ~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 242 DLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 9999999765544 7899999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.43 Aligned_cols=253 Identities=33% Similarity=0.573 Sum_probs=229.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|++|.||++.+..+++.||||++.+... .....+.+.+|+++|++++||||+++++++...+..|+|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 46777899999999999999999999999999976543 23456788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
|+.+++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|.||+++.++.+||+|||++...... ....+
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 159 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLC 159 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCC
Confidence 9999999999988889999999999999999999999999999999999999999999999999998765443 34457
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
|++.|+|||.+.+... +.++||||||+++|+|++|..||...+.....+.+..+...+|..++..+.++|.+||..||.
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 238 (290)
T cd05580 160 GTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238 (290)
T ss_pred CCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHH
Confidence 8999999999987765 789999999999999999999999888777788888888888888999999999999999999
Q ss_pred CCC-----CHHHHHhccccccc
Q psy6346 430 KRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRP-----TaeEILeHPWFke~ 446 (1238)
+|+ +++|+++||||...
T Consensus 239 ~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 239 KRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HccCcccCCHHHHHcCcccccC
Confidence 999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=376.89 Aligned_cols=254 Identities=27% Similarity=0.465 Sum_probs=223.8
Q ss_pred cEEEEEEEecCCCCccccCceEccC-CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRH-TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lkt-G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....+|.|++|.||.+....+ +..||+|.+... +......+.+|+.+|+.++||||+++++++...+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4588899999999999999988877 788999987544 3344567888999999999999999999999999999999
Q ss_pred eecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 269 EYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999987753 3468999999999999999999999999999999999999999999999999998654332
Q ss_pred --ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHH
Q psy6346 344 --KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLI 420 (1238)
Q Consensus 344 --~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLI 420 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..++...+..+.. .+|..++.++.+||
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred cccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 2345679999999999988776 8999999999999999999999999888888887776654 35667899999999
Q ss_pred HHhcccCCCCCCCHHHHHhccccccc
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+||..||++||++++++.|+|++..
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=376.32 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=209.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--------
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-------- 260 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-------- 260 (1238)
...|.....||.|+||.||+|+...+++.||||++.... ....+|+.+|+.++||||+++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 356888999999999999999999999999999986542 233479999999999999999988743
Q ss_pred CCEEEEEEeecCCCccchhhh----cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCC
Q psy6346 261 KSMIYIVSEYANQGEIFDYIA----RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGF 335 (1238)
Q Consensus 261 ~d~lyLVMEy~~GGSL~d~Lk----k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGL 335 (1238)
...+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 2357899999985 6666654 345789999999999999999999999999999999999998664 699999999
Q ss_pred cccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-----------
Q psy6346 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG----------- 404 (1238)
Q Consensus 336 S~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g----------- 404 (1238)
+............+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+....+...
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 987665555566789999999999887655589999999999999999999999987655443333210
Q ss_pred ------Cc------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 ------RF------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 ------~~------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.. .+|...++++.+||.+||..||.+|||+.|+|.||||.+.
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01 1344567899999999999999999999999999999764
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=356.75 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=223.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+++|+|.||+||+|.+..+|+.||||.++.....+..-....|||+.|+.++|+||+.|+|+|...+.+-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 46667889999999999999999999999999998876655556788999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-cccc
Q psy6346 271 ANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-LATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-l~t~ 348 (1238)
++ .+|...|+.. ..++...++.++.+++.||+|||.+.|+||||||.|+|++.+|.+||+|||+++.+..... ....
T Consensus 83 m~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~ 161 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ 161 (318)
T ss_pred cc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence 97 6788888755 4689999999999999999999999999999999999999999999999999998865543 3344
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--Cc---------c---------C
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RF---------R---------I 408 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~---------~---------~ 408 (1238)
+-|.+|+|||.+.|...|+..+||||.|||+.||+.|.+-|.|.+.-+....|... .. . +
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~ 241 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF 241 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence 78999999999999988899999999999999999999999998876666555421 00 0 1
Q ss_pred C--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 409 P--------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 409 P--------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
| ...+.++.||+.+||..||.+|+|+.|+|+|+||...
T Consensus 242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 1 1146778999999999999999999999999999973
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.08 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=216.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|.....||.|+||.||++.+..+++.||||.+...... ......+.+|+.++++++|++|+.+++.+.+.+..|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 45667899999999999999999999999998765433 23345678899999999999999999999999999999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
+.|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 9999999988643 35899999999999999999999999999999999999999999999999998765444444456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh----HHHHHHhcCCccCCCCCCHHHHHHHHHhc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN----SLRDRVLSGRFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e----eL~ekIl~g~~~~P~~iS~eLkDLIrkML 424 (1238)
.|+..|+|||++.+..+ +.++|||||||++|+|++|..||.+.... .....+......++..+++++.+||++||
T Consensus 162 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05630 162 VGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240 (285)
T ss_pred CCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHh
Confidence 79999999999988776 88999999999999999999999865422 11111122223456678899999999999
Q ss_pred ccCCCCCCC-----HHHHHhccccccc
Q psy6346 425 VREPTKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRPT-----aeEILeHPWFke~ 446 (1238)
+.||.+||| ++|+++||||.+.
T Consensus 241 ~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 241 CKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hcCHHHccCCCCCchHHHHcChhhhcc
Confidence 999999999 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=368.62 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=207.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+..+++.||||+... ..+.+|+++|++|+||||+++++++......|+|||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 458889999999999999999999999999997542 346799999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC--CCcccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP--GQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~--s~~l~t 347 (1238)
++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 995 78988888878899999999999999999999999999999999999999999999999999865322 223345
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh-------hHHHHHHh------------------
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-------NSLRDRVL------------------ 402 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-------eeL~ekIl------------------ 402 (1238)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ......+.
T Consensus 243 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 689999999999988776 8999999999999999999988743210 00011110
Q ss_pred --------cCCccC----C-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 403 --------SGRFRI----P-----YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 403 --------~g~~~~----P-----~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
...... | ..++.++.+||.+||..||.+|||++|+|+||||.+...
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 000000 1 124668999999999999999999999999999987543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.52 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=213.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+..++..||||+++..... .....+.+|+.++++++||||+++++++..++..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 4588889999999999999999989999999999765422 233467789999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t 347 (1238)
|+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 9985 787777654 35889999999999999999999999999999999999999999999999998754322 22334
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccC
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRI 408 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~ 408 (1238)
..+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+... ...+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 568999999999876555588999999999999999999999887654443333210 0111
Q ss_pred C-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 409 P-----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 409 P-----------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
+ ..+++++.+||.+||..||.+|||++|+++||||.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 1 236789999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=333.63 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=223.6
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||++....++..||+|.+..........+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 56678899999999999999999999999999877666677788999999999999999999999999999999999999
Q ss_pred CCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccc
Q psy6346 272 NQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~ 348 (1238)
+|++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... .....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 161 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI 161 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhcc
Confidence 999999999764 568899999999999999999999999999999999999999999999999987654332 22345
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHHHHhcccC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLIrkML~kD 427 (1238)
.|++.|+|||++.+..+ +.++|+|||||++|+|++|+.||...+.......+..+.. .++..++.++.++|.+||+.+
T Consensus 162 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08529 162 VGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240 (256)
T ss_pred ccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCC
Confidence 78899999999988776 7899999999999999999999998887777777666543 345568899999999999999
Q ss_pred CCCCCCHHHHHhcccc
Q psy6346 428 PTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 428 PskRPTaeEILeHPWF 443 (1238)
|++||++.++++|||+
T Consensus 241 p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 241 YRQRPDTFQLLRNPSL 256 (256)
T ss_pred cccCcCHHHHhhCCCC
Confidence 9999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=363.81 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=220.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|+||.||++.+..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 568888999999999999999999999999999976432 2334566789999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 123 Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~ 201 (371)
T cd05622 123 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201 (371)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccccc
Confidence 99999999998865 458999999999999999999999999999999999999999999999999987654322 234
Q ss_pred cccCCCCCCCcccccCCc---cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC--CCCHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKK---YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY--FMSTECESL 419 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~---y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~--~iS~eLkDL 419 (1238)
..+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+.......+.... ..+|. .++.++++|
T Consensus 202 ~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 281 (371)
T cd05622 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281 (371)
T ss_pred CcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHH
Confidence 567999999999987543 34789999999999999999999999998888888887643 33443 589999999
Q ss_pred HHHhcccCCCC--CCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTK--RYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPsk--RPTaeEILeHPWFke~ 446 (1238)
|.+||..++.+ |+++++|++|+||.+.
T Consensus 282 i~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 282 ICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999854443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.81 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=209.5
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
||.|+||.||++....+|..||+|++....... .....+..|++++++++||||++++++++++..+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 588999999999999999999999997654322 2234566799999999999999999999999999999999999999
Q ss_pred chhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCC
Q psy6346 277 FDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPY 354 (1238)
Q Consensus 277 ~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~Y 354 (1238)
.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.............|+..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 88886543 5788889999999999999999999999999999999999999999999998766544444456799999
Q ss_pred CCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh----hHHHHHHhcCCccCC-CCCCHHHHHHHHHhcccCCC
Q psy6346 355 AAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL----NSLRDRVLSGRFRIP-YFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 355 mAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~----eeL~ekIl~g~~~~P-~~iS~eLkDLIrkML~kDPs 429 (1238)
+|||++.+..+ +.++|||||||++|+|++|..||.+... ..+..........++ ..++.++.+||.+||..||.
T Consensus 161 ~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 161 MAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred cCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 99999988875 8999999999999999999999976432 233333443333332 35789999999999999999
Q ss_pred CCCCH----HHHHhccccccc
Q psy6346 430 KRYCI----EQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRPTa----eEILeHPWFke~ 446 (1238)
+||++ ++++.|+||...
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 778899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=333.61 Aligned_cols=251 Identities=26% Similarity=0.435 Sum_probs=220.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee-CCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-KSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-~d~lyLVMEy 270 (1238)
|...+.+|.|++|.||.+....++..||||++..........+.+.+|++++++++|+|++++++.+.. ...+|+||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 667788999999999999998889999999998766556667788999999999999999999998864 4568999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccc
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLAT 347 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t 347 (1238)
+++++|.+++... ..+++..+..++.+|+.||.+||+.||+||||||+||+++.++.++|+|||++...... .....
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST 161 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcccc
Confidence 9999999998763 45899999999999999999999999999999999999999999999999998765332 23345
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHHHHhccc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLIrkML~k 426 (1238)
..|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+.. ..+..+++++.+||.+||..
T Consensus 162 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 162 LIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred ccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhcc
Confidence 578999999999988776 7899999999999999999999998877766666666544 45667889999999999999
Q ss_pred CCCCCCCHHHHHhcccc
Q psy6346 427 EPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 427 DPskRPTaeEILeHPWF 443 (1238)
||.+|||+.++++||||
T Consensus 241 ~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 241 RPEKRPSVKSILRQPYI 257 (257)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.20 Aligned_cols=255 Identities=26% Similarity=0.464 Sum_probs=217.6
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||++....+++.||+|++.+... .......+..|+.++..++|++|+++++++.+.+.+|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 46778899999999999999999999999999975332 22334568889999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--cc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--LA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l~ 346 (1238)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~ 161 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceec
Confidence 99999999999773 6789999999999999999999999999999999999999999999999999865433222 23
Q ss_pred cccCCCCCCCcccccC----CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC---CCCHHHH
Q psy6346 347 TWCGSPPYAAPEVFEG----KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY---FMSTECE 417 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~g----k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~---~iS~eLk 417 (1238)
..+||+.|+|||++.+ ...++.++|||||||+||+|++|+.||.+.+..+...++.... +.+|. .+++++.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~ 241 (332)
T cd05623 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241 (332)
T ss_pred ccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHH
Confidence 4579999999999863 2334889999999999999999999999988888887776653 23333 4789999
Q ss_pred HHHHHhcccCCCC--CCCHHHHHhcccccc
Q psy6346 418 SLIRKMLVREPTK--RYCIEQIKRHRWMAE 445 (1238)
Q Consensus 418 DLIrkML~kDPsk--RPTaeEILeHPWFke 445 (1238)
+||++||..++.+ |++++++++||||..
T Consensus 242 ~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 242 DLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 9999999765555 689999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=360.32 Aligned_cols=253 Identities=23% Similarity=0.418 Sum_probs=212.6
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------C
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------S 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d 262 (1238)
...|.....||.|+||.||++.+..+++.||||++.....+....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4568888999999999999999999999999999987655556667889999999999999999999987543 4
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
.+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 57999999975 6666664 35788899999999999999999999999999999999999999999999999865444
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-----------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR----------------- 405 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~----------------- 405 (1238)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 44456689999999999988876 889999999999999999999998877655444433210
Q ss_pred -----cc--------------C------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 406 -----FR--------------I------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 406 -----~~--------------~------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.. + ....+.++.+||.+||..||.+|||++|+|+||||..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 0 0113467899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=358.61 Aligned_cols=254 Identities=24% Similarity=0.419 Sum_probs=211.7
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------C
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------S 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d 262 (1238)
...|...+.||.|+||.||++.+..++..||||++.....+......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4568888999999999999999988999999999987665566678889999999999999999999988543 3
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
..|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 57999999975 5666654 35788899999999999999999999999999999999999999999999999865544
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC------------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------ 404 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------ 404 (1238)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred cccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 44556789999999999988876 88999999999999999999999887643332221110
Q ss_pred ----C-----cc---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 ----R-----FR---------------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 ----~-----~~---------------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
. .. .+...+.++.+||.+||..||.+|||++|+|+||||...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 00 111235678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=377.78 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=228.1
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-----
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS----- 262 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d----- 262 (1238)
.+..|.....||.|+||+||++.+..+++.||||++.....+......+.+|+.+|..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346788889999999999999999999999999999887777777788999999999999999999988775332
Q ss_pred ---EEEEEEeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCC
Q psy6346 263 ---MIYIVSEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 263 ---~lyLVMEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 478999999999999988643 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccCC---CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCC
Q psy6346 336 SNYYVPG---QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYF 411 (1238)
Q Consensus 336 S~~~~~s---~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~ 411 (1238)
+..+... ......+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.+..++...+..+.. .+|..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 8765322 22345689999999999998776 8999999999999999999999999888888777776644 46778
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 412 MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 412 iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+++++.+||.+||..||.+||++.++++|||++..
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 99999999999999999999999999999998764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=355.27 Aligned_cols=254 Identities=22% Similarity=0.423 Sum_probs=215.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|.....||.|+||.||++.+..++..||+|++.... .....+.+.+|+++|++++|+||+++++++.+.+.+|+|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 45777889999999999999998899999999987653 44456789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
|+.+++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..... ......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~ 162 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSF 162 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-hccccC
Confidence 999999999998888899999999999999999999975 799999999999999999999999999875432 223345
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHH---------------------------
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRV--------------------------- 401 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekI--------------------------- 401 (1238)
.|+..|+|||++.+..+ +.++|||||||++|+|++|+.||.......+...+
T Consensus 163 ~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (333)
T cd06650 163 VGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241 (333)
T ss_pred CCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhh
Confidence 79999999999988766 88999999999999999999999765543332111
Q ss_pred -----------------hcC-CccCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 402 -----------------LSG-RFRIPY-FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 402 -----------------l~g-~~~~P~-~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
... ...++. .++.++.+||.+||.+||++|||++|++.|+||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 242 GPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 111 011111 257889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=343.88 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=219.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|.....||.|+||.||++.+..+++.||+|++....... .....+.+|+++|++++|+||+.+++++..++..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 455678999999999999999999999999997654332 2345678899999999999999999999999999999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
+.+++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 9999998888653 36999999999999999999999999999999999999999999999999998765444444456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH----HHHHHhcCCccCCCCCCHHHHHHHHHhc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS----LRDRVLSGRFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee----L~ekIl~g~~~~P~~iS~eLkDLIrkML 424 (1238)
.|+..|+|||++.+..+ +.++|+|||||++|+|++|..||.+..... +...+......++..++.++.+|+.+||
T Consensus 162 ~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05632 162 VGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240 (285)
T ss_pred CCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence 79999999999988776 889999999999999999999998765433 3333444445566778899999999999
Q ss_pred ccCCCCCCC-----HHHHHhccccccc
Q psy6346 425 VREPTKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRPT-----aeEILeHPWFke~ 446 (1238)
..||++||+ +++++.|+||+..
T Consensus 241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 241 TKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred cCCHhHcCCCcccChHHHHcChhhhcC
Confidence 999999999 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=354.44 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=217.7
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC-CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~-ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|+||.||++.+..+++.||||++.+.. ........+.+|+.++..++|++|+.+++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4677889999999999999999999999999997632 223345668889999999999999999999999999999999
Q ss_pred ecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--cc
Q psy6346 270 YANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--LA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l~ 346 (1238)
|+.||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 161 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeec
Confidence 9999999999987 46789999999999999999999999999999999999999999999999999876543322 22
Q ss_pred cccCCCCCCCcccccCC----ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC---CCCHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY---FMSTECE 417 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~---~iS~eLk 417 (1238)
..+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+..+....+.... +.+|. .+++++.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~ 241 (331)
T cd05624 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK 241 (331)
T ss_pred cccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHH
Confidence 35799999999998752 223789999999999999999999999888877777776543 33443 3689999
Q ss_pred HHHHHhcccCCCC--CCCHHHHHhcccccc
Q psy6346 418 SLIRKMLVREPTK--RYCIEQIKRHRWMAE 445 (1238)
Q Consensus 418 DLIrkML~kDPsk--RPTaeEILeHPWFke 445 (1238)
+||.+||..++.+ |++++++++|+||..
T Consensus 242 ~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 242 DLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 9999999976655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=380.60 Aligned_cols=257 Identities=26% Similarity=0.348 Sum_probs=219.6
Q ss_pred ccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-C-----CCeeEEEE
Q psy6346 183 LHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-H-----PHIIKLFQ 256 (1238)
Q Consensus 183 LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-H-----PNIVrL~d 256 (1238)
......+-.|.+.+.||.|.||.|.+|.+.++++.||||+++.. +.-..+...|+.||..|+ | -|||+++|
T Consensus 179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 33444455899999999999999999999999999999999875 345567788999999996 3 48999999
Q ss_pred EeeeCCEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC--CcEEEEe
Q psy6346 257 VMETKSMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN--LDIKLAD 332 (1238)
Q Consensus 257 vfed~d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n--G~VKLiD 332 (1238)
+|...+++|||+|++. .+|.++|+.+ ..|+...++.|+.||+.||.+||+.||||+|||||||||..- ..|||+|
T Consensus 256 ~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred ccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEe
Confidence 9999999999999995 8999999865 468999999999999999999999999999999999999753 4699999
Q ss_pred cCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--------
Q psy6346 333 FGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------- 404 (1238)
Q Consensus 333 FGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------- 404 (1238)
||.+++. .+...+++.++.|+|||++.|.+| +.+.||||||||++||++|.+.|.|.+..+....|.+-
T Consensus 335 FGSSc~~--~q~vytYiQSRfYRAPEVILGlpY-~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 335 FGSSCFE--SQRVYTYIQSRFYRAPEVILGLPY-DTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ccccccc--CCcceeeeeccccccchhhccCCC-CCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999874 444558999999999999999998 89999999999999999999999998877665554420
Q ss_pred --------------------------------------------CccCCC-----------CCCHHHHHHHHHhcccCCC
Q psy6346 405 --------------------------------------------RFRIPY-----------FMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 405 --------------------------------------------~~~~P~-----------~iS~eLkDLIrkML~kDPs 429 (1238)
....|. .....+.|||++||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 000110 0134578999999999999
Q ss_pred CCCCHHHHHhccccccc
Q psy6346 430 KRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRPTaeEILeHPWFke~ 446 (1238)
+|+|+.++|+||||...
T Consensus 492 ~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGT 508 (586)
T ss_pred hcCCHHHHhcCcccccc
Confidence 99999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.21 Aligned_cols=253 Identities=20% Similarity=0.398 Sum_probs=209.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------CE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------SM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d~ 263 (1238)
+.|.....||.|+||.||++.+..++..||||++..........+.+.+|+.+|++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 456777889999999999999999999999999987654444567788999999999999999999987543 45
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
+|++|+++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-- 170 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-- 170 (343)
T ss_pred EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC--
Confidence 79999998 678877764 45799999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC------------------
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR------------------ 405 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~------------------ 405 (1238)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 33456799999999999875555899999999999999999999998766544333322110
Q ss_pred -----ccCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 -----FRIP--------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 -----~~~P--------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...+ ...++.+.+||.+||..||.+|||+.|++.||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0001 1246678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=372.61 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=205.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCC------CCeeEEEEEeeeC-
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDH------PHIIKLFQVMETK- 261 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~H------PNIVrL~dvfed~- 261 (1238)
...|.....||.|+||.||++.+..++..||||+++... .....+..|+.+++.+.| .+|+.+++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 356889999999999999999999999999999997532 223456678888887754 4588999988754
Q ss_pred CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCC--------------
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNL-------------- 326 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG-------------- 326 (1238)
.++|||||++ |++|.+++.+.+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 5799999998 68899999888889999999999999999999997 5999999999999998765
Q ss_pred --cEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC
Q psy6346 327 --DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG 404 (1238)
Q Consensus 327 --~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g 404 (1238)
.+||+|||++... .......+||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+.+..+....+...
T Consensus 284 ~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 284 PCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred CceEEECCCCccccC--ccccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 4999999987542 223345689999999999998887 89999999999999999999999887654433322211
Q ss_pred CccCC------------------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy6346 405 RFRIP------------------------------------------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 405 ~~~~P------------------------------------------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPW 442 (1238)
...+| ...++.+.|||.+||.+||.+|||++|+|+|||
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 00000 001355779999999999999999999999999
Q ss_pred ccccCC
Q psy6346 443 MAEETP 448 (1238)
Q Consensus 443 Fke~~p 448 (1238)
|....+
T Consensus 441 ~~~~~~ 446 (467)
T PTZ00284 441 VLKYYP 446 (467)
T ss_pred ccccCC
Confidence 987544
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=338.80 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=208.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.||.|++|.||++....++..||||++.....+....+.+.+|+.++++++||||+++++++.+++.+|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 56678899999999999999889999999999776544445577889999999999999999999999999999999999
Q ss_pred CCCccchhhhcc---cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccc
Q psy6346 272 NQGEIFDYIARY---GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLAT 347 (1238)
Q Consensus 272 ~GGSL~d~Lkk~---~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t 347 (1238)
. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ....
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 7 5788777543 468999999999999999999999999999999999999999999999999987543222 2233
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC------------------C----
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------R---- 405 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------~---- 405 (1238)
..+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+... .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence 467889999999876654578999999999999999999999876543222111100 0
Q ss_pred -------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 406 -------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 406 -------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
......+++++.+||++||..||.+|||+.+|++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=337.75 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=213.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....+|.|++|.||++.+..++..||+|++..........+.+.+|+.++++++|+||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 46777889999999999999988999999999876543333445678999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
++++.|..++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 161 (286)
T cd07847 82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161 (286)
T ss_pred cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcc
Confidence 9999888887777789999999999999999999999999999999999999999999999999997654433 233456
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccCC-
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRIP- 409 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~P- 409 (1238)
++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... ....|
T Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07847 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPE 241 (286)
T ss_pred cccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCC
Confidence 8889999999877554588999999999999999999999876643332222110 00011
Q ss_pred -----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 410 -----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 410 -----------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
..++..+.+||.+||..+|++||++.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 242 PETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.44 Aligned_cols=251 Identities=30% Similarity=0.515 Sum_probs=222.6
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--eCCEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--d~d~lyLVME 269 (1238)
|.....+|.|++|.||++.+..++..||+|++..........+++..|+.++++++|+||+++++++. .....|++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 55668899999999999999999999999999887767777788999999999999999999999875 4567899999
Q ss_pred ecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhh-----ccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 270 YANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCH-----NRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLH-----SkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
|+++++|.+++... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998753 57899999999999999999999 8899999999999999999999999999988765
Q ss_pred CCCc-cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHH
Q psy6346 341 PGQK-LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECES 418 (1238)
Q Consensus 341 ~s~~-l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkD 418 (1238)
.... .....|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+...+.+.+..+.. .++..++.++.+
T Consensus 162 ~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd08217 162 HDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240 (265)
T ss_pred CCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 4433 345678999999999988775 7899999999999999999999998887777777776654 356678899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWF 443 (1238)
|+.+||..+|++||++++|++|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=334.43 Aligned_cols=248 Identities=34% Similarity=0.634 Sum_probs=220.6
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
||.|++|.||++.+..++..||||++.+.... ....+.+.+|+.+++.++||||+++++++.++..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 58899999999999888999999999876543 34557899999999999999999999999999999999999999999
Q ss_pred chhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCCCC
Q psy6346 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAA 356 (1238)
Q Consensus 277 ~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmA 356 (1238)
.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.............|++.|++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 99998888899999999999999999999999999999999999999999999999999887654433445678999999
Q ss_pred cccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC--hhHHHHHHh--cCCccCCCCCCHHHHHHHHHhcccCCCCCC
Q psy6346 357 PEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST--LNSLRDRVL--SGRFRIPYFMSTECESLIRKMLVREPTKRY 432 (1238)
Q Consensus 357 PEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d--~eeL~ekIl--~g~~~~P~~iS~eLkDLIrkML~kDPskRP 432 (1238)
||.+.+..+ +.++|+|+|||++|+|++|..||.... .......+. .....+|...+.++.++|.+||..+|.+||
T Consensus 161 PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 161 PEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 999887766 889999999999999999999998776 555666666 345667777899999999999999999999
Q ss_pred C-----HHHHHhccccccc
Q psy6346 433 C-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 433 T-----aeEILeHPWFke~ 446 (1238)
+ ++|+++||||.+.
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=360.54 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=222.3
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--eCCEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMI 264 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--d~d~l 264 (1238)
..-+.|....+|++|.||.||++.+.++++.||+|.++-+.-...---.-.|||.+|.+++|||||.+-++.. +-+.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3345688889999999999999999999999999999876532222234579999999999999999999885 34569
Q ss_pred EEEEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-
Q psy6346 265 YIVSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG- 342 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s- 342 (1238)
|||||||+ -+|..++...+ +|...+++.++.|++.||+|||.+.|+|||||++|+|+...|.+||+|||+|+.+...
T Consensus 153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99999997 67888887765 8999999999999999999999999999999999999999999999999999987654
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC------------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------ 404 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------ 404 (1238)
..+...+-|.+|+|||++.|.+.|+.++|+||+|||+.||+++++.|.|.......++|...
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 34566778999999999999998899999999999999999999999998876666665421
Q ss_pred -Ccc------------CCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 -RFR------------IPYF-MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 -~~~------------~P~~-iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
... |+.. +++...+|+..+|..||.+|.|++|.|+|.||.+.
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 011 1122 46888999999999999999999999999999985
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.62 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=223.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|...+.+|.|++|.||++.+..++..||+|++.+.... ....+.+.+|++++++++||||+++++++.+....|+||||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 66788999999999999999889999999999876543 35568899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccC
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCG 350 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~G 350 (1238)
+.|++|.+++.....+++..+..++.||+.||.|||.+|++|+||+|+||+++.++.++|+|||++.............|
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 161 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG 161 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCC
Confidence 99999999998877899999999999999999999999999999999999999999999999999876655444455678
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC---hhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d---~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kD 427 (1238)
+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...+ ...+..........+|..++.++.++|.+||..|
T Consensus 162 ~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (258)
T cd05578 162 TPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD 240 (258)
T ss_pred ChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCC
Confidence 899999999987775 889999999999999999999998776 3444444444556677788999999999999999
Q ss_pred CCCCCCH--HHHHhcccc
Q psy6346 428 PTKRYCI--EQIKRHRWM 443 (1238)
Q Consensus 428 PskRPTa--eEILeHPWF 443 (1238)
|.+||++ +|+++||||
T Consensus 241 p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 241 PQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred hhHcCCccHHHHhcCCCC
Confidence 9999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.10 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=217.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC---C--EE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK---S--MI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~---d--~l 264 (1238)
.-|.....+|.|+||.||+++...++..||||..-.+..- --+|++||++++|||||+|..+|... + +.
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 4578889999999999999999999999999988654321 12799999999999999999888432 2 45
Q ss_pred EEEEeecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-CcEEEEecCCcccc
Q psy6346 265 YIVSEYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSNYY 339 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~~~ 339 (1238)
.+||||++ .+|.++++. ..+++...++-+++||+.||.|||+.||+||||||.|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 68999998 789888875 4679999999999999999999999999999999999999976 99999999999999
Q ss_pred cCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc------------C---
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS------------G--- 404 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~------------g--- 404 (1238)
..++...++..|+.|+|||.+.|...|+.+.||||.|||+.||+.|++.|.|++.......|.. .
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 9999889999999999999999998889999999999999999999999999876655444331 0
Q ss_pred --CccC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 405 --RFRI------------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 405 --~~~~------------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.+.+ ...+++++.+|+.++|..+|.+|.++-|++.||||.+-.
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 1111 223689999999999999999999999999999998743
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.72 Aligned_cols=251 Identities=31% Similarity=0.451 Sum_probs=222.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+|.|++|.||++....++..||||++............+.+|+++|+.++||||+++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 56678899999999999999899999999999887666666788999999999999999999999999999999999999
Q ss_pred CCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-CcEEEEecCCcccccCCCccccc
Q psy6346 272 NQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
++++|.+++... ..+++..+..++.+++.||.|||++||+|+||+|+||+++.+ +.+||+|||++............
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV 161 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccccc
Confidence 999999999764 348999999999999999999999999999999999999865 46899999999876555444556
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcccC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~kD 427 (1238)
.|+..|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+.......+.... ..++..++.++.++|.+||..+
T Consensus 162 ~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 240 (256)
T cd08220 162 VGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLD 240 (256)
T ss_pred ccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCC
Confidence 78999999999987765 789999999999999999999999888777766666543 3456678999999999999999
Q ss_pred CCCCCCHHHHHhcccc
Q psy6346 428 PTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 428 PskRPTaeEILeHPWF 443 (1238)
|++|||+.|++.||||
T Consensus 241 p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 241 PSKRPQLSQIMAQPIC 256 (256)
T ss_pred hhhCCCHHHHhhCCCC
Confidence 9999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.43 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=215.9
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-------HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-------VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-------e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
|.....+|.|++|.||++.+..++..||+|++....... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 344568899999999999988889999999987654321 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
++||||+++++|.+++...+.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987654211
Q ss_pred ------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-CccCCCCCCHHH
Q psy6346 344 ------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTEC 416 (1238)
Q Consensus 344 ------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eL 416 (1238)
......|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+.......+... ...+|..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06628 162 STKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA 240 (267)
T ss_pred cCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHH
Confidence 1223468899999999988776 78999999999999999999999876554443343333 335667789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.++|++||+.||.+||++.+|++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.83 Aligned_cols=255 Identities=31% Similarity=0.504 Sum_probs=224.2
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|++|.||++....++..||||.+.+..... ...+.+.+|+++++.++|+||+++++.+......|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4677789999999999999999899999999998775543 456789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC----
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---- 343 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---- 343 (1238)
|+.|++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 99999999998754 568999999999999999999999999999999999999999999999999886542211
Q ss_pred --------------------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHH
Q psy6346 344 --------------------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL 397 (1238)
Q Consensus 344 --------------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL 397 (1238)
......|+..|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 1123468899999999988776 8899999999999999999999998887777
Q ss_pred HHHHhcCCccCCCC--CCHHHHHHHHHhcccCCCCCCC----HHHHHhccccccc
Q psy6346 398 RDRVLSGRFRIPYF--MSTECESLIRKMLVREPTKRYC----IEQIKRHRWMAEE 446 (1238)
Q Consensus 398 ~ekIl~g~~~~P~~--iS~eLkDLIrkML~kDPskRPT----aeEILeHPWFke~ 446 (1238)
...+......++.. ++.++.++|.+||..||++||+ +++++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 77777666555554 6899999999999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=371.60 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=239.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE-EEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-IYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~-lyLVM 268 (1238)
..|...+.+|.|+||.++.+.+..++..|++|.+.....+.........|+.+++++.|||||.+++.|+.++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 45777789999999999999999999999999999988887777889999999999999999999999998888 99999
Q ss_pred eecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cc
Q psy6346 269 EYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KL 345 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l 345 (1238)
+||+||+|.+.|.+.+ .|+++.+..|+.|++.||.|||++.|+|||||+.|||++.++.|||.|||+++...+.. ..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence 9999999999998664 58999999999999999999999999999999999999999999999999999887766 67
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhc
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML 424 (1238)
.+.+||+.||+||++.+.+| +.++|||||||++|||++-+++|.+.+...+..+|..+. .++|..++.+++.||+.||
T Consensus 164 ~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l 242 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSML 242 (426)
T ss_pred heecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHh
Confidence 78899999999999999998 999999999999999999999999999999999999987 6788889999999999999
Q ss_pred ccCCCCCCCHHHHHhccccccc
Q psy6346 425 VREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRPTaeEILeHPWFke~ 446 (1238)
.++|..||++.++|.+|.+...
T Consensus 243 ~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 243 RKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred hcCCccCCCHHHHhhChhhhhH
Confidence 9999999999999999887643
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.47 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=215.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||++.+..+|..||||++..........+.+.+|+.++++++||||+++++++......|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 66778899999999999999989999999999877655555678999999999999999999999999999999999999
Q ss_pred CCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccccc
Q psy6346 272 NQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~t~ 348 (1238)
+++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .....
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence 9999998865 3568999999999999999999999999999999999999999999999999987654332 23445
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------Ccc--
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFR-- 407 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~-- 407 (1238)
.|+..|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+... ...
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07832 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240 (286)
T ss_pred cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence 78999999999877665588999999999999999999999877654443333221 000
Q ss_pred ---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy6346 408 ---------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 408 ---------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFk 444 (1238)
.....+.++.+||.+||..+|.+|||+++++.||||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0123568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=328.87 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=217.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....+|.|++|+||++....++..||+|++....... ..+.+.+|+++|+.++|+||+++++.+......|+|||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3667788999999999999988899999999998765443 668899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc---cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---
Q psy6346 271 ANQGEIFDYIARY---GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--- 344 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~---~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--- 344 (1238)
+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999999764 4589999999999999999999999999999999999999999999999999876544322
Q ss_pred --cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCC-----CCCCHHH
Q psy6346 345 --LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIP-----YFMSTEC 416 (1238)
Q Consensus 345 --l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P-----~~iS~eL 416 (1238)
.....|+..|+|||++......+.++|+|||||++|+|++|+.||...+.......+..... .++ ..++.++
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 23446899999999988764458899999999999999999999988766555555444322 121 2467889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.+||.+||..||++||++++|+.||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=359.42 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=219.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC-eeEEEEEeeeCC------EE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH-IIKLFQVMETKS------MI 264 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN-IVrL~dvfed~d------~l 264 (1238)
|...+++|+|.+|+||+|+...+|..||+|++..+..++..-....+|+-+|+.|+|+| |++|++++.+.. .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 44556789999999999999999999999999887644334466789999999999999 999999998877 89
Q ss_pred EEEEeecCCCccchhhhccc----ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 265 YIVSEYANQGEIFDYIARYG----RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~----~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
++|+||+. .+|..++.... .++...++.+++||+.||+|||+++|+||||||+||||+..|.+||+|||+|+.+.
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 99999997 78888887765 57778999999999999999999999999999999999999999999999998765
Q ss_pred -CCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---------------
Q psy6346 341 -PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--------------- 404 (1238)
Q Consensus 341 -~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--------------- 404 (1238)
+.......++|.+|+|||++.+...|+..+||||+|||++||++++..|.|.........|..-
T Consensus 172 ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 172 IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccc
Confidence 4445677889999999999999988899999999999999999999999998876655554321
Q ss_pred ---CccCCCC------------CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 405 ---RFRIPYF------------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 405 ---~~~~P~~------------iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
...++.+ .+++..+++.+||+.+|.+|.+++.+|.||||.+..
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1112211 235789999999999999999999999999998763
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=340.06 Aligned_cols=251 Identities=25% Similarity=0.443 Sum_probs=207.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+|.|++|.||++.+..+|..||+|+++...........+.+|++++++++|+||+++++++.+...+|+|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 56678899999999999999999999999999765444344467788999999999999999999999999999999999
Q ss_pred CCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccccc
Q psy6346 272 NQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWC 349 (1238)
Q Consensus 272 ~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~ 349 (1238)
. ++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... .......
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence 7 577777654 467999999999999999999999999999999999999999999999999998754332 2233456
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCC-CCCChhHHHHHHhcC----------------C---c---
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF-DGSTLNSLRDRVLSG----------------R---F--- 406 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF-~g~d~eeL~ekIl~g----------------~---~--- 406 (1238)
+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+....+... . +
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07839 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240 (284)
T ss_pred cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence 7899999999887665588999999999999999988885 444443333322110 0 0
Q ss_pred -------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 407 -------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 407 -------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.....+++++.+||.+||..||.+|||+++++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=328.49 Aligned_cols=251 Identities=25% Similarity=0.464 Sum_probs=221.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+|.|++|.+|.+....++..||||.+..........+.+.+|+.++++++|+||+++++++...+..|+||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 56778999999999999999899999999999876555556678999999999999999999999999999999999999
Q ss_pred CCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccc
Q psy6346 272 NQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~ 348 (1238)
.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 161 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC 161 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhc
Confidence 9999999887543 57889999999999999999999999999999999999999999999999987653322 22234
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHHHHhcccC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLIrkML~kD 427 (1238)
.|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+..+....+..+.. ..+..++.++.++|.+||..+
T Consensus 162 ~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08218 162 IGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240 (256)
T ss_pred cCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCC
Confidence 68889999999987775 7899999999999999999999988887777777766654 356678999999999999999
Q ss_pred CCCCCCHHHHHhcccc
Q psy6346 428 PTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 428 PskRPTaeEILeHPWF 443 (1238)
|.+||++.++++||||
T Consensus 241 p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 241 PRDRPSVNSILEKNFI 256 (256)
T ss_pred hhhCcCHHHHhhCcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.01 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=212.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|.....||.|++|.||++.+..++..||+|.+..... ......+.+|+.++++++||||+++++++...+..|+|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 358888999999999999999988999999999876542 2233467789999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t 347 (1238)
|+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...... .....
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 997 5888877654 56889999999999999999999999999999999999999999999999998754322 22234
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccC
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRI 408 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~ 408 (1238)
..+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+... ...+
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 567899999999877655588999999999999999999999887765443332210 0111
Q ss_pred C-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 409 P-----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 409 P-----------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
| ..+++++.+||.+||..||.+|||++|+++||||..-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1 2367889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.80 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=218.3
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC---ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l---d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
|.....||.|++|.||+++...++..||||++..... .....+.+.+|+.+++.++|+||+++++++.....+|+||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 4456789999999999999888999999999876542 2445678999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++............
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 161 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF 161 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998765444434556
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc--CCccCCCCCCHHHHHHHHHhccc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--GRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~--g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
.|+..|++||.+......+.++|+|||||++|+|++|..||...........+.. ....++..+++++.+||.+||..
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 241 (258)
T cd06632 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQR 241 (258)
T ss_pred CCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhc
Confidence 7899999999987665348899999999999999999999977654443333333 22345667889999999999999
Q ss_pred CCCCCCCHHHHHhcccc
Q psy6346 427 EPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 427 DPskRPTaeEILeHPWF 443 (1238)
+|.+||++.+++.|||+
T Consensus 242 ~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 242 DPSLRPTAAELLEHPFV 258 (258)
T ss_pred CcccCcCHHHHhcCCCC
Confidence 99999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.37 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=216.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.+|.|++|.||++....++..+|+|++.... ....+.+.+|+.++++++||||+++++++...+.+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 45778899999999999999998899999999998654 2356789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t 347 (1238)
|+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999999998776 789999999999999999999999999999999999999999999999999987654332 3344
Q ss_pred ccCCCCCCCcccccCC---ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc-----CCCCCCHHHHHH
Q psy6346 348 WCGSPPYAAPEVFEGK---KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR-----IPYFMSTECESL 419 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk---~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~-----~P~~iS~eLkDL 419 (1238)
..++..|+|||.+.+. .+ +.++|+|||||++|+|++|..||.+.+.......+....+. .+..++.++.+|
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred ccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence 5788999999998766 55 78999999999999999999999887655544444433222 223357789999
Q ss_pred HHHhcccCCCCCCCHHHHHhccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPW 442 (1238)
|++||..+|.+|||+.+|+.|+|
T Consensus 240 i~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=326.38 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=223.4
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||.+....++..|++|.+.....+....+++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 56678899999999999888899999999999877666777788999999999999999999999999999999999999
Q ss_pred CCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccc
Q psy6346 272 NQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~ 348 (1238)
++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccccc
Confidence 999999999765 468999999999999999999999999999999999999999999999999987654333 23445
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc-CCCCCCHHHHHHHHHhcccC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR-IPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~-~P~~iS~eLkDLIrkML~kD 427 (1238)
.|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+..+.+. .+..++.++.++|.+||..+
T Consensus 162 ~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08221 162 VGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240 (256)
T ss_pred CCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccC
Confidence 68999999999988775 78999999999999999999999988887777777766543 34557899999999999999
Q ss_pred CCCCCCHHHHHhcccc
Q psy6346 428 PTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 428 PskRPTaeEILeHPWF 443 (1238)
|.+||+++++++|+|+
T Consensus 241 p~~R~s~~~ll~~~~l 256 (256)
T cd08221 241 PEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCCCHHHHhhCcCC
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.63 Aligned_cols=248 Identities=20% Similarity=0.384 Sum_probs=203.2
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee-CC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET-KS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed-~d 262 (1238)
..|.....||.|+||.||++.+. .++..||||++.... .....+.+.+|+.+|.++ +||||+++++++.. ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45677788999999999998753 345789999997543 344567899999999999 89999999998865 44
Q ss_pred EEEEEEeecCCCccchhhhcc-----------------------------------------------------------
Q psy6346 263 MIYIVSEYANQGEIFDYIARY----------------------------------------------------------- 283 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~----------------------------------------------------------- 283 (1238)
.+|+||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999988642
Q ss_pred ---cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---ccccccCCCCCCCc
Q psy6346 284 ---GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAP 357 (1238)
Q Consensus 284 ---~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAP 357 (1238)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+++.|+||
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 236777889999999999999999999999999999999999999999999987543221 11233456789999
Q ss_pred ccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChh-HHHHHHhcC-CccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy6346 358 EVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLN-SLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCI 434 (1238)
Q Consensus 358 EVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~e-eL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTa 434 (1238)
|++.+..+ +.++|||||||+||||++ |..||.+.... .+...+..+ ....|..+++++.+||.+||..||.+|||+
T Consensus 246 E~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 324 (338)
T cd05102 246 ESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTF 324 (338)
T ss_pred HHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 99988776 899999999999999997 99999876543 333334333 344567789999999999999999999999
Q ss_pred HHHHh
Q psy6346 435 EQIKR 439 (1238)
Q Consensus 435 eEILe 439 (1238)
.+|++
T Consensus 325 ~el~~ 329 (338)
T cd05102 325 SALVE 329 (338)
T ss_pred HHHHH
Confidence 99976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.19 Aligned_cols=251 Identities=19% Similarity=0.262 Sum_probs=205.4
Q ss_pred EEecCC--CCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 196 EKCGVK--SRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 196 ekIGsG--sfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
+.||.| ++++||++....+|..||||+++.........+.+.+|+++++.++||||+++++++..++..|+||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 567888 678999999999999999999987765555667788999999999999999999999999999999999999
Q ss_pred Cccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-C-------
Q psy6346 274 GEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-Q------- 343 (1238)
Q Consensus 274 GSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~------- 343 (1238)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++++||+........ .
T Consensus 84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 163 (327)
T cd08227 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHD 163 (327)
T ss_pred CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccccc
Confidence 9999998653 45899999999999999999999999999999999999999999999999865332111 1
Q ss_pred ccccccCCCCCCCcccccCC-ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc---------------
Q psy6346 344 KLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR--------------- 407 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~--------------- 407 (1238)
......++..|+|||++.+. ..++.++|||||||++|+|++|..||..............+..+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (327)
T cd08227 164 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTM 243 (327)
T ss_pred ccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhccc
Confidence 11223567789999999763 22488999999999999999999999765433322222211100
Q ss_pred -------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 408 -------------------------------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 408 -------------------------------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
....+++++.+||++||+.||++|||++++++||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 244 KPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred CCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 111246789999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.99 Aligned_cols=243 Identities=23% Similarity=0.416 Sum_probs=192.6
Q ss_pred EEecCCCCccccCceEc--cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--eCCEEEEEEeec
Q psy6346 196 EKCGVKSRSCNRPPVLL--RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIYIVSEYA 271 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~l--ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--d~d~lyLVMEy~ 271 (1238)
.+||.|+||.||+|... .++..||||++...... ..+.+|+.+|++++||||+++++++. ....+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 47899999999999865 46789999999765422 35678999999999999999999885 356789999999
Q ss_pred CCCccchhhhcc---------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc----cCCCcEEEEecCCccc
Q psy6346 272 NQGEIFDYIARY---------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDIKLADFGFSNY 338 (1238)
Q Consensus 272 ~GGSL~d~Lkk~---------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL----d~nG~VKLiDFGLS~~ 338 (1238)
. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 6 5777776432 258899999999999999999999999999999999999 4567899999999976
Q ss_pred ccCC----CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---------HHHHHHhc--
Q psy6346 339 YVPG----QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---------SLRDRVLS-- 403 (1238)
Q Consensus 339 ~~~s----~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---------eL~ekIl~-- 403 (1238)
.... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.... .....+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 5332 12345678999999999988665589999999999999999999999653311 11111100
Q ss_pred --------------------------CCcc----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 404 --------------------------GRFR----------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 404 --------------------------g~~~----------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.... .....+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 001135678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.82 Aligned_cols=253 Identities=23% Similarity=0.423 Sum_probs=215.4
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....||.|+||.||++.+..++..||+|++.... ......++.+|++++++++||||+++++++.+++.+|+||||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3677788999999999999999999999999987653 344556789999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
+++++|.+++.+.+.+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++...... .....+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~ 159 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV 159 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCC
Confidence 9999999999888889999999999999999999997 59999999999999999999999999998654322 234567
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------------
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------------- 404 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------------- 404 (1238)
|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+...
T Consensus 160 ~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06615 160 GTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238 (308)
T ss_pred CCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence 8999999999887765 88999999999999999999999765543333222111
Q ss_pred ------------CccCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 ------------RFRIPY-FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 ------------~~~~P~-~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
....|. .++.++.+||.+||..+|++|||+.+|+.||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011111 257789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.73 Aligned_cols=255 Identities=32% Similarity=0.516 Sum_probs=236.9
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|.....+|+|-||.|-.+....+++.+|||+++++.+ ...+...-..|-++|+..+||.+..|-..|.+.+++|+||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 4445678888888888888889999999999999864 556677788999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc-cCCCcccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~-~~s~~l~t~~ 349 (1238)
+.||+|+-++.+.+.|++..++.+...|+.||.|||+.+||+||||.+|+|||.+|++||+|||+++.. ..+....++|
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFC 329 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFC 329 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceecccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999764 3456788999
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
|||.|+|||++....| +.++|.|.+||++|||+||++||...+...+++.|+.++..||..++++++.|+..+|.+||.
T Consensus 330 GTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~ 408 (516)
T KOG0690|consen 330 GTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPK 408 (516)
T ss_pred CChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChH
Confidence 9999999999999988 999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCC-----CHHHHHhcccccccC
Q psy6346 430 KRY-----CIEQIKRHRWMAEET 447 (1238)
Q Consensus 430 kRP-----TaeEILeHPWFke~~ 447 (1238)
+|. .+.||.+|+||....
T Consensus 409 kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 409 KRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred hhcCCCchhHHHHHhhhhhccCC
Confidence 997 489999999998643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.75 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=213.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC----ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL----DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l----d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
|.....+|.|+||.||++.. .++..||||++..... .......+.+|+++|++++|+||+++++++.+.+..|+|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 45567899999999999865 5788999999875432 123456789999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC------
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP------ 341 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~------ 341 (1238)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999998865421
Q ss_pred -CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHH
Q psy6346 342 -GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECE 417 (1238)
Q Consensus 342 -s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLk 417 (1238)
........|+..|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+... ...++..++.++.
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239 (265)
T ss_pred ccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence 112234568999999999988776 78999999999999999999999876544333333322 2345667899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
++|++||..+|.+||++.+++.||||
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.70 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=214.8
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
||.|+||.||++....+|+.||+|++.+.... ......+.+|+++|++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 58899999999998899999999999765432 22345677899999999999999999999999999999999999999
Q ss_pred chhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCC
Q psy6346 277 FDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPY 354 (1238)
Q Consensus 277 ~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~Y 354 (1238)
.+++.+.+ .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997765 7899999999999999999999999999999999999999999999999998765444344455688899
Q ss_pred CCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh----hHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 355 AAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL----NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 355 mAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~----eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
+|||++.+..+ +.++|||||||++|+|++|+.||..... ..+...+......++..+++.+.++|.+||..||.+
T Consensus 161 ~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 161 MAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred CCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 99999987775 8899999999999999999999977543 334444444455667778999999999999999999
Q ss_pred CC-----CHHHHHhccccccc
Q psy6346 431 RY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 431 RP-----TaeEILeHPWFke~ 446 (1238)
|| ++.+++.||||.+.
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 89999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.89 Aligned_cols=251 Identities=36% Similarity=0.583 Sum_probs=221.6
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee----CCEEEEEEee
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET----KSMIYIVSEY 270 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed----~d~lyLVMEy 270 (1238)
.+||.|-.|.|..|+...++.++|+|++... .+.++|+++.-.. .|||||.++|+|++ ...+.+|||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 4678888888888999999999999998643 4678999986665 89999999999863 5678999999
Q ss_pred cCCCccchhhhcccc--cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEEecCCcccccCCCcc
Q psy6346 271 ANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLiDFGLS~~~~~s~~l 345 (1238)
++||+|+..|...+. |++.++..|++||..|+.|||+.+|.||||||+|+|+.. +..+||+|||+++.......+
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L 220 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL 220 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccc
Confidence 999999999988765 999999999999999999999999999999999999975 556999999999987777888
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC----hhHHHHHHhcCCccCCCC----CCHHHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST----LNSLRDRVLSGRFRIPYF----MSTECE 417 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d----~eeL~ekIl~g~~~~P~~----iS~eLk 417 (1238)
.+.|.||+|.|||++...+| +...|+||||||+|-||||.+||.... ...+..+|..+.+.||.. +|++++
T Consensus 221 ~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aK 299 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAK 299 (400)
T ss_pred cCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHH
Confidence 99999999999999988887 899999999999999999999996533 346788999999988864 799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccCCCCCCCc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPI 454 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~~p~~lppi 454 (1238)
|+|+.+|..+|.+|+|++++++|||+.........++
T Consensus 300 dlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 300 DLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred HHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 9999999999999999999999999987655444443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.52 Aligned_cols=247 Identities=32% Similarity=0.533 Sum_probs=220.5
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
+|.|++|.||++++..++..||+|++..... .....+.+.+|++++++++|+||+++++.+......|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5788999999999988899999999977643 234567899999999999999999999999999999999999999999
Q ss_pred chhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---------cccc
Q psy6346 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---------KLAT 347 (1238)
Q Consensus 277 ~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---------~l~t 347 (1238)
.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999887889999999999999999999999999999999999999999999999999987543321 2234
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCC--CHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFM--STECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~i--S~eLkDLIrkML~ 425 (1238)
..++..|++||.+..... +.++|||||||++|+|++|..||...........+..+...+|... +..+.+||.+||.
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999987775 8899999999999999999999999888888888887777666665 8999999999999
Q ss_pred cCCCCCCCH---HHHHhcccccc
Q psy6346 426 REPTKRYCI---EQIKRHRWMAE 445 (1238)
Q Consensus 426 kDPskRPTa---eEILeHPWFke 445 (1238)
.+|.+|||+ .++++||||.+
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.53 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=214.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC----hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD----PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld----~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
|.....+|.|++|.||.+....++..||+|++...... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 45567899999999999999899999999999765421 22457899999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCCcccccCCC---
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYVPGQ--- 343 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~s~--- 343 (1238)
|||+.|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (268)
T cd06630 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161 (268)
T ss_pred EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence 99999999999998888899999999999999999999999999999999999998776 59999999987654321
Q ss_pred --ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh-----cCCccCCCCCCHHH
Q psy6346 344 --KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL-----SGRFRIPYFMSTEC 416 (1238)
Q Consensus 344 --~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl-----~g~~~~P~~iS~eL 416 (1238)
......|+..|+|||++.+..+ +.++|||||||++|+|++|..||...........+. .....+|..+++++
T Consensus 162 ~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06630 162 GEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240 (268)
T ss_pred CccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence 1123468889999999987766 889999999999999999999997654332222221 22344566788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhccccc
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeHPWFk 444 (1238)
.++|.+||..+|.+||++.++++||||+
T Consensus 241 ~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 241 RDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.34 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=210.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|++|.||++....+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 34556677899999999999998999999999997653 2344668899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
|+++++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...... ......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 9999999999988889999999999999999999999999999999999999999999999999998654322 222345
Q ss_pred cCCCCCCCccccc---CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC-----CCCCHHHHHHH
Q psy6346 349 CGSPPYAAPEVFE---GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP-----YFMSTECESLI 420 (1238)
Q Consensus 349 ~GTp~YmAPEVL~---gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P-----~~iS~eLkDLI 420 (1238)
.|+..|+|||++. ...+ +.++|+|||||++|+|++|..||...................+ ..++..+.+||
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245 (267)
T ss_pred cCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence 7899999999974 2333 7899999999999999999999976544333333322222211 23678899999
Q ss_pred HHhcccCCCCCCCHHHHHhccc
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPW 442 (1238)
.+||..+|++||++++|++|||
T Consensus 246 ~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 246 KMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=332.38 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=215.7
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.+|.|++|.||++.+..++..||||+++....+....+.+.+|++++++++|+||+++++++...+..|+||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 47778899999999999999998999999999987655555567899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~t~ 348 (1238)
+.++.+..++.+...+++..+..++.||+.||.|||..|++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY 161 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCc
Confidence 9987777767666779999999999999999999999999999999999999999999999999987655443 33446
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc--------------------C----
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--------------------G---- 404 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~--------------------g---- 404 (1238)
.++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.. +
T Consensus 162 ~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07833 162 VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP 241 (288)
T ss_pred ccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccC
Confidence 7889999999998874458999999999999999999999987654332221110 0
Q ss_pred --------CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 405 --------RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 405 --------~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
...++..++.++.+||++||..+|++||+++++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 242 EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 001234458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=331.15 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=206.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeC--CEEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETK--SMIYIVS 268 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~--d~lyLVM 268 (1238)
|.....+|.|++|.||++....++..||||++++...+... ....+|+.++.++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 34567899999999999999999999999999765433222 34457999999884 99999999999887 8999999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+||+++. +.+||+|||++...........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 9997 577777765 356899999999999999999999999999999999999999 9999999999987654444445
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc------------------CCccCC
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS------------------GRFRIP 409 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~------------------g~~~~P 409 (1238)
..++..|+|||++......+.++|||||||++|+|++|..||.+.+..+....+.. ..+.+|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 66899999999876655558899999999999999999999988765444333321 011111
Q ss_pred -----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 410 -----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 410 -----------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
..++.++.+||.+||..+|++||++++++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 2357899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=338.69 Aligned_cols=240 Identities=15% Similarity=0.247 Sum_probs=208.0
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeee----CCEEEEEEee
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMET----KSMIYIVSEY 270 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed----~d~lyLVMEy 270 (1238)
..+|.|+++.||+|.. +|+.||||++....... ...+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 3578889999999876 78999999998764433 235778899999999999999999999876 4578999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
+.+|+|.+++.+.+.+++.....++.+++.||.|||.. +++||||||+||+++.++.+||+|||++...... .....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~ 181 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNV 181 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--ccccc
Confidence 99999999999888899999999999999999999984 9999999999999999999999999998754322 23456
Q ss_pred CCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHHHHHhcc
Q psy6346 350 GSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 350 GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDLIrkML~ 425 (1238)
|+..|+|||++.+ ..+ +.++|||||||++|||++|..||.+.+..++...+... .+.+|..+++++.+||.+||+
T Consensus 182 ~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred CcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 8999999999976 444 89999999999999999999999998888887777544 445666789999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q psy6346 426 REPTKRYCIEQIKRH 440 (1238)
Q Consensus 426 kDPskRPTaeEILeH 440 (1238)
.||++|||++++++.
T Consensus 261 ~dp~~Rps~~ell~~ 275 (283)
T PHA02988 261 HDSIKRPNIKEILYN 275 (283)
T ss_pred CCcccCcCHHHHHHH
Confidence 999999999999863
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=371.04 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=226.9
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
...|...+.||.|+||.||+|.+.++++.||||+++.+.. ..+++.+..|+.+|..++++||.++|+.+..+..++++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 3456677899999999999999999999999999998763 456788999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t 347 (1238)
|||.||++.+.++....+.+.++..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+....... ...+
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999987765443 4488
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhccc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~k 426 (1238)
++|||.|||||++.+..| +.++||||||++.+||++|.+||....+......|-... ..+...+++.+++||..||.+
T Consensus 171 fvGTPfwMAPEVI~~~~Y-~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k 249 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGY-DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDK 249 (467)
T ss_pred ccccccccchhhhccccc-cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhc
Confidence 999999999999997776 899999999999999999999998877644333333322 223345789999999999999
Q ss_pred CCCCCCCHHHHHhcccccc
Q psy6346 427 EPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 427 DPskRPTaeEILeHPWFke 445 (1238)
||+.||++.++|+|+|++.
T Consensus 250 ~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 250 NPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CcccCcCHHHHhhhHHHHh
Confidence 9999999999999999986
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=331.59 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=219.4
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+|.|++|.||++.+..++..||+|++.... .......+.+|+.+++.++|+||+++++++.+....|+|+||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 555677899999999999999999999999997654 3345567889999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-CccccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~G 350 (1238)
++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......|
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVG 160 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccC
Confidence 999999998765 8899999999999999999999999999999999999999999999999998776443 23345578
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCC-CCHHHHHHHHHhcccCC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYF-MSTECESLIRKMLVREP 428 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~-iS~eLkDLIrkML~kDP 428 (1238)
++.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.... ..++.. ++.++.++|.+||..+|
T Consensus 161 ~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p 239 (274)
T cd06609 161 TPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDP 239 (274)
T ss_pred CccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCCh
Confidence 899999999988775 899999999999999999999998776655555544442 233334 78899999999999999
Q ss_pred CCCCCHHHHHhccccccc
Q psy6346 429 TKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~ 446 (1238)
++|||+++++.||||...
T Consensus 240 ~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 240 KERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCcCHHHHhhChhhcCC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.61 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=218.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.+|.|++|.||++....++..||+|++... .....+.+.+|++++++++|+||+++++++......|+||||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 366667889999999999998888999999999754 345567889999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 271 ANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ......
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccccee
Confidence 9999999998764 56999999999999999999999999999999999999999999999999988654322 223445
Q ss_pred cCCCCCCCcccccCC----ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC---ccCCCCCCHHHHHHHH
Q psy6346 349 CGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR---FRIPYFMSTECESLIR 421 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~---~~~P~~iS~eLkDLIr 421 (1238)
.|++.|+|||++... ...+.++|||||||++|+|++|..||.+.+.......+.... +..|..++.++.+||.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (280)
T cd06611 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243 (280)
T ss_pred ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHH
Confidence 789999999997532 223678999999999999999999998887666666665543 2335567899999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||..+|.+||+++++++||||...
T Consensus 244 ~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 244 SCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.03 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=209.1
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||++++..++..||||++.... .......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 455678999999999999999999999999997653 3344567899999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGS 351 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GT 351 (1238)
++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... .....+|+
T Consensus 82 ~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 156 (279)
T cd06619 82 DGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGT 156 (279)
T ss_pred CCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCC
Confidence 99988654 35788889999999999999999999999999999999999999999999998765332 33446799
Q ss_pred CCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh-------hHHHHHHhcCC-ccC-CCCCCHHHHHHHHH
Q psy6346 352 PPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-------NSLRDRVLSGR-FRI-PYFMSTECESLIRK 422 (1238)
Q Consensus 352 p~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-------eeL~ekIl~g~-~~~-P~~iS~eLkDLIrk 422 (1238)
..|+|||++.+..+ +.++|+|||||++|+|++|..||..... ......+.... ... ....++++.+||.+
T Consensus 157 ~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (279)
T cd06619 157 NAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQ 235 (279)
T ss_pred hhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHH
Confidence 99999999988776 8999999999999999999999965321 12222222222 112 23478899999999
Q ss_pred hcccCCCCCCCHHHHHhccccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||..+|.+||++++++.||||...
T Consensus 236 ~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 236 CMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.77 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=217.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
++.|+....+|.|++|.||++.+..++..||+|++... +....+.+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 46678888999999999999999999999999999764 3456678899999999999999999999999999999999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccc
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~ 346 (1238)
||+++++|..++.+ ...+++..+..++.||+.+|.|||+.||+||||||+||+++.++.++|+|||++...... ....
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 99999999887754 456899999999999999999999999999999999999999999999999988654322 2234
Q ss_pred cccCCCCCCCcccccCC----ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---cCCCCCCHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---RIPYFMSTECESL 419 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---~~P~~iS~eLkDL 419 (1238)
...+++.|+|||++.+. ..++.++|||||||++|+|++|..||...+......++..... ..+..++.++.+|
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 45688999999998532 1237789999999999999999999987766555555544322 2345678899999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|.+||..+|++||+++++++||||...
T Consensus 249 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 249 LKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHhcCCcccCcCHHHHhcCcccccc
Confidence 999999999999999999999998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.50 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=221.5
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~lyLVME 269 (1238)
|.....+|.|++|.||++....++..|++|++..........+.+.+|+.++++++|+||+++++.+... ..+++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 5566889999999999999988999999999988765556678999999999999999999999999988 89999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---cc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---LA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---l~ 346 (1238)
|+.+++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 161 (260)
T cd06606 82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161 (260)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccccc
Confidence 999999999998888999999999999999999999999999999999999999999999999999887655443 44
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC-hhHHHHHHhc--CCccCCCCCCHHHHHHHHHh
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST-LNSLRDRVLS--GRFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d-~eeL~ekIl~--g~~~~P~~iS~eLkDLIrkM 423 (1238)
...++..|+|||.+.+... +.++||||||+++|+|++|..||.... .......+.. ....+|..++..+.+||.+|
T Consensus 162 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 240 (260)
T cd06606 162 SVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240 (260)
T ss_pred CCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHh
Confidence 5678999999999987765 889999999999999999999998765 2233333332 33456777899999999999
Q ss_pred cccCCCCCCCHHHHHhcccc
Q psy6346 424 LVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWF 443 (1238)
|..||.+||++.+++.||||
T Consensus 241 l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 241 LRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=332.09 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=215.6
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.||.|++|.||++....++..+|+|.+... .....+.+.+|+++++.++|+||+++++++......|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 44557789999999999999889999999998654 3455678899999999999999999999999999999999999
Q ss_pred CCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccccc
Q psy6346 272 NQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWC 349 (1238)
Q Consensus 272 ~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~ 349 (1238)
++++|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 99999887754 457899999999999999999999999999999999999999999999999998654322 2233457
Q ss_pred CCCCCCCccccc-----CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC---ccCCCCCCHHHHHHHH
Q psy6346 350 GSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR---FRIPYFMSTECESLIR 421 (1238)
Q Consensus 350 GTp~YmAPEVL~-----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~---~~~P~~iS~eLkDLIr 421 (1238)
|++.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+.... ...|..++.++.+||.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred ccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence 899999999984 2333 679999999999999999999998877665555554332 2345568899999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||..||.+||+++++++||||....
T Consensus 244 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 244 KCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.20 Aligned_cols=251 Identities=32% Similarity=0.487 Sum_probs=224.3
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+|.|++|.||++.+..++..||+|++..........+.+.+|+++++.++|+|++++++.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 56778899999999999999989999999999887766677788999999999999999999999999999999999999
Q ss_pred CCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccc
Q psy6346 272 NQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLA 346 (1238)
Q Consensus 272 ~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~ 346 (1238)
++++|.+++... ..+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK 161 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence 999999998764 679999999999999999999999999999999999999999999999999987654432 333
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~ 425 (1238)
...|++.|+|||.+.+..+ +.++|+||+|+++++|++|..||...+...+...+.... ..+|..++.++.++|.+||.
T Consensus 162 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (258)
T cd08215 162 TVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQ 240 (258)
T ss_pred ceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 4578999999999887776 889999999999999999999998887777766665543 34566788999999999999
Q ss_pred cCCCCCCCHHHHHhcccc
Q psy6346 426 REPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWF 443 (1238)
.+|.+|||+.++++||||
T Consensus 241 ~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 241 KDPEERPSIAQILQSPFI 258 (258)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=330.45 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=211.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....+|.|++|.||++....++..||+|++..... .....+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 457778899999999999999999999999999975432 234568899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~ 348 (1238)
|+.+++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... .....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987653322 23345
Q ss_pred cCCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccC-----CCCCCHHHHHHHH
Q psy6346 349 CGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI-----PYFMSTECESLIR 421 (1238)
Q Consensus 349 ~GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~-----P~~iS~eLkDLIr 421 (1238)
.|++.|+|||.+.. ....+.++|||||||++|+|++|..||...........+....+.. +..++..+.+||+
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHH
Confidence 68899999999853 2223678999999999999999999997654433222222222221 2346789999999
Q ss_pred HhcccCCCCCCCHHHHHhccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPW 442 (1238)
+||..+|++|||+++|++|+|
T Consensus 247 ~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 247 ISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.77 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=216.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....||.|+++.||++....++..||||+++.........+.+.+|+.++++++|+||+++++++.+.+.+++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 66778999999999999998889999999999887655567789999999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-----cc
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-----LA 346 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-----l~ 346 (1238)
++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++........ ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 161 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccccc
Confidence 9999999998877799999999999999999999999999999999999999999999999999876543322 22
Q ss_pred cccCCCCCCCcccccCCc--cCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcC-CccCCCCC--CHHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKK--YCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSG-RFRIPYFM--STECESLI 420 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~--y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g-~~~~P~~i--S~eLkDLI 420 (1238)
...+++.|+|||++.+.. ..+.++|||||||++|+|++|..||..... ......+..+ ...+|... +..+.+||
T Consensus 162 ~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (264)
T cd06626 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFL 241 (264)
T ss_pred CCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHH
Confidence 356888999999998665 237899999999999999999999976532 2222222222 33455544 89999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWF 443 (1238)
.+||..+|.+|||+++++.|||+
T Consensus 242 ~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 242 DRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.81 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=213.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC---hHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD---PVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIY 265 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld---~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~ly 265 (1238)
.|.....+|.|++|.||++....++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 466778999999999999999999999999998765432 2345678899999999999999999999865 46789
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG--- 342 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s--- 342 (1238)
++|||+++++|.+++...+.+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 99999999999999988788999999999999999999999999999999999999999999999999998654321
Q ss_pred -CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHH
Q psy6346 343 -QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESL 419 (1238)
Q Consensus 343 -~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDL 419 (1238)
.......++..|+|||.+.+..+ +.++|||||||++|+|++|+.||...........+... ...+|..+++.+.+|
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 11223458889999999988776 88999999999999999999999876544433333222 344566788999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFk 444 (1238)
| +||..+|++||+++||++||||.
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.49 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=213.6
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.+|.|++|.||++.+..+++.||+|++.+........+.+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 46778899999999999999988899999999876554444456788999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
++++.|.++......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 161 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV 161 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCccc
Confidence 9999998887766679999999999999999999999999999999999999999999999999987654332 233456
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccC--
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRI-- 408 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~-- 408 (1238)
++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+... ....
T Consensus 162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07846 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241 (286)
T ss_pred ceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccc
Confidence 8899999999877555578999999999999999999999876543322222210 0001
Q ss_pred ----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 409 ----------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 409 ----------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
...++..+.+||.+||..+|.+||++.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 12467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=333.18 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=209.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+|.|++|.||++.+..++..||||++............+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 56678899999999999999889999999999766544444567889999999999999999999999999999999999
Q ss_pred CCCccchhhhc--ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccc
Q psy6346 272 NQGEIFDYIAR--YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk--~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~ 348 (1238)
. ++|..++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 6 578888754 3568899999999999999999999999999999999999999999999999987543322 22334
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC------------------Cc----
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------RF---- 406 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------~~---- 406 (1238)
.+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+......++... ..
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence 57889999999887665588999999999999999999999876644332222110 00
Q ss_pred -------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 407 -------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 407 -------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.+...+++++.+||.+||..||.+|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0122467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.48 Aligned_cols=259 Identities=25% Similarity=0.434 Sum_probs=220.7
Q ss_pred cCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE
Q psy6346 184 HAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 184 gsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ 263 (1238)
..|.....|.....+|.|++|.||++++..++..||||.+...... ..+.+.+|+.+++.++|+||+++++.+.....
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence 3455556788889999999999999999889999999999875433 34678899999999999999999999999999
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred EEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999999998864 468899999999999999999999999999999999999999999999999987543322
Q ss_pred -ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh-cC--CccCCCCCCHHHHHH
Q psy6346 344 -KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL-SG--RFRIPYFMSTECESL 419 (1238)
Q Consensus 344 -~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl-~g--~~~~P~~iS~eLkDL 419 (1238)
......|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+. .+ ....+..++..+.+|
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred cccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 2234578999999999987766 789999999999999999999998776543322222 22 122355688899999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|.+||..+|++|||+.+++.|+||...
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.37 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=213.2
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC---ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIY 265 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l---d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~ly 265 (1238)
.|.....+|.|++|.||.+....++..||||++..... .....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 46778899999999999999999999999999865432 23456788999999999999999999999866 35788
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG--- 342 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s--- 342 (1238)
+||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence 99999999999999988788899999999999999999999999999999999999999999999999998754321
Q ss_pred -CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHH
Q psy6346 343 -QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESL 419 (1238)
Q Consensus 343 -~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDL 419 (1238)
.......|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...........+... ....|..++..+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241 (265)
T ss_pred ccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 12233568899999999987765 88999999999999999999999876544433333322 233566678889999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFk 444 (1238)
|.+|+. +|++||++++++.|||+.
T Consensus 242 i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 242 LKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.11 Aligned_cols=255 Identities=30% Similarity=0.492 Sum_probs=221.4
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....+|.|++|.||++....+++.||||.+...... ....+.+.+|+++++.++||||+++++.+..++.+|+|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 366778899999999999999999999999998766432 3345688899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-------
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG------- 342 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s------- 342 (1238)
|++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999987632100
Q ss_pred ---------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC---
Q psy6346 343 ---------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY--- 410 (1238)
Q Consensus 343 ---------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~--- 410 (1238)
.......|+..|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..++...+..+....|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (305)
T cd05609 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240 (305)
T ss_pred cccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence 01112457889999999887766 89999999999999999999999998888888777766544333
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC---HHHHHhccccccc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYC---IEQIKRHRWMAEE 446 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPT---aeEILeHPWFke~ 446 (1238)
.++.++.+||.+||..||++||+ +.++++||||...
T Consensus 241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 47889999999999999999998 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.66 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=213.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIYI 266 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~lyL 266 (1238)
...|.....||.|++|.||++.+..+|..||+|++............+.+|+.++++++|+||+++++++... +.+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3568888999999999999999999999999999976543333334567899999999999999999998754 56899
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-c
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-K 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~ 344 (1238)
||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....... .
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 9999974 787777653 678999999999999999999999999999999999999999999999999987654332 2
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------C
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------R 405 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~ 405 (1238)
.....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 233346788999999877555588999999999999999999999988776655544431 1
Q ss_pred ccCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 406 FRIP-----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 406 ~~~P-----------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+.++ ...++++.+||.+||..||++|||+++++.||||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 1111 12578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=334.71 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=214.4
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC---hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD---PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld---~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
|.....||.|++|.||++....++..||||++...... ......+..|++++++++|+||+++++++.+....|+||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 55567899999999999999889999999999876543 333456788999999999999999999999999999999
Q ss_pred eecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccc
Q psy6346 269 EYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~ 346 (1238)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... ....
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence 999 899999998766 7999999999999999999999999999999999999999999999999998765433 2233
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc--------------------
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-------------------- 406 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-------------------- 406 (1238)
...+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+......++.....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T cd07841 161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK 240 (298)
T ss_pred ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence 345788899999987655558899999999999999999988887765444444321100
Q ss_pred --------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 407 --------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 407 --------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
......+.++.+||.+||.+||++|||+.|++.|+||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 01123467899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.21 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=221.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.+|.|++|.||++.+..++..||||++...... .....+.+|+.++.+++|+||+++++++......++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 356678999999999999999999999999999876432 4567899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCcc-ccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL-ATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l-~t~ 348 (1238)
+++++|.+++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 9999999999888889999999999999999999999 99999999999999999999999999998765443322 255
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC---ChhHHHHHHhcC-CccCCCC-CCHHHHHHHHHh
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS---TLNSLRDRVLSG-RFRIPYF-MSTECESLIRKM 423 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~---d~eeL~ekIl~g-~~~~P~~-iS~eLkDLIrkM 423 (1238)
.++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ........+... ...++.. ++..+.++|.+|
T Consensus 161 ~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 161 VGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 78899999999987765 88999999999999999999999776 344444444443 2334555 789999999999
Q ss_pred cccCCCCCCCHHHHHhccccccc
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~ 446 (1238)
|..+|++||++.++++||||+..
T Consensus 240 l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 240 LQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.45 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=210.0
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCChHh-HHHHHHHH---HHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVN-LQKVYREV---EIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~-ikrf~rEI---eILkkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
||.|++|.||++....+++.||||++.+....... ...+..|. .+++..+||+|+.+++++...+..|+||||+.|
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 68999999999998889999999999876443211 12233443 345556899999999999999999999999999
Q ss_pred CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCC
Q psy6346 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353 (1238)
Q Consensus 274 GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~ 353 (1238)
++|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...... .....+|+..
T Consensus 82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~ 160 (278)
T cd05606 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHG 160 (278)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCcC
Confidence 999999988888999999999999999999999999999999999999999999999999998754332 2334579999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC---ChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS---TLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~---d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
|+|||++.+...++.++||||+||++|+|++|..||.+. ........+......+|..++.++.++|.+||..+|.+
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~ 240 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 240 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHh
Confidence 999999975543488999999999999999999999876 33444444545556677778999999999999999999
Q ss_pred CC-----CHHHHHhcccccccC
Q psy6346 431 RY-----CIEQIKRHRWMAEET 447 (1238)
Q Consensus 431 RP-----TaeEILeHPWFke~~ 447 (1238)
|| +++++++||||.+..
T Consensus 241 R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 241 RLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred ccCCCCCCHHHHHhCccccCCC
Confidence 99 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=328.89 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=208.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee------CC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET------KS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed------~d 262 (1238)
..|.....+|.|++|.||++....+++.||||++.... .....+.+|+.+++++ +|+||+++++++.. ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 34556677899999999999998999999999997653 2335788999999998 79999999999864 35
Q ss_pred EEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
.+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 689999999999999998764 358899999999999999999999999999999999999999999999999987543
Q ss_pred CC-CccccccCCCCCCCcccccCC----ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc--cCCCCCC
Q psy6346 341 PG-QKLATWCGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF--RIPYFMS 413 (1238)
Q Consensus 341 ~s-~~l~t~~GTp~YmAPEVL~gk----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~--~~P~~iS 413 (1238)
.. .......|++.|+|||++.+. ..++.++|||||||++|+|++|..||...........+..... ..+..++
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 242 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence 22 233456799999999998632 1237899999999999999999999976655444433333221 1233478
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.++.+||.+||..+|.+|||+.++++||||
T Consensus 243 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=325.19 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=214.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....+|.|++|.||++....++..||+|.+.... ..+.+.+|++++++++|+||+++++++.+....|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 34666778999999999999988889999999987542 26789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccc
Q psy6346 270 YANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t 347 (1238)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 9999999999875 4568999999999999999999999999999999999999999999999999987654433 2334
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHHHHHHHhc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLkDLIrkML 424 (1238)
..|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...........+... ....+..++.++.++|.+||
T Consensus 159 ~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred ccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence 558899999999988776 88999999999999999999999876654433333222 22334457889999999999
Q ss_pred ccCCCCCCCHHHHHhcccc
Q psy6346 425 VREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 425 ~kDPskRPTaeEILeHPWF 443 (1238)
..||++|||+.|++.||||
T Consensus 238 ~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 238 VKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hcChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.44 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=222.8
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.|.....|.....+|.|++|.||++++..++..||||.+..... ...+.+.+|+.+++.++||||+++++++...+.+
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 34445678888999999999999999999999999999976543 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
|+|+||+.+++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999999999998865 468999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECESLI 420 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLkDLI 420 (1238)
......|+..|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+.......+... ....+..+++.+.+||
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred cCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 2234578899999999987776 78999999999999999999999887665443333322 2234566889999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
++||..||.+||++.+++.||||....+
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 9999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=352.89 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=205.9
Q ss_pred cEEEEEEEecCCCCccccCceEc--cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL--RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l--ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|++|.||++... ..+..||||++.... ...+|+++|++++||||+++++++.....+|+|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 45788888999999999988654 356889999986542 345899999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---c
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---K 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---~ 344 (1238)
||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 99996 6888888777889999999999999999999999999999999999999999999999999987654332 2
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH---HHHHHhc------------------
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS---LRDRVLS------------------ 403 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee---L~ekIl~------------------ 403 (1238)
.....||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+..... ....+..
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 234679999999999988877 889999999999999999999997654211 1111100
Q ss_pred -----------CCccCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 404 -----------GRFRIP-----YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 404 -----------g~~~~P-----~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
..+.+| ..++.++.+||++||..||.+|||+.|+|.||||.+..+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 001111 124678899999999999999999999999999987543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.79 Aligned_cols=252 Identities=24% Similarity=0.438 Sum_probs=216.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.||.|++|.||++.+..++..||+|++..... ....+++.+|++++++++||||+++++++.....+++|+||+
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4455778999999999999988999999999987643 355678899999999999999999999999999999999999
Q ss_pred CCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 272 NQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 272 ~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++........ ....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 160 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KTFV 160 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hccc
Confidence 999999999876 788999999999999999999999 9999999999999999999999999999865533222 2267
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-----ChhHHHHHHhcC-CccCCCC-CCHHHHHHHHH
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-----TLNSLRDRVLSG-RFRIPYF-MSTECESLIRK 422 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-----d~eeL~ekIl~g-~~~~P~~-iS~eLkDLIrk 422 (1238)
++..|+|||.+.+..+ +.++|||||||++|+|++|..||... ......+.+... ...++.. ++.++.+||.+
T Consensus 161 ~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (265)
T cd06605 161 GTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNL 239 (265)
T ss_pred CChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHH
Confidence 8899999999988766 89999999999999999999999654 223333444333 2234444 78899999999
Q ss_pred hcccCCCCCCCHHHHHhccccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||..||++|||+.+++.||||+.-
T Consensus 240 ~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 240 CLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=336.42 Aligned_cols=243 Identities=24% Similarity=0.407 Sum_probs=191.4
Q ss_pred EEecCCCCccccCceEcc--CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--eCCEEEEEEeec
Q psy6346 196 EKCGVKSRSCNRPPVLLR--HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIYIVSEYA 271 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lk--tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--d~d~lyLVMEy~ 271 (1238)
.+||.|+||.||++.... ++..||+|.+..... ...+.+|+++|++++||||+++++++. ....+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999998653 568999999876532 235778999999999999999999884 456789999999
Q ss_pred CCCccchhhhcc---------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc----cCCCcEEEEecCCccc
Q psy6346 272 NQGEIFDYIARY---------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDIKLADFGFSNY 338 (1238)
Q Consensus 272 ~GGSL~d~Lkk~---------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL----d~nG~VKLiDFGLS~~ 338 (1238)
. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7 4677766421 247888999999999999999999999999999999999 4567899999999976
Q ss_pred ccCCC----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH---------HHHHHhc--
Q psy6346 339 YVPGQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS---------LRDRVLS-- 403 (1238)
Q Consensus 339 ~~~s~----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee---------L~ekIl~-- 403 (1238)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||....... ....+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 53322 22345789999999999876655899999999999999999999996533210 0000000
Q ss_pred --------------------------CCc----------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 404 --------------------------GRF----------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 404 --------------------------g~~----------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
... ......+..+.+||.+||..||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235668899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.60 Aligned_cols=242 Identities=25% Similarity=0.433 Sum_probs=214.1
Q ss_pred EecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 197 KCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
.||.|++|.||++..... +..||||++....... ..+.+.+|+++++.++|+||+++++++.....+++||||+++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 578899999999988866 8999999998765333 568899999999999999999999999999999999999999
Q ss_pred Cccchhhhcc---------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 274 GEIFDYIARY---------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 274 GSL~d~Lkk~---------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999875 779999999999999999999999999999999999999999999999999997664432
Q ss_pred --ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHH
Q psy6346 344 --KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESL 419 (1238)
Q Consensus 344 --~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDL 419 (1238)
......++..|+|||.+....+ +.++|||||||++|+|++ |..||.+.....+.+.+..+ ....|..++.++.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL 239 (262)
T ss_pred cccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence 2334567889999999987765 899999999999999998 69999998888887777754 345677789999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..+|.+||+++|++++
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.29 Aligned_cols=254 Identities=23% Similarity=0.416 Sum_probs=215.5
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....||.|++|.||++.+..++..||+|.+... .+......+.+|+.++++++|+||+++++++...+.+|+||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 55667899999999999999889999999998754 34455678999999999999999999999999999999999999
Q ss_pred CCCccchhhhcc---cccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 272 NQGEIFDYIARY---GRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 272 ~GGSL~d~Lkk~---~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
++++|..++... ..+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++..... .....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~ 160 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLAKT 160 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC-Ccccc
Confidence 999999888763 378999999999999999999996 5999999999999999999999999999875432 22334
Q ss_pred ccCCCCCCCcccccCCc-----cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHH---HhcC-CccCCCCCCHHHHH
Q psy6346 348 WCGSPPYAAPEVFEGKK-----YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR---VLSG-RFRIPYFMSTECES 418 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~-----y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ek---Il~g-~~~~P~~iS~eLkD 418 (1238)
..|++.|+|||++.+.. .++.++|||||||++|+|++|..||........... +..+ ...+|..++.++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQD 240 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHH
Confidence 56888999999985432 237789999999999999999999977655443332 2222 34456668999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
||.+||..+|++||++++++.||||....
T Consensus 241 li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 241 FVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.92 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=206.5
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCChH-hHHHHHHHHHHHHh---CCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV-NLQKVYREVEIMKQ---LDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e-~ikrf~rEIeILkk---L~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
||.|+||.||++....++..||||++.+...... ......+|..+++. .+||||+.+++++...+..|+||||+.+
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 7899999999999988999999999987654322 22334455544444 4799999999999999999999999999
Q ss_pred CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCC
Q psy6346 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353 (1238)
Q Consensus 274 GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~ 353 (1238)
++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... ......|++.
T Consensus 82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~ 160 (279)
T cd05633 82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHG 160 (279)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCCcC
Confidence 999999988888999999999999999999999999999999999999999999999999998654332 2234579999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC---hhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d---~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
|+|||++.....++.++|||||||++|+|++|..||.... ...+..........+|..++.++.++|.+||..||.+
T Consensus 161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 240 (279)
T cd05633 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSK 240 (279)
T ss_pred ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHH
Confidence 9999998754434889999999999999999999997543 2233333333445567778999999999999999999
Q ss_pred CC-----CHHHHHhccccccc
Q psy6346 431 RY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 431 RP-----TaeEILeHPWFke~ 446 (1238)
|+ +++++++||||+..
T Consensus 241 R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 241 RLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred hcCCCCCCHHHHHhCccccCC
Confidence 99 69999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.63 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=211.6
Q ss_pred EEEEEEecCCCCccccCceEccCC-----cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHT-----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG-----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
|...+.||.|++|.||++.....+ ..||+|.+.... .......+.+|+.++.+++||||+++++++...+..|+
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 555677888888888888766444 689999987553 34455778999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEE
Q psy6346 267 VSEYANQGEIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKL 330 (1238)
+|||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEE
Confidence 99999999999998764 45778889999999999999999999999999999999999999999
Q ss_pred EecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-
Q psy6346 331 ADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR- 405 (1238)
Q Consensus 331 iDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~- 405 (1238)
+|||++....... ......+++.|+|||.+.+..+ +.++|||||||++|||++ |..||.+....++...+..+.
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999987543322 1233456888999999987776 889999999999999998 999999988888888777654
Q ss_pred ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 406 FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 406 ~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
...|..++.++.+|+.+||..||.+||++.+|+++
T Consensus 245 ~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 245 LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.13 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=211.4
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIYIVS 268 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~lyLVM 268 (1238)
.|.....||.|++|.||++.+..++..||||.++...........+.+|+.++++++||||+++++++... ...|+||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 46667889999999999999988999999999987654444445678899999999999999999999877 8999999
Q ss_pred eecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccc
Q psy6346 269 EYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~ 346 (1238)
||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++...... ....
T Consensus 86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 164 (293)
T cd07843 86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164 (293)
T ss_pred hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccc
Confidence 9997 4888888654 35899999999999999999999999999999999999999999999999998765443 2334
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC----------------------
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---------------------- 404 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---------------------- 404 (1238)
...+++.|+|||.+.+....+.++|||||||++|+|++|..||..........++...
T Consensus 165 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (293)
T cd07843 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244 (293)
T ss_pred cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccc
Confidence 4567889999999877655578999999999999999999999877655444333210
Q ss_pred ---------CccCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 405 ---------RFRIPYF-MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 405 ---------~~~~P~~-iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
...++.. +++.+.+||.+||..+|++|||+.|++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112333 58889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.50 Aligned_cols=255 Identities=23% Similarity=0.377 Sum_probs=207.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHH-HHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEI-MKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeI-LkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||++.+..+|..||||+++....... ..++..|+.+ ++.++||||+++++++..++..|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36677889999999999999999999999999987643333 3456667765 666799999999999999999999999
Q ss_pred ecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 270 YANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 270 y~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
|++ ++|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 997 677666643 24689999999999999999999997 999999999999999999999999999876544333
Q ss_pred cccccCCCCCCCcccccCC---ccCCCccceehhhHHHHHHhhCCCCCCCCC--hhHHHHHHhcCCccCC-CCCCHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGK---KYCGPEIDIWSLGVVLYVLVCGALPFDGST--LNSLRDRVLSGRFRIP-YFMSTECES 418 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk---~y~S~KSDIWSLGVILYELLTGrlPF~g~d--~eeL~ekIl~g~~~~P-~~iS~eLkD 418 (1238)
.....|+..|+|||++.+. ..++.++|+|||||++|+|++|..||.... ...+...+......+| ..++.++.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 3345688999999988652 223789999999999999999999996532 2333333322233333 347899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
||.+||..+|.+||+++++++||||....
T Consensus 240 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 240 FVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 99999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=342.99 Aligned_cols=253 Identities=23% Similarity=0.432 Sum_probs=211.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------C
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------S 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d 262 (1238)
...|.....||.|++|.||++....++..||||++.+...+....+.+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4568888999999999999999999999999999987655555667888999999999999999999988543 3
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
..|+||||+. ++|.+++... +++..+..++.||+.||+|||..||+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999996 5787777543 889999999999999999999999999999999999999999999999999765444
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC------------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------ 404 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------ 404 (1238)
.......+++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 44445678999999999988877 89999999999999999999999876643333222110
Q ss_pred ----Ccc--------------C-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 405 ----RFR--------------I-------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 405 ----~~~--------------~-------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
... + +...+..+.+||.+||..||.+|||+.|+|.||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000 0 1124567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.55 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=216.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC---CCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD---HPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~---HPNIVrL~dvfed~d~lyLV 267 (1238)
.|.....+|.|++|.||++.+..++..||||++.... .....+.+.+|+.++++++ ||||+++++++..+...|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 3556678999999999999999999999999987653 3345677889999999996 99999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~ 346 (1238)
|||++|++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 999999999998865 478999999999999999999999999999999999999999999999999987654432 234
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCC-CCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYF-MSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~-iS~eLkDLIrkML 424 (1238)
...|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.........+.... ..++.. ++.++.++|.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL 239 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHc
Confidence 45789999999998765545889999999999999999999998876554443333221 223332 7789999999999
Q ss_pred ccCCCCCCCHHHHHhcccccccC
Q psy6346 425 VREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 425 ~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..||++||++.+++.|+||++..
T Consensus 240 ~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 240 DEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999997753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.56 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=222.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+|.|++|.||++....++..||||.+..........+.+.+|++++.+++|+|++++++++.+....++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 56678899999999999999889999999999887765567788999999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-cccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-LATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-l~t~~G 350 (1238)
.+++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........ .....+
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 161 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG 161 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccccc
Confidence 9999999998888899999999999999999999999999999999999999999999999999876544332 234568
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh-cCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL-SGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl-~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
+..|+|||.+.+... +.++|||+||+++|+|++|..||...+.......+. .....++..++..+.++|.+||..+|+
T Consensus 162 ~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 240 (254)
T cd06627 162 TPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPN 240 (254)
T ss_pred chhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChh
Confidence 899999999887764 889999999999999999999998766544333333 334456777899999999999999999
Q ss_pred CCCCHHHHHhcccc
Q psy6346 430 KRYCIEQIKRHRWM 443 (1238)
Q Consensus 430 kRPTaeEILeHPWF 443 (1238)
+|||+.+++.||||
T Consensus 241 ~R~~~~~~l~~~~~ 254 (254)
T cd06627 241 LRPTAKQLLKHPWI 254 (254)
T ss_pred hCcCHHHHhcCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=325.26 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=207.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEee-----eCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVME-----TKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfe-----d~d~ 263 (1238)
..|...+.||.|++|.||++.+..++..||+|++.... .....+.+|+.+++.+ +|+||+++++++. ..+.
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 56888899999999999999999999999999986532 1235678899999999 7999999999873 4567
Q ss_pred EEEEEeecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc
Q psy6346 264 IYIVSEYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY 339 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~ 339 (1238)
.|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++...
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999999988753 346888999999999999999999999999999999999999999999999998765
Q ss_pred cCCC-ccccccCCCCCCCcccccCC----ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCC
Q psy6346 340 VPGQ-KLATWCGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYF 411 (1238)
Q Consensus 340 ~~s~-~l~t~~GTp~YmAPEVL~gk----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~ 411 (1238)
.... ......|++.|+|||++... ..++.++|||||||++|+|++|..||...........+... ....|..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCC
Confidence 4322 23345689999999998532 22378999999999999999999999876544333333222 1223455
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 412 MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 412 iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
++.++.+||.+||..||++|||+.||++|+||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 68899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.34 Aligned_cols=248 Identities=20% Similarity=0.294 Sum_probs=211.6
Q ss_pred cEEEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
..|.....||.|+||.||++.+. ..+..||+|+++... .......+.+|+.++++++||||+++++++...+..|+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 34777888999999999998765 456789999998653 33445678999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l 345 (1238)
||||+++++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++++|||.+.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999999998764 57899999999999999999999999999999999999999999999999987653222211
Q ss_pred --ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHH
Q psy6346 346 --ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIR 421 (1238)
Q Consensus 346 --~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIr 421 (1238)
....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+.+.+..+ ..+.|..++..+.+++.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML 242 (266)
T ss_pred cccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 12335678999999988776 889999999999999775 99999988887777776655 34566778999999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q psy6346 422 KMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 422 kML~kDPskRPTaeEILe 439 (1238)
+||..+|.+||++++|++
T Consensus 243 ~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 243 DCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHcCCCchhCCCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.30 Aligned_cols=247 Identities=31% Similarity=0.469 Sum_probs=211.3
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHH-HhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIM-KQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeIL-kkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
..+|.|++|.||++....++..||||++.+.... ......+..|..++ ..++|+||+++++++...+.+|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 3578999999999999889999999999765432 22334455665554 445899999999999999999999999999
Q ss_pred CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCC
Q psy6346 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353 (1238)
Q Consensus 274 GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~ 353 (1238)
++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|+..
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence 99999998888899999999999999999999999999999999999999999999999998875432 234468899
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccC----CCCCCHHHHHHHHHhcccCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI----PYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~----P~~iS~eLkDLIrkML~kDPs 429 (1238)
|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+....... +..+++++.++|.+||..+|+
T Consensus 159 y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 159 YLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred ccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 999999988774 899999999999999999999999888877777766554332 335789999999999999999
Q ss_pred CCC---CHHHHHhccccccc
Q psy6346 430 KRY---CIEQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRP---TaeEILeHPWFke~ 446 (1238)
+|| +++|++.||||.+.
T Consensus 238 ~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 238 KRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HccCCCcHHHHHcChHhhcC
Confidence 999 55899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=327.31 Aligned_cols=252 Identities=33% Similarity=0.605 Sum_probs=224.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVM 268 (1238)
.|...+.+|.|++|.||++....++..||||++.+... .....+.+.+|+++++++. |+||+++++++...+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 36777889999999999999989999999999987543 3344577889999999998 999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-----
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ----- 343 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~----- 343 (1238)
|++.+++|.+++.+.+.+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccC
Confidence 999999999999988899999999999999999999999999999999999999999999999999987543221
Q ss_pred ----------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc
Q psy6346 344 ----------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR 407 (1238)
Q Consensus 344 ----------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~ 407 (1238)
......|+..|+|||++.+..+ +.++|||||||++++|++|..||...+.......+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05581 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240 (280)
T ss_pred CCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence 1223467889999999887765 88999999999999999999999988776777777777778
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccc
Q psy6346 408 IPYFMSTECESLIRKMLVREPTKRYCI----EQIKRHRWM 443 (1238)
Q Consensus 408 ~P~~iS~eLkDLIrkML~kDPskRPTa----eEILeHPWF 443 (1238)
+|..+++.+.+||.+||..+|.+||++ +++++||||
T Consensus 241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.91 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=200.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....||.|+||.||++....++..||+|+..+. ....|+.+|++++|+||+++++++......|+|||+
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 488889999999999999999889999999986543 234699999999999999999999999999999999
Q ss_pred cCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 271 ANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
+. ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 96 578777754 4678999999999999999999999999999999999999999999999999987544333444567
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCC-CCCCChh----------HHHHHHhc---CCccCC------
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGSTLN----------SLRDRVLS---GRFRIP------ 409 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlP-F~g~d~e----------eL~ekIl~---g~~~~P------ 409 (1238)
||+.|+|||++.+..+ +.++|||||||++|+|+++..+ |...... .+...+.. ....++
T Consensus 218 gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 9999999999988876 8999999999999999985444 4332110 11111110 000011
Q ss_pred ------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 410 ------------------------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 410 ------------------------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
..++.++.+||.+||+.||.+|||++|+|+||||++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667788999999999999999999999999974
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.68 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=210.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC--------hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD--------PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld--------~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ 263 (1238)
|...+.+|.|++|.||++....++..||||.+...... ....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 56678899999999999998889999999998643211 1124578899999999999999999999999999
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG- 342 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s- 342 (1238)
.++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 162 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY 162 (272)
T ss_pred eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccc
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred --CccccccCCCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCC----CCC
Q psy6346 343 --QKLATWCGSPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPY----FMS 413 (1238)
Q Consensus 343 --~~l~t~~GTp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~----~iS 413 (1238)
.......|+..|+|||++.... ..+.++|+||||+++|+|++|..||...........+... ...++. .++
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (272)
T cd06629 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242 (272)
T ss_pred cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCC
Confidence 1123456889999999987654 2478999999999999999999999765543333222221 222232 358
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.++.+||.+||..+|.+||+++++++||||
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 243 PVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.03 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=209.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeC------C
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETK------S 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~------d 262 (1238)
..|.....+|.|++|.||++....++..||+|++.... ...+.+.+|+.+++++ +|+||+++++++... .
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45777889999999999999998889999999987654 2346788999999999 799999999999654 4
Q ss_pred EEEEEEeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 589999999999999988653 4789999999999999999999999999999999999999999999999999875
Q ss_pred ccCC-CccccccCCCCCCCcccccCC----ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---cCCC
Q psy6346 339 YVPG-QKLATWCGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---RIPY 410 (1238)
Q Consensus 339 ~~~s-~~l~t~~GTp~YmAPEVL~gk----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---~~P~ 410 (1238)
.... .......|+..|+|||++... ..++.++|||||||+||+|++|..||...........+..... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE 242 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchh
Confidence 4332 223445689999999997542 2246789999999999999999999987655444444444322 2233
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.++.++.+||.+||..||++|||++++++|||+
T Consensus 243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.78 Aligned_cols=260 Identities=25% Similarity=0.445 Sum_probs=220.3
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.+.....|.....+|.|++|.||+++...++..||||.+...... ..+.+.+|+.+++.++|+||+++++++...+..
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 444456788889999999999999999899999999999765432 346788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999999998864 468889999999999999999999999999999999999999999999999987653332
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc-C--CccCCCCCCHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS-G--RFRIPYFMSTECESLI 420 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~-g--~~~~P~~iS~eLkDLI 420 (1238)
......+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+.......+.. + ....|..++..+.+||
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred CcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 2234578999999999988776 7899999999999999999999987654332222221 1 1224556788999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
.+||..+|++||+++++++||||....+
T Consensus 250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHccCChhhCcCHHHHhcCchhccccc
Confidence 9999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.76 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=217.6
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....+|.|++|.||.+.+..++..||||++..... ....+.+.+|+.++++++|+||+++++++.+....|+||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35555778999999999999888899999999986542 34567899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
++|++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccccc
Confidence 999999998865 578999999999999999999999999999999999999999999999999987654332 223346
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcccCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
++..|+|||++.+... +.++|+|||||++|+|++|..||...+.......+... ...++..++..+.+||.+||..+|
T Consensus 163 ~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 163 GTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred CcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCc
Confidence 8889999999987766 88999999999999999999999887766555544333 233445578899999999999999
Q ss_pred CCCCCHHHHHhccccccc
Q psy6346 429 TKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~ 446 (1238)
++||++++++.|+||...
T Consensus 242 ~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 242 SFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcCHHHHHhChHhhhc
Confidence 999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.23 Aligned_cols=266 Identities=30% Similarity=0.510 Sum_probs=232.3
Q ss_pred eccCCCCCcEEEEE-EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEee
Q psy6346 182 TLHAEKNGQTIRKR-EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVME 259 (1238)
Q Consensus 182 ~LgsGkfGqVYkar-ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfe 259 (1238)
.+..|+|-+.|+.. +.+|+|+++.|-.++.+.+|..||||++.+.. .-...++.+|++++..+ +|+||+.|+++|+
T Consensus 69 ss~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 69 SSLSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred ccccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 34566677777765 57899999999999999999999999998863 33567999999999999 7999999999999
Q ss_pred eCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc---EEEEecCCc
Q psy6346 260 TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFS 336 (1238)
Q Consensus 260 d~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~---VKLiDFGLS 336 (1238)
++..+|||||.|.||+|...|.+.+.|++.++.++++.|+.||+|||.+||.||||||+|||-..... +||+||.+.
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999875433 899999987
Q ss_pred ccccC--------CCccccccCCCCCCCccccc----CCccCCCccceehhhHHHHHHhhCCCCCCCCC-----------
Q psy6346 337 NYYVP--------GQKLATWCGSPPYAAPEVFE----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGST----------- 393 (1238)
Q Consensus 337 ~~~~~--------s~~l~t~~GTp~YmAPEVL~----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d----------- 393 (1238)
.-..- ...+.+.+|+..|||||+.. ...+|+.+.|+||||||||.||+|++||.|.-
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 54321 12355778999999999863 34557899999999999999999999997632
Q ss_pred ----hhHHHHHHhcCCccCCCC----CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy6346 394 ----LNSLRDRVLSGRFRIPYF----MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449 (1238)
Q Consensus 394 ----~eeL~ekIl~g~~~~P~~----iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p~ 449 (1238)
...+++.|.+|.+.||.. ++.+.+|||..+|..|+..|.++.+++.|||+....+.
T Consensus 307 Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred cHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 245788999999999974 89999999999999999999999999999999876543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.16 Aligned_cols=251 Identities=28% Similarity=0.461 Sum_probs=217.1
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||++....+|..||+|.+..........+.+.+|+.++++++|+||+++++++......|+|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 56678899999999999999999999999999876554455678889999999999999999999999999999999999
Q ss_pred CCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCCcccccCCC-cccc
Q psy6346 272 NQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYVPGQ-KLAT 347 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~s~-~l~t 347 (1238)
++++|.+++.+.. .+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||.+....... ....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccc
Confidence 9999999987654 478999999999999999999999999999999999999885 46999999987654332 2233
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHHHHhccc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLIrkML~k 426 (1238)
..|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..... .++..++.++.++|.+||..
T Consensus 162 ~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 240 (257)
T cd08225 162 CVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV 240 (257)
T ss_pred cCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhcc
Confidence 468999999999887765 7899999999999999999999988776666555554432 24455788999999999999
Q ss_pred CCCCCCCHHHHHhcccc
Q psy6346 427 EPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 427 DPskRPTaeEILeHPWF 443 (1238)
+|++|||++++++||||
T Consensus 241 ~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 241 SPRDRPSITSILKRPFL 257 (257)
T ss_pred ChhhCcCHHHHhhCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.64 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=216.5
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||.+....++..||+|.++... .....+.+.+|+.+++.++|+||+++++.+.+.+.+|+||||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 566789999999999999999999999999987653 2345678889999999999999999999999999999999999
Q ss_pred CCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccc
Q psy6346 272 NQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~ 348 (1238)
++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 999999988643 458899999999999999999999999999999999999999999999999987654322 23345
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHHHHhcccC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLIrkML~kD 427 (1238)
.|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. .+|..++..+.+||.+||..|
T Consensus 161 ~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 161 VGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred cCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCC
Confidence 68999999999987775 8899999999999999999999998887777777766644 356778899999999999999
Q ss_pred CCCCCCHHHHHhc
Q psy6346 428 PTKRYCIEQIKRH 440 (1238)
Q Consensus 428 PskRPTaeEILeH 440 (1238)
|++||++.+|+.-
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.53 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=209.2
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
...+.+|.|++|.||++.+..+|..||||++..........+.+.+|++++++++||||+++++++.+.+..|+||||+.
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45678999999999999999999999999998765444445678899999999999999999999999999999999995
Q ss_pred CCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccccc
Q psy6346 273 QGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 273 GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
++|.+++.... .+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++....... ......
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 160 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV 160 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence 68999887765 78999999999999999999999999999999999999999999999999987543222 223345
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------------
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------------- 404 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------------- 404 (1238)
++..|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd07835 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW 240 (283)
T ss_pred cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccc
Confidence 7889999999876554588999999999999999999999876543322222110
Q ss_pred C----ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 405 R----FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 405 ~----~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
. ......++.++.+||.+||+.||.+|||++|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 00123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=339.13 Aligned_cols=257 Identities=24% Similarity=0.394 Sum_probs=213.6
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC-----CE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK-----SM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~-----d~ 263 (1238)
+..|.....+|.|++|.||++.+..++..||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3457888899999999999999999999999999987544444566788999999999999999999988644 35
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG- 342 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s- 342 (1238)
.|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 899999996 689899888888999999999999999999999999999999999999999999999999998765433
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc-------------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS------------------- 403 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~------------------- 403 (1238)
.......++..|+|||++......+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 2334456889999999987644458999999999999999999999987654322221110
Q ss_pred ----C-----C---ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 404 ----G-----R---FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 404 ----g-----~---~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
. . ......+++++.+||++||..+|.+|||++++++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 0 00123478889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.61 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=205.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC------
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------ 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------ 262 (1238)
-..|.....+|.|++|.||++....++..||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 34588889999999999999999999999999998765433333456678999999999999999999986543
Q ss_pred --EEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc
Q psy6346 263 --MIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY 339 (1238)
Q Consensus 263 --~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~ 339 (1238)
..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 4699999997 4777777554 36899999999999999999999999999999999999999999999999998765
Q ss_pred cCCC-----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC----------
Q psy6346 340 VPGQ-----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---------- 404 (1238)
Q Consensus 340 ~~s~-----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---------- 404 (1238)
.... ......++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+..-
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 3322 1123457888999999877654478999999999999999999999877654333222110
Q ss_pred ---------CccCC-------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 405 ---------RFRIP-------------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 405 ---------~~~~P-------------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
...+| ...+..+.+||.+||..||.+|||++++++||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00011 1135678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=311.74 Aligned_cols=248 Identities=29% Similarity=0.441 Sum_probs=214.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+|.|++|.||++....++..|++|++..... ...+.+.+|++++++++|+||+++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 5566889999999999999988999999999987643 35678999999999999999999999999999999999999
Q ss_pred CCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccC
Q psy6346 272 NQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~G 350 (1238)
++++|.+++... ..+++..+..++.|++.||.+||..|++||||+|+||+++.++.++|+|||++.............+
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 999999998776 6799999999999999999999999999999999999999999999999999877654433445678
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-CccCCCC--CCHHHHHHHHHhcccC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-RFRIPYF--MSTECESLIRKMLVRE 427 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-~~~~P~~--iS~eLkDLIrkML~kD 427 (1238)
+..|++||.+.+..+ +.++||||||+++|+|++|..||...+.......+... ...++.. ++..+.++|.+||..|
T Consensus 160 ~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (253)
T cd05122 160 TPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKN 238 (253)
T ss_pred CCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCC
Confidence 999999999987765 88999999999999999999999877544433333322 2222222 4889999999999999
Q ss_pred CCCCCCHHHHHhccc
Q psy6346 428 PTKRYCIEQIKRHRW 442 (1238)
Q Consensus 428 PskRPTaeEILeHPW 442 (1238)
|++|||+.++++|||
T Consensus 239 p~~R~t~~~~l~~~~ 253 (253)
T cd05122 239 PEKRPTAEQLLKHPF 253 (253)
T ss_pred hhhCCCHHHHhcCCC
Confidence 999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=363.28 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=224.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.+|.|+||.||+++...++...|-|+|... ..+.++.++-||+||..++||+||+|++.|..++.+||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4566678899999999999999989999999999765 46678899999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc-cCCCcccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~-~~s~~l~t 347 (1238)
||.||-+..++-.. ..|++..+..+++|++.||.|||+++|||||||..|||++.+|.++|.|||.+... .......+
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 99999988877654 56999999999999999999999999999999999999999999999999987543 23356778
Q ss_pred ccCCCCCCCccccc-----CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc---CCCCCCHHHHHH
Q psy6346 348 WCGSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR---IPYFMSTECESL 419 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~-----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~---~P~~iS~eLkDL 419 (1238)
++|||+|||||++. ..+| +.++||||||++|.||..+.+|-...+.....-+|.....+ -|...+..+.||
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred ccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 99999999999975 3455 89999999999999999999999888877777666655432 356678899999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|.+||.+||..||++.+||+||||...
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999999999864
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.06 Aligned_cols=241 Identities=23% Similarity=0.375 Sum_probs=208.1
Q ss_pred EecCCCCccccCceE--ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVL--LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~--lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.+|.|+||.||+|.+ ..++..||||+++....+....+.+.+|+.++++++|+||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 478899999998865 3567899999998766556667889999999999999999999998864 4678999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc----cccccC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK----LATWCG 350 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~----l~t~~G 350 (1238)
+|.+++...+.+++..+..++.||+.||+|||++||+||||||.||+++.++.+||+|||++........ .....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 9999998888899999999999999999999999999999999999999999999999999876533321 122334
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcccCC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+..|+|||.+....+ +.++|||||||++|||++ |..||.+....++.+.+..+. ..+|..+++++.+||.+||..||
T Consensus 161 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p 239 (257)
T cd05116 161 PVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239 (257)
T ss_pred CccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence 678999999877665 789999999999999997 999999888777777777653 45677799999999999999999
Q ss_pred CCCCCHHHHHh
Q psy6346 429 TKRYCIEQIKR 439 (1238)
Q Consensus 429 skRPTaeEILe 439 (1238)
++||++++|..
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05116 240 DERPGFAVVEL 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=325.60 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=211.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeC-----C
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETK-----S 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~-----d 262 (1238)
...|.....+|.|++|.||++....+++.||+|++.... .....+.+|+.+++++ +||||+++++++... +
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 356888899999999999999999999999999987543 2235677899999999 899999999998643 4
Q ss_pred EEEEEEeecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 263 MIYIVSEYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 68999999999999998753 35689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC-ccccccCCCCCCCcccccCCc----cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC---ccCCC
Q psy6346 339 YVPGQ-KLATWCGSPPYAAPEVFEGKK----YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR---FRIPY 410 (1238)
Q Consensus 339 ~~~s~-~l~t~~GTp~YmAPEVL~gk~----y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~---~~~P~ 410 (1238)
..... ......|+..|+|||++.... ..+.++|||||||++|+|++|+.||...........+.... ...+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 44322 223456889999999986432 13789999999999999999999998776554444444332 22344
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFk 444 (1238)
..+..+.+||.+||..+|++||++.+|+.||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 5678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.19 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=213.9
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee----eCCEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME----TKSMI 264 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe----d~d~l 264 (1238)
+..|.....||.|++|.||++....++..||+|++..........+.+.+|+.+|++++||||+++++++. ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46688888999999999999999999999999999876544445678889999999999999999999875 34578
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 6899998877889999999999999999999999999999999999999999999999999986543221
Q ss_pred ----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc----------------
Q psy6346 344 ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS---------------- 403 (1238)
Q Consensus 344 ----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~---------------- 403 (1238)
......|+..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 123457899999999987654458999999999999999999999987654322211111
Q ss_pred ----------CCccC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 404 ----------GRFRI-----PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 404 ----------g~~~~-----P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..... ....+.++.++|.+||..+|.+||++++++.||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00001 123688999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.29 Aligned_cols=245 Identities=35% Similarity=0.607 Sum_probs=221.6
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
+|.|++|.||.+....++..||+|++.+.... ....+.+.+|+.++++++|+||+++++.++.+...|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 57899999999998888999999999876543 33567899999999999999999999999999999999999999999
Q ss_pred chhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-CccccccCCCCCC
Q psy6346 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWCGSPPYA 355 (1238)
Q Consensus 277 ~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~GTp~Ym 355 (1238)
.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 999988888999999999999999999999999999999999999999999999999998765443 2334556889999
Q ss_pred CcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCH-
Q psy6346 356 APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCI- 434 (1238)
Q Consensus 356 APEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTa- 434 (1238)
+||.+.+... +.++|+|+||+++|+|++|..||...+.......+......+|..++..+.++|++||..||++||++
T Consensus 161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 9999987765 78999999999999999999999888877778888888888888899999999999999999999999
Q ss_pred --HHHHhcccc
Q psy6346 435 --EQIKRHRWM 443 (1238)
Q Consensus 435 --eEILeHPWF 443 (1238)
+++++||||
T Consensus 240 ~~~~l~~~~~f 250 (250)
T cd05123 240 GAEEIKAHPFF 250 (250)
T ss_pred cHHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.18 Aligned_cols=250 Identities=25% Similarity=0.422 Sum_probs=209.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||++.+..+|..||||++..... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 6677899999999999999988999999999986542 233466788999999999999999999999999999999999
Q ss_pred CCCccchhhhcc---cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccc
Q psy6346 272 NQGEIFDYIARY---GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLAT 347 (1238)
Q Consensus 272 ~GGSL~d~Lkk~---~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t 347 (1238)
.+ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 85 788877654 358999999999999999999999999999999999999999999999999987543321 2234
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC------------------ccC-
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR------------------FRI- 408 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~------------------~~~- 408 (1238)
..++..|++||++.+...++.++|||+|||++|+|++|..||.+.+..+....+.... ..+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 5678899999998776555889999999999999999999998877655444332110 001
Q ss_pred ----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 409 ----------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 409 ----------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
...++.++.++|.+||+.||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 12357789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.61 Aligned_cols=250 Identities=29% Similarity=0.467 Sum_probs=222.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||++....++..+|||++...........++.+|+.+++.++|+||+++++++.+....|+||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 56678899999999999999889999999999877666666778899999999999999999999999999999999999
Q ss_pred CCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 272 NQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 272 ~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
++++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... ....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~ 160 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKT 160 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cccc
Confidence 99999998866 356889999999999999999999999999999999999999999999999998765443 3334
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHHHHhccc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLIrkML~k 426 (1238)
..+++.|++||.+.+..+ +.++|+||||+++|+|++|+.||...+...+...+..+.+ .++..++.++.++|.+||..
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQV 239 (256)
T ss_pred ccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCC
Confidence 568899999999988776 7899999999999999999999999888777777766654 34556889999999999999
Q ss_pred CCCCCCCHHHHHhcccc
Q psy6346 427 EPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 427 DPskRPTaeEILeHPWF 443 (1238)
+|++||++.+++.||++
T Consensus 240 ~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 240 KPKLRPNCDKILASPAV 256 (256)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.47 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=207.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCE-----E
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSM-----I 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~-----l 264 (1238)
.|.....+|.|++|.||++.+..++..||||++............+.+|+.+++++. |+||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 467788999999999999999999999999998776443334467889999999995 6999999999877665 8
Q ss_pred EEEEeecCCCccchhhhcc-----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCccc
Q psy6346 265 YIVSEYANQGEIFDYIARY-----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNY 338 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~ 338 (1238)
|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999999985 788877542 35799999999999999999999999999999999999998 89999999999875
Q ss_pred ccCC-CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC------------
Q psy6346 339 YVPG-QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR------------ 405 (1238)
Q Consensus 339 ~~~s-~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~------------ 405 (1238)
+... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 4322 222334678899999998765545889999999999999999999998766544332222100
Q ss_pred -----ccC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy6346 406 -----FRI-----------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 406 -----~~~-----------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFk 444 (1238)
..+ ...++.++.+||.+||..||.+||+++|++.||||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 123688899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=329.78 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=197.8
Q ss_pred EEEEEEecCCCCccccCceEc----------------cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL----------------RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLF 255 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l----------------ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~ 255 (1238)
|.....||.|+||.||++.+. .++..||||++.... .......+.+|+.+|.+++||||++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 455566777777777776542 234579999997653 344567899999999999999999999
Q ss_pred EEeeeCCEEEEEEeecCCCccchhhhccc-------------------ccchhHHHHHHHHHHHHHhHhhccceeeccCC
Q psy6346 256 QVMETKSMIYIVSEYANQGEIFDYIARYG-------------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLK 316 (1238)
Q Consensus 256 dvfed~d~lyLVMEy~~GGSL~d~Lkk~~-------------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLK 316 (1238)
+++.+.+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+|||||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlk 165 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcc
Confidence 99999999999999999999999886432 35667889999999999999999999999999
Q ss_pred cccccccCCCcEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh--CCCCCCC
Q psy6346 317 AENLLMDSNLDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC--GALPFDG 391 (1238)
Q Consensus 317 PeNILLd~nG~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT--GrlPF~g 391 (1238)
|+|||++.++.+||+|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ +..||.+
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 9999999999999999999876533321 223446788999999987776 899999999999999986 6788887
Q ss_pred CChhHHHHHHhc----C----CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 392 STLNSLRDRVLS----G----RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 392 ~d~eeL~ekIl~----g----~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.+.......+.. . ....|..++..+.+||.+||..||++|||+++|..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 245 LTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 665554433321 1 12234567899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=319.62 Aligned_cols=241 Identities=24% Similarity=0.398 Sum_probs=205.5
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
.||.|++|.||++.+..++..||+|++.... .......+.+|++++++++||||+++++++......|+||||+.+++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 5799999999999998899999999986543 445567899999999999999999999999999999999999999999
Q ss_pred chhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc---cccCCC
Q psy6346 277 FDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA---TWCGSP 352 (1238)
Q Consensus 277 ~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~---t~~GTp 352 (1238)
.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......... ...++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 9998754 458999999999999999999999999999999999999999999999999987543221111 112245
Q ss_pred CCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 353 ~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+... ....+..++..+.+|+.+||..+|++
T Consensus 161 ~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 161 KWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred eecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence 6999999987776 889999999999999997 99999877766665555443 34556678899999999999999999
Q ss_pred CCCHHHHHh
Q psy6346 431 RYCIEQIKR 439 (1238)
Q Consensus 431 RPTaeEILe 439 (1238)
|||+.++++
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=323.98 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=210.4
Q ss_pred EEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
|...+.+|.|++|.||++.... ++..||||++.... .....+.+.+|+++|++++|+||+++++++......|+
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 5556778899999999887653 35789999997654 33345789999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc--------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEe
Q psy6346 267 VSEYANQGEIFDYIARY--------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~--------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiD 332 (1238)
||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECC
Confidence 99999999999998654 2478889999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCcc-
Q psy6346 333 FGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRFR- 407 (1238)
Q Consensus 333 FGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~~- 407 (1238)
||++....... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.....+.+..+...
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99987543221 1123346788999999988876 889999999999999998 99999888888887777766543
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 408 IPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 408 ~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.+..++..+.+||.+||..||++||+++|+++
T Consensus 245 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 245 RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 45568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.94 Aligned_cols=253 Identities=22% Similarity=0.400 Sum_probs=214.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|+..+.||.|++|.||++....++..||+|++.... .....+.+.+|+++++.++||||+++++++.....+|+||||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 3555678999999999999999999999999987653 334567899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
+++++|.+++.+.+.+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++...... .....+
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~ 163 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFV 163 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccc
Confidence 9999999999888889999999999999999999997 69999999999999999999999999998654222 223457
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh-----------HHHHHHhcC-CccCCCC-CCHHH
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-----------SLRDRVLSG-RFRIPYF-MSTEC 416 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-----------eL~ekIl~g-~~~~P~~-iS~eL 416 (1238)
|+..|+|||++.+..+ +.++|||||||++|+|++|..||...... +....+... ...++.. ++.++
T Consensus 164 ~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd06620 164 GTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242 (284)
T ss_pred cCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHH
Confidence 8999999999987765 88999999999999999999999865431 222233322 2233333 77889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+||.+||..||.+|||++|+++|+||.+.
T Consensus 243 ~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 243 RDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=319.54 Aligned_cols=246 Identities=21% Similarity=0.353 Sum_probs=209.0
Q ss_pred EEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE------E
Q psy6346 194 KREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM------I 264 (1238)
Q Consensus 194 arekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~------l 264 (1238)
....+|.|+||.||.+....+ +..||||++............+.+|+.+++.++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 456789999999999887654 4789999998766666667889999999999999999999998865443 7
Q ss_pred EEEEeecCCCccchhhhcc------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 265 YIVSEYANQGEIFDYIARY------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
++||||+++++|..++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++..
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 162 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceee
Confidence 9999999999999888432 3588999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCcc---ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCC
Q psy6346 339 YVPGQKL---ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMS 413 (1238)
Q Consensus 339 ~~~s~~l---~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS 413 (1238)
....... ....++..|+|||++.+..+ +.++|||||||++|||++ |..||.+....++.+.+..+ ....|..++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (273)
T cd05035 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCL 241 (273)
T ss_pred ccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCC
Confidence 5433211 12235678999999877766 899999999999999999 99999888877777776655 345677789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.++.++|.+||..||++||++.+++++
T Consensus 242 ~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 242 DELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=325.09 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=207.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEee------eCC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVME------TKS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfe------d~d 262 (1238)
..|.....+|.|+||.||++.+..++..||+|++.... .....+..|+.+++++ +|+||+++++++. ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 45677788999999999999999999999999987642 3446788999999998 7999999999984 356
Q ss_pred EEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 799999999999999988653 357888899999999999999999999999999999999999999999999987543
Q ss_pred CC-CccccccCCCCCCCcccccC-----CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-c-CCCCC
Q psy6346 341 PG-QKLATWCGSPPYAAPEVFEG-----KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-R-IPYFM 412 (1238)
Q Consensus 341 ~s-~~l~t~~GTp~YmAPEVL~g-----k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~-~P~~i 412 (1238)
.. .......|++.|+|||++.. ..+ +.++|||||||++|+|++|..||...........+..... . .+..+
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW 251 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccccc
Confidence 22 22345678999999999863 233 7789999999999999999999976554333332222211 1 22347
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
+.++.+||.+||..||.+|||+.||++||||
T Consensus 252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.43 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=203.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|++|.||++....++..||||++..... ......+.+|+.+++.++|+||+++++++.+.+..|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 568888999999999999999999999999999976542 2223466789999999999999999999999999999999
Q ss_pred ecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccc
Q psy6346 270 YANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t 347 (1238)
|+. ++|.+++.. ...+.+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...... .....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 996 566666543 356788889999999999999999999999999999999999999999999998653222 22334
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhcC---------------------C
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLSG---------------------R 405 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~g---------------------~ 405 (1238)
..+++.|+|||++.+....+.++|||||||++|+|++|..||.+.... +....+... .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 567899999999876544478899999999999999999999765431 111111100 0
Q ss_pred cc--CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 406 FR--IP---------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 406 ~~--~P---------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.. .+ ...+.++.+||.+||..||.+|||++|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 00 0125678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.34 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=213.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....+|.|++|.||++.+.+.+..||+|++.... ...+.+.+|+++++.++|+||+++++++...+.+++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 4667788999999999999999999999999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--c
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--A 346 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--~ 346 (1238)
+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... .
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9999999998654 35888899999999999999999999999999999999999999999999998765433211 1
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
...++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..++.++.+||.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 242 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACW 242 (263)
T ss_pred CCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 1234567999999987776 789999999999999998 99999998887777777654 44566778999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy6346 425 VREPTKRYCIEQIKRH 440 (1238)
Q Consensus 425 ~kDPskRPTaeEILeH 440 (1238)
..||++||++.++++.
T Consensus 243 ~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 243 QWNPSDRPSFAEIHQA 258 (263)
T ss_pred cCCcccCCCHHHHHHH
Confidence 9999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.41 Aligned_cols=247 Identities=25% Similarity=0.362 Sum_probs=207.1
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
...+|.|++|.||++.+..++..||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 357899999999999998899999999987653 345578899999999999999999999999999999999999999
Q ss_pred ccchhhhcc-ccc--chhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCcccccCCC-cccccc
Q psy6346 275 EIFDYIARY-GRM--NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 275 SL~d~Lkk~-~~L--sesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
+|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++....... ......
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 170 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence 999998754 445 78888999999999999999999999999999999976 6789999999987553322 223346
Q ss_pred CCCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCChhH--HHH-HHhcCCccCCCCCCHHHHHHHHHhcc
Q psy6346 350 GSPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS--LRD-RVLSGRFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee--L~e-kIl~g~~~~P~~iS~eLkDLIrkML~ 425 (1238)
|++.|+|||++.+.. .++.++|||||||++|+|++|..||....... ... ........+|..+++++.+|+.+||.
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 250 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFE 250 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcC
Confidence 889999999986543 24789999999999999999999997543221 111 11222344677789999999999999
Q ss_pred cCCCCCCCHHHHHhcccc
Q psy6346 426 REPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWF 443 (1238)
.+|.+|||+.+++.||||
T Consensus 251 ~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 251 PDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCchhCCCHHHHHhCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=325.54 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=204.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.+|.|++|.||++....++..||||.+...... .....+.+|+++++.++|+||+++++++.+.+..|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 5688889999999999999999889999999998765322 222456789999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t 347 (1238)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .....
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 9985 898888654 46899999999999999999999999999999999999999999999999998653221 12223
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC-hhHHHHHHhcC-------------------Ccc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST-LNSLRDRVLSG-------------------RFR 407 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d-~eeL~ekIl~g-------------------~~~ 407 (1238)
..++..|+|||++.+...++.++|||||||++|+|++|..||.+.. ..+....+... ...
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 3578899999998765544889999999999999999999997654 22221111100 000
Q ss_pred C-----------CCCCC--HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 408 I-----------PYFMS--TECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 408 ~-----------P~~iS--~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
+ ...++ .++.++|.+||..+|.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 01233 788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=326.67 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=209.5
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....||.|++|.||++.+..+++.||||++..........+.+.+|++++++++|+||+++++++.+....|+||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 47778899999999999999988999999999977654444456788999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccc--cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCcccccCC-Cccc
Q psy6346 271 ANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYVPG-QKLA 346 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~~s-~~l~ 346 (1238)
+. ++|.+++..... +++..+..++.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++...... ....
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (294)
T PLN00009 83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (294)
T ss_pred cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence 96 578777755433 577888899999999999999999999999999999985 567999999998754322 2223
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC----------------------
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---------------------- 404 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---------------------- 404 (1238)
...+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+...++...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF 241 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence 4467889999999877554588999999999999999999999876554333332110
Q ss_pred -Ccc------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 -RFR------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 -~~~------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
... ....+++++.++|.+||..+|++||+++++++||||.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 000 112467889999999999999999999999999999864
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.18 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=218.5
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....||.|+||.||++.+..++..||||++..... ....+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45566789999999999999888999999999876542 34457889999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
+.+++|.+++.. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 999999998864 468999999999999999999999999999999999999999999999999986553322 223346
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcccCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
|+..|+|||.+.+... +.++|+|||||++|+|++|..||...........+.... ..++..++.++.++|.+||..+|
T Consensus 163 ~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 163 GTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred CCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 8889999999987766 789999999999999999999998776665555554432 23556688999999999999999
Q ss_pred CCCCCHHHHHhccccccc
Q psy6346 429 TKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~ 446 (1238)
.+||++.++++||||.+.
T Consensus 242 ~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 242 SFRPTAKELLKHKFIVRF 259 (277)
T ss_pred hhCcCHHHHHhCHHHhhh
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.60 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=210.4
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~lyLVME 269 (1238)
|.....+|.|++|.||++....++..||+|++............+.+|+.++++++|+||+++++++... +..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 3456789999999999999998999999999987753344456788999999999999999999999888 89999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|+. ++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 997 4888888665 579999999999999999999999999999999999999999999999999987654432 123
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc--------------------
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-------------------- 406 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-------------------- 406 (1238)
...++..|+|||.+.+...++.++|||||||++|+|++|..||...+.......+.....
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 345788899999887654458899999999999999999999988775544443322100
Q ss_pred -----------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 407 -----------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 407 -----------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.+...+++++.++|++||..+|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.03 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=213.0
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.+.||.|++|.||++.+..++..||||++..... ....+.+.+|+.++++++||||+++++++......|+||||++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence 3457889999999998888899999999876542 345678999999999999999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~GTp~ 353 (1238)
+|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|+..
T Consensus 88 ~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 166 (277)
T cd06642 88 SALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166 (277)
T ss_pred cHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCccc
Confidence 99998864 568999999999999999999999999999999999999999999999999987654332 2233468889
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcccCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVREPTKRY 432 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~kDPskRP 432 (1238)
|+|||++.+..+ +.++|||||||++|+|++|..||...........+.... ..++..++.++.+||.+||..+|++||
T Consensus 167 y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 245 (277)
T cd06642 167 WMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245 (277)
T ss_pred ccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCc
Confidence 999999988776 789999999999999999999998766555444443332 234445788999999999999999999
Q ss_pred CHHHHHhccccccc
Q psy6346 433 CIEQIKRHRWMAEE 446 (1238)
Q Consensus 433 TaeEILeHPWFke~ 446 (1238)
++.+++.||||...
T Consensus 246 ~~~~il~~~~~~~~ 259 (277)
T cd06642 246 TAKELLKHKFITRY 259 (277)
T ss_pred CHHHHHHhHHHHHH
Confidence 99999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.60 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=217.5
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....||.|++|.||++....++..||||++.... ....+.+.+|+.+++.++|+||+++++++...+..|+|+||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 444568999999999999988899999999986543 334567889999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~G 350 (1238)
.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ......|
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 177 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG 177 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence 99999999877 678999999999999999999999999999999999999999999999999876543322 2234568
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc---CCCCCCHHHHHHHHHhcccC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR---IPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~---~P~~iS~eLkDLIrkML~kD 427 (1238)
++.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+...... .+..++..+.+||.+||..+
T Consensus 178 ~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 256 (285)
T cd06648 178 TPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRD 256 (285)
T ss_pred CccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccC
Confidence 999999999988776 88999999999999999999999887776666666655322 23337889999999999999
Q ss_pred CCCCCCHHHHHhcccccccC
Q psy6346 428 PTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 428 PskRPTaeEILeHPWFke~~ 447 (1238)
|++||++.++++|+||....
T Consensus 257 p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 257 PAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred hhhCcCHHHHccCcccccCC
Confidence 99999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.77 Aligned_cols=245 Identities=20% Similarity=0.341 Sum_probs=207.6
Q ss_pred EEEecCCCCccccCceEccCCc--EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee------CCEEEE
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTV--NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET------KSMIYI 266 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~--kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed------~d~lyL 266 (1238)
...||.|++|.||++.+..++. .||||.++.........+.+.+|+++++.++|+||+++++++.. ....++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 4678999999999998876664 69999998776566777889999999999999999999998742 234789
Q ss_pred EEeecCCCccchhhhc------ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 267 VSEYANQGEIFDYIAR------YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk------~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 163 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccC
Confidence 9999999999887742 2347899999999999999999999999999999999999999999999999987654
Q ss_pred CCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHH
Q psy6346 341 PGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTE 415 (1238)
Q Consensus 341 ~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~e 415 (1238)
.... .....+++.|++||.+.+..+ +.++|||||||++|+|++ |..||.+.....+.+.+..+. ...+..++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (272)
T cd05075 164 NGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDG 242 (272)
T ss_pred cccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 3321 122346678999999988776 889999999999999999 899999888777777777654 3456678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+.++|.+||..||++|||+++|+++
T Consensus 243 ~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 243 LYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.38 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=216.9
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
..+.|.....||.|++|.||++....++..||||++.... ....+.+.+|+.++++++|+||+++++.+...+..|+|
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 3344555577899999999999888889999999986543 34456789999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~ 346 (1238)
|||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 999999999988754 56899999999999999999999999999999999999999999999999998654322 2233
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHHHHHHHh
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLkDLIrkM 423 (1238)
...|+..|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... .......++..+.++|.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 4578999999999987776 88999999999999999999999887765554444332 2222334788999999999
Q ss_pred cccCCCCCCCHHHHHhcccccccC
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~~ 447 (1238)
|..||.+|||++++++||||....
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccC
Confidence 999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=327.20 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=202.6
Q ss_pred EEEEEEecCCCCccccCceEcc--CCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLR--HTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lk--tG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~lyL 266 (1238)
|.....||.|++|.||++.... ++..||||++..... .....+.+.+|+.++++++||||+++++++.+. ..+|+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 5667889999999999999988 899999999987431 122346678999999999999999999999888 88999
Q ss_pred EEeecCCCccchhhhcc-----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC----CCcEEEEecCCcc
Q psy6346 267 VSEYANQGEIFDYIARY-----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS----NLDIKLADFGFSN 337 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~----nG~VKLiDFGLS~ 337 (1238)
||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++.
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999974 666665422 36889999999999999999999999999999999999999 8999999999987
Q ss_pred cccCCCc----cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH---------HHHHHh--
Q psy6346 338 YYVPGQK----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS---------LRDRVL-- 402 (1238)
Q Consensus 338 ~~~~s~~----l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee---------L~ekIl-- 402 (1238)
....... ....++++.|+|||++.+...++.++|||||||++|+|++|+.||.+..... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6533221 2345688999999998776545889999999999999999999997654322 000000
Q ss_pred ------------------------cCCccCC---------C--CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 403 ------------------------SGRFRIP---------Y--FMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 403 ------------------------~g~~~~P---------~--~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.....++ . ..+.++.++|.+||..||++|||+.|++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000111 1 456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=353.82 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=234.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|....++|+|+||.||-+....+|+.||+|.+.+..+.. ......++|-.||.++..+.||.|-..|++.+.+|+||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45677788999999999999999999999999998876543 23356789999999999999999999999999999999
Q ss_pred eecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 269 EYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
..|.||+|.-+|.+.+ .|++..++.++.+|+.||++||..+||+|||||+|||||+.|+++|+|+|+|..+..++...
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 9999999999998776 79999999999999999999999999999999999999999999999999999998888888
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC----hhHHHHHHhcCCccCCCCCCHHHHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST----LNSLRDRVLSGRFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d----~eeL~ekIl~g~~~~P~~iS~eLkDLIrk 422 (1238)
..+||.+|||||++.+..| +...|.|+|||+||||+.|+.||.... .+++..++......+|...++++++|++.
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~ 423 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEG 423 (591)
T ss_pred cccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHH
Confidence 8899999999999999986 999999999999999999999997543 45677778888888899999999999999
Q ss_pred hcccCCCCCC-----CHHHHHhccccccc
Q psy6346 423 MLVREPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRP-----TaeEILeHPWFke~ 446 (1238)
+|++||.+|. .++++.+||||+..
T Consensus 424 LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 424 LLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHccCHHHhccCCCcCcchhhhCcccccC
Confidence 9999999997 57899999999874
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.34 Aligned_cols=249 Identities=19% Similarity=0.282 Sum_probs=210.4
Q ss_pred cEEEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|.....+|.|++|.||++.+.. .+..||+|.+.... .......+.+|+.++++++|+||+++++++.+.+..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 446777889999999999998876 67889999887543 333446788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhccc-------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC---cEEEEecC
Q psy6346 265 YIVSEYANQGEIFDYIARYG-------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL---DIKLADFG 334 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~-------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG---~VKLiDFG 334 (1238)
|+||||+.|++|.+++...+ .+++..+..++.||+.||.|||+++++||||||+||+++.++ .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999987653 478899999999999999999999999999999999998754 59999999
Q ss_pred CcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCC
Q psy6346 335 FSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIP 409 (1238)
Q Consensus 335 LS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P 409 (1238)
++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+.+.+... ....|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP 243 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 9876532211 112233567999999987776 899999999999999996 99999988877776666543 44566
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..++..+.+++.+||..+|++||++.+|++|
T Consensus 244 ~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 244 KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7789999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.13 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=207.6
Q ss_pred EEEEEEEecCCCCccccCceEccCCcE--EEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVN--VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~k--VAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
.|...+.+|.|+||.||++.+..++.. +|+|.+... ........+.+|++++.++ +|+||+++++++...+..|+|
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 356678899999999999998877754 577776543 2344557888999999999 899999999999999999999
Q ss_pred EeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEE
Q psy6346 268 SEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLi 331 (1238)
|||+++++|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 99999999999986542 47888999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCC
Q psy6346 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIP 409 (1238)
Q Consensus 332 DFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P 409 (1238)
|||++.............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+..+.+..+ ....+
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 245 (303)
T cd05088 167 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245 (303)
T ss_pred ccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC
Confidence 9999864321111222234667999999877765 889999999999999998 99999888777777666554 23345
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+++++.+||.+||..+|++||++++++.+
T Consensus 246 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 246 LNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.08 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=217.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-----EEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS-----MIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d-----~lyL 266 (1238)
|.....||.|++|.||++....++..||||++.....+....+.+.+|+.+++.++|+||+++++++.... .+|+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 56778899999999999998888999999999876544556678999999999999999999999987765 7999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--- 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--- 343 (1238)
||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 999998 5898988887789999999999999999999999999999999999999999999999999998754432
Q ss_pred -ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc---------------
Q psy6346 344 -KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR--------------- 407 (1238)
Q Consensus 344 -~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~--------------- 407 (1238)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240 (330)
T ss_pred ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence 2344568899999999988744589999999999999999999999887765554444331100
Q ss_pred ----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 408 ----------------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 408 ----------------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
....++.++.+||.+||.++|.+||++++++.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1122578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.65 Aligned_cols=248 Identities=20% Similarity=0.362 Sum_probs=204.1
Q ss_pred EEEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~l 264 (1238)
.|...+.||.|+||.||++++.. ++..||||++.... .......+.+|+++|+.+ +|+||+++++++...+.+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46677889999999999887643 34579999998654 234457789999999999 899999999999999999
Q ss_pred EEEEeecCCCccchhhhcc-------------------------------------------------------------
Q psy6346 265 YIVSEYANQGEIFDYIARY------------------------------------------------------------- 283 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~------------------------------------------------------------- 283 (1238)
|+|||||.+|+|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999988542
Q ss_pred ---------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---cccccCC
Q psy6346 284 ---------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---LATWCGS 351 (1238)
Q Consensus 284 ---------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---l~t~~GT 351 (1238)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....++
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 2367788999999999999999999999999999999999999999999999876433221 1122355
Q ss_pred CCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHHHHHhcccCC
Q psy6346 352 PPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 352 p~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
..|||||++.+..+ +.++|||||||++|+|++ |..||...........+... ....|..+++++.++|.+||..||
T Consensus 278 ~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 356 (374)
T cd05106 278 VKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEP 356 (374)
T ss_pred cceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCCh
Confidence 67999999987776 899999999999999997 99999876554333333332 334566688999999999999999
Q ss_pred CCCCCHHHHHhc
Q psy6346 429 TKRYCIEQIKRH 440 (1238)
Q Consensus 429 skRPTaeEILeH 440 (1238)
.+|||+++|++.
T Consensus 357 ~~RPs~~~l~~~ 368 (374)
T cd05106 357 TERPTFSQISQL 368 (374)
T ss_pred hhCcCHHHHHHH
Confidence 999999999763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=316.20 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=214.4
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC---CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ---LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIY 265 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~---ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~ly 265 (1238)
.|.....+|.|++|.||++.+..++..||+|++.... ........+.+|++++++++|+||+++++++.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 5777889999999999999999999999999986432 1234567889999999999999999999998653 5689
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG--- 342 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s--- 342 (1238)
+||||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence 99999999999999988778999999999999999999999999999999999999999999999999998754321
Q ss_pred -CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHH
Q psy6346 343 -QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESL 419 (1238)
Q Consensus 343 -~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDL 419 (1238)
.......|+..|+|||++.+..+ +.++|+|||||++|+|++|+.||...........+... ...+|..+++++.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred CccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence 11234568899999999988765 78999999999999999999999876544443343332 244678899999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWF 443 (1238)
|.+||. +|.+||++.+++.|||+
T Consensus 242 i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHhc-CcccCccHHHHhcCCCC
Confidence 999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.45 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=208.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCc--EEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTV--NVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~--kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
.|.....||.|++|.||+++...++. .+|+|.++.. ......+.+.+|+.++.++ +||||+++++++...+..|+|
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46677889999999999998877664 5788887643 2334557789999999999 799999999999999999999
Q ss_pred EeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEE
Q psy6346 268 SEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLi 331 (1238)
|||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999986532 47888999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCC
Q psy6346 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIP 409 (1238)
Q Consensus 332 DFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P 409 (1238)
|||++..............+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...|
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP 240 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 9999864322111122233557999999987776 889999999999999997 999999888877777776553 3456
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..++.++.+||.+||..+|.+||+++++++.
T Consensus 241 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 241 RNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=376.57 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=217.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~lyLV 267 (1238)
..|.....||.|+||.||++.+..++..||+|++............+..|+.+|+.|+|||||+++++|.. ...+|||
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 45888899999999999999999999999999998876666777889999999999999999999998854 4679999
Q ss_pred EeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhcc-------ceeeccCCcccccccC------------
Q psy6346 268 SEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNR-------RVVHRDLKAENLLMDS------------ 324 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSk-------GIIHRDLKPeNILLd~------------ 324 (1238)
||||.+++|.++|... ..+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 9999999999998753 5699999999999999999999984 4999999999999964
Q ss_pred -----CCcEEEEecCCcccccCCCccccccCCCCCCCcccccCC-ccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHH
Q psy6346 325 -----NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSL 397 (1238)
Q Consensus 325 -----nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL 397 (1238)
.+.+||+|||++............+||+.|+|||++.+. ..++.++||||||||||+|++|..||...+. ..+
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql 252 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252 (1021)
T ss_pred cccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH
Confidence 234899999999766444444556899999999998653 2348899999999999999999999976543 333
Q ss_pred HHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 398 RDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 398 ~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
...+...........+.++.+||..||..+|.+||++.|+|.|+|+....+
T Consensus 253 i~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 253 ISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 333333322222347899999999999999999999999999999986543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.87 Aligned_cols=249 Identities=19% Similarity=0.303 Sum_probs=207.8
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|.....+|.|++|.||++.+. ..+..||||++.... ......++.+|+.+++.++|+||+++++++......
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 34677788888888888887653 235789999986543 233456788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhccc----------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecC
Q psy6346 265 YIVSEYANQGEIFDYIARYG----------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~----------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
++||||+.+++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999999986532 24667788999999999999999999999999999999999999999999
Q ss_pred CcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCC
Q psy6346 335 FSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIP 409 (1238)
Q Consensus 335 LS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P 409 (1238)
++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.....+.+.... ..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP 243 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 9875432221 112345778999999987776 899999999999999998 799999888877777666554 3456
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..++..+.++|.+||..||++|||+.|++++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 244 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.20 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=212.6
Q ss_pred EEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
.|.....+|.|+||.||+|.+... ...||||+++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 467778999999999999987643 4689999987654 344557789999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cc
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KL 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l 345 (1238)
|||+++++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 9999999999998764 468999999999999999999999999999999999999999999999999998764211 11
Q ss_pred --ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHH
Q psy6346 346 --ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIR 421 (1238)
Q Consensus 346 --~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIr 421 (1238)
....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.......+...+..+ ....+..++..+.+|+.
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLML 242 (266)
T ss_pred eccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 12334578999999987776 889999999999999998 99999887777777777654 33456668999999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy6346 422 KMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeH 440 (1238)
+||..+|++||++++|+++
T Consensus 243 ~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 243 DCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.76 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=209.2
Q ss_pred EEEEEEecCCCCccccCceEc----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
|+..+.||.|+||.||+|... .++..||+|.+.... .......+.+|+.++++++||||+++++++......|+|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 566688999999999998754 356789999997543 344557889999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcc-----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEE
Q psy6346 268 SEYANQGEIFDYIARY-----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKL 330 (1238)
|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEe
Confidence 9999999999988532 23678888999999999999999999999999999999999999999
Q ss_pred EecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-
Q psy6346 331 ADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR- 405 (1238)
Q Consensus 331 iDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~- 405 (1238)
+|||++....... ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....+.+.+....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 244 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999997653322 1233446678999999987766 899999999999999998 999998887766666665543
Q ss_pred ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 406 FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 406 ~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
...+..+++.+.++|.+||..||.+||++.+|+++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.86 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=208.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC---CCCCeeEEEEEeeeCCE-----
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL---DHPHIIKLFQVMETKSM----- 263 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL---~HPNIVrL~dvfed~d~----- 263 (1238)
|.....+|.|++|.||++....++..||||++............+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567889999999999999988899999999986544333345677888888776 59999999999988776
Q ss_pred EEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 264 IYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
++++|||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999997 47888886643 489999999999999999999999999999999999999999999999999877654
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-----cc---------
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-----FR--------- 407 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-----~~--------- 407 (1238)
........++..|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+..+...++.... ..
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 444445568889999999988776 889999999999999999999999887666555443210 00
Q ss_pred --C-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 408 --I-----------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 408 --~-----------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
+ ...+++.+.+||.+||..||.+||++++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=319.85 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=210.3
Q ss_pred EEEEEEEecCCCCccccCceEccC-----CcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRH-----TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lkt-----G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~l 264 (1238)
.|.....+|.|++|.||++..... ...||+|++.... .......+.+|+.+++++ +|+||+++++++...+.+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 366677888899999988876643 3789999998653 344557789999999999 899999999999999999
Q ss_pred EEEEeecCCCccchhhhc----------------ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcE
Q psy6346 265 YIVSEYANQGEIFDYIAR----------------YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk----------------~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~V 328 (1238)
++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeE
Confidence 999999999999999854 2458889999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC
Q psy6346 329 KLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG 404 (1238)
Q Consensus 329 KLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g 404 (1238)
||+|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 250 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999876543221 122235567999999887766 889999999999999997 99999988887777776665
Q ss_pred C-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 405 R-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 405 ~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
. ...|..++.++.+|+.+||..||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 251 YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3 34566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.47 Aligned_cols=243 Identities=23% Similarity=0.441 Sum_probs=207.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....||.|+||.||++.. +.+..+|+|.+...... .+.+.+|+.+|++++||||+++++++...+..|+||||+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred cEEeeEecCCcCceEEEEEe-ccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 55667899999999999865 45668999998755433 356889999999999999999999999999999999999
Q ss_pred CCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--ccc
Q psy6346 272 NQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--ATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--~t~ 348 (1238)
++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 999999998753 56889999999999999999999999999999999999999999999999998764332221 122
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhccc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~k 426 (1238)
.++..|+|||++.+..+ +.++|||||||++|+|++ |+.||...+..+....+..+. ...|...+.++.+||.+||..
T Consensus 162 ~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 162 KFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred CCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccC
Confidence 35567999999987776 889999999999999999 999999888877777777653 334666788999999999999
Q ss_pred CCCCCCCHHHHHh
Q psy6346 427 EPTKRYCIEQIKR 439 (1238)
Q Consensus 427 DPskRPTaeEILe 439 (1238)
+|.+||++++++.
T Consensus 241 ~p~~Rps~~~l~~ 253 (256)
T cd05114 241 KPEGRPTFAELLR 253 (256)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=322.09 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=210.5
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|.....+|.|+||.||.+... .++..||+|.+... .....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 44677788899999999988653 34567999998754 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhccc-------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEE
Q psy6346 265 YIVSEYANQGEIFDYIARYG-------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~-------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLi 331 (1238)
|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999986543 48999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCc-
Q psy6346 332 DFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRF- 406 (1238)
Q Consensus 332 DFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~- 406 (1238)
|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+..
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875433221 122345778999999987766 889999999999999998 9999998888777777777653
Q ss_pred cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 407 RIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 407 ~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..+..++.++.+|+.+||..||.+|||+++++.
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 455668899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.17 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=220.8
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.....|.....+|.|++|.||++.+..++..||+|++..... ..+.+.+|+++++.++|+||+++++++...+..|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 345667777889999999999999988899999999986542 45678899999999999999999999999999999
Q ss_pred EEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-c
Q psy6346 267 VSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-K 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~ 344 (1238)
|+||+.+++|.+++.... .++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999999998876 89999999999999999999999999999999999999999999999999886543321 2
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-c--CCCCCCHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-R--IPYFMSTECESLIR 421 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~--~P~~iS~eLkDLIr 421 (1238)
.....++..|++||++.+..+ +.++|+|||||++|+|++|..||...........+..... . .+..++.++.+||.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 234467889999999988776 8899999999999999999999988766554444443322 1 22337889999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||..+|.+||++.++++|+||...
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhcc
Confidence 9999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.37 Aligned_cols=248 Identities=21% Similarity=0.323 Sum_probs=209.9
Q ss_pred EEEEEEEecCCCCccccCceEccC-----CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRH-----TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lkt-----G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
.|.....+|.|++|.||++.+... +..||+|++.... .......+.+|+.+|+.++|+||+++++++......|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 456667888888888888877643 4789999987553 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhccc----------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCC
Q psy6346 266 IVSEYANQGEIFDYIARYG----------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~----------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence 9999999999999986432 367788999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCC
Q psy6346 336 SNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPY 410 (1238)
Q Consensus 336 S~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~ 410 (1238)
+....... ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ...+|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE 244 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC
Confidence 87543322 2234456788999999987765 889999999999999998 99999988877777766654 345677
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.++.++.+||.+||..+|++|||+.++++.
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=333.39 Aligned_cols=255 Identities=21% Similarity=0.350 Sum_probs=211.2
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC------
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------ 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------ 262 (1238)
...|.....||.|++|.||++....++..||||++.+........+.+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 45577888899999999999999899999999999765444445567889999999999999999999987543
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
.+|+||||+ |++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~- 170 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS- 170 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc-
Confidence 469999999 6788877754 5789999999999999999999999999999999999999999999999999876432
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc----------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---------------- 406 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---------------- 406 (1238)
......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+.......+.....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 171 -EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred -CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 223456789999999987644458899999999999999999999987665433333221100
Q ss_pred ---------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 407 ---------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 407 ---------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.+...+++++.++|.+||..||.+|||+.+++.||||....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 01134678899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.43 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=204.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--------C
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--------K 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--------~ 261 (1238)
..|.....||.|++|.||++.+..++..||||++............+.+|+++++.++|+||+++++++.. .
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 56888899999999999999999999999999987654333333467799999999999999999988743 3
Q ss_pred CEEEEEEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 262 SMIYIVSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
..+|+||||+.+ +|...+.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 357999999974 56665543 4579999999999999999999999999999999999999999999999999987543
Q ss_pred CCCc------------cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc--
Q psy6346 341 PGQK------------LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-- 406 (1238)
Q Consensus 341 ~s~~------------l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-- 406 (1238)
.... .....|++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 2211 12235688899999987655458899999999999999999999988776554444322100
Q ss_pred ---------------------cCC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 407 ---------------------RIP-------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 407 ---------------------~~P-------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
..+ ..+.+++.+||.+||..||.+|||+.+++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 1244678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=320.25 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=209.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIYIVS 268 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~lyLVM 268 (1238)
.|.....+|.|++|.||.+.+..++..||+|++..... .....++.+|++++++++||||+++++++.. .+.+|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36777899999999999999988999999999986542 3455789999999999999999999998854 45789999
Q ss_pred eecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 269 EYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999999887653 3458899999999999999999999999999999999999999999999999986543322
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC-----hhHHHHHHhcC-CccCCC------CC
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST-----LNSLRDRVLSG-RFRIPY------FM 412 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d-----~eeL~ekIl~g-~~~~P~------~i 412 (1238)
.....++..|+|||.+.+..+ +.++|||||||++|+|++|..||.... ..+....+... ...++. ..
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238 (287)
T ss_pred cccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence 224567889999999987776 889999999999999999999997652 23333333331 111111 24
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
++.+.+||.+||..+|.+|||+.|++.||||...
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 5789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.23 Aligned_cols=247 Identities=19% Similarity=0.297 Sum_probs=202.2
Q ss_pred CCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchh
Q psy6346 200 VKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDY 279 (1238)
Q Consensus 200 sGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~ 279 (1238)
.|++++||.+.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++..++..|+||||+.+++|.++
T Consensus 10 ~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~ 89 (328)
T cd08226 10 FCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89 (328)
T ss_pred ccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHH
Confidence 34888999999989999999999987765666678899999999999999999999999999999999999999999999
Q ss_pred hhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-c-------ccccc
Q psy6346 280 IARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-K-------LATWC 349 (1238)
Q Consensus 280 Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~-------l~t~~ 349 (1238)
+.+. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++++||+.+....... . .....
T Consensus 90 l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (328)
T cd08226 90 LKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169 (328)
T ss_pred HHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccccc
Confidence 8764 358899999999999999999999999999999999999999999999998653321111 0 01123
Q ss_pred CCCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc----------------------
Q psy6346 350 GSPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---------------------- 406 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---------------------- 406 (1238)
++..|+|||++.+.. .++.++|||||||++|+|++|..||.+...............
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (328)
T cd08226 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSG 249 (328)
T ss_pred CccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhh
Confidence 456799999997642 237899999999999999999999987654333322221110
Q ss_pred -------------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 407 -------------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 407 -------------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..+..+++.+.+||++||..||++|||++|+++||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 250 VDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0112356779999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=356.06 Aligned_cols=303 Identities=27% Similarity=0.426 Sum_probs=248.3
Q ss_pred chhhhhcccccccccCCCCCCCCcceeeccccccchhhhhhcccccccCCceeEEeeccCCCCCcEEE--EEEEecCCCC
Q psy6346 126 VSWTIFKRHFWATVKTPFNMRKETSWVQTYRRRLSIDEVNLCFQSTSIDGRRLRLDTLHAEKNGQTIR--KREKCGVKSR 203 (1238)
Q Consensus 126 VSws~~~rskWaPv~sp~nmdketSWlsd~rr~Lsiddiel~i~sesidgRy~~i~~LgsGkfGqVYk--arekIGsGsf 203 (1238)
.+|..+.++..-|+.+... ....|.+..+..........+...+..+. +.+|. ..+.+|.|-|
T Consensus 513 ~~w~~ai~~alMpV~pqss--s~~~g~~~~k~~~~s~s~s~~qiqe~vd~-------------stvYQif~devLGSGQF 577 (888)
T KOG4236|consen 513 QGWETAIQQALMPVTPQSS--SVGMGKQFHKDSSQSISVSNCQIQENVDI-------------STVYQIFADEVLGSGQF 577 (888)
T ss_pred ccCchhhhhcccccccCCC--CCCccccchhhccCCccccchhhhhhhhH-------------HHHHHhhhHhhccCCcc
Confidence 3677777777666666543 23444444443333222222222222221 12221 2478999999
Q ss_pred ccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhhh-c
Q psy6346 204 SCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIA-R 282 (1238)
Q Consensus 204 GtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lk-k 282 (1238)
|+||-|.+.++|+.||||+|++..+.......+++|+.||..+.||.||.|--.|++.+.+++|||.+.|.-|.-++. +
T Consensus 578 G~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsE 657 (888)
T KOG4236|consen 578 GTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSE 657 (888)
T ss_pred eeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhh
Confidence 999999999999999999999988876667899999999999999999999999999999999999997544444443 4
Q ss_pred ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC---CcEEEEecCCcccccCCCccccccCCCCCCCccc
Q psy6346 283 YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN---LDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEV 359 (1238)
Q Consensus 283 ~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n---G~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEV 359 (1238)
.+++++...+.++.||+.||.|||-++|+|+||||+||||... -.+||||||+++...+.....+.+|||.|+|||+
T Consensus 658 kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEV 737 (888)
T KOG4236|consen 658 KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEV 737 (888)
T ss_pred cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHH
Confidence 5789999999999999999999999999999999999999654 4599999999999888888888999999999999
Q ss_pred ccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCC----CCHHHHHHHHHhcccCCCCCCCHH
Q psy6346 360 FEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF----MSTECESLIRKMLVREPTKRYCIE 435 (1238)
Q Consensus 360 L~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~----iS~eLkDLIrkML~kDPskRPTae 435 (1238)
++.+.| ....|+||.|||+|.-|.|.+||..+ +++.++|.+..|-+|.. +++++.|||..+|++.-.+|.+++
T Consensus 738 LrnkGy-NrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 738 LRNKGY-NRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred Hhhccc-cccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchH
Confidence 999998 89999999999999999999999654 46778888888777654 899999999999999999999999
Q ss_pred HHHhccccccc
Q psy6346 436 QIKRHRWMAEE 446 (1238)
Q Consensus 436 EILeHPWFke~ 446 (1238)
..|.|||+++.
T Consensus 815 k~lsh~Wlq~y 825 (888)
T KOG4236|consen 815 KSLSHPWLQDY 825 (888)
T ss_pred hhccchhhhcc
Confidence 99999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.72 Aligned_cols=258 Identities=22% Similarity=0.388 Sum_probs=215.4
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE----
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM---- 263 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~---- 263 (1238)
++..|.....||.|++|.||++....++..||||++.....+....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3566888899999999999999999999999999987654445556778899999999999999999988866554
Q ss_pred --EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 264 --IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 264 --lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
.|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 5789888865 5799999999999999999999999999999999999999999999999999876533
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---------------
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF--------------- 406 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~--------------- 406 (1238)
. .....++..|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred c--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 2 34457889999999987654458899999999999999999999987765544443322100
Q ss_pred ----------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy6346 407 ----------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449 (1238)
Q Consensus 407 ----------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p~ 449 (1238)
.....++.++.+||++||..||.+|||+.+|+.||||.+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0112358899999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=321.23 Aligned_cols=255 Identities=25% Similarity=0.458 Sum_probs=215.6
Q ss_pred EEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCC--ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQL--DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~l--d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ly 265 (1238)
|.....+|.|++|.||.+... .+|..||+|++..... .....+.+.+|+.+|+++ +|+||+++++++..+..+|
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 456678888999988887764 4789999999976432 123346788999999999 6999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-- 343 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-- 343 (1238)
+||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCCCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCC----hhHHHHHHhcCCccCCCCCCHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGST----LNSLRDRVLSGRFRIPYFMSTECES 418 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d----~eeL~ekIl~g~~~~P~~iS~eLkD 418 (1238)
......|+..|+|||.+.+.. ..+.++|||||||++|+|++|..||.... ...+...+......+|..+++.+.+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 241 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHH
Confidence 223456899999999987532 34788999999999999999999996432 3444555555566677789999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRP-----TaeEILeHPWFke~ 446 (1238)
||.+||..||++|| ++++++.||||...
T Consensus 242 ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 242 IIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 99999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=314.23 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=210.2
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC-CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~-ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.+|.|++|.||++....++..||||++.... .+......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 4777889999999999999999999999999987643 344556778999999999999999999999999999999999
Q ss_pred ecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-c
Q psy6346 270 YANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-K 344 (1238)
Q Consensus 270 y~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~ 344 (1238)
|+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~ 162 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence 9999999988853 2447899999999999999999999999999999999999999999999999987654322 1
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC--hhHHHHHHhcCCc-cC-CCCCCHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST--LNSLRDRVLSGRF-RI-PYFMSTECESLI 420 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d--~eeL~ekIl~g~~-~~-P~~iS~eLkDLI 420 (1238)
.....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.... ...+...+..... .. +..++..+.+||
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08228 163 AHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV 241 (267)
T ss_pred HhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 234568899999999987776 789999999999999999999996553 2344444444322 12 234678899999
Q ss_pred HHhcccCCCCCCCHHHHHhc
Q psy6346 421 RKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeH 440 (1238)
.+||..+|.+||++.++++.
T Consensus 242 ~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 242 SMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.89 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=210.1
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChH------------hHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV------------NLQKVYREVEIMKQLDHPHIIKLFQVMETKS 262 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e------------~ikrf~rEIeILkkL~HPNIVrL~dvfed~d 262 (1238)
...||.|++|.||++.+..++..||||++........ ....+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 3568999999999999888999999999876543210 0125789999999999999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP- 341 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~- 341 (1238)
..|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~ 172 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccc
Confidence 9999999997 68999998878899999999999999999999999999999999999999999999999999875531
Q ss_pred --------------CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--
Q psy6346 342 --------------GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-- 405 (1238)
Q Consensus 342 --------------s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-- 405 (1238)
........+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~ 252 (335)
T PTZ00024 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT 252 (335)
T ss_pred cccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 1112234578889999999876555889999999999999999999998877655544433210
Q ss_pred ---c-----------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 406 ---F-----------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 406 ---~-----------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
. ......+.++.+||.+||..+|++||+++|++.||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 253 PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 0 001234788999999999999999999999999999987643
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=330.01 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=215.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....||.|+||.||++....++..||||++..... ...+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 34445578999999999999888999999999976432 2346788999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
+++++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... .....+
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 999999887754 568999999999999999999999999999999999999999999999999986543322 234467
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC---ccCCCCCCHHHHHHHHHhccc
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR---FRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~---~~~P~~iS~eLkDLIrkML~k 426 (1238)
|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...........+.... ...+..++..+.++|++||..
T Consensus 179 ~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 179 GTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred cCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence 8999999999988776 889999999999999999999998776655555544332 222345788999999999999
Q ss_pred CCCCCCCHHHHHhccccccc
Q psy6346 427 EPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTaeEILeHPWFke~ 446 (1238)
+|.+||++++++.||||.+.
T Consensus 258 ~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 258 EPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CcccCcCHHHHhhChhhccC
Confidence 99999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=341.23 Aligned_cols=248 Identities=19% Similarity=0.352 Sum_probs=204.0
Q ss_pred EEEEEEEecCCCCccccCceE-----ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVL-----LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~-----lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~l 264 (1238)
.|...+.||.|+||.||++.+ ..++..||||+++... .....+.+.+|+.+|..+ +||||+++++++...+..
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 467778899999999988864 2456789999997543 233456788999999999 899999999999999999
Q ss_pred EEEEeecCCCccchhhhccc------------------------------------------------------------
Q psy6346 265 YIVSEYANQGEIFDYIARYG------------------------------------------------------------ 284 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~------------------------------------------------------------ 284 (1238)
|+|||||+||+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999886421
Q ss_pred ---------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---cc
Q psy6346 285 ---------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---LA 346 (1238)
Q Consensus 285 ---------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---l~ 346 (1238)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 367778899999999999999999999999999999999999999999999876533221 11
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChh-HHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLN-SLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~e-eL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
...++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... .+.+.+..+ ....|...+.++.+||.+|
T Consensus 275 ~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 353 (375)
T cd05104 275 NARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSC 353 (375)
T ss_pred CCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHH
Confidence 2335567999999988776 899999999999999997 99999876543 333334333 2334556788999999999
Q ss_pred cccCCCCCCCHHHHHhc
Q psy6346 424 LVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 424 L~kDPskRPTaeEILeH 440 (1238)
|..||++||++.+|++.
T Consensus 354 l~~dP~~RPs~~eil~~ 370 (375)
T cd05104 354 WDADPLKRPTFKQIVQL 370 (375)
T ss_pred ccCChhHCcCHHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=352.55 Aligned_cols=248 Identities=21% Similarity=0.346 Sum_probs=203.2
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
.+..|.....||.|+||.||++.+...+..||||.... ..+.+|+++|++|+|+|||++++++...+..|+|
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 34568888999999999999999999999999996432 2456899999999999999999999999999999
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-- 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-- 344 (1238)
||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99996 6788877654 5699999999999999999999999999999999999999999999999999876533221
Q ss_pred -cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC--------ChhHHHHHHhcCCcc---CC---
Q psy6346 345 -LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS--------TLNSLRDRVLSGRFR---IP--- 409 (1238)
Q Consensus 345 -l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~--------d~eeL~ekIl~g~~~---~P--- 409 (1238)
....+||+.|+|||++.+..+ +.++|||||||+||||++|..|+... ....+...+...... ++
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 224579999999999988876 89999999999999999987654221 112222222221110 00
Q ss_pred ----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 410 ----------------------------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 410 ----------------------------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
..++.++.+||.+||..||.+|||+.|||+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 024568999999999999999999999999999964
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.84 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=207.7
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC-----C
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK-----S 262 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~-----d 262 (1238)
++..|.....+|.|++|.||++++..+|..||||++.... ......++.+|+.++++++|+||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3467888899999999999999999999999999986532 223456788999999999999999999887543 3
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
..|+||||+. ++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999997 47777664 357899999999999999999999999999999999999999999999999998754322
Q ss_pred C----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc---------------
Q psy6346 343 Q----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--------------- 403 (1238)
Q Consensus 343 ~----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~--------------- 403 (1238)
. .....+|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 1 123357899999999976654448899999999999999999999987654322211110
Q ss_pred C-----------Ccc-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 404 G-----------RFR-----IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 404 g-----------~~~-----~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
. ... .....+.++.+||.+||..+|.+|||+.++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000 0123577899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.75 Aligned_cols=250 Identities=20% Similarity=0.322 Sum_probs=204.2
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
...||.|++|.||++.+..++..||||++...... .....+.+|+.++.++. |+||+++++++..++..+++|||+.
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 35689999999999999999999999999865433 45577889999999995 9999999999999999999999986
Q ss_pred Cccchhh---h--cccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 274 GEIFDYI---A--RYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 274 GSL~d~L---k--k~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
++|.++. . ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++...........
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 166 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR 166 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcccc
Confidence 3444432 2 235689999999999999999999974 999999999999999999999999999876544443444
Q ss_pred ccCCCCCCCcccccCC--ccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcCC-ccC----CCCCCHHHHHH
Q psy6346 348 WCGSPPYAAPEVFEGK--KYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSGR-FRI----PYFMSTECESL 419 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk--~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g~-~~~----P~~iS~eLkDL 419 (1238)
..|++.|+|||++.+. ..++.++|||||||++|+|++|+.||..... .+....+..+. ..+ +..++.++.+|
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 246 (288)
T cd06616 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNF 246 (288)
T ss_pred ccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHH
Confidence 5789999999999876 2448899999999999999999999976542 11112222221 112 22378899999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|.+||..+|++|||+++|++||||+..
T Consensus 247 i~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 247 INLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHHccCChhhCcCHHHHhcChhhhch
Confidence 999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.23 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=207.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-------
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------- 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------- 262 (1238)
+.|.....+|.|++|.||++....++..||||+++...........+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 4577778999999999999999999999999999866443344456788999999999999999999987654
Q ss_pred ---EEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 263 ---MIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 263 ---~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.+|+||||+.+ +|..++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++..
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 89999999986 666666543 4689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC--ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---Cc-------
Q psy6346 339 YVPGQ--KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RF------- 406 (1238)
Q Consensus 339 ~~~s~--~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~------- 406 (1238)
..... ......++..|+|||++.+....+.++|||||||++|+|++|+.||...+.......+... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 54332 1122346788999999876554588999999999999999999999876544433332221 00
Q ss_pred --------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 407 --------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 407 --------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.....++..+.+||.+||..||.+||++++++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.92 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=205.6
Q ss_pred EecCCCCccccCceEccCC---cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHT---VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG---~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
.||.|++|.||+|.+...+ ..||+|++...... ...+.+.+|+.+++.++|+||+++++++.. +..++||||+.+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 5788999999998776554 78999999876543 455788999999999999999999998764 468999999999
Q ss_pred CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc----ccc
Q psy6346 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA----TWC 349 (1238)
Q Consensus 274 GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~----t~~ 349 (1238)
++|.+++.....+++..+..++.|++.||.|||..|++|+||||+||+++.++.+||+|||++.......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 9999999888889999999999999999999999999999999999999999999999999987654332211 112
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcccC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~kD 427 (1238)
++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+...+...+.... ...|..++..+.++|.+||..+
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 238 (257)
T cd05060 160 WPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYR 238 (257)
T ss_pred ccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 3467999999987776 889999999999999997 999998887777766665553 3456678899999999999999
Q ss_pred CCCCCCHHHHHh
Q psy6346 428 PTKRYCIEQIKR 439 (1238)
Q Consensus 428 PskRPTaeEILe 439 (1238)
|++||++.++++
T Consensus 239 p~~Rp~~~~l~~ 250 (257)
T cd05060 239 PEDRPTFSELES 250 (257)
T ss_pred hhhCcCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=313.09 Aligned_cols=245 Identities=22% Similarity=0.397 Sum_probs=208.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|+..+.+|.|++|.||++.. .++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..|+|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4577788999999999999875 466789999987543 235688999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--c
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--L 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l 345 (1238)
|+++++|.+++... ..++...+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999998653 4578888999999999999999999999999999999999999999999999976543221 1
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+... ....+..++.++.+||.+|
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 240 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240 (261)
T ss_pred CCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999987776 889999999999999998 99999988777776666554 2333445789999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|..+|++||+++++++
T Consensus 241 l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 241 WKEKAEERPTFDYLQS 256 (261)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=325.17 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=219.1
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.|.....|.....+|.|++|.||++....++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 4455577888899999999999999988899999999986543 22346788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999999998865 457889999999999999999999999999999999999999999999999886554332
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc-CC--ccCCCCCCHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS-GR--FRIPYFMSTECESLI 420 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~-g~--~~~P~~iS~eLkDLI 420 (1238)
......|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+.. +. +..+..++..+.+||
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred ccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 2334568899999999987766 8899999999999999999999987654433222221 11 223345678899999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
++||..+|.+||++++++.|+||....
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=326.64 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=208.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCc----EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTV----NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~----kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
..|.....||.|+||.||+|.+..++. .||||++.... .....+++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 347778899999999999998876655 48999987542 344567889999999999999999999998765 578
Q ss_pred EEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
+|+||+.+|+|.+++... ..++...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999999999764 4588889999999999999999999999999999999999999999999999986643332
Q ss_pred cc---cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHH
Q psy6346 345 LA---TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESL 419 (1238)
Q Consensus 345 l~---t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDL 419 (1238)
.. ...++..|+|||++.+..+ +.++|||||||++|||++ |..||.+.....+...+..+ ....|..++.++.++
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 243 (316)
T ss_pred ceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 21 2234667999999988776 899999999999999997 99999988776665544443 234456688999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..+|.+||++.+++.+
T Consensus 244 i~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.36 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=210.6
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
.....+|.|++|.||++....++..+|+|.+............+.+|+.+|++++|+||+++++++...+..|+||||+.
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 44578999999999999998899999999998766554556788899999999999999999999999999999999997
Q ss_pred CCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccccC
Q psy6346 273 QGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWCG 350 (1238)
Q Consensus 273 GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~G 350 (1238)
+ +|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+....... ......+
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 160 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV 160 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence 5 787777653 578999999999999999999999999999999999999999999999999987654433 2333568
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------Ccc----
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFR---- 407 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~---- 407 (1238)
+..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+... ...
T Consensus 161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05118 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240 (283)
T ss_pred cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence 889999999987644589999999999999999999999876654433332211 000
Q ss_pred -------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 408 -------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 408 -------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
....++.++.+||.+||..||.+||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=322.89 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=212.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
...|.....+|.|++|.||++....++..||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 3457777889999999999999888999999999875532 344557889999999999999999999999999999999
Q ss_pred EeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 268 SEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
|||+. |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++...... .
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~ 169 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---N 169 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---C
Confidence 99997 566666543 456899999999999999999999999999999999999999999999999998754322 3
Q ss_pred cccCCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccC-CCCCCHHHHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRI-PYFMSTECESLIRK 422 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~-P~~iS~eLkDLIrk 422 (1238)
...|++.|+|||++.+ ....+.++|||||||++|+|++|..||.+.+.......+.... ..+ +..++.++.+||.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence 4568889999999852 2224789999999999999999999998877655444443322 222 23467889999999
Q ss_pred hcccCCCCCCCHHHHHhccccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||..+|++||++.+|+.||||...
T Consensus 250 ~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 250 CLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HhcCChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=310.89 Aligned_cols=248 Identities=28% Similarity=0.465 Sum_probs=211.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.+|.|++|.||++....+|..||+|.++.... +....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 57778899999999999999988999999999875433 34456789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-c
Q psy6346 270 YANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-K 344 (1238)
Q Consensus 270 y~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~ 344 (1238)
|+++++|.+++.. ...+++..+..++.+|+.||.|||+.||+||||+|+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 162 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc
Confidence 9999999998864 2458899999999999999999999999999999999999999999999999987654332 2
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC--hhHHHHHHhcCCc-cCCC-CCCHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST--LNSLRDRVLSGRF-RIPY-FMSTECESLI 420 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d--~eeL~ekIl~g~~-~~P~-~iS~eLkDLI 420 (1238)
.....|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.... ...+.+.+..+.. ..|. .++.++.++|
T Consensus 163 ~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 241 (267)
T cd08224 163 AHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241 (267)
T ss_pred cceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence 334568899999999987776 789999999999999999999996543 3344444444432 2343 5788999999
Q ss_pred HHhcccCCCCCCCHHHHHh
Q psy6346 421 RKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILe 439 (1238)
.+||..+|++|||+.+|++
T Consensus 242 ~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 242 SRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHcCCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.64 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=211.3
Q ss_pred cEEEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|...+.+|.|++|.||+|.... .+..||+|++.... .......+.+|+.+++.++|+||+++++++.+.+..
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 346677888999999999876542 35689999987553 233445688999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhccc----------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecC
Q psy6346 265 YIVSEYANQGEIFDYIARYG----------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~----------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
|+||||+.+|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999999997532 23556788999999999999999999999999999999999999999999
Q ss_pred CcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCC
Q psy6346 335 FSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIP 409 (1238)
Q Consensus 335 LS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P 409 (1238)
++........ .....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+..+.+..+. ...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9875432221 122345678999999987776 889999999999999998 899999888777777766553 3456
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHh------ccccccc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKR------HRWMAEE 446 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILe------HPWFke~ 446 (1238)
..+++.+.++|.+||..||++|||+.++++ ||||...
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 677899999999999999999999999987 8887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.45 Aligned_cols=242 Identities=25% Similarity=0.432 Sum_probs=210.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....+|.|++|.||++.. .|+.||||.+..... ..+++.+|+.++++++|+||+++++++.+.+..|+|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 3466678899999999998865 488999999976542 56789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~ 158 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--S 158 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--c
Confidence 999999999997765 689999999999999999999999999999999999999999999999999876532222 3
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~ 425 (1238)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.......+...+..+ ....+..+++++.++|.+||.
T Consensus 159 ~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 159 GKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred CCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhc
Confidence 345667999999987665 789999999999999997 99999988877776666554 344566788999999999999
Q ss_pred cCCCCCCCHHHHHh
Q psy6346 426 REPTKRYCIEQIKR 439 (1238)
Q Consensus 426 kDPskRPTaeEILe 439 (1238)
.+|++||+++++++
T Consensus 238 ~~p~~Rp~~~~l~~ 251 (256)
T cd05039 238 LDPAKRPTFKQLRE 251 (256)
T ss_pred cChhhCcCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.01 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=208.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.+|.|++|.||++... .+..||||.++.... ..+.+.+|+.++++++|+||+++++++...+..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34777889999999999998754 567899999976543 24568899999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--
Q psy6346 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL-- 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l-- 345 (1238)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 999999999997654 6899999999999999999999999999999999999999999999999998765432111
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....++..|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.+...+...+... ....+..++..+.+++.+|
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 240 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDC 240 (261)
T ss_pred CCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 11122357999999987776 889999999999999999 99999988877777666544 3345566889999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|..+|.+||++++|+.
T Consensus 241 l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 241 WKEDPDDRPTFETLQW 256 (261)
T ss_pred hhcCcccCCCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=317.16 Aligned_cols=242 Identities=25% Similarity=0.391 Sum_probs=202.9
Q ss_pred EecCCCCccccCceEccCCc--EEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 197 KCGVKSRSCNRPPVLLRHTV--NVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~--kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
.+|.|++|.||++.+..++. .+|+|.+.... .....+.+.+|++++.++ +||||+++++++...+..|+||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 47899999999998877765 46888887432 344557889999999999 899999999999999999999999999
Q ss_pred Cccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 274 GEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 274 GSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999987543 47888999999999999999999999999999999999999999999999985
Q ss_pred cccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHH
Q psy6346 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTE 415 (1238)
Q Consensus 338 ~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~e 415 (1238)
.............+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 239 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHH
Confidence 3221111122234567999999977766 889999999999999996 99999888777777666554 33456668899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+.+|+.+||..||.+|||+++++..
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 240 VYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.20 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=211.1
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
...+.+|.|.+|.||++....++..||+|++..........+.+..|+.++++++|+||+++++++.+.+..++||||+.
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 45578899999999999999999999999998765444455778899999999999999999999999999999999998
Q ss_pred CCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccccC
Q psy6346 273 QGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWCG 350 (1238)
Q Consensus 273 GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~G 350 (1238)
++|.+++.+. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ......+
T Consensus 82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (282)
T cd07829 82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160 (282)
T ss_pred -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence 5899999876 579999999999999999999999999999999999999999999999999987654332 2334456
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC------------------CccCC---
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------RFRIP--- 409 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------~~~~P--- 409 (1238)
+..|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+... ...++
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd07829 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240 (282)
T ss_pred CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccC
Confidence 788999999887744588999999999999999999999887654443333210 00011
Q ss_pred --------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 410 --------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 410 --------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
..++..+.++|++||..||++||++++++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=365.24 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=214.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEE-ee-----e-C
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQV-ME-----T-K 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dv-fe-----d-~ 261 (1238)
..+.+.+.|.+|||+.||.+.+...|..||+|.+-.. ++...+.+.+||++|++| +|+|||.++|. .. . .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4577788999999999999999988899999998775 677889999999999999 59999999993 21 1 2
Q ss_pred CEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccc--eeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
-.++|+||||.||.|.|++..+ .+|++.++++||+++++||.+||..+ |||||||.|||||..+|++||||||.++
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 3588999999999999999854 56999999999999999999999987 9999999999999999999999999886
Q ss_pred cccCCCcc----------ccccCCCCCCCccccc---CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC
Q psy6346 338 YYVPGQKL----------ATWCGSPPYAAPEVFE---GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG 404 (1238)
Q Consensus 338 ~~~~s~~l----------~t~~GTp~YmAPEVL~---gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g 404 (1238)
........ ....-|+.|+|||++. +.+. +.|+|||+|||+||.|+....||++... -.|+++
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEec
Confidence 54322110 1123689999999964 5555 8999999999999999999999987632 358889
Q ss_pred CccCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 405 RFRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 405 ~~~~P~~--iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.+.||.. ++..+++||+.||+.||++||++-+++.+-+.....
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 9988874 889999999999999999999999999987655443
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.39 Aligned_cols=243 Identities=26% Similarity=0.434 Sum_probs=209.9
Q ss_pred EEEecCCCCccccCceEccCC----cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 195 REKCGVKSRSCNRPPVLLRHT----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
...+|.|++|.||.+.....+ ..||+|++.... .....+.+..|+.+++.++|+||+++++++.+.+..|+||||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 467889999999999888766 899999997654 233567899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccc--cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc--
Q psy6346 271 ANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA-- 346 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~-- 346 (1238)
+++++|.+++..... +++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK 162 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccc
Confidence 999999999976554 9999999999999999999999999999999999999999999999999987654432211
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML 424 (1238)
...+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+...+.+.+..+. ...+..++.++.+++.+||
T Consensus 163 ~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 241 (258)
T smart00219 163 GGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCW 241 (258)
T ss_pred cCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHC
Confidence 1236788999999976655 899999999999999998 899999888777777776553 3345668999999999999
Q ss_pred ccCCCCCCCHHHHHh
Q psy6346 425 VREPTKRYCIEQIKR 439 (1238)
Q Consensus 425 ~kDPskRPTaeEILe 439 (1238)
..||.+|||+.++++
T Consensus 242 ~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 242 AEDPEDRPTFSELVE 256 (258)
T ss_pred cCChhhCcCHHHHHh
Confidence 999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.83 Aligned_cols=235 Identities=23% Similarity=0.395 Sum_probs=199.1
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
+|.|+||.||++....++..+|+|++....... .|+.+...+ +|+||+++++++...+.+|+||||+++++|
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 96 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL 96 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcH
Confidence 699999999999988999999999987654322 123333222 799999999999999999999999999999
Q ss_pred chhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCCcccccCCCccccccCCCCCC
Q psy6346 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYVPGQKLATWCGSPPYA 355 (1238)
Q Consensus 277 ~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~s~~l~t~~GTp~Ym 355 (1238)
.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...... ....|+..|+
T Consensus 97 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~ 173 (267)
T PHA03390 97 FDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYF 173 (267)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCccc
Confidence 99998878999999999999999999999999999999999999999988 9999999998754322 2346889999
Q ss_pred CcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH-----HHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 356 APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS-----LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 356 APEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee-----L~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
|||++.+..+ +.++|||||||++|+|++|..||....... +.... ......+..+++.+.+||.+||+.+|.+
T Consensus 174 aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 251 (267)
T PHA03390 174 SPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINY 251 (267)
T ss_pred ChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhccChhh
Confidence 9999988776 889999999999999999999997654332 22222 3334455678999999999999999999
Q ss_pred CCC-HHHHHhccccc
Q psy6346 431 RYC-IEQIKRHRWMA 444 (1238)
Q Consensus 431 RPT-aeEILeHPWFk 444 (1238)
|++ ++++|+||||.
T Consensus 252 R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 252 RLTNYNEIIKHPFLK 266 (267)
T ss_pred CCchHHHHhcCCccc
Confidence 996 69999999996
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.63 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=208.3
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|.....||.|++|.||+|....+++.||||.+...... .......+|+..+++++ |+||+++++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 34567899999999999999888999999998765432 22334567999999998 99999999999999999999999
Q ss_pred cCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 271 ANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
+ +++|.+++.... .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 789998887664 7899999999999999999999999999999999999999999999999999876554444556
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccC-
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRI- 408 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~- 408 (1238)
.++..|+|||++.+....+.++|+||||+++++|++|..||..........++... ...+
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 78999999999866554588999999999999999999999876654433322210 0000
Q ss_pred ----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 409 ----------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 409 ----------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
....+.++.+||++||..+|++|||++|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=324.11 Aligned_cols=245 Identities=20% Similarity=0.305 Sum_probs=199.5
Q ss_pred CCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhhh
Q psy6346 202 SRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIA 281 (1238)
Q Consensus 202 sfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lk 281 (1238)
+++.||.+....++..||||++..........+.+.+|+++++.++|+||+++++++...+..|++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44556666666789999999998875566777899999999999999999999999999999999999999999999987
Q ss_pred cc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--------ccccccCC
Q psy6346 282 RY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--------KLATWCGS 351 (1238)
Q Consensus 282 k~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--------~l~t~~GT 351 (1238)
.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+....... ......++
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 54 458899999999999999999999999999999999999999999999999886543221 12234577
Q ss_pred CCCCCcccccCC-ccCCCccceehhhHHHHHHhhCCCCCCCCChhHH-HHHHhcCC------------------------
Q psy6346 352 PPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL-RDRVLSGR------------------------ 405 (1238)
Q Consensus 352 p~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL-~ekIl~g~------------------------ 405 (1238)
..|+|||++.+. ..++.++|||||||++|+|++|..||........ .+.+....
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE 251 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence 889999998763 2237899999999999999999999986543322 12221100
Q ss_pred ---------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 ---------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 ---------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...+..++.++.+||.+||..||++|||++++++||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00111235678899999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.16 Aligned_cols=244 Identities=24% Similarity=0.407 Sum_probs=210.1
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||++.... +..||+|++.... ......+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 5556788999999999998876 8999999987654 234567889999999999999999999999999999999999
Q ss_pred CCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-cccc
Q psy6346 272 NQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-LATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-l~t~ 348 (1238)
++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........ ....
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~ 164 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK 164 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCC
Confidence 999999999753 4589999999999999999999999999999999999999999999999999876533221 1233
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhccc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~k 426 (1238)
.++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....+..+++.+.++|.+||..
T Consensus 165 ~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05148 165 KIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAA 243 (261)
T ss_pred CCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCC
Confidence 45678999999987766 789999999999999998 89999988877777766654 3445667899999999999999
Q ss_pred CCCCCCCHHHHHh
Q psy6346 427 EPTKRYCIEQIKR 439 (1238)
Q Consensus 427 DPskRPTaeEILe 439 (1238)
||.+|||+.+|++
T Consensus 244 ~p~~Rpt~~~l~~ 256 (261)
T cd05148 244 EPEDRPSFKALRE 256 (261)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.32 Aligned_cols=240 Identities=23% Similarity=0.390 Sum_probs=202.1
Q ss_pred ecCCCCccccCceEc--cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCc
Q psy6346 198 CGVKSRSCNRPPVLL--RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275 (1238)
Q Consensus 198 IGsGsfGtVYKav~l--ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGS 275 (1238)
||.|+||.||+|++. .++..||||++.... .....+.+.+|+.++++++|+||++++++++. ...++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 788999999988765 446679999987653 34455779999999999999999999998864 57899999999999
Q ss_pred cchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc----cccccC
Q psy6346 276 IFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK----LATWCG 350 (1238)
Q Consensus 276 L~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~----l~t~~G 350 (1238)
|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........ .....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 9999874 45789999999999999999999999999999999999999999999999999875433221 111223
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcccCC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ...+|...++++.++|.+||..+|
T Consensus 161 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 161 PLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred CcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 568999999887766 889999999999999996 99999988877776666654 345667789999999999999999
Q ss_pred CCCCCHHHHHhc
Q psy6346 429 TKRYCIEQIKRH 440 (1238)
Q Consensus 429 skRPTaeEILeH 440 (1238)
++||++++|++.
T Consensus 240 ~~Rp~~~~i~~~ 251 (257)
T cd05115 240 EDRPNFAKVEER 251 (257)
T ss_pred hhCcCHHHHHHH
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.09 Aligned_cols=245 Identities=20% Similarity=0.309 Sum_probs=206.8
Q ss_pred EEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 194 KREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 194 arekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..+.+|.|++|.||++.+.. .+..||||++.... .....+.+.+|+.++..++||||+++++++......++++
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 34567778888888876653 35789999997553 3344567889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcc----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEe
Q psy6346 269 EYANQGEIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiD 332 (1238)
||+.+++|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~D 167 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISD 167 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecc
Confidence 999999999988532 3478888999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCc-c
Q psy6346 333 FGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRF-R 407 (1238)
Q Consensus 333 FGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~-~ 407 (1238)
||++........ .....+++.|+|||++.+..+ +.++|||||||++|||++ |..||.+.....+.+.+..... .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~ 246 (283)
T cd05091 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246 (283)
T ss_pred cccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999875433221 223446788999999987776 889999999999999998 8999999888888888877654 3
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 408 IPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 408 ~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
++..++..+.+|+.+||+.+|.+||++++|+..
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 247 CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.21 Aligned_cols=224 Identities=22% Similarity=0.316 Sum_probs=188.9
Q ss_pred CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhhhccc---------
Q psy6346 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYG--------- 284 (1238)
Q Consensus 214 tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~--------- 284 (1238)
.+..||+|++.... .....+.+.+|++++++++||||+++++++..++..++||||+.+++|.+++.+..
T Consensus 45 ~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 123 (296)
T cd05051 45 APVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123 (296)
T ss_pred CceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhccccccccccc
Confidence 45679999988654 34556789999999999999999999999999999999999999999999997765
Q ss_pred --ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---ccccccCCCCCCCccc
Q psy6346 285 --RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEV 359 (1238)
Q Consensus 285 --~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEV 359 (1238)
.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ......+++.|+|||+
T Consensus 124 ~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 203 (296)
T cd05051 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWES 203 (296)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHH
Confidence 68999999999999999999999999999999999999999999999999987543322 1223456778999999
Q ss_pred ccCCccCCCccceehhhHHHHHHhh--CCCCCCCCChhHHHHHHhcC--------CccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 360 FEGKKYCGPEIDIWSLGVVLYVLVC--GALPFDGSTLNSLRDRVLSG--------RFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 360 L~gk~y~S~KSDIWSLGVILYELLT--GrlPF~g~d~eeL~ekIl~g--------~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....+..++.++.+||.+||..||.
T Consensus 204 ~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 282 (296)
T cd05051 204 VLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE 282 (296)
T ss_pred hhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChh
Confidence 887665 899999999999999998 78899876665555544322 1223445778999999999999999
Q ss_pred CCCCHHHHHh
Q psy6346 430 KRYCIEQIKR 439 (1238)
Q Consensus 430 kRPTaeEILe 439 (1238)
+|||+.+|+.
T Consensus 283 ~Rpt~~el~~ 292 (296)
T cd05051 283 DRPTFREIHL 292 (296)
T ss_pred cCCCHHHHHH
Confidence 9999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.89 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=207.6
Q ss_pred EEEEEEecCCCCccccCceEccC--CcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee----CCEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRH--TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET----KSMI 264 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lkt--G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed----~d~l 264 (1238)
|.....||.|+||.||++..... +..||||++..........+.+.+|+.+++++ +||||+++++.+.. ...+
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 56678899999999999998877 88999999876543334456788999999999 59999999987532 2458
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
|++|||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 89999986 6899999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---------------
Q psy6346 344 ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--------------- 404 (1238)
Q Consensus 344 ----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--------------- 404 (1238)
......|++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence 1234578999999999876443488999999999999999999999876543333221110
Q ss_pred -------------CccC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 405 -------------RFRI---PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 405 -------------~~~~---P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
...+ ...++..+.+||.+||..||.+|||+++++.|||+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0001 112578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.08 Aligned_cols=248 Identities=22% Similarity=0.382 Sum_probs=208.9
Q ss_pred EEEEEEEecCCCCccccCceEcc-------CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCC
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLR-------HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS 262 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lk-------tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d 262 (1238)
.|...+.||.|+||.||.+.+.. +...||+|++.... .......+.+|+.+++++ +|+||+++++++...+
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46677788888888888876542 33579999998653 344567888999999999 8999999999999999
Q ss_pred EEEEEEeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG 326 (1238)
..|+||||+.+++|.+++...+ .++...+..++.||+.||+|||++|++||||||+||+++.++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 9999999999999999997542 478888999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHh
Q psy6346 327 DIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVL 402 (1238)
Q Consensus 327 ~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl 402 (1238)
.+||+|||++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....++...+.
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 999999999875432211 112234568999999987766 889999999999999998 999999888877777766
Q ss_pred cCC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 403 SGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 403 ~g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
... ...|..++.++.+||.+||..+|.+||++.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 257 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 554 35667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.91 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=204.5
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
.||.|++|.||++.. .++..||+|++.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 578999999999874 578899999987653 344456788999999999999999999999999999999999999999
Q ss_pred chhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--ccccCCCC
Q psy6346 277 FDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--ATWCGSPP 353 (1238)
Q Consensus 277 ~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--~t~~GTp~ 353 (1238)
.+++... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++......... ....++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 9988654 45789999999999999999999999999999999999999999999999998654322111 12234567
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcccCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKR 431 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPskR 431 (1238)
|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ...++..++..+.+|+.+||..+|++|
T Consensus 160 y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 160 WTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred ccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 999999987765 789999999999999998 99999888777666666554 334566788999999999999999999
Q ss_pred CCHHHHHhc
Q psy6346 432 YCIEQIKRH 440 (1238)
Q Consensus 432 PTaeEILeH 440 (1238)
|++.++++.
T Consensus 239 p~~~~l~~~ 247 (250)
T cd05085 239 PKFSELQKE 247 (250)
T ss_pred CCHHHHHHH
Confidence 999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=345.70 Aligned_cols=238 Identities=27% Similarity=0.454 Sum_probs=208.9
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCc
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGS 275 (1238)
..||.|-||.||.|.+. ...+||+|.++.....+ +.|.+|++||++|+|++||+++++|..++.+|||||||+.|+
T Consensus 212 ~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 212 RELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHhcCCccceEEEEEEc-CCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 56788888888888764 44589999998765443 467799999999999999999999999889999999999999
Q ss_pred cchhhhc--ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--ccccCC
Q psy6346 276 IFDYIAR--YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--ATWCGS 351 (1238)
Q Consensus 276 L~d~Lkk--~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--~t~~GT 351 (1238)
|.++|.. .+.+.......++.||++|++||+++++|||||.+.|||++++..+||+|||+++...++.-. ...--.
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfP 367 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFP 367 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCC
Confidence 9999987 467899999999999999999999999999999999999999999999999999954333211 112234
Q ss_pred CCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 352 PPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 352 p~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
..|.|||.+....+ +.++|||||||+||||+| |+.|+.+.+..+..+.+..| +.+-|..+|+++-+++..||..+|+
T Consensus 368 IkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~ 446 (468)
T KOG0197|consen 368 IKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPE 446 (468)
T ss_pred ceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcc
Confidence 56999999999888 899999999999999998 99999999999999999887 5677888999999999999999999
Q ss_pred CCCCHHHHH
Q psy6346 430 KRYCIEQIK 438 (1238)
Q Consensus 430 kRPTaeEIL 438 (1238)
+|||++.+.
T Consensus 447 ~RPtF~~L~ 455 (468)
T KOG0197|consen 447 DRPTFETLR 455 (468)
T ss_pred cCCCHHHHH
Confidence 999999664
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=329.31 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=210.5
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee--CCEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET--KSMIY 265 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed--~d~ly 265 (1238)
.+.|.....+|.|++|.||++.+..++..||||++............+.+|+.+++++ +||||+++++++.. ....|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3456667889999999999999888999999999876544445566788999999999 99999999999864 34689
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-- 343 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-- 343 (1238)
+||||+. ++|..++... .+.+..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 9999997 5888888765 78888999999999999999999999999999999999999999999999987653322
Q ss_pred ----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--------------
Q psy6346 344 ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-------------- 405 (1238)
Q Consensus 344 ----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-------------- 405 (1238)
......|+..|+|||++.+....+.++|||||||++|+|++|+.||.+........++....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 22345689999999998765555889999999999999999999998765443332221110
Q ss_pred -------------c----cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 -------------F----RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 -------------~----~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
. .....++.++.+||.+||..||.+|||+.++++|||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0111268889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.61 Aligned_cols=240 Identities=23% Similarity=0.383 Sum_probs=205.6
Q ss_pred EecCCCCccccCceEcc-CC--cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 197 KCGVKSRSCNRPPVLLR-HT--VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lk-tG--~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
.+|.|++|.||++.+.. .+ ..||||++...... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 57889999999998765 33 36999999887654 566889999999999999999999999988 899999999999
Q ss_pred Cccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc----ccc
Q psy6346 274 GEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK----LAT 347 (1238)
Q Consensus 274 GSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~----l~t 347 (1238)
++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999997654 689999999999999999999999999999999999999999999999999876543211 123
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHHHHHhc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDLIrkML 424 (1238)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..++...+... ....+..++..+.+++.+||
T Consensus 160 ~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 160 LKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 456788999999887776 889999999999999998 99999887777666655532 23345567899999999999
Q ss_pred ccCCCCCCCHHHHHh
Q psy6346 425 VREPTKRYCIEQIKR 439 (1238)
Q Consensus 425 ~kDPskRPTaeEILe 439 (1238)
..+|++||++.++++
T Consensus 239 ~~~p~~Rps~~~~~~ 253 (257)
T cd05040 239 AHNPADRPTFAALRE 253 (257)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.92 Aligned_cols=244 Identities=23% Similarity=0.448 Sum_probs=206.9
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.+|.|++|.||++.+. ++..+|||++...... ...+.+|+.+++.++|+||+++++++...+..|+||||+
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 556678899999999998764 5678999998765433 346788999999999999999999999999999999999
Q ss_pred CCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--ccc
Q psy6346 272 NQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--ATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--~t~ 348 (1238)
+|++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......... ...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 999999998754 46899999999999999999999999999999999999999999999999998764332211 111
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhccc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~k 426 (1238)
.++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ ....|..++.++.+|+.+||..
T Consensus 162 ~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05059 162 KFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240 (256)
T ss_pred CCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence 23457999999988776 889999999999999998 89999888777777766655 3455667899999999999999
Q ss_pred CCCCCCCHHHHHhc
Q psy6346 427 EPTKRYCIEQIKRH 440 (1238)
Q Consensus 427 DPskRPTaeEILeH 440 (1238)
+|++|||+.++++.
T Consensus 241 ~p~~Rpt~~~~l~~ 254 (256)
T cd05059 241 KPEDRPAFKKLLSQ 254 (256)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.99 Aligned_cols=247 Identities=24% Similarity=0.344 Sum_probs=209.8
Q ss_pred EEEEEEecCCCCccccCceEccCCc---EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~---kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
|+..+.+|.|++|.||++....++. .||||++.... +....+.+..|+.+++.++||||+++++++.++...++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 6778899999999999998876654 69999987653 4556678999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 269 EYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
||+.+++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 164 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccc
Confidence 999999999998753 5689999999999999999999999999999999999999999999999999875433221111
Q ss_pred ---cc---CCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHH
Q psy6346 348 ---WC---GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESL 419 (1238)
Q Consensus 348 ---~~---GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDL 419 (1238)
.. .+..|+|||.+.+..+ +.++|||||||++|||++ |..||...+.......+... ..+.+..++..+.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 243 (269)
T cd05065 165 YTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQL 243 (269)
T ss_pred cccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHH
Confidence 11 2357999999988776 889999999999999886 99999888777777766543 334455678999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
+.+||..+|.+||++++|+..
T Consensus 244 i~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 244 MLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.77 Aligned_cols=245 Identities=21% Similarity=0.384 Sum_probs=207.4
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.+|.|++|.||.+... .+..||||.+...... .+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 3666788999999999988654 3456999998765433 35688999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--cc
Q psy6346 271 ANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--AT 347 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--~t 347 (1238)
+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999998764 46899999999999999999999999999999999999999999999999998755333211 11
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLIrkML~ 425 (1238)
..++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.. ..+...+..+.+++.+||.
T Consensus 161 ~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWH 239 (256)
T ss_pred CccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 234567999999987776 789999999999999998 9999988877777777766533 3455678999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q psy6346 426 REPTKRYCIEQIKRH 440 (1238)
Q Consensus 426 kDPskRPTaeEILeH 440 (1238)
.+|.+||++.+|+++
T Consensus 240 ~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 240 EKAEERPTFQQLLSS 254 (256)
T ss_pred CCcccCCCHHHHHHh
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.12 Aligned_cols=241 Identities=28% Similarity=0.417 Sum_probs=206.4
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
.+|.|++|.||++.+.. ++.||+|++...... ...+.+.+|++++++++|+||+++++++.+....|+||||+.+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 57899999999998877 999999998776433 4567899999999999999999999999999999999999999999
Q ss_pred chhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc---ccccCCC
Q psy6346 277 FDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL---ATWCGSP 352 (1238)
Q Consensus 277 ~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l---~t~~GTp 352 (1238)
.+++... ..+++..+..++.+++.||.|||++|++||||||+||+++.++.++|+|||++......... ....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9998653 46888999999999999999999999999999999999999999999999998754321111 1122356
Q ss_pred CCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 353 ~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+... ....|..++.++.+||.+||..+|.+
T Consensus 160 ~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 160 KWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred ccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence 6999999987765 899999999999999998 89999888777766666554 34456678899999999999999999
Q ss_pred CCCHHHHHhc
Q psy6346 431 RYCIEQIKRH 440 (1238)
Q Consensus 431 RPTaeEILeH 440 (1238)
|||++|+++.
T Consensus 239 Rp~~~ell~~ 248 (251)
T cd05041 239 RPSFSEIYNE 248 (251)
T ss_pred CcCHHHHHHH
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.94 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=208.1
Q ss_pred EEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
|.....+|.|++|.||.+... .++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 666688889999999988754 345679999986543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEE
Q psy6346 267 VSEYANQGEIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKL 330 (1238)
||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEE
Confidence 99999999999998653 23788999999999999999999999999999999999999999999
Q ss_pred EecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCc
Q psy6346 331 ADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRF 406 (1238)
Q Consensus 331 iDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~ 406 (1238)
+|||++....... ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+..+.+..+..
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 243 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC
Confidence 9999987543322 1223456788999999988776 889999999999999998 9999988877777776666543
Q ss_pred -cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 407 -RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 407 -~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+..++..+.+|+.+||..+|++||++.++++.
T Consensus 244 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 244 LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 3455678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.04 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=205.3
Q ss_pred EEEEEecCCCCccccCceEc----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 193 RKREKCGVKSRSCNRPPVLL----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~l----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
...+.||.|.||.||+|.+. ..+..|+||++... ......+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 35678899999999998887 34678999999553 35556889999999999999999999999999888899999
Q ss_pred eecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---
Q psy6346 269 EYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--- 343 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--- 343 (1238)
|||++|+|.+++... ..++...+..++.||+.||.|||+++++|+||++.||+++.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 679999999999999999999999999999999999999999999999999987652221
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIR 421 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIr 421 (1238)
......+...|+|||.+.+..+ +.++||||||+++|||++ |..||.+.+...+...+..+. ..++..++..+.++|.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred cccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence 1233446778999999988776 899999999999999999 789999988888777776553 3456678999999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q psy6346 422 KMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 422 kML~kDPskRPTaeEILe 439 (1238)
+||..||++||++.+|++
T Consensus 240 ~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHT-SSGGGS--HHHHHH
T ss_pred HHcCCChhhCcCHHHHHh
Confidence 999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.92 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=208.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCc----EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTV----NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~----kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
..|.....||.|++|+||+|.+..++. .||||++.... .....+.+.+|+.+++.+.|+||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 446677889999999999998876665 58999987653 344557889999999999999999999998754 578
Q ss_pred EEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999999999764 5689999999999999999999999999999999999999999999999999876543222
Q ss_pred c---ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHH
Q psy6346 345 L---ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESL 419 (1238)
Q Consensus 345 l---~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDL 419 (1238)
. ....+++.|+|||.+.+..+ +.++|||||||++|||++ |..||.......+...+..+. ...+..++.++.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMI 243 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHH
Confidence 1 12234678999999987776 889999999999999998 999998877776666665543 34456688999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..||++||++.+++..
T Consensus 244 i~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 244 MVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.57 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=206.1
Q ss_pred EEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
|.....+|.|+||.||++.... ....||+|++.... .......+.+|+.+++.++||||+++++.+...+..|+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3445678888888888887653 23579999987654 34456789999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc------------------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc
Q psy6346 267 VSEYANQGEIFDYIARY------------------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM 322 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~------------------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL 322 (1238)
||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987542 246788899999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHH
Q psy6346 323 DSNLDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLR 398 (1238)
Q Consensus 323 d~nG~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ 398 (1238)
++++.+||+|||++........ .....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.....+.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999875433221 223346678999999877765 889999999999999998 99999988887777
Q ss_pred HHHhcC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 399 DRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 399 ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
+.+... ....|..++.++.+||.+||..+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 766543 33456678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.67 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=214.9
Q ss_pred EEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCCC--hHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQLD--PVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~ld--~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ly 265 (1238)
|...+.||.|++|.||++... .++..||||++.+.... ....+.+.+|+.++.++ +||||+++++++......|
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 556788999999999988764 46789999999764321 23446788999999999 6999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK- 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~- 344 (1238)
+||||+.+++|.+++.....+++..+..++.|++.+|.|||+.|++||||+|.||+++.++.++|+|||++........
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc
Confidence 9999999999999998777899999999999999999999999999999999999999999999999999876543321
Q ss_pred -cccccCCCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCC----hhHHHHHHhcCCccCCCCCCHHHHH
Q psy6346 345 -LATWCGSPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGST----LNSLRDRVLSGRFRIPYFMSTECES 418 (1238)
Q Consensus 345 -l~t~~GTp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d----~eeL~ekIl~g~~~~P~~iS~eLkD 418 (1238)
.....|+..|+|||.+.+.. ..+.++||||||+++|+|++|..||.... ..++...+.......|..++.++.+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 241 (288)
T cd05583 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARD 241 (288)
T ss_pred ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHH
Confidence 22346899999999987654 24789999999999999999999996432 3344455556666777788999999
Q ss_pred HHHHhcccCCCCCCC---HHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRYC---IEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRPT---aeEILeHPWFke~ 446 (1238)
+|.+||+.||++||| +.++|+||||+..
T Consensus 242 li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 999999999999998 5678999999765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.28 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=208.7
Q ss_pred EEEEEEEecCCCCccccCceEccCC---cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHT---VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG---~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
.|+....+|.|+||.||++.+..++ ..||+|.++... .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4667788999999999998876444 379999987654 344567899999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-c
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-L 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-l 345 (1238)
|||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 9999999999999765 4689999999999999999999999999999999999999999999999999876543221 1
Q ss_pred ---ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHH
Q psy6346 346 ---ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLI 420 (1238)
Q Consensus 346 ---~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLI 420 (1238)
....++..|+|||++.+..+ +.++|+|||||++|+|++ |..||.+.+..+....+..+ ..+.+..+++.+.+++
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM 242 (267)
T ss_pred eecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHH
Confidence 11223567999999988776 889999999999999886 99999888777776666654 2334455788999999
Q ss_pred HHhcccCCCCCCCHHHHHh
Q psy6346 421 RKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILe 439 (1238)
.+||..+|.+||++.++++
T Consensus 243 ~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 243 LDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHcccCchhCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.76 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=207.1
Q ss_pred EEEEEEEecCCCCccccCceEc-------cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCC
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLL-------RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS 262 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~l-------ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d 262 (1238)
.|.....+|.|++|.||++... .....||+|++.... .......+.+|+.+++++ +||||+++++++...+
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 3556677888888888877643 235679999987653 344567889999999999 6999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcc----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG 326 (1238)
.+|+||||+.+++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 999999999999999998653 2478888999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHh
Q psy6346 327 DIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVL 402 (1238)
Q Consensus 327 ~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl 402 (1238)
.+||+|||++....... ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+....++...+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 250 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999997653221 1122234567999999987766 889999999999999999 999999888888777776
Q ss_pred cCC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 403 SGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 403 ~g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+. ...+..++.++.+||.+||..+|++||++.++++.
T Consensus 251 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 251 EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 653 34566788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.42 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=206.8
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------ 261 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------ 261 (1238)
++..|.....||.|++|.||++....++..||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 35678888999999999999999999999999999876543 3456788999999999999999999876543
Q ss_pred --------CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEe
Q psy6346 262 --------SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLAD 332 (1238)
Q Consensus 262 --------d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiD 332 (1238)
...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 588877754 46899999999999999999999999999999999999974 56789999
Q ss_pred cCCcccccCCC----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC----
Q psy6346 333 FGFSNYYVPGQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---- 404 (1238)
Q Consensus 333 FGLS~~~~~s~----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---- 404 (1238)
||++....... ......|+..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99986542211 1123357889999998766544588999999999999999999999876543333222211
Q ss_pred ---------------------Cc-----cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 ---------------------RF-----RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 ---------------------~~-----~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.. .+...++.++.+||.+||..||.+|||+++++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 0112467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=343.43 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=232.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVME 269 (1238)
|....+||+|+||.|-.+...-+.+.+|||+++++.+ ...+.+--+.|-++|... +-|.++.|+.+|.+-+++|+|||
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME 430 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME 430 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence 4556789999999999998888889999999999864 334555667888888877 46788999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc-cCCCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~-~~s~~l~t~ 348 (1238)
|+.||+|...|+..+++.+..+..++..|+.||-|||++|||+||||.+|||||.+|++||+|||++..- ..+....++
T Consensus 431 yvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTF 510 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTF 510 (683)
T ss_pred EecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeee
Confidence 9999999999999999999999999999999999999999999999999999999999999999999764 345567789
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
||||.|+|||++...+| +..+|.|++||+||||+.|++||+|++..++.+.|.+-...+|..+|.++.++++.+|.+.|
T Consensus 511 CGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P 589 (683)
T KOG0696|consen 511 CGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHP 589 (683)
T ss_pred cCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCC
Confidence 99999999999999998 99999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----HHHHHhcccccccC
Q psy6346 429 TKRYC-----IEQIKRHRWMAEET 447 (1238)
Q Consensus 429 skRPT-----aeEILeHPWFke~~ 447 (1238)
.+|.. -.+|..||||+...
T Consensus 590 ~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 590 GKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred ccccCCCCccccchhhCcchhhcc
Confidence 99974 46899999998643
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.03 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=208.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|.....||.|++|.||++....++..||||.+..... +......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 4455778999999999999989999999998876443 344557889999999999999999999999999999999999
Q ss_pred cCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cc
Q psy6346 271 ANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KL 345 (1238)
Q Consensus 271 ~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l 345 (1238)
+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccc
Confidence 999999998863 3458899999999999999999999999999999999999999999999999987654332 22
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh--hHHHHHHhcCCcc-C-CCCCCHHHHHHHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL--NSLRDRVLSGRFR-I-PYFMSTECESLIR 421 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~--eeL~ekIl~g~~~-~-P~~iS~eLkDLIr 421 (1238)
....|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||.+... ......+...... . +..++.++.+||.
T Consensus 164 ~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (267)
T cd08229 164 HSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 242 (267)
T ss_pred ccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHH
Confidence 34578999999999987776 7899999999999999999999976543 3444444433222 2 2347889999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q psy6346 422 KMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 422 kML~kDPskRPTaeEILe 439 (1238)
+||..||.+|||+++|++
T Consensus 243 ~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 243 MCINPDPEKRPDITYVYD 260 (267)
T ss_pred HhcCCCcccCCCHHHHHH
Confidence 999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.89 Aligned_cols=250 Identities=25% Similarity=0.457 Sum_probs=212.8
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
...+|.|++|.||++....++..||||++.... ......+.+|+.+++.++|+||+++++++...+..|+||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 356899999999999988899999999986432 334567899999999999999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccccCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWCGSPP 353 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~GTp~ 353 (1238)
+|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 103 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06657 103 ALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCcc
Confidence 99987754 568999999999999999999999999999999999999999999999999886543322 2234568899
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.........+... .+.....++..+.++|.+||..+|.+
T Consensus 182 y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 260 (292)
T cd06657 182 WMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260 (292)
T ss_pred ccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCccc
Confidence 999999887766 88999999999999999999999887665554444332 12223457889999999999999999
Q ss_pred CCCHHHHHhcccccccCC
Q psy6346 431 RYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 431 RPTaeEILeHPWFke~~p 448 (1238)
||++.+++.||||....+
T Consensus 261 R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 261 RATAAELLKHPFLAKAGP 278 (292)
T ss_pred CcCHHHHhcChHHhccCC
Confidence 999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.76 Aligned_cols=243 Identities=23% Similarity=0.381 Sum_probs=204.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....+|.|++|.||++... ++..||+|++...... .+.+.+|+.++++++|+||+++++++.. ...|+||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 3556678999999999998654 6677999999875543 3568899999999999999999998854 568999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--c
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--A 346 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--~ 346 (1238)
+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 9999999998753 45889999999999999999999999999999999999999999999999999765432211 1
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
...++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....+...+..+.+||.+||
T Consensus 162 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCW 240 (260)
T ss_pred CCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHc
Confidence 2335567999999887766 889999999999999999 99999988877777766654 44456678899999999999
Q ss_pred ccCCCCCCCHHHHHh
Q psy6346 425 VREPTKRYCIEQIKR 439 (1238)
Q Consensus 425 ~kDPskRPTaeEILe 439 (1238)
..+|++|||++++++
T Consensus 241 ~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 241 KKDPEERPTFEYLQS 255 (260)
T ss_pred ccCcccCcCHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.23 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=205.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|....++|.|++|.||++.+..+ ..||||++...... .+.+.+|+.++++++|+||+++++++.. +..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 4577888999999999999977544 46999999865432 3578899999999999999999998754 56899999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc--
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL-- 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l-- 345 (1238)
|+.+++|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999999753 35788999999999999999999999999999999999999999999999998765433221
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ....+..++..+.+||.+|
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 239 (262)
T ss_pred cCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 12346678999999887776 889999999999999999 89999888777776666544 2344556889999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|..+|.+||+++++++
T Consensus 240 l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 240 WRKEPEERPTFEYLQA 255 (262)
T ss_pred ccCCcccCCCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.61 Aligned_cols=254 Identities=22% Similarity=0.404 Sum_probs=208.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------CE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------SM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d~ 263 (1238)
..|.....||.|++|.||++....++..||||++.+........+.+.+|+.++++++|+||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 557777889999999999999889999999999987544444557788999999999999999999988543 34
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
.|++++++ +++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.... .
T Consensus 97 ~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~--~ 172 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--D 172 (345)
T ss_pred EEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc--c
Confidence 78888887 6788877754 468999999999999999999999999999999999999999999999999987542 2
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC------------------
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR------------------ 405 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~------------------ 405 (1238)
......|+..|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T cd07877 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252 (345)
T ss_pred cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence 23445788999999998774444889999999999999999999998765443333222110
Q ss_pred -----ccCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 406 -----FRIP--------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 406 -----~~~P--------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..+| ...++++.+||.+||..||.+||++.+++.||||.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0001 12578899999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=307.82 Aligned_cols=240 Identities=25% Similarity=0.412 Sum_probs=203.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEe-eeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM-ETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvf-ed~d~lyLVME 269 (1238)
.|.....+|.|++|.||++.. .+..||+|.+.... ..+.+.+|+.++++++|+||+++++++ ......|+|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 466678899999999998754 58889999986542 346788999999999999999999975 45667999999
Q ss_pred ecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
|+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~ 158 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DT 158 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CC
Confidence 999999999987643 37889999999999999999999999999999999999999999999999987543222 23
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~ 425 (1238)
..++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+...+...+..+ ....+..+++.+.++|.+||.
T Consensus 159 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05082 159 GKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWH 237 (256)
T ss_pred CccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence 345668999999987766 789999999999999997 99999988877777666554 334556789999999999999
Q ss_pred cCCCCCCCHHHHHh
Q psy6346 426 REPTKRYCIEQIKR 439 (1238)
Q Consensus 426 kDPskRPTaeEILe 439 (1238)
.+|++|||+.++++
T Consensus 238 ~~p~~Rpt~~~l~~ 251 (256)
T cd05082 238 LDAATRPSFLQLRE 251 (256)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.44 Aligned_cols=245 Identities=25% Similarity=0.412 Sum_probs=209.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.+|.|++|.||++.. .++..||||++...... .+.+.+|+.++++++|+||+++++++......++|||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEE-cCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4577788999999999999875 45688999999865433 4578899999999999999999999999899999999
Q ss_pred ecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--c
Q psy6346 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--L 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l 345 (1238)
|+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 999999999997653 689999999999999999999999999999999999999999999999999876543211 1
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....++..|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+.+.....+.+..+ ....+...+.++.+++.+|
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQC 240 (261)
T ss_pred hccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 12234568999999987766 889999999999999998 99999988877777776654 3345666789999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|..+|.+||++++++.
T Consensus 241 l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 241 WDKDPEERPTFEYLQS 256 (261)
T ss_pred cccCcccCCCHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.95 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=206.1
Q ss_pred EEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
+...+.+|.|+||.||++... .++..||+|.+... .....+.+.+|+++++.++|+||+++++++...+..|+
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 344577888888888887532 34678999998754 34556789999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhccc---------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEE
Q psy6346 267 VSEYANQGEIFDYIARYG---------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~---------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLi 331 (1238)
||||+.+++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEEC
Confidence 999999999999987543 47889999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-Cc
Q psy6346 332 DFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RF 406 (1238)
Q Consensus 332 DFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~ 406 (1238)
|||++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+ ..
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL 243 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC
Confidence 9999875433221 122345678999999988776 889999999999999998 99999887766666666554 34
Q ss_pred cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 407 RIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 407 ~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..+..+++.+.+||.+||..||.+||++++|++
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 244 ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=340.16 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=215.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
|.....||.|+||.||-+.+.++...||||.+.-+.. ..+....+..|+..|++++|||+|.+-++|-.+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4445668999999999999999999999999976653 345568899999999999999999999999999999999999
Q ss_pred cCCCccchhhh-cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 271 ANQGEIFDYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lk-k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
|- |+-.|++. ..+++-+.++..|+.+.+.||.|||+++.||||||..||||++.|.|||+|||.+....+ ..+++
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFv 183 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFV 183 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhccc
Confidence 97 56666664 346899999999999999999999999999999999999999999999999999876544 46789
Q ss_pred CCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCC-CCCCHHHHHHHHHhcc
Q psy6346 350 GSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIP-YFMSTECESLIRKMLV 425 (1238)
Q Consensus 350 GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P-~~iS~eLkDLIrkML~ 425 (1238)
|||+|||||++.. ...|+-++||||||++..||.-.++|+-..+......-|..... .++ ...+..+..||..||.
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLq 263 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 263 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHh
Confidence 9999999999863 33458899999999999999999999877776655555554433 333 2367889999999999
Q ss_pred cCCCCCCCHHHHHhcccccccC
Q psy6346 426 REPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWFke~~ 447 (1238)
+-|.+|||.+++|+|+|+....
T Consensus 264 KipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 264 KIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred hCcccCCcHHHHhhcchhccCC
Confidence 9999999999999999998764
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=307.64 Aligned_cols=244 Identities=25% Similarity=0.414 Sum_probs=206.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|....+||.|++|.||++. .+++..||+|++...... .+.+.+|+.++++++|+||+++++++. .+..|+|||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~-~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeee-cCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 457778899999999999986 456788999999865543 357889999999999999999999874 456899999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--c
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--L 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l 345 (1238)
|+.+++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 99999999988653 4688899999999999999999999999999999999999999999999999876542221 1
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....++..|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.+.......+..+ ....+..++.++.++|.+|
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC 239 (260)
T ss_pred cCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999987776 789999999999999998 99999988777776666544 2345566889999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|..+|++|||+++++.
T Consensus 240 l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 240 WKEKPEERPTFEYLRS 255 (260)
T ss_pred ccCChhhCCCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.01 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=204.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|++|.||++.+.. +..||+|++..... ..+.+.+|+.++++++|+||+++++++.. +..|+|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 347777889999999999987644 45699999876442 23568899999999999999999998854 56899999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--c
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--L 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l 345 (1238)
|+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999999754 3478889999999999999999999999999999999999999999999999876533221 1
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ...++..++..+.++|.+|
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239 (260)
T ss_pred CCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence 22345678999999887775 889999999999999999 99999988777776666554 3345667889999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|.+||.+||+++++++
T Consensus 240 l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 240 WKKDPDERPTFEYIQS 255 (260)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.38 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=209.4
Q ss_pred cEEEEEEEecCCCCccccCceEc-------cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-------RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETK 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-------ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~ 261 (1238)
..|.....+|.|+||.||.+.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 44666678888888888887643 234579999987543 345567899999999999 899999999999999
Q ss_pred CEEEEEEeecCCCccchhhhcc----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n 325 (1238)
...|+||||+.+++|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~ 173 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC
Confidence 9999999999999999998753 236777889999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHH
Q psy6346 326 LDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRV 401 (1238)
Q Consensus 326 G~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekI 401 (1238)
+.+||+|||++....... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..++...+
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 252 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 999999999987653322 1223345678999999988766 889999999999999998 89999998888888777
Q ss_pred hcCC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 402 LSGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 402 l~g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+. ...+..++.++.+||.+||..+|.+||++.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 253 KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 6553 34566688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.70 Aligned_cols=253 Identities=22% Similarity=0.388 Sum_probs=206.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------CE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------SM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d~ 263 (1238)
..|.....||.|++|.||++++..++..||||++.+..........+.+|+.+++.++|+||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 457778899999999999999988999999999987544444456788999999999999999999998654 34
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
+|+||||+. .+|..++ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-- 169 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-- 169 (342)
T ss_pred EEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--
Confidence 699999996 4565544 23688999999999999999999999999999999999999999999999999875422
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC------------------
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR------------------ 405 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~------------------ 405 (1238)
......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 22345678899999998775445889999999999999999999998876444333322210
Q ss_pred -----ccCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 406 -----FRIP--------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 406 -----~~~P--------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..++ ...++++.+||.+||+.||.+||++++++.||||....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 13567899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=306.79 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=208.4
Q ss_pred EEEEEEEecCCCCccccCceEccCCc---EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~---kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
.|.....+|.|++|.||++....++. .||||++.... .....+.+..|++++++++|+||+++++++...+..|+|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 45666889999999999998876554 79999987653 344567889999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc-
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL- 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l- 345 (1238)
|||+.+++|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999999998754 57899999999999999999999999999999999999999999999999998765332211
Q ss_pred -c--cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHH
Q psy6346 346 -A--TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLI 420 (1238)
Q Consensus 346 -~--t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLI 420 (1238)
. ....+..|+|||++.+..+ +.++|||||||++|+|++ |..||...+...+...+..+ ..+.+..++.++.+|+
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 243 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLM 243 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 1 1123456999999987766 889999999999999997 99999888777777776654 2233445789999999
Q ss_pred HHhcccCCCCCCCHHHHHh
Q psy6346 421 RKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILe 439 (1238)
.+||..+|++||++.+|++
T Consensus 244 ~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 244 LQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.12 Aligned_cols=238 Identities=23% Similarity=0.311 Sum_probs=197.9
Q ss_pred EecCCCCccccCceEccCC-------cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 197 KCGVKSRSCNRPPVLLRHT-------VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG-------~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.||.|+||.||++.....+ ..||+|++.... ....+.+..|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5788899999988776544 348999886542 3345678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc--------EEEEecCCccccc
Q psy6346 270 YANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD--------IKLADFGFSNYYV 340 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~--------VKLiDFGLS~~~~ 340 (1238)
|+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999997654 5899999999999999999999999999999999999987654 6999999886543
Q ss_pred CCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC-CCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHH
Q psy6346 341 PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG-ALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESL 419 (1238)
Q Consensus 341 ~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG-rlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDL 419 (1238)
.. ....++..|+|||++.+...++.++|||||||++|+|++| ..||...+...... +......+|...+.++.+|
T Consensus 160 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 235 (258)
T cd05078 160 PK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWTELANL 235 (258)
T ss_pred Cc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcHHHHHH
Confidence 32 2346888999999998755458899999999999999998 56776655544332 3344556777788899999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||+.||++|||+++|++.
T Consensus 236 i~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 236 INQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHhccChhhCCCHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=309.77 Aligned_cols=247 Identities=22% Similarity=0.372 Sum_probs=211.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCc----EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTV----NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~----kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
..|...+.||.|+||.||++....++. .||+|++.... .......+.+|+.++++++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 446677889999999999998776654 69999987664 34556788999999999999999999999987 7899
Q ss_pred EEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
+||||+.+++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999999998764 4689999999999999999999999999999999999999999999999999976543322
Q ss_pred cc---cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHH
Q psy6346 345 LA---TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESL 419 (1238)
Q Consensus 345 l~---t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDL 419 (1238)
.. ...++..|+|||.+....+ +.++|+|||||++|+|++ |..||.+....++.+.+..+. ...|...+.++.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMV 243 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 11 1223567999999877666 789999999999999998 999999988888887777653 45566788999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy6346 420 IRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILe 439 (1238)
+.+||..||.+||++.++++
T Consensus 244 ~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 244 LVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=353.17 Aligned_cols=252 Identities=23% Similarity=0.453 Sum_probs=222.1
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC--ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE--EEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL--DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM--IYIV 267 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l--d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~--lyLV 267 (1238)
.+....||.|+|-+||+|.+..+|..||.-.++...+ .+...++|..|+++|+.|+|||||++|++|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 4445789999999999999999999999776655443 55667999999999999999999999999976554 8899
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc--ceeeccCCcccccccCC-CcEEEEecCCcccccCCCc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR--RVVHRDLKAENLLMDSN-LDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk--GIIHRDLKPeNILLd~n-G~VKLiDFGLS~~~~~s~~ 344 (1238)
.|++..|+|+.|+++.+++....++.|++||+.||.|||++ .|||||||.+||||+.+ |.|||+|+|+|+..... .
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-H 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-c
Confidence 99999999999999999999999999999999999999988 59999999999999875 99999999999875433 3
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCC-CCChhHHHHHHhcCCcc--CCCCCCHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD-GSTLNSLRDRVLSGRFR--IPYFMSTECESLIR 421 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~-g~d~eeL~ekIl~g~~~--~P~~iS~eLkDLIr 421 (1238)
....+|||.|||||++. ..| +..+||||||++++||+|+..||. ..+...+++++..|..+ +-..-++++++||.
T Consensus 201 aksvIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred cceeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence 34478999999999987 444 899999999999999999999995 46788999999998654 33445889999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||.. .++|+|+.|+|.||||....
T Consensus 279 kCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHhcC-chhccCHHHHhhChhhcccc
Confidence 99999 99999999999999998863
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=304.03 Aligned_cols=245 Identities=23% Similarity=0.427 Sum_probs=208.5
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.+|.|++|.||++.+. .+..+|+|++...... ...+.+|++++++++||||+++++++......|+||||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 4566788999999999998775 4678999998765443 34688999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--ccc
Q psy6346 271 ANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--LAT 347 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l~t 347 (1238)
+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999999998754 4688999999999999999999999999999999999999999999999999875432211 112
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~ 425 (1238)
..++..|+|||++.+..+ +.++|||||||++|+|++ |..||.......+.+.+..+ ....|...+..+.+|+.+||.
T Consensus 161 ~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 239 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWK 239 (256)
T ss_pred CccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 234568999999987766 789999999999999998 99999988877777776654 333456678999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q psy6346 426 REPTKRYCIEQIKRH 440 (1238)
Q Consensus 426 kDPskRPTaeEILeH 440 (1238)
.+|++|||+++++++
T Consensus 240 ~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 240 ERPEDRPSFSLLLHQ 254 (256)
T ss_pred cChhhCCCHHHHHHh
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=312.08 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=205.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCc----EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTV----NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~----kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.|+..+.||.|+||.||++.+..++. .||+|++.... ......++..|+.++++++||||+++++++.. ...++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35566789999999999998877766 47777775432 33445778889999999999999999998764 45789
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK- 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~- 344 (1238)
|+||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 99999999999999764 5689999999999999999999999999999999999999999999999999976543321
Q ss_pred --cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHH
Q psy6346 345 --LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLI 420 (1238)
Q Consensus 345 --l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLI 420 (1238)
.....++..|+|||++.+..+ +.++|||||||++|||++ |..||.+.....+.+.+..+. ...+..++.++.+++
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM 244 (279)
T ss_pred cccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHH
Confidence 223456778999999987776 899999999999999998 999999887776666665543 234555788899999
Q ss_pred HHhcccCCCCCCCHHHHHhc
Q psy6346 421 RKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeH 440 (1238)
.+||..||.+|||+.|+++.
T Consensus 245 ~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 245 VKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=318.45 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=210.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
++|.....+|.|++|.||++....++..||||++..... .......+.+|+++++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 345566779999999999999888999999999976543 3345577889999999999999999999999999999999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.... ....
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~ 176 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANS 176 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCC
Confidence 9996 567776654 4568999999999999999999999999999999999999999999999999886432 2234
Q ss_pred ccCCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-c-CCCCCCHHHHHHHHHh
Q psy6346 348 WCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-R-IPYFMSTECESLIRKM 423 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~-~P~~iS~eLkDLIrkM 423 (1238)
..|+..|+|||++.. ....+.++|||||||++|+|++|..||...+.......+..... . ....++..+.+||.+|
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 578999999999852 22347899999999999999999999987765554444443322 1 1234677899999999
Q ss_pred cccCCCCCCCHHHHHhccccccc
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~ 446 (1238)
|..+|.+||++.+++.||||...
T Consensus 257 l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 257 LQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.92 Aligned_cols=249 Identities=20% Similarity=0.387 Sum_probs=203.6
Q ss_pred cEEEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee-CC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET-KS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed-~d 262 (1238)
..|+....||.|+||.||++.... +++.||+|++.... .....+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346777889999999999887543 35789999997543 334557788999999999 89999999998754 46
Q ss_pred EEEEEEeecCCCccchhhhcc-----------------------------------------------------------
Q psy6346 263 MIYIVSEYANQGEIFDYIARY----------------------------------------------------------- 283 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~----------------------------------------------------------- 283 (1238)
.++++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999888532
Q ss_pred --cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---cccccCCCCCCCcc
Q psy6346 284 --GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPE 358 (1238)
Q Consensus 284 --~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPE 358 (1238)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ .....++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 2578888999999999999999999999999999999999999999999999976533221 22334567899999
Q ss_pred cccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhH-HHHHHhcC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6346 359 VFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNS-LRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIE 435 (1238)
Q Consensus 359 VL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~ee-L~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTae 435 (1238)
++.+..+ +.++|||||||+||+|++ |..||.+....+ +...+..+ ....|...++++.+++.+||+.+|++||+++
T Consensus 246 ~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 246 SIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9988877 889999999999999997 999998755433 33333332 2334666789999999999999999999999
Q ss_pred HHHhc
Q psy6346 436 QIKRH 440 (1238)
Q Consensus 436 EILeH 440 (1238)
||++|
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=354.08 Aligned_cols=254 Identities=30% Similarity=0.558 Sum_probs=236.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
++....+|.|+||.|-.+........+|+|++++..+ +....+.+..|-.||..++.|+||+||..|.+..++|++||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 4445678899999888776665555699999988764 556678999999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccC
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCG 350 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~G 350 (1238)
|-||+|+..+.+.+.|++..++.++..+++|++|||++|||+|||||+|++|+.+|-+||.|||+++....+.+..++||
T Consensus 502 ClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcG 581 (732)
T KOG0614|consen 502 CLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCG 581 (732)
T ss_pred hcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHHHHHhcccCC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
||.|.|||++..+.. +.++|.|+||+++||||+|.+||.+.++...+..|+.| .+.+|..++..+.+||+++...+|
T Consensus 582 TpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P 660 (732)
T KOG0614|consen 582 TPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNP 660 (732)
T ss_pred CcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCc
Confidence 999999999999887 89999999999999999999999999999999999988 467899999999999999999999
Q ss_pred CCCCC-----HHHHHhccccccc
Q psy6346 429 TKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRPT-----aeEILeHPWFke~ 446 (1238)
.+|.. +.+|.+|.||...
T Consensus 661 ~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 661 TERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HhhhccccCChHHHHhhhhhhcC
Confidence 99985 8999999999764
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.45 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=205.7
Q ss_pred EEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
|.....+|.|+||.||++.+. .++..||||++.... .......+.+|+.++++++||||+++++++...+..|+
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 555667788888888887653 357889999987653 34445778999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhccc----------------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC
Q psy6346 267 VSEYANQGEIFDYIARYG----------------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS 324 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~----------------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~ 324 (1238)
||||+++++|.+++.... .+++..+..++.||+.||.|||..|++||||||.||+++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~ 165 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE 165 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecC
Confidence 999999999999986432 3677888999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHH
Q psy6346 325 NLDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDR 400 (1238)
Q Consensus 325 nG~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ek 400 (1238)
++.++|+|||++....... ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~ 244 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999986543221 1122335667999999988776 889999999999999997 8899988887777777
Q ss_pred HhcCCc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 401 VLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 401 Il~g~~-~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
+..+.. ..|..++.++.+||.+||..+|.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 245 VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 765543 345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=333.66 Aligned_cols=248 Identities=22% Similarity=0.385 Sum_probs=203.8
Q ss_pred EEEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~l 264 (1238)
.|.....||.|+||.||+|.+.. .+..||||++.... .....+.+.+|+++|++++ ||||+++++++.+.+.+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 45566889999999999987643 23579999997653 3345578999999999996 99999999999999999
Q ss_pred EEEEeecCCCccchhhhcc-------------------------------------------------------------
Q psy6346 265 YIVSEYANQGEIFDYIARY------------------------------------------------------------- 283 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~------------------------------------------------------------- 283 (1238)
|||||||++|+|.+++...
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999999999887542
Q ss_pred -----------------------------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcE
Q psy6346 284 -----------------------------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328 (1238)
Q Consensus 284 -----------------------------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~V 328 (1238)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence 136777788999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChh-HHHHHHhc
Q psy6346 329 KLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLN-SLRDRVLS 403 (1238)
Q Consensus 329 KLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~e-eL~ekIl~ 403 (1238)
||+|||++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... .+...+..
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~ 355 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence 9999999876533221 223356788999999988776 899999999999999997 99999875433 33344443
Q ss_pred C-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 404 G-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 404 g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+ ....+..++.++.+||.+||..||++||++.+|.+.
T Consensus 356 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 356 GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 3 334566788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=309.37 Aligned_cols=244 Identities=22% Similarity=0.272 Sum_probs=195.4
Q ss_pred EEEEEecCCCCccccCce----EccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEEEE
Q psy6346 193 RKREKCGVKSRSCNRPPV----LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIYI 266 (1238)
Q Consensus 193 karekIGsGsfGtVYKav----~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~lyL 266 (1238)
.....||.|+||.||.+. ...++..||+|++.... .....+.+.+|+++|++++||||+++++++.. ...+|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 555677888888886543 33567899999997653 33455778899999999999999999998765 346899
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-- 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-- 344 (1238)
||||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 86 v~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164 (283)
T ss_pred EecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhh
Confidence 9999999999999875 4599999999999999999999999999999999999999999999999999876543221
Q ss_pred --cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---------------HHHHHHhc-CCc
Q psy6346 345 --LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---------------SLRDRVLS-GRF 406 (1238)
Q Consensus 345 --l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---------------eL~ekIl~-g~~ 406 (1238)
.....++..|+|||.+.+..+ +.++|||||||++|+|++|..||...... .+.+.+.. ...
T Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05080 165 RVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243 (283)
T ss_pred ccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC
Confidence 122345667999999987766 88999999999999999999998643211 01111111 122
Q ss_pred cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 407 RIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 407 ~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..+..++.++.+|+.+||..+|++|||+++++.
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 345667899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=317.59 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=213.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....+|.|+||.||++....++..||||++..... .......+.+|++++++++|+|++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 346667789999999999999888999999999976543 3344578899999999999999999999999999999999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
||+.| +|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..... ...
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~ 180 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS 180 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence 99975 67776643 45689999999999999999999999999999999999999999999999998865432 234
Q ss_pred ccCCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cC-CCCCCHHHHHHHHHh
Q psy6346 348 WCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RI-PYFMSTECESLIRKM 423 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~-P~~iS~eLkDLIrkM 423 (1238)
..|++.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+..... .. +..+++.+.+||.+|
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 568899999999742 22247899999999999999999999987766555555544432 22 334788899999999
Q ss_pred cccCCCCCCCHHHHHhcccccccCCC
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEETPR 449 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~~p~ 449 (1238)
|..+|.+||++.++++|+|+....+.
T Consensus 261 l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred ccCCcccCcCHHHHHhChhhhccCcc
Confidence 99999999999999999999776443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=316.28 Aligned_cols=248 Identities=21% Similarity=0.376 Sum_probs=205.4
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ 263 (1238)
..|.....||.|++|.||++.+. .++..||||+++... .....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 34677778888888888887652 345689999987653 334557889999999999 79999999999999999
Q ss_pred EEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 264 IYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
.|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++.....
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999997543 389999999999999999999999999999999999999999999999999875533
Q ss_pred CCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhc-C-CccCCCCCCHH
Q psy6346 342 GQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLS-G-RFRIPYFMSTE 415 (1238)
Q Consensus 342 s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~-g-~~~~P~~iS~e 415 (1238)
... .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+............ + ....+...+++
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHH
Confidence 221 122345678999999988776 889999999999999998 9999987665443333332 2 22345567899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILe 439 (1238)
+.+|+.+||..+|++|||+.|++.
T Consensus 273 ~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 273 IYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=308.39 Aligned_cols=248 Identities=20% Similarity=0.345 Sum_probs=208.5
Q ss_pred EEEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
.|.....+|.|+||.||++.... ....||+|.+.... .....+.+.+|++++++++|+||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 35566778888888888887643 35679999986543 2335678999999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhccc---------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCc
Q psy6346 266 IVSEYANQGEIFDYIARYG---------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~---------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS 336 (1238)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999997655 6899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCC--ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCcc--CCCC
Q psy6346 337 NYYVPGQ--KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRFR--IPYF 411 (1238)
Q Consensus 337 ~~~~~s~--~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~~--~P~~ 411 (1238)
....... ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+... .+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC
Confidence 6432221 2223356777999999887765 789999999999999998 89999887777777776655433 3556
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 412 MSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 412 iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
++..+.++|.+||..+|.+||++.+++..
T Consensus 244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 88999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=306.79 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=207.1
Q ss_pred EEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
.|.....+|.|++|.||+|.+... ...||||...... .....+.+.+|+.++++++||||+++++++.+ ...|+|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 356678899999999999887644 3579999986553 34556789999999999999999999999876 457899
Q ss_pred EeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc-
Q psy6346 268 SEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL- 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l- 345 (1238)
|||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 99999999999997644 5899999999999999999999999999999999999999999999999998765433211
Q ss_pred -ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHH
Q psy6346 346 -ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 346 -~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrk 422 (1238)
....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..++..+.++|.+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (270)
T cd05056 165 ASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 243 (270)
T ss_pred cCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 12234567999999887766 889999999999999986 99999888776666666554 345667789999999999
Q ss_pred hcccCCCCCCCHHHHHhc
Q psy6346 423 MLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeH 440 (1238)
||..+|.+|||+.+++..
T Consensus 244 ~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 244 CWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=313.55 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=199.1
Q ss_pred EEEEEEEecCCCCccccCceEcc--------------CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLR--------------HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ 256 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lk--------------tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~d 256 (1238)
.|...+.||.|+||.||.+.... ....||||++.... .......+.+|+++|++++|+||+++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 35556677777777777765532 23459999997653 4445678999999999999999999999
Q ss_pred EeeeCCEEEEEEeecCCCccchhhhccc------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC
Q psy6346 257 VMETKSMIYIVSEYANQGEIFDYIARYG------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS 324 (1238)
Q Consensus 257 vfed~d~lyLVMEy~~GGSL~d~Lkk~~------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~ 324 (1238)
++...+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 9999999999999999999999886432 3677888999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh--CCCCCCCCChhHHHH
Q psy6346 325 NLDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC--GALPFDGSTLNSLRD 399 (1238)
Q Consensus 325 nG~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT--GrlPF~g~d~eeL~e 399 (1238)
++.+||+|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+......
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 99999999999875433221 122345678999999987776 899999999999999987 778898776655444
Q ss_pred HHhc-----C---CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 400 RVLS-----G---RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 400 kIl~-----g---~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.+.. + ....+..+++.+.+||.+||..||++||++++|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3321 1 12234557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.16 Aligned_cols=235 Identities=23% Similarity=0.317 Sum_probs=193.1
Q ss_pred EecCCCCccccCceEccCC----------cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 197 KCGVKSRSCNRPPVLLRHT----------VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG----------~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.||.|+||.||++.+..++ ..|++|++..... ....+.+|+.+|++++||||+++++++.. ...++
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 4678888888888777655 4588888765431 15788899999999999999999999988 77899
Q ss_pred EEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-------cEEEEecCCccc
Q psy6346 267 VSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-------DIKLADFGFSNY 338 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-------~VKLiDFGLS~~ 338 (1238)
||||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999999999998766 789999999999999999999999999999999999999887 799999999876
Q ss_pred ccCCCccccccCCCCCCCcccccCC-ccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCccCCCCCCHHH
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRFRIPYFMSTEC 416 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eL 416 (1238)
... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+......... .....+......+
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (259)
T cd05037 158 VLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCAEL 233 (259)
T ss_pred ccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCchHH
Confidence 433 2234567889999999876 334889999999999999999 688887765443333332 2222333344789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHh
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILe 439 (1238)
.++|.+||..+|.+|||+.++++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 234 ANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.26 Aligned_cols=241 Identities=21% Similarity=0.356 Sum_probs=202.7
Q ss_pred EecCCCCccccCceEccCC------cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 197 KCGVKSRSCNRPPVLLRHT------VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG------~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.+|.|++|.||++.+.... ..||||.+.+.. .......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 4788888888888776433 789999986543 234567889999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc-------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-----cEEEEecCCccc
Q psy6346 271 ANQGEIFDYIARY-------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-----DIKLADFGFSNY 338 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-----~VKLiDFGLS~~ 338 (1238)
+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998642 3377888999999999999999999999999999999999877 899999999875
Q ss_pred ccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCC
Q psy6346 339 YVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMS 413 (1238)
Q Consensus 339 ~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS 413 (1238)
..... ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .+..+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence 43221 1223345778999999988776 899999999999999998 99999887776666665543 345667789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..+.+||.+||..+|.+||+++++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=319.31 Aligned_cols=249 Identities=22% Similarity=0.379 Sum_probs=206.9
Q ss_pred EEEEEEEecCCCCccccCceEcc-------CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCC
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLR-------HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS 262 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lk-------tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d 262 (1238)
.|.....||.|+||.||.+.... .+..||+|++.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35566777888888888776542 23479999887543 445567899999999999 8999999999999999
Q ss_pred EEEEEEeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG 326 (1238)
.+|+||||+.+++|.+++.+.. .++...+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 9999999999999999987532 367788889999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHh
Q psy6346 327 DIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVL 402 (1238)
Q Consensus 327 ~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl 402 (1238)
.+||+|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..++...+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 250 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999875433221 122234567999999988776 789999999999999998 899999988888877776
Q ss_pred cCC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy6346 403 SGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 403 ~g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHP 441 (1238)
.+. ...+..++.++.+||.+||..+|.+||++.+++++-
T Consensus 251 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 251 EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 653 345667889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=312.12 Aligned_cols=220 Identities=25% Similarity=0.344 Sum_probs=182.1
Q ss_pred CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhhhc-ccccchhHHHH
Q psy6346 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIAR-YGRMNENAARR 293 (1238)
Q Consensus 215 G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk-~~~Lsesea~k 293 (1238)
...||+|++.... ......+.+|+.+++.++||||+++++++.+....|+||||+++++|..++.+ .+.+++..+..
T Consensus 44 ~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~ 121 (274)
T cd05076 44 ELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121 (274)
T ss_pred eeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHH
Confidence 3569999986543 23346788999999999999999999999999999999999999999998865 46789999999
Q ss_pred HHHHHHHHHhHhhccceeeccCCcccccccCCC-------cEEEEecCCcccccCCCccccccCCCCCCCcccccCCccC
Q psy6346 294 KFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-------DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYC 366 (1238)
Q Consensus 294 I~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-------~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~ 366 (1238)
++.||+.||+|||++||+||||||+|||++..+ .+||+|||++...... ....++..|+|||.+.+....
T Consensus 122 i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~ 198 (274)
T cd05076 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSL 198 (274)
T ss_pred HHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCC
Confidence 999999999999999999999999999997643 3899999987543222 234578889999998765445
Q ss_pred CCccceehhhHHHHHHh-hCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 367 GPEIDIWSLGVVLYVLV-CGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 367 S~KSDIWSLGVILYELL-TGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+.++|||||||++|+|+ +|..||.+....+... +......+|...++++.+||.+||..+|++|||+.+|+++
T Consensus 199 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 199 STAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 89999999999999984 7999998776554433 2333344555667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.78 Aligned_cols=249 Identities=19% Similarity=0.300 Sum_probs=209.7
Q ss_pred CcEEEEEEEecCCCCccccCceEcc----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee-CCE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLR----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-KSM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lk----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-~d~ 263 (1238)
+..|...+.||.|+||.||+|.+.. .+..||+|++... ......+.+.+|+.++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3557778899999999999998875 3688999998644 355567889999999999999999999998765 577
Q ss_pred EEEEEeecCCCccchhhhcc--------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCC
Q psy6346 264 IYIVSEYANQGEIFDYIARY--------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~--------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
.++++||+.+++|.+++... ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998653 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCC
Q psy6346 336 SNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPY 410 (1238)
Q Consensus 336 S~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~ 410 (1238)
++.+..... .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..++...+..+ ....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 976533321 112345677999999987776 899999999999999998 99999988777776666554 223445
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.+++++.+++.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 57899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=309.48 Aligned_cols=238 Identities=22% Similarity=0.337 Sum_probs=192.5
Q ss_pred EecCCCCccccCceEc------------cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 197 KCGVKSRSCNRPPVLL------------RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 197 kIGsGsfGtVYKav~l------------ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.+|.|++|.||++... .....||+|++.... ......+..|+.+++.++||||+++++++..+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4667777777776543 224468999976543 33446788899999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc-------EEEEecCCc
Q psy6346 265 YIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD-------IKLADFGFS 336 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~-------VKLiDFGLS 336 (1238)
++||||+.+++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999998888653 56899999999999999999999999999999999999986654 899999998
Q ss_pred ccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHh-hCCCCCCCCChhHHHHHHhcCCccCCCCCCHH
Q psy6346 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV-CGALPFDGSTLNSLRDRVLSGRFRIPYFMSTE 415 (1238)
Q Consensus 337 ~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELL-TGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~e 415 (1238)
...... ....++..|+|||.+.+...++.++|||||||++|+|+ .|..||......+... +...........+.+
T Consensus 160 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (262)
T cd05077 160 ITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPSCKE 235 (262)
T ss_pred ccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCChHH
Confidence 654322 23467889999999875444588999999999999997 5999998766544432 333333344445688
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+.+||.+||..||.+||++.+|+++
T Consensus 236 ~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 236 LADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=305.22 Aligned_cols=242 Identities=21% Similarity=0.372 Sum_probs=199.0
Q ss_pred EecCCCCccccCceEcc---CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee-eCCEEEEEEeecC
Q psy6346 197 KCGVKSRSCNRPPVLLR---HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME-TKSMIYIVSEYAN 272 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lk---tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe-d~d~lyLVMEy~~ 272 (1238)
.||.|+||.||+|.+.. .+..||||.+.... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 47888899999887653 34679999986432 3445678899999999999999999999765 4566899999999
Q ss_pred CCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-----ccc
Q psy6346 273 QGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-----KLA 346 (1238)
Q Consensus 273 GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-----~l~ 346 (1238)
+++|.+++.+. ..++...+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999998764 346777788999999999999999999999999999999999999999999987543211 112
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML 424 (1238)
...++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+...+...+..+. ...+..++..+.+++.+||
T Consensus 161 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 239 (262)
T cd05058 161 GAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW 239 (262)
T ss_pred cCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHc
Confidence 2345678999999987776 889999999999999999 577888777767666666553 3345567899999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy6346 425 VREPTKRYCIEQIKRH 440 (1238)
Q Consensus 425 ~kDPskRPTaeEILeH 440 (1238)
..+|++||++.+++..
T Consensus 240 ~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 240 HPKPEMRPTFSELVSR 255 (262)
T ss_pred CCChhhCCCHHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=312.77 Aligned_cols=255 Identities=21% Similarity=0.352 Sum_probs=207.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....+|.|++|.||++.+..++..||||++.+.... .....+..|+.++.++ +|+||+++++++.+....|+||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4466778999999999999999888999999999865432 3345667788777666 5999999999999999999999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||+. +.|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++..........
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~ 172 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence 9986 466666554 3568899999999999999999997 599999999999999999999999999987654444344
Q ss_pred cccCCCCCCCcccccCCc---cCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcCC-ccCCC--CCCHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKK---YCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSGR-FRIPY--FMSTECESL 419 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~---y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g~-~~~P~--~iS~eLkDL 419 (1238)
...++..|+|||.+.+.. ..+.++|||||||++|+|++|+.||..... .+....+.... ..++. .++.++.+|
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSF 252 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Confidence 456888999999987653 237899999999999999999999976332 23333343332 22232 368899999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|.+||..||.+||++++++.|+||...
T Consensus 253 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 253 VDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHccCChhhCCCHHHHhcChhhhcc
Confidence 999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=340.96 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=221.3
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
.+||.+.+++|+|++|.||++++..+|..||||.+..+ .+++++..||.||.+++.|++|++|+.+-....+||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 36777888999999999999999999999999999865 36788999999999999999999999998888999999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccc
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~ 346 (1238)
|||..|++.+.+.. ++.+++.++..+++..+.||+|||...-||||||..||||+.+|..||.|||.+...... .+..
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 99999999999874 578999999999999999999999999999999999999999999999999998765432 3567
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHHHHHHHh
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLkDLIrkM 423 (1238)
+.+|||.|||||++..-.| +.++||||||+...||..|++||.+.-+....-.|-.. .|+-|...+.++.|||++|
T Consensus 188 TVIGTPFWMAPEVI~EIGY-~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGY-DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhcc-chhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 8899999999999998887 88999999999999999999999875443221112111 1223445688899999999
Q ss_pred cccCCCCCCCHHHHHhccccccc
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~ 446 (1238)
|.++|++|.|+-++++|+|++..
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999999999875
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.29 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=210.0
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee-CCEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-KSMIYIV 267 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-~d~lyLV 267 (1238)
+..|.....||.|++|.||++....++..||||++.+........+.+.+|+++++.++||||+++++++.. ....|+|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 456888899999999999999999999999999987655444456778899999999999999999999865 5678999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
|||+ +++|..++.. ..+++..+..++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++..... ....
T Consensus 89 ~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~ 164 (328)
T cd07856 89 TELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTG 164 (328)
T ss_pred eehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCC
Confidence 9999 4678777754 4678888999999999999999999999999999999999999999999999875322 2234
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh---------------cC--------
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL---------------SG-------- 404 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl---------------~g-------- 404 (1238)
..++..|+|||++.+...++.++|||||||++|+|++|..||.+.........+. ..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 5678899999998764445899999999999999999999998765422111110 00
Q ss_pred ---CccCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy6346 405 ---RFRIP-----YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449 (1238)
Q Consensus 405 ---~~~~P-----~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p~ 449 (1238)
....| ..++.++.++|.+||..+|++|||+++++.||||......
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00111 2367889999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.29 Aligned_cols=250 Identities=27% Similarity=0.483 Sum_probs=211.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCC---CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ---LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~---ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
|.....||.|++|.||++.+...+..+++|+++... ........+.+|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 566788999999999999888777777777765432 23334456778999999999999999999999999999999
Q ss_pred eecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 269 EYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence 99999999988854 356899999999999999999999999999999999999975 569999999987654332
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRK 422 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrk 422 (1238)
......|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+..+. ..++..++.++.++|.+
T Consensus 161 ~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (260)
T cd08222 161 LATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS 239 (260)
T ss_pred cccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence 2334568899999999877666 788999999999999999999998877666666665543 33456688999999999
Q ss_pred hcccCCCCCCCHHHHHhcccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWF 443 (1238)
||..+|++||+++++++||||
T Consensus 240 ~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 240 MLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.86 Aligned_cols=229 Identities=23% Similarity=0.306 Sum_probs=194.7
Q ss_pred CCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhh
Q psy6346 201 KSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYI 280 (1238)
Q Consensus 201 GsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~L 280 (1238)
|.++.||.+.+..++..||+|++.+.. ...+|...+....||||+++++++...+..|+||||++|++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 678889999999999999999997653 2334555666678999999999999999999999999999999999
Q ss_pred hcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCCCCcccc
Q psy6346 281 ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVF 360 (1238)
Q Consensus 281 kk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL 360 (1238)
.+...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .....++..|+|||.+
T Consensus 77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVG 154 (237)
T ss_pred HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCccc
Confidence 88788999999999999999999999999999999999999999999999999987654332 2334567789999998
Q ss_pred cCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCH-----H
Q psy6346 361 EGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCI-----E 435 (1238)
Q Consensus 361 ~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTa-----e 435 (1238)
.+..+ +.++|+||+||++|+|++|..||....... .......+|..+++.+.+||.+||..||++|+++ +
T Consensus 155 ~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~ 229 (237)
T cd05576 155 GISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE 229 (237)
T ss_pred CCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence 87766 789999999999999999998886432210 0112344677889999999999999999999985 9
Q ss_pred HHHhcccc
Q psy6346 436 QIKRHRWM 443 (1238)
Q Consensus 436 EILeHPWF 443 (1238)
++++||||
T Consensus 230 ~~~~h~~~ 237 (237)
T cd05576 230 DIKSHPFF 237 (237)
T ss_pred HHHcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.46 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=198.3
Q ss_pred EEEEEEecCCCCccccCceEc----------------cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL----------------RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLF 255 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l----------------ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~ 255 (1238)
|...+.||.|+||.||.+... .++..||+|++.... .......+.+|+.+|+.++|+||++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 556667777777777765322 234579999987653 344567899999999999999999999
Q ss_pred EEeeeCCEEEEEEeecCCCccchhhhccc-----------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC
Q psy6346 256 QVMETKSMIYIVSEYANQGEIFDYIARYG-----------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS 324 (1238)
Q Consensus 256 dvfed~d~lyLVMEy~~GGSL~d~Lkk~~-----------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~ 324 (1238)
+++...+..|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~ 165 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcC
Confidence 99999999999999999999999987542 3566789999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh--CCCCCCCCChhHHHH
Q psy6346 325 NLDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC--GALPFDGSTLNSLRD 399 (1238)
Q Consensus 325 nG~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT--GrlPF~g~d~eeL~e 399 (1238)
++.++|+|||++........ .....+++.|++||+..+..+ +.++|||||||++|||++ |..||...+..+...
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 99999999999876533221 122334678999999887776 899999999999999998 789998766555443
Q ss_pred HHhc--------CCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 400 RVLS--------GRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 400 kIl~--------g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.... ...+.+..+++.+.+||.+||..||.+||++.+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3211 112345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=345.80 Aligned_cols=236 Identities=24% Similarity=0.395 Sum_probs=209.1
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.+-+|.|+.|.||.|.. .++.||||+++.-. ..+|+-|++|+|+||+.+.++|.....+|||||||..|
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 35679999999999865 58899999875321 25788899999999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPY 354 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~Y 354 (1238)
-|..+|+....++......|..+|+.|+.|||.++|||||||.-||||..+..|||+|||.+...........++||..|
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaW 277 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAW 277 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhh
Confidence 99999999999999999999999999999999999999999999999999999999999999887666666788999999
Q ss_pred CCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHHHHHhcccCCCCCC
Q psy6346 355 AAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLVREPTKRY 432 (1238)
Q Consensus 355 mAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDLIrkML~kDPskRP 432 (1238)
||||++...+. +.|+|||||||||||||||..||.+.+...+.--+-.. .++.|..+++.++=||+.||.-.|..||
T Consensus 278 MAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRP 356 (904)
T KOG4721|consen 278 MAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP 356 (904)
T ss_pred hCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCc
Confidence 99999999886 99999999999999999999999876644332222111 3457888999999999999999999999
Q ss_pred CHHHHHhccc
Q psy6346 433 CIEQIKRHRW 442 (1238)
Q Consensus 433 TaeEILeHPW 442 (1238)
++.+||.|-=
T Consensus 357 SFrqil~Hld 366 (904)
T KOG4721|consen 357 SFRQILLHLD 366 (904)
T ss_pred cHHHHHHHHh
Confidence 9999999943
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=352.50 Aligned_cols=148 Identities=23% Similarity=0.397 Sum_probs=136.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+++.||||++++... +......+.+|+.+++.++|+||+++++++...+.+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 357788999999999999999999999999999986543 4445578899999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
||+.|++|.+++...+.+++..++.++.||+.||.|||.+||+||||||+||||+.++.+||+|||++.
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999888889999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=345.92 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=190.5
Q ss_pred CcEEEEEEEecCCCCccccCceEccC-CcEEEEE--------------EeccC-CCChHhHHHHHHHHHHHHhCCCCCee
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRH-TVNVAIK--------------IIDKS-QLDPVNLQKVYREVEIMKQLDHPHII 252 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lkt-G~kVAIK--------------VLkks-~ld~e~ikrf~rEIeILkkL~HPNIV 252 (1238)
...|...+.||.|+||.||++..... +..+++| ++.+. .........+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 34577777888888888887654322 2222222 11111 11223456788999999999999999
Q ss_pred EEEEEeeeCCEEEEEEeecCCCccchhhhcc-----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc
Q psy6346 253 KLFQVMETKSMIYIVSEYANQGEIFDYIARY-----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327 (1238)
Q Consensus 253 rL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~-----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~ 327 (1238)
++++++...+..|+|++++. ++|.+++... .......++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 5677666432 23346678899999999999999999999999999999999999
Q ss_pred EEEEecCCcccccCCC--ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCC-CCCCC---hhHHHHHH
Q psy6346 328 IKLADFGFSNYYVPGQ--KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGST---LNSLRDRV 401 (1238)
Q Consensus 328 VKLiDFGLS~~~~~s~--~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlP-F~g~d---~eeL~ekI 401 (1238)
+||+|||++..+.... .....+||+.|+|||++.+..+ +.++|||||||+||||++|..+ |.+.. ...+.+.+
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999997664432 2234689999999999998876 8999999999999999998754 43221 11121111
Q ss_pred hcC---CccCC----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 402 LSG---RFRIP----------------------------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 402 l~g---~~~~P----------------------------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
... ...+| ..++.++.++|.+||..||.+|||+.|+|.||||...
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 100 00000 1246678889999999999999999999999999765
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=370.15 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=229.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC-CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~-ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
+.|.....||.|+||.|..+....+++.||+|++++-. +...+-.-|..|-.||..-+.+.|+.|+..|.++.++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 44666788999999999999999999999999998743 23344567888999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
||++||+|..++.++.++++..++.++..|+.||.-||+.|+|||||||+|||||..|++||+|||.|-.+.... ...
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~ 234 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSS 234 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEec
Confidence 999999999999999999999999999999999999999999999999999999999999999999987765333 345
Q ss_pred cccCCCCCCCccccc----CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCC--CCCCHHHHH
Q psy6346 347 TWCGSPPYAAPEVFE----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIP--YFMSTECES 418 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P--~~iS~eLkD 418 (1238)
..+|||.|.+||++. +...|++.+|.||+||++|||+.|..||..++..+.+.+|+.- .+.|| ..+|+++++
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakd 314 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKD 314 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHH
Confidence 678999999999985 3245699999999999999999999999999999999999875 67778 458999999
Q ss_pred HHHHhcccCCCCCCC---HHHHHhcccccccCC
Q psy6346 419 LIRKMLVREPTKRYC---IEQIKRHRWMAEETP 448 (1238)
Q Consensus 419 LIrkML~kDPskRPT---aeEILeHPWFke~~p 448 (1238)
||+++|. +|..|.. ++++..||||.+..+
T Consensus 315 LI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 315 LIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 9999886 7899988 999999999987543
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=342.85 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=211.2
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
|..|...+.||.||.+.||++.. .+...||+|.+.....+...+.-+.+||..|.+| +|.+||.||||-..++++|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 56678888999999999999853 4456677777777777888899999999999999 699999999999999999999
Q ss_pred EeecCCCccchhhhcccccc-hhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---
Q psy6346 268 SEYANQGEIFDYIARYGRMN-ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--- 343 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Ls-esea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--- 343 (1238)
|||-+ .+|..+|.+..... ...++.+.+||+.|+.++|.+||||.||||.|+|+- .|.+||+|||+|.......
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccce
Confidence 99875 78999998776543 357888999999999999999999999999999985 5789999999998765543
Q ss_pred ccccccCCCCCCCcccccCCcc----------CCCccceehhhHHHHHHhhCCCCCCCCC-hhHHHHHHhcC--CccCCC
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKY----------CGPEIDIWSLGVVLYVLVCGALPFDGST-LNSLRDRVLSG--RFRIPY 410 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y----------~S~KSDIWSLGVILYELLTGrlPF~g~d-~eeL~ekIl~g--~~~~P~ 410 (1238)
...+.+||+.||+||.+....+ .+.++||||||||||+|+.|+.||.... .......|... .++||.
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~ 596 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD 596 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence 3457899999999999854322 3678999999999999999999996543 33333444444 345666
Q ss_pred CCCHH-HHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 411 FMSTE-CESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 411 ~iS~e-LkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.-+.. +.++++.||.+||++||++.++|+|||+.-
T Consensus 597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 55544 999999999999999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=316.48 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=210.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....+|.|++|.||++....++..||||.+..... ......++.+|+++++.++|+|++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 445566778999999999999988999999999875432 3344567889999999999999999999999999999999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~ 170 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NX 170 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---cc
Confidence 9997 577776643 456899999999999999999999999999999999999999999999999998764332 34
Q ss_pred ccCCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-c-CCCCCCHHHHHHHHHh
Q psy6346 348 WCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-R-IPYFMSTECESLIRKM 423 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~-~P~~iS~eLkDLIrkM 423 (1238)
..|++.|+|||++.+ ....+.++|||||||++|+|++|..||...+.......+..... . .+..++..+.+||++|
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence 568899999999753 22237899999999999999999999977665444444443322 2 2335788999999999
Q ss_pred cccCCCCCCCHHHHHhccccccc
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~ 446 (1238)
|..+|.+||+++++++|+|+...
T Consensus 251 l~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 251 LQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred hhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=301.76 Aligned_cols=245 Identities=22% Similarity=0.383 Sum_probs=206.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
.+.|.....+|.|++|.||++.+ ..+..||+|++.... ...+.+.+|+.++++++|+||+++++++.. ...|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 45688889999999999999964 456679999987542 345678899999999999999999999887 7789999
Q ss_pred eecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--
Q psy6346 269 EYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-- 344 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-- 344 (1238)
||+++++|.+++.+. ..++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999999753 4578888999999999999999999999999999999999999999999999876533221
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrk 422 (1238)
.....++..|+|||++.+..+ +.++|+|||||++|+|++ |..||.+.+...+...+..+ ....+...+.++.+++.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 238 (260)
T ss_pred ccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHH
Confidence 112235667999999987765 889999999999999998 99999988777766666554 223455688999999999
Q ss_pred hcccCCCCCCCHHHHHh
Q psy6346 423 MLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 423 ML~kDPskRPTaeEILe 439 (1238)
||..+|++||++.++++
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 239 CWKNRPEERPTFEYIQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.20 Aligned_cols=242 Identities=19% Similarity=0.285 Sum_probs=191.5
Q ss_pred EecCCCCccccCceEcc--CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLR--HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lk--tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+......|+||||+.+|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 46788888888875432 34578999876543 3445567889999999999999999999999999999999999999
Q ss_pred ccchhhhccc-----ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---cc
Q psy6346 275 EIFDYIARYG-----RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---LA 346 (1238)
Q Consensus 275 SL~d~Lkk~~-----~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---l~ 346 (1238)
+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999987643 245777889999999999999999999999999999999999999999999865322211 12
Q ss_pred cccCCCCCCCcccccC------CccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHh-cCCcc-----CCCCCC
Q psy6346 347 TWCGSPPYAAPEVFEG------KKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVL-SGRFR-----IPYFMS 413 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~g------k~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl-~g~~~-----~P~~iS 413 (1238)
...+++.|+|||++.. ....+.++|||||||++|+|++ |..||......+....+. ..... ++..++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 2345677999999743 1223789999999999999998 889998776555444433 33222 233578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+.+++..|+ .||++|||+++|++-
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 88999999998 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.50 Aligned_cols=241 Identities=24% Similarity=0.393 Sum_probs=204.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|.....+|.|++|.||.+. .++..||+|++.... ..+.+.+|+.++++++||||+++++++.... .|+|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEE
Confidence 346777899999999999875 478889999986542 3357889999999999999999999987654 799999
Q ss_pred ecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCC
Confidence 999999999997643 4788999999999999999999999999999999999999999999999998753322 122
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~ 425 (1238)
...+..|+|||.+.+..+ +.++|+|||||++|+|++ |+.||...+..+....+..+. ...+..++..+.+||.+||.
T Consensus 157 ~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 157 SKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred CCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcC
Confidence 334567999999987766 889999999999999997 999999888877777666552 33455678999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q psy6346 426 REPTKRYCIEQIKRH 440 (1238)
Q Consensus 426 kDPskRPTaeEILeH 440 (1238)
.+|.+||++++++..
T Consensus 236 ~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 236 TEPKKRPSFHKLREK 250 (254)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.62 Aligned_cols=248 Identities=24% Similarity=0.438 Sum_probs=210.0
Q ss_pred EEEEEEecCCCCccccCceEcc-CCcEEEEEEeccCC--------CChHhHHHHHHHHHHHHh-CCCCCeeEEEEEeeeC
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLR-HTVNVAIKIIDKSQ--------LDPVNLQKVYREVEIMKQ-LDHPHIIKLFQVMETK 261 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lk-tG~kVAIKVLkks~--------ld~e~ikrf~rEIeILkk-L~HPNIVrL~dvfed~ 261 (1238)
|...+.||.|++|.||++.+.. .+..+|+|.+.... .......++.+|+.++.+ ++|+||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4556778999999999998877 67899999986432 223455678889998875 7999999999999999
Q ss_pred CEEEEEEeecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCc
Q psy6346 262 SMIYIVSEYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFS 336 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS 336 (1238)
+..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||. .|++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999999988743 3468999999999999999999996 68999999999999999999999999998
Q ss_pred ccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccC-CC-CCCH
Q psy6346 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI-PY-FMST 414 (1238)
Q Consensus 337 ~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~-P~-~iS~ 414 (1238)
.............|+..|+|||.+.+..+ +.++|||||||++|+|++|..||...........+....... +. .+++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence 76554444455678999999999988775 889999999999999999999998877776666666554332 22 4788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
++.++|.+||..||++||++.|+..+
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 99999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.21 Aligned_cols=247 Identities=21% Similarity=0.385 Sum_probs=205.3
Q ss_pred EEEEEecCCCCccccCceEcc---CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC------E
Q psy6346 193 RKREKCGVKSRSCNRPPVLLR---HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------M 263 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lk---tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------~ 263 (1238)
.....||.|++|.||++.+.. ++..||||++..........+++.+|+.+|++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 345678999999999998653 4789999999877666667788999999999999999999999885432 3
Q ss_pred EEEEEeecCCCccchhhhcc------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 264 IYIVSEYANQGEIFDYIARY------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
.++++||+.+++|.+++... ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccc
Confidence 47899999999998876422 247888999999999999999999999999999999999999999999999987
Q ss_pred cccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCC
Q psy6346 338 YYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFM 412 (1238)
Q Consensus 338 ~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~i 412 (1238)
....... .....+++.|++||.+....+ +.++|||||||++|+|++ |..||.+.+...+...+..+ ....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 6533221 122345678999999987766 789999999999999999 99999888877777666554 33445567
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+..+.+++.+||..+|++||++.+++..
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.87 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=200.2
Q ss_pred EEEEEEEecCCCCccccCceE----ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVL----LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMI 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~----lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~l 264 (1238)
.|.....+|.|++|.||.+.. ..++..||+|.++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 356667889999999988764 3568899999987553 344567899999999999999999999998765 678
Q ss_pred EEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 265 YIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
++||||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999998664 358999999999999999999999999999999999999999999999999987654332
Q ss_pred c----cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC---------------hhHHHHHHhcC
Q psy6346 344 K----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---------------LNSLRDRVLSG 404 (1238)
Q Consensus 344 ~----l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d---------------~eeL~ekIl~g 404 (1238)
. .....++..|+|||++.+..+ +.++|||||||++|+|+++..|+.... .......+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 1 123456778999999887765 889999999999999999876653211 01111111111
Q ss_pred -CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 405 -RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 405 -~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
....+..++..+.+||.+||..+|.+|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 233456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.59 Aligned_cols=241 Identities=17% Similarity=0.254 Sum_probs=192.0
Q ss_pred EecCCCCccccCceEcc--CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLR--HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lk--tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++.+.. ++..+|+|.++.... ......+.+|+.++++++||||+++++++.+...+++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 47888888888887543 456799999876542 334457889999999999999999999999999999999999999
Q ss_pred ccchhhhccc-----ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---cc
Q psy6346 275 EIFDYIARYG-----RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---LA 346 (1238)
Q Consensus 275 SL~d~Lkk~~-----~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---l~ 346 (1238)
+|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 9999986532 346677888999999999999999999999999999999999999999999865332211 12
Q ss_pred cccCCCCCCCcccccCCc------cCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHh-cCCccC-----CCCCC
Q psy6346 347 TWCGSPPYAAPEVFEGKK------YCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVL-SGRFRI-----PYFMS 413 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~------y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl-~g~~~~-----P~~iS 413 (1238)
...|+..|+|||++.+.. ..+.++|||||||++|+|++ |..||......+...... .....+ ....+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 345778899999986432 13679999999999999996 999998766555433322 222222 22467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..+.+++.+|+ .+|.+|||+++|+.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 88999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.86 Aligned_cols=248 Identities=20% Similarity=0.379 Sum_probs=201.1
Q ss_pred EEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee-CCE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET-KSM 263 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed-~d~ 263 (1238)
.|+..+.||.|+||.||+|.+. .+++.||||+++... .......+.+|+.+|.++ +|+||+++++++.. +..
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4667788888999999888743 467899999997654 334457788999999999 68999999998754 456
Q ss_pred EEEEEeecCCCccchhhhcc------------------------------------------------------------
Q psy6346 264 IYIVSEYANQGEIFDYIARY------------------------------------------------------------ 283 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~------------------------------------------------------------ 283 (1238)
+++|||||++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 89999999999999988542
Q ss_pred -------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---cccccCCCC
Q psy6346 284 -------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---LATWCGSPP 353 (1238)
Q Consensus 284 -------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---l~t~~GTp~ 353 (1238)
..++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ .....++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 1356777888999999999999999999999999999999999999999999876432211 122345677
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChh-HHHHHHhcC-CccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLN-SLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~e-eL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... .+...+..+ ....|..+++++.+++.+||..||++
T Consensus 247 y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~ 325 (343)
T cd05103 247 WMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 325 (343)
T ss_pred eECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 999999988776 889999999999999996 99999875433 333333333 34456678899999999999999999
Q ss_pred CCCHHHHHhc
Q psy6346 431 RYCIEQIKRH 440 (1238)
Q Consensus 431 RPTaeEILeH 440 (1238)
|||+.+|++|
T Consensus 326 Rps~~eil~~ 335 (343)
T cd05103 326 RPTFSELVEH 335 (343)
T ss_pred CcCHHHHHHH
Confidence 9999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=303.48 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=197.6
Q ss_pred EEEEEEEecCCCCccccCceE----ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVL----LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMI 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~----lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~l 264 (1238)
.|+....+|.|+||.||.+.. ..++..||||++... .....+.+.+|+++|++++||||+++++++.. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 456677889999999988763 457889999998754 34456788999999999999999999998743 4568
Q ss_pred EEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 265 YIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999998654332
Q ss_pred cc----ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH----------------HHHHHhc
Q psy6346 344 KL----ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS----------------LRDRVLS 403 (1238)
Q Consensus 344 ~l----~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee----------------L~ekIl~ 403 (1238)
.. ....++..|+|||++.+..+ +.++|||||||++|||++|..++....... +.+.+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 21 11223456999999987776 889999999999999999877764332110 1111111
Q ss_pred C-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 404 G-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 404 g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
. .+..+..++.++.+||.+||..+|++|||+.+|++.
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1 223455678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=370.93 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=227.2
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
...|..+..||.|-||.||.++...+|...|+|-+.....+....+.+.+|..+|..|+|||+|+.|++-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34566677899999999999999999999999999887766666788999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-----
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ----- 343 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~----- 343 (1238)
|||.||+|.+.+...+..++...+.+..|++.||.|||++|||||||||+||+|+.+|.+|++|||.|.......
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999999988888999999999999999999999999999999999999999999999999998765442
Q ss_pred ccccccCCCCCCCcccccCCc--cCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhc-CCccCCCCCCHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKK--YCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLS-GRFRIPYFMSTECESL 419 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~--y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~-g~~~~P~~iS~eLkDL 419 (1238)
.+....||+.|||||++.+.. -..-++||||||||+.||+||+.||...+.+ .+...+-. ..+.+|..++.+.+||
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDF 1473 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHH
Confidence 344678999999999998653 2356899999999999999999999765433 23333333 4677899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|..||..||++|.++.||++|.|-+..
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhccccc
Confidence 999999999999999999999997654
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=343.96 Aligned_cols=245 Identities=30% Similarity=0.431 Sum_probs=218.2
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ly 265 (1238)
.+.+.|.....+|.|+|+.|-.+.+..++...|+|++.+... ...+|+.++.+. +||||+++.+++.+..+.|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 456778888899999999999999999999999999987732 234688777666 8999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc-cCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM-DSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL-d~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
+|||++.|+.|.+.+...+.+. .++..|+++|+.|+.|||.+|||||||||+|||+ +..++++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999999887766666 8888999999999999999999999999999999 58899999999999865444
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhcCCccCCCCCCHHHHHHHHHh
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLSGRFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~g~~~~P~~iS~eLkDLIrkM 423 (1238)
..+.|-|..|.|||++....| ++++||||||++||+||+|+.||...... ++..++..+.+. ..+|.++++||.+|
T Consensus 470 ~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQL 546 (612)
T ss_pred hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHh
Confidence 556788999999999998777 99999999999999999999999765544 777777766554 77999999999999
Q ss_pred cccCCCCCCCHHHHHhcccc
Q psy6346 424 LVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWF 443 (1238)
|+.||.+|+++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99999999999999999999
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=289.94 Aligned_cols=240 Identities=40% Similarity=0.706 Sum_probs=210.8
Q ss_pred CCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhhh
Q psy6346 202 SRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIA 281 (1238)
Q Consensus 202 sfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lk 281 (1238)
++|.||+++...++..||+|++........ .+.+.+|++++++++|+||+++++++......+++|||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 467888888888899999999987643321 6789999999999999999999999999999999999999999999998
Q ss_pred cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCCCCccccc
Q psy6346 282 RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFE 361 (1238)
Q Consensus 282 k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~ 361 (1238)
....++...+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+.............++..|++||.+.
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc
Confidence 77668999999999999999999999999999999999999999999999999998765554556677899999999998
Q ss_pred CCccCCCccceehhhHHHHHHhhCCCCCCC-CChhHHHHHHhcCCccCCCC---CCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6346 362 GKKYCGPEIDIWSLGVVLYVLVCGALPFDG-STLNSLRDRVLSGRFRIPYF---MSTECESLIRKMLVREPTKRYCIEQI 437 (1238)
Q Consensus 362 gk~y~S~KSDIWSLGVILYELLTGrlPF~g-~d~eeL~ekIl~g~~~~P~~---iS~eLkDLIrkML~kDPskRPTaeEI 437 (1238)
+..+ +.++|||+||+++++|++|..||.. .....+.+.+.......... ++.++.+++.+||..+|++||++.++
T Consensus 160 ~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 160 GKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred cCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 7766 7799999999999999999999987 56666666666555443333 78899999999999999999999999
Q ss_pred Hhcccc
Q psy6346 438 KRHRWM 443 (1238)
Q Consensus 438 LeHPWF 443 (1238)
++||||
T Consensus 239 ~~~~~~ 244 (244)
T smart00220 239 LQHPFF 244 (244)
T ss_pred hhCCCC
Confidence 999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=344.89 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=221.7
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
+-++|+|-+|+||.|.+..+...+|||-+.... ....+.+..||.+.++|+|.|||++++.+..++++-|.||-++||
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 457899999999999999999999999987653 345678899999999999999999999999999999999999999
Q ss_pred ccchhhhc-cccc--chhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCcccccCCC-cccccc
Q psy6346 275 EIFDYIAR-YGRM--NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 275 SL~d~Lkk-~~~L--sesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
+|.+++.. .+++ .+..+..+.+||++||.|||.+.|||||||-+|||++. .|.+||+|||.++....-. ...++.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 99999974 4777 78889999999999999999999999999999999975 6999999999998776544 446788
Q ss_pred CCCCCCCcccccC-CccCCCccceehhhHHHHHHhhCCCCCCCCC-hhH-HHH-HHhcCCccCCCCCCHHHHHHHHHhcc
Q psy6346 350 GSPPYAAPEVFEG-KKYCGPEIDIWSLGVVLYVLVCGALPFDGST-LNS-LRD-RVLSGRFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 350 GTp~YmAPEVL~g-k~y~S~KSDIWSLGVILYELLTGrlPF~g~d-~ee-L~e-kIl~g~~~~P~~iS~eLkDLIrkML~ 425 (1238)
||..|||||++.. ..-|+.++|||||||++.||.||++||-... +.. +++ -+.....++|..++.+++.||.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 9999999999964 3446999999999999999999999996432 221 111 11223456888899999999999999
Q ss_pred cCCCCCCCHHHHHhcccccccCCCCCCCcc
Q psy6346 426 REPTKRYCIEQIKRHRWMAEETPRLLPPIN 455 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWFke~~p~~lppi~ 455 (1238)
+||.+||++.++|..||++....+..+++.
T Consensus 818 pd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred CCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 999999999999999999987555555543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=300.90 Aligned_cols=246 Identities=25% Similarity=0.338 Sum_probs=201.5
Q ss_pred EEEEEEecCCCCccccCceEcc----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLR----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIY 265 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lk----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~ly 265 (1238)
|...+.+|.|++|.||++.... ++..||||++...... ...+.+.+|+++++.+.|+||+++++++.. ....+
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4555788999999999987643 4789999999876533 456789999999999999999999999877 66899
Q ss_pred EEEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence 9999999999999997654 689999999999999999999999999999999999999999999999999987643221
Q ss_pred c----ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH---------------HHHHHhcC-
Q psy6346 345 L----ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS---------------LRDRVLSG- 404 (1238)
Q Consensus 345 l----~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee---------------L~ekIl~g- 404 (1238)
. ....++..|++||.+.+..+ +.++|||||||++|+|++|..||....... +...+...
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 1 12234567999999987766 889999999999999999999986543221 12222221
Q ss_pred CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 405 RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 405 ~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
....+..++.++.+|+.+||..+|.+|||+.||++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 23334557789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=338.77 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=222.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC-CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~-ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
-|.....||.|+||.|+.+...++...||+|.+++.. +.......+..|-.||...+.+.||+||..|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 3667789999999999999999999999999998765 355667788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc---------
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV--------- 340 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~--------- 340 (1238)
|++||++..+|.+.+-|.|..++.++..+.+|+++.|..|+|||||||+|||||.+|+|||+|||||+-+.
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999986431
Q ss_pred CCCc----------------------------------cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCC
Q psy6346 341 PGQK----------------------------------LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386 (1238)
Q Consensus 341 ~s~~----------------------------------l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGr 386 (1238)
.+.. ....+||+.|+|||++....| +..+|.||.|||||||+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhhCC
Confidence 1100 013469999999999998887 88999999999999999999
Q ss_pred CCCCCCChhHHHHHHhcCCc--cCC--CCCCHHHHHHHHHhcccCCCCCC---CHHHHHhccccccc
Q psy6346 387 LPFDGSTLNSLRDRVLSGRF--RIP--YFMSTECESLIRKMLVREPTKRY---CIEQIKRHRWMAEE 446 (1238)
Q Consensus 387 lPF~g~d~eeL~ekIl~g~~--~~P--~~iS~eLkDLIrkML~kDPskRP---TaeEILeHPWFke~ 446 (1238)
.||-..+..+...+|.++.- .|| ..+++++.+||.++. .+++.|+ .++||..||||+..
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 99999888888777777642 233 458999999999855 4788897 47889999999864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.82 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=204.7
Q ss_pred EEEEEEecCCCCccccCceEccCCc----EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTV----NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~----kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
|+....||.|++|.||++.+..++. .||+|++.... .......+.+|+.+++.++||||+++++++... ..++|
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 5566789999999999998877765 57999887553 333445788999999999999999999998754 46799
Q ss_pred EeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--
Q psy6346 268 SEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-- 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-- 344 (1238)
+||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 99999999999987654 588999999999999999999999999999999999999999999999999976543322
Q ss_pred -cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHH
Q psy6346 345 -LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIR 421 (1238)
Q Consensus 345 -l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIr 421 (1238)
.....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.......+.+..+. +..+..++..+.+++.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMV 245 (303)
T ss_pred ccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 122345678999999987776 889999999999999997 999998877666555554432 3345567889999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy6346 422 KMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeH 440 (1238)
+||..+|++||+++++++.
T Consensus 246 ~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 246 KCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=326.70 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=202.6
Q ss_pred EEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~ly 265 (1238)
|.....||.|+||.||++.+. ..++.||||+++... .....+.+.+|+++|.++. ||||+++++++...+..|
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 444577888888888888753 345789999998653 2334467889999999997 999999999999999999
Q ss_pred EEEeecCCCccchhhhccc-------------------------------------------------------------
Q psy6346 266 IVSEYANQGEIFDYIARYG------------------------------------------------------------- 284 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~------------------------------------------------------------- 284 (1238)
+|||||.+|+|.+++.+.+
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 9999999999999986432
Q ss_pred -------------------------------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc
Q psy6346 285 -------------------------------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327 (1238)
Q Consensus 285 -------------------------------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~ 327 (1238)
.+++..+..++.||+.||.|||+.+|+||||||+|||++.++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCE
Confidence 2456677889999999999999999999999999999999999
Q ss_pred EEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHH-HHHh
Q psy6346 328 IKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLR-DRVL 402 (1238)
Q Consensus 328 VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~-ekIl 402 (1238)
+||+|||++....... ......++..|+|||++.+..+ +.++|||||||++|||++ |..||......+.. ..+.
T Consensus 278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~ 356 (401)
T cd05107 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK 356 (401)
T ss_pred EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH
Confidence 9999999987643222 1223457788999999987776 889999999999999998 89999876544433 3333
Q ss_pred cC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 403 SG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 403 ~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+ ....|..++.++.+||.+||..+|.+||++.+|++.
T Consensus 357 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 357 RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33 344566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=351.35 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=205.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|.....||.|++|.||+|.+..+++.||||++..... .....+++.+|++++++++||||+++++++.+.+..|+|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 47788899999999999999999999999999986543 23445789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-----------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 270 YANQGEIFDYIARY-----------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-----------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
|++|++|.+++... ..++...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 99999999988642 2345567789999999999999999999999999999999999999999999876
Q ss_pred ccCC-------------------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHH
Q psy6346 339 YVPG-------------------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRD 399 (1238)
Q Consensus 339 ~~~s-------------------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~e 399 (1238)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 5110 01123469999999999988877 899999999999999999999998765443322
Q ss_pred HHh-cCCccC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy6346 400 RVL-SGRFRI--PYFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 400 kIl-~g~~~~--P~~iS~eLkDLIrkML~kDPskRPTaeEILeHP 441 (1238)
... ...... ...+++.+.+++.+||..||++|++..+.+.+.
T Consensus 242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 211 111111 124788999999999999999998876666543
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=337.84 Aligned_cols=243 Identities=22% Similarity=0.354 Sum_probs=208.5
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
....+||.|+||+||+|.+- -.||||+++....+++.++.|++|+.+|++-+|.||+-+.++|..... .||..+|+
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred hccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 34589999999999999873 359999999999999999999999999999999999999999998877 99999999
Q ss_pred CCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc---ccCCCccccc
Q psy6346 273 QGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY---YVPGQKLATW 348 (1238)
Q Consensus 273 GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~---~~~s~~l~t~ 348 (1238)
|.+|+.+|+-. .+|.....+.|++||++|+.|||.++|||||||..||||.++++|||+|||++.. +.........
T Consensus 471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp 550 (678)
T KOG0193|consen 471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQP 550 (678)
T ss_pred CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCC
Confidence 99999999754 5799999999999999999999999999999999999999999999999999854 2334455666
Q ss_pred cCCCCCCCcccccCC--ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-----cCCCCCCHHHHHHHH
Q psy6346 349 CGSPPYAAPEVFEGK--KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-----RIPYFMSTECESLIR 421 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk--~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-----~~P~~iS~eLkDLIr 421 (1238)
.|...|||||++... ..+++.+|||+||||+|||++|.+||.....+.+.-.+-.|.. .+-..++.++++|+.
T Consensus 551 ~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~ 630 (678)
T KOG0193|consen 551 HGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLS 630 (678)
T ss_pred ccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHH
Confidence 788999999998633 2248999999999999999999999996655554433333311 122336779999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q psy6346 422 KMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 422 kML~kDPskRPTaeEILe 439 (1238)
.||..++++||.+.+||.
T Consensus 631 ~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 631 DCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHhcCcccCccHHHHHH
Confidence 999999999999999987
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.17 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=215.2
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
.+.+|.|..|.||++....+|..+|||.+.++. +.++.+++.+.++++.+. ++|+||+++++|..+..++|.||.|.
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 467899999999999999999999999999876 667789999999987776 59999999999999999999999985
Q ss_pred Cccchhhhc-ccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCC
Q psy6346 274 GEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGS 351 (1238)
Q Consensus 274 GSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GT 351 (1238)
-.+..++++ .++++|..+-++...++.||.||-. +||+|||+||.|||||..|++||||||++.+...........|.
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC 254 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGC 254 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCC
Confidence 334444443 3679999999999999999999985 59999999999999999999999999999998888777778899
Q ss_pred CCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCC-hhHHHHHHhcCCcc-CCCC--CCHHHHHHHHHhcc
Q psy6346 352 PPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGST-LNSLRDRVLSGRFR-IPYF--MSTECESLIRKMLV 425 (1238)
Q Consensus 352 p~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d-~eeL~ekIl~g~~~-~P~~--iS~eLkDLIrkML~ 425 (1238)
+.|||||.+.- .+.|+.++||||||+.|+||.||..||.+.+ .-+...++.+...+ +|.. .++++.+|+..||.
T Consensus 255 ~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~ 334 (391)
T KOG0983|consen 255 AAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLT 334 (391)
T ss_pred ccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhh
Confidence 99999999863 3445889999999999999999999999843 33555666665432 3332 79999999999999
Q ss_pred cCCCCCCCHHHHHhccccccc
Q psy6346 426 REPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWFke~ 446 (1238)
+|+.+||...++|+|||+..-
T Consensus 335 kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 335 KDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred cCcccCcchHHHhcCcceeec
Confidence 999999999999999999765
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.22 Aligned_cols=241 Identities=18% Similarity=0.272 Sum_probs=190.5
Q ss_pred EecCCCCccccCceEccC--CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 197 KCGVKSRSCNRPPVLLRH--TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lkt--G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
.||.|+||.||++..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....|+||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 467888888887754432 3456777766543 2345678999999999999999999999999999999999999999
Q ss_pred ccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---cccc
Q psy6346 275 EIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---KLAT 347 (1238)
Q Consensus 275 SL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---~l~t 347 (1238)
+|.+++.+. ..+++..+..++.||+.||+|||+.+++||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999998754 235667788999999999999999999999999999999999999999999875422211 1234
Q ss_pred ccCCCCCCCcccccCCc------cCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC------ccCCCCCCH
Q psy6346 348 WCGSPPYAAPEVFEGKK------YCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR------FRIPYFMST 414 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~------y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~------~~~P~~iS~ 414 (1238)
.+|+..|+|||++.... ..+.++|||||||++|+|++ |..||...+..+....+..+. ..++..+++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 56888999999975321 12678999999999999996 678998777666555544332 123344788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.+.+++..|+ .+|++||++++|++
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHH
Confidence 8999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=332.29 Aligned_cols=243 Identities=23% Similarity=0.400 Sum_probs=211.6
Q ss_pred EEecCCCCccccCceEccCC----cEEEEEEeccC-CCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 196 EKCGVKSRSCNRPPVLLRHT----VNVAIKIIDKS-QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG----~kVAIKVLkks-~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.+||+|.||.||+|.....+ ..||||..+.. ......++++++|+++|+.++|||||++|+++.....++||||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 67888888888888777542 23899999863 36778899999999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccc-cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc-
Q psy6346 271 ANQGEIFDYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW- 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~-Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~- 348 (1238)
|.||+|.++|++.+. ++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++....-......
T Consensus 243 ~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~ 322 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLK 322 (474)
T ss_pred cCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccc
Confidence 999999999999874 999999999999999999999999999999999999999999999999998764311111112
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC--ccCCCCCCHHHHHHHHHhcc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR--FRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~--~~~P~~iS~eLkDLIrkML~ 425 (1238)
.-...|+|||.+....| ++++|||||||++||+++ |..||.+....++..+|.... ..+|...+.++..++.+|+.
T Consensus 323 klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~ 401 (474)
T KOG0194|consen 323 KLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWK 401 (474)
T ss_pred cCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhcc
Confidence 24567999999998865 999999999999999998 899999999999999995543 44667788999999999999
Q ss_pred cCCCCCCCHHHHHh
Q psy6346 426 REPTKRYCIEQIKR 439 (1238)
Q Consensus 426 kDPskRPTaeEILe 439 (1238)
.+|++||++.++.+
T Consensus 402 ~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 402 KDPEDRPTMSTIKK 415 (474)
T ss_pred CChhhccCHHHHHH
Confidence 99999999999865
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=313.76 Aligned_cols=256 Identities=29% Similarity=0.517 Sum_probs=234.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
+.|....+||.|++..|-.+.+.++.+.||+|+++++.++ .++++=+..|-.++... +||.+|.|+.+|.++.++++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5677889999999999999999999999999999998764 45667778888888877 899999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc-cCCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~-~~s~~l~ 346 (1238)
.||++||+|.-.+++.++++++.++.+...|+.||.|||+.|||+||||.+|+|||..|++||+|+|+++.. .++....
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ts 409 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTS 409 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999764 4566778
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCC--------CChhHHHHHHhcCCccCCCCCCHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG--------STLNSLRDRVLSGRFRIPYFMSTECES 418 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g--------~d~eeL~ekIl~g~~~~P~~iS~eLkD 418 (1238)
++||||.|.|||++.+..| ++.+|.|+|||+++||+.|+.||+- .+..-+++-|++..+++|..++..+..
T Consensus 410 tfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~ 488 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASH 488 (593)
T ss_pred cccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHH
Confidence 9999999999999999998 9999999999999999999999952 234557788889999999999999999
Q ss_pred HHHHhcccCCCCCC------CHHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRY------CIEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRP------TaeEILeHPWFke~ 446 (1238)
+++..|.+||.+|. .+.++..|+||+..
T Consensus 489 vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 489 VLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred HHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 99999999999996 47899999999864
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=319.61 Aligned_cols=260 Identities=24% Similarity=0.342 Sum_probs=205.5
Q ss_pred CCceeEEeeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeE
Q psy6346 174 DGRRLRLDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIK 253 (1238)
Q Consensus 174 dgRy~~i~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVr 253 (1238)
..+.+....|..++ ..|.....||.|+||+||+|.. .+|..||||.+....... .++|.+|+.+|.+++|||+|+
T Consensus 61 ~~~~fs~~el~~AT--~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 61 PLRSFSYDELRKAT--NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVK 135 (361)
T ss_pred CcceeeHHHHHHHH--hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCccc
Confidence 34445555566555 4477778999999999999965 455999999887665332 456999999999999999999
Q ss_pred EEEEeeeCC-EEEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccc---eeeccCCcccccccCCCc
Q psy6346 254 LFQVMETKS-MIYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRR---VVHRDLKAENLLMDSNLD 327 (1238)
Q Consensus 254 L~dvfed~d-~lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkG---IIHRDLKPeNILLd~nG~ 327 (1238)
|++||.+.+ ..+||+||+++|+|.+++.... .+++....+|+.+++.||+|||... |||||||+.|||||.+.+
T Consensus 136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999999988 5999999999999999998765 8999999999999999999999853 999999999999999999
Q ss_pred EEEEecCCcccccC-CCccccc-cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC------hhHH-H
Q psy6346 328 IKLADFGFSNYYVP-GQKLATW-CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST------LNSL-R 398 (1238)
Q Consensus 328 VKLiDFGLS~~~~~-s~~l~t~-~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d------~eeL-~ 398 (1238)
.||+|||++..... .....+. .||.+|+|||++..... +.++|||||||+|.||++|+.+.+... ..+. .
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999976544 3333333 89999999999987655 899999999999999999998887432 1111 1
Q ss_pred HHHhcCC------ccCC-CCCC--HH---HHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 399 DRVLSGR------FRIP-YFMS--TE---CESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 399 ekIl~g~------~~~P-~~iS--~e---LkDLIrkML~kDPskRPTaeEILe 439 (1238)
..+..+. ..+. ...+ .+ +..+..+|+..+|.+||++.|+++
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1222211 1111 1222 23 446778999999999999999754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=299.84 Aligned_cols=249 Identities=17% Similarity=0.195 Sum_probs=191.7
Q ss_pred CCcEEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHh---------HHHHHHHHHHHHhCCCCCeeEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVN---------LQKVYREVEIMKQLDHPHIIKLF 255 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~---------ikrf~rEIeILkkL~HPNIVrL~ 255 (1238)
.+..|.....||.|+||.||++.+..+ +..+|+|+.......... ......++..+..++|++|++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346688889999999999999988777 677888875443311100 01122334455667999999999
Q ss_pred EEeeeCC----EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEE
Q psy6346 256 QVMETKS----MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331 (1238)
Q Consensus 256 dvfed~d----~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLi 331 (1238)
+++.... ..+++||++. .++.+.+.....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8765443 4578888874 4566666655567888899999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCC--------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh-hH------
Q psy6346 332 DFGFSNYYVPGQ--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NS------ 396 (1238)
Q Consensus 332 DFGLS~~~~~s~--------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-ee------ 396 (1238)
|||++..+.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ..
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999997653221 1223469999999999998877 8999999999999999999999987632 11
Q ss_pred --HHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 397 --LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 397 --L~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
....+..+...+ ..+++++.++++.|+..+|++||++++|++
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 CDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333343333 346789999999999999999999999975
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=305.44 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=209.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee-----eCCE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME-----TKSM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe-----d~d~ 263 (1238)
+..|+....+|.|||+.||.+..+.++..||+|.+.... .++++..++|++..++++|||+++++++.. ....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 467888999999999999999999999999999998765 467789999999999999999999988763 3456
Q ss_pred EEEEEeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccc--eeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 264 IYIVSEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
.||+++|...|+|.+.+.+. ..+++..+..|+.+|++||++||... ++||||||.||++.+.+.++|+|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999999754 25899999999999999999999998 9999999999999999999999999886
Q ss_pred cccC---CC-------ccccccCCCCCCCcccccCCcc--CCCccceehhhHHHHHHhhCCCCCCCCC--hhHHHHHHhc
Q psy6346 338 YYVP---GQ-------KLATWCGSPPYAAPEVFEGKKY--CGPEIDIWSLGVVLYVLVCGALPFDGST--LNSLRDRVLS 403 (1238)
Q Consensus 338 ~~~~---s~-------~l~t~~GTp~YmAPEVL~gk~y--~S~KSDIWSLGVILYELLTGrlPF~g~d--~eeL~ekIl~ 403 (1238)
...- +. .-.....|..|+|||.+.-+.+ .+.++|||||||+||+|+.|..||+..- ...+.-.+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 5421 11 1112347899999999864433 3789999999999999999999996431 2233334555
Q ss_pred CCccCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 404 GRFRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 404 g~~~~P~~--iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+.+.+|.. +++.+.+||+.||++||.+||++.+++.+
T Consensus 258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 66666654 89999999999999999999999999875
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=336.90 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=215.3
Q ss_pred EEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 193 RKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
..++.+|+|.||.||++... .....||||.++... +....++|+||+++|..|+|||||+|+++|..++.+|+|
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 34578999999999998765 345789999998764 445678999999999999999999999999999999999
Q ss_pred EeecCCCccchhhhccc--------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEec
Q psy6346 268 SEYANQGEIFDYIARYG--------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~--------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDF 333 (1238)
+|||..|+|.++|.... +++..+...|+.||+.|++||-++.+|||||-..|+||.++..|||+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEeccc
Confidence 99999999999996431 2788899999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCccc---cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCc-cC
Q psy6346 334 GFSNYYVPGQKLA---TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRF-RI 408 (1238)
Q Consensus 334 GLS~~~~~s~~l~---t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~-~~ 408 (1238)
|+++.....+-.. ...-..+||+||.+...++ +.++||||+||+|||+++ |..||.+.+.++..+.|..+.. .-
T Consensus 648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~ 726 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSC 726 (774)
T ss_pred ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccC
Confidence 9997654332111 2234578999999999998 999999999999999998 9999999999999999998864 56
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6346 409 PYFMSTECESLIRKMLVREPTKRYCIEQIK 438 (1238)
Q Consensus 409 P~~iS~eLkDLIrkML~kDPskRPTaeEIL 438 (1238)
|..++.++.+|+..||+.+|++||++.||-
T Consensus 727 Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 727 PENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 788999999999999999999999999984
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.52 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=219.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...++||+|-+|+||++....+++.||+|.++.+.-++..-....+||.+|+.|+|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35566889999999999999999999999999998876666667889999999999999999999999999999999999
Q ss_pred cCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccc
Q psy6346 271 ANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~ 348 (1238)
|. .+|..+... ++.++...++.++.|++.||.|+|++++.||||||.|++|+.+|.+||.|||+++.+.-.- .....
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 96 667776654 4679999999999999999999999999999999999999999999999999998764433 33445
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-------Cc----cCCCC-----
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-------RF----RIPYF----- 411 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-------~~----~~P~~----- 411 (1238)
+-|.+|++|.++.|...|+...|+||.|||+.|+.. |++.|.|.+......+|... .+ .+|.+
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 679999999999999999999999999999999986 88889998877766665421 00 11111
Q ss_pred -------------CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 412 -------------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 412 -------------iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+...-+||+.++|.-+|..|++++++++||||.+..
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 233457999999999999999999999999998753
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=311.27 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=203.9
Q ss_pred EEEEEEecCCCCccccCceEccCC----cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee-CCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHT----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-KSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-~d~lyL 266 (1238)
|+..+.||.|-+|.||+++-.+++ +.+|||.++.+.-........-||+.+++.|.||||+.|..+|.. +..+++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 556667778888888887665443 378999998774322233567799999999999999999999876 888999
Q ss_pred EEeecCCCccchhhhcc-----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC----CcEEEEecCCcc
Q psy6346 267 VSEYANQGEIFDYIARY-----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN----LDIKLADFGFSN 337 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n----G~VKLiDFGLS~ 337 (1238)
++||++ -+|+.+|+-. +.++...++.|++||+.|+.|||++-|+||||||.|||+..+ |.|||+|||+++
T Consensus 106 ~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 106 LFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred Eehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 999997 6788888533 468999999999999999999999999999999999999887 999999999998
Q ss_pred cccCCC----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---------HHHHHHhc-
Q psy6346 338 YYVPGQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---------SLRDRVLS- 403 (1238)
Q Consensus 338 ~~~~s~----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---------eL~ekIl~- 403 (1238)
.+...- .....+-|.+|+|||++.|...|++++|||++|||+.||++-.+.|.+.... ...++|.+
T Consensus 185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~v 264 (438)
T KOG0666|consen 185 LFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEV 264 (438)
T ss_pred HhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHH
Confidence 775432 2234467899999999999988899999999999999999999999774321 12222221
Q ss_pred -C-----C----ccCCCC--------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 404 -G-----R----FRIPYF--------------------------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 404 -g-----~----~~~P~~--------------------------iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
| + ..+|.+ -++...+|+.+||+.||.+|+|++++|+|+||.+..
T Consensus 265 LG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 265 LGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred cCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 0 0 011111 245578999999999999999999999999999864
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=314.35 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=204.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC--CC----CeeEEEEEeeeCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD--HP----HIIKLFQVMETKS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~--HP----NIVrL~dvfed~d 262 (1238)
...|.+...+|+|-||.|.++.+...+..|||||++.-. .-.+..+-|+++|.++. -| -+|.+.++|+..+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 566777778888888888888899889999999997532 22355678999999993 22 3788889999999
Q ss_pred EEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC----------------
Q psy6346 263 MIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---------------- 324 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---------------- 324 (1238)
+.|||+|.+ |-++++++..+ .+++...++.+.+||+.+++|||+.+++|-||||+|||+..
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999999 56999999875 46899999999999999999999999999999999999931
Q ss_pred ----CCcEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH---H
Q psy6346 325 ----NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS---L 397 (1238)
Q Consensus 325 ----nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee---L 397 (1238)
+..|+|+|||.+++.. +...+.+.|..|+|||++++.++ +..+||||+||||+||++|...|.+.+..+ +
T Consensus 244 r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred ccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 3458999999998743 33466789999999999999999 899999999999999999999998766443 4
Q ss_pred HHHHhcC------------------CccCCCC-------------------------CCHHHHHHHHHhcccCCCCCCCH
Q psy6346 398 RDRVLSG------------------RFRIPYF-------------------------MSTECESLIRKMLVREPTKRYCI 434 (1238)
Q Consensus 398 ~ekIl~g------------------~~~~P~~-------------------------iS~eLkDLIrkML~kDPskRPTa 434 (1238)
.++|+.. .+..|.. .-.++.|||++||..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 4444321 1111110 12347799999999999999999
Q ss_pred HHHHhccccccc
Q psy6346 435 EQIKRHRWMAEE 446 (1238)
Q Consensus 435 eEILeHPWFke~ 446 (1238)
.|+|.||||...
T Consensus 401 ~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 401 REALSHPFFARL 412 (415)
T ss_pred HHHhcCHHhhcC
Confidence 999999999864
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=338.61 Aligned_cols=248 Identities=20% Similarity=0.337 Sum_probs=216.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCC-----cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHT-----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG-----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
........||.|.||.||.|...... ..||||.+++.. +.++..+|.+|..+|++++|||||++++++-+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 44556688999999999999887432 349999988764 677889999999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcc-------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 265 YIVSEYANQGEIFDYIARY-------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
+|++|||+||+|..+|++. ..++..+...++.+|+.|+.||+++++|||||...|+||+....+||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999999876 348899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCcc-cc--ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHH-HHhcCCccCCCCC
Q psy6346 338 YYVPGQKL-AT--WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRD-RVLSGRFRIPYFM 412 (1238)
Q Consensus 338 ~~~~s~~l-~t--~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~e-kIl~g~~~~P~~i 412 (1238)
.....+-. .. ..-...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..++.. -...+++..|.++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C 929 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC 929 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence 43322211 11 122356999999998777 899999999999999998 999999988777777 4555678889999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
+..+.+||..||..+|++||++..|++
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999999999999999999988
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=328.75 Aligned_cols=244 Identities=27% Similarity=0.370 Sum_probs=202.5
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC------
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------ 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------ 262 (1238)
+..|.-.+.+|.|+||-||+++...+|+.||||.+++.. .....++..+|++||++|+|+|||+++++-++..
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 356777899999999999999999999999999998865 4456788999999999999999999999876544
Q ss_pred EEEEEEeecCCCccchhhhcc---cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC--CC--cEEEEecCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARY---GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NL--DIKLADFGF 335 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~---~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~--nG--~VKLiDFGL 335 (1238)
.-.+|||||.||+|+.++.+. ..+++.+.+.++..+..||.|||.+|||||||||+||++-. +| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 468999999999999999754 57999999999999999999999999999999999999842 23 489999999
Q ss_pred cccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh-----HHHHHHh--------
Q psy6346 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-----SLRDRVL-------- 402 (1238)
Q Consensus 336 S~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-----eL~ekIl-------- 402 (1238)
|+....+......+||+.|.+||++....+++..+|.|||||++|++.||.+||-..... .++..+.
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 999998888999999999999999986555699999999999999999999999543211 1222111
Q ss_pred ------cC------CccCCCCCCHHH----HHHHHHhcccCCCCCCC
Q psy6346 403 ------SG------RFRIPYFMSTEC----ESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 403 ------~g------~~~~P~~iS~eL----kDLIrkML~kDPskRPT 433 (1238)
++ .+++|..++..+ ...+..||.++|.+|..
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 11 233444555544 45677889999999874
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=335.51 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=205.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEe-----------
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM----------- 258 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvf----------- 258 (1238)
..|+....+|+||||.||++...-+|+.||||.|.... +.....++.+|+.+|.+|+|||||++|..|
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 44566678999999999999999999999999999876 667778999999999999999999987510
Q ss_pred -------------------------------------------------e------------------e-----------
Q psy6346 259 -------------------------------------------------E------------------T----------- 260 (1238)
Q Consensus 259 -------------------------------------------------e------------------d----------- 260 (1238)
. +
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 0
Q ss_pred ----------------------C--------CEEEEEEeecCCCccchhhhccccc-chhHHHHHHHHHHHHHhHhhccc
Q psy6346 261 ----------------------K--------SMIYIVSEYANQGEIFDYIARYGRM-NENAARRKFWQILSAVEYCHNRR 309 (1238)
Q Consensus 261 ----------------------~--------d~lyLVMEy~~GGSL~d~Lkk~~~L-sesea~kI~~QILsALeYLHSkG 309 (1238)
+ ..+||-||||+...|.+++.++... ....++++|++|++||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 2368999999977777777665444 58889999999999999999999
Q ss_pred eeeccCCcccccccCCCcEEEEecCCccccc-------------------CCCccccccCCCCCCCcccccCCc--cCCC
Q psy6346 310 VVHRDLKAENLLMDSNLDIKLADFGFSNYYV-------------------PGQKLATWCGSPPYAAPEVFEGKK--YCGP 368 (1238)
Q Consensus 310 IIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-------------------~s~~l~t~~GTp~YmAPEVL~gk~--y~S~ 368 (1238)
||||||||.||+|+.++.|||+|||+++... ........+||..|+|||++.+.. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997621 011345678999999999998776 4599
Q ss_pred ccceehhhHHHHHHhhCCCCCCC-CChhHHHHHHhcCCccCCCC----CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 369 EIDIWSLGVVLYVLVCGALPFDG-STLNSLRDRVLSGRFRIPYF----MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 369 KSDIWSLGVILYELLTGrlPF~g-~d~eeL~ekIl~g~~~~P~~----iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
|+||||||+||+||+. ||.. .....+...+..+.+++|.. .-+.-..+|+.||..||.+|||+.|+|++.|+
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 9999999999999985 4643 33445566666676666522 22345689999999999999999999999998
Q ss_pred c
Q psy6346 444 A 444 (1238)
Q Consensus 444 k 444 (1238)
.
T Consensus 875 p 875 (1351)
T KOG1035|consen 875 P 875 (1351)
T ss_pred C
Confidence 5
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=317.18 Aligned_cols=253 Identities=16% Similarity=0.188 Sum_probs=177.7
Q ss_pred cEEEEEEEecCCCCccccCceEccC----CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEE------ee
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRH----TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------ME 259 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lkt----G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dv------fe 259 (1238)
..|.....||.|+||.||+|.+..+ +..||||++...... +....| .+....+.++..++.. ..
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4577889999999999999999888 999999998653211 111111 1122222222222111 24
Q ss_pred eCCEEEEEEeecCCCccchhhhcccc--------------------cchhHHHHHHHHHHHHHhHhhccceeeccCCccc
Q psy6346 260 TKSMIYIVSEYANQGEIFDYIARYGR--------------------MNENAARRKFWQILSAVEYCHNRRVVHRDLKAEN 319 (1238)
Q Consensus 260 d~d~lyLVMEy~~GGSL~d~Lkk~~~--------------------Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeN 319 (1238)
....++|||||+.+++|.+++..... .....+..++.||+.||.|||++||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 56789999999999999998864321 1234467899999999999999999999999999
Q ss_pred ccccC-CCcEEEEecCCcccccCC--CccccccCCCCCCCcccccCCcc---------------------CCCccceehh
Q psy6346 320 LLMDS-NLDIKLADFGFSNYYVPG--QKLATWCGSPPYAAPEVFEGKKY---------------------CGPEIDIWSL 375 (1238)
Q Consensus 320 ILLd~-nG~VKLiDFGLS~~~~~s--~~l~t~~GTp~YmAPEVL~gk~y---------------------~S~KSDIWSL 375 (1238)
||++. ++.+||+|||++...... ......+|++.|||||.+..... ++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 589999999999754332 22345689999999997643221 1345699999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---------------------cCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy6346 376 GVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---------------------RIPYFMSTECESLIRKMLVREPTKRYCI 434 (1238)
Q Consensus 376 GVILYELLTGrlPF~g~d~eeL~ekIl~g~~---------------------~~P~~iS~eLkDLIrkML~kDPskRPTa 434 (1238)
||+||||+++..+++... ..+...+..... .+....+....+||.+||++||.+|||+
T Consensus 366 GviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999999877764321 111111111100 0111123345589999999999999999
Q ss_pred HHHHhcccccccCCC
Q psy6346 435 EQIKRHRWMAEETPR 449 (1238)
Q Consensus 435 eEILeHPWFke~~p~ 449 (1238)
.++|+||||......
T Consensus 445 ~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 445 KAALAHPYFDREGLL 459 (566)
T ss_pred HHHhCCcCcCCCCcc
Confidence 999999999876554
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-33 Score=299.94 Aligned_cols=256 Identities=22% Similarity=0.385 Sum_probs=209.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--------eC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--------TK 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--------d~ 261 (1238)
..|..+.++|.|-||.||++...++|+.||+|++--+.....--....+|+++|..|+|+|++.++++|. +.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466667889999999999999999999999986543322222345679999999999999999998874 23
Q ss_pred CEEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
..+|+||.+|+ -+|.-++... -+|+..++.+++.+++.||.|+|...|+|||+|++|+||+.+|.+||+|||+++.+.
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 45899999997 5777777665 579999999999999999999999999999999999999999999999999997664
Q ss_pred CCC-----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc--CC--------
Q psy6346 341 PGQ-----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--GR-------- 405 (1238)
Q Consensus 341 ~s~-----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~--g~-------- 405 (1238)
... .....+-|.+|++||.+.|...++++.|||..|||+.||+++.+.|.+.+.......|.. |.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 332 223345699999999999988889999999999999999999999998776554443321 00
Q ss_pred ---------c---cC-------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 ---------F---RI-------------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 ---------~---~~-------------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
. ++ |..-++++.+|+.+||..||.+|++++++++|.||..+
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 01 22235688999999999999999999999999999865
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=312.40 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=212.6
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC------CCCeeEEEEEeeeC
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD------HPHIIKLFQVMETK 261 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~------HPNIVrL~dvfed~ 261 (1238)
....|.+.+..|.|-|++|..|.+...|..||||||.... .-.+.=+.|++||++|+ --|+++|+..|...
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3456888899999999999999999999999999998753 22245578999999993 45899999999999
Q ss_pred CEEEEEEeecCCCccchhhhcccc---cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-CcEEEEecCCcc
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYGR---MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSN 337 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~~---Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~ 337 (1238)
.++|||+|-+. ..|.++|++++. |....++.++.||+.||..|-..||+|.||||+|||+++. ..+||||||.|.
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 99999999885 789999998864 8889999999999999999999999999999999999865 569999999987
Q ss_pred cccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCC------
Q psy6346 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF------ 411 (1238)
Q Consensus 338 ~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~------ 411 (1238)
.... .....+.-+..|+|||++.|.+| +...|+||.||+||||.||+..|+|.+...+....+.-.-+||..
T Consensus 586 ~~~e-neitPYLVSRFYRaPEIiLG~~y-d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 586 FASE-NEITPYLVSRFYRAPEIILGLPY-DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred cccc-ccccHHHHHHhccCcceeecCcc-cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 6543 44556677889999999999998 899999999999999999999999988766655443222111110
Q ss_pred -----------------------------------------------C-------CHHHHHHHHHhcccCCCCCCCHHHH
Q psy6346 412 -----------------------------------------------M-------STECESLIRKMLVREPTKRYCIEQI 437 (1238)
Q Consensus 412 -----------------------------------------------i-------S~eLkDLIrkML~kDPskRPTaeEI 437 (1238)
+ -..+.+||.+||..||.+|.|+.++
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 0 1247899999999999999999999
Q ss_pred Hhcccccc
Q psy6346 438 KRHRWMAE 445 (1238)
Q Consensus 438 LeHPWFke 445 (1238)
|.||||.+
T Consensus 744 L~HpFi~~ 751 (752)
T KOG0670|consen 744 LKHPFITE 751 (752)
T ss_pred hcCCcccC
Confidence 99999974
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=301.12 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=213.2
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-----HhHHHHHHHHHHHHhCCCCCeeEEEEEee-eCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-----VNLQKVYREVEIMKQLDHPHIIKLFQVME-TKS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-----e~ikrf~rEIeILkkL~HPNIVrL~dvfe-d~d 262 (1238)
.+.|.....+|.|+|+.||++.++...++||||+-....-.. .-.+...+|.+|.+.|+||.||++||+|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 345666677899999999999999999999999965443211 12366789999999999999999999995 667
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc--ceeeccCCcccccccC---CCcEEEEecCCcc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR--RVVHRDLKAENLLMDS---NLDIKLADFGFSN 337 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk--GIIHRDLKPeNILLd~---nG~VKLiDFGLS~ 337 (1238)
.+|-|+|||+|.+|.-|++..+.+++.+++.|+.||+.||.||... .|||-||||.||||.. .|.+||+|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7999999999999999999999999999999999999999999976 6999999999999953 5889999999998
Q ss_pred cccCCC--------ccccccCCCCCCCcccccC---CccCCCccceehhhHHHHHHhhCCCCCCCCC-hhHHHHH--Hh-
Q psy6346 338 YYVPGQ--------KLATWCGSPPYAAPEVFEG---KKYCGPEIDIWSLGVVLYVLVCGALPFDGST-LNSLRDR--VL- 402 (1238)
Q Consensus 338 ~~~~s~--------~l~t~~GTp~YmAPEVL~g---k~y~S~KSDIWSLGVILYELLTGrlPF~g~d-~eeL~ek--Il- 402 (1238)
.+.... ......||.+|++||.+.- .+..+.++||||+|||+|.++.|+.||...- ...+.+. |+
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 775432 1234679999999998752 3445789999999999999999999996542 2222221 22
Q ss_pred cCCccCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 403 SGRFRIP--YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 403 ~g~~~~P--~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.....|| ..++.++++||++||+..-+.|....++..||+|....
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 2233444 45899999999999999999999999999999997653
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=295.79 Aligned_cols=248 Identities=24% Similarity=0.441 Sum_probs=204.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------CEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------SMIY 265 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d~ly 265 (1238)
|.....+|.|.. .|.-+.+.-.++.||||.+.....+....++..+|..++..+.|+||++++.+|.-. ..+|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 344444555555 566666777899999999988776777789999999999999999999999998533 3589
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l 345 (1238)
+|||++. .+|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+++.-...-.+
T Consensus 98 ~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~m 174 (369)
T KOG0665|consen 98 LVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMM 174 (369)
T ss_pred HHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccccc
Confidence 9999997 67777776 45778889999999999999999999999999999999999999999999999875554456
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---------------------
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--------------------- 404 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--------------------- 404 (1238)
...+.|..|+|||++.+..| ...+||||+||++.||++|+..|.|.+.-..+.++...
T Consensus 175 tpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 175 TPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred CchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 77889999999999999986 89999999999999999999999987654444333210
Q ss_pred ------Ccc----CCCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy6346 405 ------RFR----IPYF-----------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 405 ------~~~----~P~~-----------iS~eLkDLIrkML~kDPskRPTaeEILeHPWFk 444 (1238)
.+. +|.. -...+++|+.+||..||++|.+++++|.|||++
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000 1211 134578999999999999999999999999996
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=308.31 Aligned_cols=243 Identities=29% Similarity=0.456 Sum_probs=210.3
Q ss_pred EEEEecCCCCccccCceEccC----CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 194 KREKCGVKSRSCNRPPVLLRH----TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 194 arekIGsGsfGtVYKav~lkt----G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
....||.|-||.||+|+.... ...||||..+.+. ++...+.|+.|.-+|+.++|||||+|+++|.+. ..|||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 346789999999999887743 3468999887653 666789999999999999999999999999864 5899999
Q ss_pred ecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 270 YANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
+++-|+|..|++.++ .++......++.||+.||.|||+..+|||||-..|||+.....+||+|||++++.....-....
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS 550 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS 550 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence 999999999998764 5888899999999999999999999999999999999999999999999999987665543333
Q ss_pred cC--CCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 349 CG--SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 349 ~G--Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
.| ..-|||||.+....+ +.++|||-|||++||++. |..||.|....+..-.+.+| +.+.|..+++.+..|+.+||
T Consensus 551 ~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcW 629 (974)
T KOG4257|consen 551 RGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCW 629 (974)
T ss_pred ccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHh
Confidence 33 455999999988887 899999999999999886 99999997766666666665 57789999999999999999
Q ss_pred ccCCCCCCCHHHHHh
Q psy6346 425 VREPTKRYCIEQIKR 439 (1238)
Q Consensus 425 ~kDPskRPTaeEILe 439 (1238)
+.+|.+||++.+|..
T Consensus 630 ayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 630 AYEPSKRPRFTEIKA 644 (974)
T ss_pred ccCcccCCcHHHHHH
Confidence 999999999998854
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=314.97 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=213.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEee-----eCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVME-----TKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfe-----d~d~ 263 (1238)
..|...+.+|.|-+|.||++..+++++.+||||+.... ..-+++..|.+||+.+ .|||++.+|++|. .++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 55777889999999999999999999999999997654 2335677899999988 7999999999984 4678
Q ss_pred EEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 264 IYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
+|||||||.||+..|+++.. .++.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||.+.....
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999999999865 5689999999999999999999999999999999999999999999999999876543
Q ss_pred -CCccccccCCCCCCCcccccCCcc----CCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc-CCcc--CCCCCC
Q psy6346 342 -GQKLATWCGSPPYAAPEVFEGKKY----CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS-GRFR--IPYFMS 413 (1238)
Q Consensus 342 -s~~l~t~~GTp~YmAPEVL~gk~y----~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~-g~~~--~P~~iS 413 (1238)
-....+.+|||.|||||++..... ++..+|+||||++..||--|.+|+.+.-+....-.|-. ..+. -|...+
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs 255 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS 255 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence 346788999999999999864322 36789999999999999999999977654333222222 2111 133457
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.++.++|..||.+|-.+||+..++|+|||+.+
T Consensus 256 ~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 256 KKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 88999999999999999999999999999983
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=309.54 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=220.8
Q ss_pred EEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+..+.||.|+||.|++|.|... -..||||++....... .+..|.+|+.+|.+|+|+|+++||++..+ ..+.+|||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3457789999999999988743 3579999998876554 67899999999999999999999999987 67889999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
+++.|+|.+.|.+. ..|.......++.||+.|+.||..+++|||||-..||||-....|||+|||+.+-+..++.++.
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 99999999999873 4588888999999999999999999999999999999999999999999999988776665554
Q ss_pred cc----CCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHH
Q psy6346 348 WC----GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIR 421 (1238)
Q Consensus 348 ~~----GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIr 421 (1238)
.. -...|+|||.+....+ +.++|||++||+||||++ |..||.|.....+.++|..+ .+.-|..+++++.+++.
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk 349 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMK 349 (1039)
T ss_pred ecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHH
Confidence 33 2456999999999888 899999999999999998 99999999999999988865 35668889999999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.||..+|.+|||+..|.+.-+..+.
T Consensus 350 ~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 350 NCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred HhccCCccccccHHHHHHhHHHHhc
Confidence 9999999999999999877666554
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=291.16 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=210.5
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHh-CCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQ-LDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkk-L~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
...+.||.|+||+|++-.+...|+.+|||.++.... ..+.++++.|.+...+ -+.||||++|+.+-.++..||.||+|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344678999999999999999999999999988764 4566889999987555 48999999999999999999999999
Q ss_pred CCCccchhhh-----cccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCcc
Q psy6346 272 NQGEIFDYIA-----RYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 272 ~GGSL~d~Lk-----k~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l 345 (1238)
. .+|..+-+ +...++|..+-.|....+.||.||-.. +|||||+||+||||+..|.+||||||++.....+-..
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk 224 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK 224 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh
Confidence 6 45544332 335689999999999999999999854 8999999999999999999999999999887766666
Q ss_pred ccccCCCCCCCcccccCCcc-CCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcCCccC---CCC---CCHHHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKY-CGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSGRFRI---PYF---MSTECE 417 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y-~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g~~~~---P~~---iS~eLk 417 (1238)
....|...|||||.+..... ++.++|+||||++|||+.||..|+.+.+. -+....+..+.+++ +.. ++..+.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~ 304 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMV 304 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHH
Confidence 66789999999999864433 58999999999999999999999976542 33344455565542 222 788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+|.-||.+|-..||...+++++||++.-
T Consensus 305 ~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 305 RFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 99999999999999999999999999764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=323.73 Aligned_cols=234 Identities=19% Similarity=0.302 Sum_probs=185.7
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
.....+|.|+||.||+|....++..||||++...... ...|+++|++++|||||++++++.+.+..|+||||++
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 3456899999999999999899999999998754311 1356899999999999999999999999999999999
Q ss_pred CCccchhhhcccccchhHHHHHHHHHHHHHhHhh---ccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCH---NRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 273 GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLH---SkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
+|+|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||........ ....
T Consensus 767 ~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~ 839 (968)
T PLN00113 767 GKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---TKCF 839 (968)
T ss_pred CCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---CCcc
Confidence 999999995 3788999999999999999999 6699999999999999998887765 6655432211 2336
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh--hHHH---HHHh---------cCCc----cCCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL--NSLR---DRVL---------SGRF----RIPYF 411 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~--eeL~---ekIl---------~g~~----~~P~~ 411 (1238)
|++.|+|||++.+..+ +.++|||||||++|||++|+.||+.... ..+. .... .... ..+..
T Consensus 840 ~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (968)
T PLN00113 840 ISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918 (968)
T ss_pred ccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence 8899999999988776 8999999999999999999999954321 1111 1100 0000 01111
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 412 MSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 412 iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
...++.+++.+||..||++|||+.|+++.
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 12356789999999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=301.60 Aligned_cols=257 Identities=18% Similarity=0.242 Sum_probs=186.0
Q ss_pred cEEEEEEEecCCCCccccCceEc----------------cCCcEEEEEEeccCCCCh------------HhHHHHHHHHH
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL----------------RHTVNVAIKIIDKSQLDP------------VNLQKVYREVE 241 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l----------------ktG~kVAIKVLkks~ld~------------e~ikrf~rEIe 241 (1238)
+.|...++||.|+||.||+|... ..++.||||.+....... ...+....|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 45777888888899988888642 345689999986542110 01122345777
Q ss_pred HHHhCCCCCe-----eEEEEEeee--------CCEEEEEEeecCCCccchhhhccc------------------------
Q psy6346 242 IMKQLDHPHI-----IKLFQVMET--------KSMIYIVSEYANQGEIFDYIARYG------------------------ 284 (1238)
Q Consensus 242 ILkkL~HPNI-----VrL~dvfed--------~d~lyLVMEy~~GGSL~d~Lkk~~------------------------ 284 (1238)
++.++.|.++ ++++++|.. .+..||||||+.+++|.+++....
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7888876654 566666642 456899999999999998886321
Q ss_pred ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc--ccCCCCCCCcccccC
Q psy6346 285 RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT--WCGSPPYAAPEVFEG 362 (1238)
Q Consensus 285 ~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t--~~GTp~YmAPEVL~g 362 (1238)
.++...++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++........... ..+++.|+|||++..
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 234567888999999999999999999999999999999999999999999865433322222 235789999999864
Q ss_pred Ccc-------------------C--CCccceehhhHHHHHHhhCCC-CCCCCCh-----------hHHHHHHhcCCccCC
Q psy6346 363 KKY-------------------C--GPEIDIWSLGVVLYVLVCGAL-PFDGSTL-----------NSLRDRVLSGRFRIP 409 (1238)
Q Consensus 363 k~y-------------------~--S~KSDIWSLGVILYELLTGrl-PF~g~d~-----------eeL~ekIl~g~~~~P 409 (1238)
... + ..+.||||+|||||+|++|.+ ||.+... ...+..+....+.++
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~ 464 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS 464 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc
Confidence 321 0 124799999999999999886 7754211 111112222333333
Q ss_pred --CCCCHHHHHHHHHhcccCC---CCCCCHHHHHhccccccc
Q psy6346 410 --YFMSTECESLIRKMLVREP---TKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 410 --~~iS~eLkDLIrkML~kDP---skRPTaeEILeHPWFke~ 446 (1238)
...++.+.|||.+||.++| .+|+|++|+|+||||..+
T Consensus 465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 3478899999999999876 689999999999999643
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=308.65 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=220.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCC---cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHT---VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG---~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.-.+...+||.|.||.||.|.....| ..||||.++... .+.....|+.|+.||.+++||||++|.++......+.|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 33556788999999999999888554 579999998765 56677899999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-c
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-K 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~ 344 (1238)
|.|||++|+|..+|+++ +.|+..+...+++.|+.|++||-+.|+|||||.+.|||++.+..+|++|||+++...++. .
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 99999999999999765 679999999999999999999999999999999999999999999999999999765543 2
Q ss_pred ccccc-C--CCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHH
Q psy6346 345 LATWC-G--SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESL 419 (1238)
Q Consensus 345 l~t~~-G--Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDL 419 (1238)
..+.. | ...|.|||.+...++ +.++||||+|++|||.+. |..||.+.+.++....|..+ +++.|..++..+..|
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qL 866 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQL 866 (996)
T ss_pred cccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHH
Confidence 22222 2 356999999999888 899999999999999775 99999999988888888877 566778899999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
+..||++|-.+||++.||+.+
T Consensus 867 MldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 867 MLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999998864
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=294.83 Aligned_cols=262 Identities=20% Similarity=0.333 Sum_probs=201.5
Q ss_pred EEeeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC--------CCC
Q psy6346 179 RLDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD--------HPH 250 (1238)
Q Consensus 179 ~i~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~--------HPN 250 (1238)
+.-.+|.--.+..|-+..++|.|-|+|||.+.+....+.||+||.+... .-.+..+.||++|+.++ ..+
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 3333444333456667889999999999999999999999999987542 22356789999999982 346
Q ss_pred eeEEEEEee----eCCEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCccccccc
Q psy6346 251 IIKLFQVME----TKSMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMD 323 (1238)
Q Consensus 251 IVrL~dvfe----d~d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd 323 (1238)
||+|+|.|. .+.++|+|+|++ |..|..+|... +.++...++.|++||+.||.|||.. ||||-||||+|||+.
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999999995 567899999999 68888888754 6799999999999999999999976 999999999999980
Q ss_pred C-------------------------------------------------------------------------------
Q psy6346 324 S------------------------------------------------------------------------------- 324 (1238)
Q Consensus 324 ~------------------------------------------------------------------------------- 324 (1238)
.
T Consensus 223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s 302 (590)
T KOG1290|consen 223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQES 302 (590)
T ss_pred ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q psy6346 325 -------------------------------------------------------------------------------- 324 (1238)
Q Consensus 325 -------------------------------------------------------------------------------- 324 (1238)
T Consensus 303 ~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p 382 (590)
T KOG1290|consen 303 YNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNP 382 (590)
T ss_pred cccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCC
Confidence
Q ss_pred -------CCcEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh---
Q psy6346 325 -------NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL--- 394 (1238)
Q Consensus 325 -------nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~--- 394 (1238)
+..|||+|||-|+++. ......+.|..|+||||+.|..| ++.+||||++|+++||+||...|+....
T Consensus 383 ~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY-~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 383 DIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGY-STSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred CCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCC-CCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 0014566666655421 22334567889999999999998 8999999999999999999999964321
Q ss_pred ---hHHHHHHh------------c------------------------------CCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 395 ---NSLRDRVL------------S------------------------------GRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 395 ---eeL~ekIl------------~------------------------------g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
+.-...|+ . .++.++.....++.+||.-||+.+|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 11111111 1 11122222345688999999999999
Q ss_pred CCCCHHHHHhcccccccC
Q psy6346 430 KRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 430 kRPTaeEILeHPWFke~~ 447 (1238)
+|+|+.++|+|||+....
T Consensus 540 KR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 540 KRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred ccccHHHHhcCccccCCC
Confidence 999999999999998654
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=298.88 Aligned_cols=240 Identities=25% Similarity=0.451 Sum_probs=212.8
Q ss_pred EEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 194 KREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 194 arekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
...++|-|-+|.||.|+|.+-...||||.++.+. ...++|+.|+.+|+.++|||+|+|+++|..+..+|||.|||..
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 3578899999999999999999999999998643 5678999999999999999999999999999999999999999
Q ss_pred Cccchhhhcccc--cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccC-
Q psy6346 274 GEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCG- 350 (1238)
Q Consensus 274 GSL~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~G- 350 (1238)
|.|.+||.+..+ ++.-....++.||..|++||..+++|||||-..|+|+.++..+||.|||+++++.... .....|
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGA 426 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGA 426 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCc
Confidence 999999987643 5666677888999999999999999999999999999999999999999999865443 222333
Q ss_pred --CCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhccc
Q psy6346 351 --SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 351 --Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~k 426 (1238)
.+-|.|||-+....+ +.++|||+|||+|||+.| |-.||.|.+....+..+..+ +..-|..+++.+.+|++.||++
T Consensus 427 KFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~W 505 (1157)
T KOG4278|consen 427 KFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNW 505 (1157)
T ss_pred cCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcC
Confidence 456999999988887 899999999999999998 99999999999888877665 4556888999999999999999
Q ss_pred CCCCCCCHHHHH
Q psy6346 427 EPTKRYCIEQIK 438 (1238)
Q Consensus 427 DPskRPTaeEIL 438 (1238)
.|.+||++.||-
T Consensus 506 sPsDRPsFaeiH 517 (1157)
T KOG4278|consen 506 SPSDRPSFAEIH 517 (1157)
T ss_pred CcccCccHHHHH
Confidence 999999999883
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-31 Score=312.64 Aligned_cols=268 Identities=25% Similarity=0.421 Sum_probs=206.0
Q ss_pred EEecCCCCc-cccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 196 EKCGVKSRS-CNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 196 ekIGsGsfG-tVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
+.+|.|+-| .||+|.. .|+.||||.+-.+ ..+.+.+||..|+.- +|||||++|..-.+..+.||..|+|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY--EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred HHcccCCCCcEEEEEee--CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 456777665 5677765 6889999997654 345678999999998 69999999999999999999999997
Q ss_pred Cccchhhhcc-cc---cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-----CCcEEEEecCCcccccCCC-
Q psy6346 274 GEIFDYIARY-GR---MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-----NLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 274 GSL~d~Lkk~-~~---Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-----nG~VKLiDFGLS~~~~~s~- 343 (1238)
.+|.+++... .. ......+.++.|++.||++||+.+||||||||.||||+. ...++|+|||+++.+..+.
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 8999999874 11 122456788999999999999999999999999999975 2569999999999876554
Q ss_pred ---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC-CCCCCCCChhHHHHHHhcCCccCC---CCCCHHH
Q psy6346 344 ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG-ALPFDGSTLNSLRDRVLSGRFRIP---YFMSTEC 416 (1238)
Q Consensus 344 ---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG-rlPF~g~d~eeL~ekIl~g~~~~P---~~iS~eL 416 (1238)
...+..||-+|+|||++..... ..++||||||||+|+.++| .+||...- +-...|+.+.+.+- .....++
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred hhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCchHHH
Confidence 2455679999999999988776 7799999999999999885 99996543 22345666654322 1122289
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCCCcccccccC---CCChHHHHHHHHH
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINILGEVK---NEPNEQILRLMNS 474 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeHPWFke~~p~~lppi~~l~elk---~~~~eqILelMes 474 (1238)
.+||.+||.++|..||++.+||.||+|.....+.....+.-+++. .++..++++.++.
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s~lL~~le~ 804 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPSELLRALEA 804 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCchHHHHhhcc
Confidence 999999999999999999999999999876554332222222222 2334455666654
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-31 Score=285.56 Aligned_cols=250 Identities=22% Similarity=0.425 Sum_probs=210.4
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-----EEEEEEee
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS-----MIYIVSEY 270 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d-----~lyLVMEy 270 (1238)
.-||.|.||.||.+.+.++|+.||+|++..-..+-..-+++.+|+++|-.++|.|++..+|+..-.. .+|+|.|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 4689999999999999999999999999876545556689999999999999999999988875432 36888999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~t~ 348 (1238)
+. .+|..+|..-..++.+.++-+++||+.||+|||+.+|.||||||.|+|++.+..+||||||+++.....+ .+...
T Consensus 139 mQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqE 217 (449)
T KOG0664|consen 139 MQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHE 217 (449)
T ss_pred HH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHH
Confidence 86 6788888888899999999999999999999999999999999999999999999999999998765443 34455
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh-----------------------cCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL-----------------------SGR 405 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl-----------------------~g~ 405 (1238)
+-|.+|+|||++.|...|+.++||||.|||+.||+..+..|...++.+..+.|. .+.
T Consensus 218 VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~ 297 (449)
T KOG0664|consen 218 VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAG 297 (449)
T ss_pred HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccC
Confidence 678899999999999888999999999999999999999998766544433332 122
Q ss_pred ccCCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 FRIPY-----------FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 ~~~P~-----------~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+.|. .-..+..+++..||..||++|.+.++++.|++..+.
T Consensus 298 ~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 298 LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 22221 123467789999999999999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=240.89 Aligned_cols=212 Identities=42% Similarity=0.686 Sum_probs=186.8
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccc
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~ 277 (1238)
||.|.+|.||++....++..++||++....... ..+.+.+|+++++.+.|++|+++++++......+++||++.|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 578899999999888889999999998765322 3578999999999999999999999999999999999999999999
Q ss_pred hhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCcccccCCC-ccccccCCCCC
Q psy6346 278 DYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYVPGQ-KLATWCGSPPY 354 (1238)
Q Consensus 278 d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~~s~-~l~t~~GTp~Y 354 (1238)
+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 999876 57899999999999999999999999999999999999999 8999999999987654332 13345678899
Q ss_pred CCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy6346 355 AAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCI 434 (1238)
Q Consensus 355 mAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTa 434 (1238)
++||.+......+.+.|+|+||+++++| ..+.+++.+||..+|.+||++
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 9999987763347899999999999998 568999999999999999999
Q ss_pred HHHHhcc
Q psy6346 435 EQIKRHR 441 (1238)
Q Consensus 435 eEILeHP 441 (1238)
+++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=273.18 Aligned_cols=249 Identities=24% Similarity=0.459 Sum_probs=206.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeC--CEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETK--SMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~--d~lyL 266 (1238)
+.|....++|.|.++.||.|+...++.+++||+++. ...+++.+|+.||..|. ||||+.|+++..+. ...-|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 446667788999999999999999999999999864 45678999999999995 99999999999764 44679
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-CcEEEEecCCcccccCCCcc
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~~~~~s~~l 345 (1238)
|+||+.+.+.. .-...++.-.++.++.+++.||.|||+.||+|||+||.|+|||.. -.++|+|+|+|.++.++...
T Consensus 113 iFE~v~n~Dfk---~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 113 IFEYVNNTDFK---QLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred HhhhhccccHH---HHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 99999865443 344678889999999999999999999999999999999999964 66999999999999999988
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCC-CCChhHHHHHHh-------------cCCccC---
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD-GSTLNSLRDRVL-------------SGRFRI--- 408 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~-g~d~eeL~ekIl-------------~g~~~~--- 408 (1238)
...+.+..|--||++-.-..++...|+|||||+|..|+..+-||- |.+.....-+|. .-...+
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 888999999999999888878999999999999999999998873 433222111111 000000
Q ss_pred -----------C----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 409 -----------P----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 409 -----------P----------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+ .-.++++.|||.++|..|-.+|+|+.|++.||||...
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0 1147899999999999999999999999999999753
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=290.05 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=206.4
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.....++||+|-||.|..|.. ..+.+||||+++.... ......|.+||++|.+|+||||+.|+++|..++.+++|+||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345578899999999999864 4579999999987753 33458899999999999999999999999999999999999
Q ss_pred cCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc---
Q psy6346 271 ANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--- 345 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--- 345 (1238)
++.|+|..++.+.. .+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++....+.-.
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 99999999998773 3345556779999999999999999999999999999999999999999999865444322
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHh--hCCCCCCCCChhHHHHHHhc---C-----CccCCCCCCHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV--CGALPFDGSTLNSLRDRVLS---G-----RFRIPYFMSTE 415 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELL--TGrlPF~g~d~eeL~ekIl~---g-----~~~~P~~iS~e 415 (1238)
...+-...|||+|.+...++ +.++|+|+||+++||++ |...||...+.+...+.... . -+.-|..++..
T Consensus 697 gr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~ 775 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQG 775 (807)
T ss_pred cceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHH
Confidence 22345678999999988888 89999999999999975 68899988776655544322 1 12346778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILe 439 (1238)
+.+||-+|+..|-++||+++++-.
T Consensus 776 lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 776 LYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHhchhhhcCCCHHHHHH
Confidence 999999999999999999999843
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=292.36 Aligned_cols=241 Identities=24% Similarity=0.450 Sum_probs=205.5
Q ss_pred EecCCCCccccCceEc---c----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEE
Q psy6346 197 KCGVKSRSCNRPPVLL---R----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 197 kIGsGsfGtVYKav~l---k----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVM 268 (1238)
.+|.|.||.|+++... . ....||||.++..... .+.+.+..|+++|+.+ .|+||+.+++++...+.+++|+
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 6777777777776544 1 2467999999877644 7788999999999999 5999999999999999999999
Q ss_pred eecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEe
Q psy6346 269 EYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiD 332 (1238)
|||..|+|.+++...+ .++......+.+||+.|++||++.++|||||-+.|||+..+..+||+|
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaD 461 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIAD 461 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEcc
Confidence 9999999999998765 388889999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCccc--cccC--CCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCC-hhHHHHHHhcC-C
Q psy6346 333 FGFSNYYVPGQKLA--TWCG--SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGST-LNSLRDRVLSG-R 405 (1238)
Q Consensus 333 FGLS~~~~~s~~l~--t~~G--Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d-~eeL~ekIl~g-~ 405 (1238)
||+++......... ...| ...|||||.+....| +.++||||+||+||||++ |..||.+.. ..++.+.+..| +
T Consensus 462 FGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r 540 (609)
T KOG0200|consen 462 FGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNR 540 (609)
T ss_pred ccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCC
Confidence 99998654433222 1222 234999999999666 899999999999999998 999999865 66677777776 4
Q ss_pred ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 406 FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 406 ~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..-|..++.++.++++.||..+|++||++.++.+
T Consensus 541 ~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 541 MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 5778899999999999999999999999998865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=240.08 Aligned_cols=212 Identities=39% Similarity=0.610 Sum_probs=184.5
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
.....+|.|+++.||++....++..+|||++...... ...+.+.+|++.+++++|+|++++++++......++++|++.
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4457889999999999998888999999999876433 256788999999999999999999999999999999999999
Q ss_pred CCccchhhhcccc-cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--cccccc
Q psy6346 273 QGEIFDYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLATWC 349 (1238)
Q Consensus 273 GGSL~d~Lkk~~~-Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~t~~ 349 (1238)
+++|.+++..... +++..+..++.+++.+|.+||..+++|+||+|.||+++.++.++|+|||++....... ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 9999999987766 8999999999999999999999999999999999999999999999999988765443 344567
Q ss_pred CCCCCCCcccc-cCCccCCCccceehhhHHHHHHhhCCCCCCC--CChhHHHHHHhcCCc
Q psy6346 350 GSPPYAAPEVF-EGKKYCGPEIDIWSLGVVLYVLVCGALPFDG--STLNSLRDRVLSGRF 406 (1238)
Q Consensus 350 GTp~YmAPEVL-~gk~y~S~KSDIWSLGVILYELLTGrlPF~g--~d~eeL~ekIl~g~~ 406 (1238)
++..|++||.+ ....+ +.++|+|+||+++++|++|+.||.. .....+.+.+..+..
T Consensus 161 ~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 161 GTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 88899999998 44444 6799999999999999999999977 445577777777653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=287.65 Aligned_cols=198 Identities=32% Similarity=0.548 Sum_probs=180.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC------ChHhHHHHHHHHHHHHhCC---CCCeeEEEEEeeeCC
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL------DPVNLQKVYREVEIMKQLD---HPHIIKLFQVMETKS 262 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l------d~e~ikrf~rEIeILkkL~---HPNIVrL~dvfed~d 262 (1238)
|.....+|.|+||.|+.|++.++...|+||.|.++.+ ....+..+-.||.||.+|+ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 5667889999999999999999999999999998763 1222345668999999997 999999999999999
Q ss_pred EEEEEEeec-CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 263 MIYIVSEYA-NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 263 ~lyLVMEy~-~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
++||+||-- +|.+|+++|.....++|.++..||+|++.|+++||+.||||||||-+|+.++.+|.+||+|||.+.+. .
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~-k 721 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT-K 721 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh-c
Confidence 999999975 57799999999999999999999999999999999999999999999999999999999999998754 4
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCC
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~ 390 (1238)
+.+...+.||..|.|||++.|.+|.+..-|||+||++||.++....||.
T Consensus 722 sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 5677889999999999999999999999999999999999999888875
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=273.62 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=202.2
Q ss_pred CcEEEEEEEecCCCCccccCceEcc---CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLR---HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lk---tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~l 264 (1238)
...|...++||.|.|++||++++.. ..++||+|.+.... ...++.+|+++|..+ ++.||+++.+++..++..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3567888999999999999999987 78999999998764 345799999999999 699999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCccccc---
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYV--- 340 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~--- 340 (1238)
.+||||++.....++.. .++..+++.+++.++.||.++|.+|||||||||.|+|++. .+.-.|+|||++....
T Consensus 111 ~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999877776664 4678999999999999999999999999999999999985 4778999999986210
Q ss_pred --------------C--CC--------------------------ccccccCCCCCCCcccccCCccCCCccceehhhHH
Q psy6346 341 --------------P--GQ--------------------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378 (1238)
Q Consensus 341 --------------~--s~--------------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVI 378 (1238)
. +. ......||++|+|||++...+..+.++||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 00 01123599999999999998888999999999999
Q ss_pred HHHHhhCCCCCCCCC--hhHH------------HHH-HhcCC---------------------c------c---------
Q psy6346 379 LYVLVCGALPFDGST--LNSL------------RDR-VLSGR---------------------F------R--------- 407 (1238)
Q Consensus 379 LYELLTGrlPF~g~d--~eeL------------~ek-Il~g~---------------------~------~--------- 407 (1238)
+..+++++.||-... ...+ .+. ...+. . .
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 999999999984211 1111 000 00000 0 0
Q ss_pred -CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 408 -IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 408 -~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.-...+..+.+|+++||..||.+|+|++++|+||||.+.
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 001135578999999999999999999999999999843
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=283.11 Aligned_cols=245 Identities=24% Similarity=0.420 Sum_probs=213.7
Q ss_pred EEEEEEecCCCCccccCceEccCC----cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHT----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
.+...+||.|+||+||+|++...| .+||||++.... ......++..|+-+|.+|+|||+++|++++.... +-||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 445678999999999999999654 578999987654 3344578999999999999999999999998765 8899
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
++|+++|.|.||++.. ..+.......|..||++|+.|||.+.++||||-..|||+..-..+||.|||++..........
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999999865 568899999999999999999999999999999999999999999999999998876554332
Q ss_pred cc---cCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHH
Q psy6346 347 TW---CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIR 421 (1238)
Q Consensus 347 t~---~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIr 421 (1238)
.. .-.+.|||-|.+....| +.++||||+||++||++| |..|+.+...+++.+.+..+ ++.-|..++-++--++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 22 23456999999988887 999999999999999998 99999999999998888776 45667889999999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q psy6346 422 KMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 422 kML~kDPskRPTaeEILe 439 (1238)
+||..|+..||+++++..
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999998765
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-28 Score=282.84 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=214.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|....++|.|.+|.||++.+..+++..|||+++.... .++.-+..|+-+++.++|||||.+++.+...+.++|.||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 456777889999999999999999999999999987653 345677899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~ 348 (1238)
||.||+|.+.-.-.+.+++..+..+.+..+.||+|||+.|-+|||||-.||++++.|.+|+.|||.+..+.. -.+...+
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 999999999888889999999999999999999999999999999999999999999999999998765432 2356678
Q ss_pred cCCCCCCCccccc--CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccC-----CCCCCHHHHHHHH
Q psy6346 349 CGSPPYAAPEVFE--GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI-----PYFMSTECESLIR 421 (1238)
Q Consensus 349 ~GTp~YmAPEVL~--gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~-----P~~iS~eLkDLIr 421 (1238)
+||++|||||+.. .+.-|...+|||++|+...|+---++|....-............+.. +...++.+.+|++
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK 252 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVK 252 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHH
Confidence 9999999999853 22334889999999999999987777754433332222222222322 2336788999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+|.++|++||+++.+|.|||+...
T Consensus 253 ~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 253 GALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999998765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-27 Score=291.05 Aligned_cols=198 Identities=17% Similarity=0.178 Sum_probs=147.3
Q ss_pred hCCC-CCeeEEEEEe-------eeCCEEEEEEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccC
Q psy6346 245 QLDH-PHIIKLFQVM-------ETKSMIYIVSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDL 315 (1238)
Q Consensus 245 kL~H-PNIVrL~dvf-------ed~d~lyLVMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDL 315 (1238)
.+.| +||++++++| ...+.++++||++ +++|.++|.. ...+++.++..+++||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5777888877 2334678888987 5799999965 356999999999999999999999999999999
Q ss_pred CcccccccCCC-------------------cEEEEecCCcccccCC-----------------CccccccCCCCCCCccc
Q psy6346 316 KAENLLMDSNL-------------------DIKLADFGFSNYYVPG-----------------QKLATWCGSPPYAAPEV 359 (1238)
Q Consensus 316 KPeNILLd~nG-------------------~VKLiDFGLS~~~~~s-----------------~~l~t~~GTp~YmAPEV 359 (1238)
||+||||+..+ .+||+|||+++..... ......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996544 4556666665432100 00112468999999999
Q ss_pred ccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6346 360 FEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR-IPYFMSTECESLIRKMLVREPTKRYCIEQIK 438 (1238)
Q Consensus 360 L~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~-~P~~iS~eLkDLIrkML~kDPskRPTaeEIL 438 (1238)
+.+..+ +.++|||||||+||||++|..|+..... ....+.....+ ......+.+.+++.+||.++|.+||++.||+
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 998887 8999999999999999999988764321 11222111111 0111245677899999999999999999999
Q ss_pred hccccccc
Q psy6346 439 RHRWMAEE 446 (1238)
Q Consensus 439 eHPWFke~ 446 (1238)
+||||.+.
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999764
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=264.36 Aligned_cols=236 Identities=24% Similarity=0.377 Sum_probs=189.4
Q ss_pred EEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC--CCCCeeEEEEEeeeCC----EEEEE
Q psy6346 194 KREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL--DHPHIIKLFQVMETKS----MIYIV 267 (1238)
Q Consensus 194 arekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL--~HPNIVrL~dvfed~d----~lyLV 267 (1238)
..+.+|+|.||+||+|.. +++.||||+++. .+.+.+.+|-+|.+.. +|+||++++..-+... .++||
T Consensus 214 l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hHHHhhcCccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 346789999999999976 569999999864 4567888999998765 8999999998876554 79999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc---------cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN---------RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS---------kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
++|.+.|+|.+||+. .-+++.+..+++..|+.||+|||+ ..|+|||||..|||+..++.+.|+|||+|..
T Consensus 287 t~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999999976 468999999999999999999994 2599999999999999999999999999988
Q ss_pred ccCCC---ccccccCCCCCCCcccccCCccCC-----CccceehhhHHHHHHhhCCC------------CCC-----CCC
Q psy6346 339 YVPGQ---KLATWCGSPPYAAPEVFEGKKYCG-----PEIDIWSLGVVLYVLVCGAL------------PFD-----GST 393 (1238)
Q Consensus 339 ~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S-----~KSDIWSLGVILYELLTGrl------------PF~-----g~d 393 (1238)
+.++. .....+||..|||||++.+..... .+.||||+|.|||||++... ||. ..+
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 76553 334478999999999997653322 35899999999999987432 332 134
Q ss_pred hhHHHHHHhcCC--ccCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6346 394 LNSLRDRVLSGR--FRIPYF-----MSTECESLIRKMLVREPTKRYCIEQI 437 (1238)
Q Consensus 394 ~eeL~ekIl~g~--~~~P~~-----iS~eLkDLIrkML~kDPskRPTaeEI 437 (1238)
.+++.+.++..+ ..+|.. --..+.+.++.||..||+-|+|+.=+
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 455666655443 334433 23457899999999999999997643
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=240.86 Aligned_cols=211 Identities=21% Similarity=0.396 Sum_probs=177.1
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
......+|.|++|.|-+..+..+|...|+|.+.... +....+++.+|+.+..+. .+|++|.+|+.+.....++|.||.
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 444578999999999999999999999999998764 556678889999886655 899999999999999999999999
Q ss_pred cCCCccchh----hhcccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCcc
Q psy6346 271 ANQGEIFDY----IARYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 271 ~~GGSL~d~----Lkk~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l 345 (1238)
|. -+|..+ +++.+.++|..+-+|+..++.||.|||++ .+||||+||.||||+.+|.+|+||||++....++-..
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 96 455443 34567799999999999999999999987 8999999999999999999999999999887766555
Q ss_pred ccccCCCCCCCcccccCC---ccCCCccceehhhHHHHHHhhCCCCCCC-CChhHHHHHHhcC
Q psy6346 346 ATWCGSPPYAAPEVFEGK---KYCGPEIDIWSLGVVLYVLVCGALPFDG-STLNSLRDRVLSG 404 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk---~y~S~KSDIWSLGVILYELLTGrlPF~g-~d~eeL~ekIl~g 404 (1238)
.-..|...|||||.+... .-|+.++||||||+.++||.+++.||+. .++-+...++++.
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 556788999999997532 2348999999999999999999999964 3444555555554
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=258.68 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=197.0
Q ss_pred EeeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC--CCCCeeEEEEE
Q psy6346 180 LDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL--DHPHIIKLFQV 257 (1238)
Q Consensus 180 i~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL--~HPNIVrL~dv 257 (1238)
+-.|..-+.+......+.||+|.||.||+|.+ .|..||||++... +...+.+|.+|.... +|+||+.+++.
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhc
Confidence 34455556667788889999999999999988 5999999998754 235788999998864 99999999876
Q ss_pred eeeC----CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc--------ceeeccCCcccccccCC
Q psy6346 258 METK----SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR--------RVVHRDLKAENLLMDSN 325 (1238)
Q Consensus 258 fed~----d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk--------GIIHRDLKPeNILLd~n 325 (1238)
-..+ ..+|||.+|.+.|+|+|||.+ ..++.....+++..++.||++||.. .|.|||||..|||+..+
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 5432 358999999999999999988 7789999999999999999999932 59999999999999999
Q ss_pred CcEEEEecCCcccccCCC-----ccccccCCCCCCCcccccCCc----cCC-CccceehhhHHHHHHhhC----------
Q psy6346 326 LDIKLADFGFSNYYVPGQ-----KLATWCGSPPYAAPEVFEGKK----YCG-PEIDIWSLGVVLYVLVCG---------- 385 (1238)
Q Consensus 326 G~VKLiDFGLS~~~~~s~-----~l~t~~GTp~YmAPEVL~gk~----y~S-~KSDIWSLGVILYELLTG---------- 385 (1238)
|.+.|+|+|+|....... .....+||..|||||++...- +.+ ..+||||||.|+||+...
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999999997664432 345678999999999986432 112 358999999999998752
Q ss_pred CCCCCC-----CChhHHHHHHhcCCc--cCCCC-C-CH---HHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 386 ALPFDG-----STLNSLRDRVLSGRF--RIPYF-M-ST---ECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 386 rlPF~g-----~d~eeL~ekIl~g~~--~~P~~-i-S~---eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.+||.+ ...+++.+-+...++ .+|.. - .+ .+..|++.||..||.-|.|+--|.+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 577754 334455554444433 23322 1 22 3557899999999999999876644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-25 Score=220.67 Aligned_cols=252 Identities=31% Similarity=0.512 Sum_probs=209.5
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChH-hHHHHHHHHHHHHhCCCC-CeeEEEEEeeeCCEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV-NLQKVYREVEIMKQLDHP-HIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e-~ikrf~rEIeILkkL~HP-NIVrL~dvfed~d~lyLVME 269 (1238)
|.....+|.|+|+.||.+.+. ..+|+|.+........ ....+.+|+.++..+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 455677888888888888776 8899999988765443 578899999999999988 79999999988888999999
Q ss_pred ecCCCccchhhhccc---ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCCcccccCCC--
Q psy6346 270 YANQGEIFDYIARYG---RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYVPGQ-- 343 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~---~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~s~-- 343 (1238)
++.++++.+++.... .+....+..++.|++.++.|+|..+++|||+||+||+++..+ .++++|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998777665 799999999999999999999999999999999999999988 79999999987554332
Q ss_pred -----ccccccCCCCCCCcccccCC--ccCCCccceehhhHHHHHHhhCCCCCCCCCh----hHHHHHHhcCCcc-CCCC
Q psy6346 344 -----KLATWCGSPPYAAPEVFEGK--KYCGPEIDIWSLGVVLYVLVCGALPFDGSTL----NSLRDRVLSGRFR-IPYF 411 (1238)
Q Consensus 344 -----~l~t~~GTp~YmAPEVL~gk--~y~S~KSDIWSLGVILYELLTGrlPF~g~d~----eeL~ekIl~g~~~-~P~~ 411 (1238)
.....+|+..|++||.+.+. .......|+|++|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 34667899999999999884 3458899999999999999999999877763 4455555444433 2222
Q ss_pred CC--------HHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 412 MS--------TECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 412 iS--------~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 21 478999999999999999999999998666543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=220.74 Aligned_cols=159 Identities=24% Similarity=0.295 Sum_probs=129.3
Q ss_pred Cccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCC
Q psy6346 274 GEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSP 352 (1238)
Q Consensus 274 GSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp 352 (1238)
|+|.+++... +.+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6788888764 45999999999999999999999998 999999999999999 9998765332 236899
Q ss_pred CCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcCCccC-------CCCCCH--HHHHHHHH
Q psy6346 353 PYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSGRFRI-------PYFMST--ECESLIRK 422 (1238)
Q Consensus 353 ~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g~~~~-------P~~iS~--eLkDLIrk 422 (1238)
.|||||++.+..+ +.++|||||||++|||++|..||..... ......+....... +..++. ++.++|.+
T Consensus 69 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 69 YFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred cccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999999998887 8999999999999999999999976532 22233332221111 122333 69999999
Q ss_pred hcccCCCCCCCHHHHHhcccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke 445 (1238)
||..+|.+||++.++++|+|+..
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-26 Score=274.65 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=202.2
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEecc---CCCChHh-HHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDK---SQLDPVN-LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkk---s~ld~e~-ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
...+|.|.+|.|+.+........++.|.... ....... ...+..|+.+-..|.|+|++..++.+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 4567888888777666666666666665442 1112222 23377888888999999998888777776666666999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-----Ccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-----QKL 345 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-----~~l 345 (1238)
|++ +|+.++...+.+...++..+++||+.||+|||+.||.|||||++|++++.+|.+||+|||.+..+... ...
T Consensus 403 ~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~ 481 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHES 481 (601)
T ss_pred ccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhh
Confidence 998 99999998889999999999999999999999999999999999999999999999999998766432 234
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHH--H-------HHhcCCccCCCCCCHHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLR--D-------RVLSGRFRIPYFMSTEC 416 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~--e-------kIl~g~~~~P~~iS~eL 416 (1238)
...+|+..|+|||++.+..|....+||||.|++++.|++|+.||.-....+.. + .+..+...+-..++...
T Consensus 482 ~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~ 561 (601)
T KOG0590|consen 482 SGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRET 561 (601)
T ss_pred cCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhH
Confidence 56789999999999999999888999999999999999999999654433221 1 12222223334478889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 562 ~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 562 RIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 999999999999999999999999999875
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=234.48 Aligned_cols=256 Identities=23% Similarity=0.400 Sum_probs=198.6
Q ss_pred ccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEE-eee
Q psy6346 183 LHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQV-MET 260 (1238)
Q Consensus 183 LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dv-fed 260 (1238)
|..-.+.++|.....+|.|.||.+-.+.+..+...+++|.+++.. ...+.|.+|...--.| -|.||+.-|++ |++
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 344455677888888899999999999999999999999998865 3457889998876666 58999988875 678
Q ss_pred CCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC--CCcEEEEecCCccc
Q psy6346 261 KSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADFGFSNY 338 (1238)
Q Consensus 261 ~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~--nG~VKLiDFGLS~~ 338 (1238)
.+.++++|||++-|+|..-+.. ..+.|...+.++.|++.||.|+|++++||||||.+||||-. .-.+||||||+++.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 8899999999999999987765 56888999999999999999999999999999999999942 35799999999865
Q ss_pred ccCCCccccccCCCCCCCcccccCCc----cCCCccceehhhHHHHHHhhCCCCCCCCChh----HHHHHHhcC-CccCC
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKK----YCGPEIDIWSLGVVLYVLVCGALPFDGSTLN----SLRDRVLSG-RFRIP 409 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~----y~S~KSDIWSLGVILYELLTGrlPF~g~d~e----eL~ekIl~g-~~~~P 409 (1238)
. +......--+..|.+||+..... ...+.+|+|.||+|+|.+++|.+||...... .-+.++..+ ....|
T Consensus 173 ~--g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 173 V--GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred c--CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 3 22222223456799999865332 2467899999999999999999999743211 122223322 22334
Q ss_pred C---CCCHHHHHHHHHhcccCCCCC---CCHHHHHhccccc
Q psy6346 410 Y---FMSTECESLIRKMLVREPTKR---YCIEQIKRHRWMA 444 (1238)
Q Consensus 410 ~---~iS~eLkDLIrkML~kDPskR---PTaeEILeHPWFk 444 (1238)
. -+++.+..+.++-|..++++| -++.......|..
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 3 268889999999999999999 5566666666653
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=221.22 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=195.0
Q ss_pred EEEEEEEecCCCCccccCceEccCC-cEEEEEEeccCCCChHhHHHHHHHHHHHHhCC----CCCeeEEEEEe-eeCCEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHT-VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD----HPHIIKLFQVM-ETKSMI 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG-~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~----HPNIVrL~dvf-ed~d~l 264 (1238)
.|+....||.|+||.||.+.+...+ ..+|+|+......... ..+..|+.+|..+. ..++..+++.. ....+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 6889999999999999999887764 6899999877532211 16778999999986 36999999999 588899
Q ss_pred EEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-----CcEEEEecCCcc
Q psy6346 265 YIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-----LDIKLADFGFSN 337 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-----G~VKLiDFGLS~ 337 (1238)
||||+++ |.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..++|+|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999998 68999987554 579999999999999999999999999999999999999764 469999999998
Q ss_pred --cccCCC--------c-cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--
Q psy6346 338 --YYVPGQ--------K-LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-- 404 (1238)
Q Consensus 338 --~~~~s~--------~-l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-- 404 (1238)
.+.... . .....||..|+++.+..+... +.+.|+||++.++.+|+.|.+||.+........++...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 321111 1 123459999999999999887 89999999999999999999999776533222222221
Q ss_pred -Cc-c-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 405 -RF-R-IPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 405 -~~-~-~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.. . +....+.++.+++..+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11 1 223456778888887777889999988777655
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=247.45 Aligned_cols=240 Identities=27% Similarity=0.442 Sum_probs=209.0
Q ss_pred ecCCCCccccCceEc---cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 198 CGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 198 IGsGsfGtVYKav~l---ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
+|.|.+|.|+.+... +.|..+|+|++++.............|..++..++ ||.+|++...+..+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 455666666654333 45788999999877643333335667888899886 99999999999999999999999999
Q ss_pred CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCC
Q psy6346 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353 (1238)
Q Consensus 274 GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~ 353 (1238)
|+|+..+.+...+.+..+..+...++.+++++|+.||+|||+|++||+++.+|++++.|||+++.....+.. |||..
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYE 158 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchh
Confidence 999999999999999999999999999999999999999999999999999999999999999876555433 99999
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPT 433 (1238)
|||||++.+ ...++|.||+|+++++|++|..||.+ ++...|....+.+|..++..+++++..|+..+|.+|.-
T Consensus 159 ymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 159 YRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLG 231 (612)
T ss_pred hhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhc
Confidence 999999983 26789999999999999999999988 67778888889999999999999999999999999974
Q ss_pred -----HHHHHhcccccccC
Q psy6346 434 -----IEQIKRHRWMAEET 447 (1238)
Q Consensus 434 -----aeEILeHPWFke~~ 447 (1238)
+.++++|+||....
T Consensus 232 ~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 232 AGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred cCcchhHHHhccchheeee
Confidence 68999999998653
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=224.91 Aligned_cols=242 Identities=18% Similarity=0.288 Sum_probs=198.5
Q ss_pred EEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee-eCCEEEEEEe
Q psy6346 196 EKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME-TKSMIYIVSE 269 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe-d~d~lyLVME 269 (1238)
..+.+|-||.||.|++.. +.+.|-+|.++.. ..+-+...+..|...|..+.|||+..+.+++. +....++++.
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 344556666666665553 2345677776544 35667788999999999999999999999874 4556788889
Q ss_pred ecCCCccchhhhcc--------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 270 YANQGEIFDYIARY--------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
+..-|.|..++... ..++......++.|+..|++|||++||||.||-..|++||+...+||+|=.+++-..+
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFP 448 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCc
Confidence 99889999998732 2366677788899999999999999999999999999999999999999999876655
Q ss_pred CCcc---ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHH
Q psy6346 342 GQKL---ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTEC 416 (1238)
Q Consensus 342 s~~l---~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eL 416 (1238)
.+-. ...-....||+||.+....| +.++|+|||||+||||++ |+.|+...++.++...+..| +..-|..+++++
T Consensus 449 ~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeL 527 (563)
T KOG1024|consen 449 GDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDEL 527 (563)
T ss_pred ccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHH
Confidence 4311 11123456999999999888 899999999999999998 99999999999999888887 455678899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHh
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILe 439 (1238)
-.++--||..+|++||+++|+..
T Consensus 528 f~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 528 FTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHhcCcccCCCHHHHHH
Confidence 99999999999999999999865
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=219.43 Aligned_cols=163 Identities=14% Similarity=0.121 Sum_probs=129.2
Q ss_pred CcEEEEEEEecCCCCccccCceEcc-CCcEEEEEEeccCCC---ChHhHHHHHHHHHHHHhCCCCCeeE-EEEEeeeCCE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLR-HTVNVAIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIK-LFQVMETKSM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lk-tG~kVAIKVLkks~l---d~e~ikrf~rEIeILkkL~HPNIVr-L~dvfed~d~ 263 (1238)
+..|.....||.|+||.||+|.+.. ++..||||++..... .....+.+.+|+++|++++|+||++ ++++ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 3458888899999999999998876 678889999764321 2334567999999999999999985 5442 45
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccC-CcccccccCCCcEEEEecCCcccccCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDL-KAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDL-KPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
.|||||||+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||++..+...
T Consensus 93 ~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 7999999999988632 11 11 2578899999999999999999999 999999999999999999999866433
Q ss_pred C---------ccccccCCCCCCCcccccC
Q psy6346 343 Q---------KLATWCGSPPYAAPEVFEG 362 (1238)
Q Consensus 343 ~---------~l~t~~GTp~YmAPEVL~g 362 (1238)
. .....++++.|+|||.+.-
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 2 1234568888999999853
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=208.99 Aligned_cols=211 Identities=20% Similarity=0.270 Sum_probs=179.8
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyL 266 (1238)
.|-.|++..+||.|+||..+.|..+-++.+||||...... ..-++..|.+..+.| ..++|..+|.+..++.+-.|
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 3567999999999999999999999999999999987654 334677899998888 67899999988889999999
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-----CcEEEEecCCccccc
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-----LDIKLADFGFSNYYV 340 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-----G~VKLiDFGLS~~~~ 340 (1238)
|||++ |-+|.|+..-. ++|+...+..++.|++.-++|+|++.+|+|||||+|+||... ..|.|+|||+++.+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99998 67888877655 469999999999999999999999999999999999999643 349999999998875
Q ss_pred CCC--------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC---hhHHHHHHhcC
Q psy6346 341 PGQ--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---LNSLRDRVLSG 404 (1238)
Q Consensus 341 ~s~--------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d---~eeL~ekIl~g 404 (1238)
+.. ......||..||+--..+|... +.+.|+-+||-++++.|-|.+||.|.. ..+-+++|-+.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 432 2234579999999999999887 899999999999999999999998754 44555666544
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=197.70 Aligned_cols=240 Identities=21% Similarity=0.235 Sum_probs=193.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCC-CCeeEEEEEeeeCCEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDH-PHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~H-PNIVrL~dvfed~d~lyLV 267 (1238)
+..|+...+||.|+||.+|.+.....|..||||+-......+ .+..|..+.+.|.+ ..|..+..+..+..+-.+|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345888899999999999999999999999999987664333 57789999999954 6788888888899999999
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC---CcEEEEecCCcccccCCC
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN---LDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n---G~VKLiDFGLS~~~~~s~ 343 (1238)
|+++ |-+|.+++.-. +.|+...+.-++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+++.+.+..
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 9998 67888877654 569999999999999999999999999999999999999643 569999999998764322
Q ss_pred --------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh---hHHHHHHhcCCccCC---
Q psy6346 344 --------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL---NSLRDRVLSGRFRIP--- 409 (1238)
Q Consensus 344 --------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~---eeL~ekIl~g~~~~P--- 409 (1238)
.-..+.||..|.+--...+... +.+.|+-|+|.+|.++.-|.+||.+... ...+++|.+.+...|
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV 247 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH
Confidence 2234679999999888877776 7899999999999999999999998654 345566666555433
Q ss_pred --CCCCHHHHHHHHHhcccCCCCCCCH
Q psy6346 410 --YFMSTECESLIRKMLVREPTKRYCI 434 (1238)
Q Consensus 410 --~~iS~eLkDLIrkML~kDPskRPTa 434 (1238)
...+.++.-.|.-|-..-=++-|..
T Consensus 248 LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 248 LCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 3356777777777666555555543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.1e-20 Score=190.22 Aligned_cols=140 Identities=19% Similarity=0.124 Sum_probs=110.5
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHh------------------------HHHHHHHHHHHHhCCCCCe
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVN------------------------LQKVYREVEIMKQLDHPHI 251 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~------------------------ikrf~rEIeILkkL~HPNI 251 (1238)
+.||.|++|.||.|... +|+.||||+++........ ......|+++|.++.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 57899999999999876 8999999999865322111 1223459999999988776
Q ss_pred eEEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHh-hccceeeccCCcccccccCCCcEEE
Q psy6346 252 IKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYC-HNRRVVHRDLKAENLLMDSNLDIKL 330 (1238)
Q Consensus 252 VrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYL-HSkGIIHRDLKPeNILLd~nG~VKL 330 (1238)
.....+... ..+|||||+.|+++...+.....++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 433322222 2389999999887766544557889999999999999999999 799999999999999998 578999
Q ss_pred EecCCcccc
Q psy6346 331 ADFGFSNYY 339 (1238)
Q Consensus 331 iDFGLS~~~ 339 (1238)
+|||++...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05147 159 IDVSQSVEH 167 (190)
T ss_pred EEccccccC
Confidence 999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=222.64 Aligned_cols=216 Identities=30% Similarity=0.501 Sum_probs=172.4
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|.....+..|++|.||.+.+..+..++|+|+ ++..+ +.+- ||...+.|.+|
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-------ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-------ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhcc-cccch-------hhhc--cccccCCccee-------------------
Confidence 5555678889999999998888899999955 33321 1111 45555666665
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---------
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG--------- 342 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s--------- 342 (1238)
|+-...++.-+.++... +.+++|||+-||+|||+||+|.+|+.-|++|++|||++......
T Consensus 136 --gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred --chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 44445555555565543 78999999999999999999999999999999999997543110
Q ss_pred ------C-ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCC---C
Q psy6346 343 ------Q-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF---M 412 (1238)
Q Consensus 343 ------~-~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~---i 412 (1238)
+ .-...||||.|.|||++....| +..+|+|++|+|+||.+.|..||.+++.++++..++.....+|.. +
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~ 284 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEAL 284 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCC
Confidence 0 1123589999999999999888 999999999999999999999999999999999998887766654 7
Q ss_pred CHHHHHHHHHhcccCCCCCC---CHHHHHhcccccccC
Q psy6346 413 STECESLIRKMLVREPTKRY---CIEQIKRHRWMAEET 447 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRP---TaeEILeHPWFke~~ 447 (1238)
+++++++|.++|..+|..|. .+-++.+|+||+.-.
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 88999999999999999995 577899999998643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=180.85 Aligned_cols=140 Identities=15% Similarity=0.068 Sum_probs=111.6
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChH------------------------hHHHHHHHHHHHHhCCCCCe
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV------------------------NLQKVYREVEIMKQLDHPHI 251 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e------------------------~ikrf~rEIeILkkL~HPNI 251 (1238)
+.||.|++|.||++... +|..||||+++....... ....+.+|++.+.++.|++|
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999876 899999999987632110 01234689999999999987
Q ss_pred eEEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEE
Q psy6346 252 IKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKL 330 (1238)
Q Consensus 252 VrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKL 330 (1238)
.....+.... .||||||++|+++...+.....++...+..++.|++.+|.+||. .||+||||||+||+++ ++.++|
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 5433333322 48999999988665443344678888999999999999999999 9999999999999998 889999
Q ss_pred EecCCcccc
Q psy6346 331 ADFGFSNYY 339 (1238)
Q Consensus 331 iDFGLS~~~ 339 (1238)
+|||++...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05145 159 IDVSQAVEL 167 (190)
T ss_pred EEcccceec
Confidence 999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.7e-19 Score=195.76 Aligned_cols=239 Identities=22% Similarity=0.273 Sum_probs=155.4
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCC----------CCCeeEE
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLD----------HPHIIKL 254 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~----------HPNIVrL 254 (1238)
|....++.....||.|+++.||.+.+..+|..+|||+...... .....+.+.+|.-....+. |-.++-.
T Consensus 8 ~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 8 GQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp S--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred CCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 3344667788999999999999999999999999999866542 2345677877776655542 2223333
Q ss_pred EEEe---------eeC---CE-----EEEEEeecCCCccchhhhc---cc----ccchhHHHHHHHHHHHHHhHhhccce
Q psy6346 255 FQVM---------ETK---SM-----IYIVSEYANQGEIFDYIAR---YG----RMNENAARRKFWQILSAVEYCHNRRV 310 (1238)
Q Consensus 255 ~dvf---------ed~---d~-----lyLVMEy~~GGSL~d~Lkk---~~----~Lsesea~kI~~QILsALeYLHSkGI 310 (1238)
++.. ... .. .+++|+-+. ++|.+++.- .. .+.......+..|++..+++||..|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 3322 111 12 367788775 677766542 11 12223334556899999999999999
Q ss_pred eeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCCCCcccccCC-------ccCCCccceehhhHHHHHHh
Q psy6346 311 VHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGK-------KYCGPEIDIWSLGVVLYVLV 383 (1238)
Q Consensus 311 IHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk-------~y~S~KSDIWSLGVILYELL 383 (1238)
+|+||+|+|++++.+|.++|+||+..... +........+..|.+||..... -.++.+.|.|+||+++|.|+
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~--g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRA--GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEET--TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeec--CceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999999876542 2222223456789999976432 12378899999999999999
Q ss_pred hCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCC
Q psy6346 384 CGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR 431 (1238)
Q Consensus 384 TGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskR 431 (1238)
||..||........... .+.....+++.++.||+.||+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999987654332221 233333688999999999999999988
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-19 Score=209.87 Aligned_cols=176 Identities=24% Similarity=0.422 Sum_probs=139.3
Q ss_pred CCEEEEEEeecCCCccchhhhccc---ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 261 KSMIYIVSEYANQGEIFDYIARYG---RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 261 ~d~lyLVMEy~~GGSL~d~Lkk~~---~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
..++||.|++|...+|.+||.+.. ..+......++.|+..|++| +|.+|+|+||.||++..+..+||.|||+.+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 346899999999999999997543 46777889999999999999 999999999999999999999999999987
Q ss_pred cccCCC-------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCccCC
Q psy6346 338 YYVPGQ-------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRFRIP 409 (1238)
Q Consensus 338 ~~~~s~-------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~~~P 409 (1238)
...... ....+.||..||+||.+.+..| +.++|||+||+||+||+. =...|. .......+..+.++..
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPE 480 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChH
Confidence 665444 5567889999999999999998 999999999999999997 222221 1122333444443311
Q ss_pred CC-CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 410 YF-MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 410 ~~-iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.. --++-.+|+.+||...|.+||++.+.--|.|.
T Consensus 481 ~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11 12344589999999999999988877777764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-18 Score=186.88 Aligned_cols=172 Identities=13% Similarity=0.101 Sum_probs=128.7
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChH-hHHH------HHHHHHHHHhCCCCCeeEEEEEeeeC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV-NLQK------VYREVEIMKQLDHPHIIKLFQVMETK 261 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e-~ikr------f~rEIeILkkL~HPNIVrL~dvfed~ 261 (1238)
...|+....+|.|+||.||.+.. ++..+|||++........ .... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 34566667777777777776433 466899999976654332 2233 57999999999999999998886533
Q ss_pred --------CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEec
Q psy6346 262 --------SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333 (1238)
Q Consensus 262 --------d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDF 333 (1238)
...+|||||++|.+|.++.. +++ ....+++.+|..||..|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35899999999999977632 222 3466999999999999999999999999999988 999999
Q ss_pred CCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHh
Q psy6346 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383 (1238)
Q Consensus 334 GLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELL 383 (1238)
|............ .++....+ +.++|+|+||+++..+.
T Consensus 179 g~~~~~~e~~a~d-----------~~vler~y-~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD-----------RIDLERHY-GIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH-----------HHHHHhHh-cccccccceeEeehHHH
Confidence 9876543222111 13344455 58999999999987643
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.1e-19 Score=216.81 Aligned_cols=240 Identities=23% Similarity=0.306 Sum_probs=179.5
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC--CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ--LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~--ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
.+...+.+|.+.|=.|.++.+. .|. |+||++-+.. +.-...++...|++ ...+++||++++..+.+.....|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 3455577888888888877543 344 9999986654 23334455556666 66679999999999888888899999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc--ccCCCc--
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY--YVPGQK-- 344 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~--~~~s~~-- 344 (1238)
+|.. -+|+|.+..+.-+..-+.+-|+.||+.||.-+|..||+|||||.+||||+.=.-+.|+||..-+- ...+.+
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 9997 68999998888889999999999999999999999999999999999999988899999975421 111111
Q ss_pred ----cccccCCCCCCCcccccCC----------ccCCCccceehhhHHHHHHhh-CCCCCCCCCh-------hHHHHHHh
Q psy6346 345 ----LATWCGSPPYAAPEVFEGK----------KYCGPEIDIWSLGVVLYVLVC-GALPFDGSTL-------NSLRDRVL 402 (1238)
Q Consensus 345 ----l~t~~GTp~YmAPEVL~gk----------~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~-------eeL~ekIl 402 (1238)
..+...-.+|.|||.+-.. +..+++.||||+||+++||++ |++||.-... ....+.++
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL 259 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence 1122233469999987431 213678999999999999998 7999952110 01111111
Q ss_pred cCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 403 SGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 403 ~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+ ..-+..+++||..|++.||.+|.++++.|+.
T Consensus 260 e------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 E------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred H------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 1134578999999999999999999999975
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=178.69 Aligned_cols=187 Identities=16% Similarity=0.080 Sum_probs=139.7
Q ss_pred EEEEecCCCCccccCceEccCCcEEEEEEeccCCCC--hHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEee
Q psy6346 194 KREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD--PVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 194 arekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld--~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
....++.++||+|+.+ ...+.+++.+.+.....- ......+.+|+++|++|. +++|+.++++ +..|++|||
T Consensus 6 ~~~~l~~~~f~~v~~~--~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLV--RGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEe--ecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456788888888843 347888888877655431 112236789999999995 5889999886 346999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccC-CcccccccCCCcEEEEecCCcccccCCCcc----
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDL-KAENLLMDSNLDIKLADFGFSNYYVPGQKL---- 345 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDL-KPeNILLd~nG~VKLiDFGLS~~~~~s~~l---- 345 (1238)
+.|.+|...+.. ....++.|++.+|.+||.+||+|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 999988654321 12457889999999999999999999 799999999999999999999865433310
Q ss_pred ----------ccccCCCCCCCcccccCCccCC-CccceehhhHHHHHHhhCCCCCCCCC
Q psy6346 346 ----------ATWCGSPPYAAPEVFEGKKYCG-PEIDIWSLGVVLYVLVCGALPFDGST 393 (1238)
Q Consensus 346 ----------~t~~GTp~YmAPEVL~gk~y~S-~KSDIWSLGVILYELLTGrlPF~g~d 393 (1238)
.-...++.|+.|+...-..-.+ ...+.++.|+-+|.++|+..++.++.
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0112678889998654332112 56788999999999999998876543
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=208.04 Aligned_cols=193 Identities=23% Similarity=0.314 Sum_probs=160.6
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC---CCCeeEEEEEeeeCCEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD---HPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~---HPNIVrL~dvfed~d~l 264 (1238)
.|+.|.+...+|.|++|.||.|...+ |+.||||+-+..... +|+--.+++.+|+ -+-|..+...+...+..
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 36778888999999999999998877 999999998776532 2333345555665 23344444444566778
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-------CCcEEEEecCCcc
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-------NLDIKLADFGFSN 337 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-------nG~VKLiDFGLS~ 337 (1238)
+||+||.+-|+|.+++...+.+++..+..|..|++..|+.||..||||+||||+|+||.. ..-++|||||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 999999999999999998899999999999999999999999999999999999999942 3459999999874
Q ss_pred c---ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCC
Q psy6346 338 Y---YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387 (1238)
Q Consensus 338 ~---~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrl 387 (1238)
- +.++......++|-.+-++|+..|++| +..+|.|.|+.+++.||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHH
Confidence 3 345556777889999999999999999 999999999999999999964
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.8e-17 Score=172.88 Aligned_cols=134 Identities=18% Similarity=0.281 Sum_probs=107.2
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-----CCCCeeEEEEEeeeCC---EEE-
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-----DHPHIIKLFQVMETKS---MIY- 265 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-----~HPNIVrL~dvfed~d---~ly- 265 (1238)
...||.|+++.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 46789999999995 5555555 6999876432 2346789999999999 6799999999998873 434
Q ss_pred EEEee--cCCCccchhhhcccccchhHHHHHHHHHHHHH-hHhhccceeeccCCcccccccC----CCcEEEEecCCc
Q psy6346 266 IVSEY--ANQGEIFDYIARYGRMNENAARRKFWQILSAV-EYCHNRRVVHRDLKAENLLMDS----NLDIKLADFGFS 336 (1238)
Q Consensus 266 LVMEy--~~GGSL~d~Lkk~~~Lsesea~kI~~QILsAL-eYLHSkGIIHRDLKPeNILLd~----nG~VKLiDFGLS 336 (1238)
+|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5589999999763 46555 46688888888 9999999999999999999974 347999995544
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.8e-18 Score=207.16 Aligned_cols=254 Identities=29% Similarity=0.471 Sum_probs=208.3
Q ss_pred EEEEEEecCCCCccccCceEc-cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL-RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l-ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVME 269 (1238)
|.....+|.|+++.|-..... .....+|+|.+..........+.+..|..+-+.+. |.|++.+++.....+..+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 444455788888877766543 33567888887766544555677778999988887 9999999999999999999999
Q ss_pred ecCCCccchhh-hccc-ccchhHHHHHHHHHHHHHhHhh-ccceeeccCCcccccccCCC-cEEEEecCCcccccC-CC-
Q psy6346 270 YANQGEIFDYI-ARYG-RMNENAARRKFWQILSAVEYCH-NRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYVP-GQ- 343 (1238)
Q Consensus 270 y~~GGSL~d~L-kk~~-~Lsesea~kI~~QILsALeYLH-SkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~-s~- 343 (1238)
+..|+++++.+ .... .++...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .+++.|||+++.+.. ..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~ 181 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA 181 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence 99999999999 5555 7888999999999999999999 99999999999999999999 999999999987755 22
Q ss_pred --ccccccC-CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHH-HHHhcC----CccCCCCCCHH
Q psy6346 344 --KLATWCG-SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLR-DRVLSG----RFRIPYFMSTE 415 (1238)
Q Consensus 344 --~l~t~~G-Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~-ekIl~g----~~~~P~~iS~e 415 (1238)
.....+| ++.|+|||...+..+..+..|+||+|+++..+++|..||......... ..+... .......++..
T Consensus 182 ~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (601)
T KOG0590|consen 182 ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQ 261 (601)
T ss_pred ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChh
Confidence 3445688 999999999999878889999999999999999999999765433211 111111 12223347888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
..+++.++|..+|..|.+.+++..++|+..
T Consensus 262 ~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 262 AHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhhcccccccCCchhccccccccccccccc
Confidence 999999999999999999999999999987
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-17 Score=181.84 Aligned_cols=234 Identities=18% Similarity=0.294 Sum_probs=188.9
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCcc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL 276 (1238)
++.+.-.|..|+|.+ .|..+++|++.....+......|..|.-.|+-+.||||+++++.|.....+.+|..|++-|+|
T Consensus 197 kl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 197 KLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 344555667777776 466778899988777776677888999999999999999999999999999999999999999
Q ss_pred chhhhcccc--cchhHHHHHHHHHHHHHhHhhccc--eeeccCCcccccccCCCcEEEE--ecCCcccccCCCccccccC
Q psy6346 277 FDYIARYGR--MNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDSNLDIKLA--DFGFSNYYVPGQKLATWCG 350 (1238)
Q Consensus 277 ~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd~nG~VKLi--DFGLS~~~~~s~~l~t~~G 350 (1238)
+.+++.... .+..++.+++..|+.|+.|||+.. |.--.|....+++|++...+|. |--++.. . .....
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--e----~gr~y 348 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--E----VGRAY 348 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--c----ccccc
Confidence 999987654 577889999999999999999873 4444688889999998776654 3322211 1 12235
Q ss_pred CCCCCCcccccCCccC--CCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHHHHHhccc
Q psy6346 351 SPPYAAPEVFEGKKYC--GPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~--S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDLIrkML~k 426 (1238)
.|.||+||.++.++.+ -.++|+|||+++||||.|...||.+....+.-.+|.-. +..+|..++..+..|+.-|+..
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmne 428 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNE 428 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcC
Confidence 7889999999877652 24799999999999999999999988877766655443 4568999999999999999999
Q ss_pred CCCCCCCHHHHH
Q psy6346 427 EPTKRYCIEQIK 438 (1238)
Q Consensus 427 DPskRPTaeEIL 438 (1238)
||.+||.++.|+
T Consensus 429 dpgkrpkfdmiv 440 (448)
T KOG0195|consen 429 DPGKRPKFDMIV 440 (448)
T ss_pred CCCcCCCcceeh
Confidence 999999887653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.5e-17 Score=175.23 Aligned_cols=145 Identities=14% Similarity=0.059 Sum_probs=115.3
Q ss_pred CcEEEEEEEecCCCCccccCce-EccCCcEEEEEEeccCCCCh--------------------H--hHHHHHHHHHHHHh
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPV-LLRHTVNVAIKIIDKSQLDP--------------------V--NLQKVYREVEIMKQ 245 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav-~lktG~kVAIKVLkks~ld~--------------------e--~ikrf~rEIeILkk 245 (1238)
|..|.....||.|++|.||+|+ ...+|..||||+++...... . ....+.+|+.++++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456677889999999999998 66789999999998653210 0 11346789999999
Q ss_pred CCCCC--eeEEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccc-eeeccCCcccccc
Q psy6346 246 LDHPH--IIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR-VVHRDLKAENLLM 322 (1238)
Q Consensus 246 L~HPN--IVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkG-IIHRDLKPeNILL 322 (1238)
+.+.+ +..++++ . ..+|||||+.|.+|..+......+....+..++.||+.+|.+||..| |+||||||+||++
T Consensus 107 L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 107 LYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred HHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 97533 3444443 2 35899999999888776644456677778899999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCccc
Q psy6346 323 DSNLDIKLADFGFSNY 338 (1238)
Q Consensus 323 d~nG~VKLiDFGLS~~ 338 (1238)
+ ++.++|+|||.+..
T Consensus 183 ~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 183 H-DGKVVIIDVSQSVE 197 (237)
T ss_pred E-CCCEEEEEChhhhc
Confidence 9 88999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=161.10 Aligned_cols=136 Identities=18% Similarity=0.181 Sum_probs=113.3
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChH------hHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV------NLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e------~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..||.|++|.||++.. .|..|+||+......... ...++.+|+.++..+.|++|.....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 3578899999998876 678899998765432211 23567899999999999998776667767778899999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
|++|++|.+++..... ....++.+++.+|.+||..|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998865332 7889999999999999999999999999999999 78899999998864
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.9e-16 Score=175.39 Aligned_cols=187 Identities=23% Similarity=0.328 Sum_probs=138.8
Q ss_pred CCCCeeEEEEEee---------------------------eCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHH
Q psy6346 247 DHPHIIKLFQVME---------------------------TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQIL 299 (1238)
Q Consensus 247 ~HPNIVrL~dvfe---------------------------d~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QIL 299 (1238)
+|||||+++..|. ....+|+||...+ .+|..|+... ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 6999999887552 2345799998775 6888887653 356667788899999
Q ss_pred HHHhHhhccceeeccCCccccccc--CC--CcEEEEecCCcccccCC-------CccccccCCCCCCCcccccCCcc---
Q psy6346 300 SAVEYCHNRRVVHRDLKAENLLMD--SN--LDIKLADFGFSNYYVPG-------QKLATWCGSPPYAAPEVFEGKKY--- 365 (1238)
Q Consensus 300 sALeYLHSkGIIHRDLKPeNILLd--~n--G~VKLiDFGLS~~~~~s-------~~l~t~~GTp~YmAPEVL~gk~y--- 365 (1238)
+|+.|||.+||.|||||.+|||+. ++ -.+.|.|||++-..... ......-|.-..||||+....+-
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 33 34899999987432221 11223347778999999764432
Q ss_pred --CCCccceehhhHHHHHHhhCCCCCCCCChh--HHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6346 366 --CGPEIDIWSLGVVLYVLVCGALPFDGSTLN--SLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIE 435 (1238)
Q Consensus 366 --~S~KSDIWSLGVILYELLTGrlPF~g~d~e--eL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTae 435 (1238)
.-.++|.|+.|.+.||+++...||.+.... +...--...-..+|..+++.+++|+..+|+.||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 114789999999999999999999763322 1111111223456788999999999999999999998743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=9e-16 Score=157.45 Aligned_cols=131 Identities=17% Similarity=0.164 Sum_probs=105.7
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCCh------HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP------VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld~------e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
||.|++|.||++. .++..|++|+........ ....++.+|++++..+.|+++....-++...+..++||||+
T Consensus 2 ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 6889999999997 367889999965432211 12367889999999999887654444445566679999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
+|++|.+++..... .++.+++.+|.+||..|++|+|++|.||+++ ++.++|+|||++..
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887754321 7899999999999999999999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-15 Score=157.32 Aligned_cols=139 Identities=17% Similarity=0.136 Sum_probs=108.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh--------------------HhHHHHHHHHHHHHhCCCC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP--------------------VNLQKVYREVEIMKQLDHP 249 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~--------------------e~ikrf~rEIeILkkL~HP 249 (1238)
..|.....||.|++|.||++.. .+|+.||||+++...... .....+.+|+.++..+.++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred chhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 3466668899999999999875 479999999987543110 0112367899999999877
Q ss_pred C--eeEEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc
Q psy6346 250 H--IIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327 (1238)
Q Consensus 250 N--IVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~ 327 (1238)
+ ++..++. ...++||||++|++|..+... .....++.+|+.++.++|..||+||||||+||+++.++.
T Consensus 94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4 4444442 345899999999988765431 356788999999999999999999999999999999999
Q ss_pred EEEEecCCcccc
Q psy6346 328 IKLADFGFSNYY 339 (1238)
Q Consensus 328 VKLiDFGLS~~~ 339 (1238)
++|+|||++...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.3e-15 Score=173.01 Aligned_cols=233 Identities=24% Similarity=0.352 Sum_probs=173.0
Q ss_pred HHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccce-eeccCCcccc
Q psy6346 243 MKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRV-VHRDLKAENL 320 (1238)
Q Consensus 243 LkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGI-IHRDLKPeNI 320 (1238)
|+.+.|.|+.++++.+.+....++|.+||..|+|.|.+.. .-.++.-....+++.|+.||.|||.-.| +|+.|+..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4578999999999999999999999999999999999987 3568888889999999999999998765 9999999999
Q ss_pred cccCCCcEEEEecCCcccccCC---CccccccCCCCCCCcccccCCcc------CCCccceehhhHHHHHHhhCCCCCCC
Q psy6346 321 LMDSNLDIKLADFGFSNYYVPG---QKLATWCGSPPYAAPEVFEGKKY------CGPEIDIWSLGVVLYVLVCGALPFDG 391 (1238)
Q Consensus 321 LLd~nG~VKLiDFGLS~~~~~s---~~l~t~~GTp~YmAPEVL~gk~y------~S~KSDIWSLGVILYELLTGrlPF~g 391 (1238)
++|....+||+|||+....... .......-...|.|||.+.+... .+.+.||||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998765320 11111123456999999987422 25679999999999999999999976
Q ss_pred CC----hhHHHHHHhc-CCccC-CC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCCCccccccc
Q psy6346 392 ST----LNSLRDRVLS-GRFRI-PY-----FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINILGEV 460 (1238)
Q Consensus 392 ~d----~eeL~ekIl~-g~~~~-P~-----~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p~~lppi~~l~el 460 (1238)
.. ..++...+.. +...+ |. ...+++..++++||..+|.+||++++|...--.... ....
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~----------~~~~ 230 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK----------GGSS 230 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc----------cccc
Confidence 32 2345555555 32111 11 245578999999999999999999998653110000 0001
Q ss_pred CCCChHHHHHHHHHcCCChhhhHHH
Q psy6346 461 KNEPNEQILRLMNSLGIDAAKTKEV 485 (1238)
Q Consensus 461 k~~~~eqILelMesLgid~~kike~ 485 (1238)
+......+++.|+.++-+-++..+.
T Consensus 231 ~~nl~D~m~~~le~Y~~nLe~~v~e 255 (484)
T KOG1023|consen 231 KGNLMDSLFRMLESYADNLEKLVDE 255 (484)
T ss_pred cchhHHHHHHHHHHHHhhhHHHHHH
Confidence 2244567777777776555554433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=1e-14 Score=173.64 Aligned_cols=136 Identities=16% Similarity=0.184 Sum_probs=109.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-C-----hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-D-----PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d-----~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
|...+.||.|++|.||++.+. +..+++|+...... . ....+++.+|+++++.++|++|+....++......+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 345678999999999998764 33445554322211 1 122367889999999999999988777777777789
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
+||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||++..
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999998875 356789999999999999999999999999999 678899999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-14 Score=146.91 Aligned_cols=136 Identities=18% Similarity=0.144 Sum_probs=99.9
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHH----------------------HHHHHHHHHhCCCCC--e
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQK----------------------VYREVEIMKQLDHPH--I 251 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikr----------------------f~rEIeILkkL~HPN--I 251 (1238)
..||.|++|.||++.+. ++..||||++............ ...|...+.++.+.+ +
T Consensus 3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999765 7999999998765432221111 146777777775443 4
Q ss_pred eEEEEEeeeCCEEEEEEeecCCCccchh-hhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEE
Q psy6346 252 IKLFQVMETKSMIYIVSEYANQGEIFDY-IARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIK 329 (1238)
Q Consensus 252 VrL~dvfed~d~lyLVMEy~~GGSL~d~-Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VK 329 (1238)
.+++.+ ...++||||++|+.+... +... .. ...+..++.+++.++.++|. .||+|+||||+||+++ ++.++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 455543 235899999998544321 2111 11 16788999999999999999 9999999999999999 88999
Q ss_pred EEecCCcccc
Q psy6346 330 LADFGFSNYY 339 (1238)
Q Consensus 330 LiDFGLS~~~ 339 (1238)
|+|||.+...
T Consensus 155 liDfg~a~~~ 164 (187)
T cd05119 155 IIDVPQAVEI 164 (187)
T ss_pred EEECcccccc
Confidence 9999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.8e-14 Score=131.25 Aligned_cols=130 Identities=17% Similarity=0.169 Sum_probs=109.2
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCC--CCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDH--PHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~H--PNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
..+|.|.++.||++... +..++||+...... ...+.+|+.+++.+.+ .++++++.++...+..+++|||+.|
T Consensus 4 ~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred eecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 46788888888887653 37899999876532 4578899999999976 5899999998888899999999998
Q ss_pred CccchhhhcccccchhHHHHHHHHHHHHHhHhhcc---ceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR---RVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 274 GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk---GIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
+.+..+ +......++.+++.+|.+||.. +++|+||+|+||+++..+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877654 4456677889999999999984 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.7e-14 Score=151.47 Aligned_cols=136 Identities=18% Similarity=0.269 Sum_probs=103.9
Q ss_pred EEec-CCCCccccCceEccCCcEEEEEEeccCCC-----------ChHhHHHHHHHHHHHHhCCCCCe--eEEEEEeeeC
Q psy6346 196 EKCG-VKSRSCNRPPVLLRHTVNVAIKIIDKSQL-----------DPVNLQKVYREVEIMKQLDHPHI--IKLFQVMETK 261 (1238)
Q Consensus 196 ekIG-sGsfGtVYKav~lktG~kVAIKVLkks~l-----------d~e~ikrf~rEIeILkkL~HPNI--VrL~dvfed~ 261 (1238)
..+| .|+.|+||.+.. .+..++||.+....+ +.....++.+|++++.+|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3465 678888887755 377899998864321 12334678899999999998885 6677664332
Q ss_pred -CE---EEEEEeecCC-CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCc
Q psy6346 262 -SM---IYIVSEYANQ-GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336 (1238)
Q Consensus 262 -d~---lyLVMEy~~G-GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS 336 (1238)
.. .++|||+++| .+|.+++.. ..+++. .+.+|+.+|.+||..||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999997 688887754 344443 3678999999999999999999999999999899999999988
Q ss_pred cc
Q psy6346 337 NY 338 (1238)
Q Consensus 337 ~~ 338 (1238)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 65
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-13 Score=168.31 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=205.8
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCC-CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~-ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
+....-+..++++.++...-...|...++|+..+.. +.....+.+.++-.++-...+|.++...-.+......+|||+|
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence 333445667778887777666666666777654432 1222334455555555555677777666666677789999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc-----------
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY----------- 339 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~----------- 339 (1238)
+.|++|...++..+..+..-++.++..+..++++||...+.|+|++|.|+++..+|..++.|||.....
T Consensus 886 ~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 886 LNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred hccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 999999999999888999999999999999999999999999999999999999999999999843211
Q ss_pred ----------cCC-----------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHH
Q psy6346 340 ----------VPG-----------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLR 398 (1238)
Q Consensus 340 ----------~~s-----------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ 398 (1238)
... .......||+.|.+||...+... +..+|+|++|+++++.++|..||.....+.+.
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQQIF 1044 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchhhhh
Confidence 000 01223469999999999999887 78999999999999999999999999999999
Q ss_pred HHHhcCCccCCC---CCCHHHHHHHHHhcccCCCCCCCHH---HHHhcccccccCCCC
Q psy6346 399 DRVLSGRFRIPY---FMSTECESLIRKMLVREPTKRYCIE---QIKRHRWMAEETPRL 450 (1238)
Q Consensus 399 ekIl~g~~~~P~---~iS~eLkDLIrkML~kDPskRPTae---EILeHPWFke~~p~~ 450 (1238)
+.|..+....|. ..+.++++++..+|..+|.+|..+. ++..|+||+......
T Consensus 1045 ~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1045 ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 999988776654 4789999999999999999999877 999999998865544
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.2e-13 Score=158.90 Aligned_cols=252 Identities=21% Similarity=0.237 Sum_probs=196.5
Q ss_pred cEEEEEEEecC--CCCccccCceE--ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGV--KSRSCNRPPVL--LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGs--GsfGtVYKav~--lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~l 264 (1238)
+++-....+|. |.+|.+|.+.. ..++..+|+|.-+.....+....+=++|+.-.+++ .|++.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 44445567788 89999998877 78899999998555443333334455788777777 599999999999999999
Q ss_pred EEEEeecCCCccchhhhcccc-cchhHHHHHHHHHHH----HHhHhhccceeeccCCcccccccCC-CcEEEEecCCccc
Q psy6346 265 YIVSEYANQGEIFDYIARYGR-MNENAARRKFWQILS----AVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSNY 338 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~-Lsesea~kI~~QILs----ALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~~ 338 (1238)
|+-+|+|. .+|..+...... +++..++..+.+... ||.++|+.+++|-|+||.||++..+ ..++++|||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999996 788888876655 899999999999999 9999999999999999999999999 8899999999877
Q ss_pred ccCCCcc------ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC---ChhHHHHHHhcCCccCC
Q psy6346 339 YVPGQKL------ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS---TLNSLRDRVLSGRFRIP 409 (1238)
Q Consensus 339 ~~~s~~l------~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~---d~eeL~ekIl~g~~~~P 409 (1238)
+..+... ....|...|++||+..+. +++..|||+||.++.+..++..++... .+..+.... -...+-
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e~~ 348 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLEFC 348 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cchhhh
Confidence 6554421 222577789999999765 478999999999999988887666433 222221111 111122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...+.++...+..|+..+|-.|++.+.+++|+++...
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 2356667779999999999999999999999998753
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.8e-12 Score=152.01 Aligned_cols=245 Identities=18% Similarity=0.094 Sum_probs=182.8
Q ss_pred EEEEecCCCCccccCceEc-cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 194 KREKCGVKSRSCNRPPVLL-RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 194 arekIGsGsfGtVYKav~l-ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
....||.+.|+.|+++... .++..|++|-+.+..........-..|+.+...+ -|.++++.+..|...+..||-.|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 4466888998888887655 6788999998877665544444456777777777 5899999998888888888999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-CcEEEEecCCcccccCCCccccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSNYYVPGQKLATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~~~~~s~~l~t~~G 350 (1238)
+++++...+.-.--+.+...+++..|++.++.++|+..++|+|+||.||++..+ +..++.|||+.+.+.-. ......
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~~~~~ 426 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SGVFHH 426 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--cccccc
Confidence 999887766444557888999999999999999999999999999999999876 88999999988642111 111222
Q ss_pred CCCCC-CcccccCCccCCCccceehhhHHHHHHhhCCCC-CCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 351 SPPYA-APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 351 Tp~Ym-APEVL~gk~y~S~KSDIWSLGVILYELLTGrlP-F~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
.-++. ..|++.....+..+.|+++||.-+.+.++|... +.+.. ...+..+..........++..+.+.|+..++
T Consensus 427 ~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~ 502 (524)
T KOG0601|consen 427 IDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLPGLKLQLQVLLKVMINPDR 502 (524)
T ss_pred cccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCCCchHHhhhhhhhhhcCCcc
Confidence 33344 244444433347899999999999999988643 22221 2234444443333344788999999999999
Q ss_pred CCCCCHHHHHhccccc
Q psy6346 429 TKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 429 skRPTaeEILeHPWFk 444 (1238)
..|+.+.++..|.-|.
T Consensus 503 ~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 503 KRRPSAVELSLHSEFY 518 (524)
T ss_pred ccchhhhhhcccchhh
Confidence 9999999998887554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.3e-12 Score=145.99 Aligned_cols=176 Identities=14% Similarity=0.132 Sum_probs=113.0
Q ss_pred CcceeeccccccchhhhhhcccccccCCceeEEeeccCCCCCcEEEE--EEEecCCCCccccCceEccCCcEEEEEEecc
Q psy6346 148 ETSWVQTYRRRLSIDEVNLCFQSTSIDGRRLRLDTLHAEKNGQTIRK--REKCGVKSRSCNRPPVLLRHTVNVAIKIIDK 225 (1238)
Q Consensus 148 etSWlsd~rr~Lsiddiel~i~sesidgRy~~i~~LgsGkfGqVYka--rekIGsGsfGtVYKav~lktG~kVAIKVLkk 225 (1238)
+.+-+++...+.+.+++...+..+....-. +.|.. ...+|.|+.|.||+|+ +++|+.||||+.+.
T Consensus 85 ~L~~Lqd~v~p~~~~~~~~~l~~elg~~~~------------~~F~~fd~~plasaSigQVh~A~-l~~G~~VaVKv~rp 151 (437)
T TIGR01982 85 ELSLLQDRVPPFDFKVARKVIEAALGGPLE------------ELFAEFEEKPLAAASIAQVHRAR-LVDGKEVAVKVLRP 151 (437)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHhCcCHH------------HHHhhCCCcceeeeehhheEEEE-ecCCCEEEEEeeCC
Confidence 566677888888887777766555432111 11111 2346667777777775 35789999999865
Q ss_pred CCCChH--h--------------------------H----------HHHHHHHHHHHhC-----CCCCeeEEEEEe-eeC
Q psy6346 226 SQLDPV--N--------------------------L----------QKVYREVEIMKQL-----DHPHIIKLFQVM-ETK 261 (1238)
Q Consensus 226 s~ld~e--~--------------------------i----------krf~rEIeILkkL-----~HPNIVrL~dvf-ed~ 261 (1238)
.....- + . -.+.+|+..+.++ ++++| .+-.++ ...
T Consensus 152 ~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~ 230 (437)
T TIGR01982 152 GIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGV-YVPEVYWDRT 230 (437)
T ss_pred CcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhc
Confidence 421100 0 0 0134455555555 23433 222222 234
Q ss_pred CEEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHH-HHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILS-AVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY 339 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILs-ALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~ 339 (1238)
...+|||||++|++|.++.... ... ....++..++. .+..+|..|++|+|+||.||+++.++.++|+|||++...
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 4579999999999998876432 111 23445555555 467889999999999999999999999999999998765
Q ss_pred c
Q psy6346 340 V 340 (1238)
Q Consensus 340 ~ 340 (1238)
.
T Consensus 308 ~ 308 (437)
T TIGR01982 308 S 308 (437)
T ss_pred C
Confidence 4
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.3e-11 Score=141.80 Aligned_cols=215 Identities=17% Similarity=0.213 Sum_probs=154.7
Q ss_pred ceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhhhcccccch
Q psy6346 209 PVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNE 288 (1238)
Q Consensus 209 av~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lse 288 (1238)
|....++.+|.|++.+.... .....+.+-++-|+.|+||+|+++++.++.++.+|||+|-+. .|..++++. ..
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~ 103 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GK 103 (690)
T ss_pred cceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HH
Confidence 45567889999999987653 455677889999999999999999999999999999999984 566677654 36
Q ss_pred hHHHHHHHHHHHHHhHhh-ccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-cccccCCCCCCCcccccCCccC
Q psy6346 289 NAARRKFWQILSAVEYCH-NRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-LATWCGSPPYAAPEVFEGKKYC 366 (1238)
Q Consensus 289 sea~kI~~QILsALeYLH-SkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-l~t~~GTp~YmAPEVL~gk~y~ 366 (1238)
..+.--++||+.||.||| ..+++|++|.-..|+++..|.+||++|.++........ .....--..|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 677778899999999998 56899999999999999999999999998765332221 11111222366677654332
Q ss_pred CCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHH----HH-Hhcc
Q psy6346 367 GPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIE----QI-KRHR 441 (1238)
Q Consensus 367 S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTae----EI-LeHP 441 (1238)
...|.|.|||++++++.|..+ .... ...+..++.....+..+-+.-.+..||... +. +-|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~~~--~~~~-----------~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~g 247 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSLL--TKTD-----------LSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLLGG 247 (690)
T ss_pred -cchhhhhHHHHHHHHhCcccC--cchh-----------hhccCccchhHHHHHHHHhccccccccchhhHHHHHHhccc
Confidence 357999999999999999322 1111 112233444555566555666677776532 22 3378
Q ss_pred ccccc
Q psy6346 442 WMAEE 446 (1238)
Q Consensus 442 WFke~ 446 (1238)
||++.
T Consensus 248 ff~n~ 252 (690)
T KOG1243|consen 248 FFRND 252 (690)
T ss_pred cccch
Confidence 88765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.4e-12 Score=152.03 Aligned_cols=178 Identities=15% Similarity=0.098 Sum_probs=115.4
Q ss_pred CCcceeeccccccchhhhhhcccccccCCceeEEeeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccC
Q psy6346 147 KETSWVQTYRRRLSIDEVNLCFQSTSIDGRRLRLDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKS 226 (1238)
Q Consensus 147 ketSWlsd~rr~Lsiddiel~i~sesidgRy~~i~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks 226 (1238)
.+.+.+++...+.+.+++...++.+....-.-. | ..|.. ..+|.|++|.||+++...+|+.||||+++..
T Consensus 86 ~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~--------F-~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~ 155 (537)
T PRK04750 86 DELALLQDRVPPFDGALARAIIEKALGGPVEEW--------F-DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPD 155 (537)
T ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHH--------H-HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcc
Confidence 366777888888887777766555443211100 0 11222 4677788888888877767999999999764
Q ss_pred CC---------------------------Ch-----HhHHH------HHHHHHHHHhC----CCCCeeEEEEEee-eCCE
Q psy6346 227 QL---------------------------DP-----VNLQK------VYREVEIMKQL----DHPHIIKLFQVME-TKSM 263 (1238)
Q Consensus 227 ~l---------------------------d~-----e~ikr------f~rEIeILkkL----~HPNIVrL~dvfe-d~d~ 263 (1238)
.. +. +-.+. +.+|+..+.++ .+...+.+-.++. ....
T Consensus 156 i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~ 235 (537)
T PRK04750 156 ILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSE 235 (537)
T ss_pred hHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCC
Confidence 21 10 01122 23444444444 2333344444432 2456
Q ss_pred EEEEEeecCCCccchh--hhccc----ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC----cEEEEec
Q psy6346 264 IYIVSEYANQGEIFDY--IARYG----RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL----DIKLADF 333 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~--Lkk~~----~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG----~VKLiDF 333 (1238)
.+|||||+.|+.+.++ +...+ .+.+..+..++.|++. .|++|+|+||+||+++.+| .++++||
T Consensus 236 ~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-------~GffHaDpHPGNIlv~~~g~~~~~i~llDF 308 (537)
T PRK04750 236 TVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-------DGFFHADMHPGNIFVSYDPPENPRYIALDF 308 (537)
T ss_pred ceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-------CCeeeCCCChHHeEEecCCCCCCeEEEEec
Confidence 7899999999999774 33322 3566666777777764 8999999999999999888 9999999
Q ss_pred CCcccccC
Q psy6346 334 GFSNYYVP 341 (1238)
Q Consensus 334 GLS~~~~~ 341 (1238)
|++.....
T Consensus 309 Givg~l~~ 316 (537)
T PRK04750 309 GIVGSLNK 316 (537)
T ss_pred ceEEECCH
Confidence 99876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.1e-11 Score=116.82 Aligned_cols=126 Identities=17% Similarity=0.171 Sum_probs=89.8
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCee-EEEEEeeeCCEEEEEEeecCCCc
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHII-KLFQVMETKSMIYIVSEYANQGE 275 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIV-rL~dvfed~d~lyLVMEy~~GGS 275 (1238)
.++.|..+.||++.. .+..|+||+...... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||++|.+
T Consensus 5 ~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 5 PLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred ecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 344455556665443 367899999765431 122456899999998655544 4555443 23579999999988
Q ss_pred cchhhhcccccchhHHHHHHHHHHHHHhHhhccce-----eeccCCcccccccCCCcEEEEecCCccc
Q psy6346 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRV-----VHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 276 L~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGI-----IHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
+.+. ......++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 78 l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7653 11123567899999999999875 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-10 Score=122.78 Aligned_cols=97 Identities=15% Similarity=0.246 Sum_probs=74.6
Q ss_pred HHHHHHHhCCC--CCeeEEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHh-hccceeecc
Q psy6346 238 REVEIMKQLDH--PHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYC-HNRRVVHRD 314 (1238)
Q Consensus 238 rEIeILkkL~H--PNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYL-HSkGIIHRD 314 (1238)
+|+..|+++.. -++..++++ ...+|||||+.+..+..-.-+...++...+..++.+++.+|..| |..||||+|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGD 150 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHAD 150 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 89999999954 355666654 45789999998654432222223455566778899999999998 899999999
Q ss_pred CCcccccccCCCcEEEEecCCcccc
Q psy6346 315 LKAENLLMDSNLDIKLADFGFSNYY 339 (1238)
Q Consensus 315 LKPeNILLd~nG~VKLiDFGLS~~~ 339 (1238)
|++.||++. ++.++|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-10 Score=129.08 Aligned_cols=203 Identities=19% Similarity=0.270 Sum_probs=146.2
Q ss_pred HHHHHHhCCCCCeeEEEEEeee-----CCEEEEEEeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhcc-
Q psy6346 239 EVEIMKQLDHPHIIKLFQVMET-----KSMIYIVSEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNR- 308 (1238)
Q Consensus 239 EIeILkkL~HPNIVrL~dvfed-----~d~lyLVMEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSk- 308 (1238)
-+.-|-.+.|.|||+++.|+.+ ..+..++.||+..|+|..+|++. ..+....+++|+-||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 3455667789999999998854 44588999999999999999764 3588899999999999999999987
Q ss_pred -ceeeccCCcccccccCCCcEEEEecCCcccccCC------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHH
Q psy6346 309 -RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYV 381 (1238)
Q Consensus 309 -GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYE 381 (1238)
-|+|+++..+-|++..+|-+||.----.. .... .......+-++|.+||.=..... +-++|||++|....+
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALE 274 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHH
Confidence 59999999999999999888765321111 1000 11122346788999997544433 568999999999999
Q ss_pred HhhCCCC-CCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 382 LVCGALP-FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 382 LLTGrlP-F~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|..+..- -.+....+....+..-.+... ...-++++.+||+..|..||++.+++.||.+-+.
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 9887653 222222222223322222211 1223578999999999999999999999987553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.8e-09 Score=109.67 Aligned_cols=140 Identities=14% Similarity=0.166 Sum_probs=99.6
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCC--CeeEEEEEeeeC---CEEEEEEee
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP--HIIKLFQVMETK---SMIYIVSEY 270 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HP--NIVrL~dvfed~---d~lyLVMEy 270 (1238)
..++.|..+.+|++.. .+|..+++|+....... .....+.+|+++++.+.+. .+.+++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3456666777777654 33578999997654321 1345788999999999764 456777777654 367899999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-------------------------------------------
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN------------------------------------------- 307 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS------------------------------------------- 307 (1238)
++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988776532 344555555666666666666652
Q ss_pred -------------cceeeccCCcccccccC--CCcEEEEecCCccc
Q psy6346 308 -------------RRVVHRDLKAENLLMDS--NLDIKLADFGFSNY 338 (1238)
Q Consensus 308 -------------kGIIHRDLKPeNILLd~--nG~VKLiDFGLS~~ 338 (1238)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 35799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.2e-10 Score=135.58 Aligned_cols=406 Identities=17% Similarity=0.188 Sum_probs=236.7
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEee------ccccc--cccccce--ecccCCCCCCCcceeee
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILS------ISQSG--HQKMCSF--IVGKASKQPRSSYIWYG 82 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~------~~~~~--~~~~c~~--~~gk~~~~p~~~~~~~~ 82 (1238)
..+-++|+++..+|.|+||-||+||++.||+.+|||+|-+- ..|-+ --+-|.| |+---++.++--..|+-
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 35667899999999999999999999999999999999653 33332 2344655 34555667777778887
Q ss_pred ccccCCC--cceEEEeeeeecc-----------------c---CCCC-CCCccccccc--cCCCccccc---hhhhhccc
Q psy6346 83 IHLAGEG--QTALKVGLSFYES-----------------S---RRRP-KAPVLVTTEY--AHRPNYYLV---SWTIFKRH 134 (1238)
Q Consensus 83 ~~~g~~~--~~~~~~gls~~~~-----------------~---~~rp-~aP~l~~tg~--ahrp~y~~V---Sws~~~rs 134 (1238)
.+--|+| |--+++.....+- + ..|+ ++.-++-++. ...--|..- .-++.+|+
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 7544443 5555555433321 0 1111 1111111111 111111111 11111111
Q ss_pred ccccccCCCCCCCC--------------cceeeccccccchhhhhhcccccccCCceeEEeecc--------------CC
Q psy6346 135 FWATVKTPFNMRKE--------------TSWVQTYRRRLSIDEVNLCFQSTSIDGRRLRLDTLH--------------AE 186 (1238)
Q Consensus 135 kWaPv~sp~nmdke--------------tSWlsd~rr~Lsiddiel~i~sesidgRy~~i~~Lg--------------sG 186 (1238)
- -.-+|++|..+ .-|-.. +.-+++ ..+-..-+++..+. -.
T Consensus 171 s--fiGtpywmapEvaaverkggynqlcdiwa~g------itAiel----~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 171 S--FIGTPYWMAPEVAAVERKGGYNQLCDIWALG------ITAIEL----GELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred c--ccCCccccchhHHHHHhcccccccccccccc------cchhhh----hhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 1 11222222221 112111 000000 11111111111100 00
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC-eeEEEEEeeeCCEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH-IIKLFQVMETKSMIY 265 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN-IVrL~dvfed~d~ly 265 (1238)
-....+..-...++++.+.++|.+.......+ .+++... ....-++++|.+++||| .+..++-++.++..+
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 01112222233566777777776655444444 5554432 34567899999999999 677777778888999
Q ss_pred EEEeecCCC--ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 266 IVSEYANQG--EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 266 LVMEy~~GG--SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
++|+++.++ .....-.....+..-....+.+.-..+|++||+.--+|+| ||+... +..+..||+....+....
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc
Confidence 999999887 2222222223344555556666777899999988778998 777655 678999999887666555
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCC-----HHH-H
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMS-----TEC-E 417 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS-----~eL-k 417 (1238)
...+..+++.++|||+.....+ ....|.|++|+--.+|--|.+|-...-. ....+-.+. ..|.-.+ +.. .
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p-~s~~L~~~~aw~~~~~~ 461 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGP-NSPMLTDKSAWSPVFHR 461 (829)
T ss_pred ccccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCC-CccccchhhhcCccccc
Confidence 6677889999999999988887 7889999999877777777776543110 000000000 0000001 111 2
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
++...|+...|..|++.-.++.|.+|....
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 467789999999999999999999997754
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-09 Score=130.00 Aligned_cols=162 Identities=20% Similarity=0.303 Sum_probs=120.9
Q ss_pred HHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCccc----------cccCCCCCCCcccccCCcc
Q psy6346 297 QILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA----------TWCGSPPYAAPEVFEGKKY 365 (1238)
Q Consensus 297 QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~----------t~~GTp~YmAPEVL~gk~y 365 (1238)
++..|+.|+|.. ++||++|.|++|+++.++.+||+.|+++....+..... ...-...|.|||++.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 344899999976 99999999999999999999999999876543322111 1124556999999998654
Q ss_pred CCCccceehhhHHHHHHh-hCCCCCCCCChhHHHHHHh----cCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 366 CGPEIDIWSLGVVLYVLV-CGALPFDGSTLNSLRDRVL----SGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 366 ~S~KSDIWSLGVILYELL-TGrlPF~g~d~eeL~ekIl----~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
++++|+|||||++|.+. .|+..+........+.... .+.+.....++.++++-|.++|..++..||++.+++.-
T Consensus 187 -~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 -TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred -cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 89999999999999999 5666665543222222111 12334556789999999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccc
Q psy6346 441 RWMAEETPRLLPPINILGE 459 (1238)
Q Consensus 441 PWFke~~p~~lppi~~l~e 459 (1238)
+||.+.....+..++.+.+
T Consensus 266 ~ff~D~~~~aLrfLD~l~~ 284 (700)
T KOG2137|consen 266 PFFSDPGLKALRFLDDLPQ 284 (700)
T ss_pred cccCCchhhhhhhcccccc
Confidence 9999876554444443333
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.5e-08 Score=115.69 Aligned_cols=212 Identities=16% Similarity=0.176 Sum_probs=156.8
Q ss_pred CCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee----CCEEEEEEeecCC-Ccc
Q psy6346 202 SRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET----KSMIYIVSEYANQ-GEI 276 (1238)
Q Consensus 202 sfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed----~d~lyLVMEy~~G-GSL 276 (1238)
...+.|++....+|..|++|.++.... ....+...-+++++++.|.|||++.++|.+ +..+++|++|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 346788998999999999999954332 112234466889999999999999999863 4458999999985 456
Q ss_pred chhhh---------------cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 277 FDYIA---------------RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 277 ~d~Lk---------------k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
.++-- ...+.++..++.++.||..||.++|+.|+..+-|.|.+|+++.+.+++|...|+......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 55431 123467899999999999999999999999999999999999998999998887765443
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCC-CCCChhHH-HHHHhcCCccCCCCCCHHHHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF-DGSTLNSL-RDRVLSGRFRIPYFMSTECESL 419 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF-~g~d~eeL-~ekIl~g~~~~P~~iS~eLkDL 419 (1238)
+. + |.+.+ -.+-|.--||.++..|.||..-- ..+...+. .+. +...++.+++++
T Consensus 446 d~------~-------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~yS~D~rn~ 501 (655)
T KOG3741|consen 446 DP------T-------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------ITTTYSTDLRNV 501 (655)
T ss_pred CC------C-------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------hhhhhhHHHHHH
Confidence 32 0 11211 13468889999999999996542 12222222 121 233478899999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.-+...++.+ -++.+++.+
T Consensus 502 v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 502 VEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHhcCccc-ccHHHHHHH
Confidence 99999999887 788888765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.1e-08 Score=106.60 Aligned_cols=97 Identities=20% Similarity=0.270 Sum_probs=79.5
Q ss_pred HHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeec
Q psy6346 234 QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHR 313 (1238)
Q Consensus 234 krf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHR 313 (1238)
++..+|+.+|.++.--.|.-.+=+..+.+...|+|||++|-.|.+++... ...+++.+-.-+.-||..||+|+
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHG 116 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHG 116 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecC
Confidence 56778999999997666654444555666778999999998888888654 25677788888889999999999
Q ss_pred cCCcccccccCCCcEEEEecCCccc
Q psy6346 314 DLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 314 DLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
||.+.||++...+ +.++|||++..
T Consensus 117 DLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 117 DLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCccceEEEeCCc-EEEEECCcccc
Confidence 9999999997665 99999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.5e-08 Score=106.67 Aligned_cols=123 Identities=15% Similarity=0.151 Sum_probs=89.9
Q ss_pred CCcEEEEEEeccCCCChHhH----------HHHHHHHHHHHhCCCCCe--eEEEEEeee-----CCEEEEEEeecCCC-c
Q psy6346 214 HTVNVAIKIIDKSQLDPVNL----------QKVYREVEIMKQLDHPHI--IKLFQVMET-----KSMIYIVSEYANQG-E 275 (1238)
Q Consensus 214 tG~kVAIKVLkks~ld~e~i----------krf~rEIeILkkL~HPNI--VrL~dvfed-----~d~lyLVMEy~~GG-S 275 (1238)
.|+.|.||........ ... ..+.+|...+.+|..-+| +.++.+.+. ....+||||++++. +
T Consensus 44 ~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s 122 (268)
T PRK15123 44 AGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS 122 (268)
T ss_pred CCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence 4567888865433211 111 147799999888854443 344444432 34578999999975 7
Q ss_pred cchhhhc--ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-------CCcEEEEecCCcc
Q psy6346 276 IFDYIAR--YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-------NLDIKLADFGFSN 337 (1238)
Q Consensus 276 L~d~Lkk--~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-------nG~VKLiDFGLS~ 337 (1238)
|.+++.. ....+......++.+|...+.-||..||+|+||++.|||++. ++.+.||||+.+.
T Consensus 123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 8888754 244566778899999999999999999999999999999975 4679999999775
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-07 Score=100.84 Aligned_cols=98 Identities=21% Similarity=0.269 Sum_probs=68.7
Q ss_pred HHHHHHHHHHHhCCCCC--eeEEEEEeeeCCEEEEEEeecC--CCccchhhhcccccchhHHHHHHHHHHHHHhH-hhcc
Q psy6346 234 QKVYREVEIMKQLDHPH--IIKLFQVMETKSMIYIVSEYAN--QGEIFDYIARYGRMNENAARRKFWQILSAVEY-CHNR 308 (1238)
Q Consensus 234 krf~rEIeILkkL~HPN--IVrL~dvfed~d~lyLVMEy~~--GGSL~d~Lkk~~~Lsesea~kI~~QILsALeY-LHSk 308 (1238)
....+|++.|.++..-+ +.+++++. ..+|||||+. |..+..+... .++......++.+++..+.. +|..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhc
Confidence 45678999999997664 56666553 2479999998 6555443322 22356678888899886555 6799
Q ss_pred ceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 309 RVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 309 GIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
||+|+||.+.||+++.+ .+.|+|||.+..
T Consensus 127 givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 127 GIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred CceecCCChhhEEeecc-eEEEEecCccee
Confidence 99999999999999877 899999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.1e-06 Score=102.35 Aligned_cols=173 Identities=20% Similarity=0.292 Sum_probs=125.2
Q ss_pred EEEEEEeecCCCcc-chhh------hcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCC
Q psy6346 263 MIYIVSEYANQGEI-FDYI------ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL-~d~L------kk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
.+-++|+.+.|..= .++. ..+....+..+.+..+.|+.+...||.+|.+-+|+.++|+|+.+++.+.|+|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 37788998887522 2222 1223467888999999999999999999999999999999999999999998665
Q ss_pred cccccCCCccccccCCCCCCCccccc-----CCccCCCccceehhhHHHHHHhhC-CCCCCCCCh-----hHHHHHHhcC
Q psy6346 336 SNYYVPGQKLATWCGSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCG-ALPFDGSTL-----NSLRDRVLSG 404 (1238)
Q Consensus 336 S~~~~~s~~l~t~~GTp~YmAPEVL~-----gk~y~S~KSDIWSLGVILYELLTG-rlPF~g~d~-----eeL~ekIl~g 404 (1238)
-.....+......+|...|.+||... +..- +...|.|.||+++++||.| ++||.|... ......|..+
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 44444555666778999999999865 2222 5678999999999999886 999987421 1122233333
Q ss_pred Ccc---------------CCC-CCCHHHHHHHHHhccc--CCCCCCCHHH
Q psy6346 405 RFR---------------IPY-FMSTECESLIRKMLVR--EPTKRYCIEQ 436 (1238)
Q Consensus 405 ~~~---------------~P~-~iS~eLkDLIrkML~k--DPskRPTaeE 436 (1238)
.|. +|. .++++++.|..+|+.. ++.-|||++.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 221 122 2678888888888865 3557888763
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.7e-07 Score=97.38 Aligned_cols=138 Identities=17% Similarity=0.163 Sum_probs=96.0
Q ss_pred cCCCCccccCceEccCCcEEEEEEeccCC-----CCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 199 GVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-----LDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 199 GsGsfGtVYKav~lktG~kVAIKVLkks~-----ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
-.|+-+.|+.+.+ .|+...||.-.... ++. -..++..+|+++|.++.--.|.-..-++.+...-.|+|||++
T Consensus 16 kQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~ 93 (229)
T KOG3087|consen 16 KQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFID 93 (229)
T ss_pred eccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEecc
Confidence 3344444554433 57777777543322 221 234678899999999976666544445556666789999998
Q ss_pred C-Cccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc---EEEEecCCccc
Q psy6346 273 Q-GEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFSNY 338 (1238)
Q Consensus 273 G-GSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~---VKLiDFGLS~~ 338 (1238)
| -++.+++.... .........+++.|-..|.-||..+|||+||..+||+|..++. +.|+|||++..
T Consensus 94 g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 94 GASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred chhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 7 36677775432 2223333789999999999999999999999999999976543 58999999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.4e-07 Score=97.20 Aligned_cols=105 Identities=17% Similarity=0.304 Sum_probs=85.5
Q ss_pred HHHHHHHHHHHhCCCCCe--eEEEEEeeeC----CEEEEEEeecCCC-ccchhhhcccccchhHHHHHHHHHHHHHhHhh
Q psy6346 234 QKVYREVEIMKQLDHPHI--IKLFQVMETK----SMIYIVSEYANQG-EIFDYIARYGRMNENAARRKFWQILSAVEYCH 306 (1238)
Q Consensus 234 krf~rEIeILkkL~HPNI--VrL~dvfed~----d~lyLVMEy~~GG-SL~d~Lkk~~~Lsesea~kI~~QILsALeYLH 306 (1238)
.+..+|...+..|..-+| ...+.+.+.. ...+||+|++++. +|.+++.....++......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 467889988888854433 4555555442 3468999999974 78888887555778888999999999999999
Q ss_pred ccceeeccCCcccccccCCC---cEEEEecCCccc
Q psy6346 307 NRRVVHRDLKAENLLMDSNL---DIKLADFGFSNY 338 (1238)
Q Consensus 307 SkGIIHRDLKPeNILLd~nG---~VKLiDFGLS~~ 338 (1238)
..||+|+|+++.|||++.++ .+.|+||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.6e-07 Score=111.08 Aligned_cols=172 Identities=20% Similarity=0.210 Sum_probs=108.4
Q ss_pred CCcceeeccccccchhhhhhcccccccC-----CceeEEeeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEE
Q psy6346 147 KETSWVQTYRRRLSIDEVNLCFQSTSID-----GRRLRLDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIK 221 (1238)
Q Consensus 147 ketSWlsd~rr~Lsiddiel~i~sesid-----gRy~~i~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIK 221 (1238)
.+.+.+++...+.+.+.+...+..+... +..+....++.+..|+||+ |+ +++|+.||||
T Consensus 92 ~eL~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~~~PiAsASIaQVH~---------------A~-L~sG~~VAVK 155 (517)
T COG0661 92 EELAKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFEPEPIASASIAQVHR---------------AV-LKSGEEVAVK 155 (517)
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCCCchhhhhHhhhee---------------EE-ecCCCEEEEE
Confidence 3778888888888888777776666553 3344445555565555555 43 4569999999
Q ss_pred EeccCCCC---------------------------hHh-----HHH------HHHHHHHHHhC-----CCCCeeEEEEEe
Q psy6346 222 IIDKSQLD---------------------------PVN-----LQK------VYREVEIMKQL-----DHPHIIKLFQVM 258 (1238)
Q Consensus 222 VLkks~ld---------------------------~e~-----ikr------f~rEIeILkkL-----~HPNIVrL~dvf 258 (1238)
+.+..-.. ... .+. +.+|..-+.++ +.++|.--.=|+
T Consensus 156 VqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~w 235 (517)
T COG0661 156 VQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYW 235 (517)
T ss_pred ecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeeh
Confidence 97664210 000 011 12333333333 233332222233
Q ss_pred eeCCEEEEEEeecCCCccchhhhcc-cccc-----hhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEe
Q psy6346 259 ETKSMIYIVSEYANQGEIFDYIARY-GRMN-----ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332 (1238)
Q Consensus 259 ed~d~lyLVMEy~~GGSL~d~Lkk~-~~Ls-----esea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiD 332 (1238)
+....-.|+|||+.|..+.+..... ..++ +..+..++.|++. .|++|.|.+|.||+++.+|.+.+.|
T Consensus 236 e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~-------dgffHaDpHpGNi~v~~~g~i~~lD 308 (517)
T COG0661 236 EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-------DGFFHADPHPGNILVRSDGRIVLLD 308 (517)
T ss_pred hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh-------cCccccCCCccceEEecCCcEEEEc
Confidence 4456678999999999998874221 2333 3334444444444 8999999999999999999999999
Q ss_pred cCCcccccC
Q psy6346 333 FGFSNYYVP 341 (1238)
Q Consensus 333 FGLS~~~~~ 341 (1238)
||+.....+
T Consensus 309 fGi~g~l~~ 317 (517)
T COG0661 309 FGIVGRLDP 317 (517)
T ss_pred CcceecCCH
Confidence 999876543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=9.3e-07 Score=98.82 Aligned_cols=140 Identities=22% Similarity=0.190 Sum_probs=104.9
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC------------------CC--hHhHHHHHHHHHHHHhCCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ------------------LD--PVNLQKVYREVEIMKQLDH 248 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~------------------ld--~e~ikrf~rEIeILkkL~H 248 (1238)
|.+......||.|.-+.||.|.+. .|.++|||.=+... .+ ........+|.++|.+|.-
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred ChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 345555678999999999998654 78999999732211 11 1123456789999999954
Q ss_pred C--CeeEEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC
Q psy6346 249 P--HIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326 (1238)
Q Consensus 249 P--NIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG 326 (1238)
. .+...+++ +...+|||+++|..|...- +....+..++..|++-+..+-..||||+|+.+-||+++++|
T Consensus 169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred cCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 4 56666654 5678999999997776533 24556677777888877777789999999999999999999
Q ss_pred cEEEEecCCccc
Q psy6346 327 DIKLADFGFSNY 338 (1238)
Q Consensus 327 ~VKLiDFGLS~~ 338 (1238)
.+.++||-.+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999986653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.6e-05 Score=83.52 Aligned_cols=134 Identities=12% Similarity=0.109 Sum_probs=82.2
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC--eeEEEEEeeeCCEEEEEEeecCC
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH--IIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN--IVrL~dvfed~d~lyLVMEy~~G 273 (1238)
..+|.|..+.||+. .+..+++|+..... ....+.+|.++++.+..-+ +.+.+++.+..+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 35677777777763 24567888876532 2345689999999986443 46778888888888999999998
Q ss_pred Cc-cchhhh---------------------cc--cccchhH-HHHHHHH----------HHHH-HhHhh----ccceeec
Q psy6346 274 GE-IFDYIA---------------------RY--GRMNENA-ARRKFWQ----------ILSA-VEYCH----NRRVVHR 313 (1238)
Q Consensus 274 GS-L~d~Lk---------------------k~--~~Lsese-a~kI~~Q----------ILsA-LeYLH----SkGIIHR 313 (1238)
.. +...+. .. ....... ...+..+ +... ..+|. ...++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 63 211110 00 0000000 0001000 0011 11121 1257899
Q ss_pred cCCcccccccCCCcEEEEecCCccc
Q psy6346 314 DLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 314 DLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
|++|.||++++++ +.|+||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.1e-05 Score=76.40 Aligned_cols=137 Identities=16% Similarity=0.204 Sum_probs=77.2
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCC--CeeEEEEEe---eeCCEEEEEEee
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP--HIIKLFQVM---ETKSMIYIVSEY 270 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HP--NIVrL~dvf---ed~d~lyLVMEy 270 (1238)
..++.|..+.||.+... +..+++|+.... .....+.+|+.+++.|... .+..++.+. ......+++|++
T Consensus 3 ~~l~~G~~n~~~~v~~~--~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD--DGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEESSSSEEEEEEET--TSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEEC--CcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 34555666666665443 358999997543 3456788999999888433 345666543 344568999999
Q ss_pred cCCCccch----------------hhh---cc----cccch------hHHHHH---------------HHHHHH-HHhHh
Q psy6346 271 ANQGEIFD----------------YIA---RY----GRMNE------NAARRK---------------FWQILS-AVEYC 305 (1238)
Q Consensus 271 ~~GGSL~d----------------~Lk---k~----~~Lse------sea~kI---------------~~QILs-ALeYL 305 (1238)
++|..+.. .+. .. ..+.. .....+ ...+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99987777 111 00 00000 000000 001111 22222
Q ss_pred h-------ccceeeccCCccccccc-CCCcEEEEecCCccc
Q psy6346 306 H-------NRRVVHRDLKAENLLMD-SNLDIKLADFGFSNY 338 (1238)
Q Consensus 306 H-------SkGIIHRDLKPeNILLd-~nG~VKLiDFGLS~~ 338 (1238)
+ ...++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 34699999999999999 667778999997753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=4e-05 Score=83.53 Aligned_cols=135 Identities=15% Similarity=0.138 Sum_probs=93.0
Q ss_pred CCCCccccCceEccCCcEEEEEEeccCC---CC-hHhHHHHHHHHHHHHhCCCCC--eeEEEEEee-----eCCEEEEEE
Q psy6346 200 VKSRSCNRPPVLLRHTVNVAIKIIDKSQ---LD-PVNLQKVYREVEIMKQLDHPH--IIKLFQVME-----TKSMIYIVS 268 (1238)
Q Consensus 200 sGsfGtVYKav~lktG~kVAIKVLkks~---ld-~e~ikrf~rEIeILkkL~HPN--IVrL~dvfe-----d~d~lyLVM 268 (1238)
.||.+.|+.... .|..+-||.-.... .. +-....|.+|+..|.+|..-+ +.++. ++. ..-..+||+
T Consensus 28 rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 28 RNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 345555554322 23357777654111 01 334467899999999884333 44444 322 123478999
Q ss_pred eecCC-Cccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc--EEEEecCCcc
Q psy6346 269 EYANQ-GEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD--IKLADFGFSN 337 (1238)
Q Consensus 269 Ey~~G-GSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~--VKLiDFGLS~ 337 (1238)
|-+.| .+|.+++... .+.+......++.+|..+|.-||..|+.|+|+-+.||+++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 5787777553 34577777899999999999999999999999999999987667 9999998654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.90 E-value=9e-05 Score=82.52 Aligned_cols=137 Identities=12% Similarity=0.079 Sum_probs=93.8
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhH-----------------H-----HHHHHHHHHHhCCCC--Ce
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNL-----------------Q-----KVYREVEIMKQLDHP--HI 251 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~i-----------------k-----rf~rEIeILkkL~HP--NI 251 (1238)
+.|..|.-..||+|.. .++..||||+++........+ + =...|+.-|+++.-. .+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4777777888888753 568999999987653321111 1 124678888887433 33
Q ss_pred eEEEEEeeeCCEEEEEEeecCCCccc-hhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEE
Q psy6346 252 IKLFQVMETKSMIYIVSEYANQGEIF-DYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIK 329 (1238)
Q Consensus 252 VrL~dvfed~d~lyLVMEy~~GGSL~-d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VK 329 (1238)
.+-+.+.. ..|||||+....+. -.|+. -.+...++..+..++++.+.-|-. .++||+||..-|||+. ++.+.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 44444433 47999999643111 11111 123333788889999999988876 8999999999999999 88999
Q ss_pred EEecCCcccc
Q psy6346 330 LADFGFSNYY 339 (1238)
Q Consensus 330 LiDFGLS~~~ 339 (1238)
|||||.+...
T Consensus 207 iID~~QaV~~ 216 (268)
T COG1718 207 IIDVSQAVTI 216 (268)
T ss_pred EEECcccccc
Confidence 9999988653
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.7e-05 Score=98.21 Aligned_cols=208 Identities=17% Similarity=0.193 Sum_probs=151.7
Q ss_pred HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE----EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhh
Q psy6346 231 VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI----YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH 306 (1238)
Q Consensus 231 e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l----yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLH 306 (1238)
.++....-|+..+.++.|+|++.++.|--..... .+..++|...++...+..-...+...++.+..++++||.++|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3445556677788899999999999887544332 344578999999999988899999999999999999999999
Q ss_pred ccceeeccCCcc---cccccCCCcEEEE--ecCCcccccCCCccccccCCCCCCCcccccCCccCCC--ccceehhhHHH
Q psy6346 307 NRRVVHRDLKAE---NLLMDSNLDIKLA--DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGP--EIDIWSLGVVL 379 (1238)
Q Consensus 307 SkGIIHRDLKPe---NILLd~nG~VKLi--DFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~--KSDIWSLGVIL 379 (1238)
+....|.-|... +--.+..+.+.+. ||+.+..............+..+.++|....... .. ..|+|++|..+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~-~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTA-KKSRLTDLWCLGLLL 382 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccc-hhhhhhHHHHHHHHH
Confidence 986655555554 4444566667777 9998877666555555566677888888776654 33 36999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 380 YVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 380 YELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
..+..|..+-... .....+ .+.....+..+++.+|+..++++|+.+.+++.|+|.+....
T Consensus 383 ~~~~~~~~i~~~~---~~~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS---AVPVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred hhhhhcCcccccc---cchhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 9998876442111 111111 11112226788999999999999999999999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.90 E-value=5.4e-05 Score=83.03 Aligned_cols=117 Identities=16% Similarity=0.163 Sum_probs=75.3
Q ss_pred ccCCcEEEEEEeccCCCChH-hHHH------HHHHHHHHHhC---CCCCeeEEEEEe-----eeCCEEEEEEeecCCCcc
Q psy6346 212 LRHTVNVAIKIIDKSQLDPV-NLQK------VYREVEIMKQL---DHPHIIKLFQVM-----ETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 212 lktG~kVAIKVLkks~ld~e-~ikr------f~rEIeILkkL---~HPNIVrL~dvf-----ed~d~lyLVMEy~~GGSL 276 (1238)
.-+|..+.+|.-.......+ .+.. ..+++..+.++ +--.+..++-+. .-....++||||++|..|
T Consensus 51 ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l 130 (229)
T PF06176_consen 51 EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVEL 130 (229)
T ss_pred EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeec
Confidence 34678899998765432211 1111 23444444444 333333333332 223446799999999988
Q ss_pred chhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 277 ~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
.++.. +++ .+...|.+++.-||..|++|+|++|.|++++.++ ++++||+...
T Consensus 131 ~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 131 NDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred ccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 77542 222 2445677889999999999999999999998655 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.85 E-value=2.7e-05 Score=94.29 Aligned_cols=171 Identities=16% Similarity=0.138 Sum_probs=97.8
Q ss_pred cceeeccccccchhhhhhcccccccC-----CceeEEeeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEe
Q psy6346 149 TSWVQTYRRRLSIDEVNLCFQSTSID-----GRRLRLDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKII 223 (1238)
Q Consensus 149 tSWlsd~rr~Lsiddiel~i~sesid-----gRy~~i~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVL 223 (1238)
.+-++|.-.+.+.+++...++.+... ...+....++....++|+++ .+++|..||||+-
T Consensus 130 L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA----------------~L~~G~~VaVKVQ 193 (538)
T KOG1235|consen 130 LSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRA----------------RLKNGEDVAVKVQ 193 (538)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEE----------------EecCCCEEEEEec
Confidence 33445555555556665555544433 45555666777777777665 3455899999997
Q ss_pred ccCCCCh-----------------------------HhHHHHHH------HHHHHHhC----CCCC------eeEEEEEe
Q psy6346 224 DKSQLDP-----------------------------VNLQKVYR------EVEIMKQL----DHPH------IIKLFQVM 258 (1238)
Q Consensus 224 kks~ld~-----------------------------e~ikrf~r------EIeILkkL----~HPN------IVrL~dvf 258 (1238)
+..-... +..+.+.. |.+-..++ .|-+ |.++|.
T Consensus 194 ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~-- 271 (538)
T KOG1235|consen 194 HPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW-- 271 (538)
T ss_pred CcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--
Confidence 6542111 01111222 22222222 3444 333332
Q ss_pred eeCCEEEEEEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHH-hHhhccceeeccCCcccccccC----CCcEEEEe
Q psy6346 259 ETKSMIYIVSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAV-EYCHNRRVVHRDLKAENLLMDS----NLDIKLAD 332 (1238)
Q Consensus 259 ed~d~lyLVMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsAL-eYLHSkGIIHRDLKPeNILLd~----nG~VKLiD 332 (1238)
.......|+||||+|..+.|.-.- ...++...+. ..+.++. +-|=..|++|+|-+|.||+++. ++.+.+.|
T Consensus 272 ~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~---~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 272 DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDIL---NKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHH---HHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEc
Confidence 233457899999999988775421 1233433322 2222221 1122378999999999999984 67899999
Q ss_pred cCCccccc
Q psy6346 333 FGFSNYYV 340 (1238)
Q Consensus 333 FGLS~~~~ 340 (1238)
||+.....
T Consensus 349 hGl~~~is 356 (538)
T KOG1235|consen 349 HGLYAVIS 356 (538)
T ss_pred cccccccc
Confidence 99987543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00015 Score=77.90 Aligned_cols=128 Identities=12% Similarity=0.067 Sum_probs=77.8
Q ss_pred ccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEeecCCCccchhhh-
Q psy6346 204 SCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIA- 281 (1238)
Q Consensus 204 GtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lk- 281 (1238)
..||+... .+..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.....
T Consensus 13 ~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~ 85 (244)
T cd05150 13 ATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEE 85 (244)
T ss_pred CeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcc
Confidence 44555422 23578888876542 235678999998883 4445678887777777899999999877754310
Q ss_pred ---------------cccccch-------h--HHHHH-----------------------HHHHHHHHhHh----hccce
Q psy6346 282 ---------------RYGRMNE-------N--AARRK-----------------------FWQILSAVEYC----HNRRV 310 (1238)
Q Consensus 282 ---------------k~~~Lse-------s--ea~kI-----------------------~~QILsALeYL----HSkGI 310 (1238)
+...++. . ..... ...+...|... ....+
T Consensus 86 ~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 165 (244)
T cd05150 86 LEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVV 165 (244)
T ss_pred cCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEE
Confidence 0000100 0 00000 11111111111 12359
Q ss_pred eeccCCcccccccCCCcEEEEecCCccc
Q psy6346 311 VHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 311 IHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
+|+|+.|.|||++.++.+.|+||+.+..
T Consensus 166 ~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 166 THGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 9999999999999887788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00062 Score=86.61 Aligned_cols=61 Identities=15% Similarity=0.266 Sum_probs=42.2
Q ss_pred cEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCe--eEEEEEeeeC---CEEEEEEeecCCCccc
Q psy6346 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHI--IKLFQVMETK---SMIYIVSEYANQGEIF 277 (1238)
Q Consensus 216 ~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNI--VrL~dvfed~---d~lyLVMEy~~GGSL~ 277 (1238)
..+++|+....... .....+.+|+++|+.+. |.+| .+++.++.+. +..|+||||++|..+.
T Consensus 66 ~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~ 132 (822)
T PLN02876 66 KRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFV 132 (822)
T ss_pred eeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccC
Confidence 35777776543211 12346789999999995 6665 7788877654 4678999999986543
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=97.50 E-value=6.4e-05 Score=87.56 Aligned_cols=38 Identities=45% Similarity=0.667 Sum_probs=36.2
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+|+|.+.+.||+|+||+||+|+|+.+|+.||||||
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i 43 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCI 43 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeee
Confidence 45789999999999999999999999999999999999
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=97.47 E-value=2.7e-05 Score=92.35 Aligned_cols=40 Identities=45% Similarity=0.686 Sum_probs=37.0
Q ss_pred CCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 11 KAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 11 ~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+.+-.|.|++.+|||+|-|++||||+|..||++||||||
T Consensus 12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKvi 51 (864)
T KOG4717|consen 12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVI 51 (864)
T ss_pred cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEe
Confidence 4456678899999999999999999999999999999999
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=97.46 E-value=6.1e-05 Score=91.74 Aligned_cols=39 Identities=26% Similarity=0.369 Sum_probs=37.0
Q ss_pred CCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 12 ~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....||.|++|+|||+|+-|.|++|+|..||+.+|||+|
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii 45 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKII 45 (786)
T ss_pred ccccccceeccccccCCCCceehhhhcccccceeEEEee
Confidence 356899999999999999999999999999999999998
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00097 Score=71.80 Aligned_cols=31 Identities=29% Similarity=0.323 Sum_probs=26.3
Q ss_pred cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.+++|+|+++.||+++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3599999999999998776567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0013 Score=70.87 Aligned_cols=129 Identities=20% Similarity=0.271 Sum_probs=91.2
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCC--------------CChHhHHHHHHHHHHHHhCC------CCCeeEEE
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ--------------LDPVNLQKVYREVEIMKQLD------HPHIIKLF 255 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~--------------ld~e~ikrf~rEIeILkkL~------HPNIVrL~ 255 (1238)
..+|.|+...+|.- ..+....||++.... ......+...+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45777777776643 456778999988765 11123456677777776665 78899999
Q ss_pred EEeeeCCEEEEEEeecCC------CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC--C-
Q psy6346 256 QVMETKSMIYIVSEYANQ------GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN--L- 326 (1238)
Q Consensus 256 dvfed~d~lyLVMEy~~G------GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n--G- 326 (1238)
++.+++.-.-+|+|.+.. -+|.+++.+ +.++. .+...+-+-.+||-.++|+.+||+|.||++... +
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998743 356666643 33444 333334445567888999999999999999643 2
Q ss_pred -cEEEEe
Q psy6346 327 -DIKLAD 332 (1238)
Q Consensus 327 -~VKLiD 332 (1238)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00023 Score=82.99 Aligned_cols=37 Identities=41% Similarity=0.733 Sum_probs=35.0
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+|.|+++++||+|+||+||+|+|..||+.||||++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii 50 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKII 50 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEe
Confidence 5788999999999999999999999999999999955
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.23 E-value=2e-05 Score=101.93 Aligned_cols=226 Identities=15% Similarity=0.080 Sum_probs=157.8
Q ss_pred EEEEeccCC---CChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--eCCEEEEEEeecCCCccchhhhcc----cccchh
Q psy6346 219 AIKIIDKSQ---LDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIYIVSEYANQGEIFDYIARY----GRMNEN 289 (1238)
Q Consensus 219 AIKVLkks~---ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--d~d~lyLVMEy~~GGSL~d~Lkk~----~~Lses 289 (1238)
.+|+.+... +.+...+....|..-++...|+++...+.-.. +....|.+++||.+|.+++.|-+. ..+.+.
T Consensus 1256 k~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~ 1335 (2724)
T KOG1826|consen 1256 KFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRS 1335 (2724)
T ss_pred EEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhc
Confidence 455544332 23334455566666777789999987766553 345578999999999999988653 345555
Q ss_pred HHHHHHHHHHHHHhHhhcc-----ceeeccCCcccccccCCCcEEEEecCCcc-cccCCCccccccCCCCCCCcccccCC
Q psy6346 290 AARRKFWQILSAVEYCHNR-----RVVHRDLKAENLLMDSNLDIKLADFGFSN-YYVPGQKLATWCGSPPYAAPEVFEGK 363 (1238)
Q Consensus 290 ea~kI~~QILsALeYLHSk-----GIIHRDLKPeNILLd~nG~VKLiDFGLS~-~~~~s~~l~t~~GTp~YmAPEVL~gk 363 (1238)
.+.....+.+.+..-+|+. -.+|++||+-|.+|..+-++|+.++|+.+ ............+++.|+.|++....
T Consensus 1336 ~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i 1415 (2724)
T KOG1826|consen 1336 PVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI 1415 (2724)
T ss_pred hHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHH
Confidence 5555555557777777744 27899999999999999999999999998 32233345567788999999998877
Q ss_pred ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy6346 364 KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 364 ~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPW 442 (1238)
.+ +.++|+|..|+.+|++.-|..+|-......+...+.++. +.++...+.+...+...+|-+.-..||.-..++.-+.
T Consensus 1416 k~-t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~ 1494 (2724)
T KOG1826|consen 1416 KF-TKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDH 1494 (2724)
T ss_pred hh-hhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccc
Confidence 77 667999999999999988887774332222222233332 2345555666666666667777788888888887776
Q ss_pred ccc
Q psy6346 443 MAE 445 (1238)
Q Consensus 443 Fke 445 (1238)
+..
T Consensus 1495 ~a~ 1497 (2724)
T KOG1826|consen 1495 FAV 1497 (2724)
T ss_pred ccc
Confidence 644
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00028 Score=82.57 Aligned_cols=36 Identities=33% Similarity=0.481 Sum_probs=33.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|.|.++||+|+||+||+|+.+.||+.||||++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi 205 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKII 205 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeee
Confidence 456699999999999999999999999999999999
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0002 Score=81.37 Aligned_cols=34 Identities=24% Similarity=0.269 Sum_probs=32.7
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
++|+.+..+|+|+||+|++|+|+.||+.||||-|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF 35 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKF 35 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEee
Confidence 5799999999999999999999999999999988
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0017 Score=69.08 Aligned_cols=97 Identities=16% Similarity=0.207 Sum_probs=79.4
Q ss_pred HHHHHHHhCCC-CCeeEEEEEeeeCCEEEEEEeecCCCccch---hhhcccccchhHHHHHHHHHHHHHhHhhc---cce
Q psy6346 238 REVEIMKQLDH-PHIIKLFQVMETKSMIYIVSEYANQGEIFD---YIARYGRMNENAARRKFWQILSAVEYCHN---RRV 310 (1238)
Q Consensus 238 rEIeILkkL~H-PNIVrL~dvfed~d~lyLVMEy~~GGSL~d---~Lkk~~~Lsesea~kI~~QILsALeYLHS---kGI 310 (1238)
.|.-+|+.+.+ +++++++++|.. ++|.||...+++.. .+...-..++....+++.++++.+++|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58889999965 699999999854 67889998776642 22233346888999999999999999987 358
Q ss_pred eeccCCcccccccCCCcEEEEecCCccc
Q psy6346 311 VHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 311 IHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.-.|++++|+.++++|++|++|.+....
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00059 Score=82.81 Aligned_cols=40 Identities=55% Similarity=0.689 Sum_probs=37.5
Q ss_pred CCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 11 KAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 11 ~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.....+|.|.|.+|||+|.||+|++|+|..||..||||++
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~i 89 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKII 89 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEe
Confidence 4567899999999999999999999999999999999977
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.00058 Score=83.22 Aligned_cols=33 Identities=27% Similarity=0.304 Sum_probs=32.2
Q ss_pred ceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.|+|++.||+|+||.|..|+...||+.||||+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIi 219 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKII 219 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEee
Confidence 599999999999999999999999999999999
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0055 Score=66.80 Aligned_cols=127 Identities=20% Similarity=0.178 Sum_probs=89.0
Q ss_pred cEEEEEEEecCCCC-ccccCceEccCCcEEEEEEecc---CC-------CCh---------HhHHHHHHHHHHHHhC---
Q psy6346 190 QTIRKREKCGVKSR-SCNRPPVLLRHTVNVAIKIIDK---SQ-------LDP---------VNLQKVYREVEIMKQL--- 246 (1238)
Q Consensus 190 qVYkarekIGsGsf-GtVYKav~lktG~kVAIKVLkk---s~-------ld~---------e~ikrf~rEIeILkkL--- 246 (1238)
..++..+.+|.|.- |.||++.. .|..+|||+... .. ... .....|..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 55677788888888 88888765 678999999322 10 000 1224577888887777
Q ss_pred CCCCe--eEEEEEeeeC------------------CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhh
Q psy6346 247 DHPHI--IKLFQVMETK------------------SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH 306 (1238)
Q Consensus 247 ~HPNI--VrL~dvfed~------------------d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLH 306 (1238)
++.++ |++++|+.-. ...-||.||++... .....-+.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHHHHHHHHHHHHH
Confidence 45566 8999987321 12356777765432 223345677888899999
Q ss_pred ccceeeccCCcccccccCCCcEEEEecCCc
Q psy6346 307 NRRVVHRDLKAENLLMDSNLDIKLADFGFS 336 (1238)
Q Consensus 307 SkGIIHRDLKPeNILLd~nG~VKLiDFGLS 336 (1238)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999996 3589999964
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00044 Score=82.08 Aligned_cols=41 Identities=22% Similarity=0.375 Sum_probs=38.1
Q ss_pred CCCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 10 KKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 10 ~~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+.+..|+|+++||+|.||+||||+...+|+.||||++
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil 130 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKIL 130 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEee
Confidence 44567888999999999999999999999999999999998
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0024 Score=69.58 Aligned_cols=118 Identities=17% Similarity=0.147 Sum_probs=65.7
Q ss_pred CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCe-eEEEEEeeeCCEEEEEEeecCCCccchh-------h-----
Q psy6346 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHI-IKLFQVMETKSMIYIVSEYANQGEIFDY-------I----- 280 (1238)
Q Consensus 214 tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNI-VrL~dvfed~d~lyLVMEy~~GGSL~d~-------L----- 280 (1238)
++..+++|+........ . -...+|.++++.+..-++ .+++.... -++||||++|..+... +
T Consensus 18 ~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~ 91 (256)
T TIGR02721 18 PGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAA 91 (256)
T ss_pred CCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHH
Confidence 45678888755432110 0 124679999999854433 34444432 2689999998766431 1
Q ss_pred --h---cc----cccch-hHHHHHHHHH---------HHHHhHhh--------ccceeeccCCcccccccCCCcEEEEec
Q psy6346 281 --A---RY----GRMNE-NAARRKFWQI---------LSAVEYCH--------NRRVVHRDLKAENLLMDSNLDIKLADF 333 (1238)
Q Consensus 281 --k---k~----~~Lse-sea~kI~~QI---------LsALeYLH--------SkGIIHRDLKPeNILLd~nG~VKLiDF 333 (1238)
. .. ..++. ..+..+..++ ...+..+- ...++|+|+.|.||+++.++ +.|+||
T Consensus 92 ~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDw 170 (256)
T TIGR02721 92 LLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDW 170 (256)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEec
Confidence 0 00 01111 1111211111 11111111 12589999999999999877 789999
Q ss_pred CCccc
Q psy6346 334 GFSNY 338 (1238)
Q Consensus 334 GLS~~ 338 (1238)
+.+..
T Consensus 171 E~a~~ 175 (256)
T TIGR02721 171 EYASD 175 (256)
T ss_pred cccCc
Confidence 98764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0014 Score=70.43 Aligned_cols=129 Identities=15% Similarity=0.188 Sum_probs=91.0
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCe-eEEEEEeeeCCEEEEEEeec
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHI-IKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNI-VrL~dvfed~d~lyLVMEy~ 271 (1238)
.....+++|.++.||.+.+ .|..+|+|+-..+. ....+..|+++|..+.-.++ .++|.|.++ ++.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 3445678888888888766 46689999987654 34578899999999987776 456666443 4559999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCC-cccccccCCCcEEEEecCCccc
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLK-AENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLK-PeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.|-.|.+.-... -++-+..+++.---|-..||-|+.|. |..++|..++.+.|+||.-|+.
T Consensus 95 ~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 987776654321 13334455555445677899999986 4555555666999999998874
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.00052 Score=76.04 Aligned_cols=41 Identities=27% Similarity=0.357 Sum_probs=37.6
Q ss_pred CCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 11 KAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 11 ~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.....+++|+|++.||+|.||.||+|++++++-.||+||.-
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlf 56 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLF 56 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeee
Confidence 34567899999999999999999999999999999999984
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0008 Score=81.68 Aligned_cols=44 Identities=27% Similarity=0.232 Sum_probs=40.9
Q ss_pred ceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEeecccccccc
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRITKTEVGALCSILSISQSGHQK 61 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~~~~~~~~~ 61 (1238)
.|+.++.||||+||+||.|+...||+.||+|+|-.++.+.++|.
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~r 62 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQR 62 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchH
Confidence 39999999999999999999999999999999988888887765
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.00059 Score=78.83 Aligned_cols=38 Identities=24% Similarity=0.251 Sum_probs=35.7
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+++|++++.||||+||+|++++++.||+.+|+||.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl 58 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVL 58 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhh
Confidence 35678899999999999999999999999999999998
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0057 Score=65.22 Aligned_cols=31 Identities=23% Similarity=0.535 Sum_probs=27.2
Q ss_pred cceeeccCCcccccccC-CCcEEEEecCCccc
Q psy6346 308 RRVVHRDLKAENLLMDS-NLDIKLADFGFSNY 338 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~ 338 (1238)
.+++|+|+++.|||++. ++.+.|+||..+..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 36999999999999998 57899999997753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.00086 Score=80.51 Aligned_cols=39 Identities=26% Similarity=0.359 Sum_probs=36.2
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+++|++++.||+|+||.||||+.+.||+.+|+|+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~Lk 175 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILK 175 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeeccc
Confidence 357889999999999999999999999999999999883
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0017 Score=76.73 Aligned_cols=36 Identities=22% Similarity=0.201 Sum_probs=33.8
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|++++.||+|+||+||+|++..+++.||||++.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~ 163 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR 163 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEe
Confidence 367999999999999999999999999999999984
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.002 Score=69.48 Aligned_cols=39 Identities=21% Similarity=0.212 Sum_probs=34.6
Q ss_pred ceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEeeccc
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRITKTEVGALCSILSISQ 56 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~~~~ 56 (1238)
.|++++.||+|+||+||+|++..||+.||||++.....+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~ 39 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE 39 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC
Confidence 499999999999999999999999999999988654433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0021 Score=67.57 Aligned_cols=34 Identities=21% Similarity=0.345 Sum_probs=32.3
Q ss_pred eeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 19 YDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 19 Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
|++++.||+|+||+|++|++..+|+.||+|++..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~ 34 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDK 34 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEES
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecc
Confidence 8999999999999999999999999999999943
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.002 Score=72.60 Aligned_cols=34 Identities=21% Similarity=0.253 Sum_probs=32.7
Q ss_pred ceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+|++++.||+|+||+||+|++..||+.||||++.
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~ 35 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR 35 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEE
Confidence 6999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0019 Score=79.50 Aligned_cols=38 Identities=21% Similarity=0.322 Sum_probs=35.8
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+-.+.+|.+++.||||+||||.||..+.|++.+|||+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~L 401 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVL 401 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEe
Confidence 45678899999999999999999999999999999998
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0012 Score=74.14 Aligned_cols=37 Identities=27% Similarity=0.309 Sum_probs=33.6
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEee
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILS 53 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~ 53 (1238)
..|...+.||+|+||+||+|++..||+.||||-|.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~ 38 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLG 38 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecc
Confidence 3588899999999999999999999999999998554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.017 Score=65.41 Aligned_cols=76 Identities=9% Similarity=-0.053 Sum_probs=49.6
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCC---CCeeEEEEEeee---CCEEEEEE
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDH---PHIIKLFQVMET---KSMIYIVS 268 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~H---PNIVrL~dvfed---~d~lyLVM 268 (1238)
...||.|..+.||.... .++ .+.+|+.+... ....+.+|.+.|+.|.- -.+.++++++.. .+..+|||
T Consensus 19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 19 VECISEQPYAALWALYD-SQG-NPMPLMARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eeecCCccceeEEEEEc-CCC-CEEEEEecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34566666666665422 223 46777743311 12477899999998843 357788877754 36689999
Q ss_pred eecCCCcc
Q psy6346 269 EYANQGEI 276 (1238)
Q Consensus 269 Ey~~GGSL 276 (1238)
|+++|.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0031 Score=70.67 Aligned_cols=42 Identities=21% Similarity=0.447 Sum_probs=37.5
Q ss_pred CCCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 10 KKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 10 ~~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
......+++|++.+.||+|+||+||+|++..||+.||||++.
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~ 52 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK 52 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEE
Confidence 334456889999999999999999999999999999999983
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.021 Score=64.02 Aligned_cols=31 Identities=32% Similarity=0.477 Sum_probs=26.5
Q ss_pred cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.++||+|++|.||+++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999998766568999998753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0027 Score=71.24 Aligned_cols=34 Identities=21% Similarity=0.311 Sum_probs=32.6
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
++|++++.||+|+||+|++|++..+|+.||||++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~ 34 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKIL 34 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEE
Confidence 4699999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0026 Score=72.35 Aligned_cols=35 Identities=26% Similarity=0.210 Sum_probs=33.0
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+|++++.||+|+||+||+|++..||+.||||++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~ 35 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR 35 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEc
Confidence 47999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.018 Score=68.32 Aligned_cols=78 Identities=14% Similarity=0.060 Sum_probs=52.1
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCC---C--hHhHHHHHHHHHHHHhCC---CCCeeEEEEEeeeCCEEEEE
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL---D--PVNLQKVYREVEIMKQLD---HPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~l---d--~e~ikrf~rEIeILkkL~---HPNIVrL~dvfed~d~lyLV 267 (1238)
+.+|.|....||++.....++.|.||.-..... . +...++...|.+.|+.+. -.++++++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 456777788888776643335899998542110 0 224567888999988873 34567777763 3557899
Q ss_pred EeecCCCc
Q psy6346 268 SEYANQGE 275 (1238)
Q Consensus 268 MEy~~GGS 275 (1238)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.003 Score=72.31 Aligned_cols=35 Identities=23% Similarity=0.130 Sum_probs=32.9
Q ss_pred ceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
.|++++.||+|+||+||+|++..||+.||||++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~ 36 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRK 36 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEH
Confidence 59999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.022 Score=63.01 Aligned_cols=134 Identities=13% Similarity=0.100 Sum_probs=75.7
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC--eeEEEEE------eeeCCEEEEEEe
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH--IIKLFQV------METKSMIYIVSE 269 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN--IVrL~dv------fed~d~lyLVME 269 (1238)
+..|....+|+... .+..+++|+.... ....+..|++++..|.+.+ +.+++.. ....+..++|++
T Consensus 22 i~~G~~n~~y~v~~--~~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 22 ISAGIENTNYFVTT--DSGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred ccCccccceEEEEe--CCCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 33344445554422 3346888987641 2345677888888884332 4444432 233456789999
Q ss_pred ecCCCccch----hhhcc-----------cccch--------hHHH------------HHHHHHHHHHhHhhc-------
Q psy6346 270 YANQGEIFD----YIARY-----------GRMNE--------NAAR------------RKFWQILSAVEYCHN------- 307 (1238)
Q Consensus 270 y~~GGSL~d----~Lkk~-----------~~Lse--------sea~------------kI~~QILsALeYLHS------- 307 (1238)
+++|..+.. .+... ..+.. .... .....+..++.++..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877643 11000 00000 0000 001112223333332
Q ss_pred cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.+++|+|++|.||+++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887789999997753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0031 Score=71.62 Aligned_cols=35 Identities=20% Similarity=0.261 Sum_probs=33.0
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+|++++.||+|+||+||+|++..||+.||||++.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~ 35 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR 35 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEE
Confidence 36999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1238 | ||||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-90 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-89 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-89 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-89 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-89 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-88 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-88 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-88 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-87 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-84 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-64 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-63 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-63 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-62 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-61 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-61 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-61 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-61 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-49 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-42 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-41 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-41 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-40 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-40 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-40 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-40 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-40 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-40 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-39 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-39 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-39 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-39 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-39 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-39 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-39 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-39 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-39 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-39 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-39 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-39 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-39 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-39 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-38 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-38 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-38 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-38 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-38 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-38 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-37 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-37 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-37 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-37 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-37 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-37 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-37 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-37 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-37 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-37 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-37 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-36 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-36 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-36 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-36 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-36 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-36 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-36 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-36 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-36 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-36 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-36 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-36 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-36 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-36 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-36 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-36 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-36 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-36 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-36 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-36 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-36 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-36 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-36 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-35 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-35 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-35 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-34 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-34 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-34 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-34 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-34 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-34 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-34 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-34 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-34 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-34 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-34 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-34 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-34 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-34 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-34 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-34 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-34 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-34 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-34 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-34 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-34 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-34 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-34 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-34 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-34 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-34 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-34 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-34 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-33 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-33 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-33 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-33 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-33 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-33 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-33 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-33 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-33 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-33 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-33 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-33 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-33 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-33 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-33 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-33 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-33 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-33 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-33 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-33 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-33 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-33 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-33 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-33 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-33 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-33 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-33 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-33 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-33 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-33 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-33 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-33 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-33 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-33 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-33 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-33 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-33 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-33 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-33 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-33 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-33 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-33 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-33 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-33 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-33 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-33 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-33 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-33 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-33 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-33 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-33 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-33 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-33 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-33 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-32 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-32 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-32 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-32 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-32 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-32 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-32 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-32 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-32 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-32 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-32 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-32 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-32 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-32 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-32 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-31 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-31 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-31 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-31 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-31 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-31 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-31 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-31 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-31 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-31 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-31 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-31 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-31 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-31 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-31 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-31 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-31 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-31 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-31 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-31 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-31 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-31 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-31 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-30 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-30 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-30 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-30 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-30 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-30 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-30 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-30 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-30 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-30 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-30 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-30 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-30 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-30 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-30 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-30 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-30 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-30 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-29 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-29 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-29 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-29 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-29 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-29 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-29 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-29 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-29 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-29 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-29 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-29 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-29 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-29 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-29 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-29 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-29 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-29 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-29 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-29 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-29 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-29 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-29 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-29 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-29 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-29 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-29 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-29 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-29 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-29 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-29 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-29 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-29 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-29 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-29 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-29 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-29 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-29 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-29 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-29 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-29 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-29 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-28 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-28 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-28 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-28 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-28 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-28 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-28 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-28 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-28 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-27 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-27 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-27 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-27 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-27 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-27 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-27 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-27 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-26 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-26 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-26 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-26 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-26 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-26 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-26 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-25 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-24 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-24 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-24 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-22 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-20 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-20 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-20 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-20 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-20 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-20 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-20 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-19 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-18 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-13 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-13 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-12 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 |
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-152
Identities = 148/295 (50%), Positives = 211/295 (71%), Gaps = 5/295 (1%)
Query: 213 RHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
RH + VAIKIIDK+QL+P +LQK++REV IMK L+HP+I+KLF+V+ET+ +Y++ E
Sbjct: 35 RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
YA+ GE+FDY+ +GRM E AR KF QI+SAV+YCH +R+VHRDLKAENLL+D++++IK
Sbjct: 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIK 154
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ADFGFSN + G KL +CG+PPYAAPE+F+GKKY GPE+D+WSLGV+LY LV G+LPF
Sbjct: 155 IADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
DG L LR+RVL G++RIP++MST+CE+L+++ LV P KR +EQI + RW+
Sbjct: 215 DGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274
Query: 450 LLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCY-ILKRR 503
+ + +++ + +M +G + +E T Y +L R+
Sbjct: 275 DELKP-FVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITATYLLLGRK 328
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 20/40 (50%), Positives = 25/40 (62%)
Query: 6 MAENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+A +G Y + +TIGKGNFA VKLARH +T EV
Sbjct: 4 IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREV 43
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 438 bits (1128), Expect = e-144
Identities = 122/296 (41%), Positives = 174/296 (58%), Gaps = 7/296 (2%)
Query: 213 RHTV---NVAIKIIDKSQLDPVNLQ-KVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268
H VA+K I + L ++ +V RE+ +K L HPHIIKL+ V+ T + I +V
Sbjct: 29 THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88
Query: 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
EYA GE+FDYI RM E+ RR F QI+ A+EYCH ++VHRDLK ENLL+D NL++
Sbjct: 89 EYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNV 147
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
K+ADFG SN G L T CGSP YAAPEV GK Y GPE+D+WS G+VLYV++ G LP
Sbjct: 148 KIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
Query: 389 FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
FD + +L +V S + +P F+S +SLIR+M+V +P +R I++I+R W P
Sbjct: 208 FDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267
Query: 449 RLLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEA-ETSKRRTFCYILKRR 503
L P+ + + + +L ++G E + E ++ + +L
Sbjct: 268 DYLRPMEEVQGSYADS-RIVSKLGEAMGFSEDYIVEALRSDENNEVKEAYNLLHEN 322
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 14/36 (38%), Positives = 21/36 (58%)
Query: 10 KKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+ +G Y I T+G+G+F VKLA H T+ +V
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKV 37
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 439 bits (1132), Expect = e-143
Identities = 120/359 (33%), Positives = 189/359 (52%), Gaps = 9/359 (2%)
Query: 213 RHTV---NVAIKIIDKSQLDPVN-LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268
+H + VA+KI+++ ++ ++ + K+ RE++ +K HPHIIKL+QV+ T S I++V
Sbjct: 36 KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95
Query: 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
EY + GE+FDYI + GR++E +RR F QILS V+YCH VVHRDLK EN+L+D++++
Sbjct: 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA 155
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
K+ADFG SN G+ L T CGSP YAAPEV G+ Y GPE+DIWS GV+LY L+CG LP
Sbjct: 156 KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
Query: 389 FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
FD + +L ++ G F P +++ SL++ ML +P KR I+ I+ H W ++ P
Sbjct: 216 FDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275
Query: 449 RLLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKE--VFEAETSKRRTFCYILKRRADG 506
+ L P + +E + + + +++
Sbjct: 276 KYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRI 335
Query: 507 GQTYEKEDMSAEKRTSGKPNSEAQVCTHKHCAQQNYFCPESNPRPQGYKSLKFRCYDHH 565
+ ++ S + T H + + E+ L + H
Sbjct: 336 MNEAKDFYLATSPPDSFLDDHHL---TRPHPERVPFLVAETPRARHTLDELNPQKSKHQ 391
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 11/39 (28%), Positives = 21/39 (53%)
Query: 7 AENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+ +++G Y + T+G G F VK+ +H +T +V
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKV 44
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 428 bits (1103), Expect = e-141
Identities = 113/245 (46%), Positives = 164/245 (66%), Gaps = 4/245 (1%)
Query: 213 RHTV---NVAIKIIDKSQLDPVNL-QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268
H + VA+KI+++ ++ +++ K+ RE++ +K HPHIIKL+QV+ T + ++V
Sbjct: 31 EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90
Query: 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
EY + GE+FDYI ++GR+ E ARR F QILSAV+YCH VVHRDLK EN+L+D++++
Sbjct: 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA 150
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
K+ADFG SN G+ L T CGSP YAAPEV G+ Y GPE+DIWS GV+LY L+CG LP
Sbjct: 151 KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
Query: 389 FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
FD + +L ++ G F IP +++ +L+ ML +P KR I+ I+ H W ++ P
Sbjct: 211 FDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270
Query: 449 RLLPP 453
L P
Sbjct: 271 SYLFP 275
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 11/39 (28%), Positives = 20/39 (51%)
Query: 7 AENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+++G Y + T+G G F VK+ H++T +V
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKV 39
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 414 bits (1066), Expect = e-134
Identities = 97/285 (34%), Positives = 151/285 (52%), Gaps = 14/285 (4%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L+R + VA+K I++ + V RE+ + L HP+I++ +V+ T + + I+
Sbjct: 38 LMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-- 325
EYA+ GE+++ I GR +E+ AR F Q+LS V YCH+ ++ HRDLK EN L+D +
Sbjct: 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154
Query: 326 LDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
+K+ DFG+S V + + G+P Y APEV ++Y G D+WS GV LYV++ G
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
Query: 386 ALPFDGSTLNSL----RDRVLSGRFRIP--YFMSTECESLIRKMLVREPTKRYCIEQIKR 439
A PF+ R+LS ++ IP +S EC LI ++ V +P R I +IK
Sbjct: 215 AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
Query: 440 HRWMAEETPRLLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKE 484
H W + P L + G EP + + L + I + T
Sbjct: 275 HSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 13/31 (41%), Positives = 17/31 (54%)
Query: 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
YD + IG GNF V +L R ++TK V
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELV 48
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-130
Identities = 79/278 (28%), Positives = 139/278 (50%), Gaps = 11/278 (3%)
Query: 211 LLRHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L + V VA+KI+D + + + +E+ I K L+H +++K + ++ Y+
Sbjct: 25 LAVNRVTEEAVAVKIVDMKRAVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
EY + GE+FD I M E A+R F Q+++ V Y H + HRD+K ENLL+D +
Sbjct: 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 328 IKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC 384
+K++DFG + + + L CG+ PY APE+ + +++ +D+WS G+VL ++
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 385 GALPFD--GSTLNSLRDRVLSGRFRIPYF-MSTECESLIRKMLVREPTKRYCIEQIKRHR 441
G LP+D + D + P+ + + +L+ K+LV P+ R I IK+ R
Sbjct: 204 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263
Query: 442 WMAEETPR-LLPPINILGEVKNEPNEQILRLMNSLGID 478
W + + P G V P+ + ++L
Sbjct: 264 WYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFS 301
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 12/34 (35%), Positives = 22/34 (64%)
Query: 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
A V +D+ +T+G+G + V+LA +R+T+ V
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV 35
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-129
Identities = 85/287 (29%), Positives = 142/287 (49%), Gaps = 18/287 (6%)
Query: 213 RHTVN---VAIKIIDKSQL------DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM 263
V +K I K ++ + L KV E+ I+ +++H +IIK+ + E +
Sbjct: 44 VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103
Query: 264 IYIVSE-YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM 322
+V E + + ++F +I R+ R++E A F Q++SAV Y + ++HRD+K EN+++
Sbjct: 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI 163
Query: 323 DSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL 382
+ IKL DFG + Y G+ T+CG+ Y APEV G Y GPE+++WSLGV LY L
Sbjct: 164 AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 383 VCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
V PF + + PY +S E SL+ +L P +R +E++ W
Sbjct: 224 VFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277
Query: 443 MAEETPRLLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAE 489
+ + + V N+P +L SL + +V +A+
Sbjct: 278 VTQPVNLADYTWEEVFRV-NKPESGVLSAA-SLEMGNRSLSDVAQAQ 322
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 8/31 (25%), Positives = 10/31 (32%)
Query: 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
Y +G G F V A + EV
Sbjct: 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEV 52
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 391 bits (1008), Expect = e-127
Identities = 75/253 (29%), Positives = 131/253 (51%), Gaps = 11/253 (4%)
Query: 211 LLRHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267
L + V VA+KI+D + + + +E+ I K L+H +++K + ++ Y+
Sbjct: 25 LAVNRVTEEAVAVKIVDMKRAVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
EY + GE+FD I M E A+R F Q+++ V Y H + HRD+K ENLL+D +
Sbjct: 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 328 IKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC 384
+K++DFG + + + L CG+ PY APE+ + +++ +D+WS G+VL ++
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 385 GALPFD--GSTLNSLRDRVLSGRFRIPYF-MSTECESLIRKMLVREPTKRYCIEQIKRHR 441
G LP+D + D + P+ + + +L+ K+LV P+ R I IK+ R
Sbjct: 204 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263
Query: 442 WMAEETPR-LLPP 453
W + + P
Sbjct: 264 WYNKPLKKGAKRP 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 12/34 (35%), Positives = 22/34 (64%)
Query: 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
A V +D+ +T+G+G + V+LA +R+T+ V
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV 35
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 381 bits (982), Expect = e-123
Identities = 79/277 (28%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 213 RHTVN---VAIKIIDKSQL--DPVNLQKVYREVEIMKQLDHPHIIKLFQVM--ETKSMIY 265
+ A+KI+ K +L P V +E++++++L H ++I+L V+ E K +Y
Sbjct: 25 LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84
Query: 266 IVSEYANQG--EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD 323
+V EY G E+ D + R A F Q++ +EY H++ +VH+D+K NLL+
Sbjct: 85 MVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143
Query: 324 SNLDIKLADFGFSNY---YVPGQKLATWCGSPPYAAPEVFEGKK-YCGPEIDIWSLGVVL 379
+ +K++ G + + T GSP + PE+ G + G ++DIWS GV L
Sbjct: 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 380 YVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
Y + G PF+G + L + + G + IP L++ ML EP KR+ I QI++
Sbjct: 204 YNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 440 HRWMAEETPRLLPPINILGEVKNEPNEQILRLMNSLG 476
H W ++ P P+ I + + R M +
Sbjct: 264 HSWFRKKHPPAEAPVPI---PPSPDTKDRWRSMTVVP 297
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 7/31 (22%), Positives = 13/31 (41%)
Query: 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+G Y + +G+G++ VK T
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRR 33
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-123
Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 17/258 (6%)
Query: 218 VAIKIIDKSQLD----PVNLQKVYREVEIMKQLDH--PHIIKLFQVMETKSMIYIVSEYA 271
VAIK ++K ++ N +V EV ++K++ +I+L E ++ E
Sbjct: 71 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130
Query: 272 N-QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIK 329
++FD+I G + E AR FWQ+L AV +CHN V+HRD+K EN+L+D N ++K
Sbjct: 131 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 190
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
L DFG + G+ Y+ PE +Y G +WSLG++LY +VCG +PF
Sbjct: 191 LIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE-TP 448
+ + ++ G+ +S+EC+ LIR L P+ R E+I+ H WM + P
Sbjct: 250 EH------DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303
Query: 449 RLLPPINILGEVKNEPNE 466
+ I+ L + P++
Sbjct: 304 QETAEIH-LHSLSPGPSK 320
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 8/40 (20%), Positives = 12/40 (30%)
Query: 6 MAENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+A K+ Y + +G G F V V
Sbjct: 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-123
Identities = 73/246 (29%), Positives = 122/246 (49%), Gaps = 17/246 (6%)
Query: 218 VAIKIIDKSQLDPV----NLQKVYREVEIMKQLD----HPHIIKLFQVMETKSMIYIVSE 269
VAIK+I ++++ + EV ++ ++ HP +I+L ET+ +V E
Sbjct: 59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118
Query: 270 YANQG-EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLD 327
++FDYI G + E +R F Q+++A+++CH+R VVHRD+K EN+L+D
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
KL DFG + + G+ Y+ PE +Y +WSLG++LY +VCG +
Sbjct: 179 AKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
PF+ +L P +S +C +LIR+ L +P+ R +E+I WM
Sbjct: 238 PFER------DQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
Query: 448 PRLLPP 453
+
Sbjct: 292 EDVPLN 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 8/39 (20%), Positives = 12/39 (30%)
Query: 7 AENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
K Y + +GKG F V + +V
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV 59
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-114
Identities = 82/248 (33%), Positives = 144/248 (58%), Gaps = 6/248 (2%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNLQK-VYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
L R N +A+K++ KSQL+ ++ + RE+EI L HP+I++++ + IY+
Sbjct: 32 LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
+ E+A +GE++ + ++GR +E + ++ A+ YCH R+V+HRD+K ENLLM
Sbjct: 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG 151
Query: 327 DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386
++K+ADFG+S + P + T CG+ Y PE+ EGK + ++D+W GV+ Y + G
Sbjct: 152 ELKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGM 209
Query: 387 LPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446
PFD + R+++ + P F+S + LI K+L P +R ++ + H W+
Sbjct: 210 PPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269
Query: 447 TPRLLPPI 454
+ R+LPP+
Sbjct: 270 SRRVLPPV 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 15/40 (37%), Positives = 21/40 (52%)
Query: 6 MAENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+AE K + +DI R +GKG F V LAR + K +
Sbjct: 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIM 42
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-112
Identities = 75/249 (30%), Positives = 121/249 (48%), Gaps = 7/249 (2%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNL-QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
+ A KI+ KS L + +K+ E+ I + L H H++ E +++
Sbjct: 33 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
V E + + + R + E AR QI+ +Y H RV+HRDLK NL ++ +L
Sbjct: 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 152
Query: 327 DIKLADFGFSNYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
++K+ DFG + G++ CG+P Y APEV K + E+D+WS+G ++Y L+ G
Sbjct: 153 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVG 211
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
PF+ S L R+ + IP ++ SLI+KML +PT R I ++ +
Sbjct: 212 KPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271
Query: 446 E-TPRLLPP 453
P LP
Sbjct: 272 GYIPARLPI 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 10/33 (30%), Positives = 11/33 (33%)
Query: 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
P Y R +GKG FA TK
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVF 43
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-111
Identities = 75/249 (30%), Positives = 121/249 (48%), Gaps = 7/249 (2%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNL-QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
+ A KI+ KS L + +K+ E+ I + L H H++ E +++
Sbjct: 59 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
V E + + + R + E AR QI+ +Y H RV+HRDLK NL ++ +L
Sbjct: 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 327 DIKLADFGFSNYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
++K+ DFG + G++ CG+P Y APEV K + E+D+WS+G ++Y L+ G
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVG 237
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
PF+ S L R+ + IP ++ SLI+KML +PT R I ++ +
Sbjct: 238 KPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297
Query: 446 E-TPRLLPP 453
P LP
Sbjct: 298 GYIPARLPI 306
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 10/33 (30%), Positives = 11/33 (33%)
Query: 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
P Y R +GKG FA TK
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVF 69
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-110
Identities = 75/265 (28%), Positives = 133/265 (50%), Gaps = 35/265 (13%)
Query: 213 RHTV---NVAIKIIDKSQL------------------------DPVNLQKVYREVEIMKQ 245
+ A+K++ K +L +++VY+E+ I+K+
Sbjct: 33 YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92
Query: 246 LDHPHIIKLFQVME--TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVE 303
LDHP+++KL +V++ + +Y+V E NQG + + ++E+ AR F ++ +E
Sbjct: 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIE 151
Query: 304 YCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-LATWCGSPPYAAPEVFEG 362
Y H ++++HRD+K NLL+ + IK+ADFG SN + L+ G+P + APE
Sbjct: 152 YLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSE 211
Query: 363 --KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF--MSTECES 418
K + G +D+W++GV LY V G PF + L ++ S P ++ + +
Sbjct: 212 TRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKD 271
Query: 419 LIRKMLVREPTKRYCIEQIKRHRWM 443
LI +ML + P R + +IK H W+
Sbjct: 272 LITRMLDKNPESRIVVPEIKLHPWV 296
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 11/38 (28%), Positives = 20/38 (52%)
Query: 8 ENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+ +++ Y ++ IGKG++ VVKLA + T
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYY 41
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 343 bits (882), Expect = e-109
Identities = 84/239 (35%), Positives = 133/239 (55%), Gaps = 7/239 (2%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNL-QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
VAIK+IDK + + Q+V EV+I QL HP I++L+ E + +Y+
Sbjct: 29 RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88
Query: 267 VSEYANQGEIFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
V E + GE+ Y+ R +EN AR QI++ + Y H+ ++HRDL NLL+ N
Sbjct: 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN 148
Query: 326 LDIKLADFGFSNYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC 384
++IK+ADFG + +P +K T CG+P Y +PE+ + G E D+WSLG + Y L+
Sbjct: 149 MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLI 207
Query: 385 GALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
G PFD T+ + ++V+ + +P F+S E + LI ++L R P R + + H +M
Sbjct: 208 GRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 1e-05
Identities = 10/31 (32%), Positives = 16/31 (51%)
Query: 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
++ + + +GKG+FA V A T EV
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEV 39
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-103
Identities = 74/243 (30%), Positives = 137/243 (56%), Gaps = 6/243 (2%)
Query: 211 LLRHTVN---VAIKIIDKSQLDPVNL-QKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
L R + +A+K++ K+QL+ + ++ REVEI L HP+I++L+ + +Y+
Sbjct: 27 LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
+ EYA G ++ + + + +E ++ +A+ YCH++RV+HRD+K ENLL+ S
Sbjct: 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 146
Query: 327 DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386
++K+ADFG+S + P + CG+ Y PE+ EG+ + ++D+WSLGV+ Y + G
Sbjct: 147 ELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGK 204
Query: 387 LPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446
PF+ +T R+ F P F++ LI ++L P++R + ++ H W+
Sbjct: 205 PPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264
Query: 447 TPR 449
+ +
Sbjct: 265 SSK 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 13/37 (35%), Positives = 21/37 (56%)
Query: 9 NKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
+KK + ++I R +GKG F V LAR + +K +
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFIL 37
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-101
Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 47/291 (16%)
Query: 211 LLRHT-VNVAIKIIDKSQL---------------DPVNLQKVYREVEIMKQLDHPHIIKL 254
L A+K +KS L E++I+ + + + +
Sbjct: 49 LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108
Query: 255 FQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENA--------ARRKFWQILSAVEYCH 306
++ +YI+ EY I + + +++N + +L++ Y H
Sbjct: 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH 168
Query: 307 NRR-VVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKK- 364
N + + HRD+K N+LMD N +KL+DFG S Y+ +K+ G+ + PE F +
Sbjct: 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIKGSRGTYEFMPPEFFSNESS 227
Query: 365 YCGPEIDIWSLGVVLYVLVCGALPFDG-STLNSLRDRVLSGRFRIPY------------- 410
Y G ++DIWSLG+ LYV+ +PF +L L + + + P
Sbjct: 228 YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKK 287
Query: 411 ------FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPIN 455
F+S E ++ L + P +R E +H W+A+ L +
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFS 338
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 8/30 (26%), Positives = 13/30 (43%)
Query: 9 NKKAPIRVGFYDIERTIGKGNFAVVKLARH 38
K+ + Y I RT+ +G F + L
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK 52
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = 1e-97
Identities = 92/247 (37%), Positives = 137/247 (55%), Gaps = 13/247 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A K I K ++ ++ + +E+EIMK LDHP+II+L++ E + IY+V E GE+F
Sbjct: 37 RAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF 94
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFG 334
+ + E+ A R +LSAV YCH V HRDLK EN L + + +KL DFG
Sbjct: 95 ERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ + PG+ + T G+P Y +P+V EG Y GPE D WS GV++YVL+CG PF T
Sbjct: 155 LAARFKPGKMMRTKVGTPYYVSPQVLEG-LY-GPECDEWSAGVMMYVLLCGYPPFSAPTD 212
Query: 395 NSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRL 450
+ + ++ G F + +S + ESLIR++L + P +R Q H W ++
Sbjct: 213 SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS- 271
Query: 451 LPPINIL 457
P N+L
Sbjct: 272 -SPRNLL 277
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = 1e-93
Identities = 94/290 (32%), Positives = 145/290 (50%), Gaps = 21/290 (7%)
Query: 218 VAIKIIDKSQL------DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
VAIKII K + + V E+EI+K+L+HP IIK+ + + YIV E
Sbjct: 38 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELM 96
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDI 328
GE+FD + R+ E + F+Q+L AV+Y H ++HRDLK EN+L+ S + I
Sbjct: 97 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 156
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYC--GPEIDIWSLGVVLYVLVCGA 386
K+ DFG S + T CG+P Y APEV +D WSLGV+L++ + G
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 387 LPF-DGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHR 441
PF + T SL+D++ SG+ F + +S + L++K+LV +P R+ E+ RH
Sbjct: 217 PPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 442 WMAEETPRLLPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETS 491
W+ +E + + E L + + + K EAE +
Sbjct: 277 WLQDEDMK----RKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 11/28 (39%), Positives = 15/28 (53%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
Y + +T+G G VKLA R T +V
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKV 38
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 1e-93
Identities = 78/239 (32%), Positives = 125/239 (52%), Gaps = 8/239 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A KII+ +L + QK+ RE I ++L HP+I++L ++ +S Y+V + GE+F
Sbjct: 34 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 93
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFG 334
+ I +E A QIL ++ YCH+ +VHR+LK ENLL+ S +KLADFG
Sbjct: 94 EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 153
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ + + G+P Y +PEV + Y +DIW+ GV+LY+L+ G PF
Sbjct: 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQ 212
Query: 395 NSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
+ L ++ +G + P + ++ E +SLI ML P KR +Q + W+
Sbjct: 213 HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 11/28 (39%), Positives = 17/28 (60%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
YD++ +GKG F+VV+ H+ T E
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEF 34
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 4e-93
Identities = 76/238 (31%), Positives = 127/238 (53%), Gaps = 13/238 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
IK I+K + V ++++ E+E++K LDHP+IIK+F+V E +YIV E GE+
Sbjct: 50 RVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL 108
Query: 278 DYI----ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKL 330
+ I AR ++E Q+++A+ Y H++ VVH+DLK EN+L + IK+
Sbjct: 109 ERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI 168
Query: 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
DFG + + + G+ Y APEVF+ + DIWS GVV+Y L+ G LPF
Sbjct: 169 IDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFT 226
Query: 391 GSTLNSLRDRVLSGRF---RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
G++L ++ + ++ + L+++ML ++P +R Q+ H W +
Sbjct: 227 GTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 4e-91
Identities = 81/253 (32%), Positives = 133/253 (52%), Gaps = 17/253 (6%)
Query: 218 VAIKIIDKSQLDPVNLQK-------VYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSE 269
A+KIID + + ++ +EV+I++++ HP+II+L ET + ++V +
Sbjct: 45 YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD 104
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
+GE+FDY+ ++E R+ +L + H +VHRDLK EN+L+D +++IK
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYC-----GPEIDIWSLGVVLYVLVC 384
L DFGFS PG+KL CG+P Y APE+ E G E+D+WS GV++Y L+
Sbjct: 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 385 GALPFDGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRH 440
G+ PF + ++SG F P + S + L+ + LV +P KRY E+ H
Sbjct: 225 GSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284
Query: 441 RWMAEETPRLLPP 453
+ + +
Sbjct: 285 PFFQQYVVEEVRH 297
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 8/28 (28%), Positives = 15/28 (53%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
Y+ + +G+G +VV+ H+ T E
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEY 45
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 2e-90
Identities = 78/238 (32%), Positives = 125/238 (52%), Gaps = 8/238 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A KII+ +L + QK+ RE I ++L HP+I++L ++ +S Y+V + GE+F
Sbjct: 57 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFG 334
+ I +E A QIL ++ YCH+ +VHR+LK ENLL+ S +KLADFG
Sbjct: 117 EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ + + G+P Y +PEV + Y +DIW+ GV+LY+L+ G PF
Sbjct: 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQ 235
Query: 395 NSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
+ L ++ +G + P + ++ E +SLI ML P KR +Q + W+
Sbjct: 236 HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 11/28 (39%), Positives = 17/28 (60%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
YD++ +GKG F+VV+ H+ T E
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEF 57
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 2e-90
Identities = 51/272 (18%), Positives = 104/272 (38%), Gaps = 48/272 (17%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIYIVSEYANQGE 275
AIK+ + + RE E++K+L+H +I+KLF + E T ++ E+ G
Sbjct: 37 FAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95
Query: 276 IFDYIARYGR---MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDI 328
++ + + E+ ++ + + +VHR++K N++ D
Sbjct: 96 LYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEG--------KKYCGPEIDIWSLGVVLY 380
KL DFG + ++ + G+ Y P+++E KKY G +D+WS+GV Y
Sbjct: 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFY 214
Query: 381 VLVCGALPFD----GSTLNSLRDRVLSGRF-------------------------RIPYF 411
G+LPF + ++++G+ +
Sbjct: 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRG 274
Query: 412 MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
+ ++ +L + K + +Q
Sbjct: 275 LQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 7/29 (24%), Positives = 12/29 (41%)
Query: 17 GFYDIERTIGKGNFAVVKLARHRITKTEV 45
+ + +G+G A V RH+ T
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLF 37
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 2e-89
Identities = 90/239 (37%), Positives = 136/239 (56%), Gaps = 9/239 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K+I+K+ + + REVE++K+LDHP+I+KLF+++E S YIV E GE+F
Sbjct: 50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFG 334
D I + R +E+ A R Q+ S + Y H +VHRDLK EN+L++S + DIK+ DFG
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S + K+ G+ Y APEV Y + D+WS GV+LY+L+ G PF G
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLR-GTY-DEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 395 NSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
+ RV +G+ F +P + +S + + LIRKML P+ R Q H W+ + +
Sbjct: 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 6e-89
Identities = 87/248 (35%), Positives = 134/248 (54%), Gaps = 17/248 (6%)
Query: 218 VAIKIIDKSQL------DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
VAI+II K + + V E+EI+K+L+HP IIK+ + + YIV E
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELM 221
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDI 328
GE+FD + R+ E + F+Q+L AV+Y H ++HRDLK EN+L+ S + I
Sbjct: 222 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 281
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYC--GPEIDIWSLGVVLYVLVCGA 386
K+ DFG S + T CG+P Y APEV +D WSLGV+L++ + G
Sbjct: 282 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 387 LPF-DGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHR 441
PF + T SL+D++ SG+ F + +S + L++K+LV +P R+ E+ RH
Sbjct: 342 PPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 442 WMAEETPR 449
W+ +E +
Sbjct: 402 WLQDEDMK 409
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 11/28 (39%), Positives = 15/28 (53%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
Y + +T+G G VKLA R T +V
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKV 163
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 6e-88
Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 20/249 (8%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP--HIIKLFQVMETKSMIYIVSEYANQGE 275
AIK ++ + D L E+ + +L II+L+ T IY+V E N +
Sbjct: 55 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-ID 113
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ ++ + ++ + + +L AV H +VH DLK N L+ +KL DFG
Sbjct: 114 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 336 SNYYVPGQK---LATWCGSPPYAAPEVFEG----------KKYCGPEIDIWSLGVVLYVL 382
+N P + G+ Y PE + K P+ D+WSLG +LY +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 383 VCGALPFDGST--LNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
G PF ++ L + P + + +++ L R+P +R I ++
Sbjct: 233 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
Query: 440 HRWMAEETP 448
H ++ +T
Sbjct: 293 HPYVQIQTH 301
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 3e-87
Identities = 66/295 (22%), Positives = 117/295 (39%), Gaps = 22/295 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP--HIIKLFQVMETKSMIYIVSEYANQGE 275
AIK ++ + D L E+ + +L II+L+ T IY+V E N +
Sbjct: 83 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-ID 141
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ ++ + ++ + + +L AV H +VH DLK N L+ + +KL DFG
Sbjct: 142 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGI 200
Query: 336 SNYYVPGQK---LATWCGSPPYAAPEVFEGKKY----------CGPEIDIWSLGVVLYVL 382
+N P + G+ Y PE + P+ D+WSLG +LY +
Sbjct: 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 260
Query: 383 VCGALPFDGST--LNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
G PF ++ L + P + + +++ L R+P +R I ++
Sbjct: 261 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
Query: 440 HRWMAEETPRLLPPINILGEVKNEPNEQILRL--MNSLGIDAAKTKEVFEAETSK 492
H ++ +T + E Q++ L NS+ A E + S
Sbjct: 321 HPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESH 375
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 5e-87
Identities = 62/295 (21%), Positives = 118/295 (40%), Gaps = 39/295 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------MIYIVSEYA 271
VAIK + +L P N ++ E++IMK+L+HP+++ +V + + + EY
Sbjct: 42 VAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100
Query: 272 NQGEIFDYIARYGR---MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD- 327
G++ Y+ ++ + E R I SA+ Y H R++HRDLK EN+++
Sbjct: 101 EGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQR 160
Query: 328 --IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
K+ D G++ G+ + G+ Y APE+ E KKY +D WS G + + + G
Sbjct: 161 LIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITG 219
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYFMSTEC------------------------ESLIR 421
PF + + + + + E ++
Sbjct: 220 FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
Query: 422 KMLVREPTKRYCIEQIKRHRWMAE-ETPRLLPPINILGEVKNEPNEQILRLMNSL 475
ML+ +R Q ++ L ++++ V + + +L
Sbjct: 280 CMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENL 334
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 8/31 (25%), Positives = 15/31 (48%)
Query: 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
G ++++ +G G F V H+ T +V
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQV 42
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 5e-87
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 22/298 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP--HIIKLFQVMETKSMIYIVSEYANQGE 275
AIK ++ + D L E+ + +L II+L+ T IY+V E N +
Sbjct: 36 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-ID 94
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ ++ + ++ + + +L AV H +VH DLK N L+ +KL DFG
Sbjct: 95 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGI 153
Query: 336 SNYYVPGQK---LATWCGSPPYAAPEVFEGKKY----------CGPEIDIWSLGVVLYVL 382
+N P + G+ Y PE + P+ D+WSLG +LY +
Sbjct: 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
Query: 383 VCGALPFDGST--LNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
G PF ++ L + P + + +++ L R+P +R I ++
Sbjct: 214 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
Query: 440 HRWMAEETPRLLPPINILGEVKNEPNEQILRL--MNSLGIDAAKTKEVFEAETSKRRT 495
H ++ +T + E Q++ L NS+ A E + S +
Sbjct: 274 HPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSS 331
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 8e-87
Identities = 79/242 (32%), Positives = 129/242 (53%), Gaps = 16/242 (6%)
Query: 218 VAIKIIDKSQLDPV------NLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEY 270
A+KI++ + + RE I++Q+ HPHII L E+ S +++V +
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
+GE+FDY+ ++E R +L AV + H +VHRDLK EN+L+D N+ I+L
Sbjct: 182 MRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241
Query: 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYC-----GPEIDIWSLGVVLYVLVCG 385
+DFGFS + PG+KL CG+P Y APE+ + G E+D+W+ GV+L+ L+ G
Sbjct: 242 SDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
Query: 386 ALPFDGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHR 441
+ PF + ++ G+ F P + S+ + LI ++L +P R EQ +H
Sbjct: 302 SPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361
Query: 442 WM 443
+
Sbjct: 362 FF 363
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 11/28 (39%), Positives = 15/28 (53%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
YD + IG+G +VV+ HR T E
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEF 122
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 282 bits (725), Expect = 1e-86
Identities = 84/253 (33%), Positives = 129/253 (50%), Gaps = 14/253 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K I KS + E+ ++K++ H +I+ L + E+ + Y+V + + GE+F
Sbjct: 37 FALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF 94
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLL---MDSNLDIKLADFG 334
D I G E A Q+LSAV+Y H +VHRDLK ENLL + N I + DFG
Sbjct: 95 DRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S G ++T CG+P Y APEV K Y +D WS+GV+ Y+L+CG PF T
Sbjct: 155 LSKMEQNG-IMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETE 212
Query: 395 NSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRL 450
+ L +++ G F P++ +S + I +L ++P +RY E+ H W+ T
Sbjct: 213 SKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA-- 270
Query: 451 LPPINILGEVKNE 463
+I V +
Sbjct: 271 -LHRDIYPSVSLQ 282
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 7/28 (25%), Positives = 12/28 (42%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
+ +G G F+ V L + R+T
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLF 37
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 2e-86
Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 11/255 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A II+ +L + QK+ RE I + L HP+I++L + + Y++ + GE+F
Sbjct: 39 YAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF 98
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFG 334
+ I +E A QIL AV +CH VVHR+LK ENLL+ S +KLADFG
Sbjct: 99 EDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158
Query: 335 FSNYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
+ Q + G+P Y +PEV Y G +D+W+ GV+LY+L+ G PF
Sbjct: 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDED 217
Query: 394 LNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET-- 447
+ L ++ +G F P + ++ E + LI KML P+KR + +H W++ +
Sbjct: 218 QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTV 277
Query: 448 PRLLPPINILGEVKN 462
+ + +K
Sbjct: 278 ASCMHRQETVDCLKK 292
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 284 bits (727), Expect = 6e-86
Identities = 51/271 (18%), Positives = 104/271 (38%), Gaps = 48/271 (17%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIYIVSEYANQGE 275
AIK+ + + RE E++K+L+H +I+KLF + E T ++ E+ G
Sbjct: 37 FAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95
Query: 276 IFDYIARYGR---MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDI 328
++ + + E+ ++ + + +VHR++K N++ D
Sbjct: 96 LYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEG--------KKYCGPEIDIWSLGVVLY 380
KL DFG + ++ + G+ Y P+++E KKY G +D+WS+GV Y
Sbjct: 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFY 214
Query: 381 VLVCGALPFD----GSTLNSLRDRVLSGRF-------------------------RIPYF 411
G+LPF + ++++G+ +
Sbjct: 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRG 274
Query: 412 MSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
+ ++ +L + K + +Q
Sbjct: 275 LQVLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 7/28 (25%), Positives = 12/28 (42%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
+ + +G+G A V RH+ T
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLF 37
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 4e-84
Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 13/250 (5%)
Query: 218 VAIKIIDKSQL----DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
A K I K +L V+ +++ REV I++++ HP+II L + E K+ + ++ E +
Sbjct: 33 YAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 92
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS----NLDIK 329
GE+FD++A + E+ A + QIL V Y H++R+ H DLK EN+++ N IK
Sbjct: 93 GELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIK 152
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
L DFG ++ G + G+P + APE+ + G E D+WS+GV+ Y+L+ GA PF
Sbjct: 153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPF 211
Query: 390 DGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
G T + + F YF S + IR++LV++P +R I Q H W+
Sbjct: 212 LGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271
Query: 446 ETPRLLPPIN 455
R + +
Sbjct: 272 IRRRNVRGED 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 9/28 (32%), Positives = 15/28 (53%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
Y++ +G G FA+V+ R + T E
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEY 33
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 3e-83
Identities = 71/261 (27%), Positives = 128/261 (49%), Gaps = 19/261 (7%)
Query: 218 VAIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
A+KI+D ++ ++ + + RE I L HPHI++L + + M+Y+V E+ +
Sbjct: 52 FAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA 111
Query: 275 EIFDYIARYGRM----NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLD 327
++ I + +E A QIL A+ YCH+ ++HRD+K +L+ S +
Sbjct: 112 DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAP 171
Query: 328 IKLADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386
+KL FG + G G+P + APEV + + Y G +D+W GV+L++L+ G
Sbjct: 172 VKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGC 230
Query: 387 LPFDGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
LPF G+ L + ++ G+ + +S + L+R+ML+ +P +R + + H W
Sbjct: 231 LPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289
Query: 443 MAEETPRLLPPINILGEVKNE 463
+ E L E +
Sbjct: 290 LKERDR--YAYKIHLPETVEQ 308
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 5e-83
Identities = 92/252 (36%), Positives = 140/252 (55%), Gaps = 11/252 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K+I+K+ + + REVE++K+LDHP+I+KLF+++E S YIV E GE+F
Sbjct: 50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFG 334
D I + R +E+ A R Q+ S + Y H +VHRDLK EN+L++S + DIK+ DFG
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S + K+ G+ Y APEV G Y + D+WS GV+LY+L+ G PF G
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 395 NSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR- 449
+ RV +G+ F +P + +S + + LIRKML P+ R Q H W+ + +
Sbjct: 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287
Query: 450 -LLPPINILGEV 460
+ + L
Sbjct: 288 PTISDLPSLESA 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 274 bits (701), Expect = 5e-83
Identities = 77/289 (26%), Positives = 135/289 (46%), Gaps = 57/289 (19%)
Query: 218 VAIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
AIKI++K+++ +P +++++ EV +MK+L HP+I +L++V E + I +V E + G
Sbjct: 54 RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGG 113
Query: 275 EIFDYIARYGRM----------------------------------------NENAARRK 294
+ D + + E
Sbjct: 114 HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173
Query: 295 FWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADFGFSNYYVP-----GQKLAT 347
QI SA+ Y HN+ + HRD+K EN L + + +IKL DFG S + + T
Sbjct: 174 MRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 348 WCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR 405
G+P + APEV + Y GP+ D WS GV+L++L+ GA+PF G +VL+ +
Sbjct: 234 KAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292
Query: 406 --FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRL 450
F P + +S L+ +L R +R+ + +H W+++ + ++
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 7e-83
Identities = 78/243 (32%), Positives = 126/243 (51%), Gaps = 13/243 (5%)
Query: 218 VAIKIIDKSQL----DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
A K I K + V+ + + REV I+K++ HP++I L +V E K+ + ++ E
Sbjct: 39 YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS----NLDIK 329
GE+FD++A + E A QIL+ V Y H+ ++ H DLK EN+++ IK
Sbjct: 99 GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ DFG ++ G + G+P + APE+ + G E D+WS+GV+ Y+L+ GA PF
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPF 217
Query: 390 DGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
G T V + F YF S + IR++LV++P KR I+ +H W+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
Query: 446 ETP 448
+
Sbjct: 278 KDT 280
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 11/36 (30%), Positives = 18/36 (50%), Gaps = 1/36 (2%)
Query: 10 KKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
++ + +YD +G G FAVVK R + T +
Sbjct: 5 RQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQY 39
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 1e-82
Identities = 79/244 (32%), Positives = 127/244 (52%), Gaps = 13/244 (5%)
Query: 218 VAIKIIDKSQL----DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
A K I K Q V+ +++ REV I++Q+ H ++I L V E ++ + ++ E +
Sbjct: 40 YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS----NLDIK 329
GE+FD++A+ ++E A QIL V Y H +++ H DLK EN+++ IK
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
L DFG ++ G + G+P + APE+ + G E D+WS+GV+ Y+L+ GA PF
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPF 218
Query: 390 DGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
G T + S F +F S + IRK+LV+E KR I++ RH W+
Sbjct: 219 LGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 446 ETPR 449
+
Sbjct: 279 VDNQ 282
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 15/40 (37%), Positives = 20/40 (50%), Gaps = 1/40 (2%)
Query: 6 MAENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
M K+ + FYDI +G G FA+VK R + T E
Sbjct: 2 MEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEY 40
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 2e-82
Identities = 87/254 (34%), Positives = 137/254 (53%), Gaps = 13/254 (5%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+K++ K+ V+ + V E+ ++ +L HP+IIKL ++ ET + I +V E GE+
Sbjct: 80 PYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADF 333
FD I G +E A QIL AV Y H +VHRDLK ENLL + +K+ADF
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G S + T CG+P Y APE+ G Y GPE+D+WS+G++ Y+L+CG PF
Sbjct: 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDER 254
Query: 394 LNS-LRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
+ + R+L+ F P++ +S + L+RK++V +P KR Q +H W+ +
Sbjct: 255 GDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314
Query: 449 RLLPPINILGEVKN 462
+ +++
Sbjct: 315 NFVHMDTAQKKLQE 328
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 5e-82
Identities = 86/292 (29%), Positives = 131/292 (44%), Gaps = 24/292 (8%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+KIIDKS+ D E+EI+ + HP+II L V + +Y+V+E GE+
Sbjct: 50 FAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD----IKLAD 332
D I R +E A + I VEY H + VVHRDLK N+L I++ D
Sbjct: 104 LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICD 163
Query: 333 FGFSNYYVPGQK-LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
FGF+ L T C + + APEV E + Y DIWSLGV+LY ++ G PF
Sbjct: 164 FGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFAN 222
Query: 392 STLNS---LRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444
++ + R+ SG+ Y+ +S + L+ KML +P +R + RH W+
Sbjct: 223 GPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
Query: 445 EETPRLLPPIN--ILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRR 494
+N + +N + + V + ++RR
Sbjct: 283 HWDQLPQYQLNRQDAPHLVKGAMAATYSALNRN--QSPVLEPVGRSTLAQRR 332
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 9/28 (32%), Positives = 16/28 (57%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
Y+++ IG G+++V K H+ T E
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEF 50
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 6e-82
Identities = 67/241 (27%), Positives = 104/241 (43%), Gaps = 11/241 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDH-PHIIKLFQVMETKSMIYIVSEYANQGEI 276
A K + K + ++ E+ +++ P +I L +V E S I ++ EYA GEI
Sbjct: 57 YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI 116
Query: 277 FDYIA--RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLA 331
F ++EN R QIL V Y H +VH DLK +N+L+ DIK+
Sbjct: 117 FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176
Query: 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
DFG S +L G+P Y APE+ D+W++G++ Y+L+ PF G
Sbjct: 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVG 235
Query: 392 STLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
+ + F +S I+ +LV+ P KR E H W+ +
Sbjct: 236 EDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295
Query: 448 P 448
Sbjct: 296 F 296
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 3e-81
Identities = 88/239 (36%), Positives = 130/239 (54%), Gaps = 9/239 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
AIKII K+ + + K+ EV ++K LDHP+I+KL+ E K Y+V E GE+F
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFG 334
D I + NE A Q+LS V Y H +VHRDLK ENLL++S + IK+ DFG
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S + +K+ G+ Y APEV KY + D+WS+GV+L++L+ G PF G T
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTD 242
Query: 395 NSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
+ +V G+ F P + +S + LI++ML + +R +Q H W+ E +
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 3e-81
Identities = 82/293 (27%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+KII K +E+ +K + HP+I+KL +V + ++V E N GE+
Sbjct: 39 FAVKIISKRMEA-----NTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADF 333
F+ I + +E A +++SAV + H+ VVHRDLK ENLL + NL+IK+ DF
Sbjct: 94 FERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153
Query: 334 GFSNYYVP-GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS 392
GF+ P Q L T C + YAAPE+ Y D+WSLGV+LY ++ G +PF
Sbjct: 154 GFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSH 212
Query: 393 TLNSLR-------DRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHR 441
+ ++ G F + +S E + LI+ +L +P KR + ++ +
Sbjct: 213 DRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272
Query: 442 WMAEETPRLLPPINILGEVKNEPNEQILRL------MNSLGIDAAKTKEVFEA 488
W+ + + P+ + + + N + + V +A
Sbjct: 273 WLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKA 325
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 4e-81
Identities = 89/244 (36%), Positives = 137/244 (56%), Gaps = 10/244 (4%)
Query: 218 VAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+K+I K Q+ + + + REV+++KQLDHP+I+KL++ E K Y+V E GE+
Sbjct: 54 CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL 113
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADF 333
FD I R +E A R Q+LS + Y H ++VHRDLK ENLL++S + +I++ DF
Sbjct: 114 FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G S ++ +K+ G+ Y APEV G Y + D+WS GV+LY+L+ G PF+G+
Sbjct: 174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGAN 231
Query: 394 LNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
+ +V G+ F +P + +S + LIRKML P+ R H W+ T
Sbjct: 232 EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291
Query: 450 LLPP 453
+
Sbjct: 292 QISV 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 9e-81
Identities = 80/257 (31%), Positives = 127/257 (49%), Gaps = 13/257 (5%)
Query: 218 VAIKIIDKSQL----DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
A K I K Q V +++ REV I++Q+ HP+II L V E ++ + ++ E +
Sbjct: 40 YAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSG 99
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS----NLDIK 329
GE+FD++A+ ++E A QIL V Y H +++ H DLK EN+++ IK
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
L DFG ++ G + G+P + APE+ + G E D+WS+GV+ Y+L+ GA PF
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPF 218
Query: 390 DGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
G T + + F +F S + IRK+LV+E KR I++ RH W+
Sbjct: 219 LGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 446 ETPRLLPPINILGEVKN 462
+
Sbjct: 279 VDTQQAMVRRESVVNLE 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 15/40 (37%), Positives = 20/40 (50%), Gaps = 1/40 (2%)
Query: 6 MAENKKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
M K+ + FYDI +G G FA+VK R + T E
Sbjct: 2 METFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEY 40
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 3e-80
Identities = 58/259 (22%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-------------METKSMI 264
AIK I ++ L + EV ++ L+H ++++ + ++ KS +
Sbjct: 34 YAIKKIRHTEEK---LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTL 90
Query: 265 YIVSEYANQGEIFDYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD 323
+I EY G ++D I + R F QIL A+ Y H++ ++HRDLK N+ +D
Sbjct: 91 FIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150
Query: 324 SNLDIKLADFGFS---------------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGP 368
+ ++K+ DFG + N L + G+ Y A EV +G +
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE 210
Query: 369 EIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFM----STECESLIRKML 424
+ID++SLG++ + ++ G ++ ++ S P + +IR ++
Sbjct: 211 KIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268
Query: 425 VREPTKRYCIEQIKRHRWM 443
+P KR + W+
Sbjct: 269 DHDPNKRPGARTLLNSGWL 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 5e-80
Identities = 88/254 (34%), Positives = 135/254 (53%), Gaps = 20/254 (7%)
Query: 218 VAIKIIDKSQL-----------DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266
AIK+I KSQ +++Y E+ ++K LDHP+IIKLF V E K Y+
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-- 324
V+E+ GE+F+ I + +E A QILS + Y H +VHRD+K EN+L+++
Sbjct: 124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 325 -NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
L+IK+ DFG S+++ KL G+ Y APEV + KY + D+WS GV++Y+L+
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILL 241
Query: 384 CGALPFDGSTLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKR 439
CG PF G + +V G+ F + +S E + LI+ ML + KR E+
Sbjct: 242 CGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
Query: 440 HRWMAEETPRLLPP 453
RW+ + +
Sbjct: 302 SRWIKKYANNINKS 315
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 3e-79
Identities = 60/266 (22%), Positives = 116/266 (43%), Gaps = 19/266 (7%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
K + D V +E+ I+ H +I+ L + E+ + ++ E+ + +I
Sbjct: 32 TYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88
Query: 277 FDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADF 333
F+ I +NE Q+ A+++ H+ + H D++ EN++ + + IK+ +F
Sbjct: 89 FERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G + PG +P Y APEV + D+WSLG ++YVL+ G PF T
Sbjct: 149 GQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAET 207
Query: 394 LNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
+ + +++ F F +S E + ++LV+E R + +H W+ ++ R
Sbjct: 208 NQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
Query: 450 LLPPINILGEVKNEPNEQILRLMNSL 475
+ K + R ++L
Sbjct: 268 V--------STKVIRTLKHRRYYHTL 285
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 1e-78
Identities = 67/246 (27%), Positives = 112/246 (45%), Gaps = 10/246 (4%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
K I+ ++ V E+ IM QL HP +I L E K + ++ E+ + GE+
Sbjct: 78 VFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 277 FDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADF 333
FD I A +M+E Q +++ H +VH D+K EN++ ++ +K+ DF
Sbjct: 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF 195
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G + P + + + +AAPE+ + + G D+W++GV+ YVL+ G PF G
Sbjct: 196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGED 254
Query: 394 LNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
V F F +S E + I+ +L +EP KR + H W+ +
Sbjct: 255 DLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
Query: 450 LLPPIN 455
L I
Sbjct: 315 LTSRIP 320
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 5e-78
Identities = 79/267 (29%), Positives = 123/267 (46%), Gaps = 39/267 (14%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+KII+K +V+REVE++ Q H ++++L + E + Y+V E G I
Sbjct: 41 YAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADF 333
+I + NE A + SA+++ HN+ + HRDLK EN+L + +K+ DF
Sbjct: 99 LSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDF 158
Query: 334 GFSNYYVPG--------QKLATWCGSPPYAAPEVFEG-----KKYCGPEIDIWSLGVVLY 380
+ +L T CGS Y APEV E Y D+WSLGV+LY
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILY 217
Query: 381 VLVCGALPFDG---------------STLNSLRDRVLSGR--FRIPYF--MSTECESLIR 421
+L+ G PF G + N L + + G+ F + +S + LI
Sbjct: 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS 277
Query: 422 KMLVREPTKRYCIEQIKRHRWMAEETP 448
K+LVR+ +R Q+ +H W+ P
Sbjct: 278 KLLVRDAKQRLSAAQVLQHPWVQGCAP 304
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 1e-77
Identities = 73/239 (30%), Positives = 121/239 (50%), Gaps = 10/239 (4%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
+A KII + + ++V E+ +M QLDH ++I+L+ E+K+ I +V EY + GE+
Sbjct: 116 KLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 277 FDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADF 333
FD I + E QI + + H ++H DLK EN+L + IK+ DF
Sbjct: 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDF 233
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G + Y P +KL G+P + APEV + D+WS+GV+ Y+L+ G PF G
Sbjct: 234 GLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292
Query: 394 LNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
+ +L+ R F +S E + I K+L++E + R + +H W+++
Sbjct: 293 DAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 8e-77
Identities = 72/241 (29%), Positives = 116/241 (48%), Gaps = 14/241 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ--VMETKSMIYIVSEYANQGE 275
+ K +D + Q + EV ++++L HP+I++ + + T + +YIV EY G+
Sbjct: 34 LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD 93
Query: 276 IFDYIARYGRMN----ENAARRKFWQILSAVEYCHNRR-----VVHRDLKAENLLMDSNL 326
+ I + + E R Q+ A++ CH R V+HRDLK N+ +D
Sbjct: 94 LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 153
Query: 327 DIKLADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
++KL DFG + A T+ G+P Y +PE Y + DIWSLG +LY L
Sbjct: 154 NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCAL 212
Query: 386 ALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444
PF + L ++ G+F RIPY S E +I +ML + R +E+I + +
Sbjct: 213 MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
Query: 445 E 445
E
Sbjct: 273 E 273
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 1e-75
Identities = 64/266 (24%), Positives = 120/266 (45%), Gaps = 36/266 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLF-------QVMETKSMIYIVSE 269
A+K + + + + + +EV MK+L HP+I++ + +T +++
Sbjct: 56 YALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113
Query: 270 YANQGEIFDYIARY---GRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDS 324
+G++ +++ + G ++ + + F+Q AV++ H ++ ++HRDLK ENLL+ +
Sbjct: 114 ELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173
Query: 325 NLDIKLADFGFSNYYVPG-------------QKLATWCGSPPYAAPEVFE--GKKYCGPE 369
IKL DFG + ++ T +P Y PE+ + G +
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 370 IDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF--MSTECESLIRKMLVRE 427
DIW+LG +LY+L PF+ R+++G++ IP T SLIR ML
Sbjct: 234 QDIWALGCILYLLCFRQHPFEDGAKL----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVN 289
Query: 428 PTKRYCIEQIKRHRWMAEETPRLLPP 453
P +R I ++ + P
Sbjct: 290 PEERLSIAEVVHQLQEIAAARNVNPK 315
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 7/27 (25%), Positives = 12/27 (44%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
+ R + +G FA V A+ + E
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREY 56
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-74
Identities = 80/266 (30%), Positives = 128/266 (48%), Gaps = 27/266 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET----KSMIYIVSEYAN 272
A+K++ S K +EV+ Q PHI+ + V E K + I+ E
Sbjct: 57 CALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109
Query: 273 QGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLD 327
GE+F I G E A I +A+++ H+ + HRD+K ENLL + +
Sbjct: 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAV 169
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
+KL DFGF+ L T C +P Y APEV +KY D+WSLGV++Y+L+CG
Sbjct: 170 LKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFP 227
Query: 388 PFDGST----LNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKR 439
PF +T ++ R+ G+ F P + +S + + LIR +L +PT+R I Q
Sbjct: 228 PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
Query: 440 HRWMAEETPRLLPPINILGEVKNEPN 465
H W+ + P++ ++ + +
Sbjct: 288 HPWINQSMVVPQTPLHTARVLQEDKD 313
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 257 bits (657), Expect = 3e-74
Identities = 69/238 (28%), Positives = 114/238 (47%), Gaps = 10/238 (4%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
N A K + + + V +E++ M L HP ++ L E + + ++ E+ + GE+
Sbjct: 184 NFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 277 FDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD--IKLADF 333
F+ + + +M+E+ A Q+ + + H VH DLK EN++ + +KL DF
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G + + P Q + G+ +AAPEV EGK G D+WS+GV+ Y+L+ G PF G
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGEN 360
Query: 394 LNSLRDRVLSGR--FRIPYFM--STECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
+ V S F S + + IRK+L+ +P R I Q H W+
Sbjct: 361 DDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 6e-74
Identities = 93/306 (30%), Positives = 142/306 (46%), Gaps = 37/306 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET----KSMIYIVSEYAN 272
A+K++ K REVE+ + PHI+++ V E + + IV E +
Sbjct: 90 FALKMLQDCP-------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142
Query: 273 QGEIFDYIARYGRM--NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLD 327
GE+F I G E A I A++Y H+ + HRD+K ENLL S N
Sbjct: 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 202
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
+KL DFGF+ L T C +P Y APEV +KY D+WSLGV++Y+L+CG
Sbjct: 203 LKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYP 261
Query: 388 PFDG----STLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKR 439
PF + ++ R+ G+ F P + +S E + LIR +L EPT+R I +
Sbjct: 262 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321
Query: 440 HRWMAEETPRLLPPINILGEVKNEPN--EQILRLM------NSLGIDAAKTKEVFEAETS 491
H W+ + T P++ +K + E + M + + K K++ +A
Sbjct: 322 HPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNP 381
Query: 492 ---KRR 494
KRR
Sbjct: 382 LLLKRR 387
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 7e-73
Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 25/249 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV----METKSMIYIVSEYANQ 273
A+K I + + ++ RE ++ + +HP+I++L K +++ + +
Sbjct: 57 YALKRILCHEQQ--DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114
Query: 274 GEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G +++ I R + E+ I +E H + HRDLK N+L+
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV 174
Query: 330 LADFGFSNYYVPG----------QKLATWCGSPPYAAPEVFEGKKYC--GPEIDIWSLGV 377
L D G N Q A + Y APE+F + +C D+WSLG
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGC 234
Query: 378 VLYVLVCGALPFDGSTLNS-LRDRVLSGRFRIPYF--MSTECESLIRKMLVREPTKRYCI 434
VLY ++ G P+D + + IP S+ L+ M+ +P +R I
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI 294
Query: 435 EQIKRHRWM 443
+
Sbjct: 295 PLLLSQLEA 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 3e-72
Identities = 70/309 (22%), Positives = 125/309 (40%), Gaps = 51/309 (16%)
Query: 210 VLLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIY 265
V+ + + VA+K + D E++++ + D HP++I+ + T +Y
Sbjct: 31 VVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85
Query: 266 IVSEYANQGEIFDYIARYGRMNENA-------ARRKFWQILSAVEYCHNRRVVHRDLKAE 318
I E N + D + +EN QI S V + H+ +++HRDLK +
Sbjct: 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 319 NLLMDS-------------NLDIKLADFGFSNYYVPGQ-----KLATWCGSPPYAAPEVF 360
N+L+ + NL I ++DFG GQ L G+ + APE+
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204
Query: 361 EG------KKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRFRIPYF-- 411
E K+ IDI+S+G V Y ++ G PF S ++ G F +
Sbjct: 205 EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK--YSRESNIIRGIFSLDEMKC 262
Query: 412 -----MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINILGEVKNEPNE 466
+ E LI +M+ +P KR ++ RH ++ +L + + ++ E +
Sbjct: 263 LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRD 322
Query: 467 QILRLMNSL 475
L+
Sbjct: 323 PPSALLMKF 331
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-70
Identities = 68/240 (28%), Positives = 124/240 (51%), Gaps = 5/240 (2%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
IK I+ S++ ++ REV ++ + HP+I++ + E +YIV +Y G++F
Sbjct: 52 YVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLF 111
Query: 278 DYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
I E+ F QI A+++ H+R+++HRD+K++N+ + + ++L DFG
Sbjct: 112 KRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGI 171
Query: 336 SNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ +LA G+P Y +PE+ E K Y + DIW+LG VLY L F+ ++
Sbjct: 172 ARVLNSTVELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 395 NSLRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPP 453
+L +++SG F + S + SL+ ++ R P R + I ++A+ + L P
Sbjct: 231 KNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 6e-66
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 8/231 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+K P + + EV +++ HP ++L Q E ++Y+ +E +
Sbjct: 85 YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSL 143
Query: 277 FDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ +G + E L A+ + H++ +VH D+K N+ + KL DFG
Sbjct: 144 QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203
Query: 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA-LPFDGSTL 394
G P Y APE+ +G Y G D++SLG+ + + C LP G
Sbjct: 204 LVELGTAGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGW 261
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
LR L F +S+E S++ ML +P R E + + +
Sbjct: 262 QQLRQGYLPPEF--TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 5e-65
Identities = 59/297 (19%), Positives = 116/297 (39%), Gaps = 29/297 (9%)
Query: 210 VLLRHTVN---VAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIY 265
++ R + VA+K I REV+++++ D HP++I+ F + + Y
Sbjct: 40 IVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94
Query: 266 IVSEYANQGEIFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM-- 322
I E + +Y+ + Q S + + H+ +VHRDLK N+L+
Sbjct: 95 IAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153
Query: 323 ---DSNLDIKLADFGFSNYYVPGQ----KLATWCGSPPYAAPEVFEG---KKYCGPEIDI 372
+ ++DFG G+ + + G+ + APE+ + +DI
Sbjct: 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDI 212
Query: 373 WSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRFRIPYF---MSTECESLIRKMLVREP 428
+S G V Y ++ G+ PF S + + + LI KM+ +P
Sbjct: 213 FSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDP 272
Query: 429 TKRYCIEQIKRHRWMAEETPRLLPPINILGEVKNEPNEQ-ILRLMNSLGIDAAKTKE 484
KR + + +H + +L ++ ++ E + I++ + G K
Sbjct: 273 QKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDW 329
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 222 bits (566), Expect = 3e-64
Identities = 35/283 (12%), Positives = 83/283 (29%), Gaps = 51/283 (18%)
Query: 218 VAIKIIDKSQLDPVNLQKVYRE--------------------------VEIMKQLDHPHI 251
+ + ++ P N K +E +++K +
Sbjct: 101 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 160
Query: 252 IKLFQVMETKSM--IYIVSEYANQ------GEIFDYIARYGRMNENAARRKFWQILSAVE 303
I++ + + + + + + + + +A + Q++ +
Sbjct: 161 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220
Query: 304 YCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVF--- 360
H+ +VH L+ ++++D + L F V S + PE+
Sbjct: 221 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARR 277
Query: 361 -------EGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMS 413
+ + D W+LG+V+Y + C LP + + FR +
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIP 333
Query: 414 TECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPPINI 456
+L+ L R Q + L + +
Sbjct: 334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 376
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-63
Identities = 53/249 (21%), Positives = 109/249 (43%), Gaps = 29/249 (11%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLF----------------QVMETK 261
IK + + +K REV+ + +LDH +I+
Sbjct: 39 YVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT 92
Query: 262 SMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAEN 319
++I E+ ++G + +I + ++++ A F QI V+Y H++++++RDLK N
Sbjct: 93 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152
Query: 320 LLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
+ + +K+ DFG K G+ Y +PE + Y G E+D+++LG++L
Sbjct: 153 IFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLIL 211
Query: 380 YVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
L+ + + G I + ++L++K+L ++P R +I R
Sbjct: 212 AELLHVCDTA--FETSKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
Query: 440 HRWMAEETP 448
+ +++P
Sbjct: 268 TLTVWKKSP 276
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-63
Identities = 78/258 (30%), Positives = 117/258 (45%), Gaps = 47/258 (18%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET----KSMIYIVSEYAN 272
A+K++ K REVE+ + PHI+++ V E + + IV E +
Sbjct: 46 FALKMLQDCP-------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98
Query: 273 QGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLD 327
GE+F I G E A I A++Y H+ + HRD+K ENLL S N
Sbjct: 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 158
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
+KL DFGF A E G+KY D+WSLGV++Y+L+CG
Sbjct: 159 LKLTDFGF--------------------AKET-TGEKY-DKSCDMWSLGVIMYILLCGYP 196
Query: 388 PFDG----STLNSLRDRVLSGR--FRIPYF--MSTECESLIRKMLVREPTKRYCIEQIKR 439
PF + ++ R+ G+ F P + +S E + LIR +L EPT+R I +
Sbjct: 197 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
Query: 440 HRWMAEETPRLLPPINIL 457
H W+ + T P++
Sbjct: 257 HPWIMQSTKVPQTPLHTS 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-61
Identities = 75/241 (31%), Positives = 122/241 (50%), Gaps = 25/241 (10%)
Query: 219 AIKIIDKSQLDPVNLQKV---YREVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
AIKI++K + + KV RE ++M +LDHP +KL FQ +Y YA
Sbjct: 59 AIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ---DDEKLYFGLSYAK 113
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
GE+ YI + G +E R F+ +I+SA+EY H + ++HRDLK EN+L++ ++ I++
Sbjct: 114 NGELLKYIRKIGSFDETCTR--FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQI 171
Query: 331 ADFGFSNYYVPGQKLA---TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
DFG + P K A ++ G+ Y +PE+ K D+W+LG ++Y LV G
Sbjct: 172 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLP 230
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY------CIEQIKRHR 441
PF + +++ + P + L+ K+LV + TKR +K H
Sbjct: 231 PFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
Query: 442 W 442
+
Sbjct: 291 F 291
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-60
Identities = 61/241 (25%), Positives = 124/241 (51%), Gaps = 21/241 (8%)
Query: 219 AIKIIDKSQLDPVNLQKV---YREVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
A+K ++K + V +V ++E++IM+ L+HP ++ L FQ + +++V +
Sbjct: 44 AMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ---DEEDMFMVVDLLL 98
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G++ ++ + E + + +++ A++Y N+R++HRD+K +N+L+D + + +
Sbjct: 99 GGDLRYHLQQNVHFKEETVK--LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHI 156
Query: 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCG--PEIDIWSLGVVLYVLVCGALP 388
DF + ++ T G+ PY APE+F +K G +D WSLGV Y L+ G P
Sbjct: 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
Query: 389 FDGSTLNSLRD---RVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-CIEQIKRHRWMA 444
+ + S ++ + P S E SL++K+L P +R+ + ++ +M
Sbjct: 217 YHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
Query: 445 E 445
+
Sbjct: 277 D 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-59
Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 11/239 (4%)
Query: 218 VAIKIID-KSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VA+K + +D +E++++KQL+HP++IK + + + IV E A+ G++
Sbjct: 60 VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 277 FDYIARYGRMN----ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
I + + E + F Q+ SA+E+ H+RRV+HRD+K N+ + + +KL D
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGD 179
Query: 333 FGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
G ++ A + G+P Y +PE Y + DIWSLG +LY + PF G
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYG 238
Query: 392 STLN--SLRDRVLSGRF-RIPY-FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446
+N SL ++ + +P S E L+ + +P KR + +
Sbjct: 239 DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 4e-57
Identities = 79/234 (33%), Positives = 132/234 (56%), Gaps = 17/234 (7%)
Query: 219 AIKIIDKSQLDPVNLQKV---YREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A+KI+DK ++ V L+++ E I++ ++ P ++KL + S +Y+V EY GE
Sbjct: 70 AMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+F ++ R GR +E AR F+ QI+ EY H+ +++RDLK ENLL+D I++ DF
Sbjct: 128 MFSHLRRIGRFSEPHAR--FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
GF+ + T CG+P APE+ K Y +D W+LGV++Y + G PF
Sbjct: 186 GFAKRV--KGRTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 394 LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-----CIEQIKRHRW 442
+ ++++SG+ R P S++ + L+R +L + TKR+ + IK H+W
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-56
Identities = 32/271 (11%), Positives = 69/271 (25%), Gaps = 45/271 (16%)
Query: 218 VAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVM------------------ 258
A+K+ L++++ +L +
Sbjct: 90 FALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA 149
Query: 259 --------ETKSMIYIVSEYA-----NQGEIFDYIARYGRMNENAARRKFW-QILSAVEY 304
+ ++ A D++ + A Q++
Sbjct: 150 QLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209
Query: 305 CHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKK 364
++ +VH +NL + + + L D G + YA E
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK--VGTRGPASSVPVTYAPREFLNAST 267
Query: 365 YC-GPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR---------FRIPYFMST 414
++ W LG+ +Y + C LPF T F +
Sbjct: 268 ATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD 327
Query: 415 ECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
++LI + L + +R + +
Sbjct: 328 FVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-56
Identities = 57/258 (22%), Positives = 102/258 (39%), Gaps = 35/258 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------------SMIY 265
AIK I + + +KV REV+ + +L+HP I++ F K +Y
Sbjct: 33 YAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY 91
Query: 266 IVSEYANQGEIFDYIARYGRMN---ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM 322
I + + + D++ + + F QI AVE+ H++ ++HRDLK N+
Sbjct: 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF 151
Query: 323 DSNLDIKLADFGFS-------------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPE 369
+ +K+ DFG + G+ Y +PE G Y +
Sbjct: 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHK 210
Query: 370 IDIWSLGVVLYVLVCGALPFD-GSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVRE 427
+DI+SLG++L+ L+ PF V + +F + +++ ML
Sbjct: 211 VDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPS 267
Query: 428 PTKRYCIEQIKRHRWMAE 445
P +R I + +
Sbjct: 268 PMERPEAINIIENAVFED 285
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 74/240 (30%), Positives = 127/240 (52%), Gaps = 23/240 (9%)
Query: 219 AIKIIDKSQLDPVNLQKVYR---EVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
A+K++ K + V L++V E ++ + HP II++ FQ I+++ +Y
Sbjct: 35 AMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ---DAQQIFMIMDYIE 89
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
GE+F + + R A+ F+ ++ A+EY H++ +++RDLK EN+L+D N IK+
Sbjct: 90 GGELFSLLRKSQRFPNPVAK--FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKI 147
Query: 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
DFGF+ Y T CG+P Y APEV K Y ID WS G+++Y ++ G PF
Sbjct: 148 TDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFY 204
Query: 391 GSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-----CIEQIKRHRWMAE 445
S +++L+ R P F + + + L+ +++ R+ ++R E +K H W E
Sbjct: 205 DSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 4e-54
Identities = 41/276 (14%), Positives = 85/276 (30%), Gaps = 29/276 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
+K+ + P + +E +K +K + ++ +V E + G +
Sbjct: 98 FVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 278 DYIARYGR-----MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---------- 322
+ I Y M + ++L +E H+ ++H D+K +N ++
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 323 -DSNLDIKLADFGFS---NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
D + + L D G S + G C + + E+ K + +ID + +
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAAT 274
Query: 379 LYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIK 438
+Y ++ G + + L R ML +
Sbjct: 275 VYCMLFGTYMKVKNEGGECKPEGLFRR----LPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330
Query: 439 RHRWMAEETPRLLPPINILGEVKNEPNEQILRLMNS 474
R + I L +N +L S
Sbjct: 331 RQKLKKVFQQHYTNKIRAL---RNRLIVLLLECKRS 363
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 5e-54
Identities = 65/242 (26%), Positives = 123/242 (50%), Gaps = 29/242 (11%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVE-------IMKQLDHPHIIKL---FQVMETKSMIYIVS 268
A+K++ K+ + ++ ++ I++++ HP I+ L FQ T +Y++
Sbjct: 49 AMKVLKKAMI----VRNA-KDTAHTKAERNILEEVKHPFIVDLIYAFQ---TGGKLYLIL 100
Query: 269 EYANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
EY + GE+F + R G E+ A F+ +I A+ + H + +++RDLK EN++++
Sbjct: 101 EYLSGGELFMQLEREGIFMEDTAC--FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG 158
Query: 327 DIKLADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
+KL DFG + G T+CG+ Y APE+ + +D WSLG ++Y ++ G
Sbjct: 159 HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTG 217
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRH 440
A PF G D++L + +P +++ E L++K+L R R +++ H
Sbjct: 218 APPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277
Query: 441 RW 442
+
Sbjct: 278 PF 279
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-53
Identities = 70/241 (29%), Positives = 126/241 (52%), Gaps = 29/241 (12%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVE------IMKQLDHPHIIKL---FQVMETKSMIYIVSE 269
A+K++ K+ L + V I+ +++HP I+KL FQ T+ +Y++ +
Sbjct: 56 AMKVLKKATL----KVR--DRVRTKMERDILVEVNHPFIVKLHYAFQ---TEGKLYLILD 106
Query: 270 YANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ G++F +++ E + F+ ++ A+++ H+ +++RDLK EN+L+D
Sbjct: 107 FLRGGDLFTRLSKEVMFTEEDVK--FYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 164
Query: 328 IKLADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386
IKL DFG S + +K ++CG+ Y APEV + + D WS GV+++ ++ G
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223
Query: 387 LPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRHR 441
LPF G +L + +P F+S E +SL+R + R P R +E+IKRH
Sbjct: 224 LPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283
Query: 442 W 442
+
Sbjct: 284 F 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-52
Identities = 90/259 (34%), Positives = 135/259 (52%), Gaps = 36/259 (13%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVE-------IMKQLDHPHIIKL---FQVMETKSMIYIVS 268
A+KI+ K + + K EV +++ HP + L FQ T + V
Sbjct: 34 AMKILRKEVI----IAK--DEVAHTVTESRVLQNTRHPFLTALKYAFQ---THDRLCFVM 84
Query: 269 EYANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
EYAN GE+F +++R E AR F+ +I+SA+EY H+R VV+RD+K ENL++D +
Sbjct: 85 EYANGGELFFHLSRERVFTEERAR--FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 142
Query: 327 DIKLADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
IK+ DFG + G + T+CG+P Y APEV E Y G +D W LGVV+Y ++CG
Sbjct: 143 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCG 201
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRH 440
LPF L + +L R P +S E +SL+ +L ++P +R +++ H
Sbjct: 202 RLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 441 R------WMAEETPRLLPP 453
R W +LLPP
Sbjct: 262 RFFLSINWQDVVQKKLLPP 280
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 5e-52
Identities = 36/278 (12%), Positives = 85/278 (30%), Gaps = 48/278 (17%)
Query: 218 VAIKIIDKSQLDPVN-LQKVYREVEIMKQL----------------------DHPHIIKL 254
+ + ++ P N ++++ EV ++ L P K+
Sbjct: 106 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 165
Query: 255 FQVMETKSMIYIVSEYANQ-----------GEIFDYIARYGRMNENAARRKFWQILSAVE 303
+V + ++++S + + + + + + +A + Q++ +
Sbjct: 166 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225
Query: 304 YCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC----GSPPYAAPEV 359
H+ +VH L+ ++++D + L F G + P A +
Sbjct: 226 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERM 283
Query: 360 FEGKKY----CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTE 415
++ D W+LG+ +Y + C LP + + IP
Sbjct: 284 LPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP----QP 339
Query: 416 CESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPP 453
+L+ L R Q + L
Sbjct: 340 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 377
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-51
Identities = 74/234 (31%), Positives = 120/234 (51%), Gaps = 17/234 (7%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
AIK + K D V V + V + +HP + + FQ TK ++ V EY N
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHMFCTFQ---TKENLFFVMEYLN 101
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G++ +I + + + A F+ +I+ +++ H++ +V+RDLK +N+L+D + IK+
Sbjct: 102 GGDLMYHIQSCHKFDLSRAT--FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 159
Query: 331 ADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
ADFG + K T+CG+P Y APE+ G+KY +D WS GV+LY ++ G PF
Sbjct: 160 ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPF 218
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-CIEQIKRHRW 442
G L + P ++ E + L+ K+ VREP KR I++H
Sbjct: 219 HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-50
Identities = 82/240 (34%), Positives = 131/240 (54%), Gaps = 25/240 (10%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVE-------IMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
A+KI+ K + + K EV +++ HP + L +T + V EYA
Sbjct: 177 AMKILKKEVI----VAK--DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230
Query: 272 NQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRR-VVHRDLKAENLLMDSNLDI 328
N GE+F +++R +E+ AR F+ +I+SA++Y H+ + VV+RDLK ENL++D + I
Sbjct: 231 NGGELFFHLSRERVFSEDRAR--FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288
Query: 329 KLADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
K+ DFG + G + T+CG+P Y APEV E Y G +D W LGVV+Y ++CG L
Sbjct: 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL 347
Query: 388 PFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRHRW 442
PF L + +L R P + E +SL+ +L ++P +R ++I +HR+
Sbjct: 348 PFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-50
Identities = 74/237 (31%), Positives = 117/237 (49%), Gaps = 20/237 (8%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
A+K++ K + R V ++K + HP ++ L FQ T +Y V +Y N
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGLHFSFQ---TADKLYFVLDYIN 122
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
GE+F ++ R E AR F+ +I SA+ Y H+ +V+RDLK EN+L+DS I L
Sbjct: 123 GGELFYHLQRERCFLEPRAR--FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180
Query: 331 ADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
DFG + +T+CG+P Y APEV + Y +D W LG VLY ++ G PF
Sbjct: 181 TDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPF 239
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-C---IEQIKRHRW 442
+ D +L+ ++ ++ L+ +L ++ TKR +IK H +
Sbjct: 240 YSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-50
Identities = 68/249 (27%), Positives = 130/249 (52%), Gaps = 35/249 (14%)
Query: 219 AIKIIDKSQLDPVNLQKVYREVE-------IMKQLDH-PHIIKL---FQVMETKSMIYIV 267
A+K++ K+ + +QK + E +++ + P ++ L FQ T++ ++++
Sbjct: 86 AMKVLKKATI----VQKA-KTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---TETKLHLI 137
Query: 268 SEYANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSN 325
+Y N GE+F ++++ R E+ + + +I+ A+E+ H +++RD+K EN+L+DSN
Sbjct: 138 LDYINGGELFTHLSQRERFTEHEVQ--IYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 326 LDIKLADFGFS--NYYVPGQKLATWCGSPPYAAPEVFEGKKY-CGPEIDIWSLGVVLYVL 382
+ L DFG S ++ +CG+ Y AP++ G +D WSLGV++Y L
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 383 VCGALPFDGSTLNSLR----DRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-----C 433
+ GA PF + + R+L P MS + LI+++L+++P KR
Sbjct: 256 LTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRD 315
Query: 434 IEQIKRHRW 442
++IK H +
Sbjct: 316 ADEIKEHLF 324
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-50
Identities = 71/239 (29%), Positives = 126/239 (52%), Gaps = 22/239 (9%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
A+K++ K Q D V + + + +HP + +L FQ T ++ V E+ N
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRI-LSLARNHPFLTQLFCCFQ---TPDRLFFVMEFVN 107
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G++ +I + R +E AR F+ +I+SA+ + H++ +++RDLK +N+L+D KL
Sbjct: 108 GGDLMFHIQKSRRFDEARAR--FYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKL 165
Query: 331 ADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
ADFG + G AT+CG+P Y APE+ + Y GP +D W++GV+LY ++CG PF
Sbjct: 166 ADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPF 224
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR------YCIEQIKRHRW 442
+ + L + +L+ P ++ + +++ + + PT R I RH +
Sbjct: 225 EAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-49
Identities = 76/255 (29%), Positives = 122/255 (47%), Gaps = 27/255 (10%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
A+KI+ K Q D V V + V + P + +L FQ T +Y V EY N
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLHSCFQ---TMDRLYFVMEYVN 104
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G++ +I + GR E A F+ +I + + ++ +++RDLK +N+++DS IK+
Sbjct: 105 GGDLMYHIQQVGRFKEPHAV--FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 162
Query: 331 ADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
ADFG + G T+CG+P Y APE+ + Y G +D W+ GV+LY ++ G PF
Sbjct: 163 ADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPF 221
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRHR--- 441
+G + L ++ P MS E ++ + ++ + P KR IK H
Sbjct: 222 EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
Query: 442 ---WMAEETPRLLPP 453
W E + PP
Sbjct: 282 YIDWEKLERKEIQPP 296
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-49
Identities = 57/240 (23%), Positives = 106/240 (44%), Gaps = 13/240 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLF----QVMETKSMIYIVSEYANQ 273
VA + +L Q+ E E++K L HP+I++ + ++ K I +V+E
Sbjct: 54 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS 113
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDSNL-DIKL 330
G + Y+ R+ M R QIL +++ H R ++HRDLK +N+ + +K+
Sbjct: 114 GTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173
Query: 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF- 389
D G + G+P + APE++E K +D+++ G+ + + P+
Sbjct: 174 GDLGLAT-LKRASFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYS 230
Query: 390 DGSTLNSLRDRVLSGR--FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
+ + RV SG E + +I + + +RY I+ + H + EET
Sbjct: 231 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 33/252 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
AIK K V+ Q REV L H H+++ F + I +EY N G +
Sbjct: 39 YAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 98
Query: 277 FDYIARYGR----MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI---- 328
D I+ R E + Q+ + Y H+ +VH D+K N+ +
Sbjct: 99 ADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158
Query: 329 ---------------KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIW 373
K+ D G G + A EV + P+ DI+
Sbjct: 159 EEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEGDSRFLANEVLQENYTHLPKADIF 215
Query: 374 SLGVVLYVLVCGA-LPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKR 431
+L + + LP +G + +R GR RIP +S E L++ M+ +P +R
Sbjct: 216 ALALTVVCAAGAEPLPRNGDQWHEIR----QGRLPRIPQVLSQEFTELLKVMIHPDPERR 271
Query: 432 YCIEQIKRHRWM 443
+ +H +
Sbjct: 272 PSAMALVKHSVL 283
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-48
Identities = 78/265 (29%), Positives = 138/265 (52%), Gaps = 37/265 (13%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
A+K++ K + ++ + + V + +HP ++ L FQ T+S ++ V EY N
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGLHSCFQ---TESRLFFVIEYVN 93
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G++ ++ R ++ E AR F+ +I A+ Y H R +++RDLK +N+L+DS IKL
Sbjct: 94 GGDLMFHMQRQRKLPEEHAR--FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKL 151
Query: 331 ADFGFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
D+G + PG +T+CG+P Y APE+ G+ Y G +D W+LGV+++ ++ G PF
Sbjct: 152 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPF 210
Query: 390 ---------DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR------YCI 434
D +T + L +L + RIP +S + S+++ L ++P +R
Sbjct: 211 DIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGF 270
Query: 435 EQIKRHR------WMAEETPRLLPP 453
I+ H W E +++PP
Sbjct: 271 ADIQGHPFFRNVDWDMMEQKQVVPP 295
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-48
Identities = 65/245 (26%), Positives = 122/245 (49%), Gaps = 31/245 (12%)
Query: 219 AIKIIDKSQLDPVNLQKVYR---EVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
A+K++ K ++ + E +IM + P +++L FQ +Y+V EY
Sbjct: 98 AMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ---DDRYLYMVMEYMP 152
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G++ + ++ Y + E AR F+ +++ A++ H+ +HRD+K +N+L+D + +KL
Sbjct: 153 GGDLVNLMSNY-DVPEKWAR--FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 209
Query: 331 ADFGFSNYYVPGQKLATW--CGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVC 384
ADFG + G+P Y +PEV + + Y G E D WS+GV LY ++
Sbjct: 210 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY-GRECDWWSVGVFLYEMLV 268
Query: 385 GALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYC---IEQI 437
G PF +L ++++ + + + +S E ++LI + + R +E+I
Sbjct: 269 GDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRLGRNGVEEI 327
Query: 438 KRHRW 442
KRH +
Sbjct: 328 KRHLF 332
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-47
Identities = 61/238 (25%), Positives = 111/238 (46%), Gaps = 17/238 (7%)
Query: 219 AIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A K ++K ++ + E +I+++++ ++ L ETK + +V N G+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALN--EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ +I G+ AR F+ +I +E H R+V+RDLK EN+L+D + I+++D
Sbjct: 271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDL 330
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G + + GQ + G+ Y APEV + ++Y D W+LG +LY ++ G PF
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRK 389
Query: 394 LNSLRD----RVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRHRW 442
R+ V S + SL ++L ++P +R ++K H
Sbjct: 390 KKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-47
Identities = 75/262 (28%), Positives = 137/262 (52%), Gaps = 31/262 (11%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A++++ K + ++ + + V + +HP ++ L +T+S ++ V EY N G+
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD 139
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ ++ R ++ E AR F+ +I A+ Y H R +++RDLK +N+L+DS IKL D+
Sbjct: 140 LMFHMQRQRKLPEEHAR--FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 334 GFSNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF--- 389
G + PG +T+CG+P Y APE+ G+ Y G +D W+LGV+++ ++ G PF
Sbjct: 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIV 256
Query: 390 ------DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR------YCIEQI 437
D +T + L +L + RIP +S + S+++ L ++P +R I
Sbjct: 257 GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADI 316
Query: 438 KRHR------WMAEETPRLLPP 453
+ H W E +++PP
Sbjct: 317 QGHPFFRNVDWDMMEQKQVVPP 338
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-47
Identities = 66/247 (26%), Positives = 122/247 (49%), Gaps = 31/247 (12%)
Query: 219 AIKIIDKSQLDPVNLQKVYR---EVEIMKQLDHPHIIKL---FQVMETKSMIYIVSEYAN 272
A+KI++K ++ + + E +++ D I L FQ + +Y+V +Y
Sbjct: 103 AMKILNKWEM--LKRAETACFREERDVLVNGDSKWITTLHYAFQ---DDNNLYLVMDYYV 157
Query: 273 QGEIFDYIARY-GRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G++ ++++ R+ E AR F+ +++ A++ H VHRD+K +N+LMD N I+
Sbjct: 158 GGDLLTLLSKFEDRLPEEMAR--FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 215
Query: 330 LADFGFSNYYVPGQKLATW--CGSPPYAAPEVFEGKKYC----GPEIDIWSLGVVLYVLV 383
LADFG + + + G+P Y +PE+ + + GPE D WSLGV +Y ++
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 384 CGALPFDGSTLNSLRDRVLSGRFRIPY-----FMSTECESLIRKMLVREPTKRY---CIE 435
G PF +L ++++ + R + +S + LIR+++ R IE
Sbjct: 276 YGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS-REHRLGQNGIE 334
Query: 436 QIKRHRW 442
K+H +
Sbjct: 335 DFKKHPF 341
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 9e-47
Identities = 58/244 (23%), Positives = 109/244 (44%), Gaps = 23/244 (9%)
Query: 219 AIKIIDKSQLDPVNLQKVYR---EVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A+KI++K + + +V E +++ D I +L + ++ +Y+V EY G+
Sbjct: 90 AMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGD 147
Query: 276 IFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ ++++G R+ AR +I+ A++ H VHRD+K +N+L+D I+LADFG
Sbjct: 148 LLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207
Query: 335 FSNYYVPGQKLATW--CGSPPYAAPEVFEGKKYC------GPEIDIWSLGVVLYVLVCGA 386
+ + G+P Y +PE+ + GPE D W+LGV Y + G
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 387 LPFDGSTLNSLRDRVLSGRFRIPY-----FMSTECESLIRKMLVREPTKRY---CIEQIK 438
PF + +++ + + + E I++ L+ P R +
Sbjct: 268 TPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFR 326
Query: 439 RHRW 442
H +
Sbjct: 327 THPF 330
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-46
Identities = 58/238 (24%), Positives = 111/238 (46%), Gaps = 17/238 (7%)
Query: 219 AIKIIDKSQL---DPVNLQKVYREV-EIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
A+K +DK ++ L R + ++ D P I+ + T + + + N G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 275 EIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
++ +++++G +E R F+ +I+ +E+ HNR VV+RDLK N+L+D + ++++D
Sbjct: 278 DLHYHLSQHGVFSEADMR--FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 335
Query: 333 FGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS 392
G + +K G+ Y APEV + D +SLG +L+ L+ G PF
Sbjct: 336 LGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394
Query: 393 T---LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-----CIEQIKRHRW 442
+ + L+ +P S E SL+ +L R+ +R +++K +
Sbjct: 395 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-46
Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 24/243 (9%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A K ++K + V E +I+ ++ I+ L ETK+ + +V N G+
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMV--EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD 271
Query: 276 IFDYI----ARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
I +I E A F+ QI+S +E+ H R +++RDLK EN+L+D + +++
Sbjct: 272 IRYHIYNVDEDNPGFQEPRAI--FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329
Query: 330 LADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
++D G + GQ + G+P + APE+ G++Y +D ++LGV LY ++ P
Sbjct: 330 ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGP 388
Query: 389 FDG----STLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-----CIEQIKR 439
F L+ RVL P S + +L ++P KR + ++
Sbjct: 389 FRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 440 HRW 442
H
Sbjct: 449 HPL 451
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-45
Identities = 73/250 (29%), Positives = 119/250 (47%), Gaps = 17/250 (6%)
Query: 219 AIKIIDKS---QLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
A+KI+ K Q D V V + V + P + +L +T +Y V EY N G+
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ +I + GR E A +I + + ++ +++RDLK +N+++DS IK+ADFG
Sbjct: 429 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 336 SNYYV-PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G T+CG+P Y APE+ + Y G +D W+ GV+LY ++ G PF+G
Sbjct: 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE 547
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKR-----YCIEQIKRHR------WM 443
+ L ++ P MS E ++ + ++ + P KR IK H W
Sbjct: 548 DELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607
Query: 444 AEETPRLLPP 453
E + PP
Sbjct: 608 KLERKEIQPP 617
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 9/222 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+KI+ + + + REV IMK+L HP+I+ + + IV+EY ++G ++
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 278 DYIARYGRMNENAARRKF---WQILSAVEYCHNRR--VVHRDLKAENLLMDSNLDIKLAD 332
+ + G + RR+ + + + Y HNR +VHR+LK+ NLL+D +K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 333 FGFSNYYVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
FG S + G+P + APEV + + D++S GV+L+ L P+
Sbjct: 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGN 241
Query: 392 STLNSLRDRVLSGRFR--IPYFMSTECESLIRKMLVREPTKR 431
+ V R IP ++ + ++I EP KR
Sbjct: 242 LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-43
Identities = 48/259 (18%), Positives = 92/259 (35%), Gaps = 22/259 (8%)
Query: 203 RSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS 262
+ + + + D P + ++ M + + Q K
Sbjct: 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKV 134
Query: 263 MIYIVSEYANQGEIFDYIARYGRM---NENAARRKFWQILSAVEYCHNRRVVHRDLKAEN 319
+YI + + + D++ R + F QI AVE+ H++ ++HRDLK N
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSN 194
Query: 320 LLMDSNLDIKLADFGFS-------------NYYVPGQKLATWCGSPPYAAPEVFEGKKYC 366
+ + +K+ DFG G+ Y +PE G Y
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY- 253
Query: 367 GPEIDIWSLGVVLYVLVCGALPFD-GSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKML 424
++DI+SLG++L+ L+ F + V + +F + + +++ ML
Sbjct: 254 SHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDML 310
Query: 425 VREPTKRYCIEQIKRHRWM 443
PT+R I +
Sbjct: 311 SPSPTERPEATDIIENAIF 329
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 32/251 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A+K + E+ L P I+ L+ + + I E G +
Sbjct: 86 CAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFS 336
I + G + E+ A Q L +EY H RR++H D+KA+N+L+ S+ L DFG +
Sbjct: 139 QLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 337 ------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
G+ + APEV GK ++DIWS ++ ++ G P+
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPW- 256
Query: 391 GSTLNSLRDRVLSGRFRI----------PYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
+ + +I P + I++ L +EP R +++R
Sbjct: 257 -TQYFRG--PLC---LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310
Query: 441 RWMAEETPRLL 451
A + L
Sbjct: 311 VGKALQEVGGL 321
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 48/235 (20%), Positives = 103/235 (43%), Gaps = 13/235 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K+++ + P LQ EV ++++ H +I+ T + IV+++ ++
Sbjct: 49 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLY 107
Query: 278 DYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
++ E Q ++Y H + ++HRDLK+ N+ + + +K+ DFG +
Sbjct: 108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
Query: 337 ---NYYVPGQKLATWCGSPPYAAPEVFEGKKY--CGPEIDIWSLGVVLYVLVCGALPFDG 391
+ + + GS + APEV + + D+++ G+VLY L+ G LP+
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
Query: 392 -STLNSLRDRVLSGRFR-----IPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
+ + + + V G + + L+ + L ++ +R +I
Sbjct: 228 INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 32/230 (13%), Positives = 89/230 (38%), Gaps = 14/230 (6%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIYIVSEYANQGE 275
+ +K++ + E ++ HP+++ + ++ +++ + G
Sbjct: 36 IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95
Query: 276 IFDYIARYGRMNENAARRKFW--QILSAVEYCHNRR--VVHRDLKAENLLMDSNLDIKLA 331
+++ + + ++ + + + + H + L + ++++D ++ +++
Sbjct: 96 LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155
Query: 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKY--CGPEIDIWSLGVVLYVLVCGALPF 389
+ + +P + APE + K D+WS V+L+ LV +PF
Sbjct: 156 MADVKFSFQSPGR----MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
Query: 390 DGSTLNSLRDRVLSGRFR--IPYFMSTECESLIRKMLVREPTKRYCIEQI 437
+ + +V R IP +S L++ + +P KR + I
Sbjct: 212 ADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 77/266 (28%), Positives = 116/266 (43%), Gaps = 44/266 (16%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK +S+ DPV + RE+ ++KQL HP+++ L +V K +++V EY + +
Sbjct: 31 VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVL 89
Query: 278 DYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ RY R + WQ L AV +CH +HRD+K EN+L+ + IKL DFGF+
Sbjct: 90 HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA 149
Query: 337 -NYYVPGQKL----AT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
P AT W Y +PE+ G GP +D+W++G V L+ G +
Sbjct: 150 RLLTGPSDYYDDEVATRW-----YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204
Query: 391 GS-----------TLNSLRDRVLSGRFRIPYF--------------------MSTECESL 419
G TL L R YF +S L
Sbjct: 205 GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGL 264
Query: 420 IRKMLVREPTKRYCIEQIKRHRWMAE 445
++ L +PT+R EQ+ H +
Sbjct: 265 LKGCLHMDPTERLTCEQLLHHPYFEN 290
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 60/230 (26%), Positives = 109/230 (47%), Gaps = 19/230 (8%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK I+ + E+ + +++HP+I+KL+ + + +V EYA G ++
Sbjct: 34 VAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLY 87
Query: 278 DYIARYGRMNENAARRKF---WQILSAVEYCHNRR---VVHRDLKAENLLMDSNLD-IKL 330
+ + + A Q V Y H+ + ++HRDLK NLL+ + +K+
Sbjct: 88 NVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147
Query: 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
DFG + + GS + APEVFEG Y + D++S G++L+ ++ PFD
Sbjct: 148 CDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFD 204
Query: 391 G--STLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
+ V +G R + + ESL+ + ++P++R +E+I
Sbjct: 205 EIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI 254
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 20/239 (8%)
Query: 218 VAIKII--DKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VA+K D + ++ V +E ++ L HP+II L V + + +V E+A G
Sbjct: 33 VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP 92
Query: 276 IFDYIARYGRMNENAARRKF-WQILSAVEYCHNRR---VVHRDLKAENLLMD-------- 323
+ ++ G+ + QI + Y H+ ++HRDLK+ N+L+
Sbjct: 93 LNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL 150
Query: 324 SNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
SN +K+ DFG + + K+ + G+ + APEV + D+WS GV+L+ L+
Sbjct: 151 SNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELL 208
Query: 384 CGALPFDGSTLNSLRDRVLSGRFR--IPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
G +PF G ++ V + IP L+ +P R I
Sbjct: 209 TGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 9e-39
Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 46/271 (16%)
Query: 218 VAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VAIK +S D V + RE++++KQL H +++ L +V + K Y+V E+ + I
Sbjct: 53 VAIKKFLESDDDKMVKKIAM-REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110
Query: 277 FDYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
D + + ++ ++ +QI++ + +CH+ ++HRD+K EN+L+ + +KL DFGF
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170
Query: 336 SNYY-VPGQKL----AT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ PG+ AT W Y APE+ G G +D+W++G ++ + G F
Sbjct: 171 ARTLAAPGEVYDDEVATRW-----YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225
Query: 390 DGS-----------TLNSLRDRVLSGRFRIPYF--------------------MSTECES 418
G L +L R + P F +S
Sbjct: 226 PGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVID 285
Query: 419 LIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
L +K L +P KR ++ H + +
Sbjct: 286 LAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-39
Identities = 45/231 (19%), Positives = 90/231 (38%), Gaps = 18/231 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAI++ID + + L+ REV +Q H +++ + + I++ ++
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 278 DYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + + R+ +I+ + Y H + ++H+DLK++N+ D N + + DFG
Sbjct: 118 SVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 337 ------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEI--------DIWSLGVVLYVL 382
KL G + APE+ E D+++LG + Y L
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 383 VCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLVREPTKR 431
PF ++ ++ +G M E ++ E +R
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 22/238 (9%)
Query: 218 VAIKIIDKSQLDP-----VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
VAIK + + Q+ REV IM L+HP+I+KL+ +M +V E+
Sbjct: 47 VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM-HNPP-RMVMEFVP 104
Query: 273 QGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRR--VVHRDLKAENLLMDS----- 324
G+++ + + + + + I +EY N+ +VHRDL++ N+ + S
Sbjct: 105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164
Query: 325 NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLV 383
+ K+ADFG S ++ G+ + APE + + + D +S ++LY ++
Sbjct: 165 PVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 384 CGALPFDGSTLN--SLRDRVLSGRFR--IPYFMSTECESLIRKMLVREPTKRYCIEQI 437
G PFD + + + R IP ++I +P KR I
Sbjct: 223 TGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 25/254 (9%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
+AIK I + Q ++ E+ + K L H +I++ I I E G +
Sbjct: 50 IAIKEIPERDSR--YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107
Query: 278 DYI-ARYGRM--NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADF 333
+ +++G + NE QIL ++Y H+ ++VHRD+K +N+L+++ + +K++DF
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167
Query: 334 GFSNYYVPGQ-KLATWCGSPPYAAPEVFEGKKY-CGPEIDIWSLGVVLYVLVCGALPFDG 391
G S T+ G+ Y APE+ + G DIWSLG + + G PF
Sbjct: 168 GTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-- 225
Query: 392 STLNSLRDRVLSGRFRI---------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
L + F++ P MS E ++ I K +P KR C + +
Sbjct: 226 YEL----GEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
Query: 443 M--AEETPRLLPPI 454
+ + + + P +
Sbjct: 282 LKVSSKKKKTQPKL 295
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-37
Identities = 62/256 (24%), Positives = 108/256 (42%), Gaps = 55/256 (21%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD---YI-ARYGRMNENAARR 293
RE+ ++K+L HP+I+ L V+ ++ + +V E+ + D + + ++ +
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKI 123
Query: 294 KFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKL----AT- 347
+Q+L V +CH R++HRDLK +NLL++S+ +KLADFG + + +P + T
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST-------------- 393
W Y AP+V G K +DIWS+G + ++ G F G T
Sbjct: 184 W-----YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238
Query: 394 --------LNSLRD-----------RVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCI 434
+ L + S E L+ ML +P KR
Sbjct: 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP---GFCQEGIDLLSNMLCFDPNKRISA 295
Query: 435 EQIKRHRWMAEETPRL 450
H + + P++
Sbjct: 296 RDAMNHPYFKDLDPQI 311
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-37
Identities = 46/193 (23%), Positives = 87/193 (45%), Gaps = 19/193 (9%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
+ +K + + D + +EV++M+ L+HP+++K V+ + ++EY G
Sbjct: 35 GEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92
Query: 275 EIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ I + R F I S + Y H+ ++HRDL + N L+ N ++ +ADF
Sbjct: 93 TLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADF 152
Query: 334 GFS-----NYYVPG----------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
G + P +K T G+P + APE+ G+ Y ++D++S G+V
Sbjct: 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIV 211
Query: 379 LYVLVCGALPFDG 391
L ++
Sbjct: 212 LCEIIGRVNADPD 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 11/224 (4%)
Query: 218 VAIKIIDKSQL--DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VAIK I L++ REV QL H +I+ + V E Y+V EY
Sbjct: 39 VAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ +YI +G ++ + A QIL +++ H+ R+VHRD+K +N+L+DSN +K+ DFG
Sbjct: 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157
Query: 336 SNYYVPGQKLATWC--GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
+ T G+ Y +PE +G + DI+S+G+VLY ++ G PF+G T
Sbjct: 158 AKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGET 216
Query: 394 -----LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY 432
+ ++D V + + + ++I + ++ RY
Sbjct: 217 AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 68/245 (27%), Positives = 111/245 (45%), Gaps = 50/245 (20%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ--GEIFDYIARYGRMNENAARRKF 295
RE+ I+K+L H +I+KL+ V+ TK + +V E+ +Q ++ D G + A+
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFL 106
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKL----AT-WC 349
Q+L+ + YCH+RRV+HRDLK +NLL++ ++K+ADFG + + +P +K T W
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW- 165
Query: 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---------------- 393
Y AP+V G K IDIWS+G + +V G F G +
Sbjct: 166 ----YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 394 ------LNSLRD----------RVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
+ L + + L+ KML +P +R +Q
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLK---GLDESGIDLLSKMLKLDPNQRITAKQA 278
Query: 438 KRHRW 442
H +
Sbjct: 279 LEHAY 283
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 58/262 (22%), Positives = 107/262 (40%), Gaps = 60/262 (22%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQ 297
REV ++K+L H +II+L V+ ++++ EYA ++ Y+ + ++ + +Q
Sbjct: 82 REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 298 ILSAVEYCHNRRVVHRDLKAENLLMDSNLD-----IKLADFGFSNYYVPGQKLATWCGSP 352
+++ V +CH+RR +HRDLK +NLL+ + +K+ DFG LA G P
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG----------LARAFGIP 190
Query: 353 P-----------YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST-------- 393
Y PE+ G ++ +DIWS+ + ++ F G +
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250
Query: 394 --------------LNSLRD--------RVLSGRFRIPYFMSTECESLIRKMLVREPTKR 431
+ +L D R + + + + E L+ ML +P KR
Sbjct: 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310
Query: 432 YCIEQIKRHRWMAEETPRLLPP 453
+ H + + P
Sbjct: 311 ISAKNALEHPYFSHNDF---DP 329
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 66/277 (23%), Positives = 103/277 (37%), Gaps = 67/277 (24%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD---YIARYGRMNENAARRK 294
RE++++++L HP+II L KS I +V ++ D I + + +
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKA 116
Query: 295 F-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353
+ L +EY H ++HRDLK NLL+D N +KLADFG LA GSP
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG----------LAKSFGSPN 166
Query: 354 -----------YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST--------- 393
Y APE+ G + G +D+W++G +L L+ G +
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226
Query: 394 -------------LNSLRD---------RVLSGRFRIPYFMSTECESLIRKMLVREPTKR 431
+ SL D L F + LI+ + + P R
Sbjct: 227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS---AAGDDLLDLIQGLFLFNPCAR 283
Query: 432 YCIEQIKRHRWMAEE----TPRLLPPINILGEVKNEP 464
Q + ++ + LP N E E
Sbjct: 284 ITATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQ 320
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-35
Identities = 59/251 (23%), Positives = 108/251 (43%), Gaps = 49/251 (19%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD---YIARYGR-MNENAARR 293
RE+ ++K+L H +I++L V+ + + +V E+ +Q D Y ++ +
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKS 105
Query: 294 KFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKL----AT- 347
+Q+L + +CH+R V+HRDLK +NLL++ N ++KLA+FG + + +P + T
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGST------------- 393
W Y P+V G K ID+WS G + L P F G+
Sbjct: 166 W-----YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 394 ---------LNSLRDRVLSGRFRIPY-------FMSTECESLIRKMLVREPTKRYCIEQI 437
+ L D + ++ L++ +L P +R E+
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 438 KRHRWMAEETP 448
+H + ++ P
Sbjct: 281 LQHPYFSDFCP 291
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 31/233 (13%)
Query: 218 VAIKIIDKSQL--DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
VA+K++ L DPV ++ RE +L PH++ + E +Y+ N +
Sbjct: 62 VALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ + R G + A QI SA++ H HRD+K EN+L+ ++ L DFG
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG- 179
Query: 336 SNYYVPGQKLA------------TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
+A G+ Y APE F DI++L VLY +
Sbjct: 180 ---------IASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECL 229
Query: 384 CGALPFDGSTLNS----LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY 432
G+ P+ G L+ + + P + +++I + + + P RY
Sbjct: 230 TGSPPYQGDQLSVMGAHINQAIPRPSTVRPG-IPVAFDAVIARGMAKNPEDRY 281
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-35
Identities = 62/263 (23%), Positives = 105/263 (39%), Gaps = 65/263 (24%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIFD---YIARYGR-MNENAARR 293
REV ++K L H +I+ L ++ T+ + +V EY ++ D Y+ G +N + +
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKL 104
Query: 294 KFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353
+Q+L + YCH ++V+HRDLK +NLL++ ++KLADFG LA P
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFG----------LARAKSIPT 154
Query: 354 -----------YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST--------- 393
Y P++ G +ID+W +G + Y + G F GST
Sbjct: 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF 214
Query: 394 -------------LNSLRD-----------RVLSGRFRIPYFMSTECESLIRKMLVREPT 429
+ S + L + ++ L+ K+L E
Sbjct: 215 RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAP---RLDSDGADLLTKLLQFEGR 271
Query: 430 KRYCIEQIKRHRWMAEETPRLLP 452
R E +H + R+
Sbjct: 272 NRISAEDAMKHPFFLSLGERIHK 294
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 50/261 (19%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG-----EIFDYIARYGRMNENAAR 292
RE+ +MK+L H +I++L+ V+ T++ + +V E+ + + + N +
Sbjct: 52 REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 293 RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKL----AT 347
WQ+L + +CH +++HRDLK +NLL++ +KL DFG + + +P T
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 348 -WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST------------- 393
W Y AP+V G + IDIWS G +L ++ G F G+
Sbjct: 172 LW-----YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226
Query: 394 ---------LNSLRD----------RVLSGRFR--IPYFMSTECESLIRKMLVREPTKRY 432
+ L R L + + + +L P R
Sbjct: 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 433 CIEQIKRHRWMAEETPRLLPP 453
+Q H W AE
Sbjct: 287 SAKQALHHPWFAEYYHHASMG 307
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 63/256 (24%), Positives = 125/256 (48%), Gaps = 34/256 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K++D + + ++ EV IM+ H +++++++ ++++ E+ G +
Sbjct: 73 VAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D I R+NE +L A+ Y H + V+HRD+K++++L+ + +KL+DFGF
Sbjct: 131 D-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC- 188
Query: 338 YYVPGQ------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
Q K + G+P + APEV Y E+DIWSLG+++ +V G P+
Sbjct: 189 ----AQISKDVPKRKSLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPY-- 241
Query: 392 STLNSLRDRVLSGRFRIP----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441
+ + + + + R+ + +S + +MLVR+P +R +++ H
Sbjct: 242 FSDSPV--QAM---KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296
Query: 442 WM--AEETPRLLPPIN 455
++ L+P I
Sbjct: 297 FLLQTGLPECLVPLIQ 312
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 18/230 (7%)
Query: 218 VAIKIIDKSQL--DPVNLQKVYREVEIMKQLDHPHIIKLFQVMET----KSMIYIVSEYA 271
VA+K++ ++ L DP + RE + L+HP I+ ++ E + YIV EY
Sbjct: 40 VAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
+ + D + G M A A+ + H ++HRD+K N+++ + +K+
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 332 DFG----FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
DFG ++ + A G+ Y +PE G D++SLG VLY ++ G
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEP 217
Query: 388 PFDGST-----LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY 432
PF G + +R+ + R +S + ++++ K L + P RY
Sbjct: 218 PFTGDSPVSVAYQHVREDPIPPSARHEG-LSADLDAVVLKALAKNPENRY 266
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 68/266 (25%), Positives = 123/266 (46%), Gaps = 34/266 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAI+ ++ Q + + E+ +M++ +P+I+ +++V EY G +
Sbjct: 48 VAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + M+E + L A+E+ H+ +V+HRD+K++N+L+ + +KL DFGF
Sbjct: 106 D-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC- 163
Query: 338 YYVPGQ------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
Q K +T G+P + APEV K Y GP++DIWSLG++ ++ G P+
Sbjct: 164 ----AQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPY-- 216
Query: 392 STLNSLRDRVLSGRFRIP----------YFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441
N L R L + I +S + + L + KR +++ +H+
Sbjct: 217 LNENPL--RAL---YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271
Query: 442 WM--AEETPRLLPPINILGEVKNEPN 465
++ A+ L P I E +
Sbjct: 272 FLKIAKPLSSLTPLIAAAKEATKNNH 297
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-35
Identities = 51/237 (21%), Positives = 101/237 (42%), Gaps = 4/237 (1%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
+A K+I ++ P ++ RE++++ + + P+I+ + + I I E+ + G +
Sbjct: 61 MARKLIH-LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCH-NRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + GR+ E + ++ + Y +++HRD+K N+L++S +IKL DFG S
Sbjct: 120 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
+ ++ G+ Y +PE +G Y + DIWS+G+ L + G P
Sbjct: 180 GQLIDSMA-NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
Query: 397 LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLPP 453
L + R + R + + ++ E P LP
Sbjct: 238 LELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 11/236 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEI-MKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
+A+K + + +++ ++++ +K D P+I++ F T + ++I E
Sbjct: 53 IAVKQMR-RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE 111
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRR-VVHRDLKAENLLMDSNLDIKLADFGF 335
G + E + I+ A+ Y + V+HRD+K N+L+D IKL DFG
Sbjct: 112 KLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPE----IDIWSLGVVLYVLVCGALPFDG 391
S V + G Y APE + P+ D+WSLG+ L L G P+
Sbjct: 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 392 -STLNSLRDRVLSG---RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
T + +VL S + +S ++ L ++ KR ++ H ++
Sbjct: 232 CKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 60/264 (22%), Positives = 98/264 (37%), Gaps = 71/264 (26%)
Query: 238 REVEIMKQL---DHPHIIKLFQVMETKSM-----IYIVSEYANQGEIFD---YIARYGRM 286
REV ++++L +HP++++L V T + +V E+ +Q D Y+ +
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPP 115
Query: 287 NENAARRK--FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344
A K Q L +++ H +VHRDLK EN+L+ S +KLADFG
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG---------- 165
Query: 345 LATWCGSPP----------YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST- 393
LA Y APEV Y +D+WS+G + + F G++
Sbjct: 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSE 224
Query: 394 ---------------------LNSLRD--------RVLSGRFRIPYFMSTECESLIRKML 424
SL R + M L+ +ML
Sbjct: 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVP---EMEESGAQLLLEML 281
Query: 425 VREPTKRYCIEQIKRHRWMAEETP 448
P KR + +H ++ ++
Sbjct: 282 TFNPHKRISAFRALQHSYLHKDEG 305
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 75/268 (27%), Positives = 132/268 (49%), Gaps = 34/268 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIKIID + + ++ + +E+ ++ Q D P++ K + + ++I+ EY G
Sbjct: 50 VAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL 108
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + G ++E +IL ++Y H+ + +HRD+KA N+L+ + ++KLADFG +
Sbjct: 109 D-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA- 166
Query: 338 YYVPGQ------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
GQ K T+ G+P + APEV + Y + DIWSLG+ L G P
Sbjct: 167 ----GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPH-- 219
Query: 392 STLNSLRDRVLSGRFRIPY---------FMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
S L+ + +VL F IP + S + + L +EP+ R +++ +H++
Sbjct: 220 SELHPM--KVL---FLIPKNNPPTLEGNY-SKPLKEFVEACLNKEPSFRPTAKELLKHKF 273
Query: 443 M---AEETPRLLPPINILGEVKNEPNEQ 467
+ A++T L I+ K E +
Sbjct: 274 ILRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 36/269 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK + +LQ++ +E+ IM+Q D PH++K + + ++IV EY G +
Sbjct: 57 VAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112
Query: 278 D-YIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
D R + E+ L +EY H R +HRD+KA N+L+++ KLADFG +
Sbjct: 113 DIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 337 NYYVPGQ------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFD 390
GQ K T G+P + APEV + Y DIWSLG+ + G P+
Sbjct: 173 -----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPY- 225
Query: 391 GSTLNSLRDRVLSGRFRIP----------YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
+ ++ + R + F IP S +++ LV+ P +R Q+ +H
Sbjct: 226 -ADIHPM--RAI---FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279
Query: 441 RWM--AEETPRLLPPINILGEVKNEPNEQ 467
++ A+ L IN +VK + E
Sbjct: 280 PFVRSAKGVSILRDLINEAMDVKLKRQES 308
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-33
Identities = 46/227 (20%), Positives = 87/227 (38%), Gaps = 34/227 (14%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-----KSMIYIVSEYAN 272
V +K + D E + + ++ HP I+++F +E + YIV EY
Sbjct: 109 VVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG 167
Query: 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
+ ++ A +IL A+ Y H+ +V+ DLK EN+++ +KL D
Sbjct: 168 GQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID 224
Query: 333 FGFSNYYVPGQKLAT-------WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
G + G+P + APE+ DI+++G L L
Sbjct: 225 LG----------AVSRINSFGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLD 272
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY 432
+G ++ L + + L+R+ + +P +R+
Sbjct: 273 LPTRNGRYVDGLPEDDPV--LKTY----DSYGRLLRRAIDPDPRQRF 313
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 61/270 (22%), Positives = 103/270 (38%), Gaps = 68/270 (25%)
Query: 238 REVEIMKQL---DHPHIIKLFQV-----METKSMIYIVSEYANQGEIFD---YIARYGRM 286
REV +++ L +HP++++LF V + ++ + +V E+ +Q D Y+ +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEP 115
Query: 287 NENAARRK--FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344
K +Q+L +++ H+ RVVHRDLK +N+L+ S+ IKLADFG
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG---------- 165
Query: 345 LATWCGSPP----------YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST- 393
LA Y APEV Y +D+WS+G + + F GS+
Sbjct: 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSD 224
Query: 394 ---------------------LNSLRDRVLSGRFRIPY-----FMSTECESLIRKMLVRE 427
+L + + P + + L+ K L
Sbjct: 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284
Query: 428 PTKRYCIEQIKRHRWMAEE---TPRLLPPI 454
P KR H + + L +
Sbjct: 285 PAKRISAYSALSHPYFQDLERCKENLDSHL 314
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 54/275 (19%), Positives = 107/275 (38%), Gaps = 69/275 (25%)
Query: 238 REVEIMKQLDHPHIIKLFQVMETKSM--------IYIVSEYANQGEIFD---YIARYG-R 285
RE++I++ L H +++ L ++ TK+ IY+V ++ D ++ +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVK 120
Query: 286 MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL 345
+ +R +L+ + Y H +++HRD+KA N+L+ + +KLADFG + + +
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 346 AT----------WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL------------- 382
W Y PE+ G++ GP ID+W G ++ +
Sbjct: 181 QPNRYTNRVVTLW-----YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235
Query: 383 --------VCG-----------ALP-FDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRK 422
+CG ++ L + R + R + Y LI K
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK-AYVRDPYALDLIDK 294
Query: 423 MLVREPTKRYCIEQIKRHRWMAEE----TPRLLPP 453
+LV +P +R + H + + + +
Sbjct: 295 LLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLS 329
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 42/274 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A K+I+ + L+ E+EI+ DHP+I+KL ++I+ E+ G +
Sbjct: 47 AAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD 104
Query: 278 DYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + E + Q+L A+ + H++R++HRDLKA N+LM DI+LADFG S
Sbjct: 105 AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
Query: 337 NYYVPGQ------KLATWCGSPPYAAPEV-----FEGKKYCGPEIDIWSLGVVLYVLVCG 385
+ K ++ G+P + APEV + Y + DIWSLG+ L +
Sbjct: 165 -----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQI 218
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIP----------YFMSTECESLIRKMLVREPTKRYCIE 435
P LN + RVL +I S E ++ L + P R
Sbjct: 219 EPPH--HELNPM--RVL---LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAA 271
Query: 436 QIKRHRWM--AEETPRLLPPINILGEVKNEPNEQ 467
Q+ H ++ L + E K E E+
Sbjct: 272 QLLEHPFVSSITSNKALRELVA---EAKAEVMEE 302
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 51/243 (20%), Positives = 101/243 (41%), Gaps = 24/243 (9%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEI-MKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
+A+K I + ++ +++ +++I M+ +D P + + + + ++I E +
Sbjct: 35 MAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLD 93
Query: 277 FDY---IARYGRMNENAARRKFWQILSAVEYCH-NRRVVHRDLKAENLLMDSNLDIKLAD 332
Y I + + E+ + I+ A+E+ H V+HRD+K N+L+++ +K+ D
Sbjct: 94 KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCD 153
Query: 333 FGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGP---EIDIWSLGVVLYVLVCGALPF 389
FG S Y V G PY APE + + DIWSLG+ + L P+
Sbjct: 154 FGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213
Query: 390 DGSTLNSLRDRVLSGRFRIPYF---------MSTECESLIRKMLVREPTKRYCIEQIKRH 440
D + L ++ S E + L + +R ++ +H
Sbjct: 214 DSWGTPF---QQL---KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267
Query: 441 RWM 443
+
Sbjct: 268 PFF 270
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 40/186 (21%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM--IYIVSEYANQGE 275
A+K I+ + + RE+ ++++L HP++I L +V + + ++++ +YA
Sbjct: 51 YALKQIEGTGISMSAC----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-- 104
Query: 276 IFD---YIARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDLKAENLLMD 323
D I + N + +QIL + Y H V+HRDLK N+L+
Sbjct: 105 --DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 162
Query: 324 SNLD----IKLADFGFS-NYYVPGQKLAT--------WCGSPPYAAPEVFEGKKYCGPEI 370
+K+AD GF+ + P + LA W Y APE+ G ++ I
Sbjct: 163 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW-----YRAPELLLGARHYTKAI 217
Query: 371 DIWSLG 376
DIW++G
Sbjct: 218 DIWAIG 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ + VAIK + + P +++ E +M +D+PH+ +L + S + ++++
Sbjct: 42 KVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMP 99
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G + DY+ R + N + W QI + Y +RR+VHRDL A N+L+ + +K+
Sbjct: 100 FGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158
Query: 331 ADFGFS-------NYY-VPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
DFG + Y G K+ W A E + Y + D+WS GV ++
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWM------ALESILHRIYT-HQSDVWSYGVTVWE 211
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
++ G+ P+DG + + + G R+P
Sbjct: 212 LMTFGSKPYDGIPASEISSILEKG-ERLP 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 58/275 (21%), Positives = 106/275 (38%), Gaps = 30/275 (10%)
Query: 218 VAIKIID-KSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VAIK + + Q + +EV +++L HP+ I+ + ++V EY
Sbjct: 82 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 141
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ E L + Y H+ ++HRD+KA N+L+ +KL DFG +
Sbjct: 142 DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
Query: 337 NYYVPGQ--KLATWCGSPPYAAPEV---FEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
++ G+P + APEV + +Y ++D+WSLG+ L P
Sbjct: 202 -----SIMAPANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPL-- 253
Query: 392 STLNSLRDRVLSGRFRIPY---------FMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
+N++ L + I S + + L + P R E + +HR+
Sbjct: 254 FNMNAM--SAL---YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308
Query: 443 M--AEETPRLLPPINILGEVKNEPNEQILRLMNSL 475
+ ++ I + E + R M +
Sbjct: 309 VLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 343
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 60/260 (23%), Positives = 111/260 (42%), Gaps = 45/260 (17%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK I+ + ++ ++ +E++ M Q HP+I+ + K +++V + + G +
Sbjct: 43 VAIKRINLEKCQT-SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 278 DYI--------ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
D I + G ++E+ ++L +EY H +HRD+KA N+L+ + ++
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161
Query: 330 LADFGFS------NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
+ADFG S + T+ G+P + APEV E + + DIWS G+ L
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 384 CGALPF--------------------DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKM 423
GA P+ + + + FR +I
Sbjct: 222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR----------KMISLC 271
Query: 424 LVREPTKRYCIEQIKRHRWM 443
L ++P KR ++ RH++
Sbjct: 272 LQKDPEKRPTAAELLRHKFF 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 215 TVNVAIKIIDKSQLDPVN-LQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
TV+VA+K + L + REV M LDH ++I+L+ V+ + +V+E A
Sbjct: 46 TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPL 104
Query: 274 GEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + D + R + + + Q+ + Y ++R +HRDL A NLL+ + +K+
Sbjct: 105 GSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 163
Query: 332 DFGFS-------NYYVP--GQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
DFG ++YV +K+ WC APE + + + D W GV L+
Sbjct: 164 DFGLMRALPQNDDHYVMQEHRKVPFAWC------APESLKTRTFS-HASDTWMFGVTLWE 216
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
+ G P+ G + + ++ R+P
Sbjct: 217 MFTYGQEPWIGLNGSQILHKIDKEGERLP 245
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 48/177 (27%), Positives = 92/177 (51%), Gaps = 14/177 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVM---ETKSMIYIVSEYANQ 273
V +KI+ PV +K+ RE++I++ L P+II L ++ +++ + N
Sbjct: 64 VVVKILK-----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLAD 332
D+ Y + + R ++IL A++YCH+ ++HRD+K N+++D + ++L D
Sbjct: 119 ----DFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLID 174
Query: 333 FGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+G + +Y PGQ+ S + PE+ + +D+WSLG +L ++ PF
Sbjct: 175 WGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 60/277 (21%), Positives = 115/277 (41%), Gaps = 32/277 (11%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEI-MKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
+A+K I S +D +++ ++++ M+ D P+I++ + + + +I E +
Sbjct: 50 MAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFD 108
Query: 277 FDYIARY----GRMNENAARRKFWQILSAVEYCH-NRRVVHRDLKAENLLMDSNLDIKLA 331
Y Y + E + + A+ + N +++HRD+K N+L+D + +IKL
Sbjct: 109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 168
Query: 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGP---EIDIWSLGVVLYVLVCGALP 388
DFG S V G PY APE + D+WSLG+ LY L G P
Sbjct: 169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
Query: 389 FDGSTLNSLRDRVLSGRFRIPY------------FMSTECESLIRKMLVREPTKRYCIEQ 436
+ NS+ L ++ S + + L ++ +KR ++
Sbjct: 229 Y--PKWNSVF-DQL---TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
Query: 437 IKRHRWM--AEETPRLLPP--INILGEVKNEPNEQIL 469
+ +H ++ EE + IL ++ P+ +
Sbjct: 283 LLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMY 319
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
VA+KI+ DP ++ E +M+QLD+P+I+++ + +V E A G
Sbjct: 44 VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ Y+ + + + Q+ ++Y VHRDL A N+L+ + K++DFG
Sbjct: 103 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162
Query: 335 FS-------NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLV 383
S NYY K W APE K+ + D+WS GV+++
Sbjct: 163 LSKALRADENYYKAQTHGKWPVKWY------APECINYYKFS-SKSDVWSFGVLMWEAFS 215
Query: 384 CGALPFDGSTLNSLRDRVLSGRFRIP 409
G P+ G + + + G R+
Sbjct: 216 YGQKPYRGMKGSEVTAMLEKG-ERMG 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 55/269 (20%), Positives = 103/269 (38%), Gaps = 52/269 (19%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEI--MKQLDHPHIIKLF----QVMETKSMIYIVSEY 270
NVA+KI + + +RE E+ L H +I+ + + +++++ Y
Sbjct: 33 NVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87
Query: 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR--------VVHRDLKAENLLM 322
G ++DY+ ++ + R I S + + H + HRDLK++N+L+
Sbjct: 88 HEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 323 DSNLDIKLADFGFSNYYVPGQKLA-----TWCGSPPYAAPEVFEGKKYCGPE-----IDI 372
N +AD G + + G+ Y APEV + +DI
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 373 WSLGVVLYVLVCGA----------LPFDG-----STLNSLRDRVLSGRFR--IP-YFMST 414
W+ G+VL+ + PF + +R V + R IP + S
Sbjct: 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSD 266
Query: 415 ECESLIRKMLVR----EPTKRYCIEQIKR 439
+ + K++ P+ R +IK+
Sbjct: 267 PTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ V IK+I + + + Q V + + LDH HI++L + S + +V++Y
Sbjct: 40 SIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLP 97
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G + D++ R R W QI + Y +VHR+L A N+L+ S +++
Sbjct: 98 LGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQV 156
Query: 331 ADFGFS------NYYVP--GQKL-ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
ADFG + + + K W A E KY + D+WS GV ++
Sbjct: 157 ADFGVADLLPPDDKQLLYSEAKTPIKWM------ALESIHFGKYT-HQSDVWSYGVTVWE 209
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
++ GA P+ G L + D + G R+
Sbjct: 210 LMTFGAEPYAGLRLAEVPDLLEKG-ERLA 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ + VAIK + + P +++ E +M +D+PH+ +L + S + ++++
Sbjct: 42 KVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMP 99
Query: 273 QGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G + DY+ R + N + W QI + Y +RR+VHRDL A N+L+ + +K+
Sbjct: 100 FGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158
Query: 331 ADFGFS-------NYY-VPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
DFG + Y G K+ W A E + Y + D+WS GV ++
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWM------ALESILHRIYT-HQSDVWSYGVTVWE 211
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
++ G+ P+DG + + + G R+P
Sbjct: 212 LMTFGSKPYDGIPASEISSILEKG-ERLP 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 34/248 (13%), Positives = 78/248 (31%), Gaps = 41/248 (16%)
Query: 218 VAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VA+ +D L LQ+ + ++D P + ++ V+ T++ +V+E+ G +
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL 118
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + A R + +A + H V + + + D+ LA
Sbjct: 119 QEVAD--TSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-- 174
Query: 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
P+ DI +G LY L+ P + + S
Sbjct: 175 -----------------TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209
Query: 397 --------LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY--CIEQIKRHRWMAEE 446
+ + + + ++ + + + R + + + +
Sbjct: 210 GLAPAERDTAGQPIEPADIDRD-IPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVAD 268
Query: 447 TPRLLPPI 454
+L PI
Sbjct: 269 RTEVLGPI 276
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
+ +VA+K+I + + + ++E + M +L HP ++K + V + IYIV+EY
Sbjct: 28 KWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84
Query: 271 ANQGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
+ G + +Y+ +G+ E + + + + + + + + +HRDL A N L+D +L +K
Sbjct: 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVK 144
Query: 330 LADFGFS------NYYV-PGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
++DFG + Y G K W APEVF KY + D+W+ G++++
Sbjct: 145 VSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYFKYS-SKSDVWAFGILMWE 197
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
V G +P+D T + + +V G R+
Sbjct: 198 VFSLGKMPYDLYTNSEVVLKVSQG-HRLY 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
+ VAIK I + + + E E+M +L HP +++L+ V ++ I +V+E+
Sbjct: 28 YWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84
Query: 271 ANQGEIFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G + DY+ + G + + Y V+HRDL A N L+ N IK
Sbjct: 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 144
Query: 330 LADFGFS-----NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
++DFG + + Y G K W +PEVF +Y + D+WS GV+++
Sbjct: 145 VSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPEVFSFSRYS-SKSDVWSFGVLMWE 197
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
V G +P++ + + + + + +G FR+
Sbjct: 198 VFSEGKIPYENRSNSEVVEDISTG-FRLY 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 64/241 (26%), Positives = 96/241 (39%), Gaps = 18/241 (7%)
Query: 210 VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
L VA+K + L P K +E I+KQ HP+I++L V K IYIV E
Sbjct: 134 RLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192
Query: 270 YANQGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
G+ ++ G + + +EY ++ +HRDL A N L+ +
Sbjct: 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
Query: 329 KLADFGFS------NYYVPGQKLATWCGSPPY--AAPEVFEGKKYCGPEIDIWSLGVVLY 380
K++DFG S Y G P APE +Y E D+WS G++L+
Sbjct: 253 KISDFGMSREEADGVYAASGGL-----RQVPVKWTAPEALNYGRY-SSESDVWSFGILLW 306
Query: 381 -VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIK 438
GA P+ + R+ V G R P L+ + EP +R I
Sbjct: 307 ETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366
Query: 439 R 439
+
Sbjct: 367 Q 367
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 41/184 (22%), Positives = 81/184 (44%), Gaps = 13/184 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
V ++ I+ + + E+ + K +HP+I+ + +++V+ + G
Sbjct: 55 VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 278 DYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
D I + MNE A +L A++Y H+ VHR +KA ++L+ + + L+
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 336 S-NYYVPGQKLATWC-------GSPPYAAPEVFE--GKKYCGPEIDIWSLGVVLYVLVCG 385
+ + GQ+ P+ +PEV + + Y + DI+S+G+ L G
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANG 233
Query: 386 ALPF 389
+PF
Sbjct: 234 HVPF 237
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 210 VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
V ++++ VA+K + + ++ ++ +E +MK++ HP++++L V + YI++E
Sbjct: 33 VWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89
Query: 270 YANQGEIFDYIARYGRMNENAAR--RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ G + DY+ R +A QI SA+EY + +HRDL A N L+ N
Sbjct: 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149
Query: 328 IKLADFGFS-----NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
+K+ADFG S + Y G K W APE K+ + D+W+ GV+L
Sbjct: 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAYNKFS-IKSDVWAFGVLL 202
Query: 380 Y-VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
+ + G P+ G L+ + + + +R+
Sbjct: 203 WEIATYGMSPYPGIDLSQVYELLEKD-YRME 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 45/273 (16%)
Query: 212 LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------MIY 265
L + VAIK K D + RE++IM+ + HP+++ L + +
Sbjct: 61 LVESDEVAIK---KVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 266 IVSEYANQ---GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM 322
+V EY + Y M + +Q+L ++ Y H+ + HRD+K +NLL+
Sbjct: 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174
Query: 323 DSNLD-IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYV 381
D +KL DFG + + G+ ++ S Y APE+ G IDIWS G V+
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234
Query: 382 LVCGALPFDG-STLNSLRD--RVL--------------SGRFRIPYF------------M 412
L+ G F G S ++ L + +VL + P
Sbjct: 235 LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRT 294
Query: 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
+ LI ++L P+ R + H + E
Sbjct: 295 PPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
T VAIK + + P + +E ++MK+L H +++L+ V+ ++ IYIV+EY
Sbjct: 204 TWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEY 259
Query: 271 ANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
++G + D++ + QI S + Y VHRDL+A N+L+ NL
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPY--AAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCG 385
K+ADFG + + A P APE ++ + D+WS G++L + G
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKG 378
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIP 409
+P+ G + D+V G +R+P
Sbjct: 379 RVPYPGMVNREVLDQVERG-YRMP 401
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 67/267 (25%), Positives = 110/267 (41%), Gaps = 45/267 (16%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------MIYIVSEYA 271
VAIK K D + RE++IM++LDH +I++L + + +V +Y
Sbjct: 82 VAIK---KVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135
Query: 272 NQ---GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
+ Y + + +Q+ ++ Y H+ + HRD+K +NLL+D + +
Sbjct: 136 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
Query: 329 -KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
KL DFG + V G+ ++ S Y APE+ G ID+WS G VL L+ G
Sbjct: 196 LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
Query: 388 PFDG-STLNSLRD--RVL--------------SGRFRIPYF------------MSTECES 418
F G S ++ L + +VL F+ P E +
Sbjct: 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 315
Query: 419 LIRKMLVREPTKRYCIEQIKRHRWMAE 445
L ++L PT R + H + E
Sbjct: 316 LCSRLLEYTPTARLTPLEACAHSFFDE 342
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-29
Identities = 61/294 (20%), Positives = 92/294 (31%), Gaps = 76/294 (25%)
Query: 213 RHTVNVAIKIIDKSQL---------DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM 263
+ VAIK + + D ++V RE+ ++ HP+I+ L +
Sbjct: 44 SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 264 -----IYIVSEY----------ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR 308
+Y+V+E + I +Y + IL + H
Sbjct: 104 PAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY----------FMYHILLGLHVLHEA 153
Query: 309 RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL----AT-WCGSPPYAAPEVFEGK 363
VVHRDL N+L+ N DI + DF + W Y APE+
Sbjct: 154 GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQF 208
Query: 364 KYCGPEIDIWSLGVVLYVLVCGALPFDG-STLNSLR--------------DRVLSGRFR- 407
K +D+WS G V+ + F G + N L S R
Sbjct: 209 KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARD 268
Query: 408 -----IPYF-----------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
+ LI KML P +R EQ RH +
Sbjct: 269 YLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
R +VAIK+I + + + E ++M L H +++L+ V + I+I++EY
Sbjct: 44 KWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100
Query: 271 ANQGEIFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G + +Y+ R + A+EY +++ +HRDL A N L++ +K
Sbjct: 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 160
Query: 330 LADFGFS-----NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
++DFG S + Y G K W PEV K+ + DIW+ GV+++
Sbjct: 161 VSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPEVLMYSKFS-SKSDIWAFGVLMWE 213
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
+ G +P++ T + + + G R+
Sbjct: 214 IYSLGKMPYERFTNSETAEHIAQG-LRLY 241
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 66/308 (21%), Positives = 121/308 (39%), Gaps = 67/308 (21%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM------IYIVSEY 270
VAIK + + + ++ YRE+ ++K + H ++I L V S Y+V +
Sbjct: 51 KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF 110
Query: 271 ANQGEIFDYIARYGRMNENAARRKF--WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
D + + + + + ++ +Q+L ++Y H+ VVHRDLK NL ++ + ++
Sbjct: 111 MQT----D-LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCEL 165
Query: 329 KLADFGFSNY-------YVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
K+ DFG + + YV T W Y APEV + +DIWS+G ++
Sbjct: 166 KILDFGLARHADAEMTGYV-----VTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 381 VLVCGALPFDG-STLNSLR--------------DRVLSGRFR-----IPYF--------- 411
++ G F G L+ L ++ + +P
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275
Query: 412 --MSTECESLIRKMLVREPTKRYCIEQIKRHRWMA-----EETPRLLPPINILGEVKNEP 464
S + L+ KML + KR Q H + EE P + E +
Sbjct: 276 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLT 335
Query: 465 NEQILRLM 472
++ + +
Sbjct: 336 VDEWKQHI 343
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
+NVA+K K N +K E IMK LDHPHI+KL ++ + +I+ E G
Sbjct: 40 KINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYG 97
Query: 275 EIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
E+ Y+ + + + QI A+ Y + VHRD+ N+L+ S +KL D
Sbjct: 98 ELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGD 156
Query: 333 FGFS------NYYV-PGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLV 383
FG S +YY +L W +PE +++ D+W V ++ +L
Sbjct: 157 FGLSRYIEDEDYYKASVTRLPIKWM------SPESINFRRF-TTASDVWMFAVCMWEILS 209
Query: 384 CGALPFDGSTLNSLRDRVLSGRFRIP 409
G PF + + G R+P
Sbjct: 210 FGKQPFFWLENKDVIGVLEKG-DRLP 234
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
++VAIK++ K + + +++ RE +IM QLD+P+I++L V + +V E A G
Sbjct: 37 QIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94
Query: 275 EIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
+ ++ R + Q+ ++Y + VHRDL A N+L+ + K++D
Sbjct: 95 PLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISD 153
Query: 333 FGFS-------NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-V 381
FG S +YY K W APE +K+ D+WS GV ++
Sbjct: 154 FGLSKALGADDSYYTARSAGKWPLKWY------APECINFRKFS-SRSDVWSYGVTMWEA 206
Query: 382 LVCGALPFDGSTLNSLRDRVLSGRFRIP 409
L G P+ + + G R+
Sbjct: 207 LSYGQKPYKKMKGPEVMAFIEQG-KRME 233
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 210 VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
V ++++ VA+K + + D + +++ +E +MK++ HP++++L V + YI++E
Sbjct: 240 VWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296
Query: 270 YANQGEIFDYIARYGRMNENAAR--RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ G + DY+ R +A QI SA+EY + +HR+L A N L+ N
Sbjct: 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL 356
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPY--AAPEVFEGKKYCGPEIDIWSLGVVLY-VLVC 384
+K+ADFG S A P APE K+ + D+W+ GV+L+ +
Sbjct: 357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATY 415
Query: 385 GALPFDGSTLNSLRDRVLSGRFRIP 409
G P+ G L+ + + + +R+
Sbjct: 416 GMSPYPGIDLSQVYELLEKD-YRME 439
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
+ VAIK K+ +K +E M+Q DHPHI+KL V+ T++ ++I+ E G
Sbjct: 43 ALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 100
Query: 275 EIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
E+ ++ + + + + A + Q+ +A+ Y ++R VHRD+ A N+L+ SN +KL D
Sbjct: 101 ELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159
Query: 333 FGFS------NYYV-PGQKL-ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLV 383
FG S YY KL W APE +++ D+W GV ++ +L+
Sbjct: 160 FGLSRYMEDSTYYKASKGKLPIKWM------APESINFRRFT-SASDVWMFGVCMWEILM 212
Query: 384 CGALPFDGSTLNSLRDRVLSGRFRIP 409
G PF G N + R+ +G R+P
Sbjct: 213 HGVKPFQGVKNNDVIGRIENG-ERLP 237
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 41/219 (18%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
VA+K + + + P E +MKQL H +++L+ V+ T+ IYI++EY
Sbjct: 33 YYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEY 88
Query: 271 ANQGEIFDYIARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDLKAENLL 321
G + D++ + K QI + + R +HRDL+A N+L
Sbjct: 89 MENGSLVDFL----KTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 322 MDSNLDIKLADFGFS------NYYV-PGQKLAT-WCGSPPYAAPEVFEGKKYCGPEI--D 371
+ L K+ADFG + Y G K W APE + I D
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT------APEAINYGTF---TIKSD 192
Query: 372 IWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
+WS G++L ++ G +P+ G T + + G +R+
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 72/310 (23%), Positives = 128/310 (41%), Gaps = 66/310 (21%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-----IYIVSEYA 271
VAIK I + Q+ RE++I+ + H +II + ++ ++ +YIV +
Sbjct: 54 RVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 272 ----NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ + + ++ + +QIL ++Y H+ V+HRDLK NLL+++ D
Sbjct: 113 ETDLYK------LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
Query: 328 IKLADFGFSNYYVPGQKL--------AT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
+K+ DFG + P AT W Y APE+ K IDIWS+G +
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRW-----YRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 379 LYVLVCGALPFDG-STLNSLR--------------DRVLSGRFR-----IPYF------- 411
L ++ F G L+ L + +++ + R +P+
Sbjct: 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
Query: 412 ----MSTECESLIRKMLVREPTKRYCIEQIKRHRWMA-----EETPRLLPPINILGEVKN 462
++ L+ KML P KR +EQ H ++ + P P E+ +
Sbjct: 282 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDD 341
Query: 463 EPNEQILRLM 472
P E++ L+
Sbjct: 342 LPKEKLKELI 351
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 49/269 (18%), Positives = 104/269 (38%), Gaps = 52/269 (19%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEI--MKQLDHPHIIKLF----QVMETKSMIYIVSEY 270
VA+K+ + +RE EI + H +I+ + + + +Y++++Y
Sbjct: 62 KVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR--------VVHRDLKAENLLM 322
G ++DY+ ++ + + + +S + + H + HRDLK++N+L+
Sbjct: 117 HENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 323 DSNLDIKLADFGFSNYYVPGQKLATW-----CGSPPYAAPEVFEGKKYCGPE-----IDI 372
N +AD G + ++ G+ Y PEV + D+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 373 WSLGVVLYVLVCG----------ALPFDG-----STLNSLRDRVLSGRFR--IP-YFMST 414
+S G++L+ + LP+ + +R+ V + R P + S
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295
Query: 415 ECESLIRKMLVR----EPTKRYCIEQIKR 439
EC + K++ P R ++K+
Sbjct: 296 ECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-28
Identities = 67/310 (21%), Positives = 127/310 (40%), Gaps = 73/310 (23%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM------ETKSMIYIVSEYA 271
VA+K + + ++ ++ YRE+ ++K + H ++I L V E + +Y+V+
Sbjct: 57 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 116
Query: 272 ----NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
N I + ++ ++ + +QIL ++Y H+ ++HRDLK NL ++ + +
Sbjct: 117 GADLNN------IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 170
Query: 328 IKLADFGFSNY-------YVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
+K+ DFG + + YV AT W Y APE+ + +DIWS+G ++
Sbjct: 171 LKILDFGLARHTADEMTGYV-----ATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIM 220
Query: 380 YVLVCGALPFDG-STLNSLR--------------DRVLSGRFR-----IPYF-------- 411
L+ G F G ++ L+ ++ S R +
Sbjct: 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280
Query: 412 ---MSTECESLIRKMLVREPTKRYCIEQIKRHRWMA------EETPRLLPPINILGEVKN 462
+ L+ KMLV + KR Q H + A +E P + E ++
Sbjct: 281 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA--DPYDQSLESRD 338
Query: 463 EPNEQILRLM 472
++ L
Sbjct: 339 LLIDEWKSLT 348
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-28
Identities = 57/269 (21%), Positives = 102/269 (37%), Gaps = 52/269 (19%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEI--MKQLDHPHIIKLF----QVMETKSMIYIVSEY 270
VA+KI + +RE EI L H +I+ + T + +++VS+Y
Sbjct: 67 EVAVKI-----FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121
Query: 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH--------NRRVVHRDLKAENLLM 322
G +FDY+ RY + + S + + H + HRDLK++N+L+
Sbjct: 122 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 323 DSNLDIKLADFGFSNYYVPGQKLATW-----CGSPPYAAPEVFEGKKYCGPE-----IDI 372
N +AD G + + G+ Y APEV + DI
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 373 WSLGVVLYVLVCG----------ALPFDG-----STLNSLRDRVLSGRFR--IP-YFMST 414
+++G+V + + LP+ ++ +R V + R IP + S
Sbjct: 241 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 300
Query: 415 ECESLIRKMLVR----EPTKRYCIEQIKR 439
E ++ K++ R +IK+
Sbjct: 301 EALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
T VAIK + + P + +E ++MK+L H +++L+ V+ ++ IYIV+EY
Sbjct: 287 TWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEY 342
Query: 271 ANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
++G + D++ + QI S + Y VHRDL+A N+L+ NL
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 402
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPY--AAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCG 385
K+ADFG + + A P APE ++ + D+WS G++L + G
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKG 461
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIP 409
+P+ G + D+V G +R+P
Sbjct: 462 RVPYPGMVNREVLDQVERG-YRMP 484
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 62/311 (19%), Positives = 121/311 (38%), Gaps = 73/311 (23%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM------ETKSMIYIVSEY 270
VAIK + + + ++ YRE+ ++K + H ++I L V + + Y+V +
Sbjct: 52 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 111
Query: 271 A----NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
+ + ++ ++ E+ + +Q+L + Y H ++HRDLK NL ++ +
Sbjct: 112 MGTDLGK------LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC 165
Query: 327 DIKLADFGFS-------NYYVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
++K+ DFG + YV T W Y APEV +DIWS+G +
Sbjct: 166 ELKILDFGLARQADSEMTGYV-----VTRW-----YRAPEVILNWMRYTQTVDIWSVGCI 215
Query: 379 LYVLVCGALPFDG-STLNSLR--------------DRVLSGRFR-----IPYF------- 411
+ ++ G F G L+ L+ R+ S + +P
Sbjct: 216 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 275
Query: 412 ----MSTECESLIRKMLVREPTKRYCIEQIKRHRWMA------EETPRLLPPINILGEVK 461
S +L+ KMLV + +R + H + +E + +
Sbjct: 276 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV--QKYDDSFDDV 333
Query: 462 NEPNEQILRLM 472
+ ++ R+
Sbjct: 334 DRTLDEWKRVT 344
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 65/281 (23%), Positives = 121/281 (43%), Gaps = 60/281 (21%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM------ETKSMIYIVSEY 270
NVAIK + + + + ++ YRE+ +MK ++H +II L V E +YIV E
Sbjct: 52 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111
Query: 271 --ANQGEIFDYIARYGRMNENAARRKF--WQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
AN ++ +M + R + +Q+L +++ H+ ++HRDLK N+++ S+
Sbjct: 112 MDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 327 DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA 386
+K+ DFG + + + + Y APEV G Y +DIWS+G ++ ++ G
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGG 223
Query: 387 LPFDGS-------------------TLNSLRDRV--------------LSGRFRIPYFMS 413
+ F G+ + L+ V F F +
Sbjct: 224 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA 283
Query: 414 TECES---------LIRKMLVREPTKRYCIEQIKRHRWMAE 445
+ L+ KMLV + +KR +++ +H ++
Sbjct: 284 DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 62/255 (24%), Positives = 113/255 (44%), Gaps = 45/255 (17%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLF------QVMETKSMIYIVSEY 270
AIK++D + +++ +E+ ++K+ H +I + +++V E+
Sbjct: 52 AAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108
Query: 271 ANQGEIFDYI--ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
G + D I + + E +IL + + H +V+HRD+K +N+L+ N ++
Sbjct: 109 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168
Query: 329 KLADFGFSNYYVPGQ------KLATWCGSPPYAAPEV-----FEGKKYCGPEIDIWSLGV 377
KL DFG S Q + T+ G+P + APEV Y + D+WSLG+
Sbjct: 169 KLVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGI 222
Query: 378 VLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP---------YFMSTECESLIRKMLVREP 428
+ GA P ++ + R L F IP S + +S I LV+
Sbjct: 223 TAIEMAEGAPPL--CDMHPM--RAL---FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNH 275
Query: 429 TKRYCIEQIKRHRWM 443
++R EQ+ +H ++
Sbjct: 276 SQRPATEQLMKHPFI 290
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-27
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 211 LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270
VA+K + + + E +MK L H ++KL V+ TK IYI++E+
Sbjct: 208 TYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEF 263
Query: 271 ANQGEIFDYIARYGRMNENAAR--RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
+G + D++ + + QI + + R +HRDL+A N+L+ ++L
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC 323
Query: 329 KLADFGFS-----NYYVP--GQKLA-TWCGSPPYAAPEVFEGKKYCGPEI--DIWSLGVV 378
K+ADFG + N Y G K W APE + I D+WS G++
Sbjct: 324 KIADFGLARVIEDNEYTAREGAKFPIKWT------APEAINFGSF---TIKSDVWSFGIL 374
Query: 379 LY-VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
L ++ G +P+ G + + + G +R+P
Sbjct: 375 LMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-METKSMIYIVSEYANQGEI 276
VA+K I K+ Q E +M QL H ++++L V +E K +YIV+EY +G +
Sbjct: 47 VAVKCI-KNDATA---QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102
Query: 277 FDYIARYGRMNENAAR--RKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
DY+ GR + + A+EY VHRDL A N+L+ + K++DFG
Sbjct: 103 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162
Query: 335 FS-NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPF 389
+ KL W APE KK+ + D+WS G++L+ + G +P+
Sbjct: 163 LTKEASSTQDTGKLPVKWT------APEALREKKFS-TKSDVWSFGILLWEIYSFGRVPY 215
Query: 390 DGSTLNSLRDRVLSGRFRIP 409
L + RV G +++
Sbjct: 216 PRIPLKDVVPRVEKG-YKMD 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ V VAIK + K+ + E IM Q DHP+II+L V+ + IV+EY
Sbjct: 75 QRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133
Query: 273 QGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + ++ + + + + Y + VHRDL A N+L+DSNL K++
Sbjct: 134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 332 DFGFS--------NYYVP-GQKL-ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
DFG S Y G K+ W APE + + D+WS GVV++
Sbjct: 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWT------APEAIAFRTFS-SASDVWSFGVVMWE 246
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
VL G P+ T + V G +R+P
Sbjct: 247 VLAYGERPYWNMTNRDVISSVEEG-YRLP 274
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-27
Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 59/281 (20%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-----IYIVSEYA 271
VAIK I+ P+ + RE++I+K H +II +F + S +YI+ E
Sbjct: 38 IVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM 96
Query: 272 ----NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
++ + ++++ + +Q L AV+ H V+HRDLK NLL++SN D
Sbjct: 97 QTDLHR------VISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD 150
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPP-----------YAAPEVFEGKKYCGPEIDIWSLG 376
+K+ DFG + + Y APEV +D+WS G
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210
Query: 377 VVLYVLVCGALPFDG-STLNSLR---------------DRVLSGRFR-----IPYF---- 411
+L L F G + L + S R R +P +
Sbjct: 211 CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270
Query: 412 -------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
++ + L+++MLV +P KR ++ H ++
Sbjct: 271 LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 21/181 (11%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV--METKSMIYIVSEY 270
VA+K + K + ++ + +E+EI++ L H +I+K + + + I ++ E+
Sbjct: 48 NTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 271 ANQGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G + +Y+ + + K+ QI ++Y +R+ VHRDL A N+L++S +K
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 166
Query: 330 LADFGFS-------NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
+ DFG + YY + W APE K+ D+WS GV L
Sbjct: 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWY------APECLMQSKFY-IASDVWSFGVTL 219
Query: 380 Y 380
+
Sbjct: 220 H 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-26
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
+ VAIK K+ +K +E M+Q DHPHI+KL V+ T++ ++I+ E G
Sbjct: 418 AMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 475
Query: 275 EIFDYIARYGRMNENAARRK-----FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
E+ ++ ++ + + +Q+ +A+ Y ++R VHRD+ A N+L+ SN +K
Sbjct: 476 ELRSFL----QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 531
Query: 330 LADFGFS------NYYVPGQKL--ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
L DFG S YY + W APE +++ D+W GV ++
Sbjct: 532 LGDFGLSRYMEDSTYYKASKGKLPIKWM------APESINFRRFT-SASDVWMFGVCMWE 584
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
+L+ G PF G N + R+ +G R+P
Sbjct: 585 ILMHGVKPFQGVKNNDVIGRIENG-ERLP 612
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 27/242 (11%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ ++VAIK + K + E IM Q DHP+II+L V+ + IV+EY
Sbjct: 71 KKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129
Query: 273 QGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + ++ ++ I S ++Y + VHRDL A N+L++SNL K++
Sbjct: 130 NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVS 189
Query: 332 DFGFS--------NYYVP-GQKL-ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
DFG Y G K+ W +PE +K+ D+WS G+VL+
Sbjct: 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWT------SPEAIAYRKFT-SASDVWSYGIVLWE 242
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTEC-ESLIRKMLV---REPTKRYCIEQ 436
V+ G P+ + + V G +R+P +C +L + ML ++ R EQ
Sbjct: 243 VMSYGERPYWEMSNQDVIKAVDEG-YRLP--PPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 437 IK 438
I
Sbjct: 300 IV 301
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ V VAIK + K+ E IM Q H +II+L V+ + I++EY
Sbjct: 71 KKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129
Query: 273 QGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + ++ I + ++Y N VHRDL A N+L++SNL K++
Sbjct: 130 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 189
Query: 332 DFGFS---------NYYVPGQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY- 380
DFG S Y G K+ W APE +K+ D+WS G+V++
Sbjct: 190 DFGLSRVLEDDPEATYTTSGGKIPIRW------TAPEAISYRKFT-SASDVWSFGIVMWE 242
Query: 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
V+ G P+ + + + + G FR+P
Sbjct: 243 VMTYGERPYWELSNHEVMKAINDG-FRLP 270
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 62/284 (21%), Positives = 118/284 (41%), Gaps = 66/284 (23%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM------ETKSMIYIVSEY 270
NVAIK + + + + ++ YRE+ +MK ++H +II L V E +Y+V E
Sbjct: 89 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 271 ANQGEIFDYIARYGRMNENAARRKF--WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
+ + + +M + R + +Q+L +++ H+ ++HRDLK N+++ S+ +
Sbjct: 149 MDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
Query: 329 KLADFGFSNYYVPGQKL----AT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
K+ DFG + + T + Y APEV G Y +DIWS+G ++ +V
Sbjct: 204 KILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGY-KENVDIWSVGCIMGEMV 257
Query: 384 CGALPFDGS-------------------TLNSLRDRV------LSGRFRIPY-------- 410
+ F G + L+ V + +
Sbjct: 258 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 317
Query: 411 ---------FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
+++ L+ KMLV +P KR ++ +H ++
Sbjct: 318 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-METKSMIYIVSEYANQGEI 276
VA+K I K+ Q E +M QL H ++++L V +E K +YIV+EY +G +
Sbjct: 219 VAVKCI-KNDATA---QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 277 FDYIARYGRMNENAAR-RKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
DY+ GR KF + A+EY VHRDL A N+L+ + K++DFG
Sbjct: 275 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334
Query: 335 FS-NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPF 389
+ KL W APE KK+ + D+WS G++L+ + G +P+
Sbjct: 335 LTKEASSTQDTGKLPVKW------TAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPY 387
Query: 390 DGSTLNSLRDRVLSGRFRIP 409
L + RV G +++
Sbjct: 388 PRIPLKDVVPRVEKG-YKMD 406
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 29/213 (13%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYIVS 268
V VA+K++ + ++++ RE MK+ DHPH+ KL V + ++
Sbjct: 51 FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL 110
Query: 269 EYANQGEIFDYIARYGRMNENAARRKF-------WQILSAVEYCHNRRVVHRDLKAENLL 321
+ G++ ++ R+ EN I +EY +R +HRDL A N +
Sbjct: 111 PFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169
Query: 322 MDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIW 373
+ ++ + +ADFG S +YY G P + A E Y D+W
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCA-----SKLPVKWLALESLADNLY-TVHSDVW 223
Query: 374 SLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGR 405
+ GV ++ ++ G P+ G + + ++ G
Sbjct: 224 AFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-26
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
++VAIK++ K + + +++ RE +IM QLD+P+I++L V + +V E A G
Sbjct: 363 QIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 420
Query: 275 EIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+ ++ + + Q+ ++Y + VHR+L A N+L+ + K++DF
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 334 GFS-------NYYVP--GQKLAT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VL 382
G S +YY K W APE +K+ D+WS GV ++ L
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWY------APECINFRKF-SSRSDVWSYGVTMWEAL 533
Query: 383 VCGALPFDGSTLNSLRDRVLSGRFRIP 409
G P+ + + G R+
Sbjct: 534 SYGQKPYKKMKGPEVMAFIEQG-KRME 559
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV--METKSMIYIVSEY 270
VA+K + S + L+ RE+EI+K L H +I+K V + + ++ EY
Sbjct: 37 NTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94
Query: 271 ANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
G + DY+ + + + + + QI +EY +R +HRDL N+L+++ +
Sbjct: 95 LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 329 KLADFGFS-------NYYVP--GQKL-ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
K+ DFG + ++ + W APE K+ D+WS GVV
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWY------APESLTESKF-SVASDVWSFGVV 206
Query: 379 LY----------------VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
LY + + G + L + + + R+P
Sbjct: 207 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-GRLP 252
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 48/269 (17%), Positives = 105/269 (39%), Gaps = 52/269 (19%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEI--MKQLDHPHIIKLF----QVMETKSMIYIVSEY 270
VA+KI + Q E E+ + + H +I++ + +++++ +
Sbjct: 49 YVAVKI-----FPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103
Query: 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR----------RVVHRDLKAENL 320
+G + D++ ++ N + + Y H + HRD+K++N+
Sbjct: 104 HEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162
Query: 321 LMDSNLDIKLADFGFSNYYVPGQKLA---TWCGSPPYAAPEVFEGKKYCGPE----IDIW 373
L+ +NL +ADFG + + G+ G+ Y APEV EG + ID++
Sbjct: 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222
Query: 374 SLGVVLYVLVCGALPFDGS----------------TLNSLRDRVLSGRFR--IP-YFMST 414
++G+VL+ L DG +L +++ V+ + R + Y+
Sbjct: 223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH 282
Query: 415 ECESLIRKMLVR----EPTKRYCIEQIKR 439
+++ + + + R +
Sbjct: 283 AGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 71/287 (24%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM------------- 263
VAIK I DP +++ RE++I+++LDH +I+K+F+++
Sbjct: 38 RVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95
Query: 264 -IYIVSEYA----NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAE 318
+YIV EY + G + E AR +Q+L ++Y H+ V+HRDLK
Sbjct: 96 SVYIVQEYMETDLAN------VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPA 149
Query: 319 NLLMDS-NLDIKLADFGFSNYYVPGQK--------LAT-WCGSPPYAAPEVFEGKKYCGP 368
NL +++ +L +K+ DFG + P L T W Y +P +
Sbjct: 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW-----YRSPRLLLSPNNYTK 204
Query: 369 EIDIWSLGVVLYVLVCGALPFDG-STLNSL----------------------RDRVLSGR 405
ID+W+ G + ++ G F G L + + +
Sbjct: 205 AIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDM 264
Query: 406 FRIP-----YF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
+S E + ++L P R E+ H +M+
Sbjct: 265 TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-METKSMIYIVSEYANQ 273
++ A+K + D + + E IMK HP+++ L + + ++ +V Y
Sbjct: 53 KIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 111
Query: 274 GEIFDYIARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDLKAENLLMDS 324
G++ ++I R Q+ ++Y +++ VHRDL A N ++D
Sbjct: 112 GDLRNFI----RNE----THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE 163
Query: 325 NLDIKLADFGFS------NYYVPGQKLAT-----WCGSPPYAAPEVFEGKKYCGPEIDIW 373
+K+ADFG + YY K W A E + +K+ + D+W
Sbjct: 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW------MALESLQTQKF-TTKSDVW 216
Query: 374 SLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGR 405
S GV+L+ ++ GA P+ + +L GR
Sbjct: 217 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV--METKSMIYIVSEYAN 272
VA+K + K+ P + +E++I++ L H HIIK + + +V EY
Sbjct: 60 GEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
G + DY+ R+ + QI + Y H + +HRDL A N+L+D++ +K+ D
Sbjct: 119 LGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD 177
Query: 333 FGFS-------NYYVPGQKLAT---WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
FG + YY + + W APE + K+ D+WS GV LY
Sbjct: 178 FGLAKAVPEGHEYYRVREDGDSPVFWY------APECLKEYKF-YYASDVWSFGVTLY 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV--METKSMIYIVSEY 270
VA+K + S D + RE++I+K L I+K V + + +V EY
Sbjct: 50 NTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107
Query: 271 ANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
G + D++ + R +A+R + QI +EY +RR VHRDL A N+L++S +
Sbjct: 108 LPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166
Query: 329 KLADFGFS-------NYYVPGQKLAT---WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
K+ADFG + +YYV + + W APE + + D+WS GVV
Sbjct: 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWY------APESLSDNIF-SRQSDVWSFGVV 219
Query: 379 LY-VLVCGALPFDGST 393
LY + S
Sbjct: 220 LYELFTYCDKSCSPSA 235
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV--METKSMIYIVSEY 270
VA+K + S + L+ RE+EI+K L H +I+K V + + ++ EY
Sbjct: 68 NTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 271 ANQGEIFDYIARYGRMNENAARRKF-WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
G + DY+ ++ ++ ++ QI +EY +R +HRDL N+L+++ +K
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185
Query: 330 LADFGFS-------NYYVPGQKLAT---WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVL 379
+ DFG + YY + + W APE K+ D+WS GVVL
Sbjct: 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWY------APESLTESKF-SVASDVWSFGVVL 238
Query: 380 Y 380
Y
Sbjct: 239 Y 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 45/195 (23%), Positives = 85/195 (43%), Gaps = 40/195 (20%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-----IYIVSEYAN 272
VAIK I + D ++ +++ RE+ I+ +L+H H++K+ ++ K + +Y+V E A+
Sbjct: 81 VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD 140
Query: 273 QGEIFD---YIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
D + E + + +L V+Y H+ ++HRDLK N L++ + +K
Sbjct: 141 S----DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVK 196
Query: 330 LADFGFSNYYVPGQKLATWCGSPP----------------------------YAAPEVFE 361
+ DFG + + + P Y APE+
Sbjct: 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256
Query: 362 GKKYCGPEIDIWSLG 376
++ ID+WS+G
Sbjct: 257 LQENYTEAIDVWSIG 271
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-METKSMIYIVSEYA 271
++ + AIK + + ++ RE +M+ L+HP+++ L + + + + +++ Y
Sbjct: 47 QNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105
Query: 272 NQGEIFDYIARYGRMNENAARRK-----FWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326
G++ +I R + K Q+ +EY ++ VHRDL A N ++D +
Sbjct: 106 CHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF 161
Query: 327 DIKLADFGFS------NYYVPGQKLAT-----WCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
+K+ADFG + YY Q W A E + ++ + D+WS
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRHARLPVKW------TALESLQTYRF-TTKSDVWSF 214
Query: 376 GVVLY-VLVCGALPFDGSTLNSLRDRVLSGR 405
GV+L+ +L GA P+ L + GR
Sbjct: 215 GVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 49/246 (19%), Positives = 89/246 (36%), Gaps = 36/246 (14%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
H V +K++DK+ + + + +M +L H H++ + V +V E+
Sbjct: 39 HETEVLLKVLDKAHRNYS--ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKF 96
Query: 274 GEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDS------- 324
G + Y+ + + N + Q+ +A+ + ++H ++ A+N+L+
Sbjct: 97 GSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155
Query: 325 -NLDIKLADFGFS------NYY---VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWS 374
IKL+D G S + +P W PE E K D WS
Sbjct: 156 NPPFIKLSDPGISITVLPKDILQERIP------WV------PPECIENPKNLNLATDKWS 203
Query: 375 LGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC 433
G L+ + G P ++P + E +LI + EP R
Sbjct: 204 FGTTLWEICSGGDKPLSALDSQRKLQFYEDR-HQLPAPKAAELANLINNCMDYEPDHRPS 262
Query: 434 IEQIKR 439
I R
Sbjct: 263 FRAIIR 268
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-----METKSMIYIVSE 269
++ VA+K + +++ E MK HP++I+L V + ++
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 270 YANQGEIFDYIARYGRMNENAARRKF-------WQILSAVEYCHNRRVVHRDLKAENLLM 322
+ G++ Y+ Y R+ I +EY NR +HRDL A N ++
Sbjct: 122 FMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 323 DSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWS 374
++ + +ADFG S +YY G+ P + A E + Y + D+W+
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRI-----AKMPVKWIAIESLADRVY-TSKSDVWA 234
Query: 375 LGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
GV ++ + G P+ G + + D +L G R+
Sbjct: 235 FGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLK 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-24
Identities = 62/305 (20%), Positives = 118/305 (38%), Gaps = 82/305 (26%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM--IYIVSEYA-- 271
VA+K I + + + Q+ +RE+ I+ +L H +I+ L V+ + +Y+V +Y
Sbjct: 36 VVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET 95
Query: 272 --NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
+ + R + + +Q++ ++Y H+ ++HRD+K N+L+++ +K
Sbjct: 96 DLHA------VIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVK 149
Query: 330 LADFGFSNYYVPGQKLATWCGSPP----------------------YAAPEVFEGKKYCG 367
+ADFG S +V +++ Y APE+ G
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 368 PEIDIWSLGVVLYVLVCGALPFDG-STLNSLR--------------DRVLSGRFR----- 407
ID+WSLG +L ++CG F G ST+N L + + S +
Sbjct: 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
Query: 408 ------IPYFMSTECES---------------------LIRKMLVREPTKRYCIEQIKRH 440
I + + L+ K+L P KR +H
Sbjct: 270 LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329
Query: 441 RWMAE 445
+++
Sbjct: 330 PFVSI 334
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 66/264 (25%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-----IYIVSEY- 270
NVAIK +++ D ++ +++ RE+ I+ +L +II+L+ ++ + +YIV E
Sbjct: 53 NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA 112
Query: 271 ---------ANQG---EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAE 318
E I + +L + H ++HRDLK
Sbjct: 113 DSDLKKLFKTPIFLTEEHIKTI--------------LYNLLLGENFIHESGIIHRDLKPA 158
Query: 319 NLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPP-----------------------YA 355
N L++ + +K+ DFG + + Y
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218
Query: 356 APEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTE 415
APE+ ++ IDIWS G + LN L+ + R P F +
Sbjct: 219 APELILLQENYTKSIDIWSTGCIF-----------AELLNMLQSHINDPTNRFPLFPGSS 267
Query: 416 CESLIRKMLVREPTKRYCIEQIKR 439
C L ++ ++ +Q+
Sbjct: 268 CFPLSPDRNSKKVHEKSNRDQLNI 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
VAIK + + E +MK+ + H+++L V+ ++ E +G
Sbjct: 55 ETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRG 113
Query: 275 EIFDYI-ARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDLKAENLLMDS 324
++ Y+ + M N +I + Y + + VHRDL A N ++
Sbjct: 114 DLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173
Query: 325 NLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEIDIWSLG 376
+ +K+ DFG + +YY G K G P + +PE + + D+WS G
Sbjct: 174 DFTVKIGDFGMTRDIYETDYYRKGGK-----GLLPVRWMSPESLKDGVFT-TYSDVWSFG 227
Query: 377 VVLY-VLVCGALPFDGSTLNSLRDRVLSGR 405
VVL+ + P+ G + + V+ G
Sbjct: 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 38/195 (19%), Positives = 77/195 (39%), Gaps = 37/195 (18%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMK--QLDHPHIIKLF-----QVMETKSMIYIVSE 269
VA+K+ N Q E I + ++H +I + + + +V E
Sbjct: 38 PVAVKV-----FSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH---------NRRVVHRDLKAENL 320
Y G + Y++ + + ++ R + + Y H + HRDL + N+
Sbjct: 93 YYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151
Query: 321 LMDSNLDIKLADFGFSNYYVPGQKLATW---------CGSPPYAAPEVFEGK------KY 365
L+ ++ ++DFG S + + G+ Y APEV EG +
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211
Query: 366 CGPEIDIWSLGVVLY 380
++D+++LG++ +
Sbjct: 212 ALKQVDMYALGLIYW 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 65/301 (21%), Positives = 110/301 (36%), Gaps = 81/301 (26%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-------------- 263
A+K K DP + RE++IMK LDH +IIKL T
Sbjct: 35 FALK---KVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88
Query: 264 ------------------------IYIVSEYANQGEIFDYIARYGRMNENAAR---RKF- 295
+ ++ EY + + + R + +
Sbjct: 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYI 147
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI-KLADFGFSNYYVPGQKLATWCGSPPY 354
+Q+ AV + H+ + HRD+K +NLL++S + KL DFG + +P + + S Y
Sbjct: 148 YQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFY 207
Query: 355 AAPEV-FEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG-STLNSLRD--RVL-------- 402
APE+ +Y P ID+WS+G V L+ G F G ++++ L +++
Sbjct: 208 RAPELMLGATEY-TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266
Query: 403 ------SGRFRIPYF------------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444
R P + L+ ++L EP R + H +
Sbjct: 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326
Query: 445 E 445
Sbjct: 327 H 327
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 58/279 (20%), Positives = 103/279 (36%), Gaps = 60/279 (21%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM-------IYIVSEY 270
VAIK K DP + + ++ + L HP+I++L T + +V EY
Sbjct: 51 VAIK---KVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107
Query: 271 ANQGEIFDYIARYGRMNENAARR--KF--WQILSAVEYCHNR--RVVHRDLKAENLLMD- 323
+ Y R K +Q++ ++ H V HRD+K N+L++
Sbjct: 108 VPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE 166
Query: 324 SNLDIKLADFGFSNYYVPGQKL----AT-WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
++ +KL DFG + P + + + Y APE+ G ++ +DIWS+G +
Sbjct: 167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 379 LYVLVCGALPFDG-STLNSLRD--RVL--------------SGRFRIPYF---------- 411
++ G F G ++ L + RVL +
Sbjct: 222 FAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS 281
Query: 412 -----MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
+ E L+ +L P +R + H + E
Sbjct: 282 DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 213 RHTVNVAIKII-DKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
+ + VA+K + D + + Q RE E++ L H HI+K + V + +V EY
Sbjct: 43 KDKMLVAVKALKDPTLAARKDFQ---REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 99
Query: 272 NQGEIFDY-------IARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDL 315
G++ + A+ + QI S + Y ++ VHRDL
Sbjct: 100 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDL 159
Query: 316 KAENLLMDSNLDIKLADFGFS------NYYVPGQKLAT---WCGSPPYAAPEVFEGKKYC 366
N L+ +NL +K+ DFG S +YY G W PE +K+
Sbjct: 160 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW------MPPESIMYRKFT 213
Query: 367 GPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGR 405
E D+WS GV+L+ + G P+ + + + + GR
Sbjct: 214 -TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 57/311 (18%), Positives = 115/311 (36%), Gaps = 83/311 (26%)
Query: 212 LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-----------DHPHIIKLFQVMET 260
+ + +VA+KI+ + D V + E+++++++ HI+KL
Sbjct: 41 MVNNTHVAMKIV-RG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97
Query: 261 KSMIY----IVSE--YANQGEIFDYIAR--YGRMNENAARRKFWQILSAVEYCH-NRRVV 311
K +V E N + I + + + ++ Q+L ++Y H ++
Sbjct: 98 KGPNGVHVVMVFEVLGEN---LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 154
Query: 312 HRDLKAENLLMD------SNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKY 365
H D+K EN+LM+ + + IK+AD G + +Y + + Y +PEV G +
Sbjct: 155 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSIQTREYRSPEVLLGAPW 212
Query: 366 CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR------------------VLSGRFR 407
G DIWS +++ L+ G F+ +S + +G++
Sbjct: 213 -GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT 271
Query: 408 IPYF-------------------------MSTECES-----LIRKMLVREPTKRYCIEQI 437
+F ++ E+ + ML +P KR +
Sbjct: 272 RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331
Query: 438 KRHRWMAEETP 448
H W+ +
Sbjct: 332 VNHPWLKDTLG 342
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-22
Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 38/213 (17%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-METKSMIYIVSEYANQ 273
++ A+K + D + + E IMK HP+++ L + + ++ +V Y
Sbjct: 117 KIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 175
Query: 274 GEIFDYIARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDLKAENLLMDS 324
G++ ++I R Q+ +++ +++ VHRDL A N ++D
Sbjct: 176 GDLRNFI----RNE----THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 227
Query: 325 NLDIKLADFGFS------NYYVPGQKLAT-----WCGSPPYAAPEVFEGKKYCGPEIDIW 373
+K+ADFG + + K W A E + +K+ + D+W
Sbjct: 228 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW------MALESLQTQKF-TTKSDVW 280
Query: 374 SLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGR 405
S GV+L+ ++ GA P+ + +L GR
Sbjct: 281 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-22
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 213 RHTVNVAIKII-DKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
+ + VA+K + + S+ + Q RE E++ L H HI++ F V + +V EY
Sbjct: 69 QDKMLVAVKALKEASESARQDFQ---REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125
Query: 272 NQGEIFDY------IARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDLK 316
G++ + A+ E+ A Q+ + + Y VHRDL
Sbjct: 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 185
Query: 317 AENLLMDSNLDIKLADFGFS------NYYVPGQKLAT---WCGSPPYAAPEVFEGKKYCG 367
N L+ L +K+ DFG S +YY G + W PE +K+
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW------MPPESILYRKFT- 238
Query: 368 PEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGR 405
E D+WS GVVL+ + G P+ + D + GR
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
T VAIK + K + + ++ E + +L HP+++ L V+ + ++ Y +
Sbjct: 37 EQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCS 95
Query: 273 QGEIFDY-------IARYGRMNENAARRKF---------WQILSAVEYCHNRRVVHRDLK 316
G++ ++ ++ + QI + +EY + VVH+DL
Sbjct: 96 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA 155
Query: 317 AENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGP 368
N+L+ L++K++D G +YY P + APE K+
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN-----SLLPIRWMAPEAIMYGKFS-I 209
Query: 369 EIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
+ DIWS GVVL+ V G P+ G + + + + + +P
Sbjct: 210 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLP 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
VA+K++ K P L+ + E ++KQ++HPH+IKL+ + ++ EYA G
Sbjct: 53 YTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 275 EIFDYIARYGRMNENAARRKF-------------------------WQILSAVEYCHNRR 309
+ ++ R R WQI ++Y +
Sbjct: 112 SLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170
Query: 310 VVHRDLKAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFE 361
+VHRDL A N+L+ +K++DFG S + YV + G P + A E
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ-----GRIPVKWMAIESLF 225
Query: 362 GKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSG 404
Y + D+WS GV+L+ ++ G P+ G L + + +G
Sbjct: 226 DHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-21
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQ 273
++ AIK + K + + E+E++ +L HP+II L E + +Y+ EYA
Sbjct: 52 RMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110
Query: 274 GEIFDYIARYGRMNENAARRKF-----------------WQILSAVEYCHNRRVVHRDLK 316
G + D++ R R+ E + ++Y ++ +HRDL
Sbjct: 111 GNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169
Query: 317 AENLLMDSNLDIKLADFGFS---NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEID 371
A N+L+ N K+ADFG S YV G P + A E Y D
Sbjct: 170 ARNILVGENYVAKIADFGLSRGQEVYVKKTM-----GRLPVRWMAIESLNYSVYT-TNSD 223
Query: 372 IWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGRFRIP 409
+WS GV+L+ ++ G P+ G T L +++ G +R+
Sbjct: 224 VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLE 261
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 43/212 (20%), Positives = 77/212 (36%), Gaps = 30/212 (14%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
+ VA+K + + E I+ + +H +I++ V +I+ E
Sbjct: 59 SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG 117
Query: 274 GEIFDYIARYGRMNENAARR-------KF-WQILSAVEYCHNRRVVHRDLKAENLLMD-- 323
G++ ++ R R + I +Y +HRD+ A N L+
Sbjct: 118 GDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 176
Query: 324 -SNLDIKLADFGFS------NYYVPGQKLAT---WCGSPPYAAPEVFEGKKYCGPEIDIW 373
K+ DFG + +YY G W PE F + + D W
Sbjct: 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM------PPEAFMEGIFT-SKTDTW 229
Query: 374 SLGVVLY-VLVCGALPFDGSTLNSLRDRVLSG 404
S GV+L+ + G +P+ + + + V SG
Sbjct: 230 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 43/212 (20%), Positives = 76/212 (35%), Gaps = 30/212 (14%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
+ VA+K + + E I+ + +H +I++ V +I+ E
Sbjct: 100 SPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 158
Query: 274 GEIFDYIARYGRMNENAARR-------KF-WQILSAVEYCHNRRVVHRDLKAENLLMD-- 323
G++ ++ R R + I +Y +HRD+ A N L+
Sbjct: 159 GDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 217
Query: 324 -SNLDIKLADFGFS------NYYVPGQKLAT---WCGSPPYAAPEVFEGKKYCGPEIDIW 373
K+ DFG + YY G W PE F + + D W
Sbjct: 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM------PPEAFMEGIFT-SKTDTW 270
Query: 374 SLGVVLY-VLVCGALPFDGSTLNSLRDRVLSG 404
S GV+L+ + G +P+ + + + V SG
Sbjct: 271 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-20
Identities = 63/311 (20%), Positives = 114/311 (36%), Gaps = 86/311 (27%)
Query: 218 VAIKIIDKSQLDPVNLQKVYR----EVEIMKQL------DHPHIIKLFQVMETKSMIYIV 267
VA+K++ N ++ +R E+ I++ L + ++I + + ++ I +
Sbjct: 125 VALKMV-------RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177
Query: 268 SEYANQGEIFDYIA--RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
E + +++ I ++ + R+ IL ++ H R++H DLK EN+L+
Sbjct: 178 FELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ 236
Query: 326 L--DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVL- 382
IK+ DFG S Y Q++ T+ S Y APEV G +Y P ID+WSLG +L L
Sbjct: 237 GRSGIKVIDFGSSCY--EHQRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELL 293
Query: 383 --------------------VCGALP-------------FDG------------------ 391
+ G
Sbjct: 294 TGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVV 353
Query: 392 -STLNSLRDRVLSGRFRIPYFMSTECES------LIRKMLVREPTKRYCIEQIKRHRWMA 444
+ S R ++ + + + +++ L +P R Q RH W+
Sbjct: 354 LNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
Query: 445 EETPRLLPPIN 455
P+ PP
Sbjct: 414 RRLPK--PPTG 422
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 42/225 (18%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
VA+K++ K + RE +M + D+P+I+KL V + ++ EY G
Sbjct: 77 FTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 135
Query: 275 EIFDYIARYGRMNENAARRKF-------------------------WQILSAVEYCHNRR 309
++ +++ R + + Q+ + + Y R+
Sbjct: 136 DLNEFL-RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194
Query: 310 VVHRDLKAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFE 361
VHRDL N L+ N+ +K+ADFG S +YY + P + PE
Sbjct: 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN-----DAIPIRWMPPESIF 249
Query: 362 GKKYCGPEIDIWSLGVVLY-VLVCGALPFDGSTLNSLRDRVLSGR 405
+Y E D+W+ GVVL+ + G P+ G + V G
Sbjct: 250 YNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN 293
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 47/225 (20%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQ 273
+ VA+K++ K + + E++++ L +H +I+ L +++EY
Sbjct: 53 AMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 111
Query: 274 GEIFDYIARYGRMNENAARRKF-------------------WQILSAVEYCHNRRVVHRD 314
G++ +++ R R + ++ +Q+ + + ++ +HRD
Sbjct: 112 GDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170
Query: 315 LKAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPPY--AAPEVFEGKKYC 366
L A N+L+ K+ DFG + + YV P APE Y
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN-----ARLPVKWMAPESIFNCVYT 225
Query: 367 GPEIDIWSLGVVLYVLV-CGALPFDGSTLNS-LRDRVLSGRFRIP 409
E D+WS G+ L+ L G+ P+ G ++S + G FR+
Sbjct: 226 -FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG-FRML 268
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 36/253 (14%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYA 271
+ V VA+K++ K +L + E+E+MK + H +II L +Y++ EYA
Sbjct: 111 KEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169
Query: 272 NQGEIFDYIARYGRMNENAARRKF-----------------WQILSAVEYCHNRRVVHRD 314
++G + +Y+ R R +Q+ +EY +++ +HRD
Sbjct: 170 SKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228
Query: 315 LKAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYC 366
L A N+L+ N +K+ADFG + +YY G P + APE + Y
Sbjct: 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN-----GRLPVKWMAPEALFDRVYT 283
Query: 367 GPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424
+ D+WS GV+++ + G P+ G + L + G R P + E ++R
Sbjct: 284 -HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCW 342
Query: 425 VREPTKRYCIEQI 437
P++R +Q+
Sbjct: 343 HAVPSQRPTFKQL 355
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 37/219 (16%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQV-METKSMIYIVSEYAN 272
VA+K++ K + + E++I+ + H +++ L + + ++ E+
Sbjct: 57 CRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 273 QGEIFDYIARYGRMNENAARRKF-----------------WQILSAVEYCHNRRVVHRDL 315
G + Y+ R R + +Q+ +E+ +R+ +HRDL
Sbjct: 116 FGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174
Query: 316 KAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCG 367
A N+L+ +K+ DFG + YV P + APE + Y
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD-----ARLPLKWMAPETIFDRVYT- 228
Query: 368 PEIDIWSLGVVLY-VLVCGALPFDGSTLNS-LRDRVLSG 404
+ D+WS GV+L+ + GA P+ G ++ R+ G
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 54/311 (17%), Positives = 101/311 (32%), Gaps = 86/311 (27%)
Query: 218 VAIKIIDKSQLDPVNLQKVYR----EVEIMKQL------DHPHIIKLFQVMETKSMIYIV 267
VA+KII N+ K E+ ++K++ + + + + I
Sbjct: 48 VALKII-------RNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA 100
Query: 268 SEYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
E + F+++ R +Q+ A+ + H ++ H DLK EN+L ++
Sbjct: 101 FELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159
Query: 326 L-------------------DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYC 366
I++ADFG + + + T + Y PEV +
Sbjct: 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWA 217
Query: 367 GPEIDIWSLGVVLYVLVCGALPFDGST-----------LNSLRDRVLSGRFRIPYFMS-- 413
P D+WS+G +L+ G F L + ++ + YF
Sbjct: 218 QP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGG 276
Query: 414 -------------------------------TECESLIRKMLVREPTKRYCIEQIKRHRW 442
+ L+R+ML +P +R + + H +
Sbjct: 277 LVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336
Query: 443 MAEETPRLLPP 453
A TP
Sbjct: 337 FAGLTPEERSF 347
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYA 271
+ V VA+K++ K +L + E+E+MK + H +II L +Y++ EYA
Sbjct: 65 KEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 123
Query: 272 NQGEIFDYIARYGRMNENAARRKF-----------------WQILSAVEYCHNRRVVHRD 314
++G + +Y+ R R +Q+ +EY +++ +HRD
Sbjct: 124 SKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182
Query: 315 LKAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYC 366
L A N+L+ N +K+ADFG + +YY G P + APE + Y
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN-----GRLPVKWMAPEALFDRVYT 237
Query: 367 GPEIDIWSLGVVLYVLV-CGALPFDGSTLNSLRDRVLSGR 405
+ D+WS GV+++ + G P+ G + L + G
Sbjct: 238 -HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYAN 272
VA+K++ KS +L + E+E+MK + H +II L +Y++ EYA+
Sbjct: 100 RVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 158
Query: 273 QGEIFDYIARYGRMNENAARRKF-----------------WQILSAVEYCHNRRVVHRDL 315
+G + +Y+ + R +Q+ +EY +++ +HRDL
Sbjct: 159 KGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217
Query: 316 KAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCG 367
A N+L+ + +K+ADFG + +YY G P + APE + Y
Sbjct: 218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN-----GRLPVKWMAPEALFDRIYT- 271
Query: 368 PEIDIWSLGVVLYVLV-CGALPFDGSTLNSLRDRVLSG 404
+ D+WS GV+L+ + G P+ G + L + G
Sbjct: 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYR-----EVEIMKQL------DHPHIIKLFQVMETKSMIYI 266
VAIKII K++ K + EV +++ + +I+ L + ++ + +
Sbjct: 82 VAIKII-KNK-------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133
Query: 267 VSEYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLM 322
V E + ++D + ++ N R+ Q+ +A+ + ++H DLK EN+L+
Sbjct: 134 VFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192
Query: 323 --DSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY 380
IK+ DFG S GQ++ + S Y +PEV G Y ID+WSLG +L
Sbjct: 193 CNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILV 249
Query: 381 VLVCGALPFDGST 393
+ G F G+
Sbjct: 250 EMHTGEPLFSGAN 262
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-19
Identities = 54/243 (22%), Positives = 101/243 (41%), Gaps = 33/243 (13%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQ 273
+ VA+K++ KS + + E++IM L H +I+ L + +++EY
Sbjct: 76 VLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 274 GEIFDYIARYGRMNENAARRKF--------------WQILSAVEYCHNRRVVHRDLKAEN 319
G++ +++ R R+ E Q+ + + ++ +HRD+ A N
Sbjct: 135 GDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 194
Query: 320 LLMDSNLDIKLADFGFS------NYYVPGQKLATWCGSPP--YAAPEVFEGKKYCGPEID 371
+L+ + K+ DFG + + Y+ P + APE Y + D
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGN-----ARLPVKWMAPESIFDCVYT-VQSD 248
Query: 372 IWSLGVVLYVLV-CGALPFDGSTLNS-LRDRVLSG-RFRIPYFMSTECESLIRKMLVREP 428
+WS G++L+ + G P+ G +NS V G + P F S+++ EP
Sbjct: 249 VWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 308
Query: 429 TKR 431
T R
Sbjct: 309 THR 311
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 65/306 (21%), Positives = 113/306 (36%), Gaps = 88/306 (28%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYR----EVEIMKQL------DHPHIIKLFQVMETKS 262
+VA+KI+ N+ + E+++++ L +++ + E
Sbjct: 38 AGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90
Query: 263 MIYIVSEYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAEN- 319
I IV E +D+I G + R+ +QI +V + H+ ++ H DLK EN
Sbjct: 91 HICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENI 149
Query: 320 LLMDSNL------------------DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFE 361
L + S+ DIK+ DFG + Y + +T + Y APEV
Sbjct: 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD--DEHHSTLVSTRHYRAPEVIL 207
Query: 362 GKKYCGPEIDIWSLGVVLYVL---------------------VCGALP------------ 388
+ P D+WS+G +L + G LP
Sbjct: 208 ALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKY 266
Query: 389 FDGSTLNSLRDRVLSGRFRIP-------YFMSTECE-----SLIRKMLVREPTKRYCIEQ 436
F L+ +GR+ + +S + E LI+KML +P KR + +
Sbjct: 267 FHHDRLDWDEHSS-AGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
Query: 437 IKRHRW 442
+H +
Sbjct: 326 ALKHPF 331
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-18
Identities = 51/309 (16%), Positives = 96/309 (31%), Gaps = 95/309 (30%)
Query: 218 VAIKIIDKSQLDPVNLQKVYR-----EVEIMKQL-----DHPHIIKLFQVMETKSMIYIV 267
A+K++ ++ K Y E +I+K++ ++ +I+K + ++
Sbjct: 63 YAVKVV-RNI-------KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114
Query: 268 SEYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325
E +++ I R + + +IL A+ Y + H DLK EN+L+D
Sbjct: 115 FEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP 173
Query: 326 L-------------------------DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVF 360
IKL DFG + + + + Y APEV
Sbjct: 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVI 231
Query: 361 EGKKYCGPEIDIWSLGVVLYVL---------------------VCGALP----------- 388
+ D+WS G VL L + +P
Sbjct: 232 LNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTN 290
Query: 389 ----FDGSTLNSLRDRVLSGRFRIPYFMST----------ECESLIRKMLVREPTKRYCI 434
+ L S I + + +L +PT R
Sbjct: 291 GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350
Query: 435 EQIKRHRWM 443
++ +H+++
Sbjct: 351 AELLKHKFL 359
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 50/226 (22%), Positives = 95/226 (42%), Gaps = 45/226 (19%)
Query: 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQ 273
++ VA+K++ K + D + + E+++M QL H +I+ L IY++ EY
Sbjct: 75 SIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 133
Query: 274 GEIFDYIARYGRMNENAARRKF------------------------WQILSAVEYCHNRR 309
G++ +Y+ R R + ++ +Q+ +E+ +
Sbjct: 134 GDLLNYL-RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192
Query: 310 VVHRDLKAENLLMDSNLDIKLADFGFS------NYYVPGQKLAT---WCGSPPYAAPEVF 360
VHRDL A N+L+ +K+ DFG + + YV W APE
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW------MAPESL 246
Query: 361 EGKKYCGPEIDIWSLGVVLYVLV-CGALPFDGSTLNS-LRDRVLSG 404
Y + D+WS G++L+ + G P+ G +++ + +G
Sbjct: 247 FEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 61/340 (17%), Positives = 107/340 (31%), Gaps = 123/340 (36%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-----DHP---HIIKL---FQVMETKSM-IY 265
VA+K++ KS + E+ ++K + + P +++L F++ I
Sbjct: 65 VAMKVV-KS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121
Query: 266 IVSEYANQGE-IFDYIAR--YGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLL 321
+V E G + +I + Y + ++ Q+L ++Y H + R++H D+K EN+L
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 322 M-------------------------------------------------DSNLDIKLAD 332
+ L +K+AD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 333 FGFSNYYVPGQKLATWCGSPP-YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
G + K T Y + EV G Y DIWS + + L G F+
Sbjct: 240 LGNA---CWVHKHFTEDIQTRQYRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEP 295
Query: 392 -STLNSLRDR-----------------VLSGRFRIPYF---------------------- 411
S RD +++G++ +F
Sbjct: 296 HSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV 355
Query: 412 ----MSTE----CESLIRKMLVREPTKRYCIEQIKRHRWM 443
S E + ML P KR + RH W+
Sbjct: 356 EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-14
Identities = 54/211 (25%), Positives = 84/211 (39%), Gaps = 68/211 (32%)
Query: 218 VAIKIIDKSQLDPVNLQ-----KVYREVEIMKQLDHPHIIKLFQV---METKSMIYIVSE 269
VA+K + P + Q + E+E + HPH++ L + E MI ++ +
Sbjct: 66 VALK-----RRTPESSQGIEEFET--EIETLSFCRHPHLVSL--IGFCDERNEMI-LIYK 115
Query: 270 YANQGEIFDYIARYGRMNEN--------------AARRKFWQILSAVEYCHNRRVVHRDL 315
Y G + ++ YG AAR + Y H R ++HRD+
Sbjct: 116 YMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAAR--------GLHYLHTRAIIHRDV 165
Query: 316 KAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC----------GSPPYAAPEVFE-GK- 363
K+ N+L+D N K+ DFG S K T G+ Y PE F G+
Sbjct: 166 KSINILLDENFVPKITDFGIS-------KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL 218
Query: 364 --KYCGPEIDIWSLGVVLYVLVCGALPFDGS 392
K D++S GVVL+ ++C S
Sbjct: 219 TEKS-----DVYSFGVVLFEVLCARSAIVQS 244
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 1e-13
Identities = 108/767 (14%), Positives = 204/767 (26%), Gaps = 257/767 (33%)
Query: 214 HTVNVAIKIIDKSQLD--PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
H ++ D V + D + + + + +K
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDA------FVDNFDCKDVQDMPKSILSK---------- 48
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
E D+I + R FW +LS +V + ++ L I
Sbjct: 49 ---EEIDHIIMSKD-AVSGTLRLFWTLLS-----KQEEMVQK-------FVEEVLRI--- 89
Query: 332 DFGF------SNYYVPGQKLATW--CGSPPYAAPEVFEGKKYCGPEID-IWSLGVVL--- 379
++ F + P + Y +VF KY + L L
Sbjct: 90 NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF--AKYNVSRLQPYLKLRQALLEL 147
Query: 380 ----YVLVCGALPFDGSTL--NSLRDRVLSGR--FRIPYFMS-TECESLIRKMLVREPTK 430
VL+ G L + + + + + F+I ++++ C S
Sbjct: 148 RPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKI-FWLNLKNCNS-----------P 195
Query: 431 RYCIEQIKR--HRWMAEETPRLLPPINILGEVKNEPNEQILRLM------NSLGI-DAAK 481
+E +++ ++ T R NI + + ++ RL+ N L + +
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI-HSIQAELRRLLKSKPYENCLLVLLNVQ 254
Query: 482 TKEVFEAETSKRRTF---CYIL-----KRRADGGQTYEKEDMSAEKRTSGKPNSEAQVCT 533
+ + A F C IL K+ D +S + +
Sbjct: 255 NAKAWNA-------FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT---------- 297
Query: 534 HKHCAQQNYFCPESNPRPQGYKSLKFRCYDHHAAIYYLLLERLRQQRYLPPLSSSQELPT 593
P+ + LLL+ L Q+LP
Sbjct: 298 ---------LTPD--------EVKS------------LLLKYLDC--------RPQDLP- 319
Query: 594 DPSSYKHQA---NPPPSPTLSKHQNEYP--PKRRSSVTSDQAVRKLSASGVSLNPN---P 645
+ NP +++ + V D+ + +S L P
Sbjct: 320 ------REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 646 NFMN---FPKP-DIPTMSLKR---NGTMPDNLKVNNNL--------DPQSSSNYQLPSFQ 690
F FP IPT+ L + D + V N L P+ S+ +PS
Sbjct: 374 MFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST-ISIPSIY 432
Query: 691 LLSSDNSHIDSQRYKTHSELATQQHPPFRESRYSLQQLYSLSSFNCQSPLMFQLQVNNND 750
L K E H + Y++ + + +++D
Sbjct: 433 L-----------ELKVKLENEYALHRSIVD-HYNIPKTF-----------------DSDD 463
Query: 751 LQNEAASTNFNNNNDSFYNRSQCGYIHSRPHSNESFVPHFSNSTDEGIDTDFSDDLLNRT 810
L D Y +S H H N T F L+
Sbjct: 464 L--------IPPYLD--------QYFYS--H----IGHHLKNIEHPERMTLFRMVFLD-- 499
Query: 811 HQRLSFASSSSSSGVGVYMKSFSSDSSGSSTHQGSSSLQSNFSTFESSVDY--------- 861
F K ++ + S S+ + + Y
Sbjct: 500 ---FRFLEQ----------KIRHDSTAWN----ASGSILNTLQQLKFYKPYICDNDPKYE 542
Query: 862 QYENDLTSSLPSCTSSPVRPTSTNETIVSSS-NTAQSCLFVSSNKQA 907
+ N + LP + + T+ ++ + +F ++KQ
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTD--LLRIALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 4e-09
Identities = 86/681 (12%), Positives = 184/681 (27%), Gaps = 209/681 (30%)
Query: 50 SILSISQSGHQKMCSFIVGKASKQPRSSYIWYGIHLAGEGQ------TALKVGLSF-YES 102
SILS ++ I+ + +++ + E L++ F
Sbjct: 44 SILS------KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP 97
Query: 103 SRRRPKAPVLVTTEY-AHRPNYYLVSWTIFKRHFWATVKTPFNMRKETSWVQTYRRRLSI 161
+ + P ++T Y R Y + K + R + R+ L
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS---------RLQP--YLKLRQALLE 146
Query: 162 DEVNLCFQSTSIDGRR------LRLDTLHAEKNGQTIRKREKCGV---KSRSCNRPPVLL 212
++ IDG + LD + K ++ + + ++CN P +L
Sbjct: 147 LRPA---KNVLIDGVLGSGKTWVALDVCLSYK----VQCKMDFKIFWLNLKNCNSPETVL 199
Query: 213 RHTVNVAIKI-------IDKSQLDPVNLQKVYREV-EIMKQLDHPH--II-------KLF 255
+ +I D S + + + E+ ++K + + ++ K +
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 256 QVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDL 315
I + + + + D LSA H + H
Sbjct: 260 NAFNLSCKILLTTRFKQ---VTD-------------------FLSAATTTH-ISLDHHS- 295
Query: 316 KAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
L D + L + P P E P
Sbjct: 296 --MTLTPDEVKSL----------------LLKYLDCRPQDLPR--EVLT-TNP------- 327
Query: 376 GVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIE 435
+ + +RD G + C+ L + +
Sbjct: 328 ---RRLSIIAES---------IRD----GLATWDNWKHVNCDKLTTIIES-------SLN 364
Query: 436 QIKRHRWMAEETPRLLPPINILGEVKNEPNEQILRLM--NSLGIDAAKTKEVFEAETSKR 493
++ E ++ +++ + P +L L+ + + D V + K
Sbjct: 365 VLE-----PAEYRKMFDRLSVFPPSAHIP-TILLSLIWFDVIKSDV----MVVVNKLHKY 414
Query: 494 RTFCYILKRRADGGQTYEKEDMSAEKRTSGKPNSEAQVCTHKHCAQQNY-----FCPESN 548
+++++ T + E + K +E + H+ Y F +
Sbjct: 415 S----LVEKQPKES-TISIPSIYLELKV--KLENEYAL--HRSIVDH-YNIPKTFDSDDL 464
Query: 549 PRPQ--GYKSLKFRCY-DHHAA------------IYYLLLERLRQQ-RY--LPPLSSSQE 590
P Y F + HH + +L L Q+ R+ +S
Sbjct: 465 IPPYLDQY----FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI 520
Query: 591 LPT--DPSSYKHQANPPPSPTLSKHQNEYPPKRRSSVTSDQAVRKLSASGVSLNPNPNFM 648
L T YK + + +Y ++ V + N +
Sbjct: 521 LNTLQQLKFYKPY--------ICDNDPKY----------ERLVNAILD--FLPKIEENLI 560
Query: 649 NFPKPDIPTMSLKRNGTMPDN 669
D+ ++L M ++
Sbjct: 561 CSKYTDLLRIAL-----MAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 2e-05
Identities = 82/587 (13%), Positives = 177/587 (30%), Gaps = 139/587 (23%)
Query: 563 DHHAAIYYLLLERLRQQRYLPPLSSSQELPTDPS----SYKHQANPPPSPTLSKHQNEYP 618
+ +E + + Y +S + PS Y Q + + N+
Sbjct: 73 SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD--------RLYNDNQ 124
Query: 619 PKRRSSVTSDQAVRKLSASGVSLNPNPN--------------------------FMNFPK 652
+ +V+ Q KL + + L P N M+F
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK- 183
Query: 653 PDIPTMSLKRNGTMPDNLKVNNNLDPQSSSNYQLPSFQLLSSDNSHIDSQRYKTHSELAT 712
I ++LK + L++ L Q N+ +S + H + + + HS A
Sbjct: 184 --IFWLNLKNCNSPETVLEMLQKLLYQIDPNW--------TSRSDHSSNIKLRIHSIQA- 232
Query: 713 QQHPPFRESRYSLQQLYSLSSFNCQSPLMFQLQVNNNDLQNEAASTNFNNNNDSFYNRSQ 772
R + Y NC L+ L ++QN A FN
Sbjct: 233 ------ELRRLLKSKPYE----NC---LLV-L----LNVQNAKAWNAFNL---------S 265
Query: 773 CGY-IHSRPHSNESFVP-----HFS-NSTDEGIDTDFSDDL----LNRTHQRLSFASSSS 821
C + +R F+ H S + + D L L+ Q L ++
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325
Query: 822 S----SGVGVYMKSFSSDSSGSSTHQGSSSLQSNFSTFESSVDYQYENDLTSSLPSCT-- 875
+ S + ++ + + H L + ESS++ + +
Sbjct: 326 NPRRLSIIAESIRDG-LATWDNWKHVNCDKLT---TIIESSLNVLEPAEYRKMFDRLSVF 381
Query: 876 --SSPVRPTST------------NETIVSSSNTAQSCLFVSSNKQALGRHNPIVHTQNTG 921
S+ + PT +V+ + S + + + + ++ +
Sbjct: 382 PPSAHI-PTILLSLIWFDVIKSDVMVVVNKLHK-YSLVEKQPKESTISIPS--IYLELKV 437
Query: 922 NKLSTRSITRSPVDFREGRRASDGLVAQHTLNADCPPGMSN----QTGYNNTHLFNNNQR 977
+ ++ RS VD + D + PP + G+ HL N
Sbjct: 438 KLENEYALHRSIVDHYNIPKTFDS-------DDLIPPYLDQYFYSHIGH---HLKNIEHP 487
Query: 978 LNENNKAKGVMELHLVQKEHEVLKNLYQTHLPHKEVTQRQMQHSEYR-HTRESQAEKRSP 1036
++ ++++ +++ + Q Y+ + ++ +
Sbjct: 488 ERMTLFRMVFLDFRFLEQK---IRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERL 544
Query: 1037 VHLVKKVSLPENLTYNPVESDKSSLQQQLMQHK---IIQQKRHILQK 1080
V+ + LP + N + S + L + + + I ++ +Q+
Sbjct: 545 VNAILDF-LP-KIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 2e-05
Identities = 78/511 (15%), Positives = 147/511 (28%), Gaps = 132/511 (25%)
Query: 781 HSNESFVPHFSNSTDEGIDTDFSD--DLLNR--THQRLSFASSSSSSGVGVYMKSFSSDS 836
+ + + F ++ + + D D D+ + + + S + G ++ S
Sbjct: 16 YQYKDILSVFEDAFVD--NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73
Query: 837 SGSSTHQGSSSLQSNFSTFESSVDYQYENDLTSSLPSCTSSPVRPTST-NETIVSSSNTA 895
Q F E + Y+ L S + + P T E N
Sbjct: 74 KQEEMVQ-------KF--VEEVLRINYKF-LMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 896 QSCLFVSSN----------KQALGRHNP----IVH-------TQNTGNKLSTRSITRSP- 933
Q +F N +QAL P ++ T + + +
Sbjct: 124 Q--VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD 181
Query: 934 -----VDFREGRRASDGLVAQHTLNADCPPGMSNQTGYNNTHLFNNNQRLNENNKAKGVM 988
++ + L L P +++ + H N R++ + +
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR----SDHSSNIKLRIHS---IQAEL 234
Query: 989 ELHLVQKEHE----VLKNLYQTHLPHKE------------VTQR-----------QMQHS 1021
L K +E VL N+ + + +T R H
Sbjct: 235 RRLLKSKPYENCLLVLLNVQ-----NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 1022 EYRHTRESQAEKRSPVHLVKKV-----SLP-ENLTYNPVESDKSSLQQQLMQHKI--IQQ 1073
H + L+K + LP E LT NP + S+ + ++ +
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR---RLSIIAESIRDGLATWDN 346
Query: 1074 KRHI-LQKQGAFQQSSLASDNQLNALGKRQMLRQTSYKLAQQTQIVP-----PLPAL--- 1124
+H+ K +SSL N L R+M + L+ + P P L
Sbjct: 347 WKHVNCDKLTTIIESSL---NVLEPAEYRKMFDR----LS----VFPPSAHIPTILLSLI 395
Query: 1125 -GDEFATIIEDSANGTASSLNEDLIDINNDQWEALQSSLASCQISESGMQQNNEALLNPS 1183
D + + N L++ + S+ S + ++ NE L
Sbjct: 396 WFDVIKSDVMVVVNKLHKYS---LVEKQPKE---STISIPSIYLELK-VKLENEYAL--- 445
Query: 1184 WQHQ--VTMYVNAPVNNSWNQPNSNKSPGYW 1212
H+ V Y N P + Y+
Sbjct: 446 --HRSIVDHY-NIPKTFDSDDLIPPYLDQYF 473
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 3e-05
Identities = 86/688 (12%), Positives = 175/688 (25%), Gaps = 231/688 (33%)
Query: 156 RRRLSIDEVNLCFQSTSIDGRRLRL----------------------------DTLHAEK 187
+ LS +E++ S LRL + E+
Sbjct: 43 KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102
Query: 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV-NLQKVYREVEIMKQL 246
++ R + R N V ++ V S+L P L++ + +L
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNV---------SRLQPYLKLRQA------LLEL 147
Query: 247 DHPHIIKLF-------QVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQIL 299
+ + + + ++ +M+ FW L
Sbjct: 148 RPAKNVLIDGVLGSGKTWV--------ALDVCLSYKVQC------KMDFKI----FW--L 187
Query: 300 SAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEV 359
+ ++ C++ V L+ +D N +D SN + + +
Sbjct: 188 N-LKNCNSPETVLEMLQKLLYQIDPNWT-SRSD-HSSNIKLRIHSIQAE-------LRRL 237
Query: 360 FEGKKYCGPE---I--DIWSLGVVLYVLVCGALPFDGS--TLNSLRDR----VLSGRFRI 408
+ K Y + ++ + F+ S L + R + LS
Sbjct: 238 LKSKPY--ENCLLVLLNVQNAKAWNA--------FNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 409 PY--------FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRLLP-PINILGE 459
E +SL+ K L P + E P ++I+ E
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQD------------LPREVLTTNPRRLSIIAE 335
Query: 460 -VKNEPNEQILRLMNSLGIDAAKTKEVFEA------ETSKRRTF--CYILKRRAD----- 505
+++ N ++ K + E+ R+ F + A
Sbjct: 336 SIRDGLA----TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 506 ------GGQTYEKEDMSAEKRTSGKPNSEAQVCTHKHCAQQNYFCPESNPRPQGYKSLKF 559
+ + + ++ + P Y LK
Sbjct: 392 LSLIWFDVIKSDVMVVVNK-------------LHKYSLVEKQP-KESTISIPSIYLELKV 437
Query: 560 RC---YDHHAAI--YYLLLERLRQQRYLPPLSSSQELPTDPSSYKHQANPPPSPTLSKHQ 614
+ Y H +I +Y + + +PP D Y H + H
Sbjct: 438 KLENEYALHRSIVDHYNIPKTFDSDDLIPP-------YLDQYFYSH---------IGHHL 481
Query: 615 NEYPPKRRSSVTSDQAVRKLSASGVSLNPNPNFMNFPKPDIPTMSLKRNGTMPDNLKVNN 674
+ R V L+ F L++ K+ +
Sbjct: 482 KN----------IEHPERMTLFRMVFLD-----FRF---------LEQ--------KIRH 509
Query: 675 NLDPQSSSNYQLPSFQLLSSDNSHIDSQRYKTHSELATQQHPPFRESRYSLQQ-LYSLSS 733
+ ++S L + Q + YK + P + ++ L +
Sbjct: 510 DSTAWNASGSILNTLQ---------QLKFYKPY---ICDNDPKYERLVNAILDFLPKIEE 557
Query: 734 FNCQSP----LMFQLQVNNNDLQNEAAS 757
S L L + + EA
Sbjct: 558 NLICSKYTDLLRIALMAEDEAIFEEAHK 585
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-12
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 34/173 (19%)
Query: 239 EVEIMKQLDHPHIIKL-------------FQVMETKSMIYIVSEYANQGEIFDYIARYGR 285
E+++M + H ++++L + M S++ +S + R +
Sbjct: 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSWHMRC-K 137
Query: 286 MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK- 344
+ + AA + + H +HRD+K+ N+L+D K++DFG + +
Sbjct: 138 IAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 345 -----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS 392
+ G+ Y APE G+ P+ DI+S GVVL ++ G D
Sbjct: 190 VMTSRIV---GTTAYMAPEALRGEIT--PKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 21/160 (13%)
Query: 296 WQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS------NYYVPGQKLATWC 349
+Q+ +E+ +R+ +HRDL A N+L+ +K+ DFG + YV
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD----- 254
Query: 350 GSPPYA--APEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNS-LRDRVLSG- 404
P APE + Y + D+WS GV+L+ + GA P+ G ++ R+ G
Sbjct: 255 ARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313
Query: 405 RFRIPYFMSTECESLIRKMLVREPTKR----YCIEQIKRH 440
R R P + + E + EP++R +E +
Sbjct: 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-11
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 45/211 (21%)
Query: 218 VAIKIIDKSQLDPVNLQKVYR----EVEIMKQLDHPHIIKL-------------FQVMET 260
VA+K +L Q EVE++ H ++++L + M
Sbjct: 57 VAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 261 KSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH---NRRVVHRDLKA 317
S+ + E D+ R R+ +AR + Y H + +++HRD+KA
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQ-RIALGSAR--------GLAYLHDHCDPKIIHRDVKA 162
Query: 318 ENLLMDSNLDIKLADFGFSNYYVPGQKLAT--WCGSPPYAAPE-VFEGK---KYCGPEID 371
N+L+D + + DFG + T G+ + APE + GK K D
Sbjct: 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-----TD 217
Query: 372 IWSLGVVLYVLVCGALPFDGSTLNSLRDRVL 402
++ GV+L L+ G FD + L + D +L
Sbjct: 218 VFGYGVMLLELITGQRAFDLARLANDDDVML 248
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 37/217 (17%), Positives = 79/217 (36%), Gaps = 38/217 (17%)
Query: 217 NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY---ANQ 273
+V +++P + ++ E++ ++ P I+ + + + + +
Sbjct: 61 SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 274 GEIFDY----IARYGRMNE---NAARRKF---------WQILSAVEYCHNRRVVHRDLKA 317
Y + R+G + A ++F +IL +EY H VH D+KA
Sbjct: 121 KNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKA 180
Query: 318 ENLLM---DSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEG-KKYC------G 367
NLL+ + + + L D+G + Y P + +G ++ G
Sbjct: 181 SNLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAY----AADPKRCHDGTIEFTSIDAHNG 235
Query: 368 PEI----DIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400
D+ LG + + G LP++ + + R
Sbjct: 236 VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 19/106 (17%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADFGFSNYYVPGQKLATWCGSPP 353
++L +EY H VH D+KA NLL+ + + + LAD+G S Y P +
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGLSYRYCPNGNHKQY----Q 213
Query: 354 YAAPEVFEG-KKYC------GPEI----DIWSLGVVLYVLVCGALP 388
+ G ++ G + D+ LG + +CG LP
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 28/112 (25%), Positives = 44/112 (39%), Gaps = 31/112 (27%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLD--IKLADFGFSNYYVPGQKLATWCGSPPY 354
++L A+E+ H VH ++ AEN+ +D + LA +GF+ Y P K Y
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV------AY 220
Query: 355 AAPEVFEGKK--------YC------GPEI----DIWSLGVVLYVLVCGALP 388
EG + + G D+ SLG + + G LP
Sbjct: 221 V-----EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 28/118 (23%), Positives = 57/118 (48%), Gaps = 16/118 (13%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLM------DSNLDIKLADFGFSNYY--------VPG 342
Q+L+ V+ H + +V+RD+K +N L+ ++N+ I + DFG +Y +P
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM-IYVVDFGMVKFYRDPVTKQHIPY 172
Query: 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400
++ G+ Y + G++ D+ +LG V + G+LP+ G + + +
Sbjct: 173 REKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 3e-08
Identities = 35/212 (16%), Positives = 57/212 (26%), Gaps = 71/212 (33%)
Query: 217 NVAIKIIDKSQLDPVNLQK------VYREVEIMKQL---------DHPHIIKLFQV---- 257
VAIKII D VN + E+ I K+L I L V
Sbjct: 45 PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ 104
Query: 258 --------------------------METKSMIYIVSEYANQGEIFDYIARYGRMNENAA 291
++IV E+ G + + + A
Sbjct: 105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATA 163
Query: 292 RRKFWQILSAVEYCHNR-RVVHRDLKAENLLMD--------------------SNLDIKL 330
+ Q+ +++ R HRDL N+L+ L + +
Sbjct: 164 KSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
Query: 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEG 362
D+ S G + ++F G
Sbjct: 224 IDYTLSRLERDGIVVFCD----VSMDEDLFTG 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 12/115 (10%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFSNYY--------VPGQKL 345
Q++S +EY H++ +HRD+K +N LM + + DFG + Y +P ++
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400
G+ YA+ G + D+ SLG VL G+LP+ G + R +
Sbjct: 173 KNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 29/118 (24%), Positives = 59/118 (50%), Gaps = 16/118 (13%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLM------DSNLDIKLADFGFSNYY--------VPG 342
Q++S +EY H++ +++RD+K EN L+ + I + DF + Y +P
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV-IHIIDFALAKEYIDPETKKHIPY 171
Query: 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400
++ + G+ Y + GK+ D+ +LG + + G+LP+ G ++L++R
Sbjct: 172 REHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 12/115 (10%)
Query: 297 QILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFSNYY--------VPGQKL 345
Q+++ VE+ H++ +HRD+K +N LM + + DFG + Y +P ++
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400
G+ YA+ G + D+ SLG VL + G+LP+ G + + +
Sbjct: 171 KNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1238 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.7 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.96 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 97.92 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 97.86 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.79 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.75 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.75 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 97.71 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 97.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 97.56 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 97.55 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 97.5 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 97.46 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 97.46 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 97.44 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 97.37 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 97.37 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 97.28 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 97.2 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 97.2 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 97.2 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 97.19 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 97.14 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 97.13 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 97.13 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 97.12 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 97.11 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 97.11 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 97.09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 97.08 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 97.06 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 97.03 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 97.01 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 97.01 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 97.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 96.99 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 96.99 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 96.99 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 96.99 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 96.98 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 96.98 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 96.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 96.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 96.95 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 96.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 96.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 96.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 96.94 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 96.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 96.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 96.92 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 96.91 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 96.91 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.9 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 96.9 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 96.89 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 96.89 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 96.89 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 96.89 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 96.88 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 96.88 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 96.86 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 96.86 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 96.85 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 96.84 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 96.84 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 96.83 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 96.83 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 96.83 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 96.83 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 96.82 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 96.82 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 96.81 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 96.81 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 96.81 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 96.8 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 96.8 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 96.8 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 96.8 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 96.79 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 96.79 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 96.79 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 96.78 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 96.77 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 96.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.75 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 96.74 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 96.74 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 96.74 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 96.73 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 96.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.73 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 96.73 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 96.72 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 96.72 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 96.72 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 96.71 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.71 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 96.71 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 96.71 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 96.71 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 96.71 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 96.71 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 96.7 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 96.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.7 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 96.69 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 96.69 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 96.69 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 96.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.67 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 96.67 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 96.66 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 96.64 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 96.64 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 96.64 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 96.64 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 96.63 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 96.63 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 96.62 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 96.62 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 96.62 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 96.62 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 96.62 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 96.62 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 96.61 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 96.6 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 96.58 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 96.58 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 96.58 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 96.58 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 96.58 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 96.57 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 96.57 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 96.56 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 96.56 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 96.56 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 96.55 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 96.55 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 96.55 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 96.55 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 96.54 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 96.54 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 96.53 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 96.53 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 96.52 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.51 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 96.5 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 96.5 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 96.5 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.5 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 96.49 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 96.49 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 96.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.49 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 96.48 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 96.48 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 96.48 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 96.48 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 96.47 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 96.45 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 96.44 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 96.43 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 96.43 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 96.42 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 96.42 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 96.4 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 96.38 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 96.37 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 96.36 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 96.35 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 96.35 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 96.33 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 96.33 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 96.33 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 96.29 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 96.27 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 96.26 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 96.25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 96.24 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 96.23 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 96.23 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 96.19 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 96.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.16 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 96.15 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 96.14 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 96.12 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 96.12 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 96.11 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 96.11 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 96.09 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 96.05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 96.05 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 96.04 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 96.04 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 96.02 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 96.02 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 96.02 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 96.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 95.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 95.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 95.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 95.91 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 95.91 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 95.91 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 95.9 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 95.9 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 95.86 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 95.86 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 95.84 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 95.84 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 95.81 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 95.8 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 95.8 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 95.73 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 95.73 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 95.73 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 95.72 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 95.67 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 95.67 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 95.66 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 95.66 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 95.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.64 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 95.61 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 95.6 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 95.6 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 95.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 95.56 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 95.54 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 95.52 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 95.43 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 95.41 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 95.4 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 95.3 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=487.45 Aligned_cols=258 Identities=43% Similarity=0.768 Sum_probs=224.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|+||.||+|.+..+|+.||||++++.... ....+++.+|+.+|++++|||||++++++++++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 3588889999999999999999999999999999877643 334578999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||| +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.........+.
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 999 6899999999999999999999999999999999999999999999999999999999999999877666667788
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|||||++.+..|++.++|||||||+||+|++|+.||.+.+...+...+..+.+.+|..+++++.+||.+||++||
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 251 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 251 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 99999999999999988789999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccccccCC
Q psy6346 429 TKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~~p 448 (1238)
++|||++|+++||||+...+
T Consensus 252 ~~R~s~~eil~hpw~k~~~p 271 (275)
T 3hyh_A 252 LNRISIHEIMQDDWFKVDLP 271 (275)
T ss_dssp GGSCCHHHHHHCHHHHTTCC
T ss_pred hHCcCHHHHHcCcccccCCC
Confidence 99999999999999986544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-56 Score=491.82 Aligned_cols=255 Identities=29% Similarity=0.539 Sum_probs=237.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||+|.+..+|+.||||++.+... +....+.+.+|+++|++|+|||||+++++|++++.+|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 48888999999999999999999999999999986543 22346789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---Cccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG---QKLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s---~~l~ 346 (1238)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+... ....
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 192 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999876433 2456
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
+.|||+.|||||++.+..| +.++|||||||+||+|++|+.||.+.+..++..+|..+.+.+|..+++++++||.+||++
T Consensus 193 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~ 271 (311)
T 4aw0_A 193 SFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVL 271 (311)
T ss_dssp CCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCS
T ss_pred CcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccC
Confidence 7899999999999998887 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCHHH------HHhccccccc
Q psy6346 427 EPTKRYCIEQ------IKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTaeE------ILeHPWFke~ 446 (1238)
||++|||++| |++||||++.
T Consensus 272 dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 272 DATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp SGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 9999999887 6899999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=493.79 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=230.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|+||.||+|.+..+|+.||||++.+...+....+++.+|+.+|++|+|||||++++++++++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46889999999999999999999999999999999888888888999999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccc
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~ 346 (1238)
||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 183 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccccc
Confidence 99999999999754 357899999999999999999999999999999999999999999999999998764432 345
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHHHHHHHHhcc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eLkDLIrkML~ 425 (1238)
+.+||+.|||||++.+..| +.++||||||||||||++|+.||.+.+..++..++..+.+ .++..+++++.+||.+||+
T Consensus 184 ~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 184 ACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp HHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcc
Confidence 6789999999999999887 8999999999999999999999999999999999988865 4667799999999999999
Q ss_pred cCCCCCCCHHHHHhccccccc
Q psy6346 426 REPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWFke~ 446 (1238)
+||++|||++|+|+||||++.
T Consensus 263 ~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 263 RNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SSGGGSCCHHHHHTSHHHHTT
T ss_pred CChhHCcCHHHHhcCHHhhcC
Confidence 999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=484.06 Aligned_cols=254 Identities=24% Similarity=0.431 Sum_probs=230.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||+|.+..+|+.||||++++.... ..+.+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4588888999999999999999999999999999765432 33568899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
||+||+|.+++.+ +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|...... ....+.
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 9999999998875 67999999999999999999999999999999999999999999999999999876543 455678
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---cCCCCCCHHHHHHHHHhcc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---RIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---~~P~~iS~eLkDLIrkML~ 425 (1238)
+||+.|||||++.+..| +.++||||||||||||++|+.||.+.+..++...+..... ..+..+++++.+||.+||+
T Consensus 231 ~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 309 (346)
T 4fih_A 231 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 309 (346)
T ss_dssp CSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred ccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence 99999999999998887 8999999999999999999999999998888888876532 2344689999999999999
Q ss_pred cCCCCCCCHHHHHhcccccccC
Q psy6346 426 REPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||++|||++|+|+||||++..
T Consensus 310 ~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 310 RDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SSTTTSCCHHHHTTCGGGGGCC
T ss_pred CChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=467.34 Aligned_cols=255 Identities=25% Similarity=0.456 Sum_probs=225.3
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee----CCEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET----KSMI 264 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed----~d~l 264 (1238)
|.-|+....||.|+||.||+|.+..++..||||++..........+++.+|+++|++|+|||||+++++|++ ++.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 334566678999999999999999999999999998877777778899999999999999999999999865 4568
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccc--eeeccCCcccccccC-CCcEEEEecCCcccccC
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDS-NLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~~ 341 (1238)
|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+.. .
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~-~ 183 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-R 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-C
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC-C
Confidence 999999999999999999999999999999999999999999998 999999999999985 799999999999753 3
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-ChhHHHHHHhcCCc--cCCCCCCHHHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-TLNSLRDRVLSGRF--RIPYFMSTECES 418 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-d~eeL~ekIl~g~~--~~P~~iS~eLkD 418 (1238)
.....+.+||+.|||||++.+ .| +.++|||||||+||||++|+.||.+. +...+...+..+.. .++..+++++.+
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 445567899999999999876 45 89999999999999999999999764 45566666766543 355668899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||.+||.+||++|||++|+|+||||++.
T Consensus 262 li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=479.76 Aligned_cols=256 Identities=27% Similarity=0.492 Sum_probs=228.4
Q ss_pred cEEEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
..|+..+.||.|+||.||+|... .+++.||||++++.........++.+|+++|++++|||||++++++++++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 34888899999999999998775 357899999998765444445578899999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCcc
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKL 345 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l 345 (1238)
|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ....
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 183 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCC
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999986543 3445
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcc
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~ 425 (1238)
.+.+||+.|||||++.+..| +.++|||||||+||||++|+.||.+.+..++..++..+.+.+|..+++++.+||.+||+
T Consensus 184 ~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 262 (304)
T 3ubd_A 184 YSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFK 262 (304)
T ss_dssp CSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcc
Confidence 67899999999999998887 89999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCC-----HHHHHhccccccc
Q psy6346 426 REPTKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 426 kDPskRPT-----aeEILeHPWFke~ 446 (1238)
+||++||| ++|+++||||++.
T Consensus 263 ~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 263 RNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp SSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred cCHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999998 6899999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=485.84 Aligned_cols=254 Identities=24% Similarity=0.438 Sum_probs=231.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 4588889999999999999999999999999999876433 34578899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
||+||+|.+++.. +.+++..++.|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+... ....+.
T Consensus 229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 9999999998864 67999999999999999999999999999999999999999999999999999876543 456678
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC---ccCCCCCCHHHHHHHHHhcc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR---FRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~---~~~P~~iS~eLkDLIrkML~ 425 (1238)
+||+.|||||++.+..| +.++|||||||+||||++|+.||.+.+..++...|.... +..+..+++++.+||.+||+
T Consensus 308 ~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 308 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp EECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred ccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence 99999999999998887 899999999999999999999999999888888887653 33445689999999999999
Q ss_pred cCCCCCCCHHHHHhcccccccC
Q psy6346 426 REPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||++|||++|||+||||++..
T Consensus 387 ~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 387 RDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SSTTTSCCHHHHTTCGGGGGCC
T ss_pred CChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=451.79 Aligned_cols=312 Identities=48% Similarity=0.874 Sum_probs=283.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....||.|+||.||++.+..+|+.||||++.+...+....+++.+|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 48888999999999999999999999999999988777777888999999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccC
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCG 350 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~G 350 (1238)
++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............+|
T Consensus 96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~g 175 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG 175 (328)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSS
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccC
Confidence 99999999999889999999999999999999999999999999999999999999999999999987776667778899
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
|+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...+...+..+.+.+|..+++++.+||++||..||.+
T Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 255 (328)
T 3fe3_A 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIK 255 (328)
T ss_dssp SGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTT
T ss_pred CcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhH
Confidence 99999999999988867899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccccccCCCC-CCCcccccccCCCChHHHHHHHHHcCCChhhhHHHHhhhccchhhHHHHHhhcc
Q psy6346 431 RYCIEQIKRHRWMAEETPRL-LPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRRTFCYILKRRA 504 (1238)
Q Consensus 431 RPTaeEILeHPWFke~~p~~-lppi~~l~elk~~~~eqILelMesLgid~~kike~le~E~~~rkt~~YiLkrr~ 504 (1238)
|||++|+++||||....... ..+. .........+..++.|..+|++.+.+.+.+.....++.+.+|.|.+++
T Consensus 256 R~t~~eil~h~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~y~ll~~k 328 (328)
T 3fe3_A 256 RGTLEQIMKDRWINAGHEEDELKPF--VEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITATYLLLGRK 328 (328)
T ss_dssp SCCHHHHTTCTTTTTTCTTCCCCCC--CCCCCCCCCHHHHHHHHHTTCCHHHHHHHHHTTCCSHHHHHHHHHTC-
T ss_pred CcCHHHHhcCHhhcCCCcccccCcc--cCCCcCcccHHHHHHHHHCCCCHHHHHHHHHcCCCCHHHHHHHHhcCC
Confidence 99999999999998653221 1111 111223445778899999999999999999999999999999887763
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=469.73 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=229.1
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee------C
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET------K 261 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed------~ 261 (1238)
.|+.|...+.||.|+||.||+|.+..+|+.||||++++........+++.+|+++|+.|+|||||++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3567999999999999999999999999999999998877677777889999999999999999999999864 3
Q ss_pred CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
+.+|||||||. |+|.+++.+.+.+++..++.+++||+.||.|||++|||||||||+|||++.+|.+||+|||+++.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67999999996 67999999999999999999999999999999999999999999999999999999999999986533
Q ss_pred -----CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccC--------
Q psy6346 342 -----GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI-------- 408 (1238)
Q Consensus 342 -----s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~-------- 408 (1238)
.....+.+||+.|||||++.+..+++.++||||||||||||++|++||.+.+..+....|.......
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2345578999999999999988777999999999999999999999999998887777765421110
Q ss_pred -----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 409 -----------------------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 409 -----------------------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...+++++.+||.+||.+||.+|||++|+|+||||++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 12368899999999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=466.55 Aligned_cols=242 Identities=24% Similarity=0.324 Sum_probs=217.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|....+||.|+||.||+|.+..+|+.||||++++.... .+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4577888999999999999999999999999999876432 379999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCCcccccCCCc----
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYVPGQK---- 344 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~s~~---- 344 (1238)
||+||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.......
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 999999999999999999999999999999999999999999999999999999988 599999999987644321
Q ss_pred --cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---cCCCCCCHHHHHH
Q psy6346 345 --LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---RIPYFMSTECESL 419 (1238)
Q Consensus 345 --l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---~~P~~iS~eLkDL 419 (1238)
....+||+.|||||++.+..| +.++|||||||+||||++|+.||.+.+...+..++..+.. .+|..+++++.+|
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 289 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHH
T ss_pred ecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHH
Confidence 234689999999999999887 8999999999999999999999999888888888887754 3677899999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy6346 420 IRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILe 439 (1238)
|.+||++||.+|||+.||++
T Consensus 290 i~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 290 IQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHH
Confidence 99999999999999999853
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=441.40 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=202.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-------
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------- 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------- 262 (1238)
..|...+.||.|+||.||+|.+..+|+.||||+++... .....+++.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45888899999999999999999999999999998764 4455678999999999999999999999986543
Q ss_pred -----EEEEEEeecCCCccchhhhcccccc---hhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecC
Q psy6346 263 -----MIYIVSEYANQGEIFDYIARYGRMN---ENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 263 -----~lyLVMEy~~GGSL~d~Lkk~~~Ls---esea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
++|||||||.||+|.+++.....++ +..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 4799999999999999998766544 45588999999999999999999999999999999999999999999
Q ss_pred CcccccCCC-------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHH
Q psy6346 335 FSNYYVPGQ-------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDR 400 (1238)
Q Consensus 335 LS~~~~~s~-------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ek 400 (1238)
+|+...... ...+.+||+.|||||++.+..| +.++|||||||+||||++ ||.+... ......
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 998764322 1234689999999999999887 899999999999999996 7865422 122333
Q ss_pred HhcCCcc-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 401 VLSGRFR-IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 401 Il~g~~~-~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+....++ .+...++.+.+||.+||++||.+|||+.|+++||||++.
T Consensus 240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 3333321 112346678899999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=466.02 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=234.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|+||.||+|.+..+|+.||||++.+.. ....+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 45888899999999999999999999999999998753 4456788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC--CcEEEEecCCcccccCCCccc
Q psy6346 270 YANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN--LDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n--G~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||.||+|+++|.. .+.+++.+++.+++||+.||+|||++||+||||||+||||+.+ +.+||+|||++..........
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 9999999999864 4689999999999999999999999999999999999999854 899999999999887777778
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECESLIRK 422 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLkDLIrk 422 (1238)
+.+||+.|||||++.+..| +.++|||||||+||+|++|..||.+.+..++...|....+.++ ..+++++++||.+
T Consensus 315 ~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ 393 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393 (573)
T ss_dssp EECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHT
T ss_pred eeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 8899999999999999887 8999999999999999999999999999999999988876654 3589999999999
Q ss_pred hcccCCCCCCCHHHHHhccccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||.+||.+|||++|+|+||||+..
T Consensus 394 ~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 394 LLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp TSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HccCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=441.97 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=206.0
Q ss_pred cEEEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ly 265 (1238)
..|+..+.||.|+||.||+|.+. .+++.||||++.+.. ...++.+|+++|+.+ +|||||+++++|.+.+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 45777788888889999888764 357899999987653 345788999999998 6999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-CcEEEEecCCcccccCC--
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSNYYVPG-- 342 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~~~~~s-- 342 (1238)
||||||+||+|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999999884 58999999999999999999999999999999999999876 89999999999754321
Q ss_pred ---------------------------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-Ch
Q psy6346 343 ---------------------------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-TL 394 (1238)
Q Consensus 343 ---------------------------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-d~ 394 (1238)
....+.+||+.|||||++.+..+++.++||||+|||+|+|++|+.||.+. +.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 12345689999999999998876799999999999999999999999543 33
Q ss_pred hHHHHHHhc--------------------------------------CCcc----------------CCCCCCHHHHHHH
Q psy6346 395 NSLRDRVLS--------------------------------------GRFR----------------IPYFMSTECESLI 420 (1238)
Q Consensus 395 eeL~ekIl~--------------------------------------g~~~----------------~P~~iS~eLkDLI 420 (1238)
......|.. .... ....+++++.|||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 222222211 0000 1124789999999
Q ss_pred HHhcccCCCCCCCHHHHHhccccccc
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
++||++||++|+|++|+|+||||++.
T Consensus 334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=435.00 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=218.9
Q ss_pred EEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
.|...+.||.|+||.||+|.+. .++..||||+++.. +....++|.+|+++|++|+|||||++++++.+++.+|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 3556678999999999998765 35789999999764 4556788999999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhcc-------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEe
Q psy6346 266 IVSEYANQGEIFDYIARY-------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~-------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiD 332 (1238)
||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 999999999999999764 3589999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-cc
Q psy6346 333 FGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FR 407 (1238)
Q Consensus 333 FGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~ 407 (1238)
||+++....... ....+||+.|||||++.+..| +.++|||||||+||||+| |+.||.+.+..++...+..+. ..
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 250 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 250 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999976543322 223569999999999998887 899999999999999998 999999999999888888775 46
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 408 IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 408 ~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.|..+++++.+||.+||+.||++|||+++| |+|+.+
T Consensus 251 ~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 251 RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 788899999999999999999999999999 556654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=436.09 Aligned_cols=312 Identities=40% Similarity=0.682 Sum_probs=271.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|+||.||++.+..++..||||++.+..... .....+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34888899999999999999999999999999997643211 12357889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....+......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~ 167 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCC
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccc
Confidence 999 6899999988889999999999999999999999999999999999999999999999999999887777677788
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|+|||++.+..+.++++|||||||++|+|++|..||.+.....+...+..+...+|..+++++.+||++||..||
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 247 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADP 247 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSG
T ss_pred cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 99999999999999887788999999999999999999999988877777777777888899999999999999999999
Q ss_pred CCCCCHHHHHhcccccccCCCCCCCcccccccCCCChHHHHHH-HHHcCCChhhhHHHHhhhccchhhHHHHHhhcc
Q psy6346 429 TKRYCIEQIKRHRWMAEETPRLLPPINILGEVKNEPNEQILRL-MNSLGIDAAKTKEVFEAETSKRRTFCYILKRRA 504 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~~p~~lppi~~l~elk~~~~eqILel-MesLgid~~kike~le~E~~~rkt~~YiLkrr~ 504 (1238)
.+|||++|+++||||....+....+.... .....+..+... .+.+|++.+.+.+.+..+..++.+..|.|..++
T Consensus 248 ~~Rpt~~eil~hp~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~y~ll~~~ 322 (336)
T 3h4j_B 248 MQRITIQEIRRDPWFNVNLPDYLRPMEEV--QGSYADSRIVSKLGEAMGFSEDYIVEALRSDENNEVKEAYNLLHEN 322 (336)
T ss_dssp GGSCCHHHHTTCHHHHTTCCGGGSCCCCC--CCCCCCHHHHHHHHHTTCCCHHHHHHHTTSSSCCSSTTHHHHHHHH
T ss_pred hHCcCHHHHHhChhhccCCccccCCchhc--ccccCCHHHHHHHHHHcCCCHHHHHHHHhcCCCCHHHHHHHHHHhC
Confidence 99999999999999998765544333221 112334455544 478999999999999998888888888776543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=433.56 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=212.6
Q ss_pred EEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
+...+.||.|+||.||+|.+. .++..||||+++.. +....+.|.+|+++|++|+|||||+++++|.+.+.+||
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 455678999999999999764 46889999999764 45667889999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc---------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEE
Q psy6346 267 VSEYANQGEIFDYIARY---------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~---------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLi 331 (1238)
|||||++|+|.+++... +++++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEc
Confidence 99999999999999754 358999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-Cc
Q psy6346 332 DFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RF 406 (1238)
Q Consensus 332 DFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~ 406 (1238)
|||+++...... .....+||+.|||||++.+..+ +.++|||||||+||||+| |+.||.+.+..++...+..+ ..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~ 279 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999998654332 2234679999999999999887 899999999999999998 99999999988888888776 46
Q ss_pred cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 407 RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 407 ~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..|..+++++.+||.+||..||++|||++||+++
T Consensus 280 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6788899999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=466.97 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=226.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC----hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD----PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld----~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
..|.....||.|+||.||+|.+..+|+.||||++++..+. .........++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 4588899999999999999999999999999999765321 122233344566777889999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l 345 (1238)
||||||.||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|..... ...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~-~~~ 347 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKP 347 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-CCC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC-CCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999987543 345
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC---ChhHHHHHHhcCCccCCCCCCHHHHHHHHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS---TLNSLRDRVLSGRFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~---d~eeL~ekIl~g~~~~P~~iS~eLkDLIrk 422 (1238)
.+.|||+.|||||++.+...++.++||||||||||||++|..||.+. +...+...+......+|..+++++++||.+
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~ 427 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHH
Confidence 67899999999999976544499999999999999999999999764 344667778888889999999999999999
Q ss_pred hcccCCCCCCC-----HHHHHhccccccc
Q psy6346 423 MLVREPTKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRPT-----aeEILeHPWFke~ 446 (1238)
||++||.+|++ ++||++||||+..
T Consensus 428 lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999999998 7999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=428.60 Aligned_cols=247 Identities=21% Similarity=0.336 Sum_probs=217.4
Q ss_pred EEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
++..+.||.|+||.||+|.+. .+++.||||+++... +....+.|.+|+.+|++|+|||||++++++.+.+.+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 455678999999999999864 467899999997653 34456789999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEE
Q psy6346 267 VSEYANQGEIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKL 330 (1238)
|||||++|+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEE
Confidence 99999999999999643 35889999999999999999999999999999999999999999999
Q ss_pred EecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-
Q psy6346 331 ADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR- 405 (1238)
Q Consensus 331 iDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~- 405 (1238)
+|||+++...... .....+||+.|||||++.+..| +.++|||||||+||||+| |..||.+.+..++...+..+.
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 265 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 265 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999998654332 2345689999999999998887 899999999999999998 899999999999988888764
Q ss_pred ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 406 FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 406 ~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+.|..+++++.+||.+||..||.+|||+.||+++
T Consensus 266 ~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 266 LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 45788899999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=426.38 Aligned_cols=246 Identities=21% Similarity=0.294 Sum_probs=205.0
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
...++||.|+||+||+|.+. ..||||+++....+....+.|.+|+.+|++++|||||++++++.+ +.+|||||||+
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred EEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 34578999999999999653 359999998777777788999999999999999999999998865 56899999999
Q ss_pred CCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---Cccccc
Q psy6346 273 QGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG---QKLATW 348 (1238)
Q Consensus 273 GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s---~~l~t~ 348 (1238)
||+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+..... ....+.
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~ 194 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP 194 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------C
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeeccc
Confidence 99999999754 57999999999999999999999999999999999999999999999999999765432 234567
Q ss_pred cCCCCCCCcccccCCc--cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHH-HHhcCCc-----cCCCCCCHHHHHHH
Q psy6346 349 CGSPPYAAPEVFEGKK--YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRD-RVLSGRF-----RIPYFMSTECESLI 420 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~--y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~e-kIl~g~~-----~~P~~iS~eLkDLI 420 (1238)
+||+.|||||++.+.. .++.++|||||||+||||+||+.||.+.+...... .+..+.. .++..+++++.+||
T Consensus 195 ~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li 274 (307)
T 3omv_A 195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLV 274 (307)
T ss_dssp CCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHH
T ss_pred ccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHH
Confidence 8999999999997542 24889999999999999999999998866544333 3333321 24456899999999
Q ss_pred HHhcccCCCCCCCHHHHHhccc
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPW 442 (1238)
.+||+.||++|||+.||+++-.
T Consensus 275 ~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 275 ADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp HHHTCSSSTTSCCHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHH
Confidence 9999999999999999887643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=443.37 Aligned_cols=261 Identities=43% Similarity=0.782 Sum_probs=240.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|+||.||+|.+..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3478889999999999999999999999999999764321 123568899999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
|||.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....+....+.
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 175 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999887666666778
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...+..++..+.+..|..+++++.+||.+||..||
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 255 (476)
T 2y94_A 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDP 255 (476)
T ss_dssp CSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred CCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCc
Confidence 99999999999998887788999999999999999999999999988999999999988999999999999999999999
Q ss_pred CCCCCHHHHHhcccccccCCCC
Q psy6346 429 TKRYCIEQIKRHRWMAEETPRL 450 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~~p~~ 450 (1238)
.+|||++||++||||....+..
T Consensus 256 ~~Rpt~~eil~hp~~~~~~~~~ 277 (476)
T 2y94_A 256 MKRATIKDIREHEWFKQDLPKY 277 (476)
T ss_dssp TTSCCHHHHHTCHHHHTTCCTT
T ss_pred hhCcCHHHHHhCHHhhhcCccc
Confidence 9999999999999999765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=416.06 Aligned_cols=261 Identities=31% Similarity=0.509 Sum_probs=238.0
Q ss_pred cCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----HhHHHHHHHHHHHHhCCCCCeeEEEEEee
Q psy6346 184 HAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----VNLQKVYREVEIMKQLDHPHIIKLFQVME 259 (1238)
Q Consensus 184 gsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----e~ikrf~rEIeILkkL~HPNIVrL~dvfe 259 (1238)
....+...|...+.||.|+||.||++.+..+|..||||++.+..... ...+.+.+|+.+|++++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 34556677999999999999999999999999999999998765432 13578899999999999999999999999
Q ss_pred eCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC----cEEEEecCC
Q psy6346 260 TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL----DIKLADFGF 335 (1238)
Q Consensus 260 d~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG----~VKLiDFGL 335 (1238)
+.+.+|+|||||.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999999999888999999999999999999999999999999999999998776 799999999
Q ss_pred cccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CC
Q psy6346 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YF 411 (1238)
Q Consensus 336 S~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~ 411 (1238)
+............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceEcCCCCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 987766666677889999999999988877 8999999999999999999999999999999999988877665 45
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 412 MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 412 iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
+++++.+||.+||..||.+|||++|+++||||..
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 8999999999999999999999999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=411.53 Aligned_cols=256 Identities=32% Similarity=0.520 Sum_probs=235.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++....+|+.||||++++... .......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 357888999999999999999999999999999976432 2234567889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCcccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~t 347 (1238)
||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... ......+
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~ 164 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999997643 3345567
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccC
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kD 427 (1238)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+......+|..+++++.+||.+||..|
T Consensus 165 ~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~d 243 (337)
T 1o6l_A 165 FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp CEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 789999999999998877 8999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----CHHHHHhccccccc
Q psy6346 428 PTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 428 PskRP-----TaeEILeHPWFke~ 446 (1238)
|.+|| +++||++||||...
T Consensus 244 P~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 244 PKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhcCCCCCCHHHHHcCCCcCCC
Confidence 99999 99999999999763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=422.60 Aligned_cols=249 Identities=20% Similarity=0.369 Sum_probs=214.5
Q ss_pred cEEEEEEEecCCCCccccCceEccC-----CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCC-CCeeEEEEEeee-CC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRH-----TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDH-PHIIKLFQVMET-KS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lkt-----G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~H-PNIVrL~dvfed-~d 262 (1238)
+.|...+.||.|+||.||+|.+... ++.||||++.... .....+.+.+|+++|++++| ||||+++++|.+ ++
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 3466778899999999999887643 4689999998654 44566789999999999976 899999999865 56
Q ss_pred EEEEEEeecCCCccchhhhcc----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG 326 (1238)
.+|||||||++|+|.++|+.. ..+++..+..++.||+.||+|||+++||||||||+|||++.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 799999999999999999753 2388999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCCh-hHHHHHH
Q psy6346 327 DIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTL-NSLRDRV 401 (1238)
Q Consensus 327 ~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~-eeL~ekI 401 (1238)
.+||+|||+|+...... ...+.+||+.|||||++.+..| +.++|||||||+||||+| |..||.+... ..+...+
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999998654433 2345679999999999998887 899999999999999998 9999998664 4455555
Q ss_pred hcC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 402 LSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 402 l~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+ .+.+|..+++++.+||.+||..||++|||+.||++|
T Consensus 302 ~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 554 466788899999999999999999999999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=410.74 Aligned_cols=258 Identities=32% Similarity=0.560 Sum_probs=237.7
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
+...|...+.||.|+||.||++.+..++..||||++..........+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 44668899999999999999999999999999999998877777788999999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC---cEEEEecCCcccccCCCc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL---DIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG---~VKLiDFGLS~~~~~s~~ 344 (1238)
||||.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999999998888899999999999999999999999999999999999998654 599999999987766555
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESLI 420 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkDLI 420 (1238)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+.+.+|. .+++++.+||
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred cccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 667789999999999988776 89999999999999999999999999998999999888776653 4799999999
Q ss_pred HHhcccCCCCCCCHHHHHhccccccc
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+||..||.+|||++++|+||||...
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=417.36 Aligned_cols=256 Identities=28% Similarity=0.522 Sum_probs=230.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|+||.||++.+..+++.||||++.+... .....+.+.+|+.+|+.+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 458888999999999999999999999999999986532 233456788999999998 799999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~ 346 (1238)
||||.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.... ......
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 182 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC------
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcccc
Confidence 9999999999999998999999999999999999999999999999999999999999999999999997543 334456
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+..+...+|..+++++.+||++||.+
T Consensus 183 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~ 261 (353)
T 3txo_A 183 TFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261 (353)
T ss_dssp ---CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Confidence 7789999999999988776 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCH------HHHHhccccccc
Q psy6346 427 EPTKRYCI------EQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTa------eEILeHPWFke~ 446 (1238)
||.+||++ ++|++||||++.
T Consensus 262 dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 262 NPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp SGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999998 999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=385.71 Aligned_cols=260 Identities=32% Similarity=0.561 Sum_probs=238.7
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.+...|...+.||.|++|.||++.+..++..||||++..........+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 45677999999999999999999999999999999998877777778899999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc---EEEEecCCcccccCCC
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~---VKLiDFGLS~~~~~s~ 343 (1238)
||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999999999999988889999999999999999999999999999999999999987655 9999999998766655
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESL 419 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkDL 419 (1238)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...+|. .+++++.+|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred cccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence 5566789999999999998877 89999999999999999999999999988888888887665553 578999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
|.+||..||.+|||++|+++||||.+..
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 242 IDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=399.48 Aligned_cols=259 Identities=30% Similarity=0.510 Sum_probs=233.6
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----VNLQKVYREVEIMKQLDHPHIIKLFQVMETKS 262 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d 262 (1238)
.+...|...+.||.|+||.||++.+..++..||||++.+..... ...+.+.+|+.+|++++||||+++++++.+..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34456888999999999999999999999999999998765322 23578999999999999999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC----cEEEEecCCccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL----DIKLADFGFSNY 338 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG----~VKLiDFGLS~~ 338 (1238)
.+|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999999999888999999999999999999999999999999999999999887 799999999987
Q ss_pred ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCH
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMST 414 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~ 414 (1238)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......++ ..++.
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 765556667789999999999988776 8999999999999999999999999988888887777665544 45789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+.+||.+||..||.+|||++|+++||||...
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 99999999999999999999999999999753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=402.61 Aligned_cols=254 Identities=28% Similarity=0.535 Sum_probs=233.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++....+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 3478889999999999999999999999999999764321 124567889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ...+.
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~~~~ 163 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTL 163 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCCC
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--ccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999976432 34567
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||..||
T Consensus 164 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp 242 (318)
T 1fot_A 164 CGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 242 (318)
T ss_dssp CSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred cCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 89999999999998877 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-----CHHHHHhccccccc
Q psy6346 429 TKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRP-----TaeEILeHPWFke~ 446 (1238)
.+|| ++++|++||||++.
T Consensus 243 ~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 243 SQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp TTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHcCCCcCCCHHHHhcCccccCC
Confidence 9999 99999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=387.02 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=219.5
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.||.|+||+||++.+..+++.||||++..........+.+.+|+.+|++++||||+++++++.+.+.+|+||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 47888999999999999999999999999999988776666678899999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~ 349 (1238)
+.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 162 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCC
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCc
Confidence 986544444444678999999999999999999999999999999999999999999999999999765432 3345568
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCC-CCCCChhHHHHHHhcCC-----------------------
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGSTLNSLRDRVLSGR----------------------- 405 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlP-F~g~d~eeL~ekIl~g~----------------------- 405 (1238)
||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+.......+....
T Consensus 163 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T 3o0g_A 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc
Confidence 999999999998877569999999999999999987777 56666555555543210
Q ss_pred ------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 406 ------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 406 ------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
......+++++.+||.+||..||++|||++|+++||||.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 011224788999999999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=400.48 Aligned_cols=255 Identities=22% Similarity=0.395 Sum_probs=232.7
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
...|...+.||.|+||.||++.+..++..||+|++... ......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 35688889999999999999999999999999999754 344567889999999999999999999999999999999
Q ss_pred eecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC--CCcEEEEecCCcccccCCCcc
Q psy6346 269 EYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~--nG~VKLiDFGLS~~~~~s~~l 345 (1238)
|||.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 9999999999997654 7999999999999999999999999999999999999987 789999999999887666666
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHHHHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESLIR 421 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkDLIr 421 (1238)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+...++. .++.++.+||.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence 67789999999999988776 89999999999999999999999999998888988888776653 58999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||..||.+|||+.|+|+||||.+..
T Consensus 240 ~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 240 RLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHcCCChhHCcCHHHHhcChhhccCc
Confidence 99999999999999999999998653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=403.42 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=231.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|+||.||++.+..+++.||||++.+... .....+.+.+|+.+|+++ +||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 458888999999999999999999999999999987654 445667889999999998 899999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~ 346 (1238)
|||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~ 168 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999997633 334556
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCC---------CChhHHHHHHhcCCccCCCCCCHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG---------STLNSLRDRVLSGRFRIPYFMSTECE 417 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g---------~d~eeL~ekIl~g~~~~P~~iS~eLk 417 (1238)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.. .....+...+......+|..++.++.
T Consensus 169 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 247 (345)
T 3a8x_A 169 TFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 7789999999999998877 8999999999999999999999975 34455677788888889999999999
Q ss_pred HHHHHhcccCCCCCCCH------HHHHhccccccc
Q psy6346 418 SLIRKMLVREPTKRYCI------EQIKRHRWMAEE 446 (1238)
Q Consensus 418 DLIrkML~kDPskRPTa------eEILeHPWFke~ 446 (1238)
+||.+||..||.+||++ +||++||||...
T Consensus 248 ~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 99999999999999984 899999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=420.94 Aligned_cols=259 Identities=32% Similarity=0.524 Sum_probs=235.6
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.+.+.|...+.||.|+||.||++.+..+|..||+|++..........+.+.+|+.+|++++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34567889999999999999999999999999999999887777777889999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc---CCCcEEEEecCCcccccCCC
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD---SNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd---~nG~VKLiDFGLS~~~~~s~ 343 (1238)
|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999999999989999999999999999999999999999999999999998 45789999999997665433
Q ss_pred -ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHH
Q psy6346 344 -KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECES 418 (1238)
Q Consensus 344 -~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkD 418 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+.+.+|. .+++++.+
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 3456789999999999988877 89999999999999999999999999999999999988776654 57999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||.+||..||.+|||+.|+|+||||...
T Consensus 247 li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999999999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=408.56 Aligned_cols=256 Identities=28% Similarity=0.486 Sum_probs=234.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|+||.||++.+..+++.||||++++... .....+.+.+|..+|..+ +||||+++++++.+.+.+|+|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888999999999999999999999999999976431 122456788999999987 999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~ 346 (1238)
||||.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 176 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999976432 33456
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+...+|..+++++.+||.+||..
T Consensus 177 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~ 255 (345)
T 1xjd_A 177 TFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred CCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcC
Confidence 7789999999999998877 899999999999999999999999999999999999998889999999999999999999
Q ss_pred CCCCCCCHH-HHHhccccccc
Q psy6346 427 EPTKRYCIE-QIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTae-EILeHPWFke~ 446 (1238)
||.+||++. +|++||||+..
T Consensus 256 dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 256 EPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp SGGGSBTTBSCGGGSGGGTTC
T ss_pred CHhHcCCChHHHHcCccccCC
Confidence 999999998 99999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=385.19 Aligned_cols=255 Identities=30% Similarity=0.584 Sum_probs=219.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh------------------------HhHHHHHHHHHHHHh
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP------------------------VNLQKVYREVEIMKQ 245 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~------------------------e~ikrf~rEIeILkk 245 (1238)
..|...+.||.|+||.||++.+..+++.||||++....... ...+.+.+|+++|++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 34888899999999999999999999999999998764321 124678899999999
Q ss_pred CCCCCeeEEEEEeee--CCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc
Q psy6346 246 LDHPHIIKLFQVMET--KSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD 323 (1238)
Q Consensus 246 L~HPNIVrL~dvfed--~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd 323 (1238)
++||||+++++++.+ .+.+|+||||+.+++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 999999999999986 678999999999999998764 46799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCcccccCCC-ccccccCCCCCCCcccccCCcc--CCCccceehhhHHHHHHhhCCCCCCCCChhHHHHH
Q psy6346 324 SNLDIKLADFGFSNYYVPGQ-KLATWCGSPPYAAPEVFEGKKY--CGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400 (1238)
Q Consensus 324 ~nG~VKLiDFGLS~~~~~s~-~l~t~~GTp~YmAPEVL~gk~y--~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ek 400 (1238)
.++.+||+|||++....... .....+||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.....+...
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 251 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHH
Confidence 99999999999998654432 3345689999999999986542 46789999999999999999999999888888887
Q ss_pred HhcCCccCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 401 VLSGRFRIP--YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 401 Il~g~~~~P--~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
+......+| ..+++++.+||.+||..||.+|||++|+++||||.+
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 777765555 358999999999999999999999999999999963
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=405.16 Aligned_cols=254 Identities=31% Similarity=0.540 Sum_probs=234.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+|..||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 458888999999999999999999999999999976432 1234578889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ...+.
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--~~~~~ 198 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWTL 198 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCCC
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--Ccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999986533 33567
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+...+|..+++++.+||.+||..||
T Consensus 199 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp 277 (350)
T 1rdq_E 199 CGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp EECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred cCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 89999999999998876 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----HHHHHhccccccc
Q psy6346 429 TKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRPT-----aeEILeHPWFke~ 446 (1238)
.+||+ +++|++||||...
T Consensus 278 ~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 278 TKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HhccCCccCCHHHHHhCcCcCCC
Confidence 99998 9999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=396.19 Aligned_cols=256 Identities=25% Similarity=0.467 Sum_probs=221.9
Q ss_pred cEEEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCC--ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQL--DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~l--d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|...+.||.|+||.||++... .+++.||||++++... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 45888899999999999998875 6889999999987643 223456788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CC
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQ 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~ 343 (1238)
|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 176 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999875432 23
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHh
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkM 423 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..++.++.+||.+|
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 255 (327)
T 3a62_A 177 VTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKL 255 (327)
T ss_dssp --CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 3456789999999999988776 899999999999999999999999999988999999988889999999999999999
Q ss_pred cccCCCCCC-----CHHHHHhccccccc
Q psy6346 424 LVREPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 424 L~kDPskRP-----TaeEILeHPWFke~ 446 (1238)
|..||.+|| +++++++||||...
T Consensus 256 L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 256 LKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp SCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999 89999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=413.00 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=230.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|+||.||++....+++.||||++++.... ....+.+.+|+.+|.++ +||||+++++++.+.+.+|||
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 4588889999999999999999999999999999876543 33446788999999887 899999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc-cCCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY-VPGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~-~~s~~l~ 346 (1238)
||||.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++... .......
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~ 211 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 211 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccc
Confidence 999999999999998899999999999999999999999999999999999999999999999999999763 3445566
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC---------ChhHHHHHHhcCCccCCCCCCHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS---------TLNSLRDRVLSGRFRIPYFMSTECE 417 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~---------d~eeL~ekIl~g~~~~P~~iS~eLk 417 (1238)
+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+. ....+.+.+......+|..+++++.
T Consensus 212 ~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 290 (396)
T 4dc2_A 212 TFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290 (396)
T ss_dssp CCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHH
Confidence 7899999999999998887 89999999999999999999999642 3345777888888999999999999
Q ss_pred HHHHHhcccCCCCCCC------HHHHHhccccccc
Q psy6346 418 SLIRKMLVREPTKRYC------IEQIKRHRWMAEE 446 (1238)
Q Consensus 418 DLIrkML~kDPskRPT------aeEILeHPWFke~ 446 (1238)
+||++||.+||.+||+ ++||++||||+..
T Consensus 291 ~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999998 4899999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=391.37 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=225.0
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
....|...+.||.|+||.||++.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 345577788999999999999999999999999999765432 346788999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~ 346 (1238)
||||.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 999999999999876 468999999999999999999999999999999999999999999999999987654432 345
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHHHHHHHh
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLkDLIrkM 423 (1238)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... ....|..+++.+.+||.+|
T Consensus 175 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 5689999999999998887 89999999999999999999999988766555544432 3345667899999999999
Q ss_pred cccCCCCCCCHHHHHhcccccccC
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~~ 447 (1238)
|..||.+|||++|+++||||+...
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999998653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=390.02 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=215.8
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
+...|...+.||.|+||.||++.+ .+++.||||++.....+....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 457789999999999999999987 4689999999987655555567889999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccc
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKL 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l 345 (1238)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 999985 777777654 45999999999999999999999999999999999999999999999999999765432 334
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--------------------
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-------------------- 405 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-------------------- 405 (1238)
...+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 456899999999999876555899999999999999999999998877665555443210
Q ss_pred -c---------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 406 -F---------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 406 -~---------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
+ .+...+++++.+||.+||..||.+|||++|+++||||++..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 0 012236789999999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=407.10 Aligned_cols=256 Identities=26% Similarity=0.441 Sum_probs=234.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|+||.||++....+++.||||++.+... .....+.+.+|..+|..+ +||||+++++++.+.+.+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 448888999999999999999998999999999986532 123456788999999988 899999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~ 346 (1238)
|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... ......
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 179 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 179 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999997643 334456
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+......+|..+++++.+||.+||..
T Consensus 180 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~ 258 (353)
T 2i0e_A 180 TFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 258 (353)
T ss_dssp CCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence 7789999999999998887 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-----CHHHHHhccccccc
Q psy6346 427 EPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRP-----TaeEILeHPWFke~ 446 (1238)
||.+|| ++++|++||||+..
T Consensus 259 dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 259 HPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp CTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred CHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999 47999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.21 Aligned_cols=257 Identities=36% Similarity=0.623 Sum_probs=234.5
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
+.+...|.....||.|+||.||++.+..++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 3445678899999999999999999999999999999987543 23568899999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc---cCCCcEEEEecCCcccccCC
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL---d~nG~VKLiDFGLS~~~~~s 342 (1238)
+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999999999988889999999999999999999999999999999999999 77899999999999877666
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHH
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECES 418 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkD 418 (1238)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+.......+..+...+|. .+++++.+
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 666777899999999998765 489999999999999999999999999988888888888777665 58999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||.+||..||.+|||+.++++||||.+.
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=402.23 Aligned_cols=259 Identities=19% Similarity=0.258 Sum_probs=220.9
Q ss_pred CcEEEEEEEecCC--CCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 189 GQTIRKREKCGVK--SRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 189 GqVYkarekIGsG--sfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
+..|...+.||.| ++|.||++.+..+++.||||++..........+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4668999999999 99999999999999999999998877677777889999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC--
Q psy6346 267 VSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-- 342 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-- 342 (1238)
|||||.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 99999999999999765 67999999999999999999999999999999999999999999999999987544221
Q ss_pred ------CccccccCCCCCCCcccccCC-ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---------
Q psy6346 343 ------QKLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF--------- 406 (1238)
Q Consensus 343 ------~~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~--------- 406 (1238)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+..+..
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence 122334789999999999873 2348999999999999999999999988665544433332211
Q ss_pred -------------------------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 407 -------------------------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 407 -------------------------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.++..+++++.+||++||..||.+|||++|+|+||||++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 13445788999999999999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=381.21 Aligned_cols=259 Identities=43% Similarity=0.777 Sum_probs=226.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|++|.||++.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 347888999999999999999999999999999975432 1223568899999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++............
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999876555555567
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+|++.|+|||++.+..+.+.++|||||||++|+|++|..||.+.....+...+..+...+|..++.++.+||.+||..||
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 250 (276)
T 2h6d_A 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 250 (276)
T ss_dssp ------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCCh
Confidence 89999999999988776578999999999999999999999999888888888888888888999999999999999999
Q ss_pred CCCCCHHHHHhcccccccCC
Q psy6346 429 TKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~~p 448 (1238)
.+|||++++++||||++..+
T Consensus 251 ~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 251 LKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp GGSCCHHHHHHSHHHHTTCC
T ss_pred hhCCCHHHHHhChhhccCch
Confidence 99999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=399.57 Aligned_cols=258 Identities=35% Similarity=0.589 Sum_probs=215.4
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
....|...+.||.|+||.||++.+..+++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 346688899999999999999999999999999999875432 25678999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc--EEEEecCCcccccCCCcc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD--IKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~--VKLiDFGLS~~~~~s~~l 345 (1238)
||||.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.........
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 999999999999988889999999999999999999999999999999999999987765 999999999765555555
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh----hHHHHHHhcCCccCCC--CCCHHHHHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL----NSLRDRVLSGRFRIPY--FMSTECESL 419 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~----eeL~ekIl~g~~~~P~--~iS~eLkDL 419 (1238)
...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+... ......+......+|. .+++++.+|
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 6678999999999999888755669999999999999999999987543 4455556666655555 479999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
|.+||..||.+|||++||++||||....+
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 99999999999999999999999976543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=388.36 Aligned_cols=259 Identities=31% Similarity=0.504 Sum_probs=234.0
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----VNLQKVYREVEIMKQLDHPHIIKLFQVMETKS 262 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d 262 (1238)
.+...|...+.||.|+||.||++.+..+|..||||++....... ...+.+.+|+.+|++++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34566888999999999999999999999999999998765322 13578999999999999999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC----cEEEEecCCccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL----DIKLADFGFSNY 338 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG----~VKLiDFGLS~~ 338 (1238)
.+|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999999888899999999999999999999999999999999999999887 799999999987
Q ss_pred ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCH
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMST 414 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~ 414 (1238)
...........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......++ ..+++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCccccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 666555566789999999999988776 8999999999999999999999999988888888877765554 45889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+.+||.+||..||.+|||++|+++||||...
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=383.02 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=218.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|++|.||++.+..+|..||||++.....+....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 45888899999999999999999999999999998876666667888999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
|+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 162 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCC
Confidence 9999999999888888999999999999999999999999999999999999999999999999999765432 334556
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRIP 409 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~P 409 (1238)
+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+... ...++
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCC
Confidence 89999999999987555589999999999999999999999988766554443221 00011
Q ss_pred ------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 410 ------------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 410 ------------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..++.++.+||.+||..||.+|||++|+++||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 2478889999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=386.94 Aligned_cols=262 Identities=31% Similarity=0.514 Sum_probs=219.0
Q ss_pred CCCCCcEEEEE-EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCC
Q psy6346 185 AEKNGQTIRKR-EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS 262 (1238)
Q Consensus 185 sGkfGqVYkar-ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d 262 (1238)
.|.+...|... +.||.|+||.||++.+..+++.||||++.... ....+.+.+|+.+|.++ +||||+++++++.+.+
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 45667778774 67999999999999999999999999998653 23456889999999995 7999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc---EEEEecCCcccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFSNYY 339 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~---VKLiDFGLS~~~ 339 (1238)
.+|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999998889999999999999999999999999999999999999998776 999999998754
Q ss_pred cCC--------CccccccCCCCCCCcccccCC----ccCCCccceehhhHHHHHHhhCCCCCCCCCh-------------
Q psy6346 340 VPG--------QKLATWCGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTL------------- 394 (1238)
Q Consensus 340 ~~s--------~~l~t~~GTp~YmAPEVL~gk----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~------------- 394 (1238)
... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 321 122345799999999998751 2238899999999999999999999987542
Q ss_pred --hHHHHHHhcCCccCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 395 --NSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 395 --eeL~ekIl~g~~~~P~----~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
..+...+..+...+|. .+++++.+||.+||..||.+|||++|+++||||+...+
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 3456667777666663 58899999999999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=380.51 Aligned_cols=257 Identities=28% Similarity=0.560 Sum_probs=230.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|++|.||++.+..++..||||++....... .....+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 45888899999999999999999999999999997643221 23467889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-~~~~~~ 167 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDL 167 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-cccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999998865432 233456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
.|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||..||
T Consensus 168 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 246 (279)
T 3fdn_A 168 CGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 246 (279)
T ss_dssp CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSG
T ss_pred CCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccCh
Confidence 89999999999988776 88999999999999999999999999999999999888888999999999999999999999
Q ss_pred CCCCCHHHHHhcccccccCC
Q psy6346 429 TKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~~p 448 (1238)
.+|||++|+++||||.....
T Consensus 247 ~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 247 SQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp GGSCCHHHHHHCHHHHHHCS
T ss_pred hhCCCHHHHhhCccccCCcc
Confidence 99999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=391.61 Aligned_cols=259 Identities=28% Similarity=0.475 Sum_probs=222.1
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
+-..|...+.||.|+||.||++.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 446789999999999999999999999999999999765422 2346788999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---Cc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG---QK 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s---~~ 344 (1238)
||||.|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999999765332 22
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhcCCccCC--CCCCHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLSGRFRIP--YFMSTECESLIR 421 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~g~~~~P--~~iS~eLkDLIr 421 (1238)
....+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.... .....+.......+ ..+++++.+||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence 346789999999999988877678999999999999999999999876543 22233333322222 458999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||..||.+|||++|+++||||....
T Consensus 244 ~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 244 KILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHccCChhhCcCHHHHhhChhhcccc
Confidence 99999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=397.82 Aligned_cols=257 Identities=28% Similarity=0.554 Sum_probs=223.4
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC---ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL---DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l---d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
+...|...+.||.|+||.||++.+..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34568899999999999999999999999999999965321 112356789999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhccc----ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc---EEEEecCCcc
Q psy6346 265 YIVSEYANQGEIFDYIARYG----RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFSN 337 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~----~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~---VKLiDFGLS~ 337 (1238)
|+|||||.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999999988886542 4899999999999999999999999999999999999987655 9999999997
Q ss_pred cccCCCc-cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCC
Q psy6346 338 YYVPGQK-LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFM 412 (1238)
Q Consensus 338 ~~~~s~~-l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~i 412 (1238)
....... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ..+...+..+...++ ..+
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence 7654332 445689999999999998877 899999999999999999999998854 456666766665544 458
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
++++.+||.+||..||.+|||+.|+++||||.+.
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 9999999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=380.04 Aligned_cols=263 Identities=30% Similarity=0.585 Sum_probs=237.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|++|.||++.+..++..||||++...... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4588889999999999999999999999999999754321 123467889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 172 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTM 172 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-SCBCCC
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-cccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999865432 233456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..++.++.+||.+||..||
T Consensus 173 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 251 (284)
T 2vgo_A 173 CGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 251 (284)
T ss_dssp CSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred cCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCH
Confidence 79999999999998876 89999999999999999999999999888888888888888899999999999999999999
Q ss_pred CCCCCHHHHHhcccccccCCCCCCCc
Q psy6346 429 TKRYCIEQIKRHRWMAEETPRLLPPI 454 (1238)
Q Consensus 429 skRPTaeEILeHPWFke~~p~~lppi 454 (1238)
.+||+++++++||||+.......|+.
T Consensus 252 ~~Rps~~~ll~h~~~~~~~~~~~p~~ 277 (284)
T 2vgo_A 252 PQRLPLKGVMEHPWVKANSRRVLPPV 277 (284)
T ss_dssp GGSCCHHHHHTCHHHHHHCCCCCCCC
T ss_pred hhCCCHHHHhhCHHHHhhccccCCCc
Confidence 99999999999999998776665543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=416.33 Aligned_cols=263 Identities=34% Similarity=0.575 Sum_probs=234.2
Q ss_pred ccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC
Q psy6346 183 LHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS 262 (1238)
Q Consensus 183 LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d 262 (1238)
+..|.+...|.....||.|+||+||++.+..++..||||++.+..........+.+|+.+|++++||||+++++++.+..
T Consensus 15 ~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp TTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 34566778899999999999999999999999999999999764333344678899999999999999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc---CCCcEEEEecCCcccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD---SNLDIKLADFGFSNYY 339 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd---~nG~VKLiDFGLS~~~ 339 (1238)
.+|+|||||.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999999998889999999999999999999999999999999999999995 4567999999999877
Q ss_pred cCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHH
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTE 415 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~e 415 (1238)
.........+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..++++
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred CCCCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 666666777899999999999864 4 8999999999999999999999999999888888888765543 347999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+.+||.+||..||.+|||+.++|+||||+...
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=412.99 Aligned_cols=262 Identities=35% Similarity=0.598 Sum_probs=234.2
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-----------HhHHHHHHHHHHHHhCCCCCeeE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-----------VNLQKVYREVEIMKQLDHPHIIK 253 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-----------e~ikrf~rEIeILkkL~HPNIVr 253 (1238)
.+.++..|.....||.|+||+||+|.+..++..||||++.+..... ...+.+.+|+.+|++++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 3556778999999999999999999999999999999998765332 33578899999999999999999
Q ss_pred EEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC---cEEE
Q psy6346 254 LFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL---DIKL 330 (1238)
Q Consensus 254 L~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG---~VKL 330 (1238)
+++++.+...+|+|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999999888999999999999999999999999999999999999998776 6999
Q ss_pred EecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC-
Q psy6346 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP- 409 (1238)
Q Consensus 331 iDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P- 409 (1238)
+|||++............+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..++...+..+.+.++
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 99999988766666677889999999999875 34 8999999999999999999999999999999999998877655
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 410 ---YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 410 ---~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
..+++++.+||++||..||.+|||++|+|+||||+....
T Consensus 269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 468999999999999999999999999999999987643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=378.47 Aligned_cols=262 Identities=28% Similarity=0.484 Sum_probs=238.9
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
......|.....||.|+||.||++.+..++..||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 3456779999999999999999999999999999999977643 445667899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CC
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQ 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~ 343 (1238)
|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999976543 23
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHh
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkM 423 (1238)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+......+|..+++.+.+||.+|
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHH
Confidence 3445679999999999988776 899999999999999999999999998888888888888888999999999999999
Q ss_pred cccCCCCCCCHHHHHhcccccccCC
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~~p 448 (1238)
|..||.+|||++|+++||||.....
T Consensus 250 l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 250 LQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred cccChhhCcCHHHHhhChheecCCc
Confidence 9999999999999999999987643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=412.97 Aligned_cols=256 Identities=32% Similarity=0.525 Sum_probs=224.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..++..||||++.+... .......+.+|+.+|+.++||||+++++++.+.+.+||||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 458889999999999999999999999999999976432 3344567889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCccccc-CCCccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~ 346 (1238)
|||.|++|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||++.... ......
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 307 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----C
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccc
Confidence 999999999999988899999999999999999999998 899999999999999999999999999997643 334456
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
..+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.+...+...+......+|..+++++.+||.+||..
T Consensus 308 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 386 (446)
T 4ejn_A 308 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK 386 (446)
T ss_dssp CSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccc
Confidence 6789999999999988887 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-----CHHHHHhccccccc
Q psy6346 427 EPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRP-----TaeEILeHPWFke~ 446 (1238)
||.+|| +++|+++||||...
T Consensus 387 dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 387 DPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=381.95 Aligned_cols=258 Identities=29% Similarity=0.528 Sum_probs=221.8
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.|++...|...+.||.|+||.||++.+..++..||||++.... .....+.+.+|+++|++++||||+++++++.+.+..
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 4666778999999999999999999999999999999998754 223457889999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc---cCCCcEEEEecCCcc
Q psy6346 265 YIVSEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADFGFSN 337 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL---d~nG~VKLiDFGLS~ 337 (1238)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999999988643 579999999999999999999999999999999999999 446789999999998
Q ss_pred cccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC---CCCCH
Q psy6346 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP---YFMST 414 (1238)
Q Consensus 338 ~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P---~~iS~ 414 (1238)
...........+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+......++ ..+++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253 (285)
T ss_dssp C----------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred ecCCcccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence 7666555667789999999999864 34 7899999999999999999999999988887777765544433 23789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
++.+||.+||..||.+|||++|+++||||++
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999999999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=399.69 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=209.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCC--EEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKS--MIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d--~lyL 266 (1238)
..|.....||.|+||.||++.+..+++.||||++.+........+++.+|+.+|+.+. ||||+++++++...+ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 4588889999999999999999999999999999877667777889999999999997 999999999997544 7999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-----
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP----- 341 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~----- 341 (1238)
|||||. ++|..++.. +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 999998 588888865 5799999999999999999999999999999999999999999999999999976432
Q ss_pred -----------------CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC
Q psy6346 342 -----------------GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG 404 (1238)
Q Consensus 342 -----------------s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g 404 (1238)
.......+||+.|+|||++.+...++.++||||||||||+|++|+.||.+.+.......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 246 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 112345689999999999987555599999999999999999999999998876666555421
Q ss_pred Cc-----------------------------------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6346 405 RF-----------------------------------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQI 437 (1238)
Q Consensus 405 ~~-----------------------------------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEI 437 (1238)
.. ..+..+++++.+||.+||..||.+|||++|+
T Consensus 247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~ 326 (388)
T 3oz6_A 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326 (388)
T ss_dssp HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence 00 0112568899999999999999999999999
Q ss_pred Hhccccccc
Q psy6346 438 KRHRWMAEE 446 (1238)
Q Consensus 438 LeHPWFke~ 446 (1238)
|+||||...
T Consensus 327 l~Hp~~~~~ 335 (388)
T 3oz6_A 327 LKHPFVSIF 335 (388)
T ss_dssp TTSTTTTTT
T ss_pred hCCHHHHHh
Confidence 999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=405.26 Aligned_cols=257 Identities=23% Similarity=0.431 Sum_probs=231.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+++.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 458888999999999999999999999999999976432 2234578899999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++............
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~ 174 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM 174 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCC
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceecc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999877666677788
Q ss_pred cCCCCCCCcccccCCc--cCCCccceehhhHHHHHHhhCCCCCCCC---ChhHHHHHHhcCCccCCCCCCHHHHHHHHHh
Q psy6346 349 CGSPPYAAPEVFEGKK--YCGPEIDIWSLGVVLYVLVCGALPFDGS---TLNSLRDRVLSGRFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~--y~S~KSDIWSLGVILYELLTGrlPF~g~---d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkM 423 (1238)
+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+. ....+...+......+|..+++++.+||.+|
T Consensus 175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~l 254 (384)
T 4fr4_A 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKL 254 (384)
T ss_dssp CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHH
Confidence 9999999999997432 2488999999999999999999999753 4456666777778888999999999999999
Q ss_pred cccCCCCCCC-HHHHHhccccccc
Q psy6346 424 LVREPTKRYC-IEQIKRHRWMAEE 446 (1238)
Q Consensus 424 L~kDPskRPT-aeEILeHPWFke~ 446 (1238)
|..||.+||+ ++++++||||.+.
T Consensus 255 L~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 255 LEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp SCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred hcCCHhHhcccHHHHHcChhhhcC
Confidence 9999999998 9999999999763
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=404.73 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=225.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHH-HHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEI-MKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeI-LkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|+||.||++.+..++..||||++.+... .......+.+|..+ ++.++||||+++++++.+.+.+|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 458888999999999999999999999999999987653 23345667788887 5778999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~ 346 (1238)
|||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... ......
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~ 197 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999997643 334556
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
..+||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.+..++...+......+|..++.++.+||.+||..
T Consensus 198 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~ 276 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 276 (373)
T ss_dssp SBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCS
T ss_pred cccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHccc
Confidence 7899999999999998877 899999999999999999999999999999999999998889999999999999999999
Q ss_pred CCCCCCCH----HHHHhccccccc
Q psy6346 427 EPTKRYCI----EQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTa----eEILeHPWFke~ 446 (1238)
||.+||++ ++|++||||...
T Consensus 277 dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 277 DRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp SGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred CHHhCCCCCCCHHHHhCCccccCC
Confidence 99999986 799999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=382.09 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=214.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.||.|+||.||++.+ .++..||||++.....+....+.+.+|+.+|++++||||+++++++.+.+.+|+||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 478889999999999999987 6799999999987654444457788999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 271 ANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
+.+ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 985 888888764 67999999999999999999999999999999999999999999999999998765432 234456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--C------------------c--
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--R------------------F-- 406 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~------------------~-- 406 (1238)
+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+... . +
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence 79999999999987655589999999999999999999999988766555544321 0 0
Q ss_pred -------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 407 -------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 407 -------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+...+++++.+||.+||..||.+|||++|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1123478999999999999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=412.82 Aligned_cols=258 Identities=34% Similarity=0.543 Sum_probs=228.7
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.+...|.....||.|+||+||++.+..++..||||++.+..........+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34456899999999999999999999999999999998876555556789999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC---CcEEEEecCCcccccCCC
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN---LDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n---G~VKLiDFGLS~~~~~s~ 343 (1238)
|||||.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+|||++.......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999999999988899999999999999999999999999999999999999764 459999999998877666
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECESL 419 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLkDL 419 (1238)
.....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..+++++.+|
T Consensus 194 ~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred cccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 6677889999999999864 44 8999999999999999999999999999999999988876654 2489999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|++||..||.+|||++|+|+||||++.
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=402.41 Aligned_cols=254 Identities=33% Similarity=0.548 Sum_probs=211.4
Q ss_pred CCCCcEEEEE-EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHH-hCCCCCeeEEEEEeee---
Q psy6346 186 EKNGQTIRKR-EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMK-QLDHPHIIKLFQVMET--- 260 (1238)
Q Consensus 186 GkfGqVYkar-ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILk-kL~HPNIVrL~dvfed--- 260 (1238)
+.....|... ..||.|+||.||++.+..+++.||||++... ..+.+|+.++. .++||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 3333446555 6899999999999999999999999999743 35678999874 4589999999999876
Q ss_pred -CCEEEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEEecC
Q psy6346 261 -KSMIYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFG 334 (1238)
Q Consensus 261 -~d~lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLiDFG 334 (1238)
...+|||||||.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 678999999999999999998754 5999999999999999999999999999999999999997 7889999999
Q ss_pred CcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh----HHHHHHhcCCccCC-
Q psy6346 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN----SLRDRVLSGRFRIP- 409 (1238)
Q Consensus 335 LS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e----eL~ekIl~g~~~~P- 409 (1238)
++..........+.+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.... .....+..+.+.+|
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 9987665555667899999999999988777 89999999999999999999999876533 24566666666555
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 410 ---YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 410 ---~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..++.++.+||++||..||.+|||++|+++||||....
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 35899999999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=382.73 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=216.5
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC---hHhHHHHHHHHHHHHhC---CCCCeeEEEEEeeeCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD---PVNLQKVYREVEIMKQL---DHPHIIKLFQVMETKS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld---~e~ikrf~rEIeILkkL---~HPNIVrL~dvfed~d 262 (1238)
...|.....||.|+||+||++.+..+++.||||++...... ......+.+|+.+++++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 35688889999999999999999999999999999754321 11234566788887776 4999999999997755
Q ss_pred -----EEEEEEeecCCCccchhhhcccc--cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCC
Q psy6346 263 -----MIYIVSEYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 263 -----~lyLVMEy~~GGSL~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
.+++||||+. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 6899999997 599999987654 99999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---------
Q psy6346 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF--------- 406 (1238)
Q Consensus 336 S~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~--------- 406 (1238)
+............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 987766666677889999999999988887 8999999999999999999999999887776666543210
Q ss_pred ------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 407 ------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 407 ------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.+...+++++.+||.+||..||.+|||+.|+|+||||.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 01124788999999999999999999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=390.63 Aligned_cols=262 Identities=22% Similarity=0.359 Sum_probs=213.7
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.+..-..|.....||.|+||.||++.+..+++.||||++..........+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 34445668999999999999999999999999999999987765555567788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc-----CCCcEEEEecCCcccc
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD-----SNLDIKLADFGFSNYY 339 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd-----~nG~VKLiDFGLS~~~ 339 (1238)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999998 59999999888999999999999999999999999999999999999994 4556999999999765
Q ss_pred cCC-CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc------------
Q psy6346 340 VPG-QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF------------ 406 (1238)
Q Consensus 340 ~~s-~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~------------ 406 (1238)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 432 3345567899999999998866558999999999999999999999998877666555543100
Q ss_pred ------cC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 407 ------RI------------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 407 ------~~------------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.+ +..+++++.+||.+||..||.+|||++|+|+||||....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 00 112678999999999999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=387.41 Aligned_cols=256 Identities=24% Similarity=0.425 Sum_probs=208.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+..+++.||||++.... .....+.+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45778889999999999999999999999999997654 22334678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-
Q psy6346 270 YANQGEIFDYIARY------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG- 342 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s- 342 (1238)
|+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 998 5899888654 35899999999999999999999999999999999999999999999999999765432
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-----------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR----------------- 405 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~----------------- 405 (1238)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 334456899999999999876545899999999999999999999999988776665553210
Q ss_pred -----------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 406 -----------------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 406 -----------------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
...+..++.++.+||.+||..||.+|||++|+++||||.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 001224788999999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=412.40 Aligned_cols=260 Identities=34% Similarity=0.575 Sum_probs=235.9
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
.+...|.....||.|+||.||++.+..++..||||++.+.... ....+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3456789999999999999999999999999999999876543 345678999999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc---cCCCcEEEEecCCcccccCC
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL---d~nG~VKLiDFGLS~~~~~s 342 (1238)
+|||||.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999999988999999999999999999999999999999999999999 46788999999999877666
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHHH
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECES 418 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLkD 418 (1238)
......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..++...+..+.+.++ ..+++++.+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred cccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 66677789999999999987 34 8999999999999999999999999999999888888865543 348999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
||++||..||.+|||++|+|+||||+....
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 999999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=373.43 Aligned_cols=260 Identities=24% Similarity=0.438 Sum_probs=225.9
Q ss_pred cCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee---
Q psy6346 184 HAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--- 260 (1238)
Q Consensus 184 gsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--- 260 (1238)
+....|..|.....||.|+||.||++.+..++..||+|++.....+....+.+.+|+.+|++++||||+++++++..
T Consensus 20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred hcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 33445677888899999999999999999999999999998877777788899999999999999999999999865
Q ss_pred -CCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccc--eeeccCCccccccc-CCCcEEEEecCCc
Q psy6346 261 -KSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMD-SNLDIKLADFGFS 336 (1238)
Q Consensus 261 -~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd-~nG~VKLiDFGLS 336 (1238)
...+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+.| |+||||||+||+++ .++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 4679999999999999999998889999999999999999999999999 99999999999998 7899999999999
Q ss_pred ccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-ChhHHHHHHhcCC--ccCCCCCC
Q psy6346 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-TLNSLRDRVLSGR--FRIPYFMS 413 (1238)
Q Consensus 337 ~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-d~eeL~ekIl~g~--~~~P~~iS 413 (1238)
.... ........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+. ........+..+. ..++...+
T Consensus 180 ~~~~-~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 180 TLKR-ASFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred cccc-ccccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 6543 3334456799999999998754 489999999999999999999999874 4445555555442 23455678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+++.+||.+||..||.+|||++|+++||||++.
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 999999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=385.68 Aligned_cols=260 Identities=28% Similarity=0.492 Sum_probs=238.0
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
.....|.....||.|+||.||++.+..++..||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 345678889999999999999999999999999999987643 4556688999999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCc
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~ 344 (1238)
+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999976543 233
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhc
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML 424 (1238)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+......+|..+++++.+||.+||
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence 455679999999999988776 8999999999999999999999999988888888888888889999999999999999
Q ss_pred ccCCCCCCCHHHHHhcccccccC
Q psy6346 425 VREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 425 ~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..||.+|||++|+++|+||....
T Consensus 277 ~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 277 QTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTSC
T ss_pred cCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=400.47 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=232.7
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.+.....|...+.||.|+||.||+|.+..++..||+|++.... ......+.+|+.+|+.++||||+++++++.+...+
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 3445566899999999999999999999999999999998653 34456789999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC--CCcEEEEecCCcccccC
Q psy6346 265 YIVSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~--nG~VKLiDFGLS~~~~~ 341 (1238)
|+|||||.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999997654 7999999999999999999999999999999999999974 47799999999987766
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECE 417 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLk 417 (1238)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..+++++.
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 555566789999999999998876 8999999999999999999999999988888888777655443 35799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
+||.+||..||.+|||++|+++||||.....
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.19 Aligned_cols=256 Identities=31% Similarity=0.542 Sum_probs=225.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
..|...+.||.|+||.||++.+..++..||||++....... ...+.+.+|+.+|++++||||+++++++.+....|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45888899999999999999999999999999998765432 23678999999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC----cEEEEecCCcccccC
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL----DIKLADFGFSNYYVP 341 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG----~VKLiDFGLS~~~~~ 341 (1238)
+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999998877 799999999987655
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECE 417 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLk 417 (1238)
........|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..++..+.
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence 555556679999999999988776 8999999999999999999999999888888777776655443 45789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||.+||..||.+|||+.++++||||+..
T Consensus 244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=395.97 Aligned_cols=252 Identities=30% Similarity=0.473 Sum_probs=221.7
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
+...+.||.|+||.||++.+..+|..||||++.... ....+.+.+|+.+|++++||||+++++++.+.+.+||||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 344578999999999999999999999999998753 345678999999999999999999999999999999999999
Q ss_pred CCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc--cCCCcEEEEecCCcccccCCCccccc
Q psy6346 272 NQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM--DSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL--d~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++............
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 248 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence 999999988654 469999999999999999999999999999999999999 56788999999999887666666677
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHHHHHHHhc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECESLIRKML 424 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLkDLIrkML 424 (1238)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..+++++.+||.+||
T Consensus 249 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 327 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLL 327 (373)
T ss_dssp CSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTS
T ss_pred cCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHc
Confidence 89999999999987766 8899999999999999999999999988888888887765544 357999999999999
Q ss_pred ccCCCCCCCHHHHHhccccccc
Q psy6346 425 VREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRPTaeEILeHPWFke~ 446 (1238)
..||.+|||++|+|+||||.+.
T Consensus 328 ~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 328 IKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CSSGGGSCCHHHHHHSHHHHCH
T ss_pred CCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=393.25 Aligned_cols=255 Identities=34% Similarity=0.565 Sum_probs=209.5
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
....|.....||.|+||.||++.+..+++.||||++.... ..+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3456888899999999999999999999999999998653 335688999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEEecCCcccccCCCc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLiDFGLS~~~~~s~~ 344 (1238)
|||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++........
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 999999999999998888999999999999999999999999999999999999975 88999999999987655555
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH-HHHHHhcCCccCC----CCCCHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS-LRDRVLSGRFRIP----YFMSTECESL 419 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee-L~ekIl~g~~~~P----~~iS~eLkDL 419 (1238)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..... +...+......++ ..++.++.+|
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 285 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285 (349)
T ss_dssp ------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred cccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHH
Confidence 566789999999999998876 899999999999999999999997765443 6666666654433 3578999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
|++||..||++|||+.|+++||||....
T Consensus 286 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 286 VRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=395.39 Aligned_cols=255 Identities=32% Similarity=0.569 Sum_probs=227.3
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChH------hHHHHHHHHHHHHhCCCCCeeEEEEEee
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV------NLQKVYREVEIMKQLDHPHIIKLFQVME 259 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e------~ikrf~rEIeILkkL~HPNIVrL~dvfe 259 (1238)
|.+...|.....||.|+||.||++.+..++..||||++........ ..+.+.+|+.+|++++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3445678899999999999999999999999999999987653221 3456778999999999999999999999
Q ss_pred eCCEEEEEEeecCCC-ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 260 TKSMIYIVSEYANQG-EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 260 d~d~lyLVMEy~~GG-SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
+.+.+++||||+.+| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999999766 9999999888999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHH
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECES 418 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkD 418 (1238)
..........+||+.|+|||++.+..+++.++|||||||++|+|++|..||.... .........|..+++++.+
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMS 253 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHH
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHH
Confidence 7666666678899999999999988877889999999999999999999997632 2333445567779999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||.+||..||.+|||++++++||||.+.
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=376.80 Aligned_cols=256 Identities=33% Similarity=0.585 Sum_probs=203.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+++.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4588899999999999999999999999999999754321 123467899999999999999999999999999999999
Q ss_pred eecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccc
Q psy6346 269 EYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~ 346 (1238)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 170 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence 999999999999865 67999999999999999999999999999999999999999999999999998765422 2334
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+......+|..++.++.+||.+||..
T Consensus 171 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 249 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCS
T ss_pred eccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHccc
Confidence 5679999999999988776 889999999999999999999999887776666776677778888999999999999999
Q ss_pred CCCCCCCHHHHHhccccccc
Q psy6346 427 EPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTaeEILeHPWFke~ 446 (1238)
||.+|||++++++||||...
T Consensus 250 dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 250 NPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SGGGSCCHHHHTTSTTTC--
T ss_pred CHhhCCCHHHHhcCccccCC
Confidence 99999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=387.01 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=217.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--------C
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--------K 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--------~ 261 (1238)
..|.....||.|+||.||++.+..+|+.||||++............+.+|+.+|+.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 45888899999999999999999999999999997766554455678899999999999999999999976 4
Q ss_pred CEEEEEEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 262 SMIYIVSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
+.+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 578999999985 66666654 3679999999999999999999999999999999999999999999999999997653
Q ss_pred C-----CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCC----
Q psy6346 341 P-----GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYF---- 411 (1238)
Q Consensus 341 ~-----s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~---- 411 (1238)
. .......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+......++..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 2 2233456789999999999876655899999999999999999999999988777666654321111111
Q ss_pred ----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 412 ----------------------------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 412 ----------------------------iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.++++.+||.+||..||.+|||++|+|+||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 26779999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=404.69 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=201.2
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee-----eCCE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME-----TKSM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe-----d~d~ 263 (1238)
...|.....||.|+||.||++.+..+++.||||++.+...+....+++.+|+.+|++++||||+++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 35578888999999999999999999999999999877667777889999999999999999999999994 3367
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG- 342 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s- 342 (1238)
+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 999999985 789999988888999999999999999999999999999999999999999999999999999765322
Q ss_pred ---------------------------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-----------
Q psy6346 343 ---------------------------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC----------- 384 (1238)
Q Consensus 343 ---------------------------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT----------- 384 (1238)
......+||+.|+|||++.....++.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 123456899999999987655545999999999999999998
Q ss_pred CCCCCCCCCh--------------------hHHHHHHhc-----------------------C---C-----ccCCCCCC
Q psy6346 385 GALPFDGSTL--------------------NSLRDRVLS-----------------------G---R-----FRIPYFMS 413 (1238)
Q Consensus 385 GrlPF~g~d~--------------------eeL~ekIl~-----------------------g---~-----~~~P~~iS 413 (1238)
|.++|.+.+. ......+.. . . ......++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 7777876541 011111110 0 0 00112358
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+++.+||++||..||.+|||++|+|+||||.+.
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 999999999999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=384.01 Aligned_cols=259 Identities=30% Similarity=0.522 Sum_probs=220.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC---CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ---LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~---ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
..|...+.||.|+||.||++.+..++..||||++.+.. .+....+.+.+|+.+|++++||||+++++++.+.+..|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 55888899999999999999999999999999997642 234566789999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhc----------------------------------------ccccchhHHHHHHHHHHHHHhHhh
Q psy6346 267 VSEYANQGEIFDYIAR----------------------------------------YGRMNENAARRKFWQILSAVEYCH 306 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk----------------------------------------~~~Lsesea~kI~~QILsALeYLH 306 (1238)
|||||+|++|.+++.. ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998852 123467888999999999999999
Q ss_pred ccceeeccCCcccccccCCC--cEEEEecCCcccccCCC-----ccccccCCCCCCCcccccCC-ccCCCccceehhhHH
Q psy6346 307 NRRVVHRDLKAENLLMDSNL--DIKLADFGFSNYYVPGQ-----KLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVV 378 (1238)
Q Consensus 307 SkGIIHRDLKPeNILLd~nG--~VKLiDFGLS~~~~~s~-----~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVI 378 (1238)
++||+||||||+|||++.++ .+||+|||++....... ......||+.|+|||++.+. ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998776 89999999997653321 23456799999999999752 334889999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 379 LYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 379 LYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
+|+|++|..||.+.+.......+......++. .+++++.+||.+||..||.+|||+.++++||||.+...
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 99999999999999888888888777654433 37899999999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=393.59 Aligned_cols=244 Identities=21% Similarity=0.273 Sum_probs=192.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC----EEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS----MIYI 266 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d----~lyL 266 (1238)
.|...+.||.|+||.||+|.+ +|+.||||+++... ........|+.++.+++|||||++++++.+.+ .+||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 466678999999999999976 68999999997542 11122334666667889999999999997653 6899
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc--------ceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR--------RVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk--------GIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
|||||+||+|.+++.. ..+++..+..++.|++.||.|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999999975 5689999999999999999999987 999999999999999999999999999987
Q ss_pred ccCCCc-----cccccCCCCCCCcccccCCc-----cCCCccceehhhHHHHHHhhCCCCCCCC---------------C
Q psy6346 339 YVPGQK-----LATWCGSPPYAAPEVFEGKK-----YCGPEIDIWSLGVVLYVLVCGALPFDGS---------------T 393 (1238)
Q Consensus 339 ~~~s~~-----l~t~~GTp~YmAPEVL~gk~-----y~S~KSDIWSLGVILYELLTGrlPF~g~---------------d 393 (1238)
...... ....+||+.|||||++.+.. .++.++|||||||+||||+||..||... .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 644322 23468999999999997652 1367899999999999999997766321 2
Q ss_pred hhHHHHHHhcCCc--cCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 394 LNSLRDRVLSGRF--RIPYF-----MSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 394 ~eeL~ekIl~g~~--~~P~~-----iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
...+...+..... .+|.. .+..+.+||.+||..||++|||+.||++.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2334444444432 23332 23467899999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=366.96 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=218.2
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyL 266 (1238)
+...|...+.||.|++|.||++.+..+++.||||++............+.+|+.++..+ +||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 44568889999999999999999999999999999998766666778899999999999 99999999999999999999
Q ss_pred EEeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-----------------
Q psy6346 267 VSEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN----------------- 325 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n----------------- 325 (1238)
||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999865 568999999999999999999999999999999999999844
Q ss_pred --CcEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc
Q psy6346 326 --LDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS 403 (1238)
Q Consensus 326 --G~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~ 403 (1238)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|..++.... ....+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~ 242 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQ 242 (289)
T ss_dssp -CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHT
T ss_pred CceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHc
Confidence 47999999998765432 234699999999999877555789999999999999999998775442 2333444
Q ss_pred CC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 404 GR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 404 g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+. ..+|..+++++.+||.+||..||.+|||+.|+++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 43 35677899999999999999999999999999999999865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=397.20 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=215.2
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC----
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK---- 261 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~---- 261 (1238)
...+..|.....||.|+||.||++.+..+++.||||++.....+....+++.+|+.+|++++||||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 3455678999999999999999999999999999999987766677778999999999999999999999999766
Q ss_pred -CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 262 -SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 262 -d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 57999999997 5999999888889999999999999999999999999999999999999999999999999998654
Q ss_pred CCC-----------------------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC-----------C
Q psy6346 341 PGQ-----------------------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG-----------A 386 (1238)
Q Consensus 341 ~s~-----------------------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG-----------r 386 (1238)
... .....+||+.|+|||++.....++.++||||||||||||++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 321 235678999999999976555559999999999999999984 4
Q ss_pred CCCCCCCh-----------------hHHH------------------------HHHhcCCccC-------CCCCCHHHHH
Q psy6346 387 LPFDGSTL-----------------NSLR------------------------DRVLSGRFRI-------PYFMSTECES 418 (1238)
Q Consensus 387 lPF~g~d~-----------------eeL~------------------------ekIl~g~~~~-------P~~iS~eLkD 418 (1238)
++|.+.+. .... ..+....... ...+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44544321 0011 1111111111 1347899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
||++||..||.+|||++|+|+||||.+..
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=392.08 Aligned_cols=252 Identities=35% Similarity=0.560 Sum_probs=223.4
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyL 266 (1238)
+.+.|...+.||.|+||.||++.+..+++.||||++.+.... ..+|+++|.++ +||||+++++++.+.+.+|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 346688899999999999999999999999999999876432 34788898888 79999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC----CcEEEEecCCcccccCC
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN----LDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n----G~VKLiDFGLS~~~~~s 342 (1238)
|||||.||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++......
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999999988899999999999999999999999999999999999998433 35999999999865443
Q ss_pred -CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCC---CChhHHHHHHhcCCccCC----CCCCH
Q psy6346 343 -QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG---STLNSLRDRVLSGRFRIP----YFMST 414 (1238)
Q Consensus 343 -~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g---~d~eeL~ekIl~g~~~~P----~~iS~ 414 (1238)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+..++...+..+.+.++ ..+++
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 34556789999999999987766 7899999999999999999999976 456677888888777655 45899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
++.+||++||..||.+|||++++++||||.+.
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 99999999999999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=365.31 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=222.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|++|.||++.+..++..||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 458888999999999999999999999999999976542 2345788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---ccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---KLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---~l~ 346 (1238)
|+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987653322 234
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhcCCccC--CCCCCHHHHHHHHHh
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLSGRFRI--PYFMSTECESLIRKM 423 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~g~~~~--P~~iS~eLkDLIrkM 423 (1238)
..+|++.|+|||++.+..+.+.++|||||||++|+|++|..||.+.... .....+....... ...+++++.+||.+|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHH
Confidence 5679999999999988776678899999999999999999999876543 2233333332222 235889999999999
Q ss_pred cccCCCCCCCHHHHHhcccccccC
Q psy6346 424 LVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 424 L~kDPskRPTaeEILeHPWFke~~ 447 (1238)
|..||.+|||++|+++||||.+..
T Consensus 246 l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 246 LVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp SCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=406.57 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=226.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+++.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.+.+||||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 558888999999999999999999999999999976321 1112245789999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++....... ...
T Consensus 149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 99999999998865 579999999999999999999999999999999999999999999999999997654433 234
Q ss_pred cccCCCCCCCcccccCCc---cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCC--CCCHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKK---YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPY--FMSTECESL 419 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~---y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~--~iS~eLkDL 419 (1238)
+.+||+.|+|||++.+.. +++.++|||||||+||+|++|..||.+.+......++..+. +.+|. .+++++.+|
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~l 307 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHH
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHH
Confidence 678999999999998665 24789999999999999999999999999999888887653 34443 689999999
Q ss_pred HHHhcccCCCC--CCCHHHHHhcccccccC
Q psy6346 420 IRKMLVREPTK--RYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 420 IrkML~kDPsk--RPTaeEILeHPWFke~~ 447 (1238)
|.+||..+|.+ |++++||++||||+...
T Consensus 308 i~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 308 ICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred HHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 99999999998 99999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=370.60 Aligned_cols=261 Identities=32% Similarity=0.556 Sum_probs=231.1
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC---C----hHhHHHHHHHHHHHHhCC-CCCeeEEEEEe
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL---D----PVNLQKVYREVEIMKQLD-HPHIIKLFQVM 258 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l---d----~e~ikrf~rEIeILkkL~-HPNIVrL~dvf 258 (1238)
.+-..|.....||.|++|.||++.+..+++.||||++..... . ....+.+.+|+.+|+++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 445678999999999999999999999999999999986542 1 123467889999999995 99999999999
Q ss_pred eeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 259 ETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 259 ed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
...+..|+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999999888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCccccccCCCCCCCccccc-----CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP---- 409 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~-----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P---- 409 (1238)
..........+|++.|+|||++. ....++.++|||||||++|+|++|..||.+.+.......+..+...++
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence 76666666778999999999985 222348899999999999999999999999888888888877765544
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..++.++.+||.+||..||.+|||++|+++||||.+..
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 24789999999999999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=408.25 Aligned_cols=253 Identities=24% Similarity=0.426 Sum_probs=212.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------CE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------SM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d~ 263 (1238)
..|.....||.|+||.||++.+..+++.||||++.+........+++.+|+.+|+.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 458889999999999999999999999999999987765667788999999999999999999999999644 46
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
+||||||+.++ |.+.+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 142 ~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 142 VYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred EEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 89999999865 6665543 58999999999999999999999999999999999999999999999999998776665
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC------------------
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR------------------ 405 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~------------------ 405 (1238)
.....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.+......++....
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp CC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred ccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 6677899999999999999877 899999999999999999999999988766655554310
Q ss_pred ---------cc----CCCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 ---------FR----IPYF-----------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 ---------~~----~P~~-----------iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.. +|.. .++++.+||.+||..||.+|||++|+|+||||...
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00 0110 15679999999999999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=373.74 Aligned_cols=256 Identities=32% Similarity=0.520 Sum_probs=226.6
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
+...|...+.||.|++|.||++.+..+|+.||||++..... ...+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 34568888999999999999999999999999999986532 2345788999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc---cCCCcEEEEecCCcccccCCCc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL---d~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
|||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.... ...
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~-~~~ 163 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGI 163 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC-CBT
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC-CCc
Confidence 9999999999999888899999999999999999999999999999999999999 778899999999987543 233
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECESLI 420 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLkDLI 420 (1238)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+...++ ..+++++.+||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 445679999999999988776 8999999999999999999999999988888888887755443 45789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.+||..||.+|||++++++||||....
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=386.96 Aligned_cols=256 Identities=32% Similarity=0.587 Sum_probs=228.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC--Ch----HhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL--DP----VNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l--d~----e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d 262 (1238)
..|.....||.|++|.||+|.+..+|..||||++..... .. ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 458888999999999999999988999999999976542 22 2246788999999999 8999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
..|+||||+.|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999877666
Q ss_pred CccccccCCCCCCCcccccCC-----ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCC
Q psy6346 343 QKLATWCGSPPYAAPEVFEGK-----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMS 413 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk-----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS 413 (1238)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+..+...++ ..++
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 333 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 666778899999999998632 2248899999999999999999999999888888888877765543 3578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.++.+||.+||..||.+|||++++++||||++
T Consensus 334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 89999999999999999999999999999963
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=382.37 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=223.1
Q ss_pred cEEEEE-EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKR-EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkar-ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|... +.||.|+||.||++.+..+++.||||++............+.+|+.+++.+ .||||+++++++.+.+.+|+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 345555 789999999999999999999999999987665555677899999999999 569999999999999999999
Q ss_pred EeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEEecCCcccccCC
Q psy6346 268 SEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLiDFGLS~~~~~s 342 (1238)
|||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999998653 67999999999999999999999999999999999999987 789999999999876655
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHHH
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECES 418 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLkD 418 (1238)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..+++.+.+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 266 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD 266 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence 55566789999999999988876 8999999999999999999999999988887777766554433 347899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
||.+||..||.+|||++++|+||||+...
T Consensus 267 li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 267 FIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 99999999999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=388.14 Aligned_cols=247 Identities=33% Similarity=0.554 Sum_probs=201.0
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
..||.|+||.||++.+..+++.||||++.+. ....+.+|+.+|+.+. ||||+++++++.+....|+||||+.|+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 5689999999999999999999999999753 3467789999999996 999999999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC---cEEEEecCCcccccCC-CccccccC
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL---DIKLADFGFSNYYVPG-QKLATWCG 350 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG---~VKLiDFGLS~~~~~s-~~l~t~~G 350 (1238)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......+|
T Consensus 92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 171 (325)
T 3kn6_A 92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171 (325)
T ss_dssp BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCC
Confidence 9999999988999999999999999999999999999999999999998765 8999999999765433 34456789
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC-------hhHHHHHHhcCCccCCC----CCCHHHHHH
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST-------LNSLRDRVLSGRFRIPY----FMSTECESL 419 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d-------~eeL~ekIl~g~~~~P~----~iS~eLkDL 419 (1238)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ..++...+..+.+.++. .+++++.+|
T Consensus 172 t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (325)
T 3kn6_A 172 TLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250 (325)
T ss_dssp ------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred CcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence 999999999988877 899999999999999999999997643 35667778777766553 479999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
|.+||..||.+|||++|+++||||.+...
T Consensus 251 i~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp HHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred HHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 99999999999999999999999987644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=382.23 Aligned_cols=257 Identities=23% Similarity=0.357 Sum_probs=219.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+..+++.||||++..........+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 45888899999999999999999999999999998776666667788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
|+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ......
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 184 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------C
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCC
Confidence 9999999998887788999999999999999999999999999999999999999999999999999765432 334556
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------CccC-
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------------RFRI- 408 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------------~~~~- 408 (1238)
+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+... ...+
T Consensus 185 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
T 4aaa_A 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264 (331)
T ss_dssp CCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCC
T ss_pred cCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCc
Confidence 79999999999987755589999999999999999999999988765544443211 0011
Q ss_pred -----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 409 -----------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 409 -----------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...+++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 12468899999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=376.86 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=211.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||+||+|.+..+++.||||++...........+...|+..+.++ +||||+++++++.+.+.+|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 458888999999999999999999999999999987766666666677777776665 9999999999999999999999
Q ss_pred eecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 269 EYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 999 578888877654 599999999999999999999999999999999999999999999999999987655555556
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc--cCCCCCCHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF--RIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~--~~P~~iS~eLkDLIrkML~ 425 (1238)
.+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.. ....+..+.. .++..+++++.+||.+||.
T Consensus 216 ~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 216 QEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp CCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred cCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHHcC
Confidence 779999999999987 44 899999999999999999977665432 2333333322 2455689999999999999
Q ss_pred cCCCCCCCHHHHHhcccccc
Q psy6346 426 REPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWFke 445 (1238)
+||.+|||++|+++||||++
T Consensus 291 ~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 291 PDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp SSTTTSCCHHHHHTSGGGSC
T ss_pred CChhhCcCHHHHHhCccccC
Confidence 99999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=424.35 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=235.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|.....||.|+||.||++.+..+++.||||++++... .....+.+..|..+|..+ +||+|+.+++++.+.+.+|||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 458888999999999999999999999999999986432 223456788999999988 799999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc-CCCccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV-PGQKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~-~s~~l~ 346 (1238)
|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.... ......
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~ 500 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 500 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBC
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccc
Confidence 9999999999999998999999999999999999999999999999999999999999999999999998643 334556
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
+.+||+.|+|||++.+..+ +.++|||||||+||||++|..||.+.+..++.+.|......+|..+++++.+||++||.+
T Consensus 501 ~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~ 579 (674)
T 3pfq_A 501 TFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 579 (674)
T ss_dssp CCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCS
T ss_pred cccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccC
Confidence 7899999999999998887 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCH-----HHHHhccccccc
Q psy6346 427 EPTKRYCI-----EQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTa-----eEILeHPWFke~ 446 (1238)
||.+||++ +||++||||+..
T Consensus 580 dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 580 HPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp SSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred CHHHCCCCCCCcHHHHhcCccccCC
Confidence 99999997 999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=379.31 Aligned_cols=252 Identities=24% Similarity=0.427 Sum_probs=223.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|.....||.|+||.||++.+..+|+.||||++..... ...+.+.+|+.+|++++||||+++++++...+..|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 46666789999999999999988999999999976542 3456788999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .....+
T Consensus 124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence 999999998865 569999999999999999999999999999999999999999999999999987654432 345568
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---cCCCCCCHHHHHHHHHhccc
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---RIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---~~P~~iS~eLkDLIrkML~k 426 (1238)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..... ..+..+++++.+||.+||..
T Consensus 203 gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (321)
T 2c30_A 203 GTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281 (321)
T ss_dssp SCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred CCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence 9999999999988776 8999999999999999999999998887777776665532 22345789999999999999
Q ss_pred CCCCCCCHHHHHhccccccc
Q psy6346 427 EPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTaeEILeHPWFke~ 446 (1238)
||.+|||++++++||||...
T Consensus 282 dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 282 DPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp STTTSCCHHHHHTSGGGGGC
T ss_pred ChhhCcCHHHHhcChhhccC
Confidence 99999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=389.79 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=215.0
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------C
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------S 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d 262 (1238)
...|.....||.|+||.||++.+..+|+.||||++..........+++.+|+.+|+.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3568888999999999999999999999999999987766666778899999999999999999999999765 3
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~-- 179 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-- 179 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc--
Confidence 469999999 7899998875 679999999999999999999999999999999999999999999999999998643
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-----------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR----------------- 405 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~----------------- 405 (1238)
......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 234556899999999999884445899999999999999999999999887666555443210
Q ss_pred --------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 --------------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 --------------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..+....++++.+||.+||..||.+|||++|+|+||||.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 01223468999999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=407.59 Aligned_cols=257 Identities=26% Similarity=0.460 Sum_probs=225.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+++.||||++.+... .......+.+|+.+|..++||||+++++++.+.+.+||||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 458888999999999999999999999999999976321 1112234789999999999999999999999999999999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--c
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--L 345 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l 345 (1238)
|||.||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 99999999999987 47899999999999999999999999999999999999999999999999999976544332 2
Q ss_pred ccccCCCCCCCccccc-----CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCC---CCHH
Q psy6346 346 ATWCGSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYF---MSTE 415 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~-----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~---iS~e 415 (1238)
...+||+.|+|||++. ...+ +.++|||||||++|||++|+.||.+.+..+...++... .+.+|.. ++++
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 312 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHH
T ss_pred ccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHH
Confidence 3468999999999987 3344 89999999999999999999999999998888888764 3455544 8999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHHhcccccccC
Q psy6346 416 CESLIRKMLVREPTK--RYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 416 LkDLIrkML~kDPsk--RPTaeEILeHPWFke~~ 447 (1238)
+.+||++||..+|++ |++++|+++||||+...
T Consensus 313 ~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 313 AKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp HHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 999999999998888 99999999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=382.93 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=215.2
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-----CCCeeEEEEEeeeCCE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-----HPHIIKLFQVMETKSM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-----HPNIVrL~dvfed~d~ 263 (1238)
...|.....||.|+||.||++.+..+++.||||++... ......+..|+.+|+.+. ||||+++++++...+.
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 45688899999999999999999999999999999753 345567888999999996 9999999999999999
Q ss_pred EEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-----------------
Q psy6346 264 IYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS----------------- 324 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~----------------- 324 (1238)
.|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 99999999 899999997654 5999999999999999999999999999999999999975
Q ss_pred --------CCcEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH
Q psy6346 325 --------NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396 (1238)
Q Consensus 325 --------nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee 396 (1238)
++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~ 266 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFRTHEHME 266 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence 7889999999997643 23346689999999999998887 899999999999999999999999887666
Q ss_pred HHHHHhcCCccCC--------------------------C--------------------CCCHHHHHHHHHhcccCCCC
Q psy6346 397 LRDRVLSGRFRIP--------------------------Y--------------------FMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 397 L~ekIl~g~~~~P--------------------------~--------------------~iS~eLkDLIrkML~kDPsk 430 (1238)
....+......+| . ..++.+.+||.+||+.||.+
T Consensus 267 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 346 (360)
T 3llt_A 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTL 346 (360)
T ss_dssp HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhh
Confidence 5554443221111 1 12367889999999999999
Q ss_pred CCCHHHHHhccccc
Q psy6346 431 RYCIEQIKRHRWMA 444 (1238)
Q Consensus 431 RPTaeEILeHPWFk 444 (1238)
|||++|+|+||||+
T Consensus 347 Rpta~elL~hp~f~ 360 (360)
T 3llt_A 347 RPSPAELLKHKFLE 360 (360)
T ss_dssp SCCHHHHTTSGGGC
T ss_pred CCCHHHHhcCcccC
Confidence 99999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.07 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=208.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-------
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------- 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------- 262 (1238)
..|...+.||.|+||.||++.+..+++.||||++.... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 45888899999999999999999999999999998654 3445678999999999999999999999985433
Q ss_pred --------------------------------------------------EEEEEEeecCCCccchhhhcccc---cchh
Q psy6346 263 --------------------------------------------------MIYIVSEYANQGEIFDYIARYGR---MNEN 289 (1238)
Q Consensus 263 --------------------------------------------------~lyLVMEy~~GGSL~d~Lkk~~~---Lses 289 (1238)
.+|+|||||+|++|.+++..... ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 48999999999999999987654 3445
Q ss_pred HHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-------------ccccccCCCCCCC
Q psy6346 290 AARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-------------KLATWCGSPPYAA 356 (1238)
Q Consensus 290 ea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-------------~l~t~~GTp~YmA 356 (1238)
.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 689999999999999999999999999999999999999999999997654432 2234579999999
Q ss_pred cccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc-CCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6346 357 PEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR-IPYFMSTECESLIRKMLVREPTKRYCIE 435 (1238)
Q Consensus 357 PEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~-~P~~iS~eLkDLIrkML~kDPskRPTae 435 (1238)
||++.+..+ +.++|||||||++|+|++|..|+... ......+.....+ .+...++++.+||.+||..||.+|||++
T Consensus 245 PE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 245 PEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp HHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred hHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 999998877 89999999999999999987765321 2223333333221 1123567889999999999999999999
Q ss_pred HHHhcccccc
Q psy6346 436 QIKRHRWMAE 445 (1238)
Q Consensus 436 EILeHPWFke 445 (1238)
|+++||||++
T Consensus 322 ~~l~~~~f~~ 331 (332)
T 3qd2_B 322 DIIENAIFEN 331 (332)
T ss_dssp HHHHSTTCCC
T ss_pred HHhhchhhhc
Confidence 9999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=374.53 Aligned_cols=260 Identities=35% Similarity=0.580 Sum_probs=232.9
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.|.+...|.....||.|++|.||++.+..+++.||||++..........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 45556778899999999999999999988999999999987655555677899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC---CcEEEEecCCcccccC
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN---LDIKLADFGFSNYYVP 341 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n---G~VKLiDFGLS~~~~~ 341 (1238)
|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999888899999999999999999999999999999999999999764 4699999999987665
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECE 417 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLk 417 (1238)
........|++.|+|||++.+. + +.++|||||||++|+|++|..||.+.+...+...+..+...++ ..+++++.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 5555566789999999998765 4 8899999999999999999999999988888888887765443 35789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||.+||..||.+|||++++++||||.+.
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=367.84 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=228.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--eCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--d~d~lyLV 267 (1238)
..|...+.||.|++|.||++.+..+++.||||++..........+.+.+|+.++++++||||+++++++. ....+|+|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 4688889999999999999999999999999999988777777889999999999999999999999874 46789999
Q ss_pred EeecCCCccchhhhccc----ccchhHHHHHHHHHHHHHhHhhccc-----eeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 268 SEYANQGEIFDYIARYG----RMNENAARRKFWQILSAVEYCHNRR-----VVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~----~Lsesea~kI~~QILsALeYLHSkG-----IIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
|||+++++|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++..
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999999997653 3899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCC-ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHH
Q psy6346 339 YVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTEC 416 (1238)
Q Consensus 339 ~~~s~-~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eL 416 (1238)
..... ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+.. .+|..++.++
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 244 (279)
T 2w5a_A 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244 (279)
T ss_dssp C---CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred eccccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHH
Confidence 54332 2234579999999999988876 8999999999999999999999999888888888877765 5677899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.+||.+||..||.+||+++||++|+|+.+..
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 9999999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=380.87 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=217.0
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCC--CCeeEEEEEeeeCCEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDH--PHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~H--PNIVrL~dvfed~d~ly 265 (1238)
.+..|.....||.|+||.||++.+ .++..||||++.....+....+.+.+|+.+|+++.| +||+++++++.+.+.+|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 357799999999999999999976 568999999999887777778899999999999987 99999999999999999
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-- 343 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-- 343 (1238)
+||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9999 56789999999988999999999999999999999999999999999999997 6789999999998764332
Q ss_pred -ccccccCCCCCCCcccccC----------CccCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhc--CCccCC
Q psy6346 344 -KLATWCGSPPYAAPEVFEG----------KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLS--GRFRIP 409 (1238)
Q Consensus 344 -~l~t~~GTp~YmAPEVL~g----------k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~--g~~~~P 409 (1238)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.... .....+.. ....+|
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 2335689999999999864 123488999999999999999999999875332 23333333 234567
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...+.++.+||.+||..||.+|||+.|+++||||...
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 7788999999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=383.43 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=211.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.||.|+||.||++.+..++..||||++..... ......+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 48888999999999999999999999999999976542 11222455799999999999999999999999999999999
Q ss_pred cCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 271 ANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 98 5888888765 45899999999999999999999999999999999999999999999999998755432 234456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc----------------------
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---------------------- 406 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---------------------- 406 (1238)
+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 7899999999998765558999999999999999999999999887766655543100
Q ss_pred --------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy6346 407 --------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449 (1238)
Q Consensus 407 --------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p~ 449 (1238)
..+..+++++.+||.+||..||.+|||++|+|+||||.+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 0122468899999999999999999999999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=400.23 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=224.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++....+++.||||++++... .....+.+.+|+.+|..++||||+++++++.+.+.+||||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 458888999999999999999999999999999976421 1223455889999999999999999999999999999999
Q ss_pred eecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--c
Q psy6346 269 EYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--L 345 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l 345 (1238)
|||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++........ .
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 9999999999998764 799999999999999999999999999999999999999999999999999976644332 3
Q ss_pred ccccCCCCCCCcccccC-------CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCC---CCCC
Q psy6346 346 ATWCGSPPYAAPEVFEG-------KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIP---YFMS 413 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~g-------k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P---~~iS 413 (1238)
...+||+.|+|||++.+ ..+ +.++|||||||++|||++|+.||.+.+..+.+.++.... ..+| ..++
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 299 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCC
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCC
Confidence 35689999999999872 344 899999999999999999999999999888888887642 3344 5689
Q ss_pred HHHHHHHHHhcccCCCCC---CCHHHHHhcccccccC
Q psy6346 414 TECESLIRKMLVREPTKR---YCIEQIKRHRWMAEET 447 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskR---PTaeEILeHPWFke~~ 447 (1238)
+++.+||++||. +|.+| ++++||++||||+...
T Consensus 300 ~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 999999999999 99998 5999999999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=367.93 Aligned_cols=256 Identities=21% Similarity=0.313 Sum_probs=202.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||++.+..+++.||||++..........+.+..+..+++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 45888899999999999999999999999999998765444444555556666888899999999999999999999999
Q ss_pred ecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 270 YANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 270 y~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
|+.| +|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 9984 77776653 46799999999999999999999998 999999999999999999999999999987665555
Q ss_pred cccccCCCCCCCccccc---CCccCCCccceehhhHHHHHHhhCCCCCCCC-C-hhHHHHHHhcCCccCC-CCCCHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFE---GKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-T-LNSLRDRVLSGRFRIP-YFMSTECES 418 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~---gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-d-~eeL~ekIl~g~~~~P-~~iS~eLkD 418 (1238)
.....||+.|+|||++. ....++.++|||||||++|+|++|..||... . ...+...+.......+ ..+++++.+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHH
Confidence 55568999999999972 2333488999999999999999999999863 2 2333333444333333 358999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||.+||..||.+|||++|+++||||...
T Consensus 246 li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 246 FTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 9999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=387.41 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=214.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--------
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-------- 260 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-------- 260 (1238)
...|.....||.|+||.||++.+..+|+.||||++..... ...+|+.+|+.++||||+++++++..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4568899999999999999999999999999999976532 12379999999999999999999843
Q ss_pred ------------------------------CCEEEEEEeecCCCccchhhh----cccccchhHHHHHHHHHHHHHhHhh
Q psy6346 261 ------------------------------KSMIYIVSEYANQGEIFDYIA----RYGRMNENAARRKFWQILSAVEYCH 306 (1238)
Q Consensus 261 ------------------------------~d~lyLVMEy~~GGSL~d~Lk----k~~~Lsesea~kI~~QILsALeYLH 306 (1238)
...+++||||+.+ +|.+.+. ....+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3458999999984 6666654 4567999999999999999999999
Q ss_pred ccceeeccCCccccccc-CCCcEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC
Q psy6346 307 NRRVVHRDLKAENLLMD-SNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385 (1238)
Q Consensus 307 SkGIIHRDLKPeNILLd-~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG 385 (1238)
++||+||||||+|||++ .++.+||+|||++............+||+.|+|||++.+...++.++|||||||++|+|++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 99999999999999998 68899999999998776666667788999999999998876558999999999999999999
Q ss_pred CCCCCCCChhHHHHHHhcC-----------------C------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6346 386 ALPFDGSTLNSLRDRVLSG-----------------R------------FRIPYFMSTECESLIRKMLVREPTKRYCIEQ 436 (1238)
Q Consensus 386 rlPF~g~d~eeL~ekIl~g-----------------~------------~~~P~~iS~eLkDLIrkML~kDPskRPTaeE 436 (1238)
+.||.+.+..+....+... . ..+|..+++++.+||.+||..||.+|||+.|
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999998876655554321 0 0145568899999999999999999999999
Q ss_pred HHhccccccc
Q psy6346 437 IKRHRWMAEE 446 (1238)
Q Consensus 437 ILeHPWFke~ 446 (1238)
+++||||.+.
T Consensus 319 ~l~hp~f~~~ 328 (383)
T 3eb0_A 319 AMAHPFFDHL 328 (383)
T ss_dssp HHTSGGGHHH
T ss_pred HhcCHHHHHH
Confidence 9999999763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=380.23 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=220.6
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC---
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS--- 262 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d--- 262 (1238)
.+...|...+.||.|+||.||++.+..+++.||||++..... +......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 345678889999999999999999999999999999987654 3455678999999999999999999999987544
Q ss_pred -EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 263 -MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 263 -~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 4599999999999999999888999999999999999999999999999999999999999999999999999976543
Q ss_pred CC----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccC----CCCCC
Q psy6346 342 GQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI----PYFMS 413 (1238)
Q Consensus 342 s~----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~----P~~iS 413 (1238)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+....... +..++
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp -------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred cccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 32 2234579999999999998876 889999999999999999999999988777666665554332 24589
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.++.+||.+||..||.+||++.+++.|+|++...
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 9999999999999999999999999999997643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=385.81 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=208.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC------E
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------M 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------~ 263 (1238)
..|.....||.|+||.||++.+..++..||||++..........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 4588899999999999999999999999999999877666677788999999999999999999999997654 7
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred eEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 9999999984 6777775 468999999999999999999999999999999999999999999999999998765554
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc----------------
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR---------------- 407 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~---------------- 407 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......
T Consensus 182 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp --------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred ccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 5556789999999999998876 89999999999999999999999998876666555432110
Q ss_pred --------------------CCCC------CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 408 --------------------IPYF------MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 408 --------------------~P~~------iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+|.. .+.++.+||.+||..||.+|||++|+|+||||...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0100 15678999999999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=379.29 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=218.9
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC-----CE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK-----SM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~-----d~ 263 (1238)
+..|.....||.|+||.||++.+..++..||||++.... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 456899999999999999999999999999999997543 445567899999999999999999999999654 46
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
.|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999999998 588888865 569999999999999999999999999999999999999999999999999997654322
Q ss_pred ----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--------------
Q psy6346 344 ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-------------- 405 (1238)
Q Consensus 344 ----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-------------- 405 (1238)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 23456899999999998766545899999999999999999999999887766655553210
Q ss_pred -----------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 406 -----------------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 406 -----------------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..+...+++++.+||.+||..||.+|||++|+|+||||.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 001234688999999999999999999999999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=373.99 Aligned_cols=257 Identities=34% Similarity=0.594 Sum_probs=215.9
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC------hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD------PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld------~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d 262 (1238)
...|...+.||.|+||.||++.+..+++.||||++...... ......+.+|+++|++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45688889999999999999999999999999999765421 123356889999999999999999999998765
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc---EEEEecCCcccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFSNYY 339 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~---VKLiDFGLS~~~ 339 (1238)
.|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988889999999999999999999999999999999999999987665 999999999876
Q ss_pred cCCCccccccCCCCCCCccccc--CCccCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhcCCccC----CCCC
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFE--GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLSGRFRI----PYFM 412 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~--gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~g~~~~----P~~i 412 (1238)
.........+||+.|+|||++. +...++.++|||||||++|+|++|..||.+.... .+...+..+...+ +..+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 5444445567999999999974 2233488999999999999999999999765432 4555555554433 2457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+.++.+||.+||..||.+|||++++++||||.+.
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 8999999999999999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=381.11 Aligned_cols=255 Identities=22% Similarity=0.412 Sum_probs=220.5
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
...|.....||.|+||.||++.+..++..||+|++.... .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 356888899999999999999999999999999998763 5566788999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
||++|++|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...... ....
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 189 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 189 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C---
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccC
Confidence 9999999999999888999999999999999999999996 9999999999999999999999999998654322 2345
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHH--------------------------
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRV-------------------------- 401 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekI-------------------------- 401 (1238)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...+...+
T Consensus 190 ~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp -CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 679999999999998876 89999999999999999999999877654432221
Q ss_pred ----------------hcCC-ccC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 402 ----------------LSGR-FRI-PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 402 ----------------l~g~-~~~-P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.... ... +..++.++.+||.+||..||.+|||++|+++||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 1111 111 22368899999999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=375.94 Aligned_cols=254 Identities=20% Similarity=0.364 Sum_probs=214.8
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC--EE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS--MI 264 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d--~l 264 (1238)
..+..|...+.||.|+||.||++.+..+++.||||++..... ....+.+.+|+++|++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 346789999999999999999999999999999999976432 233567889999999999999999999997655 78
Q ss_pred EEEEeecCCCccchhhhcccc---cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc----cCCCcEEEEecCCcc
Q psy6346 265 YIVSEYANQGEIFDYIARYGR---MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDIKLADFGFSN 337 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~---Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL----d~nG~VKLiDFGLS~ 337 (1238)
|+||||+.+++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999987644 9999999999999999999999999999999999999 788889999999998
Q ss_pred cccCCCccccccCCCCCCCccccc--------CCccCCCccceehhhHHHHHHhhCCCCCCCCCh----hHHHHHHhcCC
Q psy6346 338 YYVPGQKLATWCGSPPYAAPEVFE--------GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL----NSLRDRVLSGR 405 (1238)
Q Consensus 338 ~~~~s~~l~t~~GTp~YmAPEVL~--------gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~----eeL~ekIl~g~ 405 (1238)
...........+||+.|+|||++. +..+ +.++|||||||++|+|++|..||..... .+....+..+.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 776666666778999999999986 3444 8999999999999999999999965332 23333443322
Q ss_pred c---------------------c----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy6346 406 F---------------------R----IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 406 ~---------------------~----~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPW 442 (1238)
. + ++..++..+.+||++||+.||++|||++|+|+||-
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1 1 11224567889999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=371.64 Aligned_cols=259 Identities=29% Similarity=0.543 Sum_probs=223.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC--hHhHHHHHHHHHHHHhCCCCCeeEEEEEe--eeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD--PVNLQKVYREVEIMKQLDHPHIIKLFQVM--ETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld--~e~ikrf~rEIeILkkL~HPNIVrL~dvf--ed~d~ly 265 (1238)
..|...+.||.|+||.||++.+..++..||||++...... ....+.+.+|+.++++++||||+++++++ .+....|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 4466778899999999999999999999999999764321 23457899999999999999999999998 4556899
Q ss_pred EEEeecCCCccchhhhc--ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC--
Q psy6346 266 IVSEYANQGEIFDYIAR--YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-- 341 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk--~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-- 341 (1238)
+||||+.++ |.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999876 6666654 35689999999999999999999999999999999999999999999999999976532
Q ss_pred -CCccccccCCCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHH
Q psy6346 342 -GQKLATWCGSPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESL 419 (1238)
Q Consensus 342 -s~~l~t~~GTp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDL 419 (1238)
........||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+.+.......+..+...+|..+++++.+|
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 243 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDL 243 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHH
Confidence 22234567999999999998643 3467899999999999999999999999988888999888888899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEETPR 449 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~~p~ 449 (1238)
|.+||..||.+|||++|+++||||.+..+.
T Consensus 244 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 244 LKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 999999999999999999999999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=387.04 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=219.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC--CCCeeEEEEEeeeCCEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD--HPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~--HPNIVrL~dvfed~d~lyL 266 (1238)
+..|.....||.|+||.||++.+.. +..||||++.....+....+.+.+|+.+|+++. ||||+++++++...+.+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4669999999999999999997754 899999999887777777889999999999996 5999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--- 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--- 343 (1238)
||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 56789999999888999999999999999999999999999999999999995 5899999999998764332
Q ss_pred ccccccCCCCCCCcccccCC----------ccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcC--CccCCC
Q psy6346 344 KLATWCGSPPYAAPEVFEGK----------KYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSG--RFRIPY 410 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk----------~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g--~~~~P~ 410 (1238)
.....+||+.|+|||++.+. ..++.++||||||||||+|++|..||.+... ......+... ...+|.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 23456899999999998752 2348899999999999999999999987543 2334444443 345677
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..+.++.+||.+||..||.+|||+.|+++||||....
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 7889999999999999999999999999999998643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=372.33 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=212.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeee--CCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMET--KSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed--~d~lyL 266 (1238)
..|...+.||.|+||.||++.+..+++.||||++.... .+.+.+|+.+|++++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 56888899999999999999999999999999997532 467889999999997 9999999999987 678999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCCcccccCCCcc
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~s~~l 345 (1238)
||||+.+++|.+++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 999999999998874 489999999999999999999999999999999999999776 8999999999877666666
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-ChhHHHH-------------HHhcCCcc----
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-TLNSLRD-------------RVLSGRFR---- 407 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-d~eeL~e-------------kIl~g~~~---- 407 (1238)
...+|++.|+|||++.+...++.++|||||||++|+|++|..||... ....... .+......
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 77789999999999988555589999999999999999999999543 2211111 11111111
Q ss_pred --------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 408 --------------------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 408 --------------------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+..+++++.+||.+||..||.+|||++|+|+||||++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 112278999999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=391.82 Aligned_cols=257 Identities=33% Similarity=0.570 Sum_probs=210.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC------hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD------PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld------~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d 262 (1238)
...|...+.||.|+||.||+|.+..+++.||||++.+.... ......+.+|+.+|++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 35688889999999999999999999999999999765321 1223457899999999999999999999865 4
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC---cEEEEecCCcccc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL---DIKLADFGFSNYY 339 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG---~VKLiDFGLS~~~ 339 (1238)
.+|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999999889999999999999999999999999999999999999997544 5999999999877
Q ss_pred cCCCccccccCCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcCCccCC----CCC
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSGRFRIP----YFM 412 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g~~~~P----~~i 412 (1238)
.........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+... ..+...+..+...++ ..+
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 372 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence 66555667889999999999864 22237899999999999999999999976543 345566666655433 357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
++++.+||.+||..||.+|||++|+|+||||++.
T Consensus 373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 8999999999999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=373.62 Aligned_cols=254 Identities=26% Similarity=0.458 Sum_probs=216.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+ ++..||||++..........+.+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 4588889999999999999865 68899999998887777778899999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccc---cchhHHHHHHHHHHHHHhHhhccc--eeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 270 YANQGEIFDYIARYGR---MNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~---Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
|+.+++|.+++...+. +++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 9999999999987653 999999999999999999999999 9999999999999999999999999997543322
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHh--cCCccCCCCCCHHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVL--SGRFRIPYFMSTECESLIR 421 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl--~g~~~~P~~iS~eLkDLIr 421 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. .....+|..+++++.+||.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273 (309)
T ss_dssp -------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred ccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 2345679999999999998877 899999999999999999999999988877766663 3456678889999999999
Q ss_pred HhcccCCCCCCCHHHHHh--ccccccc
Q psy6346 422 KMLVREPTKRYCIEQIKR--HRWMAEE 446 (1238)
Q Consensus 422 kML~kDPskRPTaeEILe--HPWFke~ 446 (1238)
+||..||.+|||++++++ .+++...
T Consensus 274 ~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 999999999999999998 5666543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=377.04 Aligned_cols=254 Identities=25% Similarity=0.442 Sum_probs=223.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChH---------------hHHHHHHHHHHHHhCCCCCeeEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV---------------NLQKVYREVEIMKQLDHPHIIKL 254 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e---------------~ikrf~rEIeILkkL~HPNIVrL 254 (1238)
..|.....||.|+||.||++.+ ++..||||++........ ..+.+.+|+.++++++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 4688889999999999999988 899999999976432111 12789999999999999999999
Q ss_pred EEEeeeCCEEEEEEeecCCCccchh------hhc--ccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCC
Q psy6346 255 FQVMETKSMIYIVSEYANQGEIFDY------IAR--YGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSN 325 (1238)
Q Consensus 255 ~dvfed~d~lyLVMEy~~GGSL~d~------Lkk--~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~n 325 (1238)
++++.+.+..|+||||+++++|.++ +.. ...+++..+..++.||+.||.|||+ +||+||||||+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999999 665 5679999999999999999999999 999999999999999999
Q ss_pred CcEEEEecCCcccccCCCccccccCCCCCCCcccccCC-ccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhc
Q psy6346 326 LDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLS 403 (1238)
Q Consensus 326 G~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~ 403 (1238)
+.+||+|||++...... ......|++.|+|||++.+. .+.+.++|||||||++|+|++|..||.+... ..+...+..
T Consensus 189 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 99999999999765433 44556799999999999887 4423399999999999999999999988776 778888887
Q ss_pred CCccCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 404 GRFRIP-------------------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 404 g~~~~P-------------------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+...+| ..++.++.+||.+||..||.+|||++|+++||||.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 777666 5689999999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=364.57 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=226.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|++|.||++.+..++..||||++..... ....+.+.+|+.++++++||||+++++++.+....|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 458888999999999999999999999999999987643 2356789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-ccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~ 348 (1238)
|+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 179 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCC
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCcc
Confidence 9999999998865 679999999999999999999999999999999999999999999999999997654432 33456
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhcccC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~kD 427 (1238)
.|++.|+|||++.+..+ +.++|||||||++|+|++|..||...........+.... ..++..++..+.+||.+||..|
T Consensus 180 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 258 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 258 (303)
T ss_dssp CSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSS
T ss_pred CCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCC
Confidence 79999999999988876 889999999999999999999999887776666655443 3456678999999999999999
Q ss_pred CCCCCCHHHHHhcccccccC
Q psy6346 428 PTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 428 PskRPTaeEILeHPWFke~~ 447 (1238)
|.+|||++++++||||....
T Consensus 259 p~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 259 PSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp GGGSCCHHHHTTCHHHHHHC
T ss_pred hhhCcCHHHHhhChhhhcCC
Confidence 99999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=413.87 Aligned_cols=256 Identities=24% Similarity=0.349 Sum_probs=230.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+|+.||||++.+.... ......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4588889999999999999999999999999999764321 223467889999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccc--cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 269 EYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||+.||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..........
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 343 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence 99999999999977544 9999999999999999999999999999999999999999999999999998776665666
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC----hhHHHHHHhcCCccCCCCCCHHHHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST----LNSLRDRVLSGRFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d----~eeL~ekIl~g~~~~P~~iS~eLkDLIrk 422 (1238)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ...+...+......+|..+++++.+||.+
T Consensus 344 ~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~ 422 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422 (576)
T ss_dssp CCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 7799999999999998877 899999999999999999999998753 45667777777778888899999999999
Q ss_pred hcccCCCCCC-----CHHHHHhccccccc
Q psy6346 423 MLVREPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRP-----TaeEILeHPWFke~ 446 (1238)
||..||.+|| +++||++||||+..
T Consensus 423 lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 423 LLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred hccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999 89999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=364.75 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=211.6
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--------
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME-------- 259 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe-------- 259 (1238)
++..|...+.||.|++|.||++.+..+++.||||++... +....+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 356688889999999999999999999999999999764 4566788999999999999999999999873
Q ss_pred ------eCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc-CCCcEEEEe
Q psy6346 260 ------TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD-SNLDIKLAD 332 (1238)
Q Consensus 260 ------d~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd-~nG~VKLiD 332 (1238)
+....|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4578999999998 589998864 6789999999999999999999999999999999999997 567999999
Q ss_pred cCCcccccCC----CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc--
Q psy6346 333 FGFSNYYVPG----QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-- 406 (1238)
Q Consensus 333 FGLS~~~~~s----~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-- 406 (1238)
||++...... .......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999765322 2234557899999999987644458999999999999999999999998877665555443211
Q ss_pred ----------------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 407 ----------------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 407 ----------------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.++..++.++.+||.+||..||.+|||++|+++||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 11245789999999999999999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=407.77 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=229.9
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
...|.....||.|+||.||++.+..+|+.||||++.+.... ....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688889999999999999999999999999999765321 12356788999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 268 SEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
|||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999999998764 369999999999999999999999999999999999999999999999999998765443
Q ss_pred c-cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC----ChhHHHHHHhcCCccCCCCCCHHHHH
Q psy6346 344 K-LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS----TLNSLRDRVLSGRFRIPYFMSTECES 418 (1238)
Q Consensus 344 ~-l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~----d~eeL~ekIl~g~~~~P~~iS~eLkD 418 (1238)
. ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. ....+...+......+|..+++++.+
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 422 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred cccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHH
Confidence 3 345689999999999998877 89999999999999999999999875 34677888888888899999999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHhccccccc
Q psy6346 419 LIRKMLVREPTKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 419 LIrkML~kDPskRPT-----aeEILeHPWFke~ 446 (1238)
||.+||.+||.+||+ +++|++||||+..
T Consensus 423 li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 999999999999996 5899999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=385.05 Aligned_cols=253 Identities=21% Similarity=0.394 Sum_probs=201.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------CE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------SM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d~ 263 (1238)
..|.....||.|+||.||++.+..+|..||||++.....+....+++.+|+.+|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 458888999999999999999999999999999987766667778999999999999999999999998654 56
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
+|+|||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-- 184 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184 (367)
T ss_dssp CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc--
Confidence 89999999 6899998865 6799999999999999999999999999999999999999999999999999976432
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC------------------
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR------------------ 405 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~------------------ 405 (1238)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 34456899999999999885555899999999999999999999999987665555443210
Q ss_pred -----cc--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 -----FR--------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 -----~~--------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.. ....+++++.+||.+||..||.+|||++|+|+||||.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 00 112367889999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=367.07 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=218.9
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
+...|...+.||.|+||.||++.+..++..||||++..... .....+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 34568888999999999999999999999999999976543 44566889999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--c
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--K 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~ 344 (1238)
||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997654332 2
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-----cCCCCCCHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-----RIPYFMSTECESL 419 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-----~~P~~iS~eLkDL 419 (1238)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+............. ..+..+++.+.++
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp ------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred cCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 344679999999999998876 8999999999999999999999999887666555554432 2345689999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFk 444 (1238)
|.+||.+||.+||+..+.+.+.|..
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHhcCCHhHccccHHHHHHHHHH
Confidence 9999999999999666666667653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=364.74 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=217.5
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
....|.....||.|+||.||++.+..+|..||||++.... ..+.+.+|+.++++++||||+++++++...+.+|+|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3466888899999999999999999999999999998653 245788999999999999999999999999999999
Q ss_pred EeecCCCccchhhh-cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccc
Q psy6346 268 SEYANQGEIFDYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKL 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lk-k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l 345 (1238)
|||+.+++|.+++. ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...... ...
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence 99999999999987 3467999999999999999999999999999999999999999999999999999765433 233
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHHHHHHH
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLkDLIrk 422 (1238)
....|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+... .+..+..++.++.+||.+
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred CccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 45679999999999988776 89999999999999999999999887765554444333 223455678999999999
Q ss_pred hcccCCCCCCCHHHHHhccccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||..||.+|||++++++||||...
T Consensus 262 ~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 262 CLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=377.16 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=214.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh---HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP---VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~---e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
...|...+.||.|+||.||++.+..+|..||||++....... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 456888899999999999999999999999999997654321 12356889999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-C
Q psy6346 266 IVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-Q 343 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~ 343 (1238)
+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999986 788877654 46899999999999999999999999999999999999999999999999999866433 3
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-----c-----------
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-----R----------- 407 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-----~----------- 407 (1238)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+..... .
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 445678999999999998766558999999999999999999999999887766665543200 0
Q ss_pred ------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 408 ------------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 408 ------------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+...++.++.+||.+||..||.+|||++|+++||||.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 013457899999999999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=366.99 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=218.4
Q ss_pred CCcEEEEEEEecCCCCccccCceEc-cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC---CCCCeeEEEEEee----
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLL-RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL---DHPHIIKLFQVME---- 259 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~l-ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL---~HPNIVrL~dvfe---- 259 (1238)
....|.....||.|+||.||++.+. .+++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3466888999999999999999986 6789999999976543333334566788777766 8999999999987
Q ss_pred -eCCEEEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCc
Q psy6346 260 -TKSMIYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336 (1238)
Q Consensus 260 -d~d~lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS 336 (1238)
.....++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678999999998 69999987653 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-----------
Q psy6346 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR----------- 405 (1238)
Q Consensus 337 ~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~----------- 405 (1238)
.............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccccCCCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 87655445556789999999999988776 899999999999999999999999888766665554210
Q ss_pred ----------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 406 ----------------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 406 ----------------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..++..++.++.+||.+||..||.+|||+.|+++||||.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 012345789999999999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=367.62 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=212.5
Q ss_pred CcEEEEEEEecCCCCccccCceE-ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCC------CeeEEEEEeeeC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVL-LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP------HIIKLFQVMETK 261 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~-lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HP------NIVrL~dvfed~ 261 (1238)
+..|...+.||.|+||.||++.+ ..+++.||||++... ....+.+.+|+.+++.++|+ +|+++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 45688889999999999999988 457899999999753 34567889999999998655 499999999999
Q ss_pred CEEEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---------------
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--------------- 324 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~--------------- 324 (1238)
+.+|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999999 899999998765 6889999999999999999999999999999999999987
Q ss_pred ----CCcEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHH
Q psy6346 325 ----NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400 (1238)
Q Consensus 325 ----nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ek 400 (1238)
++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred ccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 6679999999997643 23345689999999999998876 8999999999999999999999998876654443
Q ss_pred HhcCCccC--------------------------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6346 401 VLSGRFRI--------------------------------------------PYFMSTECESLIRKMLVREPTKRYCIEQ 436 (1238)
Q Consensus 401 Il~g~~~~--------------------------------------------P~~iS~eLkDLIrkML~kDPskRPTaeE 436 (1238)
+......+ +...++++.+||.+||..||.+|||++|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 32211111 1123567899999999999999999999
Q ss_pred HHhccccccc
Q psy6346 437 IKRHRWMAEE 446 (1238)
Q Consensus 437 ILeHPWFke~ 446 (1238)
+++||||...
T Consensus 326 ll~hp~f~~~ 335 (339)
T 1z57_A 326 ALKHPFFDLL 335 (339)
T ss_dssp HTTSGGGGGG
T ss_pred HhcCHHHHHH
Confidence 9999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=388.27 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=210.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee------CCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET------KSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed------~d~ 263 (1238)
..|.....||.|+||.||++.+..+|+.||||++..... ...+|+++|++++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 468889999999999999999999999999999976431 23379999999999999999998843 234
Q ss_pred EEEEEeecCCCccchhhh----cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-CcEEEEecCCccc
Q psy6346 264 IYIVSEYANQGEIFDYIA----RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIKLADFGFSNY 338 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lk----k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-G~VKLiDFGLS~~ 338 (1238)
+++||||+.+ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 7799999985 5655554 24679999999999999999999999999999999999999965 6789999999987
Q ss_pred ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhc---------------
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLS--------------- 403 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~--------------- 403 (1238)
..........+||+.|+|||++.+...++.++||||||||||||++|+.||.+.+..+....+..
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 66666666778999999999998765558999999999999999999999998876554444332
Q ss_pred --CCcc------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 404 --GRFR------------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 404 --g~~~------------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..+. ++..+++++.+||.+||..||.+|||+.|+++||||.+.
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0111 233568999999999999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=390.83 Aligned_cols=251 Identities=12% Similarity=0.171 Sum_probs=207.7
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHH---HHHhCCCCCeeEEE-------
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVE---IMKQLDHPHIIKLF------- 255 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIe---ILkkL~HPNIVrL~------- 255 (1238)
.....|...+.||.|+||.||+|.+..+|+.||||++..... .....+.+.+|+. +|++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 345789999999999999999999989999999999986543 3456688999995 55555899999988
Q ss_pred EEeeeCC-----------------EEEEEEeecCCCccchhhhcccccch-------hHHHHHHHHHHHHHhHhhcccee
Q psy6346 256 QVMETKS-----------------MIYIVSEYANQGEIFDYIARYGRMNE-------NAARRKFWQILSAVEYCHNRRVV 311 (1238)
Q Consensus 256 dvfed~d-----------------~lyLVMEy~~GGSL~d~Lkk~~~Lse-------sea~kI~~QILsALeYLHSkGII 311 (1238)
+++++.+ ..||||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 7776654 289999999 5899999987666665 77888999999999999999999
Q ss_pred eccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCCCCcccccCC-----------ccCCCccceehhhHHHH
Q psy6346 312 HRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGK-----------KYCGPEIDIWSLGVVLY 380 (1238)
Q Consensus 312 HRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk-----------~y~S~KSDIWSLGVILY 380 (1238)
||||||+||||+.++.+||+|||++... +......+| +.|+|||++.+. .+ +.++|||||||+||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~ 304 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIY 304 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHH
Confidence 9999999999999999999999999753 334456678 999999999877 55 89999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 381 ELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+|++|+.||.+.+.......+.. .+..+++++.+||.+||..||.+|||+.|+++||||.+.
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHSSCCC------CCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHCCCCCcccccccchhhhhh----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 99999999987665444433332 235688999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=363.95 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=217.1
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
....|...+.||.|+||.||++.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3466888999999999999999999999999999997653 33567889999999999999999999999999999999
Q ss_pred EeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccc
Q psy6346 268 SEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKL 345 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l 345 (1238)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 999999999998875 456999999999999999999999999999999999999999999999999987543211 223
Q ss_pred ccccCCCCCCCccccc-----CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---cCCCCCCHHHH
Q psy6346 346 ATWCGSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---RIPYFMSTECE 417 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~-----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---~~P~~iS~eLk 417 (1238)
....||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+..... ..+..++.++.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 3457999999999984 4444 8899999999999999999999998887776666655533 23456889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||.+||..||.+|||++++++||||...
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=376.08 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=220.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+++.||||++...... ....+.+.+|+++|++++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999999999999999999876433 345578999999999999999999999999999999999
Q ss_pred eecCCCccchhhh-cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 269 EYANQGEIFDYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lk-k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
||+. |+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence 9998 57777775 346799999999999999999999999999999999999999999999999999976533 235
Q ss_pred ccCCCCCCCccccc---CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc--CCCCCCHHHHHHHHH
Q psy6346 348 WCGSPPYAAPEVFE---GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR--IPYFMSTECESLIRK 422 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~---gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~--~P~~iS~eLkDLIrk 422 (1238)
.+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+...... .+..+++.+.+||.+
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 67999999999985 3444 88999999999999999999999888776665555554332 244688999999999
Q ss_pred hcccCCCCCCCHHHHHhcccccccC
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
||..||.+|||++++++||||....
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HcccChhhCcCHHHHhhChhhhccC
Confidence 9999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=381.02 Aligned_cols=257 Identities=26% Similarity=0.471 Sum_probs=222.0
Q ss_pred cEEEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCC--ChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQL--DPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~l--d~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ 263 (1238)
..|.....||.|+||.||++... .+++.||||++++... .....+.+.+|+++|+++ .||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 45888899999999999999875 4789999999976432 112234577899999999 69999999999999999
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG- 342 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s- 342 (1238)
+||||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999765332
Q ss_pred -CccccccCCCCCCCcccccCC-ccCCCccceehhhHHHHHHhhCCCCCCCC----ChhHHHHHHhcCCccCCCCCCHHH
Q psy6346 343 -QKLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPFDGS----TLNSLRDRVLSGRFRIPYFMSTEC 416 (1238)
Q Consensus 343 -~~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLTGrlPF~g~----d~eeL~ekIl~g~~~~P~~iS~eL 416 (1238)
......+||+.|+|||++.+. ..++.++|||||||+||+|++|..||... ....+...+......+|..++..+
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHH
Confidence 233456899999999999863 23478999999999999999999999754 344556666677777888899999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHhccccccc
Q psy6346 417 ESLIRKMLVREPTKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 417 kDLIrkML~kDPskRP-----TaeEILeHPWFke~ 446 (1238)
.+||.+||..||.+|| +++|+++||||...
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 9999999999999999 99999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=369.95 Aligned_cols=259 Identities=21% Similarity=0.374 Sum_probs=203.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCc---EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE--
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI-- 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~---kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l-- 264 (1238)
..|...+.||.|+||.||++.+..++. .||||++..........+.+.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 457788899999999999998876664 899999988766666788999999999999999999999999877665
Q ss_pred ----EEEEeecCCCccchhhhccc------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecC
Q psy6346 265 ----YIVSEYANQGEIFDYIARYG------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 265 ----yLVMEy~~GGSL~d~Lkk~~------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
++||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 99999999999999996543 58999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCcc---ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCC
Q psy6346 335 FSNYYVPGQKL---ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIP 409 (1238)
Q Consensus 335 LS~~~~~s~~l---~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P 409 (1238)
++......... ....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+...+..+. ...+
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 261 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP 261 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCC
Confidence 99765443322 23456778999999988776 899999999999999999 999999988888887777654 5567
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCC-------HHHHHhcccccccCCC
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYC-------IEQIKRHRWMAEETPR 449 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPT-------aeEILeHPWFke~~p~ 449 (1238)
..+++++.+||.+||..||.+||| +++++.|+|+....+.
T Consensus 262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 789999999999999999999999 7888999999876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=368.69 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=215.3
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC-----C
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK-----S 262 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~-----d 262 (1238)
.+..|.....||.|+||.||++.+..+|+.||||++.... .......+.+|+.+|++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3466888999999999999999999999999999997543 445567888999999999999999999998654 6
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
..|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 7999999997 588888865 57999999999999999999999999999999999999999999999999999765322
Q ss_pred C-----------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------
Q psy6346 343 Q-----------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------- 404 (1238)
Q Consensus 343 ~-----------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------- 404 (1238)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1 1234578999999999876444589999999999999999999999988765444333210
Q ss_pred -----------------Cc--------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 405 -----------------RF--------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 405 -----------------~~--------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.. ..+..+++++.+||.+||..||.+|||++|+++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 01235789999999999999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=367.08 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=214.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE------
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM------ 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~------ 263 (1238)
..|.....||.|+||.||++.+..+|+.||||++..........+++.+|+.+|+.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 45888899999999999999999999999999998876666667889999999999999999999999987654
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
+|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-- 178 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-- 178 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC--
Confidence 599999998 588887753 589999999999999999999999999999999999999999999999999976432
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC-------------------
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG------------------- 404 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g------------------- 404 (1238)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 2345679999999999987544589999999999999999999999988765554443321
Q ss_pred ---------C---ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 ---------R---FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 ---------~---~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
. ...+..+++++.+||.+||..||.+|||++++++||||...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 01223578999999999999999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=372.10 Aligned_cols=254 Identities=20% Similarity=0.273 Sum_probs=203.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-------
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS------- 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d------- 262 (1238)
..|.....||.|+||.||++.+..++..||||++..... ...+..+|++.+..++||||+++++++...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 347788899999999999999999999999999866532 2235667888899999999999999986533
Q ss_pred EEEEEEeecCCCccchh----hhcccccchhHHHHHHHHHHHHHhHhh--ccceeeccCCcccccccC-CCcEEEEecCC
Q psy6346 263 MIYIVSEYANQGEIFDY----IARYGRMNENAARRKFWQILSAVEYCH--NRRVVHRDLKAENLLMDS-NLDIKLADFGF 335 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~----Lkk~~~Lsesea~kI~~QILsALeYLH--SkGIIHRDLKPeNILLd~-nG~VKLiDFGL 335 (1238)
.+++||||+.++ |.+. +.....+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 389999999865 4333 335567899999999999999999999 999999999999999996 89999999999
Q ss_pred cccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC----------
Q psy6346 336 SNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR---------- 405 (1238)
Q Consensus 336 S~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~---------- 405 (1238)
+............+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 9877666666677899999999999877656899999999999999999999999988766665554310
Q ss_pred ----------------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 406 ----------------------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 406 ----------------------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
...+...++++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 001122567899999999999999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=373.71 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=215.2
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE----
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI---- 264 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l---- 264 (1238)
...|.....||.|+||.||++.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4568888999999999999999999999999999988766666778999999999999999999999999877654
Q ss_pred --EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 265 --YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 265 --yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~-- 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-- 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc--
Confidence 99999998 57877774 359999999999999999999999999999999999999999999999999997543
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-----------------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR----------------- 405 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~----------------- 405 (1238)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 234456899999999999885445899999999999999999999999887665555443210
Q ss_pred --------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 --------------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 --------------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..++..+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 01123468999999999999999999999999999999854
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.83 Aligned_cols=257 Identities=24% Similarity=0.428 Sum_probs=196.6
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
...|...+.||.|++|.||++.+..++..||||++..... ....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3557888999999999999999888999999999876542 234567889999999999999999999999999999999
Q ss_pred eecCCCccchhhhc--------ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 269 EYANQGEIFDYIAR--------YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk--------~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999999999874 3568999999999999999999999999999999999999999999999999987553
Q ss_pred CCC------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc--------
Q psy6346 341 PGQ------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-------- 406 (1238)
Q Consensus 341 ~s~------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-------- 406 (1238)
... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+...............
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence 321 223457999999999987633348899999999999999999999988776555444433321
Q ss_pred --cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 407 --RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 407 --~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.....++.++.+||.+||..||.+|||+.++++||||...
T Consensus 253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1224578899999999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=387.83 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=215.8
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC------CCCCeeEEEEEeee
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL------DHPHIIKLFQVMET 260 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL------~HPNIVrL~dvfed 260 (1238)
.....|...+.||.|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3445689999999999999999999999999999999753 34456788899998887 57799999999999
Q ss_pred CCEEEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc--EEEEecCCc
Q psy6346 261 KSMIYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD--IKLADFGFS 336 (1238)
Q Consensus 261 ~d~lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~--VKLiDFGLS 336 (1238)
.+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999996 68999887654 4899999999999999999999999999999999999999887 999999999
Q ss_pred ccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc----------
Q psy6346 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---------- 406 (1238)
Q Consensus 337 ~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---------- 406 (1238)
... .....+.+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.+..+....+.....
T Consensus 250 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 250 CYE--HQRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp EET--TCCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred eec--CCcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 653 334456789999999999998887 8999999999999999999999999877665544432100
Q ss_pred -------------------------------------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6346 407 -------------------------------------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQI 437 (1238)
Q Consensus 407 -------------------------------------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEI 437 (1238)
.++...++++.+||++||.+||.+|||++|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 0111237889999999999999999999999
Q ss_pred HhcccccccCC
Q psy6346 438 KRHRWMAEETP 448 (1238)
Q Consensus 438 LeHPWFke~~p 448 (1238)
|+||||++..+
T Consensus 407 L~Hpw~~~~~~ 417 (429)
T 3kvw_A 407 LRHPWLRRRLP 417 (429)
T ss_dssp HTSTTTC----
T ss_pred hCChhhccCCC
Confidence 99999997644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=377.60 Aligned_cols=250 Identities=20% Similarity=0.341 Sum_probs=206.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC--------CCCeeEEEEEee-
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD--------HPHIIKLFQVME- 259 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~--------HPNIVrL~dvfe- 259 (1238)
...|...+.||.|+||.||++.+..+++.||||++... ....+.+.+|+.+|+.+. |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 45688999999999999999999999999999999753 445678899999999995 788999999997
Q ss_pred ---eCCEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCC-------
Q psy6346 260 ---TKSMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNL------- 326 (1238)
Q Consensus 260 ---d~d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG------- 326 (1238)
....+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 567899999999 56666666543 5699999999999999999999998 999999999999998775
Q ss_pred ------------------------------------------cEEEEecCCcccccCCCccccccCCCCCCCcccccCCc
Q psy6346 327 ------------------------------------------DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKK 364 (1238)
Q Consensus 327 ------------------------------------------~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~ 364 (1238)
.+||+|||++..... .....+||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCC
Confidence 799999999976533 344568999999999999888
Q ss_pred cCCCccceehhhHHHHHHhhCCCCCCCCChhH------HHHHHhc------------C----------------------
Q psy6346 365 YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS------LRDRVLS------------G---------------------- 404 (1238)
Q Consensus 365 y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee------L~ekIl~------------g---------------------- 404 (1238)
+ +.++|||||||+||+|++|..||.+.+... ....+.. +
T Consensus 270 ~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 Y-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp C-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred C-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 6 899999999999999999999998654221 1111111 0
Q ss_pred --------CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 405 --------RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 405 --------~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.+.++...+.++.+||.+||..||.+|||++|||+||||+.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00112223567889999999999999999999999999963
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=364.15 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=212.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee------C
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET------K 261 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed------~ 261 (1238)
...|...+.||.|+||.||++.+..+++.||||++..... ..+.+.+|+.+++++ +||||+++++++.. .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 3568888999999999999999999999999999976542 335788999999999 89999999999976 5
Q ss_pred CEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY 339 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~ 339 (1238)
+.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 6899999999999999999764 56899999999999999999999999999999999999999999999999998765
Q ss_pred cCC-CccccccCCCCCCCccccc-----CCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc--CCCC
Q psy6346 340 VPG-QKLATWCGSPPYAAPEVFE-----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR--IPYF 411 (1238)
Q Consensus 340 ~~s-~~l~t~~GTp~YmAPEVL~-----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~--~P~~ 411 (1238)
... .......|++.|+|||++. +..+ +.++|||||||++|+|++|..||.+.........+...... .+..
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258 (326)
T ss_dssp -----------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSC
T ss_pred CcCccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccc
Confidence 432 2334567999999999987 3344 88999999999999999999999888776665555544322 2455
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 412 MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 412 iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
++..+.+||.+||..||.+||+++++++||||.+.
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 78999999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=375.04 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=204.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC---------hHhHHHHHHHHHHHHhCCCCCeeEEEEEee-
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD---------PVNLQKVYREVEIMKQLDHPHIIKLFQVME- 259 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld---------~e~ikrf~rEIeILkkL~HPNIVrL~dvfe- 259 (1238)
..|.....||.|+||.||++.+. ++..||||++...... ....+.+.+|+.+|++++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 44777788999999999998765 4899999999664322 233478999999999999999999999984
Q ss_pred ----eCCEEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecC
Q psy6346 260 ----TKSMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 260 ----d~d~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
....+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 3447999999998 5777777654 469999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC---------
Q psy6346 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--------- 405 (1238)
Q Consensus 335 LS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--------- 405 (1238)
++............+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (362)
T 3pg1_A 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259 (362)
T ss_dssp C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh
Confidence 99865555555667899999999999875545899999999999999999999999987666555543210
Q ss_pred ---------------c--------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 ---------------F--------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 ---------------~--------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
. ..+..+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0 1123468889999999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=360.40 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=218.4
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|...+.||.|+||.||++.+. .++..||||++.... .....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45777888999999999998774 345899999998653 556678899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccc------------------------cchhHHHHHHHHHHHHHhHhhccceeeccCCcccc
Q psy6346 265 YIVSEYANQGEIFDYIARYGR------------------------MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENL 320 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~------------------------Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNI 320 (1238)
|+||||+.+++|.+++..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 999999999999999976543 89999999999999999999999999999999999
Q ss_pred cccCCCcEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhH
Q psy6346 321 LMDSNLDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNS 396 (1238)
Q Consensus 321 LLd~nG~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~ee 396 (1238)
+++.++.+||+|||++....... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999997654332 2234457788999999988776 899999999999999999 999999998888
Q ss_pred HHHHHhcCC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 397 LRDRVLSGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 397 L~ekIl~g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+...+..+. ...+..+++++.+||.+||..||.+||++++++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 887777653 45677799999999999999999999999999876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=375.33 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=218.0
Q ss_pred cEEEEEEEecCCCCccccCceEc-------cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-------RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETK 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-------ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~ 261 (1238)
..|.....||.|+||.||++.+. .++..||||+++... .....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 45777788999999999988764 345689999997653 455678899999999999 899999999999999
Q ss_pred CEEEEEEeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n 325 (1238)
+.+|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 99999999999999999997643 47889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHH
Q psy6346 326 LDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRV 401 (1238)
Q Consensus 326 G~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekI 401 (1238)
+.+||+|||++....... ......+|+.|+|||++.+..+ +.++|||||||++|||++ |..||.+....++...+
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999997654332 2234467889999999988876 899999999999999999 99999999888888777
Q ss_pred hcCC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 402 LSGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 402 l~g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+. ...|..++.++.+||.+||..||.+|||+.|++++
T Consensus 319 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7663 45677899999999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=355.06 Aligned_cols=252 Identities=23% Similarity=0.414 Sum_probs=208.0
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--------
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-------- 260 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-------- 260 (1238)
...|.....||.|+||.||++.+..+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 45688889999999999999999999999999999653 4556789999999999999999999998754
Q ss_pred -----CCEEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecC
Q psy6346 261 -----KSMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 261 -----~d~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 46789999999999999999754 467889999999999999999999999999999999999999999999999
Q ss_pred CcccccCC---------------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCC-CChhHHH
Q psy6346 335 FSNYYVPG---------------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG-STLNSLR 398 (1238)
Q Consensus 335 LS~~~~~s---------------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g-~d~eeL~ 398 (1238)
++...... ......+||+.|+|||++.+...++.++|||||||++|+|++ ||.. .+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 98765321 223456799999999999876545899999999999999998 5543 2334455
Q ss_pred HHHhcCCccCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 399 DRVLSGRFRIP----YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 399 ekIl~g~~~~P----~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..+......+| ...+..+.+||.+||..||.+|||++++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 55555544444 3456779999999999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=380.79 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=209.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC------C
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK------S 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~------d 262 (1238)
...|.....||.|+||.||++.+..++. ||+|++...... ..+|+++|+.++||||+++++++... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3458888999999999999998876665 888887654311 23799999999999999999999543 3
Q ss_pred EEEEEEeecCCCccchhh---hcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc-CCCcEEEEecCCccc
Q psy6346 263 MIYIVSEYANQGEIFDYI---ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD-SNLDIKLADFGFSNY 338 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~L---kk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd-~nG~VKLiDFGLS~~ 338 (1238)
.+|+||||+.++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 488999999865433222 2346799999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--------------
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG-------------- 404 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g-------------- 404 (1238)
..........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 766666667889999999999987765699999999999999999999999998766555444321
Q ss_pred ---Cc------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 405 ---RF------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 405 ---~~------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.. .++..+++++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00 12334789999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=380.63 Aligned_cols=254 Identities=13% Similarity=0.125 Sum_probs=196.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhC--CCCCeeEEE-------EEe
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQL--DHPHIIKLF-------QVM 258 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL--~HPNIVrL~-------dvf 258 (1238)
...|.....||.|+||.||++.+..+++.||||++..... .....+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4568999999999999999999999999999999998765 334567788886555555 699988755 555
Q ss_pred eeC-----------------CEEEEEEeecCCCccchhhhcccc-cchhHH------HHHHHHHHHHHhHhhccceeecc
Q psy6346 259 ETK-----------------SMIYIVSEYANQGEIFDYIARYGR-MNENAA------RRKFWQILSAVEYCHNRRVVHRD 314 (1238)
Q Consensus 259 ed~-----------------d~lyLVMEy~~GGSL~d~Lkk~~~-Lsesea------~kI~~QILsALeYLHSkGIIHRD 314 (1238)
... ..+|||||||. ++|.+++...+. +.+... ..++.||+.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 44899999999 899999987543 444444 46679999999999999999999
Q ss_pred CCcccccccCCCcEEEEecCCcccccCCCccccccCCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCCCCC
Q psy6346 315 LKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGS 392 (1238)
Q Consensus 315 LKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF~g~ 392 (1238)
|||+||||+.++.+||+|||++.... .......+|+.|+|||++.+ ..+ +.++|||||||+||+|++|+.||.+.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CCHHHEEECCCCCEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999998643 22224567799999999987 455 89999999999999999999999876
Q ss_pred ChhHH--HHH-----HhcCCccCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 393 TLNSL--RDR-----VLSGRFRIP--YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 393 d~eeL--~ek-----Il~g~~~~P--~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..... ... .....+.++ ..+++++.+||.+||..||++|||++++++||||.+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 43211 110 111122223 4689999999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=364.43 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=210.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCC-cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC------eeEEEEEeeeC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHT-VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH------IIKLFQVMETK 261 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG-~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN------IVrL~dvfed~ 261 (1238)
...|...+.||.|+||.||++.+..++ ..||||+++.. ....+.+.+|+.+|+++.|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 456888899999999999999988776 79999999753 345677889999999997655 99999999999
Q ss_pred CEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc-----------------
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----------------- 322 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL----------------- 322 (1238)
+..|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 56777777654 369999999999999999999999999999999999999
Q ss_pred --cCCCcEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHH
Q psy6346 323 --DSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR 400 (1238)
Q Consensus 323 --d~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ek 400 (1238)
+.++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp EEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 567889999999997643 23345689999999999998877 8999999999999999999999998776554433
Q ss_pred HhcCCccCC--------------------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6346 401 VLSGRFRIP--------------------------------------------YFMSTECESLIRKMLVREPTKRYCIEQ 436 (1238)
Q Consensus 401 Il~g~~~~P--------------------------------------------~~iS~eLkDLIrkML~kDPskRPTaeE 436 (1238)
+......+| ...+.++.+||.+||..||.+|||++|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 322111111 112457889999999999999999999
Q ss_pred HHhccccccc
Q psy6346 437 IKRHRWMAEE 446 (1238)
Q Consensus 437 ILeHPWFke~ 446 (1238)
+++||||.+.
T Consensus 331 ~l~hp~f~~~ 340 (355)
T 2eu9_A 331 ALLHPFFAGL 340 (355)
T ss_dssp HTTSGGGGGC
T ss_pred HhcChhhcCC
Confidence 9999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.88 Aligned_cols=245 Identities=20% Similarity=0.307 Sum_probs=211.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+..++..||+|++... +....+.+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 3477889999999999999999999999999998653 56677889999999999999999999999999999999999
Q ss_pred ecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc----
Q psy6346 270 YANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---- 344 (1238)
Q Consensus 270 y~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---- 344 (1238)
|+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9999999999987 46799999999999999999999999999999999999999999999999999976533221
Q ss_pred -----------cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHH-----HHHHhcCCccC
Q psy6346 345 -----------LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL-----RDRVLSGRFRI 408 (1238)
Q Consensus 345 -----------l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL-----~ekIl~g~~~~ 408 (1238)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ..... ....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~ 244 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DRYC 244 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--HHTC
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--cccC
Confidence 125679999999999998877 8999999999999999999999876432211 01111 1124
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 409 PYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 409 P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
|..+++++.+||.+||..||.+|||++++++
T Consensus 245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 6678899999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.45 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=216.6
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|...+.||.|+||.||++.+. .++..||||+++... .....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 44666778888888888888776 345899999998654 455667899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcc------------------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccc
Q psy6346 265 YIVSEYANQGEIFDYIARY------------------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENL 320 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~------------------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNI 320 (1238)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 9999999999999999764 5689999999999999999999999999999999999
Q ss_pred cccCCCcEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhH
Q psy6346 321 LMDSNLDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNS 396 (1238)
Q Consensus 321 LLd~nG~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~ee 396 (1238)
|++.++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 99999999999999987543321 2234567889999999987776 899999999999999999 999999998888
Q ss_pred HHHHHhcCCc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 397 LRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 397 L~ekIl~g~~-~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+...+..+.. .+|..+++++.+||.+||..||.+||++.+++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 285 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8888777653 5677899999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=367.20 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=218.6
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCc---EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~---kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
....|.....||.|+||.||++.+..++. .||||++.... .....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34568888999999999999999885554 59999998653 455668899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 265 YIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
|+||||+.|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999999654 579999999999999999999999999999999999999999999999999998654332
Q ss_pred c----cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHH
Q psy6346 344 K----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECE 417 (1238)
Q Consensus 344 ~----l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLk 417 (1238)
. .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....+...+..+ ....+..+++++.
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 284 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH 284 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHH
Confidence 1 223346778999999988776 889999999999999999 99999999888888877766 4556778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeH 440 (1238)
+||.+||..||.+|||+.+|++.
T Consensus 285 ~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 285 QLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.45 Aligned_cols=246 Identities=24% Similarity=0.431 Sum_probs=217.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||++.+. ++..||||++...... .+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 45888899999999999999876 5778999999876543 3568899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999999654 468999999999999999999999999999999999999999999999999997653321 223
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
...+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ....|..+++++.+||.+||
T Consensus 166 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 244 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 244 (269)
T ss_dssp STTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred CcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHc
Confidence 4457778999999987776 899999999999999999 99999999988888887776 44556778999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy6346 425 VREPTKRYCIEQIKRH 440 (1238)
Q Consensus 425 ~kDPskRPTaeEILeH 440 (1238)
..||.+|||+.++++|
T Consensus 245 ~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 245 RERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCCcccCcCHHHHHHH
Confidence 9999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.10 Aligned_cols=249 Identities=20% Similarity=0.372 Sum_probs=212.0
Q ss_pred cEEEEEEEecCCCCccccCce-----EccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCC-
Q psy6346 190 QTIRKREKCGVKSRSCNRPPV-----LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS- 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav-----~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d- 262 (1238)
..|.....||.|+||.||++. ...+++.||||+++... .....+.+.+|+++|+++ +||||+++++++.+.+
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 457788889999999999988 44567899999997653 445567899999999999 7899999999997754
Q ss_pred EEEEEEeecCCCccchhhhcccc---------------------------------------------------------
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGR--------------------------------------------------------- 285 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~--------------------------------------------------------- 285 (1238)
.+++|||||.+|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 49999999999999999976543
Q ss_pred ---------cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---ccccccCCCC
Q psy6346 286 ---------MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---KLATWCGSPP 353 (1238)
Q Consensus 286 ---------Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---~l~t~~GTp~ 353 (1238)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 8999999999999999999999999999999999999999999999999997653332 2334568889
Q ss_pred CCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhH-HHHHHhcC-CccCCCCCCHHHHHHHHHhcccCCCC
Q psy6346 354 YAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNS-LRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTK 430 (1238)
Q Consensus 354 YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~ee-L~ekIl~g-~~~~P~~iS~eLkDLIrkML~kDPsk 430 (1238)
|+|||++.+..+ +.++|||||||++|+|++ |..||.+..... +...+..+ ....|..+++++.+||.+||..||.+
T Consensus 261 y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 339 (359)
T 3vhe_A 261 WMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 339 (359)
T ss_dssp GCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred eEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 999999988776 899999999999999998 999998876443 33333333 45567789999999999999999999
Q ss_pred CCCHHHHHhc
Q psy6346 431 RYCIEQIKRH 440 (1238)
Q Consensus 431 RPTaeEILeH 440 (1238)
|||+.|+++|
T Consensus 340 Rps~~ell~~ 349 (359)
T 3vhe_A 340 RPTFSELVEH 349 (359)
T ss_dssp SCCHHHHHHH
T ss_pred CCCHHHHHHH
Confidence 9999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=365.64 Aligned_cols=253 Identities=30% Similarity=0.527 Sum_probs=213.2
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----HhHHHHHHHHHHHHhC----CCCCeeEEEEEee
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----VNLQKVYREVEIMKQL----DHPHIIKLFQVME 259 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----e~ikrf~rEIeILkkL----~HPNIVrL~dvfe 259 (1238)
+...|...+.||.|+||.||++.+..+++.||||++....... .....+.+|+.+++++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3456888899999999999999999999999999997764322 2234566899999999 8999999999999
Q ss_pred eCCEEEEEEee-cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc-CCCcEEEEecCCcc
Q psy6346 260 TKSMIYIVSEY-ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD-SNLDIKLADFGFSN 337 (1238)
Q Consensus 260 d~d~lyLVMEy-~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd-~nG~VKLiDFGLS~ 337 (1238)
..+..++|||+ +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 99999999999 78999999999888899999999999999999999999999999999999999 78999999999987
Q ss_pred cccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHH
Q psy6346 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECE 417 (1238)
Q Consensus 338 ~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLk 417 (1238)
.... .......|++.|+|||++.+..+.+.++|||||||++|+|++|+.||... ..+......++..++.++.
T Consensus 189 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~~~ 261 (312)
T 2iwi_A 189 LLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCC 261 (312)
T ss_dssp ECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCHHHH
T ss_pred hccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCHHHH
Confidence 6543 33455679999999999987776566899999999999999999999753 2344556677888999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||.+||..||.+|||++|+++||||....
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 999999999999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=356.18 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=197.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+..+++.||||++..........+.+..+..+++.++||||+++++++.+.+..|+|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 45788899999999999999999999999999998775444444455556667888899999999999999999999999
Q ss_pred ecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 270 YANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
|+ ++.+..+... ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccc
Confidence 99 4445444433 46799999999999999999999995 999999999999999999999999999977655555556
Q ss_pred ccCCCCCCCcccccC----CccCCCccceehhhHHHHHHhhCCCCCCCC-ChhHHHHHHhcCCc-cCC--CCCCHHHHHH
Q psy6346 348 WCGSPPYAAPEVFEG----KKYCGPEIDIWSLGVVLYVLVCGALPFDGS-TLNSLRDRVLSGRF-RIP--YFMSTECESL 419 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~g----k~y~S~KSDIWSLGVILYELLTGrlPF~g~-d~eeL~ekIl~g~~-~~P--~~iS~eLkDL 419 (1238)
..||+.|+|||++.+ ...++.++|||||||++|+|++|..||... ........+..+.. .+| ..+++++.+|
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 263 (318)
T 2dyl_A 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263 (318)
T ss_dssp ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHH
T ss_pred cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHH
Confidence 689999999999852 223478999999999999999999999873 44445555554432 233 3478999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|.+||..||.+||++++|++||||++.
T Consensus 264 i~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 264 VKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=354.62 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=209.4
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCCCc
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~GGS 275 (1238)
..||.|+||.||++.+..++..||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 47899999999999999999999999998653 3345788999999999999999999999999999999999999999
Q ss_pred cchhhhccc---ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCcccccCCC-ccccccC
Q psy6346 276 IFDYIARYG---RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYVPGQ-KLATWCG 350 (1238)
Q Consensus 276 L~d~Lkk~~---~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~~s~-~l~t~~G 350 (1238)
|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....... ......|
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 185 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG 185 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCC
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCC
Confidence 999997652 4668889999999999999999999999999999999987 8999999999997654322 2345679
Q ss_pred CCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCChhH--HH-HHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 351 SPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS--LR-DRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee--L~-ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
++.|+|||++.+.. .++.++|||||||++|+|++|..||....... .. .........+|..+++++.+||.+||..
T Consensus 186 ~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 265 (295)
T 2clq_A 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 265 (295)
T ss_dssp CGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCS
T ss_pred CccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccC
Confidence 99999999987643 23789999999999999999999997643221 11 1122334556778999999999999999
Q ss_pred CCCCCCCHHHHHhccccccc
Q psy6346 427 EPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 427 DPskRPTaeEILeHPWFke~ 446 (1238)
||.+||+++++++||||...
T Consensus 266 dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 266 DPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp STTTSCCHHHHHTSGGGCC-
T ss_pred ChhhCCCHHHHhcChhhhhc
Confidence 99999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=378.04 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=192.4
Q ss_pred EEEEE-EEecCCCCccccCceEc--cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--eCCEEE
Q psy6346 191 TIRKR-EKCGVKSRSCNRPPVLL--RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKSMIY 265 (1238)
Q Consensus 191 VYkar-ekIGsGsfGtVYKav~l--ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--d~d~ly 265 (1238)
.|... .+||.|+||.||+|... .++..||||++...... ..+.+|+.+|++++||||+++++++. ....+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34442 36899999999999865 56889999999866433 36789999999999999999999994 478899
Q ss_pred EEEeecCCCccchhhhccc---------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc----cCCCcEEEEe
Q psy6346 266 IVSEYANQGEIFDYIARYG---------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDIKLAD 332 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~---------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL----d~nG~VKLiD 332 (1238)
|||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999997 57887775332 48999999999999999999999999999999999999 6778999999
Q ss_pred cCCcccccCC----CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---------HHHH
Q psy6346 333 FGFSNYYVPG----QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---------SLRD 399 (1238)
Q Consensus 333 FGLS~~~~~s----~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---------eL~e 399 (1238)
||++...... ......+||+.|+|||++.+...++.++||||||||||+|++|..||.+.... ....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999865432 23345689999999999988665689999999999999999999999765432 1222
Q ss_pred HHhcC--C--------------------------cc----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy6346 400 RVLSG--R--------------------------FR----------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 400 kIl~g--~--------------------------~~----------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHP 441 (1238)
.+... . +. .....++++.+||.+||..||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 22110 0 00 0011267899999999999999999999999999
Q ss_pred cccccC
Q psy6346 442 WMAEET 447 (1238)
Q Consensus 442 WFke~~ 447 (1238)
||.+..
T Consensus 336 ~f~~~~ 341 (405)
T 3rgf_A 336 YFLEDP 341 (405)
T ss_dssp GGTSSS
T ss_pred hhccCC
Confidence 998753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=369.44 Aligned_cols=252 Identities=31% Similarity=0.565 Sum_probs=220.6
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----HhHHHHHHHHHHHHhCC--CCCeeEEEEEeeeC
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----VNLQKVYREVEIMKQLD--HPHIIKLFQVMETK 261 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----e~ikrf~rEIeILkkL~--HPNIVrL~dvfed~ 261 (1238)
+...|...+.||.|+||.||++.+..+++.||||++....... ...+.+.+|+.+++++. |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3456888899999999999999999999999999997764322 12245678999999996 59999999999999
Q ss_pred CEEEEEEeecCC-CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc-CCCcEEEEecCCcccc
Q psy6346 262 SMIYIVSEYANQ-GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD-SNLDIKLADFGFSNYY 339 (1238)
Q Consensus 262 d~lyLVMEy~~G-GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd-~nG~VKLiDFGLS~~~ 339 (1238)
+..++|||++.+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999999986 89999999888999999999999999999999999999999999999999 7899999999999765
Q ss_pred cCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHH
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESL 419 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDL 419 (1238)
.. .......||+.|+|||++.+..+++.++|||||||++|+|++|..||.... .+......++..+++++.+|
T Consensus 201 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~l 273 (320)
T 3a99_A 201 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHL 273 (320)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHH
T ss_pred cc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHHHHH
Confidence 43 334456799999999999877766788999999999999999999997542 34445556777899999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
|.+||..||.+|||+++|++||||.+.
T Consensus 274 i~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 274 IRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=373.78 Aligned_cols=256 Identities=17% Similarity=0.235 Sum_probs=221.8
Q ss_pred CcEEEEEEEecCCCCccccCceE-----ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVL-----LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~-----lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ 263 (1238)
...|.....||.|+||.||++.+ ..++..||||+++... .......+.+|+.+|++++||||+++++++.+...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 35578888999999999999984 4567899999997543 45566788999999999999999999999999999
Q ss_pred EEEEEeecCCCccchhhhccc-------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC---cEEEEec
Q psy6346 264 IYIVSEYANQGEIFDYIARYG-------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL---DIKLADF 333 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~-------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG---~VKLiDF 333 (1238)
.|+|||||.||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999999997653 488999999999999999999999999999999999999655 4999999
Q ss_pred CCcccccCC---CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccC
Q psy6346 334 GFSNYYVPG---QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRI 408 (1238)
Q Consensus 334 GLS~~~~~s---~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~ 408 (1238)
|++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....++...+..+. ...
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~ 307 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 307 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999754221 23345678999999999988776 899999999999999998 999999999888888887764 456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 409 PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 409 P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+..++..+.+||.+||..||.+|||+++|+++.++...
T Consensus 308 ~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 308 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 77799999999999999999999999999999887654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.72 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=214.3
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC--CCCeeEEEEEeeeCCEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD--HPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~--HPNIVrL~dvfed~d~lyL 266 (1238)
+..|.....||.|+||.||++.+. ++..||||++.....+....+.+.+|+.++++++ |+||+++++++.+.+..|+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 467889999999999999999774 5889999999887777777889999999999997 5999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--- 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--- 343 (1238)
||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccc
Confidence 999 56789999999888999999999999999999999999999999999999996 4899999999997654332
Q ss_pred ccccccCCCCCCCcccccCC----------ccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcC--CccCCC
Q psy6346 344 KLATWCGSPPYAAPEVFEGK----------KYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSG--RFRIPY 410 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk----------~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g--~~~~P~ 410 (1238)
.....+|++.|+|||++.+. ..++.++|||||||++|+|++|..||..... ......+... ...+|.
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc
Confidence 22345799999999998762 2347899999999999999999999977543 2233333332 334667
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..+.++.+||.+||..||.+||+++|+++||||....
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred cchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 7889999999999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.29 Aligned_cols=246 Identities=24% Similarity=0.450 Sum_probs=216.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||++.+ .++..||||++...... .+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 4578889999999999999855 46778999999876543 3568899999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--cc
Q psy6346 270 YANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--LA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l~ 346 (1238)
|+++++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 999999999998764 599999999999999999999999999999999999999999999999999976544322 22
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML 424 (1238)
...+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+. ...|..+++++.+||.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 242 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCW 242 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTT
T ss_pred CCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHc
Confidence 3446678999999988776 899999999999999998 999999988888777777664 3456678999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy6346 425 VREPTKRYCIEQIKRH 440 (1238)
Q Consensus 425 ~kDPskRPTaeEILeH 440 (1238)
..||.+|||+.+++++
T Consensus 243 ~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 243 HELPEKRPTFQQLLSS 258 (268)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=351.76 Aligned_cols=247 Identities=21% Similarity=0.386 Sum_probs=214.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+. ++..||||++...... .+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 45788889999999999998654 6778999999876543 3568899999999999999999999999999999999
Q ss_pred ecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 270 YANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 9999999999977 4679999999999999999999999999999999999999999999999999997653321 223
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML 424 (1238)
...+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++.+.+||.+||
T Consensus 180 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 258 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 258 (283)
T ss_dssp STTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred CCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHc
Confidence 3456778999999987776 899999999999999998 999999988888888777763 4456678999999999999
Q ss_pred ccCCCCCCCHHHHHhcc
Q psy6346 425 VREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 425 ~kDPskRPTaeEILeHP 441 (1238)
..||.+|||++++++|-
T Consensus 259 ~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 259 HEKADERPTFKILLSNI 275 (283)
T ss_dssp CSSGGGSCCHHHHHHHH
T ss_pred cCChhHCcCHHHHHHHH
Confidence 99999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=364.64 Aligned_cols=245 Identities=20% Similarity=0.247 Sum_probs=210.0
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyL 266 (1238)
.+..|.....||.|+||.||++.+..+++.||||++...... +.+.+|+.+++++ +||||+++++++...+..|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 356688999999999999999999999999999999765422 3578999999999 99999999999999999999
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc-----EEEEecCCccccc
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD-----IKLADFGFSNYYV 340 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~-----VKLiDFGLS~~~~ 340 (1238)
||||+ +++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 89999999864 67999999999999999999999999999999999999999887 9999999998654
Q ss_pred CCCc--------cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC---hhHHHHHHhcCCccCC
Q psy6346 341 PGQK--------LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---LNSLRDRVLSGRFRIP 409 (1238)
Q Consensus 341 ~s~~--------l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d---~eeL~ekIl~g~~~~P 409 (1238)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ..+....+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 3321 246789999999999998877 899999999999999999999998854 3344444444333322
Q ss_pred -----CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 410 -----YFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 410 -----~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..++ ++.+||..||..||.+||++++|++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2244 8999999999999999999998876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=361.52 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=215.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEE--EEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNV--AIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kV--AIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyL 266 (1238)
..|.....||.|+||.||++.+..++..+ |||++.... .....+.+.+|+++|+++ +||||+++++++.+.+..|+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 34777889999999999999998888765 999987543 334557789999999999 99999999999999999999
Q ss_pred EEeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEE
Q psy6346 267 VSEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKL 330 (1238)
||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 999999999999997654 6899999999999999999999999999999999999999999999
Q ss_pred EecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccC
Q psy6346 331 ADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRI 408 (1238)
Q Consensus 331 iDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~ 408 (1238)
+|||++.............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+...+..+ ....
T Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (327)
T 1fvr_A 184 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 262 (327)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCC
T ss_pred cccCcCccccccccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCC
Confidence 99999875433333445567889999999988776 899999999999999998 99999999888888877765 3456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy6346 409 PYFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 409 P~~iS~eLkDLIrkML~kDPskRPTaeEILeHP 441 (1238)
+..+++++.+||.+||..||.+|||+++++++-
T Consensus 263 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 263 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 677899999999999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=346.12 Aligned_cols=245 Identities=14% Similarity=0.257 Sum_probs=216.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~lyLV 267 (1238)
..|.....||.|++|.||++.+ ++..||||++..........+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 4577788999999999999987 488999999998877777788999999999999999999999999877 789999
Q ss_pred EeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccc--eeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 268 SEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
|||+++++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 99999999999998765 4899999999999999999999999 9999999999999999999999999875432
Q ss_pred ccccccCCCCCCCcccccCCccCC--CccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC--CccCCCCCCHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCG--PEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESL 419 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S--~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--~~~~P~~iS~eLkDL 419 (1238)
.....||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+.......+... ...+|..+++++.+|
T Consensus 165 -~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (271)
T 3kmu_A 165 -SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL 243 (271)
T ss_dssp -CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHH
T ss_pred -ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 23457899999999998876532 2799999999999999999999998877776666544 345677899999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..||.+|||++++++.
T Consensus 244 i~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 244 MKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=353.97 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=209.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCC-------cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHT-------VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG-------~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d 262 (1238)
+.|...+.||.|+||.||++.+..++ ..||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 45778889999999999999888776 579999997643 345678999999999999999999999999999
Q ss_pred EEEEEEeecCCCccchhhhcccc-cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc--------EEEEec
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD--------IKLADF 333 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~-Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~--------VKLiDF 333 (1238)
..|+||||+.|++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999999987654 999999999999999999999999999999999999998877 999999
Q ss_pred CCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC-CCCCCCCChhHHHHHHhcCCccCCCCC
Q psy6346 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG-ALPFDGSTLNSLRDRVLSGRFRIPYFM 412 (1238)
Q Consensus 334 GLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG-rlPF~g~d~eeL~ekIl~g~~~~P~~i 412 (1238)
|++..... .....||+.|+|||++.+...++.++|||||||++|+|++| .+||........ ..+......+|...
T Consensus 166 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 241 (289)
T 4fvq_A 166 GISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDRHQLPAPK 241 (289)
T ss_dssp CSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCS
T ss_pred cccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhccCCCCCCC
Confidence 99865432 23456889999999998844458999999999999999995 555555554433 34444556677778
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
++++.+||.+||..||.+|||++++++|
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.66 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=219.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|++|.||++.+..++..||||++.... ...+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45888899999999999999999999999999997643 356788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--cc
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KL 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l 345 (1238)
|+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 99999999999764 458999999999999999999999999999999999999999999999999997654332 22
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ....|..+++++.+||.+|
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 248 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 33457788999999988776 899999999999999999 99999998888777777665 4556777999999999999
Q ss_pred cccCCCCCCCHHHHHhc
Q psy6346 424 LVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 424 L~kDPskRPTaeEILeH 440 (1238)
|..||.+|||++++++.
T Consensus 249 l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 249 WQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred hCCChhhCcCHHHHHHH
Confidence 99999999999999763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=367.80 Aligned_cols=250 Identities=32% Similarity=0.551 Sum_probs=182.9
Q ss_pred CcEEEEE-EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHH-HHHHhCCCCCeeEEEEEeee----CC
Q psy6346 189 GQTIRKR-EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREV-EIMKQLDHPHIIKLFQVMET----KS 262 (1238)
Q Consensus 189 GqVYkar-ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEI-eILkkL~HPNIVrL~dvfed----~d 262 (1238)
...|... ..||.|+||.||++.+..+++.||||++.... ...+|+ ..++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 3456664 46999999999999999999999999997531 222333 34677799999999999976 56
Q ss_pred EEEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEEecCCcc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFGFSN 337 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLiDFGLS~ 337 (1238)
.+|+|||||.|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 6899999999999999998764 6999999999999999999999999999999999999986 4559999999997
Q ss_pred cccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHH----HHHHhcCCccCC----
Q psy6346 338 YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL----RDRVLSGRFRIP---- 409 (1238)
Q Consensus 338 ~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL----~ekIl~g~~~~P---- 409 (1238)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+...... ...+......++
T Consensus 180 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 180 ETTQ-NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EC-----------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred eccc-cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 6432 33455679999999999987776 7899999999999999999999977654433 223333333333
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
..+++++.+||.+||..||.+|||++|+++||||.+..
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 35899999999999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.85 Aligned_cols=246 Identities=17% Similarity=0.198 Sum_probs=210.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
+..|...+.||.|++|.||++.+..+++.||||++..... .+.+.+|+.+++.+ +|+||+++++++......|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 4568889999999999999999999999999999976542 23577899999999 899999999999999999999
Q ss_pred EeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc-----EEEEecCCcccccC
Q psy6346 268 SEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD-----IKLADFGFSNYYVP 341 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~-----VKLiDFGLS~~~~~ 341 (1238)
|||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999 999999998654 5999999999999999999999999999999999999987776 99999999976544
Q ss_pred CC--------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC---hhHHHHHHhcCCc----
Q psy6346 342 GQ--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---LNSLRDRVLSGRF---- 406 (1238)
Q Consensus 342 s~--------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d---~eeL~ekIl~g~~---- 406 (1238)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. .......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 32 2345679999999999988876 899999999999999999999998743 3333344333222
Q ss_pred -cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 407 -RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 407 -~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+...+++++.+||.+||..||.+||++++|++.
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1234688999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.57 Aligned_cols=249 Identities=23% Similarity=0.402 Sum_probs=219.7
Q ss_pred cEEEEEEEecCCCCccccCceEcc-------CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLR-------HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETK 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lk-------tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~ 261 (1238)
..|...+.||.|+||.||++.+.. .+..||||++.... .....+.+.+|+++++++ +||||+++++++.+.
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457778889999999999988653 33689999998763 556678899999999999 999999999999999
Q ss_pred CEEEEEEeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n 325 (1238)
+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence 99999999999999999997653 48999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHH
Q psy6346 326 LDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRV 401 (1238)
Q Consensus 326 G~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekI 401 (1238)
+.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..++...+
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~ 306 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999997654332 2334567889999999988776 899999999999999999 99999999988888887
Q ss_pred hcC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 402 LSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 402 l~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+ ....|..+++++.+||.+||..||.+|||++||+++
T Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 307 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 766 445677899999999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=349.04 Aligned_cols=248 Identities=22% Similarity=0.357 Sum_probs=216.0
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee-------
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET------- 260 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed------- 260 (1238)
++..|...+.||.|++|.||++.+..+++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4566889999999999999999999899999999998653 356789999999999999999998864
Q ss_pred ---------CCEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEE
Q psy6346 261 ---------KSMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329 (1238)
Q Consensus 261 ---------~d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VK 329 (1238)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999754 5789999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC
Q psy6346 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP 409 (1238)
Q Consensus 330 LiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P 409 (1238)
|+|||++.............|++.|+|||++.+..+ +.++|||||||++|+|++|..||... ......+..+ .++
T Consensus 163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~ 237 (284)
T 2a19_B 163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--IIS 237 (284)
T ss_dssp ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCC
T ss_pred ECcchhheeccccccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--ccc
Confidence 999999987666555566789999999999988776 89999999999999999999887532 2233333333 246
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..++.++.+||.+||..||.+|||+.|+++|.|....
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 6789999999999999999999999999999887654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=369.80 Aligned_cols=251 Identities=24% Similarity=0.294 Sum_probs=211.7
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CC-----CeeEEEEEeeeCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HP-----HIIKLFQVMETKS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HP-----NIVrL~dvfed~d 262 (1238)
...|.....||.|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 45688899999999999999999999999999999753 345577888999999885 44 4999999999999
Q ss_pred EEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhh--ccceeeccCCccccccc--CCCcEEEEecCCc
Q psy6346 263 MIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCH--NRRVVHRDLKAENLLMD--SNLDIKLADFGFS 336 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLH--SkGIIHRDLKPeNILLd--~nG~VKLiDFGLS 336 (1238)
.+||||||+. ++|.+++... +.+++..++.++.||+.||.||| ..||+||||||+||||+ .++.+||+|||++
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999996 5999998765 46899999999999999999999 46999999999999995 4788999999999
Q ss_pred ccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc---------
Q psy6346 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR--------- 407 (1238)
Q Consensus 337 ~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~--------- 407 (1238)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 209 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 209 CQLG--QRIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp EETT--CCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred eecc--cccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 7653 33456789999999999998886 89999999999999999999999998876666555431000
Q ss_pred ---------CCC-------------------C---------------------------CCHHHHHHHHHhcccCCCCCC
Q psy6346 408 ---------IPY-------------------F---------------------------MSTECESLIRKMLVREPTKRY 432 (1238)
Q Consensus 408 ---------~P~-------------------~---------------------------iS~eLkDLIrkML~kDPskRP 432 (1238)
+|. . ..+++.+||.+||++||++||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 000 0 013789999999999999999
Q ss_pred CHHHHHhccccccc
Q psy6346 433 CIEQIKRHRWMAEE 446 (1238)
Q Consensus 433 TaeEILeHPWFke~ 446 (1238)
|++|+|+||||++.
T Consensus 366 ta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 366 QPYYALQHSFFKKT 379 (382)
T ss_dssp CHHHHTTSGGGCC-
T ss_pred CHHHHhcCcccccC
Confidence 99999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=365.18 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=207.9
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-----------CCCeeEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-----------HPHIIKLFQV 257 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-----------HPNIVrL~dv 257 (1238)
...|...+.||.|+||.||++.+..+++.||||++... ....+.+.+|+.+++++. |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 34688899999999999999999999999999999753 345577889999999886 8999999999
Q ss_pred eeeCC----EEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCccccccc------C
Q psy6346 258 METKS----MIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMD------S 324 (1238)
Q Consensus 258 fed~d----~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd------~ 324 (1238)
+...+ .+++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++ .
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 97654 799999999 89999999764 4599999999999999999999998 999999999999994 3
Q ss_pred CCcEEEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh------HHH
Q psy6346 325 NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN------SLR 398 (1238)
Q Consensus 325 nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e------eL~ 398 (1238)
.+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.. ...
T Consensus 174 ~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 45799999999976533 3345679999999999998887 89999999999999999999999865421 111
Q ss_pred HHHh------------------------------------------cCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6346 399 DRVL------------------------------------------SGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQ 436 (1238)
Q Consensus 399 ekIl------------------------------------------~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeE 436 (1238)
..+. .....++..++.++.+||.+||..||.+|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 1111 1122233445678999999999999999999999
Q ss_pred HHhcccccccC
Q psy6346 437 IKRHRWMAEET 447 (1238)
Q Consensus 437 ILeHPWFke~~ 447 (1238)
||+||||++..
T Consensus 331 ll~hp~f~~~~ 341 (373)
T 1q8y_A 331 LVNHPWLKDTL 341 (373)
T ss_dssp HHTCGGGTTCT
T ss_pred HhhChhhhccc
Confidence 99999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.54 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=205.5
Q ss_pred cEEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
..|.....||.|+||.||++.+..+ +..||||++.... .....+.+.+|+.++++++||||+++++++. .+..|+
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4578888999999999999988653 5679999987653 4556678999999999999999999999985 456899
Q ss_pred EEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-
Q psy6346 267 VSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK- 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~- 344 (1238)
||||+.+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence 999999999999997654 699999999999999999999999999999999999999999999999999976544322
Q ss_pred -cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHH
Q psy6346 345 -LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIR 421 (1238)
Q Consensus 345 -l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIr 421 (1238)
.....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ..++..+++++.+||.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 251 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 251 (281)
T ss_dssp ------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 233457788999999987776 889999999999999996 999999988888777776653 4567789999999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy6346 422 KMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeH 440 (1238)
+||..||.+|||+.+++++
T Consensus 252 ~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 252 KCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.98 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=212.5
Q ss_pred cEEEEEE-EecCCCCccccCceE--ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKRE-KCGVKSRSCNRPPVL--LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkare-kIGsGsfGtVYKav~--lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
..|...+ .||.|+||.||++.+ ..++..||||++.....+....+.+.+|+.+++.++||||+++++++ ..+..|+
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3456666 899999999999854 45678999999987765556678899999999999999999999999 5667899
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK-- 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~-- 344 (1238)
||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 999999999999999888899999999999999999999999999999999999999999999999999976543322
Q ss_pred --cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHH
Q psy6346 345 --LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLI 420 (1238)
Q Consensus 345 --l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLI 420 (1238)
.....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+...+..+. ..+|..+++++.+||
T Consensus 175 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 253 (291)
T ss_dssp EC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 123346788999999988776 789999999999999999 999999988888877776653 456778999999999
Q ss_pred HHhcccCCCCCCCHHHHHh
Q psy6346 421 RKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILe 439 (1238)
.+||..||.+||++.++++
T Consensus 254 ~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 254 NLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=354.02 Aligned_cols=250 Identities=20% Similarity=0.345 Sum_probs=207.7
Q ss_pred cEEEEEEEecCCCCccccCceEcc---CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC----
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLR---HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS---- 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lk---tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d---- 262 (1238)
..|...+.||.|+||.||++.+.. ++..||||++..........+.+.+|+.++++++||||+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 457777889999999999887765 4568999999887767777889999999999999999999999997655
Q ss_pred -EEEEEEeecCCCccchhhh------cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCC
Q psy6346 263 -MIYIVSEYANQGEIFDYIA------RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 263 -~lyLVMEy~~GGSL~d~Lk------k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
..|+||||+.+++|.+++. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 3599999999999999984 335699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCC
Q psy6346 336 SNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPY 410 (1238)
Q Consensus 336 S~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~ 410 (1238)
+....... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....+...+..+ ....+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE 272 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBT
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCc
Confidence 97654332 1233457888999999988776 899999999999999999 99999998888887777765 345677
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+++++.+||.+||..||.+|||+.+++++
T Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=361.28 Aligned_cols=251 Identities=19% Similarity=0.354 Sum_probs=211.7
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ 263 (1238)
..|.....||.|+||.||++.+. .++..||||++.... .....+.+.+|+.+|+++ +||||+++++++...+.
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 55788889999999999998863 356789999998643 334457899999999999 99999999999999999
Q ss_pred EEEEEeecCCCccchhhhccc-----------------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccc
Q psy6346 264 IYIVSEYANQGEIFDYIARYG-----------------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENL 320 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~-----------------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNI 320 (1238)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 999999999999999997653 378999999999999999999999999999999999
Q ss_pred cccCCCcEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhH
Q psy6346 321 LMDSNLDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNS 396 (1238)
Q Consensus 321 LLd~nG~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~ee 396 (1238)
|++.++.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 999999999999999976544322 234557889999999988776 899999999999999998 999998876554
Q ss_pred HHHHHhcC--CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy6346 397 LRDRVLSG--RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 397 L~ekIl~g--~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPW 442 (1238)
....+... ....|..+++++.+||.+||..||.+|||+.+|++|-.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 44444333 34456778999999999999999999999999999854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=345.73 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=209.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHh-----HHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVN-----LQKVYREVEIMKQLDHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~-----ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ 263 (1238)
...|.....||.|+||.||++.+..+++.||||++......... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 45688889999999999999999999999999999765433221 168899999999999999999999998766
Q ss_pred EEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccc--eeeccCCcccccccCCCc-----EEEEecCC
Q psy6346 264 IYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDSNLD-----IKLADFGF 335 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd~nG~-----VKLiDFGL 335 (1238)
++||||+.+++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 6999999999998888654 46999999999999999999999999 999999999999988776 99999999
Q ss_pred cccccCCCccccccCCCCCCCcccccCC-ccCCCccceehhhHHHHHHhhCCCCCCCCChhHH--HHHHhcC--CccCCC
Q psy6346 336 SNYYVPGQKLATWCGSPPYAAPEVFEGK-KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL--RDRVLSG--RFRIPY 410 (1238)
Q Consensus 336 S~~~~~s~~l~t~~GTp~YmAPEVL~gk-~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL--~ekIl~g--~~~~P~ 410 (1238)
+.... .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+...... ...+... ...++.
T Consensus 176 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 4f0f_A 176 SQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253 (287)
T ss_dssp CBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT
T ss_pred ccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc
Confidence 97533 234456799999999998432 2237899999999999999999999987654433 3333332 345677
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+++++.+||.+||..||.+|||++++++.
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 899999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.95 Aligned_cols=249 Identities=20% Similarity=0.338 Sum_probs=212.6
Q ss_pred cEEEEEEEecCCCCccccCceE-----ccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVL-----LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~-----lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ 263 (1238)
..|.....||.|+||.||++.+ ..++..||||++.... .....+.+.+|+.+|+++ +||||+++++++.+.+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 4577778899999999998875 3567899999998654 445568899999999999 99999999999999999
Q ss_pred EEEEEeecCCCccchhhhccc------------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYG------------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~------------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n 325 (1238)
.|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 999999999999999997654 48999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHH
Q psy6346 326 LDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRV 401 (1238)
Q Consensus 326 G~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekI 401 (1238)
+.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 260 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence 9999999999976544332 233457788999999987776 899999999999999998 99999887654443333
Q ss_pred hcC--CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 402 LSG--RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 402 l~g--~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
... ....+..++.++.+||.+||..||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 322 233466789999999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=361.33 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=213.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcE----EEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVN----VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~k----VAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
...|.....||.|+||.||++.+..++.. ||+|++.... .......+.+|+.++++++||||+++++++.+ +..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence 35588889999999999999998877765 7777775443 22233567789999999999999999999874 568
Q ss_pred EEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 265 YIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999999775 579999999999999999999999999999999999999999999999999998764432
Q ss_pred ---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHH
Q psy6346 344 ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECES 418 (1238)
Q Consensus 344 ---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkD 418 (1238)
......|++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....+...+..+ ....|..++.++.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM 248 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTH
T ss_pred ccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHH
Confidence 2344568889999999987776 899999999999999999 99999998888887777765 45567778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhc
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeH 440 (1238)
||.+||..||.+||++.+++++
T Consensus 249 li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 249 VMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.84 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=202.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC--hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD--PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld--~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
..|...+.||.|+||.||++.+ .+..||||++...... ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 4578889999999999999976 4889999998765432 23457889999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccc---eeeccCCcccccccC--------CCcEEEEecCCc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR---VVHRDLKAENLLMDS--------NLDIKLADFGFS 336 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkG---IIHRDLKPeNILLd~--------nG~VKLiDFGLS 336 (1238)
|||+.+++|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+||+++. ++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999999999885 467999999999999999999999999 999999999999986 778999999999
Q ss_pred ccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC--ccCCCCCCH
Q psy6346 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR--FRIPYFMST 414 (1238)
Q Consensus 337 ~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~--~~~P~~iS~ 414 (1238)
....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.... ..++..+++
T Consensus 164 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3dtc_A 164 REWHRTT-KMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred ccccccc-ccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence 7654332 335679999999999988776 889999999999999999999999988777666665543 445677899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
++.+||.+||..||.+|||+.|++++
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 242 PFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=359.54 Aligned_cols=254 Identities=21% Similarity=0.352 Sum_probs=190.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHH-HHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVE-IMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIe-ILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||++.+..+++.||||++.... .......+..|+. +++.++||||+++++++...+..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 45777889999999999999999999999999998764 3444556667776 677789999999999999999999999
Q ss_pred eecCCCccchhhhc-----ccccchhHHHHHHHHHHHHHhHhhcc-ceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 269 EYANQGEIFDYIAR-----YGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-----~~~Lsesea~kI~~QILsALeYLHSk-GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 99985 77777753 46789999999999999999999999 9999999999999999999999999999876555
Q ss_pred CccccccCCCCCCCccccc----CCccCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhcCC-ccCC----CCC
Q psy6346 343 QKLATWCGSPPYAAPEVFE----GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLSGR-FRIP----YFM 412 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~----gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~g~-~~~P----~~i 412 (1238)
.......||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.... .....+..+. ..++ ..+
T Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3aln_A 180 IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258 (327)
T ss_dssp --------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCC
T ss_pred cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccC
Confidence 4445557999999999983 4444 88999999999999999999999864321 2222222221 1222 347
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
++++.+||.+||..||.+|||+.+|++||||...
T Consensus 259 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 8999999999999999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=347.77 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=214.8
Q ss_pred EEEEE-EecCCCCccccCceEc--cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 192 IRKRE-KCGVKSRSCNRPPVLL--RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 192 Ykare-kIGsGsfGtVYKav~l--ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
|...+ .||.|+||.||++.+. .++..||||++.... .....+.+.+|++++++++||||+++++++. .+..|+||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~ 88 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVM 88 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEE
Confidence 44444 8999999999999754 467889999998753 4566788999999999999999999999994 55689999
Q ss_pred eecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc---
Q psy6346 269 EYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--- 344 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--- 344 (1238)
||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 999999999998654 5699999999999999999999999999999999999999999999999999976543322
Q ss_pred -cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHH
Q psy6346 345 -LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIR 421 (1238)
Q Consensus 345 -l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIr 421 (1238)
.....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+...+..+. ..+|..+++++.+||.
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 247 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 247 (287)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHH
Confidence 223456889999999987776 889999999999999998 999999988877777777653 4567789999999999
Q ss_pred HhcccCCCCCCCHHHHHhccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPW 442 (1238)
+||..||.+||++.+++++.+
T Consensus 248 ~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 248 DCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HTTCSSGGGSCCHHHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999998865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.93 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=216.9
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|.....||.|+||.||+|.+. .++..||||++.... .......+.+|+.+|++++||||+++++++.+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 45777788888888899888766 457899999997653 445567899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcc----------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecC
Q psy6346 265 YIVSEYANQGEIFDYIARY----------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~----------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999999999764 346889999999999999999999999999999999999999999999999
Q ss_pred CcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCC
Q psy6346 335 FSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIP 409 (1238)
Q Consensus 335 LS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P 409 (1238)
++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 262 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCC
Confidence 997654332 2233457889999999987776 889999999999999999 999999998888887777654 3466
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..++.++.+||.+||..||.+|||+.|+++|
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 263 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7789999999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=353.08 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=209.4
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
+..-..|...+.||.|+||.||++.+..+++.||||++..... +....+.+.+|+.++++++||||+++++++...+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 3344568899999999999999999999999999999986543 344457899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---cCCCCCCHHHHHH
Q psy6346 344 -KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---RIPYFMSTECESL 419 (1238)
Q Consensus 344 -~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---~~P~~iS~eLkDL 419 (1238)
......|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....+...+..... .++..+++++.+|
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 2335679999999999988776 8899999999999999999999998876655555544322 2455689999999
Q ss_pred HHHhcccCCCCCC-CHHHHHhc
Q psy6346 420 IRKMLVREPTKRY-CIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRP-TaeEILeH 440 (1238)
|.+||..||.+|| +++++++.
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHHH
Confidence 9999999999999 78877753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.90 Aligned_cols=246 Identities=24% Similarity=0.437 Sum_probs=216.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|++|.||++.+. ++..||||++...... .+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 45778889999999999999875 6788999999876533 3578899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999999765 568999999999999999999999999999999999999999999999999987653321 223
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
...|++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..++..+.+||.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l 242 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 242 (267)
T ss_dssp STTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHc
Confidence 3457788999999987776 889999999999999999 99999998888888777766 34456678999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy6346 425 VREPTKRYCIEQIKRH 440 (1238)
Q Consensus 425 ~kDPskRPTaeEILeH 440 (1238)
..||.+||++.+++++
T Consensus 243 ~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 243 RERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=356.94 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=216.4
Q ss_pred cEEEEEEEecCCCCccccCceEc-------cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-------RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETK 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-------ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~ 261 (1238)
..|...+.||.|+||.||++.+. .++..||||++.... .....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 45777788899999999988765 457889999998654 455678899999999999 999999999999999
Q ss_pred CEEEEEEeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n 325 (1238)
+.+|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence 99999999999999999997654 38899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHH
Q psy6346 326 LDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRV 401 (1238)
Q Consensus 326 G~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekI 401 (1238)
+.+||+|||++....... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....++...+
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 272 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence 999999999997654332 1233457788999999987776 899999999999999999 99999999888887777
Q ss_pred hcCC-ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 402 LSGR-FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 402 l~g~-~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+. ...+..++.++.+||.+||..||.+|||+.+++++
T Consensus 273 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6653 45677789999999999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.10 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=206.3
Q ss_pred CcEEEEEEEecCCCCccccCce----EccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPV----LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav----~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d 262 (1238)
...|+..+.||.|+||.||++. ...++..||||++... .....+.+.+|+.+|++++||||+++++++.. ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4568888999999999999987 4568999999999764 45566889999999999999999999999854 45
Q ss_pred EEEEEEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
.+|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 6899999999999999997754 599999999999999999999999999999999999999999999999999986543
Q ss_pred CC----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh----------------HHHHHH
Q psy6346 342 GQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN----------------SLRDRV 401 (1238)
Q Consensus 342 s~----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e----------------eL~ekI 401 (1238)
.. ......++..|+|||++.+..+ +.++|||||||++|+|++|..||...... .+...+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 32 1223457778999999988876 89999999999999999999998653221 112222
Q ss_pred h-cCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 402 L-SGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 402 l-~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
. ......|..+++++.+||.+||..||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 2 23455677899999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=370.70 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=217.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||+|.+..++..||||++... ......+.+.+|+.+|++++||||+++++++...+.+|+|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 4577788999999999999999889999999999754 345556778999999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc---
Q psy6346 270 YANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL--- 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l--- 345 (1238)
|+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 999999999998654 5999999999999999999999999999999999999999999999999998754332111
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....+++.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+.....+.+..+ ....|..+++++.+||.+|
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 11234667999999987776 889999999999999998 99999998888777776655 4556778999999999999
Q ss_pred cccCCCCCCCHHHHHhc
Q psy6346 424 LVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 424 L~kDPskRPTaeEILeH 440 (1238)
|..||.+|||+++|++.
T Consensus 352 l~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 352 WAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCchhCcCHHHHHHH
Confidence 99999999999999763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.84 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=213.4
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCC----cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHT----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK 261 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~ 261 (1238)
......|...+.||.|+||.||+|.+..++ ..||||++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 334456788889999999999999876543 469999998654 455667899999999999999999999999999
Q ss_pred CEEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
+..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999999764 579999999999999999999999999999999999999999999999999997654
Q ss_pred CCCc----cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCH
Q psy6346 341 PGQK----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMST 414 (1238)
Q Consensus 341 ~s~~----l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~ 414 (1238)
.... .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....++...+..+ ....+..++.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 3221 122346778999999988776 889999999999999998 99999998888888777765 4556677899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 415 ECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 415 eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
++.+||.+||..||.+||++.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.27 Aligned_cols=248 Identities=21% Similarity=0.360 Sum_probs=208.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcE----EEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVN----VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~k----VAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
..|.....||.|+||.||+|.+..++.. ||+|.+.... .....+.+.+|+.+|++++||||+++++++.+.. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 4588889999999999999998877765 5777775432 3345678999999999999999999999998765 78
Q ss_pred EEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
+|+||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 899999999999999764 5799999999999999999999999999999999999999999999999999976543322
Q ss_pred ---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHH
Q psy6346 345 ---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESL 419 (1238)
Q Consensus 345 ---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDL 419 (1238)
.....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....+...+..+. ...+..++.++.+|
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred cccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 223456789999999988776 899999999999999999 999999988888777776653 45677789999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..||.+||++.+++++
T Consensus 252 i~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 252 MVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=368.60 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=206.6
Q ss_pred CcEEEEEEEecCCCCccccCceEc---cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLL---RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~l---ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
...|.....||.|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|++++||||+++++++.+.+..|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 345667788999999999999876 467789999997653 5556788999999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 9999999999999997654 699999999999999999999999999999999999999999999999999976543321
Q ss_pred ----cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHH
Q psy6346 345 ----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECES 418 (1238)
Q Consensus 345 ----l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkD 418 (1238)
.....+++.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+...+...+..+ ....+..++.++.+
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 281 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281 (373)
T ss_dssp -----------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHH
T ss_pred cceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence 122345778999999988776 889999999999999997 99999998888887777665 34456678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhc
Q psy6346 419 LIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 419 LIrkML~kDPskRPTaeEILeH 440 (1238)
||.+||..||.+||++++|++.
T Consensus 282 li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 282 LMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCcChhhCcCHHHHHHH
Confidence 9999999999999999998863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.09 Aligned_cols=255 Identities=18% Similarity=0.241 Sum_probs=214.7
Q ss_pred cEEEEEEEecCCCCccccCce-----EccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPV-----LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav-----~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
..|.....||.|+||.||++. ...++..||||++.... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 456677788888888888887 44678899999997543 455667899999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhccc-------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC---CcEEEEecC
Q psy6346 265 YIVSEYANQGEIFDYIARYG-------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN---LDIKLADFG 334 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~-------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n---G~VKLiDFG 334 (1238)
|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999999999999998653 48899999999999999999999999999999999999854 459999999
Q ss_pred CcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCC
Q psy6346 335 FSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIP 409 (1238)
Q Consensus 335 LS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P 409 (1238)
++....... ......|++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....+...+..+ ....+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 267 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCC
Confidence 987543322 2334568899999999987776 899999999999999998 99999998888877777665 34566
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..++..+.+||.+||..||.+||++.+|++|.|+...
T Consensus 268 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 268 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 7789999999999999999999999999999987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=350.81 Aligned_cols=249 Identities=20% Similarity=0.375 Sum_probs=212.2
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeC-C
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETK-S 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~-d 262 (1238)
..|.....||.|+||.||++.+. .+++.||||++.... .....+.+.+|+.+|+++ +||||+++++++... .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 45788888999999999998753 467899999998654 445667899999999999 799999999998765 4
Q ss_pred EEEEEEeecCCCccchhhhcccc----------------cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGR----------------MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~----------------Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG 326 (1238)
.+|+||||+.+++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 59999999999999999987544 89999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChh-HHHHHH
Q psy6346 327 DIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLN-SLRDRV 401 (1238)
Q Consensus 327 ~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~e-eL~ekI 401 (1238)
.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... .+...+
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence 999999999976543322 234567889999999988776 899999999999999998 99999876643 333444
Q ss_pred hcC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 402 LSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 402 l~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+ ....|..+++++.+||.+||..||.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 433 355677799999999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=370.61 Aligned_cols=254 Identities=20% Similarity=0.362 Sum_probs=212.0
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC--EE
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS--MI 264 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d--~l 264 (1238)
..+..|...+.||.|+||.||++.+..+++.||||++..... ....+.+.+|+++|++++||||+++++++...+ ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 346789999999999999999999999999999999976432 233567889999999999999999999998655 78
Q ss_pred EEEEeecCCCccchhhhcccc---cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc----cCCCcEEEEecCCcc
Q psy6346 265 YIVSEYANQGEIFDYIARYGR---MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM----DSNLDIKLADFGFSN 337 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~---Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL----d~nG~VKLiDFGLS~ 337 (1238)
|+|||||.|++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999987544 9999999999999999999999999999999999999 778889999999998
Q ss_pred cccCCCccccccCCCCCCCcccccCC-------ccCCCccceehhhHHHHHHhhCCCCCCCC----ChhHHHHHHhcCCc
Q psy6346 338 YYVPGQKLATWCGSPPYAAPEVFEGK-------KYCGPEIDIWSLGVVLYVLVCGALPFDGS----TLNSLRDRVLSGRF 406 (1238)
Q Consensus 338 ~~~~s~~l~t~~GTp~YmAPEVL~gk-------~y~S~KSDIWSLGVILYELLTGrlPF~g~----d~eeL~ekIl~g~~ 406 (1238)
...........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||... ...+....+..+..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 76665556677899999999998641 22378999999999999999999999642 23344444444321
Q ss_pred c-------------------CC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy6346 407 R-------------------IP------YFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 407 ~-------------------~P------~~iS~eLkDLIrkML~kDPskRPTaeEILeHP 441 (1238)
. +| ..++..+.+||++||.+||++||++++++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 1 11 12456788999999999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.91 Aligned_cols=249 Identities=20% Similarity=0.334 Sum_probs=213.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCc---EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE-E
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI-Y 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~---kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l-y 265 (1238)
..|...+.||.|+||.||+|.+..++. .||+|++.... .....+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 467777899999999999998765554 79999997643 455678899999999999999999999999766655 9
Q ss_pred EEEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC--
Q psy6346 266 IVSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-- 342 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-- 342 (1238)
+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 456899999999999999999999999999999999999999999999999999754322
Q ss_pred ---CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHH
Q psy6346 343 ---QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECE 417 (1238)
Q Consensus 343 ---~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLk 417 (1238)
.......+++.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+...+...+..+. ...+..+++++.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 22334568889999999988876 899999999999999999 566677777777776666553 456777899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeH 440 (1238)
+||.+||..||.+|||++++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.67 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=211.9
Q ss_pred CcEEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
...|.....||.|++|.||++.+..+ +..||||++.... .....+.+.+|+.++++++||||+++++++.+. ..|
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 35688888999999999999886643 4569999998763 455678899999999999999999999998754 468
Q ss_pred EEEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 266 IVSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
+||||+.+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 9999999999999997654 59999999999999999999999999999999999999999999999999997654332
Q ss_pred -ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHH
Q psy6346 344 -KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLI 420 (1238)
Q Consensus 344 -~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLI 420 (1238)
......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+ ....|..+++.+.+||
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLM 247 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 2233457888999999987776 889999999999999998 99999887777776666654 3456777899999999
Q ss_pred HHhcccCCCCCCCHHHHHhc
Q psy6346 421 RKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeH 440 (1238)
.+||..||.+|||+.+++++
T Consensus 248 ~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 248 TRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCchhCcCHHHHHHH
Confidence 99999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=344.54 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=203.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCC-CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~-ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|+||.||++.+..++..||||++.... .+....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 35888899999999999999999999999999998644 34566788999999999999999999999999999999999
Q ss_pred eecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-
Q psy6346 269 EYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ- 343 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~- 343 (1238)
||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 99999999999875 3558999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC--hhHHHHHHhcCCcc-C-CCCCCHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST--LNSLRDRVLSGRFR-I-PYFMSTECESL 419 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d--~eeL~ekIl~g~~~-~-P~~iS~eLkDL 419 (1238)
......|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ...+...+....+. . +..+++++.+|
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 270 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270 (310)
T ss_dssp -------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHH
T ss_pred cccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHH
Confidence 2344579999999999988776 889999999999999999999997653 33455555554432 1 24588999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..||.+|||+.+++++
T Consensus 271 i~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 271 VNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=358.63 Aligned_cols=251 Identities=18% Similarity=0.204 Sum_probs=202.1
Q ss_pred CCcEEEEEEEecCCCCccccCceEcc---CCcEEEEEEeccCCCChH---------hHHHHHHHHHHHHhCCCCCeeEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLR---HTVNVAIKIIDKSQLDPV---------NLQKVYREVEIMKQLDHPHIIKLF 255 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lk---tG~kVAIKVLkks~ld~e---------~ikrf~rEIeILkkL~HPNIVrL~ 255 (1238)
.+..|...+.||.|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34678899999999999999999887 788999999987642111 113466889999999999999999
Q ss_pred EEeee----CCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC--cEE
Q psy6346 256 QVMET----KSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL--DIK 329 (1238)
Q Consensus 256 dvfed----~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG--~VK 329 (1238)
+++.. ....|+||||+ |++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99987 78899999999 999999999888999999999999999999999999999999999999999877 999
Q ss_pred EEecCCcccccCCC--------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC--ChhHHHH
Q psy6346 330 LADFGFSNYYVPGQ--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS--TLNSLRD 399 (1238)
Q Consensus 330 LiDFGLS~~~~~s~--------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~--d~eeL~e 399 (1238)
|+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999997653221 1245679999999999998876 89999999999999999999999653 2222222
Q ss_pred HHhcCCccCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 400 RVLSGRFRIP---------YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 400 kIl~g~~~~P---------~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
........+| ..+++++.+||.+||..||.+||++++|++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111111122 1688999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.40 Aligned_cols=247 Identities=19% Similarity=0.192 Sum_probs=207.5
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEE-EeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ-VMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~d-vfed~d~lyL 266 (1238)
.+..|...+.||.|++|.||++.+..+++.||||++...... +.+.+|+.+++.+.|++++..+. ++...+..|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 356788999999999999999999999999999998765432 35889999999999887665554 4477888999
Q ss_pred EEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc---cCCCcEEEEecCCcccccCC
Q psy6346 267 VSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL---d~nG~VKLiDFGLS~~~~~s 342 (1238)
||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 8999999974 4579999999999999999999999999999999999999 47889999999999765443
Q ss_pred Cc--------cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC---hhHHHHHHhcCCccC---
Q psy6346 343 QK--------LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---LNSLRDRVLSGRFRI--- 408 (1238)
Q Consensus 343 ~~--------l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d---~eeL~ekIl~g~~~~--- 408 (1238)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. .......+.......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 22 245679999999999998876 899999999999999999999998743 223344444333333
Q ss_pred --CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 409 --PYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 409 --P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+..+++++.+||.+||..||.+|||++++++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 36689999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=353.37 Aligned_cols=249 Identities=20% Similarity=0.352 Sum_probs=212.9
Q ss_pred cEEEEEEEecCCCCccccCceEccCC-----cEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHT-----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG-----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ 263 (1238)
..|.....||.|+||.||++.+..++ ..||||++.... .....+.+.+|+.+|+++ +||||+++++++.+.+.
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 45778889999999999999887655 479999997654 445668899999999999 89999999999999999
Q ss_pred EEEEEeecCCCccchhhhcc--------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEE
Q psy6346 264 IYIVSEYANQGEIFDYIARY--------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~--------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VK 329 (1238)
+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEE
Confidence 99999999999999999754 2478999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-
Q psy6346 330 LADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG- 404 (1238)
Q Consensus 330 LiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g- 404 (1238)
|+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+...
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 283 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence 999999976543322 233456788999999987776 899999999999999998 99999887655444444333
Q ss_pred -CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 405 -RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 405 -~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
....|..+++++.+||.+||..||.+|||+++++++
T Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 334566789999999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.63 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=206.0
Q ss_pred cEEEEEEEecCCCCccccCce----EccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC--CE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPV----LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK--SM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav----~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~--d~ 263 (1238)
..|+..+.||.|+||.||++. ...+++.||||++.... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 347778889999999999987 46789999999998654 334567899999999999999999999999876 66
Q ss_pred EEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 264 IYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 89999999999999999544 56999999999999999999999999999999999999999999999999999776543
Q ss_pred C----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCC---------------hhHHHHHHhc
Q psy6346 343 Q----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST---------------LNSLRDRVLS 403 (1238)
Q Consensus 343 ~----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d---------------~eeL~ekIl~ 403 (1238)
. ......||..|+|||++.+..+ +.++|||||||++|+|++|..||.... ...+...+..
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 3 2334568888999999988877 789999999999999999998864321 1122222222
Q ss_pred -CCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 404 -GRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 404 -g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.....|..+++++.+||.+||..||.+|||++++++.
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 2445677899999999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.55 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=191.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEe--------e
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVM--------E 259 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvf--------e 259 (1238)
+..|.....||.|+||.||++.+..+++.||||++... .....+.+.+|+.+++++. ||||+++++++ .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 35788999999999999999999999999999998654 3455678899999999995 99999999998 3
Q ss_pred eCCEEEEEEeecCCCccchhhhc---ccccchhHHHHHHHHHHHHHhHhhccc--eeeccCCcccccccCCCcEEEEecC
Q psy6346 260 TKSMIYIVSEYANQGEIFDYIAR---YGRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 260 d~d~lyLVMEy~~GGSL~d~Lkk---~~~Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 4556899999996 788888865 456999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCc-------------cccccCCCCCCCcccc---cCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHH
Q psy6346 335 FSNYYVPGQK-------------LATWCGSPPYAAPEVF---EGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLR 398 (1238)
Q Consensus 335 LS~~~~~s~~-------------l~t~~GTp~YmAPEVL---~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ 398 (1238)
++........ ....+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||.+.....+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 9976543221 1245699999999998 34444 78999999999999999999999876544332
Q ss_pred HHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy6346 399 DRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 399 ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFk 444 (1238)
.... ....+...+..+.+||.+||..||.+|||++|+++|-+-.
T Consensus 263 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 263 NGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ---C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2221 2233455778899999999999999999999999986543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.82 Aligned_cols=251 Identities=23% Similarity=0.270 Sum_probs=207.1
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee----eCCEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME----TKSMI 264 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe----d~d~l 264 (1238)
+..|...+.||.|+||.||++....+++.||||++... .....+.+.+|+.++++++||||+++++++. .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 36799999999999999999999999999999998764 3556788999999999999999999999986 34578
Q ss_pred EEEEeecCCCccchhhhc----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 265 YIVSEYANQGEIFDYIAR----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
|+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999999876 3669999999999999999999999999999999999999999999999999886542
Q ss_pred CCC----------ccccccCCCCCCCcccccCCcc--CCCccceehhhHHHHHHhhCCCCCCCCC--hhHHHHHHhc-CC
Q psy6346 341 PGQ----------KLATWCGSPPYAAPEVFEGKKY--CGPEIDIWSLGVVLYVLVCGALPFDGST--LNSLRDRVLS-GR 405 (1238)
Q Consensus 341 ~s~----------~l~t~~GTp~YmAPEVL~gk~y--~S~KSDIWSLGVILYELLTGrlPF~g~d--~eeL~ekIl~-g~ 405 (1238)
... ......||+.|+|||++.+... ++.++|||||||++|+|++|..||.... .......+.. ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence 211 1123458999999999976542 3789999999999999999999995421 1112222222 12
Q ss_pred ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy6346 406 FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 406 ~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHP 441 (1238)
...+..++.++.+||.+||..||.+|||+++++++-
T Consensus 266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 333456899999999999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=338.86 Aligned_cols=244 Identities=24% Similarity=0.415 Sum_probs=212.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|++|.||++.+ .++..||||++...... .+.+.+|+++|++++||||+++++++.. +..|+|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 4578888999999999999875 46778999999765433 4678899999999999999999999874 45899999
Q ss_pred ecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--cc
Q psy6346 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KL 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l 345 (1238)
|+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999999997654 69999999999999999999999999999999999999999999999999997654332 12
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..++...+..+ ....+..+++++.+||.+|
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 246 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHH
Confidence 33457888999999987776 889999999999999999 99999998888777777665 3445677899999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|..||.+|||++++++
T Consensus 247 l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 247 WKERPEDRPTFDYLRS 262 (279)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred hccChhhCCCHHHHHH
Confidence 9999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.77 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=213.7
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEe-eeC
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM-ETK 261 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvf-ed~ 261 (1238)
+.....|...+.||.|+||.||+|.+..+ ...||||++.... +....+.+.+|+.++++++||||+++++++ ..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 44456788899999999999999987643 3468999998643 556678899999999999999999999985 566
Q ss_pred CEEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCccccc
Q psy6346 262 SMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYV 340 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~ 340 (1238)
+..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 7889999999999999999764 568999999999999999999999999999999999999999999999999997653
Q ss_pred CCC-----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCc-cCCCCCC
Q psy6346 341 PGQ-----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRF-RIPYFMS 413 (1238)
Q Consensus 341 ~s~-----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~-~~P~~iS 413 (1238)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..+.. ..|..++
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 322 2233457788999999988776 899999999999999999 7788888777777766666543 3467789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 414 TECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 414 ~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+.+||.+||..||.+|||+.++++.
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.98 Aligned_cols=246 Identities=20% Similarity=0.211 Sum_probs=202.9
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEE-EeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ-VMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~d-vfed~d~lyL 266 (1238)
.+..|...+.||.|+||.||++.+..+++.||||++...... ..+.+|+.+++.+.|++++..+. ++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 456788999999999999999999999999999997665422 35788999999998887665555 4477889999
Q ss_pred EEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc---cCCCcEEEEecCCcccccCC
Q psy6346 267 VSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL---d~nG~VKLiDFGLS~~~~~s 342 (1238)
||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 8999999874 4579999999999999999999999999999999999999 78899999999999765443
Q ss_pred C--------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---HHHHHHhcCCccCC--
Q psy6346 343 Q--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---SLRDRVLSGRFRIP-- 409 (1238)
Q Consensus 343 ~--------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---eL~ekIl~g~~~~P-- 409 (1238)
. ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.... .....+.......|
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 2 2235679999999999998876 89999999999999999999999874332 23333333333233
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 410 ---YFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 410 ---~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..+++++.+||.+||..||.+|||++++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 567899999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.50 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=205.7
Q ss_pred CcEEEEEEEecCCCCccccCceEcc-CC--cEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLR-HT--VNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lk-tG--~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
...|...+.||.|++|.||++.+.. ++ ..||||+++.... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3568888999999999999998653 33 3699999987643 3356688999999999999999999999998765 8
Q ss_pred EEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 265 YIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999999999764 569999999999999999999999999999999999999999999999999987654332
Q ss_pred c----cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC--ccCCCCCCHHH
Q psy6346 344 K----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR--FRIPYFMSTEC 416 (1238)
Q Consensus 344 ~----l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~--~~~P~~iS~eL 416 (1238)
. .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+...+.... ...+..++.++
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 254 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred cchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence 2 223457888999999988776 789999999999999999 999999998888887776653 34456789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+||.+||..||.+|||+.+++++
T Consensus 255 ~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 255 YNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.54 Aligned_cols=247 Identities=21% Similarity=0.374 Sum_probs=197.5
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
+..|.....||.|+||.||++.+ ...||||+++.........+.+.+|+.+|++++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 34577778899999999998864 34599999988877777788999999999999999999999965 455689999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC---CCc
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP---GQK 344 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~---s~~ 344 (1238)
||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 99999999999864 45699999999999999999999999999999999999999999999999999875432 223
Q ss_pred cccccCCCCCCCccccc---CCccCCCccceehhhHHHHHHhhCCCCCCCCCh-hHHHHHHhcCCcc-----CCCCCCHH
Q psy6346 345 LATWCGSPPYAAPEVFE---GKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-NSLRDRVLSGRFR-----IPYFMSTE 415 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~---gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-eeL~ekIl~g~~~-----~P~~iS~e 415 (1238)
.....||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+... ..+...+..+... ++..++++
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp -----CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred ccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 34567999999999986 4444 7899999999999999999999987544 3444444444322 23457899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+.+||.+||..||.+|||++++++.
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHH
Confidence 9999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.57 Aligned_cols=245 Identities=20% Similarity=0.312 Sum_probs=199.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC----CEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK----SMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~----d~ly 265 (1238)
..|...+.||.|+||.||++.+. ++.||||++... ........+|+.+|++++||||+++++++... ..+|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 56888899999999999999764 899999999754 23445566799999999999999999999764 3589
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc----------ceeeccCCcccccccCCCcEEEEecCC
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR----------RVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk----------GIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
+|||||++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999999966 4599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC---ccccccCCCCCCCcccccCC----ccCCCccceehhhHHHHHHhhCCCCCCCCCh--------------
Q psy6346 336 SNYYVPGQ---KLATWCGSPPYAAPEVFEGK----KYCGPEIDIWSLGVVLYVLVCGALPFDGSTL-------------- 394 (1238)
Q Consensus 336 S~~~~~s~---~l~t~~GTp~YmAPEVL~gk----~y~S~KSDIWSLGVILYELLTGrlPF~g~d~-------------- 394 (1238)
+....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+...
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 97654332 23346799999999999873 2235688999999999999999999976432
Q ss_pred --hHHHHHHhcCCcc--CCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 395 --NSLRDRVLSGRFR--IPY-----FMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 395 --eeL~ekIl~g~~~--~P~-----~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+...+...... ++. ..++++.+||.+||..||.+|||+.||++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222333222211 111 123459999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=374.20 Aligned_cols=246 Identities=24% Similarity=0.418 Sum_probs=218.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||+|.+..++..||||+++.... ..+.+.+|+.+|++++||||+++++++...+.+|||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 457888999999999999999998899999999986543 35679999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--c
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--L 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l 345 (1238)
||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 99999999999764 4589999999999999999999999999999999999999999999999999986543321 2
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....+++.|+|||++.+..+ +.++|||||||+||||++ |..||.+.+...+.+.+..+ ....|..+++++.+||.+|
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 455 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 23346778999999988776 899999999999999999 99999998888877776655 3456778999999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|..||.+|||+.+|++
T Consensus 456 l~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 456 WQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCcChhHCcCHHHHHH
Confidence 9999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=367.75 Aligned_cols=241 Identities=24% Similarity=0.407 Sum_probs=211.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-EEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS-MIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d-~lyLVM 268 (1238)
..|.....||.|+||.||++.+ .+..||||+++... ..+.+.+|+.+|++++||||+++++++...+ .+||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 4578889999999999999876 47899999998653 3467899999999999999999999986654 799999
Q ss_pred eecCCCccchhhhcccc--cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 269 EYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
|||.+|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 344 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 344 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--cc
Confidence 99999999999987654 789999999999999999999999999999999999999999999999999754322 23
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
...+++.|+|||++.+..+ +.++|||||||+||||++ |..||.+.+..++...+..+ ....|..+++++.+||.+||
T Consensus 345 ~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 423 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCW 423 (450)
T ss_dssp --CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHc
Confidence 3467889999999988876 899999999999999998 99999998887777777665 45677889999999999999
Q ss_pred ccCCCCCCCHHHHHh
Q psy6346 425 VREPTKRYCIEQIKR 439 (1238)
Q Consensus 425 ~kDPskRPTaeEILe 439 (1238)
..||.+|||+.+|++
T Consensus 424 ~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 424 HLDAATRPTFLQLRE 438 (450)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhHCcCHHHHHH
Confidence 999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=355.75 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=205.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||++.+ +++..||||++.... ....+.+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred hccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 4566677889999999999875 578999999987653 3456789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc----ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---
Q psy6346 270 YANQGEIFDYIARYG----RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG--- 342 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~----~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s--- 342 (1238)
|+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999997543 5899999999999999999999999999999999999999999999999998764322
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHH-------HHHhcCCc---------
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLR-------DRVLSGRF--------- 406 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~-------ekIl~g~~--------- 406 (1238)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....... .....+.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred ccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 12234568999999999988776 89999999999999999999999765432211 11111111
Q ss_pred -cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy6346 407 -RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442 (1238)
Q Consensus 407 -~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPW 442 (1238)
.++..++..+.+||.+||..||++|||+.|++++-.
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 112224567889999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.98 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=211.4
Q ss_pred CcEEEEEEEecCCCCccccCce----EccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee--eCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPV----LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME--TKS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav----~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe--d~d 262 (1238)
...|+..+.||.|+||.||++. ...++..||||++... .....+.+.+|+++|++++||||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 3568888999999999999987 4578899999999865 3555678999999999999999999999886 567
Q ss_pred EEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 263 MIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 799999999999999999874 5699999999999999999999999999999999999999999999999999976543
Q ss_pred CC----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---------------HHHHHHh
Q psy6346 342 GQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---------------SLRDRVL 402 (1238)
Q Consensus 342 s~----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---------------eL~ekIl 402 (1238)
.. ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .+...+.
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 32 2233468888999999988776 88999999999999999999998654322 2222222
Q ss_pred cC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 403 SG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 403 ~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+ ....+..+++++.+||.+||..||.+|||+++++++
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22 345677789999999999999999999999999765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.54 Aligned_cols=242 Identities=24% Similarity=0.408 Sum_probs=204.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee-CCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-KSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-~d~lyLVM 268 (1238)
..|...+.||.|++|.||++.+ +|..||||++.... ..+.+.+|+.++++++||||+++++++.. .+..|+||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 5588889999999999999865 58899999997653 45678999999999999999999998754 45799999
Q ss_pred eecCCCccchhhhcccc--cchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 269 EYANQGEIFDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~--Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||+++++|.+++...+. +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 172 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 172 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--cc
Confidence 99999999999987644 899999999999999999999999999999999999999999999999998754332 23
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
...+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+ ....+..+++.+.+||.+||
T Consensus 173 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 251 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 251 (278)
T ss_dssp ---CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHh
Confidence 4468899999999987776 889999999999999998 99999998888877777665 44567779999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy6346 425 VREPTKRYCIEQIKRH 440 (1238)
Q Consensus 425 ~kDPskRPTaeEILeH 440 (1238)
..||.+|||+.++++.
T Consensus 252 ~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 252 HLDAAMRPSFLQLREQ 267 (278)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCCCHHHHHHH
Confidence 9999999999999863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=343.78 Aligned_cols=237 Identities=32% Similarity=0.550 Sum_probs=195.7
Q ss_pred ccCCCCCcEEEEE-EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHH-HhCCCCCeeEEEEEeee
Q psy6346 183 LHAEKNGQTIRKR-EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIM-KQLDHPHIIKLFQVMET 260 (1238)
Q Consensus 183 LgsGkfGqVYkar-ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeIL-kkL~HPNIVrL~dvfed 260 (1238)
+..+.+...|... ..||.|+||.||++.+..+++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3344554556666 6799999999999999999999999999743 3577899998 66699999999999987
Q ss_pred ----CCEEEEEEeecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEE
Q psy6346 261 ----KSMIYIVSEYANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLA 331 (1238)
Q Consensus 261 ----~d~lyLVMEy~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLi 331 (1238)
...+|+||||+.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 778999999999999999998754 6999999999999999999999999999999999999998 7889999
Q ss_pred ecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHH----HHHhcCCcc
Q psy6346 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLR----DRVLSGRFR 407 (1238)
Q Consensus 332 DFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~----ekIl~g~~~ 407 (1238)
|||++.... +..+ +.++|||||||++|+|++|..||.+....... ..+..+...
T Consensus 163 Dfg~a~~~~---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 163 DFGFAKETT---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp CCTTCEECT---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccccccccc---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 999986432 1233 78999999999999999999999876543322 222223333
Q ss_pred CC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 408 IP----YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 408 ~P----~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
+| ..+++++.+||.+||..||.+|||++|+++||||.+...
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 34 458999999999999999999999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=341.09 Aligned_cols=245 Identities=24% Similarity=0.388 Sum_probs=197.8
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHh--CCCCCeeEEEEEeee----C
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQ--LDHPHIIKLFQVMET----K 261 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkk--L~HPNIVrL~dvfed----~ 261 (1238)
++..|...+.||.|+||.||++.+ ++..||||++... ....+.+|.+++.. ++||||+++++++.. .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 345688889999999999999876 6899999998653 34566778888877 799999999998643 4
Q ss_pred CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhh--------ccceeeccCCcccccccCCCcEEEEec
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH--------NRRVVHRDLKAENLLMDSNLDIKLADF 333 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLH--------SkGIIHRDLKPeNILLd~nG~VKLiDF 333 (1238)
..+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 568999999999999999954 57999999999999999999999 999999999999999999999999999
Q ss_pred CCcccccCCCc-----cccccCCCCCCCcccccCCcc-----CCCccceehhhHHHHHHhhC----------CCCCCCCC
Q psy6346 334 GFSNYYVPGQK-----LATWCGSPPYAAPEVFEGKKY-----CGPEIDIWSLGVVLYVLVCG----------ALPFDGST 393 (1238)
Q Consensus 334 GLS~~~~~s~~-----l~t~~GTp~YmAPEVL~gk~y-----~S~KSDIWSLGVILYELLTG----------rlPF~g~d 393 (1238)
|++........ ....+||+.|+|||++.+... ++.++|||||||++|+|++| ..||.+..
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99976543322 233479999999999987632 14689999999999999999 88886532
Q ss_pred -----hhHHHHHHhcC--CccCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 394 -----LNSLRDRVLSG--RFRIPY-----FMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 394 -----~eeL~ekIl~g--~~~~P~-----~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
...+...+... ...+|. .+++++.+||.+||..||.+|||+++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 22222222222 122221 245679999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.58 Aligned_cols=250 Identities=15% Similarity=0.172 Sum_probs=199.3
Q ss_pred CCcEEEEEEEecCCCCccccCceEccC-----CcEEEEEEeccCCCChH---------hHHHHHHHHHHHHhCCCCCeeE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRH-----TVNVAIKIIDKSQLDPV---------NLQKVYREVEIMKQLDHPHIIK 253 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lkt-----G~kVAIKVLkks~ld~e---------~ikrf~rEIeILkkL~HPNIVr 253 (1238)
.+..|.....||.|+||.||++.+..+ ++.||||++........ ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 445789999999999999999988654 58899999986541100 0022345566677788999999
Q ss_pred EEEEeeeC----CEEEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc--CCC
Q psy6346 254 LFQVMETK----SMIYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD--SNL 326 (1238)
Q Consensus 254 L~dvfed~----d~lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd--~nG 326 (1238)
+++++... ...||||||| |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 5689999999 99999999876 6799999999999999999999999999999999999999 889
Q ss_pred cEEEEecCCcccccCCC--------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHH
Q psy6346 327 DIKLADFGFSNYYVPGQ--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLR 398 (1238)
Q Consensus 327 ~VKLiDFGLS~~~~~s~--------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ 398 (1238)
.+||+|||++..+.... .....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 99999999997653321 1234569999999999998886 89999999999999999999999864322211
Q ss_pred HHHhc-----CC------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 399 DRVLS-----GR------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 399 ekIl~-----g~------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..... .. ...+..+++++.+||..||..||.+||++++|++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11110 00 0012457899999999999999999999999876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=346.32 Aligned_cols=245 Identities=25% Similarity=0.334 Sum_probs=204.4
Q ss_pred EEEEEEecCCCCccccC----ceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEEE
Q psy6346 192 IRKREKCGVKSRSCNRP----PVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIY 265 (1238)
Q Consensus 192 YkarekIGsGsfGtVYK----av~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~ly 265 (1238)
|+....||.|+||.||+ +....+++.||||++.... .....+.+.+|+++|++++||||+++++++.+ ...+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 47778888899998854 4455689999999998763 55667889999999999999999999999987 46899
Q ss_pred EEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-
Q psy6346 266 IVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK- 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~- 344 (1238)
+||||+++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 999999999999999764 489999999999999999999999999999999999999999999999999987654322
Q ss_pred ---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---------------HHHHHHhcC-C
Q psy6346 345 ---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---------------SLRDRVLSG-R 405 (1238)
Q Consensus 345 ---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---------------eL~ekIl~g-~ 405 (1238)
.....|++.|+|||++.+..+ +.++|||||||++|+|++|..||...... .+...+..+ .
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred cccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 234568888999999988776 78999999999999999999999754221 112222222 3
Q ss_pred ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 406 FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 406 ~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
...+..++.++.+||.+||..||.+|||++++++
T Consensus 270 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4567779999999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=362.72 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=194.8
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
...|.....||.|+||+||.+ ...+|+.||||++... ..+.+.+|+.+|+++ +||||+++++++.+.+.+|||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 345666778899999998754 4567999999998753 235678999999876 899999999999999999999
Q ss_pred EeecCCCccchhhhccccc-------chhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC-------------Cc
Q psy6346 268 SEYANQGEIFDYIARYGRM-------NENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-------------LD 327 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~L-------sesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n-------------G~ 327 (1238)
||||. |+|.+++...... .+..+..++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 6999999765432 334567899999999999999999999999999999754 48
Q ss_pred EEEEecCCcccccCCC-----ccccccCCCCCCCcccccC------CccCCCccceehhhHHHHHHhh-CCCCCCCCChh
Q psy6346 328 IKLADFGFSNYYVPGQ-----KLATWCGSPPYAAPEVFEG------KKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLN 395 (1238)
Q Consensus 328 VKLiDFGLS~~~~~s~-----~l~t~~GTp~YmAPEVL~g------k~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~e 395 (1238)
+||+|||++....... .....+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998764432 1234679999999999976 1334899999999999999998 99999766543
Q ss_pred HHHHHHhcCCccCCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 396 SLRDRVLSGRFRIPY-------FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 396 eL~ekIl~g~~~~P~-------~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
. ..+..+...++. .+++++.+||.+||..||.+|||+.+|++||||..
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3 334444333222 24578999999999999999999999999999964
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=366.24 Aligned_cols=244 Identities=23% Similarity=0.388 Sum_probs=212.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||++.+. ++..||||+++.... ..+.+.+|+.+|++++||||+++++++. .+.+|||||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 45788899999999999999764 578899999986542 3578999999999999999999999987 567899999
Q ss_pred ecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--cc
Q psy6346 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KL 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l 345 (1238)
||.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 999999999997653 68899999999999999999999999999999999999999999999999997653321 12
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....+++.|+|||++.+..+ +.++|||||||+||||++ |..||.+.+..++...+..+ ....|..+++++.+||.+|
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 421 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 421 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred CCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 23346778999999987776 899999999999999999 99999999888887777665 4456778999999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy6346 424 LVREPTKRYCIEQIKR 439 (1238)
Q Consensus 424 L~kDPskRPTaeEILe 439 (1238)
|..||.+|||+++|++
T Consensus 422 l~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 422 WKNRPEERPTFEYIQS 437 (454)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHHH
Confidence 9999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=350.64 Aligned_cols=248 Identities=21% Similarity=0.369 Sum_probs=208.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEE----EEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNV----AIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kV----AIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
..|.....||.|+||.||++.+..++..| |+|.+.... .....+.+.+|+.+|++++||||+++++++.... .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 45888899999999999999988777655 666665432 3345678999999999999999999999998765 78
Q ss_pred EEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
+|+||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999999999764 5699999999999999999999999999999999999999999999999999976543322
Q ss_pred ---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHH
Q psy6346 345 ---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESL 419 (1238)
Q Consensus 345 ---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDL 419 (1238)
.....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....+...+..+. ...+..++.++.+|
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 251 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred cccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 223456778999999998776 899999999999999999 999999988888877776653 55677799999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..||.+||++.|+++.
T Consensus 252 i~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 252 MRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=352.31 Aligned_cols=244 Identities=14% Similarity=0.219 Sum_probs=203.7
Q ss_pred CCcEEEEEEEecCCCCccccCceEcc--------CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeE------
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLR--------HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIK------ 253 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lk--------tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVr------ 253 (1238)
.+..|...+.||.|+||.||++.+.. .+..||||++... +.+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 35789999999999999999999887 4889999999865 36789999999999999887
Q ss_pred ---------EEEEeee-CCEEEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCccccc
Q psy6346 254 ---------LFQVMET-KSMIYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLL 321 (1238)
Q Consensus 254 ---------L~dvfed-~d~lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNIL 321 (1238)
+++++.. .+..|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777765 78899999999 99999999876 78999999999999999999999999999999999999
Q ss_pred ccCCC--cEEEEecCCcccccCCC--------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCC
Q psy6346 322 MDSNL--DIKLADFGFSNYYVPGQ--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391 (1238)
Q Consensus 322 Ld~nG--~VKLiDFGLS~~~~~s~--------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g 391 (1238)
++.++ .+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 89999999997654321 1234579999999999998776 8999999999999999999999987
Q ss_pred CC--hhHHHHHH---hcCCccCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 392 ST--LNSLRDRV---LSGRFRIP------YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 392 ~d--~eeL~ekI---l~g~~~~P------~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.. ...+.... ......++ ..+++++.+||.+||..||.+|||+++|++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 53 22232222 22222222 1468999999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=382.60 Aligned_cols=244 Identities=21% Similarity=0.344 Sum_probs=212.7
Q ss_pred EEEecCCCCccccCceEc--cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 195 REKCGVKSRSCNRPPVLL--RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~l--ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
...||.|+||.||+|.+. ..++.||||+++....+....+.+.+|+++|++++|||||++++++..+ .++||||||.
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccC
Confidence 457999999999999654 4568999999987665666678999999999999999999999999754 5889999999
Q ss_pred CCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC----ccccc
Q psy6346 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ----KLATW 348 (1238)
Q Consensus 273 GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~----~l~t~ 348 (1238)
+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .....
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 99999999988889999999999999999999999999999999999999999999999999997654332 12234
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHHhccc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrkML~k 426 (1238)
.||+.|+|||++.+..+ +.++|||||||+||||++ |..||.+.+..++...+..+. ...|..+++++.+||.+||..
T Consensus 533 ~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 533 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp --CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 56788999999988777 899999999999999998 999999999888888887764 456788999999999999999
Q ss_pred CCCCCCCHHHHHhc
Q psy6346 427 EPTKRYCIEQIKRH 440 (1238)
Q Consensus 427 DPskRPTaeEILeH 440 (1238)
||++||++++|++.
T Consensus 612 dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 612 DVENRPGFAAVELR 625 (635)
T ss_dssp STTTSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=353.33 Aligned_cols=243 Identities=15% Similarity=0.223 Sum_probs=200.2
Q ss_pred CcEEEEEEEecCCCCccccCce-----EccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC---CCCeeEEEEEeee
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPV-----LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD---HPHIIKLFQVMET 260 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav-----~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~---HPNIVrL~dvfed 260 (1238)
+..|.....||.|+||.||+|+ ...+++.||||++.... ...+.+|+++++.+. |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4678889999999999999994 56789999999997642 456788899998886 9999999999999
Q ss_pred CCEEEEEEeecCCCccchhhhc-----ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-----------
Q psy6346 261 KSMIYIVSEYANQGEIFDYIAR-----YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS----------- 324 (1238)
Q Consensus 261 ~d~lyLVMEy~~GGSL~d~Lkk-----~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~----------- 324 (1238)
.+..|||||||.||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred CCcEEEEecCCccccc---CCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHH
Q psy6346 325 NLDIKLADFGFSNYYV---PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRV 401 (1238)
Q Consensus 325 nG~VKLiDFGLS~~~~---~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekI 401 (1238)
++.+||+|||++.... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~--- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCcee---
Confidence 8999999999996542 3334556789999999999999886 89999999999999999999999644321110
Q ss_pred hcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy6346 402 LSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 402 l~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHP 441 (1238)
....+. ....++.+.+++..||..+|.+|++..+.+.+.
T Consensus 295 ~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 295 PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred echhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 011111 113467899999999999999997655544443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=362.86 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=197.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|...+.||.|+||+|+. ....+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 4588889999999999763 4456899999999976532 2356899999999 8999999999999999999999
Q ss_pred eecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-----CCcEEEEecCCcccccCC
Q psy6346 269 EYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-----NLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-----nG~VKLiDFGLS~~~~~s 342 (1238)
|||. |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++......
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9997 59999987654 4666778899999999999999999999999999999953 335889999999766433
Q ss_pred ----CccccccCCCCCCCcccccCC--ccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCcc---CCCCC
Q psy6346 343 ----QKLATWCGSPPYAAPEVFEGK--KYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRFR---IPYFM 412 (1238)
Q Consensus 343 ----~~l~t~~GTp~YmAPEVL~gk--~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~~---~P~~i 412 (1238)
......+||+.|+|||++.+. ..++.++|||||||++|+|++ |..||...........+...... .+...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 233456799999999999742 223779999999999999999 99999766544433322222211 12224
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
+..+.+||.+||..||.+|||+++|++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 566899999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=362.02 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=211.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||++.+. .+..||||+++..... .+.+.+|+.+|++++||||+++++++.+ +.+|||||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 45778889999999999999775 4567999999875433 4578999999999999999999999876 67899999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--cc
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KL 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l 345 (1238)
|+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 99999999999753 458999999999999999999999999999999999999999999999999997654322 12
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....+++.|+|||++.+..+ +.++|||||||+||+|++ |..||.+....++...+..+ ....|..+++.+.+||.+|
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 417 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 417 (452)
T ss_dssp ----CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred cCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 23456788999999987776 899999999999999999 99999999888888777665 4556778999999999999
Q ss_pred cccCCCCCCCHHHHHhc--ccccc
Q psy6346 424 LVREPTKRYCIEQIKRH--RWMAE 445 (1238)
Q Consensus 424 L~kDPskRPTaeEILeH--PWFke 445 (1238)
|..||.+|||+++|++. .++..
T Consensus 418 l~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 418 WRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ccCChhhCcCHHHHHHHHHHHhcc
Confidence 99999999999999873 44443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=339.97 Aligned_cols=240 Identities=26% Similarity=0.404 Sum_probs=197.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+ .+..||||++... ...+.+.+|+.+|++++||||+++++++.+ ..|+|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 4577888999999999999876 4789999998653 345788999999999999999999998874 3799999
Q ss_pred ecCCCccchhhhccc---ccchhHHHHHHHHHHHHHhHhhc---cceeeccCCcccccccCCCc-EEEEecCCcccccCC
Q psy6346 270 YANQGEIFDYIARYG---RMNENAARRKFWQILSAVEYCHN---RRVVHRDLKAENLLMDSNLD-IKLADFGFSNYYVPG 342 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~---~Lsesea~kI~~QILsALeYLHS---kGIIHRDLKPeNILLd~nG~-VKLiDFGLS~~~~~s 342 (1238)
|++|++|.+++.... .++...+..++.||+.||.|||+ +||+||||||+||+++.++. +||+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~- 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT- 158 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-
Confidence 999999999998654 36788999999999999999999 89999999999999998886 79999999875432
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh--HHHHHHhc-CCccCCCCCCHHHHHH
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN--SLRDRVLS-GRFRIPYFMSTECESL 419 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e--eL~ekIl~-g~~~~P~~iS~eLkDL 419 (1238)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .....+.. ....++..++..+.+|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp -------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred -ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence 2334569999999999988776 89999999999999999999999864332 22223333 2344566789999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..||.+|||+++++++
T Consensus 237 i~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=356.88 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=205.3
Q ss_pred CcEEEEEEEecCCCCccccCceEccCC---cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee-eCCEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHT---VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME-TKSMI 264 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG---~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe-d~d~l 264 (1238)
...|...+.||.|+||.||+|.+..++ ..||||+++... +....+.+.+|+.+|++++||||+++++++. .++..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 345777889999999999999876443 468999987643 4456788999999999999999999999864 56688
Q ss_pred EEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 265 YIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999765 458899999999999999999999999999999999999999999999999997653322
Q ss_pred -----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHH
Q psy6346 344 -----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTEC 416 (1238)
Q Consensus 344 -----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eL 416 (1238)
......+++.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+..+....+..+. ...|..++..+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 1223457788999999988776 899999999999999999 788998877766666666553 34567789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+||.+||..||.+|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.07 Aligned_cols=251 Identities=19% Similarity=0.213 Sum_probs=201.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||++. ..++..||||++...... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred hccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 446666788999999999886 456899999999765422 222368899999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc----ccchhHHHHHHHHHHHHHhHhhcc---ceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 270 YANQGEIFDYIARYG----RMNENAARRKFWQILSAVEYCHNR---RVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~----~Lsesea~kI~~QILsALeYLHSk---GIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
|+.+++|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 999999999997653 389999999999999999999999 9999999999999999999999999999765432
Q ss_pred C--ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-----ChhHHHHHHhc---C-C------
Q psy6346 343 Q--KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-----TLNSLRDRVLS---G-R------ 405 (1238)
Q Consensus 343 ~--~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-----d~eeL~ekIl~---g-~------ 405 (1238)
. ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||... ........+.. . .
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 3uim_A 188 DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266 (326)
T ss_dssp SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence 2 2344569999999999988776 89999999999999999999999521 11111111110 0 0
Q ss_pred ----ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 406 ----FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 406 ----~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
..++...+..+.+||.+||..||.+|||+.||++|-.-
T Consensus 267 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 01111234678999999999999999999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=337.36 Aligned_cols=241 Identities=20% Similarity=0.308 Sum_probs=199.8
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCC--CChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ--LDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~--ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
..||.|++|.||++.. ++..||||++.... ......+.+.+|+.++++++||||+++++++.+.+..|+||||+++
T Consensus 37 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp CEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred CccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 6789999999999865 68899999997643 2334567899999999999999999999999999999999999999
Q ss_pred Cccchhhhcc---cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---cccc
Q psy6346 274 GEIFDYIARY---GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---KLAT 347 (1238)
Q Consensus 274 GSL~d~Lkk~---~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---~l~t 347 (1238)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 194 (307)
T 2nru_A 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194 (307)
T ss_dssp CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSS
T ss_pred CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccc
Confidence 9999998743 458999999999999999999999999999999999999999999999999987654322 1234
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH----HHHHHhcCCc-----------cCCCCC
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS----LRDRVLSGRF-----------RIPYFM 412 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee----L~ekIl~g~~-----------~~P~~i 412 (1238)
..||+.|+|||++.+. + +.++|||||||++|+|++|..||.+..... +...+..... ..+...
T Consensus 195 ~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (307)
T 2nru_A 195 IVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS 272 (307)
T ss_dssp CCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHH
T ss_pred cCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHH
Confidence 5799999999998764 4 789999999999999999999998754332 2222222111 112234
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+..+.+||.+||..||.+|||+.+++++
T Consensus 273 ~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 273 VEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5678999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=373.96 Aligned_cols=250 Identities=21% Similarity=0.359 Sum_probs=210.8
Q ss_pred EEEEEEecCCCCccccCceEc--cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 192 IRKREKCGVKSRSCNRPPVLL--RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~l--ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.....||.|+||.||+|.+. .++..||||+++... .....+.+.+|+++|++++||||+++++++.. +.+|||||
T Consensus 338 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 333447999999999999776 356789999998753 33456789999999999999999999999976 56999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc----
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---- 344 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---- 344 (1238)
||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999999998754 4699999999999999999999999999999999999999999999999999986543321
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIRK 422 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIrk 422 (1238)
.....+++.|+|||++.+..+ +.++|||||||+||||++ |..||.+.+..++...+..+. ..+|..+++++.+||.+
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 574 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSD 574 (613)
T ss_dssp ------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 123346688999999987776 899999999999999998 999999988888888887664 55677899999999999
Q ss_pred hcccCCCCCCCHHHHH---hccccc
Q psy6346 423 MLVREPTKRYCIEQIK---RHRWMA 444 (1238)
Q Consensus 423 ML~kDPskRPTaeEIL---eHPWFk 444 (1238)
||..||.+||++.+|+ ++.|+.
T Consensus 575 cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 575 CWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp TTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999975 444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.95 Aligned_cols=247 Identities=19% Similarity=0.242 Sum_probs=206.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|...+.||.|+||.||++.+. ..||||++.....+....+.+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~---~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEES---SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHeEEeeEeccCCceEEEEEEEc---CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 44677788889999999988663 359999998765554455677899999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC------C
Q psy6346 270 YANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP------G 342 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~------s 342 (1238)
|+.|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++..... .
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 999999999998755 699999999999999999999999999999999999998 67999999999765421 1
Q ss_pred CccccccCCCCCCCcccccCC--------ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccC--CCCC
Q psy6346 343 QKLATWCGSPPYAAPEVFEGK--------KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI--PYFM 412 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk--------~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~--P~~i 412 (1238)
.......|++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+..+.... +..+
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGM 268 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCC
Confidence 223345689999999998752 224789999999999999999999999988887777776654332 2357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 413 STECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 413 S~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+.++.+||.+||..||.+|||+.++++.
T Consensus 269 ~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 269 GKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 8899999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=334.96 Aligned_cols=246 Identities=20% Similarity=0.361 Sum_probs=196.6
Q ss_pred CCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC--CCCCeeEEEEEeeeC---
Q psy6346 187 KNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL--DHPHIIKLFQVMETK--- 261 (1238)
Q Consensus 187 kfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL--~HPNIVrL~dvfed~--- 261 (1238)
.+...|...+.||.|+||.||++.+ .+..||||++... ......+|.+++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3345688889999999999999876 4899999998643 234555666666655 999999999999877
Q ss_pred -CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc--------ceeeccCCcccccccCCCcEEEEe
Q psy6346 262 -SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR--------RVVHRDLKAENLLMDSNLDIKLAD 332 (1238)
Q Consensus 262 -d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk--------GIIHRDLKPeNILLd~nG~VKLiD 332 (1238)
..+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 789999999999999999965 4799999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccCCCc-----cccccCCCCCCCcccccCCccCCC-----ccceehhhHHHHHHhhC----------CCCCCCC
Q psy6346 333 FGFSNYYVPGQK-----LATWCGSPPYAAPEVFEGKKYCGP-----EIDIWSLGVVLYVLVCG----------ALPFDGS 392 (1238)
Q Consensus 333 FGLS~~~~~s~~-----l~t~~GTp~YmAPEVL~gk~y~S~-----KSDIWSLGVILYELLTG----------rlPF~g~ 392 (1238)
||++........ ....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999976543322 235579999999999987765222 38999999999999999 7777543
Q ss_pred C-----hhHHHHHHhcCC--ccCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 393 T-----LNSLRDRVLSGR--FRIPY-----FMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 393 d-----~eeL~ekIl~g~--~~~P~-----~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
. .......+.... ..+|. .+++++.+||.+||..||.+|||+.+|++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2 222333232221 22232 345679999999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=366.76 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=213.4
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
..|.....||.|+||.||++.+. .+..||||+++..... .+.+.+|+.+|++|+||||+++++++.+ +.+|||||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 45788899999999999999775 4567999999876533 4578999999999999999999999876 67899999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--cc
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KL 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l 345 (1238)
||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 99999999999753 458999999999999999999999999999999999999999999999999997653321 12
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....++..|+|||++.+..+ +.++|||||||+||||++ |..||.+....++...+..+ ....|..++.++.+||.+|
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 500 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 500 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 23456788999999987776 899999999999999999 99999999888888777665 3456778999999999999
Q ss_pred cccCCCCCCCHHHHHhc
Q psy6346 424 LVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 424 L~kDPskRPTaeEILeH 440 (1238)
|..||++|||+++|++.
T Consensus 501 l~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 501 WRKEPEERPTFEYLQAF 517 (535)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhHCcCHHHHHHH
Confidence 99999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=339.32 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=206.6
Q ss_pred cEEEEEEEecCCCCccccCce----EccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC--E
Q psy6346 190 QTIRKREKCGVKSRSCNRPPV----LLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS--M 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav----~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d--~ 263 (1238)
..|...+.||.|++|.||++. ...++..||||++... .....+.+.+|+.+|++++||||+++++++...+ .
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 457888899999999999987 3567999999999864 3456678999999999999999999999986544 7
Q ss_pred EEEEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 264 IYIVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 89999999999999999875 45999999999999999999999999999999999999999999999999999765443
Q ss_pred Cc----cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh----------------HHHHHHh
Q psy6346 343 QK----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN----------------SLRDRVL 402 (1238)
Q Consensus 343 ~~----l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e----------------eL~ekIl 402 (1238)
.. .....++..|+|||++.+..+ +.++|||||||++|+|++|..||...... .+.+.+.
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 22 223457778999999988776 88999999999999999999998643110 1122222
Q ss_pred c-CCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 403 S-GRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 403 ~-g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
. .....|..++.++.+||.+||..||.+|||+.+|++
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 234567779999999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.00 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=202.7
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHh--CCCCCeeEEEEEeeeCC----
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQ--LDHPHIIKLFQVMETKS---- 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkk--L~HPNIVrL~dvfed~d---- 262 (1238)
...|...+.||.|+||.||++.+ +++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 35678889999999999999876 5899999998643 34678899999988 79999999999998776
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhh--------ccceeeccCCcccccccCCCcEEEEecC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCH--------NRRVVHRDLKAENLLMDSNLDIKLADFG 334 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLH--------SkGIIHRDLKPeNILLd~nG~VKLiDFG 334 (1238)
.+|+||||+.+++|.+++.+ ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999975 46899999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCC-----ccccccCCCCCCCcccccCCccC-----CCccceehhhHHHHHHhhC----------CCCCCCCC-
Q psy6346 335 FSNYYVPGQ-----KLATWCGSPPYAAPEVFEGKKYC-----GPEIDIWSLGVVLYVLVCG----------ALPFDGST- 393 (1238)
Q Consensus 335 LS~~~~~s~-----~l~t~~GTp~YmAPEVL~gk~y~-----S~KSDIWSLGVILYELLTG----------rlPF~g~d- 393 (1238)
++....... ......||+.|+|||++.+.... +.++|||||||++|+|++| ..||....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 997655433 23455799999999999875321 3689999999999999999 78986642
Q ss_pred ----hhHHHHHHhcCCc--cCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 394 ----LNSLRDRVLSGRF--RIPY-----FMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 394 ----~eeL~ekIl~g~~--~~P~-----~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
...+...+..... .+|. .++..+.+||.+||..||.+|||+++|++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 3444454444322 2222 233578899999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.33 Aligned_cols=250 Identities=19% Similarity=0.295 Sum_probs=189.8
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHH--HHhCCCCCeeEEEEEee-----eCC
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEI--MKQLDHPHIIKLFQVME-----TKS 262 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeI--LkkL~HPNIVrL~dvfe-----d~d 262 (1238)
..|...+.||.|+||.||++.. +++.||||++.... ...+..|.++ +..++||||+++++.+. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4588889999999999999865 78999999997542 3344445555 44589999999997553 344
Q ss_pred EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhcc---------ceeeccCCcccccccCCCcEEEEec
Q psy6346 263 MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNR---------RVVHRDLKAENLLMDSNLDIKLADF 333 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSk---------GIIHRDLKPeNILLd~nG~VKLiDF 333 (1238)
.+|+|||||++|+|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred eEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 689999999999999999654 458889999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCC---------CccccccCCCCCCCcccccCC------ccCCCccceehhhHHHHHHhhCCCCCCC-CCh---
Q psy6346 334 GFSNYYVPG---------QKLATWCGSPPYAAPEVFEGK------KYCGPEIDIWSLGVVLYVLVCGALPFDG-STL--- 394 (1238)
Q Consensus 334 GLS~~~~~s---------~~l~t~~GTp~YmAPEVL~gk------~y~S~KSDIWSLGVILYELLTGrlPF~g-~d~--- 394 (1238)
|++...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. ...
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 999765432 122345799999999999873 2236789999999999999999766532 221
Q ss_pred --------------hHHHHHHhcC--CccCCCC------CCHHHHHHHHHhcccCCCCCCCHHHHH------hccccccc
Q psy6346 395 --------------NSLRDRVLSG--RFRIPYF------MSTECESLIRKMLVREPTKRYCIEQIK------RHRWMAEE 446 (1238)
Q Consensus 395 --------------eeL~ekIl~g--~~~~P~~------iS~eLkDLIrkML~kDPskRPTaeEIL------eHPWFke~ 446 (1238)
......+... ...+|.. +++++.+||.+||..||++|||++|++ -++|-++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 1111111111 1223332 334799999999999999999999995 46676654
Q ss_pred C
Q psy6346 447 T 447 (1238)
Q Consensus 447 ~ 447 (1238)
.
T Consensus 325 ~ 325 (336)
T 3g2f_A 325 S 325 (336)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=354.36 Aligned_cols=251 Identities=14% Similarity=0.143 Sum_probs=198.8
Q ss_pred CCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCC-CCe---------e--
Q psy6346 186 EKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDH-PHI---------I-- 252 (1238)
Q Consensus 186 GkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~H-PNI---------V-- 252 (1238)
+.....|.....||.|+||.||++.+..+|+.||||++..... .....+.+.+|+.+++.+.| .|+ +
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 3344668888999999999999999999999999999984432 23346789999999999987 211 1
Q ss_pred ----------EEEEEeee-----CCEEEEEEeecCCCccchhhhc-------ccccchhHHHHHHHHHHHHHhHhhccce
Q psy6346 253 ----------KLFQVMET-----KSMIYIVSEYANQGEIFDYIAR-------YGRMNENAARRKFWQILSAVEYCHNRRV 310 (1238)
Q Consensus 253 ----------rL~dvfed-----~d~lyLVMEy~~GGSL~d~Lkk-------~~~Lsesea~kI~~QILsALeYLHSkGI 310 (1238)
.++.++.. ...++++|+++ +++|.+++.. .+.+++..+..++.||+.||.|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 11111221 22467788876 5889888842 3457888999999999999999999999
Q ss_pred eeccCCcccccccCCCcEEEEecCCcccccCCCccccccCCCCCCCcccc----------cCCccCCCccceehhhHHHH
Q psy6346 311 VHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVF----------EGKKYCGPEIDIWSLGVVLY 380 (1238)
Q Consensus 311 IHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL----------~gk~y~S~KSDIWSLGVILY 380 (1238)
+||||||+||||+.++.+||+|||++.... ......+| +.|+|||++ .+..+ +.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT--EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecC--CccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHH
Confidence 999999999999999999999999987543 23556678 999999999 44444 88999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 381 VLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 381 ELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
+|++|+.||.+.+.......+... ...+++++.+||.+||..||.+||++.++++||||.+
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHCCCCCCCcchhhhHHHHHhh----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999999887665554444332 2357899999999999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.83 Aligned_cols=240 Identities=19% Similarity=0.227 Sum_probs=193.3
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC------ChHhHHHHHHHHHHHHhCC---------CCCeeEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL------DPVNLQKVYREVEIMKQLD---------HPHIIKLF 255 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l------d~e~ikrf~rEIeILkkL~---------HPNIVrL~ 255 (1238)
.|...+.||.|+||.||++.+ +|+.||||++..... .....+.+.+|+.+|+.++ ||||+++.
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 355567899999999999977 789999999987643 2234578899999999885 88888877
Q ss_pred EEee------------------------------eCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHh
Q psy6346 256 QVME------------------------------TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYC 305 (1238)
Q Consensus 256 dvfe------------------------------d~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYL 305 (1238)
+++. ..+.+|||||||.+|++.+.+.+ +.+++..++.++.||+.||.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence 7642 26889999999999988777754 6789999999999999999999
Q ss_pred h-ccceeeccCCcccccccCCC--------------------cEEEEecCCcccccCCCccccccCCCCCCCcccccCCc
Q psy6346 306 H-NRRVVHRDLKAENLLMDSNL--------------------DIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKK 364 (1238)
Q Consensus 306 H-SkGIIHRDLKPeNILLd~nG--------------------~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~ 364 (1238)
| ++||+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||++.+..
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~ 253 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG 253 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC
Confidence 9 99999999999999999887 8999999999875432 458999999999998765
Q ss_pred cCCCccceehhhHH-HHHHhhCCCCCCCCCh-hHHHHHHhcC-Ccc------CCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6346 365 YCGPEIDIWSLGVV-LYVLVCGALPFDGSTL-NSLRDRVLSG-RFR------IPYFMSTECESLIRKMLVREPTKRYCIE 435 (1238)
Q Consensus 365 y~S~KSDIWSLGVI-LYELLTGrlPF~g~d~-eeL~ekIl~g-~~~------~P~~iS~eLkDLIrkML~kDPskRPTae 435 (1238)
+.++||||||++ .++++.|..||.+... ..+.+.+... ... .+..+++++.+||++||++| |++
T Consensus 254 --~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 254 --DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp --SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred --ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 689999998777 7788999999954321 1222333311 111 11236788999999999977 999
Q ss_pred HHH-hccccc
Q psy6346 436 QIK-RHRWMA 444 (1238)
Q Consensus 436 EIL-eHPWFk 444 (1238)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=379.97 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=212.0
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee------CC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET------KS 262 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed------~d 262 (1238)
...|...+.||.|+||.||++.+..+|..||||++... ......+.+.+|+++|++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 35688889999999999999999999999999999765 356667889999999999999999999999765 77
Q ss_pred EEEEEEeecCCCccchhhhccc---ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc---EEEEecCCc
Q psy6346 263 MIYIVSEYANQGEIFDYIARYG---RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD---IKLADFGFS 336 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~---~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~---VKLiDFGLS 336 (1238)
..|+|||||.|++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999998754 6999999999999999999999999999999999999997665 999999999
Q ss_pred ccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHH---------H-----HHh
Q psy6346 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLR---------D-----RVL 402 (1238)
Q Consensus 337 ~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~---------e-----kIl 402 (1238)
............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....... . ...
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cccccccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 88766666667789999999999988877 89999999999999999999999764322110 0 001
Q ss_pred cCCcc----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 403 SGRFR----------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 403 ~g~~~----------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.+... ++..+++.+.+||.+||.+||.+|||+.++++||||..
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 11111 11225678999999999999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=356.39 Aligned_cols=246 Identities=20% Similarity=0.225 Sum_probs=207.1
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCC-CCeeEEEEEeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDH-PHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~H-PNIVrL~dvfed~d~lyL 266 (1238)
++..|.....||.|+||.||++.+..+++.||||++...... ..+.+|+++++.|.| ++|..+..++...+..||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 356688889999999999999999999999999998765432 357899999999977 566667777788899999
Q ss_pred EEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccc---cCCCcEEEEecCCcccccCC
Q psy6346 267 VSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILL---d~nG~VKLiDFGLS~~~~~s 342 (1238)
||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 8999999975 4679999999999999999999999999999999999999 57899999999999866443
Q ss_pred Cc--------cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCCh---hHHHHHHhcCCc-----
Q psy6346 343 QK--------LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL---NSLRDRVLSGRF----- 406 (1238)
Q Consensus 343 ~~--------l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~---eeL~ekIl~g~~----- 406 (1238)
.. ....+||+.|+|||++.+..+ +.++||||||||||+|++|..||.+... ...+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 22 225689999999999998887 8999999999999999999999987543 233333332221
Q ss_pred cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 407 RIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 407 ~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.++..++.++.+||.+||..||.+||++++|++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 233567899999999999999999999998876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=365.18 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=213.1
Q ss_pred cEEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
..|.....||.|+||.||+|.+..+ +..||||++.... .....+.+.+|+.+|++++||||+++++++.+ +..|+
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 5588889999999999999988643 4679999987643 44556789999999999999999999999854 56899
Q ss_pred EEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-
Q psy6346 267 VSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK- 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~- 344 (1238)
||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 999999999999997654 689999999999999999999999999999999999999999999999999986544322
Q ss_pred -cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHH
Q psy6346 345 -LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIR 421 (1238)
Q Consensus 345 -l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIr 421 (1238)
.....+++.|+|||++.+..+ +.++|||||||++|||++ |..||.+....+....+..+. ..+|..+++.+.+||.
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 626 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 626 (656)
T ss_dssp ------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred eccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHH
Confidence 223457789999999987776 899999999999999997 999999998888877777653 5577889999999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy6346 422 KMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeH 440 (1238)
+||..||.+|||+.+|++.
T Consensus 627 ~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 627 KCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=321.66 Aligned_cols=223 Identities=16% Similarity=0.147 Sum_probs=189.0
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.+..|...+.||.|+||.||++.+..+++.||||++...... ....+.+.+|+.++.+++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 345588889999999999999999999999999999877543 5566889999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||||+.|++|.+++... ....++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 99999999999999643 3556788999999999999999999999999999999999999998554
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHH---HHhcCCc----cCCCCCCHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRD---RVLSGRF----RIPYFMSTECESL 419 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~e---kIl~g~~----~~P~~iS~eLkDL 419 (1238)
|++| ++.++|||||||++|+|++|+.||.+.+...... +...+.. .++..+++++.+|
T Consensus 175 -------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (286)
T 3uqc_A 175 -------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239 (286)
T ss_dssp -------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred -------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence 3332 3789999999999999999999998876533111 1112211 1335689999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..||.+| |+.|+++.
T Consensus 240 i~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 240 AARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHcccCCccC-CHHHHHHH
Confidence 999999999999 99999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=364.34 Aligned_cols=241 Identities=20% Similarity=0.259 Sum_probs=200.6
Q ss_pred CcEEEEEEEecCCCCccccCceEcc-CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE----
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLR-HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM---- 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lk-tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~---- 263 (1238)
...|.....||.|+||.||++.+.. +++.||||++.... +......+.+|+.+|++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3568889999999999999999876 78999999987643 45566788999999999999999999999987655
Q ss_pred -EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC
Q psy6346 264 -IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 264 -lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s 342 (1238)
.||||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 7999999999999998765 79999999999999999999999999999999999999875 8999999999765433
Q ss_pred CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHH
Q psy6346 343 QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 343 ~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrk 422 (1238)
...+||+.|+|||++.+.. +.++|||||||+||+|++|..||.+.....+. . .......++.+.+||.+
T Consensus 235 ---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----~--~~~~~~~~~~l~~li~~ 303 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----E--DDPVLKTYDSYGRLLRR 303 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----T--TCHHHHHCHHHHHHHHH
T ss_pred ---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccccc----c--cccccccCHHHHHHHhh
Confidence 4567999999999987653 78999999999999999999998763211110 0 00001135789999999
Q ss_pred hcccCCCCCCCHHHHHhccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFk 444 (1238)
||..||.+||+..+++.|+|+.
T Consensus 304 ~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 304 AIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHH
T ss_pred hccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999998864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-31 Score=312.73 Aligned_cols=230 Identities=13% Similarity=0.027 Sum_probs=161.8
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCCC----C----hHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL----D----PVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~l----d----~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
..+.|+++.+..+...-.|..||||++.+... . +...+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45566777777777777899999999987642 1 23457799999999999 799999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLA 346 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~ 346 (1238)
||||+|++|.++|.+.+.+++. +|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++..... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 9999999999999998888764 58999999999999999999999999999999999999999999865433 3456
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
+.+||+.|||||++.+.. ..++|+|++|+++++|+++..+| ...+... +.. ...+..++..++..
T Consensus 398 t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-~~~~~~l~~~l~~~ 462 (569)
T 4azs_A 398 NLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-RWNFVLLLALFEKK 462 (569)
T ss_dssp HHHHHHHHHHHHHC-------------------CCCCTTHHHH--------HHHHHTS----CGG-GCSHHHHHHHHHTG
T ss_pred CceechhhccHHHhCCCC--CCcccccccccchhhhccccchh--------HHHhhcC----CCC-CCcHHHHHHHHhCC
Confidence 778999999999998753 57899999999999887764433 1111111 110 11255677777788
Q ss_pred CCCCCCCHHHHHhccccc
Q psy6346 427 EPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 427 DPskRPTaeEILeHPWFk 444 (1238)
+|..|+.......++|..
T Consensus 463 ~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 463 AKLPSAEQQRGATEQWII 480 (569)
T ss_dssp GGSCCGGGSSCCHHHHHH
T ss_pred CCCCCCChhhhccchhHH
Confidence 888887766666666654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-25 Score=258.26 Aligned_cols=182 Identities=18% Similarity=0.166 Sum_probs=143.7
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCChH------hHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPV------NLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e------~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
.+.||.|+||.||++ ...+..+|+|++........ ..+++.+|+++|++++||||+++..++...+..||||
T Consensus 341 ~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 468999999999998 44678999998765443221 2356899999999999999995544455666779999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc----
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK---- 344 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~---- 344 (1238)
|||+|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 99999999999876 6789999999999999999999999999999998 999999999987644322
Q ss_pred ----cccccCCCCCCCcccccC--CccCCCccceehhhHHHHHHhhCCCCC
Q psy6346 345 ----LATWCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPF 389 (1238)
Q Consensus 345 ----l~t~~GTp~YmAPEVL~g--k~y~S~KSDIWSLGVILYELLTGrlPF 389 (1238)
....+||+.|||||++.+ ..| +...|+|+..+-..+.+.++.+|
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhcccc
Confidence 235689999999999976 444 66789999988888877766555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.2e-22 Score=215.71 Aligned_cols=148 Identities=17% Similarity=0.145 Sum_probs=119.6
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----------------HhHHHHHHHHHHHHhCCCCCee
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----------------VNLQKVYREVEIMKQLDHPHII 252 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----------------e~ikrf~rEIeILkkL~HPNIV 252 (1238)
+..|.....||.|++|.||++.+ .+|..||||+++...... .....+.+|+.+|++++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34455669999999999999998 889999999997543211 23567899999999999 4 5
Q ss_pred EEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEe
Q psy6346 253 KLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332 (1238)
Q Consensus 253 rL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiD 332 (1238)
++++++.. +..|+||||++|++|.+ +. ...+..++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 55555543 45699999999999988 42 234567999999999999999999999999999999 99999999
Q ss_pred cCCcccccCCCccccccCCCCCCCccccc
Q psy6346 333 FGFSNYYVPGQKLATWCGSPPYAAPEVFE 361 (1238)
Q Consensus 333 FGLS~~~~~s~~l~t~~GTp~YmAPEVL~ 361 (1238)
||++.. +..++|||++.
T Consensus 236 FG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHH
Confidence 999863 44678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-18 Score=182.75 Aligned_cols=141 Identities=11% Similarity=0.086 Sum_probs=110.3
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcE--EEEEEeccCCCCh----------------------HhHHHHHHHHHHHH
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVN--VAIKIIDKSQLDP----------------------VNLQKVYREVEIMK 244 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~k--VAIKVLkks~ld~----------------------e~ikrf~rEIeILk 244 (1238)
|..|.....||.|++|.||+|.+..+|.. ||||+++...... .....+.+|+.+|.
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 35677889999999999999988788999 9999986542110 11246789999999
Q ss_pred hCCCCCe--eEEEEEeeeCCEEEEEEeecCC-C----ccchhhhcccccchhHHHHHHHHHHHHHhHhh-ccceeeccCC
Q psy6346 245 QLDHPHI--IKLFQVMETKSMIYIVSEYANQ-G----EIFDYIARYGRMNENAARRKFWQILSAVEYCH-NRRVVHRDLK 316 (1238)
Q Consensus 245 kL~HPNI--VrL~dvfed~d~lyLVMEy~~G-G----SL~d~Lkk~~~Lsesea~kI~~QILsALeYLH-SkGIIHRDLK 316 (1238)
++.|++| +.++++ +..+|||||+.+ | .|.++.. .+++..+..++.||+.+|.||| ..||+|||||
T Consensus 126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 9988754 444443 356899999942 4 4444332 2346688999999999999999 9999999999
Q ss_pred cccccccCCCcEEEEecCCccc
Q psy6346 317 AENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 317 PeNILLd~nG~VKLiDFGLS~~ 338 (1238)
|+|||++. .++|+|||++..
T Consensus 199 p~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEE
T ss_pred HHHEEEcC--cEEEEECccccc
Confidence 99999988 899999999965
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=4.2e-15 Score=170.52 Aligned_cols=139 Identities=12% Similarity=0.070 Sum_probs=104.5
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC---------------hHh---H--HHHHHHHHHHHhCCC
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD---------------PVN---L--QKVYREVEIMKQLDH 248 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld---------------~e~---i--krf~rEIeILkkL~H 248 (1238)
|.+|.....||.|++|.||.|.+ .+|+.||||+++..... ... . ....+|+..|.++.+
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 46788999999999999999976 46999999998643110 000 0 112467888888855
Q ss_pred CCee--EEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC
Q psy6346 249 PHII--KLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326 (1238)
Q Consensus 249 PNIV--rL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG 326 (1238)
.++. ..++. . ..+|||||+.|++|..+.. ...+..++.||+.+|.+||..|||||||||.|||++.+|
T Consensus 173 ~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 173 EGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp TTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred cCCCCCeeeec--c--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 5442 33332 1 2379999999988876542 235678899999999999999999999999999998876
Q ss_pred ----------cEEEEecCCccc
Q psy6346 327 ----------DIKLADFGFSNY 338 (1238)
Q Consensus 327 ----------~VKLiDFGLS~~ 338 (1238)
.+.||||+.+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=9.7e-11 Score=122.71 Aligned_cols=134 Identities=16% Similarity=0.123 Sum_probs=101.3
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEeecCCC
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQG 274 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy~~GG 274 (1238)
..++.++++.||++. ..+..+++|+....... ....+.+|+.+|+.+. +..+.++++++.+.+..|+||||++|.
T Consensus 20 ~~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp ECCSCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred eeccCCCCCeEEEEE--CCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence 344445556666553 23678999998753211 1235889999999984 667888999999999999999999999
Q ss_pred ccchhhhcccccchhHHHHHHHHHHHHHhHhhc-----------------------------------------------
Q psy6346 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHN----------------------------------------------- 307 (1238)
Q Consensus 275 SL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS----------------------------------------------- 307 (1238)
+|.+.+. +......++.++..+|..||.
T Consensus 96 ~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 96 LCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp EHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred ehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 8876531 223445788899999999998
Q ss_pred ------------cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 ------------RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 ------------kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4599999999999998766677999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=2.6e-10 Score=117.30 Aligned_cols=124 Identities=13% Similarity=0.086 Sum_probs=90.1
Q ss_pred CCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC--eeEEEEEeeeCCEEEEEEeecCCCccch
Q psy6346 201 KSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH--IIKLFQVMETKSMIYIVSEYANQGEIFD 278 (1238)
Q Consensus 201 GsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN--IVrL~dvfed~d~lyLVMEy~~GGSL~d 278 (1238)
|..+.||++. ..+|..++||+..... ...+.+|+.+|+.+.+.+ +.+++.+....+..|+||||++|.+|.
T Consensus 31 g~~~~v~~~~-~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 31 CSDAAVFRLS-AQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp TSSCEEEEEE-CTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred CCCceEEEEe-cCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 3346666653 3456789999976542 235778999999985444 456888888888899999999998884
Q ss_pred hhhcccccchhHHHHHHHHHHHHHhHhhccc-------------------------------------------------
Q psy6346 279 YIARYGRMNENAARRKFWQILSAVEYCHNRR------------------------------------------------- 309 (1238)
Q Consensus 279 ~Lkk~~~Lsesea~kI~~QILsALeYLHSkG------------------------------------------------- 309 (1238)
... . ....++.++...|..||...
T Consensus 104 -~~~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 104 -SSH---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp -TSC---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred -cCc---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 211 1 12355666667777777532
Q ss_pred ---------eeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 310 ---------VVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 310 ---------IIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
++|+|++|.||+++.++.+.|+|||.+..
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=4.7e-09 Score=115.65 Aligned_cols=138 Identities=16% Similarity=0.240 Sum_probs=98.1
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEec--cCCCChHhHHHHHHHHHHHHhCCC--CCeeEEEEEeeeC---CEEEEEE
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIID--KSQLDPVNLQKVYREVEIMKQLDH--PHIIKLFQVMETK---SMIYIVS 268 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLk--ks~ld~e~ikrf~rEIeILkkL~H--PNIVrL~dvfed~---d~lyLVM 268 (1238)
..++.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+|+.|.. ..+++++.++.+. +..|+||
T Consensus 44 ~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3445555555554432 34578888876 33211 123467899999999964 4578888888776 4589999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-----------------------------------------
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN----------------------------------------- 307 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS----------------------------------------- 307 (1238)
||++|..+.+.. ...++......++.+++..|..||.
T Consensus 121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999998885422 2346777888899999999999996
Q ss_pred -----------------cceeeccCCcccccccCCCc--EEEEecCCccc
Q psy6346 308 -----------------RRVVHRDLKAENLLMDSNLD--IKLADFGFSNY 338 (1238)
Q Consensus 308 -----------------kGIIHRDLKPeNILLd~nG~--VKLiDFGLS~~ 338 (1238)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.70 E-value=6.9e-09 Score=112.03 Aligned_cols=181 Identities=13% Similarity=0.197 Sum_probs=112.9
Q ss_pred ecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCC--eeEEEEEeeeCC---EEEEEEeec
Q psy6346 198 CGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPH--IIKLFQVMETKS---MIYIVSEYA 271 (1238)
Q Consensus 198 IGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPN--IVrL~dvfed~d---~lyLVMEy~ 271 (1238)
++.|....||.+ +..+++|+... ......+.+|+++|+.+ .+.. +..++......+ ..|+||+++
T Consensus 28 ~~~G~~n~v~~v-----~~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 28 SGEGNDCIAYEI-----NRDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp EEECSSEEEEES-----TTSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred cCCCCcceEEEE-----CCEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 455555555544 24589998643 23457889999999988 3333 345555544333 358999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc--------------------------------------------
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-------------------------------------------- 307 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-------------------------------------------- 307 (1238)
+|..|.+... ..++..+...++.++...|..||.
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988875322 345556666666666666666664
Q ss_pred --------------cceeeccCCcccccccC--CCcEEEEecCCcccccCCCccccccCCCCCCCcccccC--CccC---
Q psy6346 308 --------------RRVVHRDLKAENLLMDS--NLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEG--KKYC--- 366 (1238)
Q Consensus 308 --------------kGIIHRDLKPeNILLd~--nG~VKLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~g--k~y~--- 366 (1238)
..++|+|++|.||+++. .+.+.|+||+.+....+............-..|+.... ..|.
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 24799999999999998 56689999998865432211111110000022222110 0010
Q ss_pred --------CCccceehhhHHHHHHhhCCCCC
Q psy6346 367 --------GPEIDIWSLGVVLYVLVCGALPF 389 (1238)
Q Consensus 367 --------S~KSDIWSLGVILYELLTGrlPF 389 (1238)
..-.++|++|.++|.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11258999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.5e-06 Score=87.58 Aligned_cols=125 Identities=14% Similarity=0.109 Sum_probs=86.8
Q ss_pred cccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEeecCCCccchhhhcc
Q psy6346 205 CNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARY 283 (1238)
Q Consensus 205 tVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~ 283 (1238)
.||+......+..+.+|+-.. .....+.+|+.+|+.|. +--+.+++.++.+.+..|+|||+++|.++.+.....
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~ 114 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY 114 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC
T ss_pred eEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC
Confidence 456554445667899998653 24567889999999884 333678889999999999999999988776543221
Q ss_pred cccchhHHHHHHHHHHHHHhHhhc--------------------------------------------------------
Q psy6346 284 GRMNENAARRKFWQILSAVEYCHN-------------------------------------------------------- 307 (1238)
Q Consensus 284 ~~Lsesea~kI~~QILsALeYLHS-------------------------------------------------------- 307 (1238)
......+..++...|.-||.
T Consensus 115 ----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 190 (272)
T 4gkh_A 115 ----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFS 190 (272)
T ss_dssp ----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCC
T ss_pred ----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccccc
Confidence 11222333333333333331
Q ss_pred --cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 --RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 --kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
..++|+|+++.|||++.++.+-|+||+.+..
T Consensus 191 ~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 191 PDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1389999999999999887778999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.4e-05 Score=87.21 Aligned_cols=118 Identities=12% Similarity=0.155 Sum_probs=75.6
Q ss_pred CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCC---CeeEEEEEee-eCCEEEEEEeecCCCccchhhhcccccchhH
Q psy6346 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP---HIIKLFQVME-TKSMIYIVSEYANQGEIFDYIARYGRMNENA 290 (1238)
Q Consensus 215 G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HP---NIVrL~dvfe-d~d~lyLVMEy~~GGSL~d~Lkk~~~Lsese 290 (1238)
+..+++|+-. .......+.+|+++|+.|.+. .+..++.+.. ..+..|+|||+++|..|.+..- ..++...
T Consensus 39 g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~ 112 (306)
T 3tdw_A 39 NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDA 112 (306)
T ss_dssp TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHH
T ss_pred CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHH
Confidence 4568888843 233457889999999999652 3556666664 4566789999999988765211 1112222
Q ss_pred HHHHHHHHHHHHhHhh------------------------------------------------------------ccce
Q psy6346 291 ARRKFWQILSAVEYCH------------------------------------------------------------NRRV 310 (1238)
Q Consensus 291 a~kI~~QILsALeYLH------------------------------------------------------------SkGI 310 (1238)
...++.++...|..|| ...+
T Consensus 113 ~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~ 192 (306)
T 3tdw_A 113 KDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRL 192 (306)
T ss_dssp HHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEE
T ss_pred HHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCee
Confidence 2222222222222222 2357
Q ss_pred eeccCCcccccccC---CCc-EEEEecCCccc
Q psy6346 311 VHRDLKAENLLMDS---NLD-IKLADFGFSNY 338 (1238)
Q Consensus 311 IHRDLKPeNILLd~---nG~-VKLiDFGLS~~ 338 (1238)
+|+|+++.||+++. ++. +.|+||+.+..
T Consensus 193 ~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 193 IHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp ECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred EeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 99999999999987 455 48999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=97.92 E-value=4.8e-06 Score=91.11 Aligned_cols=39 Identities=36% Similarity=0.523 Sum_probs=29.7
Q ss_pred CCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 12 ~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+..||+|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 8 ~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i 46 (275)
T 3hyh_A 8 DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKII 46 (275)
T ss_dssp ------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEE
T ss_pred CCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEE
Confidence 356789999999999999999999999999999999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=97.86 E-value=1.4e-05 Score=89.21 Aligned_cols=37 Identities=27% Similarity=0.354 Sum_probs=35.0
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...++|+|++.||+|+||+||+|+|+.||+.||||++
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i 65 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL 65 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEE
Confidence 4567899999999999999999999999999999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=1.1e-05 Score=88.77 Aligned_cols=39 Identities=18% Similarity=0.257 Sum_probs=33.9
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
+.+++|++++.||+|+||+||+|+++.||+.||||++..
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~ 40 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL 40 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEE
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEec
Confidence 457889999999999999999999999999999999844
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=3.2e-05 Score=86.56 Aligned_cols=78 Identities=15% Similarity=0.132 Sum_probs=47.6
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCC--C---hHhHHHHHHHHHHHHhCCC--CC-eeEEEEEeeeCCEEEEE
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL--D---PVNLQKVYREVEIMKQLDH--PH-IIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~l--d---~e~ikrf~rEIeILkkL~H--PN-IVrL~dvfed~d~lyLV 267 (1238)
..+|.|..+.||++.....+..|+||....... . .....++..|+++|+.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 467777778888775555678899998653211 0 0123467789999988732 33 4456654 33446899
Q ss_pred EeecCCCc
Q psy6346 268 SEYANQGE 275 (1238)
Q Consensus 268 MEy~~GGS 275 (1238)
||++.|..
T Consensus 114 mE~l~g~~ 121 (397)
T 2olc_A 114 MEDLSHLK 121 (397)
T ss_dssp ECCCTTSE
T ss_pred EEeCCCcc
Confidence 99998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=6.2e-05 Score=82.58 Aligned_cols=64 Identities=6% Similarity=0.091 Sum_probs=41.9
Q ss_pred CcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCC-C--CCeeEEEEEeeeC---CEEEEEEeecCCCccch
Q psy6346 215 TVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLD-H--PHIIKLFQVMETK---SMIYIVSEYANQGEIFD 278 (1238)
Q Consensus 215 G~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~-H--PNIVrL~dvfed~---d~lyLVMEy~~GGSL~d 278 (1238)
+..+++|+...... .......+.+|+.+|+.|. + -.+.+++.++.+. +..|+|||+++|..+.+
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 56788998654220 0000135678999998884 2 3467788877655 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=8e-05 Score=79.95 Aligned_cols=30 Identities=23% Similarity=0.330 Sum_probs=27.3
Q ss_pred cceeeccCCcccccccCCCcEEEEecCCcc
Q psy6346 308 RRVVHRDLKAENLLMDSNLDIKLADFGFSN 337 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~nG~VKLiDFGLS~ 337 (1238)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=1.8e-05 Score=89.55 Aligned_cols=36 Identities=17% Similarity=0.129 Sum_probs=28.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+++|++++.||+|+||+||+|+++.||+.||||++
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i 57 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI 57 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 467899999999999999999999999999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.71 E-value=2.5e-05 Score=89.40 Aligned_cols=34 Identities=38% Similarity=0.527 Sum_probs=32.7
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
++|++++.||+|+||+||+|+++.||+.||||++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i 87 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI 87 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEE
Confidence 3699999999999999999999999999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=97.56 E-value=6.1e-05 Score=92.22 Aligned_cols=41 Identities=22% Similarity=0.311 Sum_probs=37.7
Q ss_pred CCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 11 KAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 11 ~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+..+++|+|+++||+|+||+||+|+++.||+.||||++-
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~ 223 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 223 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEe
Confidence 34567899999999999999999999999999999999983
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=6.4e-05 Score=85.01 Aligned_cols=35 Identities=23% Similarity=0.209 Sum_probs=33.2
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
-..|++++.||+|+||+||+|+++.||+.||||++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i 107 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM 107 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEE
Confidence 45699999999999999999999999999999988
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=9.5e-05 Score=83.29 Aligned_cols=37 Identities=16% Similarity=0.250 Sum_probs=34.4
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..++.|++++.||+|+||+||+|+|+.||+.||||++
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i 91 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV 91 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEE
Confidence 3466799999999999999999999999999999988
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.46 E-value=9.5e-05 Score=85.80 Aligned_cols=36 Identities=22% Similarity=0.195 Sum_probs=33.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.-..|++++.||+|+||+||+|+++.||+.||||++
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i 184 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM 184 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEE
Confidence 346799999999999999999999999999999988
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00011 Score=81.38 Aligned_cols=39 Identities=36% Similarity=0.471 Sum_probs=36.8
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+|.|+++++||+|+||+||+|++..||+.||||++.
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~ 43 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFIS 43 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEe
Confidence 468899999999999999999999999999999999984
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00011 Score=80.70 Aligned_cols=40 Identities=48% Similarity=0.638 Sum_probs=36.4
Q ss_pred CCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 11 KAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 11 ~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.....++.|+++++||+|+||+||+|+|..||+.||||++
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~ 48 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII 48 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEE
Confidence 3456789999999999999999999999999999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00018 Score=79.89 Aligned_cols=35 Identities=14% Similarity=0.259 Sum_probs=31.9
Q ss_pred ccceeEEeeeeeecceEEEEEEEc---cCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHR---ITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~---~Tg~~vAI~~~ 50 (1238)
.++|+|++.||+|+||+||+|++. .||+.||||++
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i 60 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEE
Confidence 357999999999999999999985 57999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00014 Score=86.74 Aligned_cols=38 Identities=29% Similarity=0.456 Sum_probs=35.1
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+++|+|++.||+|+||+||+|+++.||+.||||++.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~ 191 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEe
Confidence 34678999999999999999999999999999999883
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00017 Score=76.77 Aligned_cols=39 Identities=18% Similarity=0.255 Sum_probs=35.1
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
..++.|++++.||+|+||+||+|++..||+.||||++..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~ 41 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRL 41 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEEC
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeec
Confidence 467889999999999999999999999999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0003 Score=78.32 Aligned_cols=40 Identities=25% Similarity=0.322 Sum_probs=34.3
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
...+++|++++.||+|+||+||+|+++.||+.||||++..
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~ 58 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK 58 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEH
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEH
Confidence 3567889999999999999999999999999999999843
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00021 Score=80.57 Aligned_cols=39 Identities=28% Similarity=0.420 Sum_probs=33.5
Q ss_pred CccccceeEEeeeeeecceEEEEEEEc---cCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHR---ITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~---~Tg~~vAI~~~i 51 (1238)
|...+.|+|++.||+|+||+||+|+++ .|++.||||+++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~ 58 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLI 58 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEEC
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEc
Confidence 444567999999999999999999986 578999999873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0003 Score=77.43 Aligned_cols=34 Identities=26% Similarity=0.320 Sum_probs=31.5
Q ss_pred cce-eEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFY-DIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y-~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
|.| ++.+.||+|+||+||+|+++.||..||||++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i 59 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL 59 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEE
Confidence 444 8899999999999999999999999999988
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00036 Score=73.95 Aligned_cols=37 Identities=27% Similarity=0.303 Sum_probs=34.4
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
+++|++++.||+|+||+||+|++..||+.||||++..
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~ 37 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL 37 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEES
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeec
Confidence 4679999999999999999999999999999999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00038 Score=77.03 Aligned_cols=37 Identities=24% Similarity=0.293 Sum_probs=34.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+++|++++.||+|+||+|++|++..||+.||||++.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~ 39 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR 39 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEe
Confidence 5678999999999999999999999999999999983
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00031 Score=81.97 Aligned_cols=42 Identities=26% Similarity=0.508 Sum_probs=38.2
Q ss_pred CCCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 10 KKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 10 ~~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
......+|.|.++++||+|+||+||+|+|..||+.||||++.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~ 50 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN 50 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEE
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEE
Confidence 344568899999999999999999999999999999999983
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00034 Score=74.29 Aligned_cols=39 Identities=28% Similarity=0.395 Sum_probs=33.8
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~ 47 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLS 47 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEE
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEee
Confidence 356789999999999999999999999999999999984
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00035 Score=77.67 Aligned_cols=39 Identities=21% Similarity=0.309 Sum_probs=34.6
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+++|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~ 51 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK 51 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEE
Confidence 457789999999999999999999999999999999984
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00047 Score=75.15 Aligned_cols=37 Identities=30% Similarity=0.436 Sum_probs=35.1
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..++.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~ 40 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV 40 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEE
Confidence 3678899999999999999999999999999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00033 Score=78.18 Aligned_cols=41 Identities=17% Similarity=0.255 Sum_probs=34.6
Q ss_pred CCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 11 KAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 11 ~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.....+++|++++.||+|+||+||+|++..||+.||||++.
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~ 54 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK 54 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEE
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEE
Confidence 33457889999999999999999999999999999999983
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00048 Score=76.25 Aligned_cols=39 Identities=28% Similarity=0.422 Sum_probs=36.2
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+..+++|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~ 43 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK 43 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEE
Confidence 346788999999999999999999999999999999984
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00049 Score=75.37 Aligned_cols=37 Identities=27% Similarity=0.327 Sum_probs=35.1
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+++|++++.||+|+||+||+|++..||+.||||++.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~ 40 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK 40 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEE
Confidence 5788999999999999999999999999999999984
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00038 Score=75.84 Aligned_cols=39 Identities=33% Similarity=0.342 Sum_probs=36.2
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...++.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 51 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL 51 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECC
T ss_pred cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEe
Confidence 357889999999999999999999999999999999883
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00061 Score=73.86 Aligned_cols=35 Identities=20% Similarity=0.258 Sum_probs=33.4
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
++.|++++.||+|+||+||+|++..||+.||||++
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~ 35 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI 35 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEE
Confidence 46799999999999999999999999999999988
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00061 Score=71.46 Aligned_cols=37 Identities=16% Similarity=0.188 Sum_probs=34.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 41 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR 41 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEee
Confidence 5678999999999999999999999999999999884
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00057 Score=75.96 Aligned_cols=37 Identities=16% Similarity=0.224 Sum_probs=32.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~ 41 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL 41 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEE
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEe
Confidence 4567999999999999999999999999999999884
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00084 Score=70.47 Aligned_cols=40 Identities=28% Similarity=0.370 Sum_probs=36.9
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
...+++|++++.||+|+||+||+|++..+|+.||||++..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~ 44 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 44 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEH
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEec
Confidence 4578899999999999999999999999999999999843
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0006 Score=77.68 Aligned_cols=39 Identities=26% Similarity=0.338 Sum_probs=35.9
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
..+.+|++++.||+|+||+|++|+++.||+.||||++..
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k 87 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK 87 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEG
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEh
Confidence 456789999999999999999999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00059 Score=74.68 Aligned_cols=36 Identities=28% Similarity=0.300 Sum_probs=33.9
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 71 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK 71 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEe
Confidence 467999999999999999999999999999999984
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00072 Score=75.13 Aligned_cols=40 Identities=20% Similarity=0.317 Sum_probs=36.8
Q ss_pred CCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 12 ~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....++.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~ 75 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEE
Confidence 3457889999999999999999999999999999999983
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0008 Score=75.28 Aligned_cols=39 Identities=36% Similarity=0.479 Sum_probs=35.4
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~ 46 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK 46 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEE
Confidence 345567999999999999999999999999999999983
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00072 Score=76.07 Aligned_cols=38 Identities=26% Similarity=0.363 Sum_probs=35.6
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+++|++++.||+|+||+||+|++..||+.||||++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~ 71 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL 71 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEE
Confidence 35678899999999999999999999999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0006 Score=72.77 Aligned_cols=39 Identities=21% Similarity=0.190 Sum_probs=33.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEee
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILS 53 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~ 53 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~ 45 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP 45 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecc
Confidence 346799999999999999999999999999999998544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00075 Score=71.81 Aligned_cols=36 Identities=28% Similarity=0.305 Sum_probs=33.4
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
++.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 37 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL 37 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEee
Confidence 568999999999999999999999999999999884
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00056 Score=74.94 Aligned_cols=32 Identities=25% Similarity=0.275 Sum_probs=29.3
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..|.|.+.||+|+||+||+|++ +|+.||||++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l 34 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF 34 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEE
Confidence 3589999999999999999987 6999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00055 Score=73.58 Aligned_cols=34 Identities=15% Similarity=-0.058 Sum_probs=33.0
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
|.|++++.||+|+||.||+|++..||+.||||++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~ 64 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFV 64 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEES
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEE
Confidence 6799999999999999999999999999999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00074 Score=73.68 Aligned_cols=37 Identities=22% Similarity=0.222 Sum_probs=34.2
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~ 69 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR 69 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEec
Confidence 3467999999999999999999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00079 Score=74.81 Aligned_cols=38 Identities=29% Similarity=0.345 Sum_probs=35.0
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~ 88 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 88 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEe
Confidence 34678999999999999999999999999999999983
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00092 Score=69.97 Aligned_cols=39 Identities=26% Similarity=0.212 Sum_probs=36.0
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+..++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~ 45 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID 45 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEee
Confidence 346788999999999999999999999999999999984
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00076 Score=77.14 Aligned_cols=38 Identities=26% Similarity=0.482 Sum_probs=35.3
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...++|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~ 103 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS 103 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEe
Confidence 45678999999999999999999999999999999983
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00075 Score=72.56 Aligned_cols=36 Identities=19% Similarity=0.176 Sum_probs=33.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 42 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF 42 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEe
Confidence 346799999999999999999999999999999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00084 Score=72.04 Aligned_cols=37 Identities=19% Similarity=0.190 Sum_probs=34.6
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 69 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 69 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEe
Confidence 4567899999999999999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00058 Score=75.50 Aligned_cols=38 Identities=24% Similarity=0.329 Sum_probs=35.0
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~ 55 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII 55 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEE
Confidence 45677899999999999999999999999999999988
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0037 Score=69.52 Aligned_cols=74 Identities=14% Similarity=0.061 Sum_probs=54.6
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC---CCCeeEEEEEeeeCCEEEEEEeecC
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD---HPHIIKLFQVMETKSMIYIVSEYAN 272 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~---HPNIVrL~dvfed~d~lyLVMEy~~ 272 (1238)
..++.|....+|+... ++..++||+.... ....+.+|++.|+.|. ...+++++.+....+..|+||||++
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4455565566665432 4667889987643 3567889999999883 3567888888888889999999999
Q ss_pred CCcc
Q psy6346 273 QGEI 276 (1238)
Q Consensus 273 GGSL 276 (1238)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.00068 Score=73.67 Aligned_cols=41 Identities=20% Similarity=0.233 Sum_probs=35.9
Q ss_pred CCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 12 ~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
....++.|++++.||+|+||+||+|++..+|+.||||++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~ 69 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL 69 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCC
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcc
Confidence 34678899999999999999999999999999999999843
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.001 Score=69.47 Aligned_cols=40 Identities=28% Similarity=0.530 Sum_probs=36.3
Q ss_pred CCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 12 ~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 45 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN 45 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEec
Confidence 3457789999999999999999999999999999999984
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00082 Score=72.14 Aligned_cols=37 Identities=22% Similarity=0.285 Sum_probs=34.4
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 45 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL 45 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEe
Confidence 3456799999999999999999999999999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00079 Score=76.32 Aligned_cols=40 Identities=25% Similarity=0.351 Sum_probs=36.7
Q ss_pred CCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 12 ~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....+++|++++.||+|+||+||+|++..||+.||||++.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~ 49 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN 49 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEe
Confidence 3456789999999999999999999999999999999983
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00097 Score=70.64 Aligned_cols=37 Identities=22% Similarity=0.179 Sum_probs=33.3
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEee
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILS 53 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~ 53 (1238)
++.|++++.||+|+||+||+|++ .+|+.||||++...
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~ 37 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLE 37 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCS
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecc
Confidence 46799999999999999999999 78999999998543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00079 Score=77.01 Aligned_cols=38 Identities=18% Similarity=0.294 Sum_probs=35.2
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...++|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~ 95 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN 95 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEe
Confidence 35678999999999999999999999999999999983
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00076 Score=74.34 Aligned_cols=37 Identities=27% Similarity=0.342 Sum_probs=34.3
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.-+.|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~ 58 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVD 58 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEE
Confidence 4467999999999999999999999999999999984
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0012 Score=70.64 Aligned_cols=38 Identities=24% Similarity=0.313 Sum_probs=34.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~ 46 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI 46 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEEC
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEecc
Confidence 44669999999999999999999999999999999843
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0005 Score=74.74 Aligned_cols=38 Identities=26% Similarity=0.449 Sum_probs=25.6
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..++.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 57 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI 57 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEe
Confidence 56788999999999999999999999999999999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0011 Score=69.42 Aligned_cols=39 Identities=21% Similarity=0.204 Sum_probs=35.7
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+..++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 40 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD 40 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEE
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEE
Confidence 456789999999999999999999999999999999983
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0009 Score=72.13 Aligned_cols=34 Identities=15% Similarity=0.136 Sum_probs=32.5
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~ 90 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS 90 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEe
Confidence 5699999999999999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00066 Score=74.84 Aligned_cols=34 Identities=26% Similarity=0.239 Sum_probs=27.7
Q ss_pred cceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
.+|.+++.||+|+||+||+|++. .+|+.||||++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l 51 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL 51 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEe
Confidence 57999999999999999999976 47899999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0014 Score=70.02 Aligned_cols=41 Identities=15% Similarity=0.096 Sum_probs=37.0
Q ss_pred CCCCccccceeEE-eeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 10 KKAPIRVGFYDIE-RTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 10 ~~~~~~ig~Y~i~-~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
......++.|.+. +.||+|+||+||+|++..+|+.||||++
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~ 51 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML 51 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEe
Confidence 4455688899998 8899999999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.001 Score=75.68 Aligned_cols=38 Identities=18% Similarity=0.286 Sum_probs=35.2
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..++.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~ 182 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK 182 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEE
Confidence 35678999999999999999999999999999999983
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0011 Score=75.04 Aligned_cols=36 Identities=11% Similarity=-0.047 Sum_probs=33.0
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....|++++.||+|+||+||+|++..||+.||||++
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~ 111 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVP 111 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEE
Confidence 344599999999999999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00085 Score=77.53 Aligned_cols=37 Identities=19% Similarity=0.151 Sum_probs=34.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~ 96 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS 96 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEE
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEEC
Confidence 3567999999999999999999999999999999884
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00062 Score=75.65 Aligned_cols=38 Identities=21% Similarity=0.282 Sum_probs=28.0
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..++.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~ 43 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF 43 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEEC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEec
Confidence 35678999999999999999999999999999999883
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00087 Score=69.75 Aligned_cols=37 Identities=30% Similarity=0.425 Sum_probs=34.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 41 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD 41 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEee
Confidence 5678999999999999999999999999999999883
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00087 Score=72.13 Aligned_cols=36 Identities=31% Similarity=0.274 Sum_probs=33.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||.||+|++..||+.||||++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 43 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKII 43 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEe
Confidence 346799999999999999999999999999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0012 Score=69.46 Aligned_cols=41 Identities=32% Similarity=0.446 Sum_probs=36.5
Q ss_pred CCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 11 KAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 11 ~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.....++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~ 48 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF 48 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEE
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEc
Confidence 34567889999999999999999999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00069 Score=75.21 Aligned_cols=37 Identities=35% Similarity=0.531 Sum_probs=34.6
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~ 53 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI 53 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEE
Confidence 3457899999999999999999999999999999988
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.001 Score=69.07 Aligned_cols=38 Identities=18% Similarity=0.096 Sum_probs=35.3
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 45 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK 45 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEec
Confidence 45678999999999999999999999999999999884
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00097 Score=71.53 Aligned_cols=38 Identities=24% Similarity=0.056 Sum_probs=35.4
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~ 53 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM 53 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEe
Confidence 45677899999999999999999999999999999988
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0011 Score=72.32 Aligned_cols=36 Identities=28% Similarity=0.396 Sum_probs=34.1
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~ 52 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV 52 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEe
Confidence 456899999999999999999999999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0012 Score=69.53 Aligned_cols=36 Identities=25% Similarity=0.318 Sum_probs=33.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 42 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE 42 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEe
Confidence 456799999999999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0014 Score=74.01 Aligned_cols=39 Identities=13% Similarity=0.091 Sum_probs=35.3
Q ss_pred CCccccceeEE-eeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 12 APIRVGFYDIE-RTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 12 ~~~~ig~Y~i~-~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+++|.+. +.||+|+||+||+|++..||+.||||++
T Consensus 56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~ 95 (400)
T 1nxk_A 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML 95 (400)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEe
Confidence 34567889997 7999999999999999999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0014 Score=68.71 Aligned_cols=37 Identities=32% Similarity=0.449 Sum_probs=34.5
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 40 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 40 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEee
Confidence 4577999999999999999999999999999999983
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0015 Score=71.34 Aligned_cols=41 Identities=20% Similarity=0.116 Sum_probs=35.5
Q ss_pred CCCCccccceeEEe-eeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 10 KKAPIRVGFYDIER-TIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 10 ~~~~~~ig~Y~i~~-tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+.....+.|++.+ .||+|+||+||+|++..||+.||||++
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~ 62 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL 62 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEe
Confidence 33445678899965 699999999999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0011 Score=75.34 Aligned_cols=37 Identities=27% Similarity=0.293 Sum_probs=34.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~ 60 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeC
Confidence 4567999999999999999999999999999999983
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0013 Score=69.41 Aligned_cols=38 Identities=21% Similarity=0.171 Sum_probs=34.7
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 50 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKII 50 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEE
Confidence 35678899999999999999999999999999999998
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0032 Score=71.45 Aligned_cols=32 Identities=22% Similarity=0.454 Sum_probs=28.4
Q ss_pred hccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 306 HNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 306 HSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
+...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 466899999999999998876 99999998865
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00081 Score=71.20 Aligned_cols=37 Identities=19% Similarity=0.189 Sum_probs=33.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~ 39 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK 39 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEEC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEec
Confidence 5688999999999999999999999999999999983
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0012 Score=73.28 Aligned_cols=37 Identities=11% Similarity=-0.052 Sum_probs=33.5
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~ 107 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPY 107 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEe
Confidence 3567999999999999999999999999999999984
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0012 Score=76.33 Aligned_cols=37 Identities=16% Similarity=0.244 Sum_probs=34.6
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..++|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~ 108 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN 108 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEE
Confidence 4578999999999999999999999999999999983
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0011 Score=69.56 Aligned_cols=36 Identities=25% Similarity=0.318 Sum_probs=31.1
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 42 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE 42 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEee
Confidence 346799999999999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0012 Score=69.39 Aligned_cols=36 Identities=22% Similarity=0.363 Sum_probs=33.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 43 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE 43 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEe
Confidence 345699999999999999999999999999999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0032 Score=68.65 Aligned_cols=32 Identities=31% Similarity=0.436 Sum_probs=27.7
Q ss_pred ccceeeccCCcccccccCC----CcEEEEecCCccc
Q psy6346 307 NRRVVHRDLKAENLLMDSN----LDIKLADFGFSNY 338 (1238)
Q Consensus 307 SkGIIHRDLKPeNILLd~n----G~VKLiDFGLS~~ 338 (1238)
...++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6799999998864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0011 Score=72.08 Aligned_cols=38 Identities=32% Similarity=0.407 Sum_probs=34.7
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~ 45 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK 45 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEE
Confidence 34567999999999999999999999999999999983
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0012 Score=74.81 Aligned_cols=36 Identities=31% Similarity=0.277 Sum_probs=33.8
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|.+++.||+|+||+||+|++..||+.||||++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~ 169 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEE
Confidence 467999999999999999999999999999999983
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0013 Score=73.02 Aligned_cols=37 Identities=22% Similarity=0.165 Sum_probs=34.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~ 59 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS 59 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEE
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEec
Confidence 4678999999999999999999999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0013 Score=68.92 Aligned_cols=37 Identities=16% Similarity=0.146 Sum_probs=34.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 40 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR 40 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEe
Confidence 4568999999999999999999999999999999884
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=96.71 E-value=0.002 Score=73.06 Aligned_cols=36 Identities=25% Similarity=0.201 Sum_probs=33.5
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....|++++.||+|+||+||+|++..||+.||||++
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~ 87 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV 87 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEe
Confidence 344699999999999999999999999999999987
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0033 Score=67.84 Aligned_cols=137 Identities=12% Similarity=0.049 Sum_probs=72.8
Q ss_pred EEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC--eeEEEEE------eeeCCEEEEE
Q psy6346 196 EKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH--IIKLFQV------METKSMIYIV 267 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN--IVrL~dv------fed~d~lyLV 267 (1238)
..++.|....+|.+.. .+| .+++|+..... ....+..|+.++..|...+ +.+++.. ....+..++|
T Consensus 28 ~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHT-TKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEECC---EEEEEEEE-SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eccCCCcccceEEEEe-CCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 3445555556665533 233 68899987531 1234567888887773222 2233311 1234678999
Q ss_pred EeecCCCccchh--------------hhcc-ccc--------chhHHHHHH---------------HHHHHHHhHhh---
Q psy6346 268 SEYANQGEIFDY--------------IARY-GRM--------NENAARRKF---------------WQILSAVEYCH--- 306 (1238)
Q Consensus 268 MEy~~GGSL~d~--------------Lkk~-~~L--------sesea~kI~---------------~QILsALeYLH--- 306 (1238)
|+|++|..+... ++.. ..+ ........+ ..+...++.+.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999998765321 0100 000 000000000 01223333333
Q ss_pred ----ccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 307 ----NRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 307 ----SkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
..+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 24799999999999998876668999997753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00068 Score=77.17 Aligned_cols=36 Identities=25% Similarity=0.331 Sum_probs=24.8
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~ 87 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL 87 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEEC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEec
Confidence 467999999999999999999999999999999884
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0013 Score=71.16 Aligned_cols=36 Identities=22% Similarity=0.267 Sum_probs=34.0
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~ 44 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI 44 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEee
Confidence 456799999999999999999999999999999988
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0013 Score=73.69 Aligned_cols=36 Identities=19% Similarity=0.176 Sum_probs=33.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~ 42 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF 42 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEe
Confidence 345799999999999999999999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0012 Score=75.11 Aligned_cols=36 Identities=25% Similarity=0.280 Sum_probs=33.4
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~ 131 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR 131 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEEC
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEEC
Confidence 345999999999999999999999999999999984
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0012 Score=71.05 Aligned_cols=41 Identities=20% Similarity=0.311 Sum_probs=33.4
Q ss_pred CCCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 10 KKAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 10 ~~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
......++.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~ 67 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLM 67 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEEC
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEec
Confidence 44567889999999999999999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0014 Score=70.75 Aligned_cols=39 Identities=36% Similarity=0.479 Sum_probs=35.3
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 46 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIK 46 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEe
Confidence 345567999999999999999999999999999999984
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0014 Score=69.29 Aligned_cols=37 Identities=27% Similarity=0.345 Sum_probs=33.7
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
++.|++++.||+|+||+||+|++..+|+.||||++..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~ 38 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL 38 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeec
Confidence 5789999999999999999999999999999998843
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0042 Score=66.60 Aligned_cols=80 Identities=9% Similarity=-0.048 Sum_probs=53.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCC---CeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP---HIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HP---NIVrL~dvfed~d~lyLV 267 (1238)
.......+|.|..+.||+.. +.+|+.|.+|+-...... ....+.+|+..|+.|.-- -+++++.+. . -++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence 34556778888888899875 467899999987644321 123577899999988421 244555542 2 3789
Q ss_pred EeecCCCccc
Q psy6346 268 SEYANQGEIF 277 (1238)
Q Consensus 268 MEy~~GGSL~ 277 (1238)
|||+.++...
T Consensus 89 ~e~l~~~~~~ 98 (288)
T 3f7w_A 89 MEWVDERPPT 98 (288)
T ss_dssp EECCCCCCCC
T ss_pred EEeecccCCC
Confidence 9999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0019 Score=69.13 Aligned_cols=38 Identities=18% Similarity=0.289 Sum_probs=35.4
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~ 57 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM 57 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEE
Confidence 45677899999999999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0016 Score=69.63 Aligned_cols=36 Identities=22% Similarity=0.089 Sum_probs=34.0
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|.+++.||+|+||+||+|++..+|+.||||++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~ 43 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL 43 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEe
Confidence 457899999999999999999999999999999987
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0017 Score=72.13 Aligned_cols=40 Identities=33% Similarity=0.346 Sum_probs=36.5
Q ss_pred CccccceeEEeeeeee--cceEEEEEEEccCCCEEEEEEeEe
Q psy6346 13 PIRVGFYDIERTIGKG--NFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkG--sFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
....+.|++++.||+| +||+||+|++..||+.||||++..
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~ 62 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL 62 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEG
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecc
Confidence 3567889999999999 999999999999999999999843
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0011 Score=73.33 Aligned_cols=37 Identities=14% Similarity=0.087 Sum_probs=31.3
Q ss_pred ccccceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
...+.+++++.||+|+||+||+|+.. .+++.||||++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l 64 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL 64 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEEC
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEE
Confidence 45678999999999999999999964 57899999987
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0066 Score=65.45 Aligned_cols=29 Identities=28% Similarity=0.437 Sum_probs=25.1
Q ss_pred ceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 309 RVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 309 GIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5667889999997754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0017 Score=69.20 Aligned_cols=38 Identities=24% Similarity=0.269 Sum_probs=33.6
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...++.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~ 65 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEee
Confidence 35678899999999999999999999999999999988
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0017 Score=70.86 Aligned_cols=36 Identities=22% Similarity=0.273 Sum_probs=34.0
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..||+.||+|++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~ 38 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV 38 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEE
Confidence 456899999999999999999999999999999988
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0015 Score=72.72 Aligned_cols=36 Identities=33% Similarity=0.487 Sum_probs=33.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~ 62 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 446799999999999999999999999999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0015 Score=71.85 Aligned_cols=34 Identities=24% Similarity=0.234 Sum_probs=32.8
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~ 60 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEe
Confidence 4799999999999999999999999999999988
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.00093 Score=72.34 Aligned_cols=35 Identities=23% Similarity=0.343 Sum_probs=31.9
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 42 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE 42 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEe
Confidence 35699999999999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0013 Score=72.05 Aligned_cols=39 Identities=28% Similarity=0.258 Sum_probs=30.6
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~ 44 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK 44 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEe
Confidence 346788999999999999999999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0015 Score=72.17 Aligned_cols=38 Identities=13% Similarity=0.072 Sum_probs=34.5
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEee
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILS 53 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~ 53 (1238)
...|++++.||+|+||+||+|++..||+.||||++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~ 98 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMG 98 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEec
Confidence 44599999999999999999999999999999999543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00087 Score=72.45 Aligned_cols=37 Identities=16% Similarity=0.153 Sum_probs=20.1
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 39 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK 39 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEee
Confidence 3567999999999999999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0013 Score=69.99 Aligned_cols=38 Identities=16% Similarity=0.073 Sum_probs=29.6
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..++.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 59 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR 59 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEec
Confidence 46788999999999999999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0016 Score=69.42 Aligned_cols=36 Identities=17% Similarity=0.160 Sum_probs=31.4
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 63 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEe
Confidence 356999999999999999999999999999999883
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0016 Score=68.09 Aligned_cols=35 Identities=29% Similarity=0.482 Sum_probs=33.2
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~ 39 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK 39 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhh
Confidence 56999999999999999999999999999999983
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.002 Score=68.11 Aligned_cols=39 Identities=26% Similarity=0.149 Sum_probs=35.7
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+...+.|.+++.||+|+||+||+|++..+|+.||+|++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~ 49 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP 49 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEec
Confidence 346678999999999999999999999999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0011 Score=71.73 Aligned_cols=40 Identities=18% Similarity=0.160 Sum_probs=36.7
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
-..++.|++++.||+|+||+||+|++..+|+.||||++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~ 60 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEES
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEec
Confidence 3578899999999999999999999999999999998843
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0015 Score=69.72 Aligned_cols=37 Identities=19% Similarity=0.229 Sum_probs=31.5
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~ 64 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEE
Confidence 4456799999999999999999999999999999988
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0016 Score=72.68 Aligned_cols=34 Identities=24% Similarity=0.201 Sum_probs=29.4
Q ss_pred cceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
.+|.+.+.||+|+||+||+|++. .+|+.||||++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l 79 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEE
Confidence 56999999999999999999865 57999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=96.60 E-value=0.00086 Score=72.76 Aligned_cols=35 Identities=20% Similarity=0.119 Sum_probs=32.2
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
.+.|++++.||+|+||+||+|++ +|+.||||++..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~ 53 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAI 53 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEE
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEec
Confidence 47799999999999999999998 899999999954
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0018 Score=69.00 Aligned_cols=34 Identities=21% Similarity=0.202 Sum_probs=32.5
Q ss_pred ceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 62 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL 62 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEec
Confidence 6999999999999999999999999999999884
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0024 Score=72.20 Aligned_cols=39 Identities=26% Similarity=0.284 Sum_probs=35.8
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~ 85 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN 85 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEec
Confidence 456678999999999999999999999999999999983
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0016 Score=70.24 Aligned_cols=37 Identities=22% Similarity=0.294 Sum_probs=34.1
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
.+.|++++.||+|+||+||+|++..+++.||||++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~ 61 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEH
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhh
Confidence 4569999999999999999999999999999999843
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0018 Score=68.59 Aligned_cols=36 Identities=25% Similarity=0.318 Sum_probs=33.1
Q ss_pred cccceeEEeeeeeecceEEEEEE----EccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLAR----HRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~----h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|+ +..+|+.||||++
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~ 47 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 47 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEE
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEc
Confidence 45679999999999999999999 6789999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0015 Score=70.27 Aligned_cols=39 Identities=13% Similarity=0.066 Sum_probs=34.7
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~ 57 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS 57 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEEC
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeec
Confidence 456789999999999999999999999999999999843
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.002 Score=74.54 Aligned_cols=38 Identities=18% Similarity=0.156 Sum_probs=33.0
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~ 70 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEE
Confidence 44567999999999999999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0017 Score=74.42 Aligned_cols=37 Identities=32% Similarity=0.451 Sum_probs=34.3
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~ 59 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI 59 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEE
Confidence 3446799999999999999999999999999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0019 Score=68.83 Aligned_cols=37 Identities=22% Similarity=0.310 Sum_probs=34.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 43 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK 43 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEe
Confidence 4567999999999999999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0019 Score=70.49 Aligned_cols=36 Identities=17% Similarity=0.120 Sum_probs=33.7
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|.+++.||+|+||+||+|++..||+.||||++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 58 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS 58 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEES
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEec
Confidence 467999999999999999999999999999999883
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0021 Score=68.43 Aligned_cols=37 Identities=22% Similarity=0.241 Sum_probs=33.1
Q ss_pred cccceeEEeeeeeecceEEEEEEE-ccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARH-RITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h-~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++ ..+|+.||||++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~ 49 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK 49 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEC
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEe
Confidence 346799999999999999999998 6789999999983
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0018 Score=73.12 Aligned_cols=35 Identities=17% Similarity=0.147 Sum_probs=30.1
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCC-----CEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITK-----TEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg-----~~vAI~~~ 50 (1238)
-++|++++.||+|+||+||+|++..++ +.||||.+
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l 102 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 102 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEE
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEE
Confidence 367999999999999999999987655 57888876
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0019 Score=71.53 Aligned_cols=34 Identities=18% Similarity=0.162 Sum_probs=32.7
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.|.+++.||+|+||+||+|++..||+.||||++
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~ 75 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL 75 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEe
Confidence 5699999999999999999999999999999988
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0024 Score=70.48 Aligned_cols=38 Identities=16% Similarity=0.242 Sum_probs=34.3
Q ss_pred CccccceeEEeeeeeecceEEEEEEEc---cCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHR---ITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~---~Tg~~vAI~~~ 50 (1238)
...++.|++++.||+|+||+||+|++. .+|+.||||++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~ 90 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 90 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEE
Confidence 345688999999999999999999995 59999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0015 Score=75.10 Aligned_cols=39 Identities=28% Similarity=0.323 Sum_probs=35.6
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~ 56 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEe
Confidence 345677999999999999999999999999999999983
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.002 Score=68.09 Aligned_cols=37 Identities=30% Similarity=0.380 Sum_probs=34.8
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~ 55 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI 55 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEe
Confidence 4567899999999999999999999999999999988
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0022 Score=70.71 Aligned_cols=37 Identities=16% Similarity=0.323 Sum_probs=33.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..+++.||||++.
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~ 87 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK 87 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEec
Confidence 3456999999999999999999999999999999883
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0014 Score=69.40 Aligned_cols=38 Identities=16% Similarity=-0.024 Sum_probs=29.6
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 45 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV 45 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEE
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEe
Confidence 34567999999999999999999999999999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0014 Score=68.92 Aligned_cols=38 Identities=32% Similarity=0.366 Sum_probs=34.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
..+.|++.+.||+|+||+||+|++..+|+.||||++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~ 54 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCC
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeec
Confidence 44679999999999999999999999999999999843
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0014 Score=72.93 Aligned_cols=35 Identities=20% Similarity=0.174 Sum_probs=27.2
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~ 58 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL 58 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEe
Confidence 45699999999999999999999999999999987
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0069 Score=69.72 Aligned_cols=55 Identities=16% Similarity=0.240 Sum_probs=36.2
Q ss_pred CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCe-eEEEEEeeeCCEEEEEEeecCCCccc
Q psy6346 215 TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHI-IKLFQVMETKSMIYIVSEYANQGEIF 277 (1238)
Q Consensus 215 G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNI-VrL~dvfed~d~lyLVMEy~~GGSL~ 277 (1238)
+..|.+|+..... . ...+.+|+.+++.|...++ .++++.+.+ .+|+||++|..|.
T Consensus 105 ~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 105 PNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS 160 (429)
T ss_dssp CSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred CceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcccC
Confidence 5679999984321 1 1345589999998843333 567766543 2899999875553
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.002 Score=68.26 Aligned_cols=38 Identities=21% Similarity=0.231 Sum_probs=35.0
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|.+.+.||+|+||+||+|++..+|..||||++.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~ 56 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN 56 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEee
Confidence 45577999999999999999999999999999999984
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0028 Score=69.01 Aligned_cols=38 Identities=24% Similarity=0.302 Sum_probs=34.5
Q ss_pred CccccceeEEeeeeeecceEEEEEEEc---cCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHR---ITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~---~Tg~~vAI~~~ 50 (1238)
....+.|++++.||+|+||+||+|++. .+|+.||||++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~ 53 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL 53 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEE
Confidence 345678999999999999999999996 79999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0018 Score=70.10 Aligned_cols=37 Identities=16% Similarity=0.135 Sum_probs=34.6
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~ 76 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEE
Confidence 4566799999999999999999999999999999998
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.50 E-value=0.015 Score=62.73 Aligned_cols=132 Identities=11% Similarity=0.071 Sum_probs=74.0
Q ss_pred CCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC--eeEEEEE-----eeeCCEEEEEEeecCC
Q psy6346 201 KSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH--IIKLFQV-----METKSMIYIVSEYANQ 273 (1238)
Q Consensus 201 GsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN--IVrL~dv-----fed~d~lyLVMEy~~G 273 (1238)
|....||.+. ..+|..+++|+....... ...+..|+.+++.|.... +++++.. ....+..++||++++|
T Consensus 36 g~~n~~y~v~-~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 36 SYENRVYQFQ-DEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp CSSSEEEEEC-CTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred CcccceEEEE-cCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 4445555432 234667999998744322 345667888888773222 3333332 2235677899999998
Q ss_pred Cccch----hh----------hc----c-----cccchhH----------------------HHHHHHHHHHHHhHh---
Q psy6346 274 GEIFD----YI----------AR----Y-----GRMNENA----------------------ARRKFWQILSAVEYC--- 305 (1238)
Q Consensus 274 GSL~d----~L----------kk----~-----~~Lsese----------------------a~kI~~QILsALeYL--- 305 (1238)
..+.. .+ +. . ..+.... ....+..++..+.-+
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 65431 01 00 0 0011000 011122222223222
Q ss_pred -hccceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 306 -HNRRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 306 -HSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999998 4 899999997754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0024 Score=68.62 Aligned_cols=38 Identities=13% Similarity=0.203 Sum_probs=33.5
Q ss_pred CCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 12 APIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 12 ~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....++.|++++.||+|+||+||+|++ +|+.||||++.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~ 45 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFS 45 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEee
Confidence 346788999999999999999999976 79999999983
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0023 Score=69.91 Aligned_cols=39 Identities=18% Similarity=0.157 Sum_probs=35.6
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++..
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~ 68 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecc
Confidence 456789999999999999999999999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0024 Score=76.10 Aligned_cols=39 Identities=18% Similarity=0.207 Sum_probs=35.8
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+...+.|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~ 219 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN 219 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEE
Confidence 356688999999999999999999999999999999983
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0057 Score=69.89 Aligned_cols=147 Identities=15% Similarity=0.146 Sum_probs=80.5
Q ss_pred eeEEeeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEE
Q psy6346 177 RLRLDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLF 255 (1238)
Q Consensus 177 y~~i~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~ 255 (1238)
.+.+..+..|....+|++.. +.+ ... ....+..|.+|+..... .....+.+|..+++.|. +.-..+++
T Consensus 52 ~l~v~~lsGG~TN~~y~v~~--~~~-~~~-----~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll 120 (379)
T 3feg_A 52 ELRVYPVSGGLSNLLFRCSL--PDH-LPS-----VGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLY 120 (379)
T ss_dssp GCCCEEC-----CCEEEEEC--CTT-SCC-----CSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEE
T ss_pred ceEEEEcCCcccccEEEEEe--CCC-ccc-----cCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 33455666666666666422 110 000 01135678999853311 12445668999998884 22235677
Q ss_pred EEeeeCCEEEEEEeecCCCccchh-hh----------------cc----c-cc--chhHHHHHHHHHHH-----------
Q psy6346 256 QVMETKSMIYIVSEYANQGEIFDY-IA----------------RY----G-RM--NENAARRKFWQILS----------- 300 (1238)
Q Consensus 256 dvfed~d~lyLVMEy~~GGSL~d~-Lk----------------k~----~-~L--sesea~kI~~QILs----------- 300 (1238)
.++.+ .+||||++|..|..- +. .. + .. -...+.+++.++-.
T Consensus 121 ~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~ 196 (379)
T 3feg_A 121 GVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNL 196 (379)
T ss_dssp EEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCH
T ss_pred EEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhh
Confidence 66654 299999998666421 10 00 0 01 12344555544322
Q ss_pred --------HHhHhh--------ccceeeccCCcccccccCC----CcEEEEecCCccc
Q psy6346 301 --------AVEYCH--------NRRVVHRDLKAENLLMDSN----LDIKLADFGFSNY 338 (1238)
Q Consensus 301 --------ALeYLH--------SkGIIHRDLKPeNILLd~n----G~VKLiDFGLS~~ 338 (1238)
.+..|. ...++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 197 ~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 197 LEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 122222 2369999999999999876 7899999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0015 Score=79.29 Aligned_cols=38 Identities=18% Similarity=0.261 Sum_probs=34.5
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+++|++++.||+|+||+||+|++..||+.||||++.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~ 375 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK 375 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEe
Confidence 46788999999999999999999999999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0026 Score=76.39 Aligned_cols=39 Identities=23% Similarity=0.259 Sum_probs=35.8
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+...+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~ 218 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE 218 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEE
Confidence 356678999999999999999999999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0025 Score=68.52 Aligned_cols=36 Identities=19% Similarity=0.232 Sum_probs=32.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCC-CEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITK-TEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg-~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..++ +.||||++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~ 53 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII 53 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEE
Confidence 3467999999999999999999999887 79999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0025 Score=67.42 Aligned_cols=38 Identities=21% Similarity=0.210 Sum_probs=35.3
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~ 52 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI 52 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEe
Confidence 35667899999999999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0045 Score=66.13 Aligned_cols=42 Identities=19% Similarity=0.056 Sum_probs=36.1
Q ss_pred CccccceeEEeeeeeecceEEEEEEEc-cCCCEEEEEEeEeec
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHR-ITKTEVGALCSILSI 54 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~-~Tg~~vAI~~~i~~~ 54 (1238)
....+.|++++.||+|+||+||+|++. .+|+.||||++....
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~ 49 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT 49 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEB
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCc
Confidence 345578999999999999999999996 789999999986543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0012 Score=72.55 Aligned_cols=37 Identities=22% Similarity=0.171 Sum_probs=34.9
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~ 57 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFI 57 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEE
Confidence 4567899999999999999999999999999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0019 Score=70.05 Aligned_cols=37 Identities=19% Similarity=0.183 Sum_probs=33.5
Q ss_pred cccceeEEeeeeeecceEEEEEE-----EccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLAR-----HRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~-----h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|+ +..+|+.||||++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~ 61 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 61 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEec
Confidence 45779999999999999999999 77888999999984
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0028 Score=66.83 Aligned_cols=35 Identities=14% Similarity=0.094 Sum_probs=31.8
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++ +|+.||||++
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~ 39 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIF 39 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEe
Confidence 3567899999999999999999988 7999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.003 Score=68.77 Aligned_cols=38 Identities=24% Similarity=0.086 Sum_probs=35.1
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|.+++.||+|+||+||+|++..+|+.||+|++.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~ 75 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP 75 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEec
Confidence 45567999999999999999999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0016 Score=72.80 Aligned_cols=35 Identities=20% Similarity=0.117 Sum_probs=29.2
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+.|++++.||+|+||+||+|++..||+.||||++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~ 62 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 62 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEe
Confidence 36799999999999999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0024 Score=70.88 Aligned_cols=37 Identities=30% Similarity=0.335 Sum_probs=34.1
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
.+.|++++.||+|+||.||+|++..||+.||||++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~ 129 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEET
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEc
Confidence 3569999999999999999999999999999999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0027 Score=68.58 Aligned_cols=37 Identities=19% Similarity=0.153 Sum_probs=33.3
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|++++.||+|+||+||+|++. +|+.||||++.
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~ 54 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR 54 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEe
Confidence 45678999999999999999999995 59999999884
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0019 Score=70.35 Aligned_cols=37 Identities=16% Similarity=0.414 Sum_probs=33.4
Q ss_pred ccccceeEE---eeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIE---RTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~---~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.....|++. +.||+|+||+||+|++..||+.||||++
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~ 44 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII 44 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEE
Confidence 455678885 8899999999999999999999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0023 Score=73.93 Aligned_cols=37 Identities=22% Similarity=0.344 Sum_probs=31.0
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..||..||||++.
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~ 71 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEe
Confidence 3446999999999999999999999999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0029 Score=68.59 Aligned_cols=37 Identities=30% Similarity=0.421 Sum_probs=33.0
Q ss_pred cccceeEE-eeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIE-RTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~-~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|.+. +.||+|+||+||+|++..+|+.||||++.
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~ 63 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEe
Confidence 34458887 89999999999999999999999999883
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0032 Score=65.88 Aligned_cols=36 Identities=31% Similarity=0.445 Sum_probs=33.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++.+.||+|+||+||+|++..++..||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~ 42 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI 42 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEee
Confidence 456799999999999999999999999999999988
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0023 Score=73.87 Aligned_cols=38 Identities=24% Similarity=0.298 Sum_probs=33.0
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...+.|++++.||+|+||+||+|++..||+.||||++.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~ 45 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN 45 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEE
Confidence 45577999999999999999999999999999999983
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0024 Score=66.62 Aligned_cols=37 Identities=24% Similarity=0.116 Sum_probs=34.1
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 45 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK 45 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEec
Confidence 4467999999999999999999999999999999883
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0021 Score=75.14 Aligned_cols=37 Identities=24% Similarity=0.303 Sum_probs=34.2
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~ 40 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE 40 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEe
Confidence 4557799999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0027 Score=67.64 Aligned_cols=38 Identities=21% Similarity=0.235 Sum_probs=34.1
Q ss_pred CccccceeEE-eeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIE-RTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~-~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+.|+|. +.||+|+||+||+|++..+|+.||||++
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~ 46 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII 46 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEE
Confidence 3456679995 7899999999999999999999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0037 Score=66.38 Aligned_cols=36 Identities=22% Similarity=0.194 Sum_probs=33.3
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....|++++.||+|+||+||+|++..+|+.||||++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~ 55 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII 55 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEe
Confidence 345599999999999999999999999999999988
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.003 Score=68.25 Aligned_cols=40 Identities=18% Similarity=0.155 Sum_probs=35.4
Q ss_pred CCCccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 11 KAPIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 11 ~~~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
.....++.|++++.||+|+||+||+|++ +|+.||||++..
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~ 64 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEK 64 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEH
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeec
Confidence 3445678999999999999999999999 999999999843
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0037 Score=69.54 Aligned_cols=36 Identities=28% Similarity=0.276 Sum_probs=33.5
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~ 147 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC 147 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEc
Confidence 346799999999999999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0034 Score=68.41 Aligned_cols=40 Identities=15% Similarity=0.164 Sum_probs=34.6
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEeec
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILSI 54 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~~ 54 (1238)
..+.|++++.||+|+||+||+|++..+|+.||+|+++-.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~ 52 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL 52 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEee
Confidence 4567999999999999999999999999998887765443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0033 Score=67.01 Aligned_cols=37 Identities=22% Similarity=0.267 Sum_probs=28.1
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||.||+|++..||+.||||++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~ 62 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEec
Confidence 3456699999999999999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0036 Score=66.18 Aligned_cols=34 Identities=29% Similarity=0.418 Sum_probs=31.6
Q ss_pred cceeEEeeeeeecceEEEEEE----EccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLAR----HRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~----h~~Tg~~vAI~~~ 50 (1238)
..|++++.||+|+||+||+|+ +..+|+.||||++
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~ 58 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL 58 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEe
Confidence 349999999999999999999 7889999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0037 Score=69.14 Aligned_cols=35 Identities=26% Similarity=0.295 Sum_probs=32.9
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..|++++.||+|+||+||+|++..+|+.||||++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~ 88 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEc
Confidence 45999999999999999999999999999999884
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0032 Score=69.25 Aligned_cols=34 Identities=21% Similarity=0.218 Sum_probs=28.5
Q ss_pred cceeEEeeeeeecceEEEEE-----EEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLA-----RHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA-----~h~~Tg~~vAI~~~ 50 (1238)
+.|.+++.||+|+||+||+| .+..+|+.||||++
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~ 103 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ 103 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEe
Confidence 55999999999999999999 58889999999997
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0033 Score=68.26 Aligned_cols=37 Identities=16% Similarity=0.169 Sum_probs=28.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++..+|+.||+|+++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vai 49 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI 49 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEE
Confidence 4567999999999999999999999999988666654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0086 Score=66.44 Aligned_cols=30 Identities=27% Similarity=0.588 Sum_probs=24.9
Q ss_pred cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
..++|+|+++.|||++.++ +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 3699999999999998654 89999997753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.002 Score=67.88 Aligned_cols=36 Identities=28% Similarity=0.290 Sum_probs=26.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..+|+.||||++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~ 48 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI 48 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEE
Confidence 456799999999999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=96.14 E-value=0.0036 Score=66.44 Aligned_cols=37 Identities=19% Similarity=0.170 Sum_probs=32.6
Q ss_pred cccceeEEeeeeeecceEEEEEEE-----ccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARH-----RITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h-----~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++ ..+|+.||||++.
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~ 66 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecc
Confidence 456799999999999999999994 5788999999983
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0038 Score=68.19 Aligned_cols=35 Identities=20% Similarity=0.106 Sum_probs=31.3
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|++++.||+|+||+||+|++ .+|+.||||++.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~ 42 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN 42 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEee
Confidence 34599999999999999999998 569999999984
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0052 Score=66.71 Aligned_cols=34 Identities=26% Similarity=0.303 Sum_probs=32.0
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..|++.+.||+|+||+||+|++..+|+.||||++
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~ 78 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM 78 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEE
Confidence 3499999999999999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0062 Score=68.39 Aligned_cols=38 Identities=26% Similarity=0.239 Sum_probs=32.9
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
....+.|++++.||+|+||+||+|++..+++ ||||.++
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~ 73 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL 73 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEe
Confidence 3455679999999999999999999999887 8888774
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0041 Score=67.29 Aligned_cols=38 Identities=13% Similarity=0.082 Sum_probs=32.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
..+.|++++.||+|+||+||+|++..+|+.+|+|+++-
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K 48 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK 48 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEE
Confidence 45679999999999999999999999999866666543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=96.09 E-value=0.0056 Score=64.58 Aligned_cols=36 Identities=25% Similarity=0.225 Sum_probs=33.0
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
..|++.+.||+|+||+||+|++..++..||||++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~ 61 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEG
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecc
Confidence 349999999999999999999999999999998843
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0051 Score=66.94 Aligned_cols=37 Identities=27% Similarity=0.334 Sum_probs=32.9
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCE---EEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTE---VGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~---vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|.. ||||++
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~ 85 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL 85 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEE
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEec
Confidence 3456799999999999999999999977765 999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0046 Score=67.63 Aligned_cols=34 Identities=12% Similarity=0.060 Sum_probs=29.8
Q ss_pred cceeEEeeeeeecceEEEEEEEccC--------CCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRIT--------KTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~T--------g~~vAI~~~ 50 (1238)
+.|++++.||+|+||+||+|++..| |+.||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~ 83 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLD 83 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEE
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEe
Confidence 6899999999999999999999986 899999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0044 Score=66.35 Aligned_cols=35 Identities=20% Similarity=0.305 Sum_probs=31.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++. |+.||||++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~ 69 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFF 69 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEe
Confidence 3467999999999999999999885 9999999983
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=96.04 E-value=0.003 Score=66.26 Aligned_cols=36 Identities=11% Similarity=0.083 Sum_probs=33.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++.+.||+|+||+||+|++..+|..||||++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~ 46 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 46 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEec
Confidence 456799999999999999999999999999999988
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0049 Score=65.45 Aligned_cols=33 Identities=15% Similarity=-0.000 Sum_probs=31.2
Q ss_pred eeEEeeeeeecceEEEEEEEccCCCE--EEEEEeE
Q psy6346 19 YDIERTIGKGNFAVVKLARHRITKTE--VGALCSI 51 (1238)
Q Consensus 19 Y~i~~tLGkGsFgkVklA~h~~Tg~~--vAI~~~i 51 (1238)
|++++.||+|+||.||+|++..+|+. ||||++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~ 83 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYR 83 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEEC
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEE
Confidence 88999999999999999999999999 9999973
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0047 Score=69.41 Aligned_cols=34 Identities=24% Similarity=0.199 Sum_probs=31.0
Q ss_pred ceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
.|++++.||+|+||+||+|++.. |+.||||++..
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~ 90 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL 90 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEEC
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEec
Confidence 49999999999999999999876 99999999843
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0046 Score=66.90 Aligned_cols=34 Identities=15% Similarity=0.038 Sum_probs=30.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++. |+.||||++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~ 55 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF 55 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEe
Confidence 4567999999999999999999875 899999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0054 Score=66.13 Aligned_cols=36 Identities=28% Similarity=0.277 Sum_probs=32.7
Q ss_pred cccceeEEeeeeeecceEEEEEE----EccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLAR----HRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~----h~~Tg~~vAI~~~ 50 (1238)
....|++++.||+|+||+||+|+ +..+|+.||||++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~ 60 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEe
Confidence 34579999999999999999999 6789999999987
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.96 E-value=0.018 Score=62.28 Aligned_cols=122 Identities=22% Similarity=0.214 Sum_probs=79.9
Q ss_pred Cccchhhhcc-cccchhHHHHHHHHHHHHHhHh-hccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccccCC
Q psy6346 274 GEIFDYIARY-GRMNENAARRKFWQILSAVEYC-HNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWCGS 351 (1238)
Q Consensus 274 GSL~d~Lkk~-~~Lsesea~kI~~QILsALeYL-HSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~GT 351 (1238)
.+|.++|..+ .++++++++.++.|.+.+|.-+ +...-..+=+.|..|+|..+|.|.+.+ +.+. ...
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~ 100 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE 100 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence 4778888755 5799999999999999998776 211112444567889999999887764 2111 122
Q ss_pred CCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhccc
Q psy6346 352 PPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 352 p~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~k 426 (1238)
..+.+||.... ..+.+.=|||||+++|.-+-=.+|- .-+..+|+.+..||..|...
T Consensus 101 ~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 101 PPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred cCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 35678887641 2256788999999999877422211 12345899999999999866
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=95.95 E-value=0.006 Score=66.61 Aligned_cols=37 Identities=16% Similarity=0.139 Sum_probs=33.0
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
..+.|++++.||+|+||+||+|++.. |+.||||++..
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~ 56 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFN 56 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccc
Confidence 45679999999999999999999976 99999999843
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0056 Score=66.34 Aligned_cols=36 Identities=17% Similarity=0.208 Sum_probs=30.3
Q ss_pred cccceeEEeeeeeecceEEEEEEEc-------cCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHR-------ITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~-------~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++. .++..||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~ 75 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeee
Confidence 4478999999999999999999986 57889999988
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0066 Score=65.72 Aligned_cols=36 Identities=25% Similarity=0.325 Sum_probs=32.1
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...++|++++.||+|+||+||+|++ +|+.||||++.
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~ 69 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILM 69 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEC
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEec
Confidence 4567899999999999999999987 68999999883
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0051 Score=65.91 Aligned_cols=38 Identities=24% Similarity=0.342 Sum_probs=27.2
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCC---EEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKT---EVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~---~vAI~~~i 51 (1238)
...+.|++++.||+|+||+||+|++..++. .||||++.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~ 60 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEec
Confidence 345679999999999999999999999886 89999883
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0054 Score=65.01 Aligned_cols=36 Identities=19% Similarity=0.150 Sum_probs=32.3
Q ss_pred cccceeEEeeeeeecceEEEEEEE-----ccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARH-----RITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h-----~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++ ..+++.||||++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~ 61 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhc
Confidence 346799999999999999999994 678999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0048 Score=66.37 Aligned_cols=37 Identities=27% Similarity=0.171 Sum_probs=33.1
Q ss_pred ccccceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++. .+++.||||++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~ 85 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML 85 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEEC
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEe
Confidence 34578999999999999999999998 56799999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0037 Score=69.47 Aligned_cols=36 Identities=17% Similarity=0.161 Sum_probs=30.5
Q ss_pred cccceeEEeeeeeecceEEEEEE-----EccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLAR-----HRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~-----h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|+ +..+++.||||++
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~ 109 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 109 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEEC
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEec
Confidence 45679999999999999999999 6678999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0073 Score=62.30 Aligned_cols=37 Identities=5% Similarity=-0.012 Sum_probs=33.1
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
...++.|++++.||+|+||+||+|++. |+.||||++.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~ 42 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLK 42 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEEC
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEec
Confidence 346788999999999999999999985 8999999983
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=95.86 E-value=0.0066 Score=63.69 Aligned_cols=36 Identities=19% Similarity=0.150 Sum_probs=32.6
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCC-------EEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKT-------EVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~-------~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..+|+ .||||++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~ 48 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL 48 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhc
Confidence 45679999999999999999999999984 6999887
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.0064 Score=65.69 Aligned_cols=37 Identities=24% Similarity=0.319 Sum_probs=33.1
Q ss_pred ccccceeEEeeeeeecceEEEEEE----EccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLAR----HRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~----h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|+ +..+|+.||||++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~ 78 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 78 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEE
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEe
Confidence 345569999999999999999999 6789999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=95.84 E-value=0.0062 Score=67.07 Aligned_cols=33 Identities=18% Similarity=0.309 Sum_probs=29.8
Q ss_pred ceeEEeeeeeecceEEEEEEEccC-----CCEEEEEEe
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRIT-----KTEVGALCS 50 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~T-----g~~vAI~~~ 50 (1238)
.|++++.||+|+||+||+|++..+ ++.||||++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~ 73 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE 73 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEe
Confidence 799999999999999999999875 689999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=95.84 E-value=0.0077 Score=62.61 Aligned_cols=35 Identities=26% Similarity=0.217 Sum_probs=31.2
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+.|++.+.||+|+||+||+|++. |+.||||++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~ 39 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAAR 39 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEe
Confidence 4678999999999999999999974 8999999884
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=95.81 E-value=0.0078 Score=62.76 Aligned_cols=34 Identities=24% Similarity=0.294 Sum_probs=30.9
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+.|++++.||+|+||+||+|++. ++..||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~ 42 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI 42 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEe
Confidence 457999999999999999999998 4778999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=95.80 E-value=0.0051 Score=68.50 Aligned_cols=36 Identities=17% Similarity=0.194 Sum_probs=31.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEc-------cCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHR-------ITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~-------~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++. .++..||||++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~ 121 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML 121 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEe
Confidence 4578999999999999999999976 45678999988
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=95.80 E-value=0.0072 Score=65.47 Aligned_cols=31 Identities=16% Similarity=0.028 Sum_probs=28.1
Q ss_pred eeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 19 YDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 19 Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
|.+++.||+|+||.||+|++ .+|+.||||++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~ 122 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFH 122 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEE
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEE
Confidence 34449999999999999999 99999999988
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=95.73 E-value=0.0078 Score=64.35 Aligned_cols=35 Identities=20% Similarity=0.135 Sum_probs=31.4
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+.|++++.||+|+||+||+|++. +|+.||||++.
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~ 61 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN 61 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEec
Confidence 346999999999999999999996 59999999984
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=95.73 E-value=0.0098 Score=61.86 Aligned_cols=35 Identities=23% Similarity=0.398 Sum_probs=31.2
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++. ++..||||++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~ 40 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMI 40 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEe
Confidence 4567999999999999999999776 5778999988
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=95.72 E-value=0.007 Score=64.13 Aligned_cols=36 Identities=22% Similarity=0.152 Sum_probs=32.0
Q ss_pred cccceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++. .+|+.||||++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~ 61 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEEC
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEec
Confidence 4567999999999999999999984 56689999988
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=95.67 E-value=0.011 Score=63.66 Aligned_cols=36 Identities=19% Similarity=0.115 Sum_probs=32.0
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCC-----EEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKT-----EVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~-----~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++..+|. .||||++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~ 84 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhc
Confidence 34679999999999999999999988876 7999887
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.67 E-value=0.009 Score=64.58 Aligned_cols=37 Identities=16% Similarity=0.129 Sum_probs=32.1
Q ss_pred cccceeEEeeeeeecceEEEEEEE-----ccCCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARH-----RITKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h-----~~Tg~~vAI~~~i 51 (1238)
..+.|++++.||+|+||+||+|++ ..++..||||++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~ 84 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 84 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecc
Confidence 346799999999999999999998 3567899999983
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.008 Score=64.63 Aligned_cols=32 Identities=25% Similarity=0.275 Sum_probs=30.0
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.|++++.||+|+||+||+|++ +|+.||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~ 73 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF 73 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEe
Confidence 5799999999999999999998 5999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=95.66 E-value=0.0083 Score=62.89 Aligned_cols=35 Identities=23% Similarity=0.325 Sum_probs=28.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+|++++.||+|+||+||+|++. ++..||||++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~ 56 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI 56 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEe
Confidence 4457999999999999999999887 6888999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0061 Score=65.15 Aligned_cols=37 Identities=19% Similarity=0.275 Sum_probs=33.0
Q ss_pred ccccceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++. .+++.||||++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~ 63 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 63 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEEC
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEec
Confidence 34467999999999999999999988 57899999988
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.64 E-value=0.027 Score=62.49 Aligned_cols=31 Identities=23% Similarity=0.334 Sum_probs=27.7
Q ss_pred cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.012 Score=60.98 Aligned_cols=34 Identities=24% Similarity=0.294 Sum_probs=31.1
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+.|++++.||+|+||+||+|++. ++..||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~ 40 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI 40 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEc
Confidence 457999999999999999999997 6889999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.0056 Score=66.89 Aligned_cols=35 Identities=17% Similarity=0.237 Sum_probs=26.6
Q ss_pred cceeEEeeeeeecceEEEEEEEcc---CCCEEEEEEeE
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRI---TKTEVGALCSI 51 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~---Tg~~vAI~~~i 51 (1238)
+.|++++.||+|+||+||+|++.. ++..||||++.
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~ 74 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY 74 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeee
Confidence 469999999999999999999998 99999999883
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=95.60 E-value=0.0058 Score=65.89 Aligned_cols=37 Identities=16% Similarity=0.185 Sum_probs=28.4
Q ss_pred ccccceeEEeeeeeecceEEEEEE-----EccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLAR-----HRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~-----h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|+ +..+|+.||||++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~ 68 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEe
Confidence 355789999999999999999999 6788999999988
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0096 Score=62.41 Aligned_cols=35 Identities=29% Similarity=0.440 Sum_probs=31.6
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++ +|+.||||++
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~ 52 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI 52 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEEC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEe
Confidence 4567899999999999999999987 4899999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=95.56 E-value=0.008 Score=69.50 Aligned_cols=32 Identities=13% Similarity=0.152 Sum_probs=29.8
Q ss_pred eeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 19 YDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 19 Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
|.|++.||.|+||.||+|++. +|+.||||+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r 128 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHR 128 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEEC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEe
Confidence 999999999999999999985 69999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.54 E-value=0.0053 Score=68.17 Aligned_cols=32 Identities=19% Similarity=0.209 Sum_probs=27.7
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+++++++.||+|+||+||+|++.. .||||++
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~ 66 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKIL 66 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEE
Confidence 3568899999999999999998754 4999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=95.52 E-value=0.01 Score=64.04 Aligned_cols=37 Identities=22% Similarity=0.223 Sum_probs=33.1
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEE--EEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEV--GALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~v--AI~~~ 50 (1238)
...+.|++++.||+|+||+||+|++..+|..+ |||.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~ 60 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeee
Confidence 45678999999999999999999999999977 77776
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=95.43 E-value=0.014 Score=60.96 Aligned_cols=35 Identities=17% Similarity=0.194 Sum_probs=31.1
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|++. ++..||||++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~ 45 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL 45 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEe
Confidence 4467999999999999999999975 5788999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.41 E-value=0.014 Score=64.94 Aligned_cols=36 Identities=22% Similarity=0.200 Sum_probs=31.3
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCC-------CEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITK-------TEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg-------~~vAI~~~ 50 (1238)
..+.|.+++.||+|+||+||+|++..++ ..||||++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~ 109 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 109 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEee
Confidence 3467999999999999999999987554 58999988
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.40 E-value=0.015 Score=61.04 Aligned_cols=37 Identities=22% Similarity=0.168 Sum_probs=31.2
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCC---EEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKT---EVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~---~vAI~~~ 50 (1238)
..--.|++++.||+|+||+||+|++..++. .||||++
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~ 57 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL 57 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEE
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeec
Confidence 334458889999999999999999877666 8999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=95.30 E-value=0.0094 Score=63.59 Aligned_cols=37 Identities=16% Similarity=0.221 Sum_probs=30.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEcc---CCCEEEEEEeE
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRI---TKTEVGALCSI 51 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~---Tg~~vAI~~~i 51 (1238)
..+.|.+++.||+|+||+||+|++.. ++..||||++.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~ 71 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK 71 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC-
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEe
Confidence 34579999999999999999998876 67799999983
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1238 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-73 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 0.003 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-68 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 0.001 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 0.002 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 0.004 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-66 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 0.004 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 0.002 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-64 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-64 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 0.003 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-64 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-64 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 0.004 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-61 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-60 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 0.002 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-59 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 0.003 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 0.001 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 0.003 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-58 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-57 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-55 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 0.003 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-53 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-52 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-52 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 0.003 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-50 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-48 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-48 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 0.001 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 0.003 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 0.003 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-17 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 3e-73
Identities = 73/231 (31%), Positives = 134/231 (58%), Gaps = 3/231 (1%)
Query: 218 VAIKIIDKSQLDPVNLQK-VYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
+A+K++ K+QL+ ++ + REVEI L HP+I++L+ + +Y++ EYA G +
Sbjct: 34 LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 93
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + + + +E ++ +A+ YCH++RV+HRD+K ENLL+ S ++K+ADFG+S
Sbjct: 94 YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 153
Query: 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
+ P + T CG+ Y PE+ EG+ + ++D+WSLGV+ Y + G PF+ +T
Sbjct: 154 V-HAPSSRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
Query: 397 LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447
R+ F P F++ LI ++L P++R + ++ H W+ +
Sbjct: 212 TYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 262
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (90), Expect = 0.003
Identities = 11/27 (40%), Positives = 17/27 (62%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
++I R +GKG F V LAR + +K +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFIL 34
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-68
Identities = 70/238 (29%), Positives = 124/238 (52%), Gaps = 7/238 (2%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+KI+D + + + +E+ I K L+H +++K + ++ Y+ EY + GE+F
Sbjct: 33 VAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D I M E A+R F Q+++ V Y H + HRD+K ENLL+D ++K++DFG +
Sbjct: 92 DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 151
Query: 338 YYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ + L CG+ PY APE+ + +++ +D+WS G+VL ++ G LP+D +
Sbjct: 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211
Query: 395 NSLRDRVLSG---RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPR 449
+ + + +L+ K+LV P+ R I IK+ RW + +
Sbjct: 212 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 0.001
Identities = 10/27 (37%), Positives = 20/27 (74%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
+D+ +T+G+G + V+LA +R+T+ V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAV 33
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 4e-67
Identities = 63/253 (24%), Positives = 118/253 (46%), Gaps = 13/253 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A K+ID + L+ E++I+ DHP+I+KL ++ ++I+ E+ G +
Sbjct: 40 AAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97
Query: 278 DYIARYGR-MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ R + E+ + Q L A+ Y H+ +++HRDLKA N+L + DIKLADFG S
Sbjct: 98 AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS 157
Query: 337 NYYV-PGQKLATWCGSPPYAAPEVFEGKKYC----GPEIDIWSLGVVLYVLVCGALPFDG 391
Q+ ++ G+P + APEV + + D+WSLG+ L + P
Sbjct: 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217
Query: 392 STLNSLRDRVLSG---RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448
+ ++ P S+ + ++K L + R+ Q+ +H ++ ++
Sbjct: 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277
Query: 449 RLLPPINILGEVK 461
+ + ++ E K
Sbjct: 278 KPIRE--LIAEAK 288
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 0.002
Identities = 8/28 (28%), Positives = 14/28 (50%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
F++I +G G F V A+++ T
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLA 40
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 8e-67
Identities = 70/238 (29%), Positives = 115/238 (48%), Gaps = 14/238 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVM--ETKSMIYIVSEYANQGE 275
+ K +D + Q + EV ++++L HP+I++ + + T + +YIV EY G+
Sbjct: 32 LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD 91
Query: 276 IFDYIARYGR----MNENAARRKFWQILSAVEYCHNR-----RVVHRDLKAENLLMDSNL 326
+ I + + ++E R Q+ A++ CH R V+HRDLK N+ +D
Sbjct: 92 LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151
Query: 327 DIKLADFGFSNYYVPGQKLA-TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
++KL DFG + A + G+P Y +PE Y + DIWSLG +LY L
Sbjct: 152 NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCAL 210
Query: 386 ALPFDGSTLNSLRDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRW 442
PF + L ++ G+F RIPY S E +I +ML + R +E+I +
Sbjct: 211 MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (89), Expect = 0.004
Identities = 6/27 (22%), Positives = 13/27 (48%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
Y++ TIG G++ + R + +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKIL 32
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 9e-66
Identities = 72/238 (30%), Positives = 121/238 (50%), Gaps = 11/238 (4%)
Query: 218 VAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
AIKI++K + + V RE ++M +LDHP +KL+ + +Y YA GE+
Sbjct: 36 YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 95
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
YI + G +E R +I+SA+EY H + ++HRDLK EN+L++ ++ I++ DFG +
Sbjct: 96 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 155
Query: 337 NYYVPGQKLA---TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
P K A ++ G+ Y +PE+ K D+W+LG ++Y LV G PF
Sbjct: 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGN 214
Query: 394 LNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQ------IKRHRWMAE 445
+ +++ + P + L+ K+LV + TKR E+ +K H +
Sbjct: 215 EYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (89), Expect = 0.004
Identities = 9/27 (33%), Positives = 15/27 (55%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
+ + +G+G+F+ V LAR T E
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREY 36
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 220 bits (562), Expect = 2e-65
Identities = 80/245 (32%), Positives = 132/245 (53%), Gaps = 17/245 (6%)
Query: 218 VAIKIIDKSQLDPVNLQKV-------YREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSE 269
A+KIID + + ++V +EV+I++++ HP+II+L ET + ++V +
Sbjct: 31 YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD 90
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
+GE+FDY+ ++E R+ +L + H +VHRDLK EN+L+D +++IK
Sbjct: 91 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 150
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEG-----KKYCGPEIDIWSLGVVLYVLVC 384
L DFGFS PG+KL CG+P Y APE+ E G E+D+WS GV++Y L+
Sbjct: 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210
Query: 385 GALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYCIEQIKRH 440
G+ PF + ++SG ++ S + L+ + LV +P KRY E+ H
Sbjct: 211 GSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270
Query: 441 RWMAE 445
+ +
Sbjct: 271 PFFQQ 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 39.3 bits (91), Expect = 0.002
Identities = 8/27 (29%), Positives = 15/27 (55%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
Y+ + +G+G +VV+ H+ T E
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEY 31
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (559), Expect = 2e-64
Identities = 59/265 (22%), Positives = 103/265 (38%), Gaps = 10/265 (3%)
Query: 218 VAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VAIK + S Q + +EV +++L HP+ I+ + ++V EY
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ E L + Y H+ ++HRD+KA N+L+ +KL DFG +
Sbjct: 103 DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162
Query: 337 NYYVPGQKLATWCGSPPYAAPEVFEG--KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ P ++ G+P + APEV + ++D+WSLG+ L P
Sbjct: 163 SIMAPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
Query: 395 NSLRDRVLSGRFR--IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP--RL 450
S + S + + L + P R E + +HR++ E P +
Sbjct: 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279
Query: 451 LPPINILGEVKNEPNEQILRLMNSL 475
+ I + E + R M +
Sbjct: 280 MDLIQRTKDAVRELDNLQYRKMKKI 304
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (558), Expect = 2e-64
Identities = 92/284 (32%), Positives = 144/284 (50%), Gaps = 21/284 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK I K L+ + E+ ++ ++ HP+I+ L + E+ +Y++ + + GE+F
Sbjct: 37 VAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 95
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLL---MDSNLDIKLADFG 334
D I G E A R +Q+L AV+Y H+ +VHRDLK ENLL +D + I ++DFG
Sbjct: 96 DRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
S PG L+T CG+P Y APEV K Y +D WS+GV+ Y+L+CG PF
Sbjct: 156 LSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDEND 214
Query: 395 NSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRL 450
L +++L + +S + IR ++ ++P KR+ EQ +H W+A +T
Sbjct: 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA-- 272
Query: 451 LPPINILGEVKNEPNEQILRLMNSLGIDAAKTKEVFEAETSKRR 494
NI V + + + +K K+ F A R
Sbjct: 273 -LDKNIHQSVSEQIKKNFAK---------SKWKQAFNATAVVRH 306
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 0.003
Identities = 10/28 (35%), Positives = 14/28 (50%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
YD +G G F+ V LA + T+ V
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLV 37
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-64
Identities = 62/243 (25%), Positives = 118/243 (48%), Gaps = 10/243 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAI+ ++ Q + + E+ +M++ +P+I+ +++V EY G +
Sbjct: 48 VAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
D + M+E + L A+E+ H+ +V+HRD+K++N+L+ + +KL DFGF
Sbjct: 106 DVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164
Query: 338 -YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
K +T G+P + APEV K Y GP++DIWSLG++ ++ G P+
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223
Query: 397 LRDRVLSG---RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM--AEETPRLL 451
+ + + P +S + + L + KR +++ +H+++ A+ L
Sbjct: 224 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
Query: 452 PPI 454
P I
Sbjct: 284 PLI 286
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 218 bits (557), Expect = 9e-64
Identities = 68/243 (27%), Positives = 116/243 (47%), Gaps = 10/243 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
A K + + + V +E++ M L HP ++ L E + + ++ E+ + GE+F
Sbjct: 54 FAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 111
Query: 278 DYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD--IKLADFG 334
+ +A + +M+E+ A Q+ + + H VH DLK EN++ + +KL DFG
Sbjct: 112 EKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ + P Q + G+ +AAPEV EGK G D+WS+GV+ Y+L+ G PF G
Sbjct: 172 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGEND 230
Query: 395 NSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRL 450
+ V S + + +S + + IRK+L+ +P R I Q H W+
Sbjct: 231 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290
Query: 451 LPP 453
Sbjct: 291 RDS 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 38.5 bits (89), Expect = 0.004
Identities = 10/27 (37%), Positives = 11/27 (40%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
YDI +G G F VV R T
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNF 54
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 218 bits (555), Expect = 2e-63
Identities = 66/244 (27%), Positives = 112/244 (45%), Gaps = 10/244 (4%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
K I+ P++ V E+ IM QL HP +I L E K + ++ E+ + GE+F
Sbjct: 57 FVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 114
Query: 278 DYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD--IKLADFG 334
D IA +M+E Q +++ H +VH D+K EN++ ++ +K+ DFG
Sbjct: 115 DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ P + + + +AAPE+ + + G D+W++GV+ YVL+ G PF G
Sbjct: 175 LATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDD 233
Query: 395 NSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRL 450
V + +S E + I+ +L +EP KR + H W+ + L
Sbjct: 234 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
Query: 451 LPPI 454
I
Sbjct: 294 TSRI 297
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-63
Identities = 55/271 (20%), Positives = 119/271 (43%), Gaps = 16/271 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
K + D V ++ +E+ I+ H +I+ L + E+ + ++ E+ + +IF
Sbjct: 33 YMAKFVKVKGTDQVLVK---KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89
Query: 278 DYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADFG 334
+ I +NE Q+ A+++ H+ + H D++ EN++ + + IK+ +FG
Sbjct: 90 ERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ PG +P Y APEV + D+WSLG ++YVL+ G PF T
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 395 NSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETPRL 450
+ + +++ + +S E + ++LV+E R + +H W+ ++ R+
Sbjct: 209 QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
Query: 451 LPPINILGEVKNEPNEQILRLMNSLGIDAAK 481
+ ++ + + + ++
Sbjct: 269 STKV-----IRTLKHRRYYHTLIKKDLNMVV 294
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 1e-62
Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 27/283 (9%)
Query: 171 TSIDGRRLRLDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP 230
S DGR L+ D + G S + TV VA + +L
Sbjct: 4 MSNDGRFLKFD--------------IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 49
Query: 231 VNLQKVYREVEIMKQLDHPHIIKLFQVMET----KSMIYIVSEYANQGEIFDYIARYGRM 286
Q+ E E++K L HP+I++ + E+ K I +V+E G + Y+ R+ M
Sbjct: 50 SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM 109
Query: 287 NENAARRKFWQILSAVEYCH--NRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYVPGQ 343
R QIL +++ H ++HRDLK +N+ + +K+ D G +
Sbjct: 110 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRAS 168
Query: 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-TLNSLRDRVL 402
G+P + APE++E K +D+++ G+ + + P+ + RV
Sbjct: 169 FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226
Query: 403 SG--RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
SG E + +I + + +RY I+ + H +
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 8e-62
Identities = 57/273 (20%), Positives = 112/273 (41%), Gaps = 48/273 (17%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
+A K+I ++ P ++ RE++++ + + P+I+ + + I I E+ + G +
Sbjct: 34 MARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNR-RVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ + GR+ E + ++ + Y + +++HRD+K N+L++S +IKL DFG S
Sbjct: 93 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
Query: 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
+ ++ G+ Y +PE +G Y + DIWS+G+ L + G P
Sbjct: 153 GQLIDSM-ANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 397 LR----------------DRVLSGRFRIPYFM---------------------------- 412
L GR Y M
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270
Query: 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
S E + + K L++ P +R ++Q+ H ++
Sbjct: 271 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-61
Identities = 50/250 (20%), Positives = 105/250 (42%), Gaps = 14/250 (5%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ +VA+K+++ + P LQ EV ++++ H +I+ T + IV+++
Sbjct: 28 KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCE 86
Query: 273 QGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
++ ++ + Q ++Y H + ++HRDLK+ N+ + +L +K+
Sbjct: 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIG 146
Query: 332 DFGFSNYYVPG---QKLATWCGSPPYAAPEVFEGKKYC--GPEIDIWSLGVVLYVLVCGA 386
DFG + + GS + APEV + + D+++ G+VLY L+ G
Sbjct: 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206
Query: 387 LPFDGSTLNSLRDRVLSGRFRIPYF------MSTECESLIRKMLVREPTKRYCIEQIKRH 440
LP+ ++ + P + L+ + L ++ +R QI
Sbjct: 207 LPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
Query: 441 -RWMAEETPR 449
+A P+
Sbjct: 267 IELLARSLPK 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 7e-60
Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 5/232 (2%)
Query: 218 VAIKIIDKSQ-LDPVNLQKVYREVEIM-KQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
AIK + K L +++ E ++ +HP + +F +TK ++ V EY N G+
Sbjct: 30 FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 89
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ +I + + + A +I+ +++ H++ +V+RDLK +N+L+D + IK+ADFG
Sbjct: 90 LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM 149
Query: 336 SNYYVPGQKLATW-CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTL 394
+ G CG+P Y APE+ G+KY +D WS GV+LY ++ G PF G
Sbjct: 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDE 208
Query: 395 NSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIE-QIKRHRWMAE 445
L + P ++ E + L+ K+ VREP KR + I++H E
Sbjct: 209 EELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (91), Expect = 0.002
Identities = 8/27 (29%), Positives = 14/27 (51%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
+ + + +GKG+F V LA + T
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFF 30
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 205 bits (522), Expect = 2e-59
Identities = 68/234 (29%), Positives = 122/234 (52%), Gaps = 9/234 (3%)
Query: 218 VAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+K++ K + ++ E ++ + HP II+++ + I+++ +Y GE+
Sbjct: 32 YAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL 91
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
F + + R A+ ++ A+EY H++ +++RDLK EN+L+D N IK+ DFGF+
Sbjct: 92 FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
Query: 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
Y T CG+P Y APEV K Y ID WS G+++Y ++ G PF S
Sbjct: 152 KYV--PDVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
Query: 397 LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC-----IEQIKRHRWMAE 445
+++L+ R P F + + + L+ +++ R+ ++R E +K H W E
Sbjct: 209 TYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 38.9 bits (90), Expect = 0.003
Identities = 10/27 (37%), Positives = 13/27 (48%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
+ I RT+G G+F V L R R
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYY 32
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-59
Identities = 79/249 (31%), Positives = 129/249 (51%), Gaps = 14/249 (5%)
Query: 218 VAIKIIDKSQL----DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
A K I K + V+ + + REV I+K++ HP++I L +V E K+ + ++ E
Sbjct: 38 YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN----LDIK 329
GE+FD++A + E A QIL+ V Y H+ ++ H DLK EN+++ IK
Sbjct: 98 GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
+ DFG ++ G + G+P + APE+ + G E D+WS+GV+ Y+L+ GA PF
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPF 216
Query: 390 DGSTLNSLRDRVLSGRFRIP--YF--MSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445
G T V + + YF S + IR++LV++P KR I+ +H W+
Sbjct: 217 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
Query: 446 -ETPRLLPP 453
+T + L
Sbjct: 277 KDTQQALSS 285
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (93), Expect = 0.001
Identities = 11/28 (39%), Positives = 15/28 (53%)
Query: 18 FYDIERTIGKGNFAVVKLARHRITKTEV 45
+YD +G G FAVVK R + T +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQY 38
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 4e-59
Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 16/248 (6%)
Query: 218 VAIKIIDKSQL----DPVNLQKVYREVEIMKQLDHPH--IIKLFQVMETKSMIYIVSEYA 271
VAIK ++K ++ + N +V EV ++K++ +I+L E ++ E
Sbjct: 32 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 91
Query: 272 -NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LDIK 329
++FD+I G + E AR FWQ+L AV +CHN V+HRD+K EN+L+D N ++K
Sbjct: 92 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 151
Query: 330 LADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
L DFG + + G+ Y+ PE +Y G +WSLG++LY +VCG +PF
Sbjct: 152 LIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 390 DGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE-ETP 448
+ + ++ G+ +S+EC+ LIR L P+ R E+I+ H WM + P
Sbjct: 211 EHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264
Query: 449 RLLPPINI 456
+ I++
Sbjct: 265 QETAEIHL 272
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (90), Expect = 0.003
Identities = 7/33 (21%), Positives = 10/33 (30%), Gaps = 1/33 (3%)
Query: 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
P+ Y + +G G F V V
Sbjct: 1 PLE-SQYQVGPLLGSGGFGSVYSGIRVSDNLPV 32
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-58
Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 14/250 (5%)
Query: 218 VAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+KI+ K + + E +++ HP + L +T + V EYAN GE+
Sbjct: 33 YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL 92
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
F +++R E AR +I+SA+EY H+R VV+RD+K ENL++D + IK+ DFG
Sbjct: 93 FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
Query: 337 -NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN 395
G + T+CG+P Y APEV E Y G +D W LGVV+Y ++CG LPF
Sbjct: 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 396 SLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC-----IEQIKRHRWMAE----- 445
L + +L R P +S E +SL+ +L ++P +R +++ HR+
Sbjct: 212 RLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271
Query: 446 -ETPRLLPPI 454
+LLPP
Sbjct: 272 VVQKKLLPPF 281
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-57
Identities = 87/291 (29%), Positives = 137/291 (47%), Gaps = 32/291 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET----KSMIYIVSEYAN 272
A+K++ K REVE+ + PHI+++ V E + + IV E +
Sbjct: 40 FALKMLQDCP-------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92
Query: 273 QGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLD 327
GE+F I G E A I A++Y H+ + HRD+K ENLL S N
Sbjct: 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 152
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
+KL DFGF+ L T C +P Y APEV +KY D+WSLGV++Y+L+CG
Sbjct: 153 LKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYP 211
Query: 388 PFDG----STLNSLRDRVLSGRFRIPY----FMSTECESLIRKMLVREPTKRYCIEQIKR 439
PF + ++ R+ G++ P +S E + LIR +L EPT+R I +
Sbjct: 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
Query: 440 HRWMAEETPRLLPPINILGEVKNEP------NEQILRLMNSLGIDAAKTKE 484
H W+ + T P++ +K + E++ + ++ +D + K
Sbjct: 272 HPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKI 322
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 196 bits (499), Expect = 7e-56
Identities = 57/255 (22%), Positives = 113/255 (44%), Gaps = 19/255 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVY----REVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273
A+K +DK ++ + + + ++ D P I+ + T + + + N
Sbjct: 32 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 91
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
G++ +++++G +E R +I+ +E+ HNR VV+RDLK N+L+D + ++++D
Sbjct: 92 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 151
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G + + +K G+ Y APEV + D +SLG +L+ L+ G PF
Sbjct: 152 GLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210
Query: 394 LNS---LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRY-----CIEQIKRHRWMAE 445
+ L+ +P S E SL+ +L R+ +R +++K +
Sbjct: 211 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
Query: 446 ------ETPRLLPPI 454
+ PP+
Sbjct: 271 LDWQMVFLQKYPPPL 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-55
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 12/228 (5%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-METKSMIYIVSEYANQGEI 276
VA+K I Q E +M QL H ++++L V +E K +YIV+EY +G +
Sbjct: 33 VAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88
Query: 277 FDYIARYGR--MNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
DY+ GR + + + + A+EY VHRDL A N+L+ + K++DFG
Sbjct: 89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 148
Query: 335 FSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV-CGALPFDGST 393
+ Q T + APE KK+ + D+WS G++L+ + G +P+
Sbjct: 149 LTKEASSTQD--TGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIP 205
Query: 394 LNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
L + RV G + P +++ + R Q++
Sbjct: 206 LKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-55
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 8/229 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+KI+ DP ++ E +M+QLD+P+I+++ + E +S +V E A G +
Sbjct: 37 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLN 95
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
Y+ + + + Q+ ++Y VHRDL A N+L+ + K++DFG S
Sbjct: 96 KYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 155
Query: 338 YYVPGQKLAT----WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGS 392
+ + APE K+ + D+WS GV+++ G P+ G
Sbjct: 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGM 214
Query: 393 TLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
+ + + G R P E L+ + R ++
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-54
Identities = 60/271 (22%), Positives = 103/271 (38%), Gaps = 33/271 (12%)
Query: 218 VAIKIIDK---SQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG 274
VAIK I S+ + RE++++++L HP+II L KS I +V ++
Sbjct: 26 VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD 85
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ + + L +EY H ++HRDLK NLL+D N +KLADFG
Sbjct: 86 LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG 145
Query: 335 FSNYYVPGQKLATW-CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
+ + + T + Y APE+ G + G +D+W++G +L L+ G +
Sbjct: 146 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205
Query: 394 LNSLRDRVLSGRF----------------------------RIPYFMSTECESLIRKMLV 425
R+ I + LI+ + +
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265
Query: 426 REPTKRYCIEQIKRHRWMAEETPRLLPPINI 456
P R Q + ++ + P P +
Sbjct: 266 FNPCARITATQALKMKYFSNR-PGPTPGCQL 295
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 187 bits (476), Expect = 7e-54
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 14/239 (5%)
Query: 218 VAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS----MIYIVSEYAN 272
VA+K++ DP + RE + L+HP I+ ++ E ++ + YIV EY +
Sbjct: 35 VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 94
Query: 273 QGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLAD 332
+ D + G M A A+ + H ++HRD+K N+++ + +K+ D
Sbjct: 95 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 154
Query: 333 FGFSNYYVPGQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
FG + + A G+ Y +PE G D++SLG VLY ++ G P
Sbjct: 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPP 213
Query: 389 FDGSTLNSLRDRVLSGRFRIPYF----MSTECESLIRKMLVREPTKRYCIEQIKRHRWM 443
F G + S+ + + P +S + ++++ K L + P RY R +
Sbjct: 214 FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 38.6 bits (89), Expect = 0.003
Identities = 8/27 (29%), Positives = 13/27 (48%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
Y++ +G G + V LAR +V
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDV 35
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 52/234 (22%), Positives = 110/234 (47%), Gaps = 9/234 (3%)
Query: 212 LRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
R +VAIK+I + + + E ++M L H +++L+ V + I+I++EY
Sbjct: 25 WRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 272 NQGEIFDYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G + +Y+ R + A+EY +++ +HRDL A N L++ +K+
Sbjct: 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 141
Query: 331 ADFGFSNYYVPGQKLATW--CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGAL 387
+DFG S Y + + ++ ++ PEV K+ + DIW+ GV+++ + G +
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKM 200
Query: 388 PFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
P++ T + + + G R P+ S + +++ + +R + + +
Sbjct: 201 PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 186 bits (473), Expect = 2e-53
Identities = 70/266 (26%), Positives = 114/266 (42%), Gaps = 30/266 (11%)
Query: 210 VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
+ A+K I + D RE+ I+K+L H +I+KL+ V+ TK + +V E
Sbjct: 21 AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
+ +Q G + A+ Q+L+ + YCH+RRV+HRDLK +NLL++ ++K
Sbjct: 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK 140
Query: 330 LADFGFS-NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
+ADFG + + +P +K + Y AP+V G K IDIWS+G + +V G
Sbjct: 141 IADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 389 FDGSTLNSLRDRVLSGRF-----------------------------RIPYFMSTECESL 419
F G + R+ + L
Sbjct: 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
Query: 420 IRKMLVREPTKRYCIEQIKRHRWMAE 445
+ KML +P +R +Q H + E
Sbjct: 261 LSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-53
Identities = 57/236 (24%), Positives = 107/236 (45%), Gaps = 9/236 (3%)
Query: 210 VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
+ VAIK I + ++ + E E+M +L HP +++L+ V ++ I +V E
Sbjct: 24 GYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80
Query: 270 YANQGEIFDY-IARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
+ G + DY + G + + Y V+HRDL A N L+ N I
Sbjct: 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 140
Query: 329 KLADFGFSNYYVPGQKLATWC--GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-G 385
K++DFG + + + Q ++ +A+PEVF +Y + D+WS GV+++ + G
Sbjct: 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEG 199
Query: 386 ALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
+P++ + + + + + +G R P ST ++ P R ++ R
Sbjct: 200 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 3e-52
Identities = 77/234 (32%), Positives = 127/234 (54%), Gaps = 9/234 (3%)
Query: 218 VAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
A+KI+DK ++ ++ E I++ ++ P ++KL + S +Y+V EY GE+
Sbjct: 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
F ++ R GR +E AR QI+ EY H+ +++RDLK ENLL+D I++ DFGF+
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 337 NYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS 396
T CG+P APE+ K Y +D W+LGV++Y + G PF
Sbjct: 189 KRVKGRTW--TLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 397 LRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC-----IEQIKRHRWMAE 445
+ ++++SG+ R P S++ + L+R +L + TKR+ + IK H+W A
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (464), Expect = 6e-52
Identities = 56/237 (23%), Positives = 98/237 (41%), Gaps = 11/237 (4%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ + VAIK + + E IM Q DHP++I L V+ + + I++E+
Sbjct: 52 KREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110
Query: 273 QGEIFDY-IARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + + G+ I + ++Y + VHRDL A N+L++SNL K++
Sbjct: 111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVS 170
Query: 332 DFGFSNYYVPGQKLAT------WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVC 384
DFG S + T + APE + +K+ D+WS G+V++ V+
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSY 229
Query: 385 GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
G P+ T + + + R P + L+ ++ R QI
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-52
Identities = 65/299 (21%), Positives = 121/299 (40%), Gaps = 46/299 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI----YIVSEYANQ 273
VAIK I + Q+ RE++I+ + H +II + ++ ++ + +
Sbjct: 36 VAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 94
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
+++ + + ++ + +QIL ++Y H+ V+HRDLK NLL+++ D+K+ DF
Sbjct: 95 ADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 153
Query: 334 GFSNYYVPGQ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF 389
G + P L + + Y APE+ K IDIWS+G +L ++ F
Sbjct: 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213
Query: 390 DGSTLNSLRDRVLSGRF-------------------------------RIPYFMSTECES 418
G + +L R+ ++
Sbjct: 214 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 273
Query: 419 LIRKMLVREPTKRYCIEQIKRHRWMAE-----ETPRLLPPINILGEVKNEPNEQILRLM 472
L+ KML P KR +EQ H ++ + + P P E+ + P E++ L+
Sbjct: 274 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELI 332
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-51
Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 32/270 (11%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQG-EI 276
VA+K I RE+ ++K+L+HP+I+KL V+ T++ +Y+V E+ +Q +
Sbjct: 30 VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK 89
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
F + + + +Q+L + +CH+ RV+HRDLK +NLL+++ IKLADFG +
Sbjct: 90 FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 149
Query: 337 NYY-VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST-- 393
+ VP + + Y APE+ G KY +DIWSLG + +V F G +
Sbjct: 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 394 ---------LNSLRDRVLSGRFRIPYF------------------MSTECESLIRKMLVR 426
L + + V G +P + + + SL+ +ML
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY 269
Query: 427 EPTKRYCIEQIKRHRWMAEETPRLLPPINI 456
+P KR + H + ++ + +P + +
Sbjct: 270 DPNKRISAKAALAHPFF-QDVTKPVPHLRL 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-51
Identities = 66/255 (25%), Positives = 113/255 (44%), Gaps = 13/255 (5%)
Query: 210 VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
T VAIK + + P + +E ++MK+L H +++L+ V+ + IYIV+E
Sbjct: 36 GTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTE 91
Query: 270 YANQGEIFDYIA--RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
Y ++G + D++ + QI S + Y VHRDL+A N+L+ NL
Sbjct: 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 151
Query: 328 IKLADFGFSNYYVPGQKLAT--WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC- 384
K+ADFG + + A + APE ++ + D+WS G++L L
Sbjct: 152 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTK 210
Query: 385 GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR--HR 441
G +P+ G + D+V G R P L+ + +EP +R E ++
Sbjct: 211 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 442 WMAEETPRLLPPINI 456
+ P+ P N+
Sbjct: 271 YFTSTEPQYQPGENL 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-51
Identities = 54/239 (22%), Positives = 106/239 (44%), Gaps = 13/239 (5%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
++VAIK++ + + + +++ RE +IM QLD+P+I++L V + ++ + +V E A G
Sbjct: 37 IDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGP 94
Query: 276 IFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
+ ++ + + + Q+ ++Y + VHRDL A N+L+ + K++DFG
Sbjct: 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154
Query: 335 FSNYYVPGQKLATW----CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPF 389
S T + APE +K+ D+WS GV ++ L G P+
Sbjct: 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPY 213
Query: 390 DGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIK---RHRWMA 444
+ + G R P E +L+ + + R ++ R + +
Sbjct: 214 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-51
Identities = 66/258 (25%), Positives = 133/258 (51%), Gaps = 21/258 (8%)
Query: 218 VAIKIIDKSQL--DPVNLQKVYREVEIMKQLDH-PHIIKLFQVMETKSMIYIVSEYANQG 274
A+K++ K+ + + E ++++ + P ++ L +T++ ++++ +Y N G
Sbjct: 55 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFG 334
E+F ++++ R E+ + +I+ A+E+ H +++RD+K EN+L+DSN + L DFG
Sbjct: 115 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 174
Query: 335 FSNYYVP--GQKLATWCGSPPYAAPEVFEGKKY-CGPEIDIWSLGVVLYVLVCGALPFDG 391
S +V ++ +CG+ Y AP++ G +D WSLGV++Y L+ GA PF
Sbjct: 175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
Query: 392 ----STLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPTKRYC-----IEQIKRHRW 442
++ + R+L P MS + LI+++L+++P KR ++IK H +
Sbjct: 235 DGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294
Query: 443 MAE------ETPRLLPPI 454
+ ++ P
Sbjct: 295 FQKINWDDLAAKKVPAPF 312
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 5e-50
Identities = 48/253 (18%), Positives = 101/253 (39%), Gaps = 32/253 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VA+K++ + + D + + E+++M QL H +I+ L IY++ EY G++
Sbjct: 70 VAVKMLKE-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 277 FDYI-----------------------ARYGRMNENAARRKFWQILSAVEYCHNRRVVHR 313
+Y+ + +Q+ +E+ + VHR
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188
Query: 314 DLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW---CGSPPYAAPEVFEGKKYCGPEI 370
DL A N+L+ +K+ DFG + + + APE Y +
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKS 247
Query: 371 DIWSLGVVLYVLV-CGALPFDGSTLNSLRDRVLSGRFR--IPYFMSTECESLIRKMLVRE 427
D+WS G++L+ + G P+ G +++ +++ F+ P++ + E +++ +
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307
Query: 428 PTKRYCIEQIKRH 440
KR +
Sbjct: 308 SRKRPSFPNLTSF 320
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-50
Identities = 53/274 (19%), Positives = 101/274 (36%), Gaps = 45/274 (16%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--------KSMIYIVSE 269
VA+K + RE++I++ L H +++ L ++ T K IY+V +
Sbjct: 38 VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD 97
Query: 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIK 329
+ + + +R +L+ + Y H +++HRD+KA N+L+ + +K
Sbjct: 98 FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 157
Query: 330 LADFGFSNYYVPGQK-----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC 384
LADFG + + + + Y PE+ G++ GP ID+W G ++ +
Sbjct: 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217
Query: 385 GALPFDGSTLNSLRDRVLSGRFRIP--------------------------------YFM 412
+ G+T + I Y
Sbjct: 218 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR 277
Query: 413 STECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446
LI K+LV +P +R + H + +
Sbjct: 278 DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (89), Expect = 0.003
Identities = 13/31 (41%), Positives = 16/31 (51%)
Query: 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
V Y+ IG+G F V ARHR T +V
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKV 38
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 9e-50
Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 33/283 (11%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQG 274
++ AIK + + + + E+E++ +L HP+II L E + +Y+ EYA G
Sbjct: 38 MDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 96
Query: 275 EIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAE 318
+ D++ + ++ + ++Y ++ +HRDL A
Sbjct: 97 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156
Query: 319 NLLMDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVV 378
N+L+ N K+ADFG S K + A E D+WS GV+
Sbjct: 157 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVL 215
Query: 379 LY-VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQ 436
L+ ++ G P+ G T L +++ G R P E L+R+ +P +R Q
Sbjct: 216 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 437 IKRHRWMAEETPRLLPPINILGEVKNEPNEQILRLMNSLGIDA 479
I +L E K N + GID
Sbjct: 276 ILVSLN------------RMLEERKTYVNTTLYEKFTYAGIDC 306
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 9e-50
Identities = 59/262 (22%), Positives = 115/262 (43%), Gaps = 31/262 (11%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K + D RE+ ++K+L H +I++L V+ + + +V E+ +Q
Sbjct: 30 VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK 89
Query: 278 DYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSN 337
+ + G ++ + +Q+L + +CH+R V+HRDLK +NLL++ N ++KLA+FG +
Sbjct: 90 YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
Query: 338 -YYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP-FDGSTLN 395
+ +P + + + Y P+V G K ID+WS G + L P F G+ ++
Sbjct: 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 396 SLRDRVLSGRFRIPYF-----------------------------MSTECESLIRKMLVR 426
R+ ++ L++ +L
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269
Query: 427 EPTKRYCIEQIKRHRWMAEETP 448
P +R E+ +H + ++ P
Sbjct: 270 NPVQRISAEEALQHPYFSDFCP 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 8/228 (3%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK +K +E M+Q DHPHI+KL V+ T++ ++I+ E GE+
Sbjct: 38 VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 95
Query: 278 DY-IARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336
+ R ++ + +Q+ +A+ Y ++R VHRD+ A N+L+ SN +KL DFG S
Sbjct: 96 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
Query: 337 NYYVPGQKLATWC--GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLY-VLVCGALPFDGST 393
Y + APE +++ D+W GV ++ +L+ G PF G
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 394 LNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
N + R+ +G R +P SL+ K +P++R ++K
Sbjct: 215 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 11/235 (4%)
Query: 213 RHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271
TV+VA+K + L P + REV M LDH ++I+L+ V+ T M +V+E A
Sbjct: 34 GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELA 92
Query: 272 NQGEIFDY-IARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKL 330
G + D G R Q+ + Y ++R +HRDL A NLL+ + +K+
Sbjct: 93 PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKI 152
Query: 331 ADFGFSNYYVPGQKLAT----WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-G 385
DFG + APE + + + D W GV L+ + G
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYG 211
Query: 386 ALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIK 438
P+ G + + ++ R P + +++ + +P R ++
Sbjct: 212 QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-48
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 8/242 (3%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGE 275
+ VAIK + ++ P +++ E +M +D+PH+ +L + T ++ I
Sbjct: 39 IPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCL 97
Query: 276 IFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335
+ + QI + Y +RR+VHRDL A N+L+ + +K+ DFG
Sbjct: 98 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 157
Query: 336 SNYYVPGQKLATWC---GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDG 391
+ +K + A E + Y + D+WS GV ++ L+ G+ P+DG
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDG 216
Query: 392 STLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH-RWMAEETPR 449
+ + + G R P + + ++ K + + R ++ MA + R
Sbjct: 217 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276
Query: 450 LL 451
L
Sbjct: 277 YL 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-48
Identities = 59/264 (22%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL---DHPHIIKLFQVM-----ETKSMIYIVSE 269
VA+K + + REV +++ L +HP++++LF V + ++ + +V E
Sbjct: 36 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 95
Query: 270 YANQGEI-FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDI 328
+ +Q + + + +Q+L +++ H+ RVVHRDLK +N+L+ S+ I
Sbjct: 96 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 155
Query: 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALP 388
KLADFG + Y L + + Y APEV Y +D+WS+G + +
Sbjct: 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPL 214
Query: 389 FDGSTLNSLRDRVLSG---------------------------RFRIPYFMSTECESLIR 421
F GS+ ++L + + + L+
Sbjct: 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274
Query: 422 KMLVREPTKRYCIEQIKRHRWMAE 445
K L P KR H + +
Sbjct: 275 KCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-48
Identities = 56/296 (18%), Positives = 113/296 (38%), Gaps = 45/296 (15%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM------IYIVSEYA 271
VAIK + + + ++ YRE+ ++K + H ++I L V Y+V +
Sbjct: 46 VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM 105
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + ++ ++ E+ + +Q+L + Y H ++HRDLK NL ++ + ++K+
Sbjct: 106 --GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 163
Query: 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
DFG + ++ + + Y APEV +DIWS+G ++ ++ G F G
Sbjct: 164 DFGLA--RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 392 STLNSLRDRVLSGRFRIPYFM-------------------------------STECESLI 420
S ++ P S +L+
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281
Query: 421 RKMLVREPTKRYCIEQIKRHRWMAE----ETPRLLPPINILGEVKNEPNEQILRLM 472
KMLV + +R + H + E + + + + ++ R+
Sbjct: 282 EKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVT 337
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 3e-48
Identities = 61/236 (25%), Positives = 112/236 (47%), Gaps = 10/236 (4%)
Query: 210 VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
V ++++ VA+K + + D + +++ +E +MK++ HP++++L V + YI++E
Sbjct: 37 VWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93
Query: 270 YANQGEIFDYIARYGRMNENAARRKFW--QILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
+ G + DY+ R +A + QI SA+EY + +HRDL A N L+ N
Sbjct: 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 153
Query: 328 IKLADFGFSNYYVPGQKLATW--CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC- 384
+K+ADFG S A + APE K+ + D+W+ GV+L+ +
Sbjct: 154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATY 212
Query: 385 GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
G P+ G L+ + + + R P + L+R P+ R +I +
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 4e-48
Identities = 59/236 (25%), Positives = 100/236 (42%), Gaps = 11/236 (4%)
Query: 210 VLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269
VA+K + + + P E +MKQL H +++L+ V+ T+ IYI++E
Sbjct: 32 GYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITE 87
Query: 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
Y G + D++ ++ N QI + + R +HRDL+A N+L+ L
Sbjct: 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147
Query: 328 IKLADFGFSNYYVPGQKLATW--CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC- 384
K+ADFG + + A + APE + D+WS G++L +V
Sbjct: 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTH 206
Query: 385 GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439
G +P+ G T + + G R P E L+R P R + ++
Sbjct: 207 GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-47
Identities = 56/294 (19%), Positives = 119/294 (40%), Gaps = 41/294 (13%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY----ANQ 273
VA+K + + ++ ++ YRE+ ++K + H ++I L V + ++
Sbjct: 46 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 105
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
G + I + ++ ++ + +QIL ++Y H+ ++HRDLK NL ++ + ++K+ DF
Sbjct: 106 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 165
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G + + ++ + + Y APE+ + +DIWS+G ++ L+ G F G+
Sbjct: 166 GLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223
Query: 394 LNSLRDRVLSGRFRIPYFM-------------------------------STECESLIRK 422
+L + + L+ K
Sbjct: 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283
Query: 423 MLVREPTKRYCIEQIKRHRWMAE----ETPRLLPPINILGEVKNEPNEQILRLM 472
MLV + KR Q H + A+ + + P + E ++ ++ L
Sbjct: 284 MLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLT 337
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-47
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 47/292 (16%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET------KSMIYIVSEYA 271
VAIK + + + + RE++IM++LDH +I++L + + + +V +Y
Sbjct: 48 VAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101
Query: 272 NQG---EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN-LD 327
+ Y + + +Q+ ++ Y H+ + HRD+K +NLL+D +
Sbjct: 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 328 IKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL 387
+KL DFG + V G+ ++ S Y APE+ G ID+WS G VL L+ G
Sbjct: 162 LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
Query: 388 PFDGSTLNSLRDRVLS-----------------GRFRIPYF------------MSTECES 418
F G + ++ F+ P E +
Sbjct: 222 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 281
Query: 419 LIRKMLVREPTKRYCIEQIKRHRWMAEETPRL--LPPINILGEVKNEPNEQI 468
L ++L PT R + H + E LP + N +++
Sbjct: 282 LCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 333
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 1e-45
Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 31/251 (12%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VA+K++ + RE +M + D+P+I+KL V + ++ EY G++
Sbjct: 46 VAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104
Query: 278 DYIARYGR------------------------MNENAARRKFWQILSAVEYCHNRRVVHR 313
+++ ++ Q+ + + Y R+ VHR
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164
Query: 314 DLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA---TWCGSPPYAAPEVFEGKKYCGPEI 370
DL N L+ N+ +K+ADFG S + PE +Y E
Sbjct: 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTES 223
Query: 371 DIWSLGVVLYVLVCGAL-PFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREP 428
D+W+ GVVL+ + L P+ G + V G P E +L+R + P
Sbjct: 224 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 283
Query: 429 TKRYCIEQIKR 439
R I R
Sbjct: 284 ADRPSFCSIHR 294
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 6e-45
Identities = 47/234 (20%), Positives = 98/234 (41%), Gaps = 11/234 (4%)
Query: 216 VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV-METKSMIYIVSEYANQG 274
++ A+K +++ D + + E IMK HP+++ L + + ++ +V Y G
Sbjct: 56 IHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114
Query: 275 EIFDYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333
++ ++I Q+ +++ +++ VHRDL A N ++D +K+ADF
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 174
Query: 334 GFSNYYVPGQKLATWC-----GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GAL 387
G + + + + A E + +K + D+WS GV+L+ L+ GA
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAP 233
Query: 388 PFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
P+ + +L G R P + ++ K + R ++
Sbjct: 234 PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 24/245 (9%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VA+K++ + +L + E+E+MK + H +II L +Y++ EYA++G +
Sbjct: 48 VAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 277 FDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENL 320
+Y+ +++ +Q+ +EY +++ +HRDL A N+
Sbjct: 107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166
Query: 321 LMDSNLDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGV 377
L+ + +K+ADFG + K + APE + Y + D+WS GV
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGV 225
Query: 378 VLY-VLVCGALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIE 435
+L+ + G P+ G + L + G R P + E ++R P++R +
Sbjct: 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
Query: 436 QIKRH 440
Q+
Sbjct: 286 QLVED 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-44
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 9/232 (3%)
Query: 213 RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYAN 272
+ V VAIK + E IM Q H +II+L V+ + I++EY
Sbjct: 34 KKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 92
Query: 273 QGEIFDY-IARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
G + + + G + I + ++Y N VHRDL A N+L++SNL K++
Sbjct: 93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 152
Query: 332 DFGFSNYYVPGQK----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GA 386
DFG S + + + APE +K+ D+WS G+V++ ++ G
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGE 211
Query: 387 LPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQI 437
P+ + + + + G R P + L+ + +E +R I
Sbjct: 212 RPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 50/257 (19%), Positives = 103/257 (40%), Gaps = 29/257 (11%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIVSEYANQGEI 276
VA+K++ S + + E++++ L +H +I+ L +++EY G++
Sbjct: 56 VAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 277 FDYIARYG------------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAE 318
+++ R ++ +Q+ + + ++ +HRDL A
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174
Query: 319 NLLMDSNLDIKLADFGFSNYYVPGQKLAT---WCGSPPYAAPEVFEGKKYCGPEIDIWSL 375
N+L+ K+ DFG + + APE E D+WS
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSY 233
Query: 376 GVVLYVLVC-GALPFDGSTLNSLRDRVLSGRFR--IPYFMSTECESLIRKMLVREPTKRY 432
G+ L+ L G+ P+ G ++S +++ FR P E +++ +P KR
Sbjct: 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 433 CIEQIKRH--RWMAEET 447
+QI + + ++E T
Sbjct: 294 TFKQIVQLIEKQISEST 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 157 bits (398), Expect = 6e-43
Identities = 55/267 (20%), Positives = 108/267 (40%), Gaps = 50/267 (18%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVME--TKSMIYIVSEYANQG 274
V +KI+ + +K+ RE++I++ L P+II L +++ +V E+ N
Sbjct: 63 VVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 275 EIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADF 333
+ + + R ++IL A++YCH+ ++HRD+K N+++D + ++L D+
Sbjct: 118 DFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW 174
Query: 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGST 393
G + +Y PGQ+ S + PE+ + +D+WSLG +L ++ PF
Sbjct: 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
Query: 394 --------------------------------LNSLRDRVLSGRFR------IPYFMSTE 415
N + R R+ + +S E
Sbjct: 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294
Query: 416 CESLIRKMLVREPTKRYCIEQIKRHRW 442
+ K+L + R + H +
Sbjct: 295 ALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 4e-42
Identities = 43/242 (17%), Positives = 83/242 (34%), Gaps = 25/242 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ-VMETKSMIYIVSEYANQGEI 276
VAIK+ P +++ E +I K + I + +V E
Sbjct: 35 VAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLE 90
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLM---DSNLDIKLADF 333
+ + + Q++S +EY H++ +HRD+K +N LM + + DF
Sbjct: 91 DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150
Query: 334 GFSNYYVPGQ--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG 385
G + Y + + G+ YA+ G + D+ SLG VL G
Sbjct: 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLG 209
Query: 386 ALPFDGSTLNSLRDRVLSGRFRIPYF--------MSTECESLIRKMLVREPTKRYCIEQI 437
+LP+ G + R + + +E + + + +
Sbjct: 210 SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269
Query: 438 KR 439
++
Sbjct: 270 RQ 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.2 bits (93), Expect = 0.001
Identities = 12/33 (36%), Positives = 16/33 (48%), Gaps = 1/33 (3%)
Query: 14 IRVG-FYDIERTIGKGNFAVVKLARHRITKTEV 45
+RVG Y + R IG G+F + L EV
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEV 35
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-40
Identities = 58/288 (20%), Positives = 112/288 (38%), Gaps = 56/288 (19%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQV------METKSMIYIVSEYA 271
VAIK + + + + ++ YRE+ +MK ++H +II L V +E +Y+V E
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331
+ ++ +Q+L +++ H+ ++HRDLK N+++ S+ +K+
Sbjct: 105 DANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG 391
DFG + + + + Y APEV G +DIWS+G ++ +V + F G
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 392 STLNSLRDRVLSGRFRIPY----------------------------------------- 410
++V+
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 411 -FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE----ETPRLLPP 453
+++ L+ KMLV +P KR ++ +H ++ PP
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 328
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-40
Identities = 47/238 (19%), Positives = 88/238 (36%), Gaps = 17/238 (7%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQGEIF 277
VAIK ++++ + E +MK+ + H+++L V+ ++ E +G++
Sbjct: 53 VAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 111
Query: 278 DYIARYGRMNENAARRK----------FWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327
Y+ N +I + Y + + VHRDL A N ++ +
Sbjct: 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171
Query: 328 IKLADFGFSNYYVPGQKLATW---CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC 384
+K+ DFG + + +PE + + D+WS GVVL+ +
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIAT 230
Query: 385 GA-LPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440
A P+ G + + V+ G P L+R P R +I
Sbjct: 231 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-40
Identities = 50/266 (18%), Positives = 93/266 (34%), Gaps = 48/266 (18%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME----TKSMIYIVSEYANQ 273
VA+KI + + E+ L H +I+ T + +++VS+Y
Sbjct: 29 VAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85
Query: 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCH--------NRRVVHRDLKAENLLMDSN 325
G +FDY+ RY + + S + + H + HRDLK++N+L+ N
Sbjct: 86 GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144
Query: 326 LDIKLADFGFSNYYVPGQ-----KLATWCGSPPYAAPEVFEGKKYC-----GPEIDIWSL 375
+AD G + + G+ Y APEV + DI+++
Sbjct: 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204
Query: 376 GVVLYVLVCGALPFDGS---------------TLNSLRDRVLSGRFRIPY---FMSTECE 417
G+V + + ++ +R V + R + S E
Sbjct: 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL 264
Query: 418 ----SLIRKMLVREPTKRYCIEQIKR 439
++R+ R +IK+
Sbjct: 265 RVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 9e-40
Identities = 40/244 (16%), Positives = 82/244 (33%), Gaps = 27/244 (11%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDH-PHIIKLFQVMETKSMIYIVSEYANQGEI 276
VAIK + P ++ E K L I ++ + +V +
Sbjct: 33 VAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLE 88
Query: 277 FDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-----DIKLA 331
+ + Q+L+ V+ H + +V+RD+K +N L+ I +
Sbjct: 89 DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148
Query: 332 DFGFSNYY--------VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLV 383
DFG +Y +P ++ G+ Y + G++ D+ +LG V +
Sbjct: 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFL 207
Query: 384 CGALPFDGSTLNSLR---DRVLSGRFRIP-----YFMSTECESLIRKMLVREPTKRYCIE 435
G+LP+ G + + +R+ + P E + +
Sbjct: 208 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD 267
Query: 436 QIKR 439
++
Sbjct: 268 YLQG 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.0 bits (90), Expect = 0.003
Identities = 8/27 (29%), Positives = 15/27 (55%)
Query: 19 YDIERTIGKGNFAVVKLARHRITKTEV 45
Y + R IG+G+F V+ + + +V
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQV 33
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 46/247 (18%), Positives = 95/247 (38%), Gaps = 26/247 (10%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQ--VMETKSMIYIVSEYANQGE 275
VA+K++ + + + E++I+ + H + + + ++ E+ G
Sbjct: 46 VAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104
Query: 276 IFDYIARYGR----------------MNENAARRKFWQILSAVEYCHNRRVVHRDLKAEN 319
+ Y+ + +Q+ +E+ +R+ +HRDL A N
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164
Query: 320 LLMDSNLDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLG 376
+L+ +K+ DFG + + + APE + Y + D+WS G
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFG 223
Query: 377 VVLYVLVCG-ALPFDGSTLNSLRDRVLSG--RFRIPYFMSTECESLIRKMLVREPTKRYC 433
V+L+ + A P+ G ++ R L R R P + + E + EP++R
Sbjct: 224 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 434 IEQIKRH 440
++ H
Sbjct: 284 FSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (319), Expect = 3e-32
Identities = 57/322 (17%), Positives = 110/322 (34%), Gaps = 80/322 (24%)
Query: 218 VAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP-----------HIIKLFQVMETKS---- 262
VA+KI+ D V + E++++++++ HI+KL K
Sbjct: 41 VAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97
Query: 263 -MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR-VVHRDLKAENL 320
++ + + + ++ Q+L ++Y H R ++H D+K EN+
Sbjct: 98 HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157
Query: 321 LMDSN------LDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWS 374
LM+ + IK+AD G + +Y + Y +PEV G + G DIWS
Sbjct: 158 LMEIVDSPENLIQIKIADLGNACWYDEHYT--NSIQTREYRSPEVLLGAPW-GCGADIWS 214
Query: 375 LGVVLYVLVCGALPFDGSTLNSLRD----------------------------------- 399
+++ L+ G F+ +S
Sbjct: 215 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 274
Query: 400 -------------RVLSGRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446
VL+ +++ + E + ML +P KR + H W+ +
Sbjct: 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334
Query: 447 TPR---LLPPINILGEVKNEPN 465
+P + G + P
Sbjct: 335 LGMEEIRVPDRELYGSGSDIPG 356
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 39.2 bits (90), Expect = 0.003
Identities = 11/33 (33%), Positives = 18/33 (54%)
Query: 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEV 45
P + Y + R +G G+F+ V LA+ + T V
Sbjct: 9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHV 41
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.1 bits (194), Expect = 3e-17
Identities = 28/186 (15%), Positives = 53/186 (28%), Gaps = 43/186 (23%)
Query: 218 VAIKIIDKSQLDPVNLQKVY----------------REVEIMKQLDHPHIIKLFQVMETK 261
+K +++ E +++L + K++
Sbjct: 27 CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN- 85
Query: 262 SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLL 321
++ E + R+ IL V ++R +VH DL N+L
Sbjct: 86 ---AVLMELIDAK-------ELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 135
Query: 322 MDSNLDIKLADFGFSNYYVPGQKLATWCGSPPYAAPEV-----FEGKKYCGPEIDIWSLG 376
+ I + DF S G +V + + Y E DI S
Sbjct: 136 VS-EEGIWIIDFPQS-------VEVGEEGWREILERDVRNIITYFSRTY-RTEKDINS-- 184
Query: 377 VVLYVL 382
+ +L
Sbjct: 185 AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1238 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 98.04 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 97.9 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 97.88 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 97.88 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 97.87 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 97.83 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 97.82 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 97.81 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 97.8 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 97.79 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 97.79 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 97.79 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 97.78 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 97.78 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 97.78 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 97.78 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 97.78 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 97.75 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.72 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 97.72 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 97.71 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 97.71 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 97.7 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 97.68 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 97.66 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 97.65 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 97.63 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 97.63 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 97.59 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 97.58 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 97.58 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 97.58 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 97.57 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 97.55 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 97.53 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 97.5 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 97.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.48 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 97.46 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 97.31 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 97.23 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 97.21 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 97.2 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 97.12 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 97.08 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 97.04 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 96.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 96.91 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 96.9 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 96.88 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 96.86 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 96.81 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 96.76 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 96.71 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 96.69 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 96.66 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 96.62 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 96.55 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 96.52 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 96.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.48 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 96.2 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 96.11 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 96.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.77 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.76 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 95.31 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 94.95 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=460.17 Aligned_cols=254 Identities=29% Similarity=0.567 Sum_probs=235.2
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||+|.+..+++.||||++.+.... ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 477888999999999999999999999999999765322 2335678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... ......+
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-~~~~~~~ 165 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLC 165 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-CCCEETT
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-CcccccC
Confidence 999999999999989999999999999999999999999999999999999999999999999999976543 3445678
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
||+.|||||++.+..+ +.++|||||||+||+|++|+.||.+.+..++...+....+.+|..+++++.+||.+||+.||+
T Consensus 166 Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~ 244 (263)
T d2j4za1 166 GTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 244 (263)
T ss_dssp EEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHh
Confidence 9999999999999887 899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccccccc
Q psy6346 430 KRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRPTaeEILeHPWFke~ 446 (1238)
+|||++|+|+||||...
T Consensus 245 ~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 245 QRPMLREVLEHPWITAN 261 (263)
T ss_dssp GSCCHHHHHTCHHHHHH
T ss_pred HCcCHHHHHcCcCcCCc
Confidence 99999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=456.95 Aligned_cols=259 Identities=28% Similarity=0.470 Sum_probs=223.7
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLV 267 (1238)
+-+.|+..+.||.|+||.||+|.+..+|+.||||++++... ....+.+.+|+++|++++|||||++++++.+++.+|||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 34678999999999999999999999999999999987643 23346789999999999999999999999999999999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC---c
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---K 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---~ 344 (1238)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... .
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999998764332 3
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH-HHHHHhcCCccC--CCCCCHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS-LRDRVLSGRFRI--PYFMSTECESLIR 421 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee-L~ekIl~g~~~~--P~~iS~eLkDLIr 421 (1238)
....+||+.|||||++.+..+++.++|||||||+||+|++|+.||.+..... ....+....... ...+++++.+||.
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence 4567899999999999998887789999999999999999999997765433 233333332222 2458999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||+.||++|||++|+|+||||++..
T Consensus 242 ~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 242 KILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 99999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-52 Score=454.87 Aligned_cols=255 Identities=34% Similarity=0.591 Sum_probs=214.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|+||.||+|.+..+++.||||++.+..... ..+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 44888899999999999999999999999999998765432 34678899999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc---CCCcEEEEecCCcccccCCCccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD---SNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd---~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||+||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+. .++.+||+|||++..........
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 999999999999989999999999999999999999999999999999999995 47899999999998776666667
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECESLIRK 422 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLkDLIrk 422 (1238)
+.+||+.|||||++.+..| +.++|||||||+||+|++|..||.+.....+...+..+...++ ..+++++.+||.+
T Consensus 168 ~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 246 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246 (307)
T ss_dssp -----CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred eeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence 7899999999999998887 8999999999999999999999999999999999988766543 4589999999999
Q ss_pred hcccCCCCCCCHHHHHhccccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||.+||++|||++|+++||||+..
T Consensus 247 ~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 247 LMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=457.33 Aligned_cols=256 Identities=29% Similarity=0.538 Sum_probs=232.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
+.|...+.||.|+||.||+|.+..+|+.||||++.+... +....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 348888999999999999999999999999999976432 2234578999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---Ccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG---QKL 345 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s---~~l 345 (1238)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876432 234
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcc
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~ 425 (1238)
.+.+||+.|||||++.+..+ +.++|||||||+||+|++|..||.+.+...+..++..+.+.+|..+++++.+||.+||+
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 246 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSC
T ss_pred ccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence 45789999999999998887 89999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCHHH------HHhccccccc
Q psy6346 426 REPTKRYCIEQ------IKRHRWMAEE 446 (1238)
Q Consensus 426 kDPskRPTaeE------ILeHPWFke~ 446 (1238)
.||.+|||++| |++||||.+.
T Consensus 247 ~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 247 LDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp SSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999987 6889999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=446.97 Aligned_cols=258 Identities=30% Similarity=0.511 Sum_probs=236.0
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ 263 (1238)
+.+.|...+.||.|+||.||+|.+..+|+.||||++++..... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4466888999999999999999999999999999998765432 235789999999999999999999999999999
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC----cEEEEecCCcccc
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL----DIKLADFGFSNYY 339 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG----~VKLiDFGLS~~~ 339 (1238)
+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999999889999999999999999999999999999999999999998776 4999999999887
Q ss_pred cCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHH
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTE 415 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~e 415 (1238)
.......+.+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.+..+....+......++ ..++++
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 76667777899999999999998776 8999999999999999999999999999999888888766554 468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+.+||++||..||.+|||++|+|+||||+..
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=451.18 Aligned_cols=253 Identities=25% Similarity=0.437 Sum_probs=225.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|+||.||+|.+..+|+.||||++...... ..+.+.+|+++|++++|||||++++++.+.+.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 3477778899999999999999999999999999865432 34678999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
||+||+|.+++.+ +.+++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ......
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 9999999998765 57999999999999999999999999999999999999999999999999999876543 345667
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---CccCCCCCCHHHHHHHHHhcc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---RFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---~~~~P~~iS~eLkDLIrkML~ 425 (1238)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... .+..|..+++++++||.+||.
T Consensus 177 ~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp CSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred ccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence 89999999999999887 89999999999999999999999988876655555433 334566789999999999999
Q ss_pred cCCCCCCCHHHHHhccccccc
Q psy6346 426 REPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 426 kDPskRPTaeEILeHPWFke~ 446 (1238)
.||.+|||++|+|+||||+..
T Consensus 256 ~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 256 MDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp SSTTTSCCHHHHTTCGGGGGC
T ss_pred CChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=459.42 Aligned_cols=255 Identities=32% Similarity=0.523 Sum_probs=237.6
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||+|.+..+|+.||||++++... +....+.+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 47888999999999999999999999999999986542 23346788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC-CCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-GQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-s~~l~t~ 348 (1238)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... .....+.
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~ 165 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCC
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999986543 4455678
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|||||++.+..| +.++|||||||+||||++|+.||.+.+..++.+.+..+.+.+|..+++++++||.+||++||
T Consensus 166 ~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP 244 (337)
T d1o6la_ 166 CGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244 (337)
T ss_dssp EECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSST
T ss_pred eeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCc
Confidence 99999999999999888 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-----CHHHHHhccccccc
Q psy6346 429 TKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRP-----TaeEILeHPWFke~ 446 (1238)
.+|+ +++||++||||.+.
T Consensus 245 ~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 245 KQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hhhcccccccHHHHHcCcccccC
Confidence 9999 49999999999763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=440.93 Aligned_cols=250 Identities=24% Similarity=0.447 Sum_probs=221.9
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee----CCEEEEE
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET----KSMIYIV 267 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed----~d~lyLV 267 (1238)
|+....||.|+||.||+|.+..++..||||++..........+.+.+|+++|++++|||||++++++++ ...+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 455568999999999999999999999999998877777778899999999999999999999999865 4568999
Q ss_pred EeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccc--eeeccCCccccccc-CCCcEEEEecCCcccccCCCc
Q psy6346 268 SEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRR--VVHRDLKAENLLMD-SNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkG--IIHRDLKPeNILLd-~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+||||+ .++.+||+|||+++.. ....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~-~~~~ 169 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASF 169 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC-CTTS
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec-cCCc
Confidence 999999999999999899999999999999999999999998 99999999999997 4789999999999753 3334
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCC-ChhHHHHHHhcCCc--cCCCCCCHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGS-TLNSLRDRVLSGRF--RIPYFMSTECESLIR 421 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~-d~eeL~ekIl~g~~--~~P~~iS~eLkDLIr 421 (1238)
..+.+||+.|||||++.+. + +.++|||||||+||+|++|+.||.+. +...+...+..+.. .++..+++++.+||.
T Consensus 170 ~~~~~GT~~Y~aPE~~~~~-~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247 (270)
T ss_dssp BEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred cCCcccCccccCHHHhCCC-C-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence 4567899999999998764 4 89999999999999999999999765 45566677766543 345668999999999
Q ss_pred HhcccCCCCCCCHHHHHhccccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFk 444 (1238)
+||..||++|||++|+|+||||+
T Consensus 248 ~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=447.30 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=219.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--CCEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--KSMIYIV 267 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--~d~lyLV 267 (1238)
+.|+..+.||.|+||.||+|.+..+|+.||||++.....++...+.+.+|+++|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 45888899999999999999999999999999999888788788899999999999999999999999854 5668999
Q ss_pred EeecCCCccchhhhcc----cccchhHHHHHHHHHHHHHhHhhccc-----eeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 268 SEYANQGEIFDYIARY----GRMNENAARRKFWQILSAVEYCHNRR-----VVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~----~~Lsesea~kI~~QILsALeYLHSkG-----IIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
||||+||+|.+++.+. +.+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643 56999999999999999999999876 99999999999999999999999999987
Q ss_pred ccCCC-ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc-cCCCCCCHHH
Q psy6346 339 YVPGQ-KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF-RIPYFMSTEC 416 (1238)
Q Consensus 339 ~~~s~-~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~-~~P~~iS~eL 416 (1238)
..... .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||.+.+..++..++..+.+ .+|..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 65433 3456789999999999988887 8999999999999999999999999999999999888765 4677899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccc
Q psy6346 417 ESLIRKMLVREPTKRYCIEQIKRHRWM 443 (1238)
Q Consensus 417 kDLIrkML~kDPskRPTaeEILeHPWF 443 (1238)
.+||.+||+.||.+|||++||++|||+
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-51 Score=458.31 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=236.5
Q ss_pred CCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEE
Q psy6346 185 AEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMI 264 (1238)
Q Consensus 185 sGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~l 264 (1238)
.|..-+.|+..+.||.|+||.||+|.+..+|+.||||++++.. ....+.+.+|+.+|++|+|||||+++++|.+++.+
T Consensus 24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3444456899999999999999999999999999999998754 34456788999999999999999999999999999
Q ss_pred EEEEeecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCccccccc--CCCcEEEEecCCcccccC
Q psy6346 265 YIVSEYANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMD--SNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd--~nG~VKLiDFGLS~~~~~ 341 (1238)
|||||||+||+|.+++...+ ++++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999999998876554 699999999999999999999999999999999999998 578999999999998877
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCC----CCCCHHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIP----YFMSTECE 417 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P----~~iS~eLk 417 (1238)
.....+.+||+.|||||++.+..+ +.++|||||||+||+|++|..||.+.+...+...+..+.+.+| ..+++++.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 777778899999999999998887 8999999999999999999999999999999999988876655 35899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
+||.+||++||.+|||++|+|+||||+...
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=446.68 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=226.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|+..+.||.|+||.||+|.+..++..||||++++.. ....+.+.+|+++|++++|||||++++++.+.+.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 35888899999999999999999999999999998753 3456788999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccc
Q psy6346 270 YANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t 347 (1238)
||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 99999999987654 56999999999999999999999999999999999999999999999999999765332 23456
Q ss_pred ccCCCCCCCcccccC----CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc---cCCCCCCHHHHHHH
Q psy6346 348 WCGSPPYAAPEVFEG----KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF---RIPYFMSTECESLI 420 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~g----k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~---~~P~~iS~eLkDLI 420 (1238)
.+||+.|||||++.+ ...++.++|||||||+||+|++|+.||.+.+..+...++..+.. ..|..+++++.+||
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 789999999999852 22248899999999999999999999999988888888877643 34556899999999
Q ss_pred HHhcccCCCCCCCHHHHHhccccccc
Q psy6346 421 RKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.+||+.||.+|||++|+|+||||...
T Consensus 250 ~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=453.00 Aligned_cols=254 Identities=22% Similarity=0.424 Sum_probs=219.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|+||+||+|.+..+|+.||||++++.. +....+++.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45888899999999999999999999999999998764 44556789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|..... ....+.
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~~~~~ 163 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSF 163 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-HTC---
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-Cccccc
Confidence 99999999999998999999999999999999999997 5999999999999999999999999999986543 234567
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHH----------------------------
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDR---------------------------- 400 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ek---------------------------- 400 (1238)
+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.+.......
T Consensus 164 ~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 164 VGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred cCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 99999999999999887 8999999999999999999999987654322111
Q ss_pred --------------HhcC-CccCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 401 --------------VLSG-RFRIP-YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 401 --------------Il~g-~~~~P-~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+... ...+| ..++.++.+||.+||..||.+|||++|+|+||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 1111 01112 1257899999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-51 Score=449.51 Aligned_cols=253 Identities=28% Similarity=0.537 Sum_probs=234.7
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
.|...+.||.|+||.||+|.+..+|+.||||++++... .....+.+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 47888999999999999999999999999999976532 22345789999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATWC 349 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~~ 349 (1238)
||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..... ...+.+
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~~~~ 162 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLC 162 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCCCC
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--cccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999987533 345678
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCCC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREPT 429 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDPs 429 (1238)
||+.|||||++.+..| +.++|||||||+||+|++|+.||.+.+..++..++..+...+|..+++++.+||.+||.+||.
T Consensus 163 Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~ 241 (316)
T d1fota_ 163 GTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 241 (316)
T ss_dssp SCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTT
T ss_pred CcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHH
Confidence 9999999999998887 899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCC-----CHHHHHhccccccc
Q psy6346 430 KRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 430 kRP-----TaeEILeHPWFke~ 446 (1238)
+|+ |+++|++||||++.
T Consensus 242 ~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 242 QRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp TCTTSSTTTTHHHHTSGGGSSC
T ss_pred hccccchhhHHHHHcCcccccC
Confidence 996 99999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-51 Score=454.15 Aligned_cols=255 Identities=28% Similarity=0.472 Sum_probs=233.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|+||.||+|.+..+|+.||||++.+.. ....+.+.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35888899999999999999999999999999997653 4456789999999999999999999999999999999999
Q ss_pred ecCCCccchhhh-cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC--CCcEEEEecCCcccccCCCccc
Q psy6346 270 YANQGEIFDYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS--NLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lk-k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~--nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||+||+|.+++. ..+.+++..++.++.||+.||+|||++|||||||||+||||+. ++.+||+|||++..........
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 999999999985 4467999999999999999999999999999999999999964 6789999999998877767777
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESLIRK 422 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkDLIrk 422 (1238)
+.+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+.+..++...+......++. .+++++.+||.+
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 262 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262 (350)
T ss_dssp EECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 7899999999999999887 89999999999999999999999999999999998887765543 489999999999
Q ss_pred hcccCCCCCCCHHHHHhcccccccC
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
||..||++|||++|+|+||||.+..
T Consensus 263 ~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 263 LLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-50 Score=436.20 Aligned_cols=258 Identities=32% Similarity=0.566 Sum_probs=233.7
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh-------HhHHHHHHHHHHHHhCC-CCCeeEEEEEee
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP-------VNLQKVYREVEIMKQLD-HPHIIKLFQVME 259 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~-------e~ikrf~rEIeILkkL~-HPNIVrL~dvfe 259 (1238)
|.+.|...+.||.|+||+||+|.+..+|+.||||++++..... ...+.+.+|+.+|++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 3467889999999999999999999999999999998765432 22356889999999996 999999999999
Q ss_pred eCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc
Q psy6346 260 TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY 339 (1238)
Q Consensus 260 d~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~ 339 (1238)
+++.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred cCCCccccccCCCCCCCcccccC-----CccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFEG-----KKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY---- 410 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~g-----k~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~---- 410 (1238)
.........+||+.|+|||++.+ ...++.++||||+||+||+|++|+.||.+.+.......+..+...++.
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 76666677889999999999863 233488999999999999999999999999999888888888665443
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
.+|+++.+||.+||+.||.+|||++|||+||||++
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-50 Score=443.80 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=227.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC-hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD-PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld-~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
..|.....||.|+||.||+|.+..+++.||||++++.... ....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4578888999999999999999999999999999877654 445678999999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
|||.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~ 171 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSF 171 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCcc
Confidence 9999999988888888999999999999999999999999999999999999999999999999999986533 3456
Q ss_pred cCCCCCCCcccccCC--ccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc--CCCCCCHHHHHHHHHhc
Q psy6346 349 CGSPPYAAPEVFEGK--KYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR--IPYFMSTECESLIRKML 424 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk--~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~--~P~~iS~eLkDLIrkML 424 (1238)
+||+.|||||++.+. ..++.++|||||||++|+|++|..||.+.+.......+..+... .+..+++++.+||.+||
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 899999999998753 22488999999999999999999999998887777777766443 34458999999999999
Q ss_pred ccCCCCCCCHHHHHhccccccc
Q psy6346 425 VREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 425 ~kDPskRPTaeEILeHPWFke~ 446 (1238)
+.||.+|||++|+|+||||...
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHHSC
T ss_pred cCChhHCcCHHHHHhCHHhcCC
Confidence 9999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-51 Score=451.17 Aligned_cols=254 Identities=31% Similarity=0.540 Sum_probs=235.1
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
+.|...+.||.|+||.||+|.+..+|+.||||++.+... +....+.+.+|+.+|+.++|||||++++++.+...+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 458888999999999999999999999999999976432 2234578899999999999999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLATW 348 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t~ 348 (1238)
||+.||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.... ...+.
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~~~ 198 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWTL 198 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCCC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--ccccc
Confidence 9999999999999989999999999999999999999999999999999999999999999999999987543 34567
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccCC
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVREP 428 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kDP 428 (1238)
+||+.|||||++.+..+ +.++|||||||+||+|++|+.||.+.+...+..++..+.+.+|..+++++.+||++||.+||
T Consensus 199 ~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 277 (350)
T d1rdqe_ 199 CGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp EECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred cCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCH
Confidence 89999999999999887 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-----CHHHHHhccccccc
Q psy6346 429 TKRY-----CIEQIKRHRWMAEE 446 (1238)
Q Consensus 429 skRP-----TaeEILeHPWFke~ 446 (1238)
.+|+ |+++|++||||+..
T Consensus 278 ~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 278 TKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HhccccccccHHHHHcCccccCC
Confidence 9995 99999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=443.77 Aligned_cols=253 Identities=22% Similarity=0.404 Sum_probs=232.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|+||.||+|.+..+++.||||++++.. .....+.+|+++|++++|||||++++++++.+.+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 45888899999999999999999999999999998754 334568899999999999999999999999999999999
Q ss_pred ecCCCccchhhhccc-ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC--CcEEEEecCCcccccCCCccc
Q psy6346 270 YANQGEIFDYIARYG-RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN--LDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~-~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n--G~VKLiDFGLS~~~~~s~~l~ 346 (1238)
||.||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|||++..........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 999999999998765 79999999999999999999999999999999999999854 579999999998876666677
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC----CCCHHHHHHHHH
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY----FMSTECESLIRK 422 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~----~iS~eLkDLIrk 422 (1238)
+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+.+.++. .+++++.+||.+
T Consensus 162 ~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 240 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240 (321)
T ss_dssp EEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred ccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHH
Confidence 7889999999999998887 89999999999999999999999999999999999988877664 589999999999
Q ss_pred hcccCCCCCCCHHHHHhccccccc
Q psy6346 423 MLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeHPWFke~ 446 (1238)
||.+||.+|||++|+++||||++.
T Consensus 241 ~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 241 LLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=443.61 Aligned_cols=254 Identities=29% Similarity=0.502 Sum_probs=232.6
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHH-hCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMK-QLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILk-kL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
.|...+.||.|+||+||+|.+..+|+.||||++++... .....+.+.+|+.++. .++|||||++++++.+++.+||||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 47888999999999999999999999999999976432 2234567778888765 689999999999999999999999
Q ss_pred eecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Ccccc
Q psy6346 269 EYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLAT 347 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t 347 (1238)
|||+||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~ 162 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999865433 34455
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHHHhcccC
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIrkML~kD 427 (1238)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++..+.+.+|..+++++.+||.+||++|
T Consensus 163 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~d 241 (320)
T d1xjda_ 163 FCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE 241 (320)
T ss_dssp CCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred cCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccC
Confidence 789999999999999887 8999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHH-HHHhcccccc
Q psy6346 428 PTKRYCIE-QIKRHRWMAE 445 (1238)
Q Consensus 428 PskRPTae-EILeHPWFke 445 (1238)
|.+|||+. ++++||||++
T Consensus 242 P~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 242 PEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp GGGSBTTBSCGGGSGGGTT
T ss_pred CCCCcCHHHHHHhCchhcc
Confidence 99999995 8999999976
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=432.67 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=216.3
Q ss_pred EEEecCCCCccccCceEccCCcEEEEEEeccCCCCh---HhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 195 REKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP---VNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~---e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
.+.||.|+||+||+|.+..+|+.||||+++...... ...+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999999999999999997664322 12357889999999999999999999999999999999999
Q ss_pred CCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-CccccccC
Q psy6346 272 NQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATWCG 350 (1238)
Q Consensus 272 ~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~~G 350 (1238)
.|+.+..++...+.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+|
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~g 162 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 162 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceec
Confidence 99988888877888999999999999999999999999999999999999999999999999999765443 34456789
Q ss_pred CCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCc--------------------c---
Q psy6346 351 SPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRF--------------------R--- 407 (1238)
Q Consensus 351 Tp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~--------------------~--- 407 (1238)
|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+...++..... .
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ua2a_ 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242 (299)
T ss_dssp CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC
T ss_pred ChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCC
Confidence 99999999998776669999999999999999999999999887776666543100 0
Q ss_pred -----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 408 -----IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 408 -----~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+...+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 243 ~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 012468899999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-49 Score=443.55 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=222.7
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC----hHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD----PVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld----~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.|...+.||.|+||.||+|.+..+|+.||||++.+.... .....+..+|+.+++.++|||||++++++.+.+.+||
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 478889999999999999999999999999999764321 1122233445777778899999999999999999999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCccc
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLA 346 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~ 346 (1238)
|||||+||+|.+++.+...+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++..... ...
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~~~ 163 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH 163 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-CCC
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-ccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999865443 445
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---HHHHHHhcCCccCCCCCCHHHHHHHHHh
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---SLRDRVLSGRFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---eL~ekIl~g~~~~P~~iS~eLkDLIrkM 423 (1238)
..+||+.|||||++.....++.++|||||||+||+|++|+.||.+.+.. .+...+......+|..+++++.+||.+|
T Consensus 164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 243 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243 (364)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHH
T ss_pred ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHH
Confidence 6789999999999976555589999999999999999999999876543 3445555667778888999999999999
Q ss_pred cccCCCCCCC-----HHHHHhccccccc
Q psy6346 424 LVREPTKRYC-----IEQIKRHRWMAEE 446 (1238)
Q Consensus 424 L~kDPskRPT-----aeEILeHPWFke~ 446 (1238)
|.+||.+||| ++||++||||++.
T Consensus 244 L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 244 LQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp TCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred cccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999 7999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=437.74 Aligned_cols=251 Identities=33% Similarity=0.555 Sum_probs=217.2
Q ss_pred cEEEEEE-EecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHh-CCCCCeeEEEEEeee----CCE
Q psy6346 190 QTIRKRE-KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQ-LDHPHIIKLFQVMET----KSM 263 (1238)
Q Consensus 190 qVYkare-kIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkk-L~HPNIVrL~dvfed----~d~ 263 (1238)
+.|...+ .||.|+||.||+|.+..+++.||||++++. +.+.+|+.++.+ ++|||||+++++|++ ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4577665 599999999999999999999999999753 367789999765 589999999999975 567
Q ss_pred EEEEEeecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEEecCCccc
Q psy6346 264 IYIVSEYANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFGFSNY 338 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLiDFGLS~~ 338 (1238)
+|||||||+||+|.+++.+. ..+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++..
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 99999999999999999764 46999999999999999999999999999999999999985 46799999999988
Q ss_pred ccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHH----HHHHhcCCccCCC----
Q psy6346 339 YVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSL----RDRVLSGRFRIPY---- 410 (1238)
Q Consensus 339 ~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL----~ekIl~g~~~~P~---- 410 (1238)
..........+||+.|||||++.+..| +.++|||||||+||+|++|+.||.+.+.... ...+..+.+.+|.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred ccCCCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccc
Confidence 777777778899999999999998887 8999999999999999999999987664433 3444455555554
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEETP 448 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~p 448 (1238)
.+++++.+||.+||++||++|||++|+++||||.+...
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 47999999999999999999999999999999987644
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=426.31 Aligned_cols=250 Identities=31% Similarity=0.575 Sum_probs=221.5
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCCh----HhHHHHHHHHHHHHhCC--CCCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDP----VNLQKVYREVEIMKQLD--HPHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~----e~ikrf~rEIeILkkL~--HPNIVrL~dvfed~d~ 263 (1238)
..|...+.||.|+||.||+|++..+|+.||||++.+..... ....++.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 45888899999999999999999999999999998754322 12245678999999996 8999999999999999
Q ss_pred EEEEEeecCC-CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-CCcEEEEecCCcccccC
Q psy6346 264 IYIVSEYANQ-GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-NLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 264 lyLVMEy~~G-GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-nG~VKLiDFGLS~~~~~ 341 (1238)
+|+||||+.+ +++.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~- 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK- 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC-
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc-
Confidence 9999999986 678888888889999999999999999999999999999999999999985 4799999999997643
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCCCCCHHHHHHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPYFMSTECESLIR 421 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~~iS~eLkDLIr 421 (1238)
.....+.+||+.|+|||++.+..+++.++|||||||+||+|++|+.||.+. ..+..+...++..+|+++.+||+
T Consensus 163 ~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~li~ 236 (273)
T d1xwsa_ 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIR 236 (273)
T ss_dssp SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHHHH
T ss_pred cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHHHH
Confidence 334556789999999999988887778899999999999999999999763 34666777788899999999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy6346 422 KMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeHPWFke~ 446 (1238)
+||..||++|||++|+++||||++.
T Consensus 237 ~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 237 WCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=423.11 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=216.5
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|+..+.||.|+||.||+|.+..+|+.||||+++.........+.+.+|+++|++++|||||++++++.+++.+|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 57888999999999999999999999999999987655545567899999999999999999999999999999999999
Q ss_pred cCCCccchhhh-cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 271 ANQGEIFDYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 271 ~~GGSL~d~Lk-k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
|.++.+..... ..+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++...... ......
T Consensus 83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 162 (298)
T d1gz8a_ 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162 (298)
T ss_dssp CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCC
T ss_pred cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceee
Confidence 98654443333 3467999999999999999999999999999999999999999999999999999766433 345567
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC------------------ccC--
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR------------------FRI-- 408 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~------------------~~~-- 408 (1238)
+||+.|+|||++....+++.++|||||||++|+|++|+.||.+.+......++.... ..+
T Consensus 163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T d1gz8a_ 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242 (298)
T ss_dssp BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCC
T ss_pred cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccc
Confidence 899999999999888887899999999999999999999999887666554443210 001
Q ss_pred ---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 409 ---------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 409 ---------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...+++++.+||++||..||.+|||++|||+||||++.
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 11357899999999999999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=419.86 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=217.8
Q ss_pred cEEEEEEEecCCCCccccCceEccC-CcEEEEEEeccCCCChHhHHHHHHHHHHHHhC---CCCCeeEEEEEee-----e
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRH-TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL---DHPHIIKLFQVME-----T 260 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lkt-G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL---~HPNIVrL~dvfe-----d 260 (1238)
+.|+..+.||.|+||+||+|.+.++ ++.||||+++....+......+.+|+.+|+.| +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5688899999999999999998765 67899999977654443344566788887766 8999999999985 3
Q ss_pred CCEEEEEEeecCCCccchhhh-cccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccc
Q psy6346 261 KSMIYIVSEYANQGEIFDYIA-RYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYY 339 (1238)
Q Consensus 261 ~d~lyLVMEy~~GGSL~d~Lk-k~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~ 339 (1238)
...+|++||||.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 457899999999887654443 4467999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---------------
Q psy6346 340 VPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--------------- 404 (1238)
Q Consensus 340 ~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--------------- 404 (1238)
.........+||+.|||||++.+.+| +.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cccccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 66666778899999999999999887 89999999999999999999999998877766655421
Q ss_pred ------------CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 ------------RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 ------------~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
...++..+++++.+||.+||++||++|||++|+|+||||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 011234578999999999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-48 Score=415.95 Aligned_cols=255 Identities=28% Similarity=0.384 Sum_probs=219.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|...+.||.|+||+||+|.+ ++|+.||||+++....+....+++.+|+.+|++++|||||++++++.+.+..|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 3578889999999999999987 478999999998776555556889999999999999999999999999999999999
Q ss_pred ecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-Cccccc
Q psy6346 270 YANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG-QKLATW 348 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s-~~l~t~ 348 (1238)
++.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 9998888888888889999999999999999999999999999999999999999999999999999775433 234556
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC-----------------------
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR----------------------- 405 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~----------------------- 405 (1238)
.|++.|+|||++.+..+++.++|||||||++|||++|+.||.+.+..+...++....
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence 799999999999887777999999999999999999999999887666555543210
Q ss_pred ------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy6346 406 ------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAE 445 (1238)
Q Consensus 406 ------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke 445 (1238)
..++..+++++.+||++||++||++|||++|+|+||||++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123346889999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6e-48 Score=411.26 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=216.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC----E
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS----M 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d----~ 263 (1238)
++.|...+.||.|+||.||+|.+..+|+.||||++++... +....+++.+|+++|++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4568888999999999999999999999999999988765 4556678999999999999999999999997543 4
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC-
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG- 342 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s- 342 (1238)
+|||||||+|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 8999999999999999999899999999999999999999999999999999999999999999999999988654322
Q ss_pred ---CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccC----CCCCCHH
Q psy6346 343 ---QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRI----PYFMSTE 415 (1238)
Q Consensus 343 ---~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~----P~~iS~e 415 (1238)
......+||+.|||||++.+..+ ++++|||||||+||+|++|+.||.+.+..+...++....... ...+|++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp -------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred ccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 23455689999999999998877 899999999999999999999999998888777777665433 3458999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy6346 416 CESLIRKMLVREPTKRYCIEQIKRHRWMA 444 (1238)
Q Consensus 416 LkDLIrkML~kDPskRPTaeEILeHPWFk 444 (1238)
+.+||.+||++||.+||+..+.+.|+|.+
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999544455677764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=413.51 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=216.2
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee--------C
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET--------K 261 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed--------~ 261 (1238)
..|+..+.||.|+||+||+|.+..+|+.||||++.+........+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 34788899999999999999999999999999998776665566789999999999999999999998854 4
Q ss_pred CEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 262 SMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 262 d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
+.+|+|||||.++.+..+......+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence 56899999999888777777778899999999999999999999999999999999999999999999999999976542
Q ss_pred C-----CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCccCCC------
Q psy6346 342 G-----QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFRIPY------ 410 (1238)
Q Consensus 342 s-----~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~~P~------ 410 (1238)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+......++.
T Consensus 170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (318)
T d3blha1 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249 (318)
T ss_dssp -----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTC
T ss_pred ccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcccc
Confidence 2 23345689999999999988766699999999999999999999999988876665554432111110
Q ss_pred --------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 411 --------------------------FMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 411 --------------------------~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
..++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred chhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 136788999999999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=411.82 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=213.1
Q ss_pred EEecCCCCccccCceEcc--CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeecCC
Q psy6346 196 EKCGVKSRSCNRPPVLLR--HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYANQ 273 (1238)
Q Consensus 196 ekIGsGsfGtVYKav~lk--tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~~G 273 (1238)
..||.|+||.||+|.+.. +++.||||+++....++...+++.+|+++|++++|||||++++++.++ ..|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999997653 457899999987666666678899999999999999999999999765 56899999999
Q ss_pred CccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc----ccccc
Q psy6346 274 GEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK----LATWC 349 (1238)
Q Consensus 274 GSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~----l~t~~ 349 (1238)
|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 99999999989999999999999999999999999999999999999999999999999999986543322 23356
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcccC
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVRE 427 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~kD 427 (1238)
||+.|||||++.+..+ +.++|||||||++|||++ |..||.+.+..++...+..+ ...+|..+++++.+||.+||..|
T Consensus 172 gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 172 WPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence 8999999999988877 899999999999999997 99999999988888888776 45678889999999999999999
Q ss_pred CCCCCCHHHHH---hcccc
Q psy6346 428 PTKRYCIEQIK---RHRWM 443 (1238)
Q Consensus 428 PskRPTaeEIL---eHPWF 443 (1238)
|.+|||+++|+ +|+|+
T Consensus 251 p~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 251 VENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TTTSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHhhCHHh
Confidence 99999999984 56554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=402.61 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=224.8
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|+..+.||.|+||+||+|++..+++.||||+++.........+++.+|+.+|+.++||||+++++++.+....++||++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 58888999999999999999999999999999988776666778999999999999999999999999999999999999
Q ss_pred cCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-cccccc
Q psy6346 271 ANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-KLATWC 349 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-~l~t~~ 349 (1238)
+.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....... ......
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 162 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCC
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeec
Confidence 9999999999888999999999999999999999999999999999999999999999999999998765433 334456
Q ss_pred CCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCC-CCCChhHHHHHHhcC------------------------
Q psy6346 350 GSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPF-DGSTLNSLRDRVLSG------------------------ 404 (1238)
Q Consensus 350 GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF-~g~d~eeL~ekIl~g------------------------ 404 (1238)
+++.|+|||++.+..+++.++|||||||++|+|++|..|| .+.+..+...++...
T Consensus 163 ~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T d1unla_ 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence 7888999999988877799999999999999999999885 555555554443321
Q ss_pred -----CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 -----RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 -----~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
....+..+++++.+||++||+.||.+|||++|||+||||++-
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 011223468899999999999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=417.23 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=214.9
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-----
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS----- 262 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d----- 262 (1238)
+.+.|...+.||.|+||+||+|.+..+|+.||||++++...+....+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 346788999999999999999999999999999999887777777889999999999999999999999997654
Q ss_pred -EEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC
Q psy6346 263 -MIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 263 -~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~ 341 (1238)
.+|+||||| +.+|..++ +.+.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 45565554 45789999999999999999999999999999999999999999999999999997643
Q ss_pred CCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCC----------------
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGR---------------- 405 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~---------------- 405 (1238)
......+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 173 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 173 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp -SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred -CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 345567899999999999887777999999999999999999999999887655443332110
Q ss_pred ---------------ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 406 ---------------FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 406 ---------------~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
......+++++.+||.+||..||.+|||++|||+||||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 01223478999999999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-47 Score=411.31 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=209.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCc---EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTV---NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~---kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
..|...+.||.|+||.||+|.+..++. .||||++.... .....+.+.+|+++|++++|||||++++++.+.+.+|+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 347777899999999999998876654 68999987654 45667889999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcc
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l 345 (1238)
|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999999999988764 56999999999999999999999999999999999999999999999999999876443221
Q ss_pred ------ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHH
Q psy6346 346 ------ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECE 417 (1238)
Q Consensus 346 ------~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLk 417 (1238)
....||+.|||||++.+..+ +.++|||||||+||||++ |..||.+.+..++...+..+ ..+.|..+++++.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 263 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263 (299)
T ss_dssp -----------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHH
Confidence 22457899999999998877 899999999999999998 89999999988888888765 3567778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhc
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILeH 440 (1238)
+||.+||..||.+|||+.||+++
T Consensus 264 ~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=408.56 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=218.3
Q ss_pred EEEEE-EecCCCCccccCceEcc--CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEE
Q psy6346 192 IRKRE-KCGVKSRSCNRPPVLLR--HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 192 Ykare-kIGsGsfGtVYKav~lk--tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVM 268 (1238)
+...+ .||.|+||.||+|++.. ++..||||+++... +....+++.+|+++|++++|||||++++++.++ .+||||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvm 87 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVM 87 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEE
Confidence 44455 49999999999997753 45689999998653 566778999999999999999999999999764 579999
Q ss_pred eecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC----
Q psy6346 269 EYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ---- 343 (1238)
Q Consensus 269 Ey~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~---- 343 (1238)
|||++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 99999999998765 4679999999999999999999999999999999999999999999999999998764432
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIR 421 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIr 421 (1238)
.....+||+.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+..++...+..+. ..+|..+++++.+||.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 246 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 246 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 2234568999999999988876 899999999999999998 999999988888888887764 5678889999999999
Q ss_pred HhcccCCCCCCCHHHH---Hhcccccc
Q psy6346 422 KMLVREPTKRYCIEQI---KRHRWMAE 445 (1238)
Q Consensus 422 kML~kDPskRPTaeEI---LeHPWFke 445 (1238)
+||..||++|||+.+| |+|+|+.-
T Consensus 247 ~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 247 DCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999887 67788753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=415.11 Aligned_cols=250 Identities=25% Similarity=0.324 Sum_probs=213.0
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee------CCEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET------KSMI 264 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed------~d~l 264 (1238)
.|.....||.|+||+||+|.+..+|+.||||++.+... .+.+|+++|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 47888899999999999999999999999999987542 22479999999999999999999843 3468
Q ss_pred EEEEeecCCCccchh---hhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCCccccc
Q psy6346 265 YIVSEYANQGEIFDY---IARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYV 340 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~---Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~ 340 (1238)
|||||||.++.+..+ ......+++..++.+++||+.||+|||++||+||||||+||||+.++ .+||+|||++....
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999987643333 23445799999999999999999999999999999999999999775 89999999998877
Q ss_pred CCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC----------------
Q psy6346 341 PGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG---------------- 404 (1238)
Q Consensus 341 ~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g---------------- 404 (1238)
......+.+||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 7777778899999999999987766699999999999999999999999988766655554320
Q ss_pred -Ccc------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 -RFR------------IPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 -~~~------------~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
... ....+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 011 122468899999999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=401.02 Aligned_cols=245 Identities=24% Similarity=0.433 Sum_probs=207.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.||.|+||.||+|.+. ++..||||+++..... .+++.+|+++|++++|||||++++++.+++.+|+||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4677789999999999999764 6778999999875543 35789999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--cccc
Q psy6346 271 ANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLAT 347 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~t 347 (1238)
|++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999999988654 568899999999999999999999999999999999999999999999999998664432 2234
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~ 425 (1238)
..||+.|+|||++.+..+ +.++|||||||+||||++ |.+||.+.+..++...+..+ ....|..+++++.+||.+||.
T Consensus 162 ~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 240 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240 (263)
T ss_dssp ---CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred eecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHcc
Confidence 679999999999998887 899999999999999998 67888888888888887776 345677889999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q psy6346 426 REPTKRYCIEQIKRH 440 (1238)
Q Consensus 426 kDPskRPTaeEILeH 440 (1238)
.||++|||++||++|
T Consensus 241 ~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 241 ERPEDRPAFSRLLRQ 255 (263)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-47 Score=408.97 Aligned_cols=245 Identities=24% Similarity=0.417 Sum_probs=215.1
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.||.|+||.||+|.+..+++.||||+++.+.. ..+++.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 36667889999999999999999999999999986543 356789999999999999999999999999999999999
Q ss_pred cCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc--cc
Q psy6346 271 ANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK--LA 346 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~--l~ 346 (1238)
|++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... ..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 9999999998654 5689999999999999999999999999999999999999999999999999987544332 22
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCC-CCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGAL-PFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrl-PF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
...|++.|+|||++.+..+ +.++|||||||++|||++|.. ||.+.+...+.+.+..+ ...+|..+++++.+||.+||
T Consensus 175 ~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 253 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253 (287)
T ss_dssp TEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHc
Confidence 3458899999999998887 899999999999999999554 56667777777666554 45677889999999999999
Q ss_pred ccCCCCCCCHHHHHh
Q psy6346 425 VREPTKRYCIEQIKR 439 (1238)
Q Consensus 425 ~kDPskRPTaeEILe 439 (1238)
..||++|||++||++
T Consensus 254 ~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 254 QWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCCHhHCcCHHHHHH
Confidence 999999999999965
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=415.59 Aligned_cols=249 Identities=19% Similarity=0.367 Sum_probs=212.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCC-----cEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHT-----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG-----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ 263 (1238)
+.|...+.||.|+||.||+|.+...+ ..||||++.... +......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 34777789999999999999887544 379999987653 334456889999999998 89999999999999999
Q ss_pred EEEEEeecCCCccchhhhcc-----------------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccc
Q psy6346 264 IYIVSEYANQGEIFDYIARY-----------------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENL 320 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~-----------------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNI 320 (1238)
+|||||||+||+|.++|... ..+++..++.++.||+.||.|||++|||||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 99999999999999999654 2478999999999999999999999999999999999
Q ss_pred cccCCCcEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhH
Q psy6346 321 LMDSNLDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNS 396 (1238)
Q Consensus 321 LLd~nG~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~ee 396 (1238)
|++.++.+||+|||+|+....... ..+.+||+.|||||++.+..+ +.++|||||||+||||++ |..||.+.+...
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999986554432 235678999999999988877 899999999999999997 999999876655
Q ss_pred HHHHHhcC--CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 397 LRDRVLSG--RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 397 L~ekIl~g--~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
...++... .+..|..+++++.+||.+||+.||++|||++||++|
T Consensus 275 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55555544 345677899999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=411.37 Aligned_cols=254 Identities=20% Similarity=0.346 Sum_probs=217.7
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeC-----CEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETK-----SMI 264 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~-----d~l 264 (1238)
+.|+..+.||.|+||+||+|.+..+|+.||||++++...+....+++.+|+++|++++|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 458888999999999999999999999999999998877777788999999999999999999999998532 334
Q ss_pred EEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 265 YIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 265 yLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
++||+++.||+|.+++.. +++++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||++... ...
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~--~~~ 174 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDE 174 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC--TGG
T ss_pred EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc--Ccc
Confidence 666777889999998854 57999999999999999999999999999999999999999999999999998753 334
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcCCcc-----------------
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSGRFR----------------- 407 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g~~~----------------- 407 (1238)
..+.+|++.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 456789999999999888877789999999999999999999999998876666555432111
Q ss_pred ------C--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 408 ------I--------PYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 408 ------~--------P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
. ...+++++.+||++||..||.+|||++|+|+||||++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 12478899999999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=402.72 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=216.4
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEee
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEY 270 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy 270 (1238)
.|...+.||.|+||.||+|.+ +++..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.+||||||
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 466778899999999999975 46789999999875433 4578999999999999999999998865 457999999
Q ss_pred cCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccc
Q psy6346 271 ANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLA 346 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~ 346 (1238)
|++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ...
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 99999999776543 58999999999999999999999999999999999999999999999999998765433 233
Q ss_pred cccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhc
Q psy6346 347 TWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKML 424 (1238)
Q Consensus 347 t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML 424 (1238)
...||+.|||||++.+..+ +.++|||||||+||||+| |.+||...+..++...+..+ ....|..+++++.+||.+||
T Consensus 169 ~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 247 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHc
Confidence 4578999999999988776 899999999999999999 56667777777787877765 45567889999999999999
Q ss_pred ccCCCCCCCHHHHHh--cccccc
Q psy6346 425 VREPTKRYCIEQIKR--HRWMAE 445 (1238)
Q Consensus 425 ~kDPskRPTaeEILe--HPWFke 445 (1238)
..||++|||+++|++ |+||..
T Consensus 248 ~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 248 KERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999998 788853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=408.61 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=212.4
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCC-----E
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKS-----M 263 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d-----~ 263 (1238)
|..|.....||.|+||+||+|++..+|+.||||++++.. .....+++++|+.+|++|+||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456888999999999999999999999999999998654 4556678999999999999999999999997543 3
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ 343 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~ 343 (1238)
+|++ +++.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 4555 55668999999865 579999999999999999999999999999999999999999999999999997653322
Q ss_pred ----ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---------------
Q psy6346 344 ----KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--------------- 404 (1238)
Q Consensus 344 ----~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--------------- 404 (1238)
.....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2455679999999999977666689999999999999999999999887755444332210
Q ss_pred -----------Cc-----cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy6346 405 -----------RF-----RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEET 447 (1238)
Q Consensus 405 -----------~~-----~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~~ 447 (1238)
.. .....+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00 01234678999999999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=407.45 Aligned_cols=245 Identities=21% Similarity=0.347 Sum_probs=204.2
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|...+.||.|+||.||+|.. +..||||+++....+....+.+.+|+.+|++++|||||++++++.+ +.+|||||||
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 33446789999999999864 3469999998877777788899999999999999999999998754 5689999999
Q ss_pred CCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCC---Ccccc
Q psy6346 272 NQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPG---QKLAT 347 (1238)
Q Consensus 272 ~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s---~~l~t 347 (1238)
+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++...... .....
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 165 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccc
Confidence 999999999754 56999999999999999999999999999999999999999999999999999765432 23445
Q ss_pred ccCCCCCCCcccccCCc--cCCCccceehhhHHHHHHhhCCCCCCCCChhH-HHHHHhcCCc-----cCCCCCCHHHHHH
Q psy6346 348 WCGSPPYAAPEVFEGKK--YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS-LRDRVLSGRF-----RIPYFMSTECESL 419 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~--y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee-L~ekIl~g~~-----~~P~~iS~eLkDL 419 (1238)
.+||+.|||||++.+.. .++.++|||||||+||||++|+.||.+.+... +...+..+.. .++..+++++.+|
T Consensus 166 ~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~l 245 (276)
T d1uwha_ 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 245 (276)
T ss_dssp CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHH
T ss_pred cccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHH
Confidence 68999999999997542 24889999999999999999999998866543 3344433321 2456689999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy6346 420 IRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILeH 440 (1238)
|.+||..||.+|||++||+++
T Consensus 246 i~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 246 MAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999988
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-46 Score=402.74 Aligned_cols=249 Identities=23% Similarity=0.402 Sum_probs=212.0
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeee--CCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMET--KSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed--~d~lyL 266 (1238)
+.|+....||.|+||+||+|++..+|+.||||++++.. .+++.+|+++|+++. ||||+++++++.. ...+|+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 56889999999999999999999999999999997542 467889999999995 9999999999974 456999
Q ss_pred EEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC-cEEEEecCCcccccCCCcc
Q psy6346 267 VSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL-DIKLADFGFSNYYVPGQKL 345 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG-~VKLiDFGLS~~~~~s~~l 345 (1238)
|||||.+++|..+. +.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 99999999987764 4699999999999999999999999999999999999998654 6999999999887777777
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh-HHHHHHhc-------------CCc-----
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN-SLRDRVLS-------------GRF----- 406 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e-eL~ekIl~-------------g~~----- 406 (1238)
...+||+.|+|||++.+...++.++|||||||++|+|++|..||...... .....+.. ...
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 78899999999999988776699999999999999999999999764422 11111100 000
Q ss_pred -------------------cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 407 -------------------RIPYFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 407 -------------------~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
.....+++++.+||++||..||.+|||++|+|+||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0112368899999999999999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=412.64 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=210.3
Q ss_pred eccCCCCC--cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee
Q psy6346 182 TLHAEKNG--QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME 259 (1238)
Q Consensus 182 ~LgsGkfG--qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe 259 (1238)
.++..+|. +.|+..+.||.|+||+||+|++..+|+.||||++.+...+....+++.+|+.+|++++|||||+++++|.
T Consensus 7 ~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~ 86 (355)
T d2b1pa1 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_dssp EETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred EeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence 34444443 4599999999999999999999999999999999988777777889999999999999999999999995
Q ss_pred ------eCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEec
Q psy6346 260 ------TKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADF 333 (1238)
Q Consensus 260 ------d~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDF 333 (1238)
+...+|+|||||.++.+. .+ ...+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++||
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred cccccccCceeEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeech
Confidence 447899999999866544 33 356899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHHhcC---------
Q psy6346 334 GFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRVLSG--------- 404 (1238)
Q Consensus 334 GLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekIl~g--------- 404 (1238)
|++............+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.+.+......++...
T Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp CC---------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhhccccccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 99987766666777889999999999998876 89999999999999999999999988766555444311
Q ss_pred -------------Ccc---------C-----C------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy6346 405 -------------RFR---------I-----P------YFMSTECESLIRKMLVREPTKRYCIEQIKRHRWMAEE 446 (1238)
Q Consensus 405 -------------~~~---------~-----P------~~iS~eLkDLIrkML~kDPskRPTaeEILeHPWFke~ 446 (1238)
... + + ...++++.+||++||..||++|||++|||+||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 000 0 0 0136678999999999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=396.66 Aligned_cols=244 Identities=22% Similarity=0.414 Sum_probs=218.0
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEeec
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSEYA 271 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVMEy~ 271 (1238)
|+..+.||.|+||.||+|.+ +++..||||++++..... +.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred CEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 34456799999999999986 578899999998865543 57889999999999999999999999999999999999
Q ss_pred CCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--ccccc
Q psy6346 272 NQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KLATW 348 (1238)
Q Consensus 272 ~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l~t~ 348 (1238)
.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 99999998654 4678999999999999999999999999999999999999999999999999997654432 23346
Q ss_pred cCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhccc
Q psy6346 349 CGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLVR 426 (1238)
Q Consensus 349 ~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~k 426 (1238)
.||+.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+..++..++..+ ....|..+++++.+||.+||+.
T Consensus 162 ~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp CCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred CCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccC
Confidence 78999999999998887 899999999999999998 89999999999998888876 4567788999999999999999
Q ss_pred CCCCCCCHHHHHhc
Q psy6346 427 EPTKRYCIEQIKRH 440 (1238)
Q Consensus 427 DPskRPTaeEILeH 440 (1238)
||++|||+++|++|
T Consensus 241 dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 241 KADERPTFKILLSN 254 (258)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=394.48 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=208.0
Q ss_pred cEEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
+.|...+.||.|+||.||+|++..+ +..||||+++... .....+.+.+|+.+|++++|||||++++++. .+.+|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3577788999999999999987654 4578999986543 4556688999999999999999999999996 467899
Q ss_pred EEeecCCCccchhhhc-ccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--
Q psy6346 267 VSEYANQGEIFDYIAR-YGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-- 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk-~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-- 343 (1238)
|||||.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 9999999999998755 4579999999999999999999999999999999999999999999999999998754332
Q ss_pred ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHHH
Q psy6346 344 KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLIR 421 (1238)
Q Consensus 344 ~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLIr 421 (1238)
......||+.|+|||++.+..+ +.++|||||||+||||++ |.+||.+.+..++...+..+. .++|..+++++.+||.
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243 (273)
T ss_dssp ------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 2344568999999999988877 889999999999999997 999999999999888888774 5678889999999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy6346 422 KMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 422 kML~kDPskRPTaeEILeH 440 (1238)
+||..||++|||++||++|
T Consensus 244 ~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 244 KCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999886
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=391.05 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=207.5
Q ss_pred EEEEEEEecCCCCccccCceEccCC----cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHT----VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG----~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.|.....||.|+||.||+|.+..++ ..||||+++... .......+.+|+.+|++++|||||++++++.+.+..++
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3666788999999999999877544 579999997654 45566789999999999999999999999999999999
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-- 343 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-- 343 (1238)
|||||.+++|.+++... +.+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999999877654 579999999999999999999999999999999999999999999999999998754332
Q ss_pred --ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC-CCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHH
Q psy6346 344 --KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG-ALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESL 419 (1238)
Q Consensus 344 --~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG-rlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDL 419 (1238)
......||+.|||||++.+..+ +.++|||||||+||||++| .+||.+.+..++...+..+ ..+.|..++.++.+|
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 245 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHH
T ss_pred ceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHH
Confidence 1223468999999999998877 8899999999999999984 5666777777777777765 456677899999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy6346 420 IRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 420 IrkML~kDPskRPTaeEILe 439 (1238)
|.+||..||++|||+.||++
T Consensus 246 i~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 246 MMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=404.42 Aligned_cols=256 Identities=26% Similarity=0.473 Sum_probs=222.4
Q ss_pred cEEEEEEEecCCCCccccCceEcc---CCcEEEEEEeccCCC--ChHhHHHHHHHHHHHHhCCC-CCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLR---HTVNVAIKIIDKSQL--DPVNLQKVYREVEIMKQLDH-PHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lk---tG~kVAIKVLkks~l--d~e~ikrf~rEIeILkkL~H-PNIVrL~dvfed~d~ 263 (1238)
+.|+..+.||.|+||.||+|.... +|+.||||++++... +....+.+.+|+++|++++| |||+++++++++...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 448889999999999999998753 689999999976542 22234578899999999977 899999999999999
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccC--
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVP-- 341 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~-- 341 (1238)
+|+||||+.+|+|.+++...+.+.+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999976533
Q ss_pred CCccccccCCCCCCCcccccCCc-cCCCccceehhhHHHHHHhhCCCCCCCCChhH----HHHHHhcCCccCCCCCCHHH
Q psy6346 342 GQKLATWCGSPPYAAPEVFEGKK-YCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS----LRDRVLSGRFRIPYFMSTEC 416 (1238)
Q Consensus 342 s~~l~t~~GTp~YmAPEVL~gk~-y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee----L~ekIl~g~~~~P~~iS~eL 416 (1238)
.....+..|++.|+|||.+.+.. +++.++|||||||+||+|++|..||.+.+... +..........+|..+++++
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 263 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHH
Confidence 23345678999999999998654 35789999999999999999999998765443 34444456677888899999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHhcccccc
Q psy6346 417 ESLIRKMLVREPTKRY-----CIEQIKRHRWMAE 445 (1238)
Q Consensus 417 kDLIrkML~kDPskRP-----TaeEILeHPWFke 445 (1238)
.+||++||.+||.+|| |++|+++||||++
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999 5899999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=394.24 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=214.3
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEEEEe
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYIVSE 269 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyLVME 269 (1238)
+.|+..+.||.|+||.||+|.+. ++..||||+++....+ .+.+.+|+.+|++++|||||++++++.+ +.+|+|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 34778889999999999999775 4567999999876543 3578999999999999999999999865 45789999
Q ss_pred ecCCCccchhhhcc--cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC--cc
Q psy6346 270 YANQGEIFDYIARY--GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ--KL 345 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~--~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~--~l 345 (1238)
||++|+|..++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999999888653 469999999999999999999999999999999999999999999999999998654332 23
Q ss_pred ccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHh
Q psy6346 346 ATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKM 423 (1238)
Q Consensus 346 ~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkM 423 (1238)
....||+.|+|||++.+..+ +.++|||||||+||||++ |.+||.+....++...+..+ ..+++..+++++.+||.+|
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250 (285)
T ss_dssp ----CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHH
Confidence 34679999999999988877 899999999999999999 56666777777788877765 4567888999999999999
Q ss_pred cccCCCCCCCHHHHHh--cccccccCCCC
Q psy6346 424 LVREPTKRYCIEQIKR--HRWMAEETPRL 450 (1238)
Q Consensus 424 L~kDPskRPTaeEILe--HPWFke~~p~~ 450 (1238)
|+.||++||++++|++ ++||....+..
T Consensus 251 l~~dP~~Rps~~~i~~~L~~~~~~~~p~~ 279 (285)
T d1fmka3 251 WRKEPEERPTFEYLQAFLEDYFTSTEPQY 279 (285)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred cccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence 9999999999999988 88987765433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=395.76 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=214.6
Q ss_pred EEEEEEEecCCCCccccCceEccCCcE--EEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCEEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVN--VAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~k--VAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~lyLV 267 (1238)
.|...+.||.|+||.||+|.+..+|.. ||||.++... .....+.+.+|+++|.++ +|||||++++++.+++.+|+|
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 455668899999999999999888764 6777776443 334567899999999999 799999999999999999999
Q ss_pred EeecCCCccchhhhcc----------------cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEE
Q psy6346 268 SEYANQGEIFDYIARY----------------GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLA 331 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~----------------~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLi 331 (1238)
||||+||+|.++|.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999999999999654 468999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC-CCCCCCCChhHHHHHHhcC-CccCC
Q psy6346 332 DFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG-ALPFDGSTLNSLRDRVLSG-RFRIP 409 (1238)
Q Consensus 332 DFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG-rlPF~g~d~eeL~ekIl~g-~~~~P 409 (1238)
|||++.............||+.|+|||.+.+..+ +.++|||||||++|||++| .+||.+.+..++...+..+ .+.+|
T Consensus 170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~ 248 (309)
T d1fvra_ 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 248 (309)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC
T ss_pred cccccccccccccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 9999976555444556679999999999998887 8999999999999999996 5689999999998888775 55677
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 410 YFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 410 ~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
..+++++.+||.+||..||++|||++||++|
T Consensus 249 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 249 LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7899999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=393.62 Aligned_cols=248 Identities=21% Similarity=0.353 Sum_probs=211.9
Q ss_pred EEEEEEEecCCCCccccCceEccCCc----EEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTV----NVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIYI 266 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~----kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~lyL 266 (1238)
.|+..+.||.|+||.||+|.+..+|+ +||||+++... +....+.+.+|+.+|++++|||||++++++.++. .++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence 38888999999999999999887775 68888886543 3445678999999999999999999999998754 677
Q ss_pred EEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc-
Q psy6346 267 VSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK- 344 (1238)
Q Consensus 267 VMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~- 344 (1238)
+||++.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 88999999998877654 5799999999999999999999999999999999999999999999999999987644332
Q ss_pred --cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCC-ccCCCCCCHHHHHHH
Q psy6346 345 --LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGR-FRIPYFMSTECESLI 420 (1238)
Q Consensus 345 --l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~-~~~P~~iS~eLkDLI 420 (1238)
.....||+.|||||++.+..+ +.++|||||||+||||+| |.+||.+.+..++...+..+. ...|..+++++.+||
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li 246 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 246 (317)
T ss_dssp -------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHH
T ss_pred ccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 233468999999999998877 899999999999999998 899999998888888887764 567788999999999
Q ss_pred HHhcccCCCCCCCHHHHHhcc
Q psy6346 421 RKMLVREPTKRYCIEQIKRHR 441 (1238)
Q Consensus 421 rkML~kDPskRPTaeEILeHP 441 (1238)
.+||..||.+|||+.||++|.
T Consensus 247 ~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 247 VKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhCCCChhhCcCHHHHHHHH
Confidence 999999999999999999984
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-44 Score=389.00 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=214.9
Q ss_pred EEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
.|...+.||.|+||.||+|... .++..||||+++... .....+++.+|+++|++++||||+++++++.+.+..+
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 3667788888999999988764 356889999997654 4556788999999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhccc------------------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCccccc
Q psy6346 266 IVSEYANQGEIFDYIARYG------------------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLL 321 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~------------------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNIL 321 (1238)
+||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence 9999999999999986432 3788899999999999999999999999999999999
Q ss_pred ccCCCcEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCC-CCCCCCChhHH
Q psy6346 322 MDSNLDIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGA-LPFDGSTLNSL 397 (1238)
Q Consensus 322 Ld~nG~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGr-lPF~g~d~eeL 397 (1238)
|+.++.+||+|||++....... ...+.+|++.|+|||.+.+..+ +.++|||||||+||||++|. .||.+.+..++
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 9999999999999997553332 2335678999999999998887 89999999999999999985 78999999998
Q ss_pred HHHHhcCCc-cCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 398 RDRVLSGRF-RIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 398 ~ekIl~g~~-~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
...+..+.. .+|..+++++.+||.+||..||++|||+.||++
T Consensus 252 ~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888754 467789999999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=385.35 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=205.7
Q ss_pred EEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEee-eCCEEEEEEe
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVME-TKSMIYIVSE 269 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfe-d~d~lyLVME 269 (1238)
.|+..+.||.|+||.||+|.+ +|..||||+++++. ..+.+.+|+++|++++||||+++++++. ..+.+|+|||
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 366678899999999999986 57899999997653 3467899999999999999999999885 4566899999
Q ss_pred ecCCCccchhhhccc--ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCcccc
Q psy6346 270 YANQGEIFDYIARYG--RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQKLAT 347 (1238)
Q Consensus 270 y~~GGSL~d~Lkk~~--~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~l~t 347 (1238)
|+++|+|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..... ....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--~~~~ 159 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDT 159 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--CCcc
Confidence 999999999997643 589999999999999999999999999999999999999999999999999986433 3345
Q ss_pred ccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcC-CccCCCCCCHHHHHHHHHhcc
Q psy6346 348 WCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSG-RFRIPYFMSTECESLIRKMLV 425 (1238)
Q Consensus 348 ~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrkML~ 425 (1238)
..+++.|+|||++.+..+ +.++|||||||++|||++ |++||.+.+...+...+..+ ...+|..+++++.+||.+||.
T Consensus 160 ~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~ 238 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238 (262)
T ss_dssp --CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcc
Confidence 678999999999988776 899999999999999998 89999999988888888765 456788899999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q psy6346 426 REPTKRYCIEQIKRH 440 (1238)
Q Consensus 426 kDPskRPTaeEILeH 440 (1238)
.||.+|||+.+|+++
T Consensus 239 ~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 239 LDAAMRPSFLQLREQ 253 (262)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred cCHhHCcCHHHHHHH
Confidence 999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=386.75 Aligned_cols=248 Identities=19% Similarity=0.358 Sum_probs=200.3
Q ss_pred EEEEEEEecCCCCccccCceEcc-----CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeee-CCE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLR-----HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMET-KSM 263 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lk-----tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed-~d~ 263 (1238)
.|...+.||.|+||.||+|.+.. +++.||||+++... .....+.+.+|+.++.++ .|+||+.+++++.. +..
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 46777888999999999888653 34689999997654 445567788888888877 68899999998754 557
Q ss_pred EEEEEeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCc
Q psy6346 264 IYIVSEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLD 327 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~ 327 (1238)
+++|||||++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||||+.++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 899999999999999996532 4889999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC-CCCCCCCChh-HHHHHHh
Q psy6346 328 IKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG-ALPFDGSTLN-SLRDRVL 402 (1238)
Q Consensus 328 VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG-rlPF~g~d~e-eL~ekIl 402 (1238)
+||+|||+++...... .....+||+.|||||++.+..+ +.++|||||||++|||++| ..||.+.... .+...+.
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999997654332 2345679999999999998877 8999999999999999986 5788776544 3444444
Q ss_pred cC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 403 SG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 403 ~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+ .+.+|..+++++.+||.+||..||++|||++||++|
T Consensus 252 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 43 456778899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=383.80 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=204.2
Q ss_pred cEEEEEEEecCCCCccccCceEccC---CcEEEEEEeccCCC-ChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRH---TVNVAIKIIDKSQL-DPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lkt---G~kVAIKVLkks~l-d~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
+.|+..+.||.|+||.||+|..... ...||||++.+... +....+.+.+|+.+|++++||||+++++++.++ .++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 3478888999999999999986533 34799999987654 334567899999999999999999999999764 678
Q ss_pred EEEeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCCc
Q psy6346 266 IVSEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQK 344 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~~ 344 (1238)
+|||||.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+|+.++.+||+|||++........
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 999999999999877654 5799999999999999999999999999999999999999999999999999987644322
Q ss_pred ----cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHhcCCc--cCCCCCCHHHH
Q psy6346 345 ----LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVLSGRF--RIPYFMSTECE 417 (1238)
Q Consensus 345 ----l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl~g~~--~~P~~iS~eLk 417 (1238)
.....|+..|+|||++.+..+ +.++|||||||++|||++ |..||.+.+..+....+..... +.+..+++++.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 245 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence 233457889999999998876 899999999999999998 8999999999998888876644 45677899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHh
Q psy6346 418 SLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 418 DLIrkML~kDPskRPTaeEILe 439 (1238)
+||.+||..||++|||+++|++
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=385.07 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=211.5
Q ss_pred EEEEEEEecCCCCccccCceEccC-------CcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCC
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLLRH-------TVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKS 262 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~lkt-------G~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d 262 (1238)
.|...+.||.|+||.||+|..... +..||||++++.. ......++.+|+.++.++ +|||||++++++.+++
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 355566777777777777765533 3579999998764 555678899999999888 8999999999999999
Q ss_pred EEEEEEeecCCCccchhhhccc----------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCC
Q psy6346 263 MIYIVSEYANQGEIFDYIARYG----------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNL 326 (1238)
Q Consensus 263 ~lyLVMEy~~GGSL~d~Lkk~~----------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG 326 (1238)
.+|+|||||.+|+|.++|...+ .+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence 9999999999999999997543 489999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHHh
Q psy6346 327 DIKLADFGFSNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRVL 402 (1238)
Q Consensus 327 ~VKLiDFGLS~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekIl 402 (1238)
.+||+|||++....... .....+|++.|+|||++.+..| +.++|||||||++|||++ |.+||.+.+...+...+.
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~ 251 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 99999999998664433 2344678999999999988877 899999999999999997 799999999888888877
Q ss_pred cC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 403 SG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 403 ~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
.+ .+.+|..+++++.+||.+||+.||.+|||+.||++
T Consensus 252 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 65 45678889999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=381.18 Aligned_cols=248 Identities=20% Similarity=0.302 Sum_probs=216.1
Q ss_pred EEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeeeCCEEE
Q psy6346 191 TIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMETKSMIY 265 (1238)
Q Consensus 191 VYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed~d~ly 265 (1238)
.|...+.||.|+||+||+|.+. .++..||||+++... .......+.+|+.++++++|||||++++++...+..+
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 4566688999999999998775 246789999998654 4556678999999999999999999999999999999
Q ss_pred EEEeecCCCccchhhhccc----------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCC
Q psy6346 266 IVSEYANQGEIFDYIARYG----------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 266 LVMEy~~GGSL~d~Lkk~~----------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
+|||||.+|+|.+++.... .++...+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999999986432 367888999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhC-CCCCCCCChhHHHHHHhcCC-ccCCC
Q psy6346 336 SNYYVPGQ---KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCG-ALPFDGSTLNSLRDRVLSGR-FRIPY 410 (1238)
Q Consensus 336 S~~~~~s~---~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTG-rlPF~g~d~eeL~ekIl~g~-~~~P~ 410 (1238)
+....... .....+||+.|+|||.+.+..+ +.++|||||||+||||++| ..||.+.+..+....+..+. ...|.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~ 258 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 97654332 2234468999999999998887 7899999999999999997 58899999988888887764 45677
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 411 FMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 411 ~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
.+++.+.+||.+||+.||++|||+++|+++
T Consensus 259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 899999999999999999999999999983
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=380.89 Aligned_cols=248 Identities=20% Similarity=0.355 Sum_probs=211.5
Q ss_pred cEEEEEEEecCCCCccccCceEc-----cCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhC-CCCCeeEEEEEeeeCCE
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLL-----RHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQL-DHPHIIKLFQVMETKSM 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~l-----ktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL-~HPNIVrL~dvfed~d~ 263 (1238)
+.|...+.||.|+||.||+|.+. .+++.||||+++... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 34666788999999999998763 456799999998764 455667899999999999 69999999999999999
Q ss_pred EEEEEeecCCCccchhhhccc------------------ccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYG------------------RMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSN 325 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~------------------~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~n 325 (1238)
+|||||||++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence 999999999999999987543 58899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCCc---cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhh-CCCCCCCCChhHHHHHH
Q psy6346 326 LDIKLADFGFSNYYVPGQK---LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVC-GALPFDGSTLNSLRDRV 401 (1238)
Q Consensus 326 G~VKLiDFGLS~~~~~s~~---l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLT-GrlPF~g~d~eeL~ekI 401 (1238)
+.+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|||++ |.+||.+....+...++
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987654322 234578999999999988776 899999999999999998 67777776665544444
Q ss_pred h-cC-CccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 402 L-SG-RFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 402 l-~g-~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
. .+ ....|..+++++.+||.+||..||++|||+++|++
T Consensus 261 i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 33 34456778999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=375.68 Aligned_cols=244 Identities=20% Similarity=0.325 Sum_probs=205.3
Q ss_pred EEEecCCCCccccCceEccCC---cEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCeeEEEEEeee-CCEEEEEEee
Q psy6346 195 REKCGVKSRSCNRPPVLLRHT---VNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHIIKLFQVMET-KSMIYIVSEY 270 (1238)
Q Consensus 195 rekIGsGsfGtVYKav~lktG---~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNIVrL~dvfed-~d~lyLVMEy 270 (1238)
.+.||.|+||+||+|.+..++ ..||||++++. .+....+++.+|+++|++++||||+++++++.. ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 477999999999999887543 46999999754 356677899999999999999999999999865 5689999999
Q ss_pred cCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCcccccCCC-----c
Q psy6346 271 ANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFSNYYVPGQ-----K 344 (1238)
Q Consensus 271 ~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS~~~~~s~-----~ 344 (1238)
|++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||||+.++.+||+|||+++...... .
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~ 190 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence 9999999988754 457788899999999999999999999999999999999999999999999998654332 1
Q ss_pred cccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCC-CChhHHHHHHhcC-CccCCCCCCHHHHHHHHH
Q psy6346 345 LATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDG-STLNSLRDRVLSG-RFRIPYFMSTECESLIRK 422 (1238)
Q Consensus 345 l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g-~d~eeL~ekIl~g-~~~~P~~iS~eLkDLIrk 422 (1238)
.....||+.|+|||++....+ +.++|||||||+||||++|..||.. .+...+...+..+ ....|..+++++.+||.+
T Consensus 191 ~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~ 269 (311)
T d1r0pa_ 191 KTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269 (311)
T ss_dssp TTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHH
Confidence 223468999999999988776 8999999999999999997777654 3444555666555 445677899999999999
Q ss_pred hcccCCCCCCCHHHHHhc
Q psy6346 423 MLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 423 ML~kDPskRPTaeEILeH 440 (1238)
||..||++||++.||++|
T Consensus 270 cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 270 CWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHH
Confidence 999999999999999988
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-42 Score=367.58 Aligned_cols=253 Identities=20% Similarity=0.180 Sum_probs=203.3
Q ss_pred CCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCC-eeEEEEEeeeCCEEEE
Q psy6346 188 NGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPH-IIKLFQVMETKSMIYI 266 (1238)
Q Consensus 188 fGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPN-IVrL~dvfed~d~lyL 266 (1238)
.|..|...+.||.|+||.||+|.+..+|+.||||++...... +++.+|+++++.++|++ |+.+.+++.+.+..++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 355699999999999999999999999999999998875432 35788999999998766 5556667788899999
Q ss_pred EEeecCCCccchhh-hcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC---CCcEEEEecCCcccccCC
Q psy6346 267 VSEYANQGEIFDYI-ARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS---NLDIKLADFGFSNYYVPG 342 (1238)
Q Consensus 267 VMEy~~GGSL~d~L-kk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~---nG~VKLiDFGLS~~~~~s 342 (1238)
||||+.+ +|.+.+ ...+.+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||++......
T Consensus 81 vme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999964 554444 44568999999999999999999999999999999999998753 456999999999876433
Q ss_pred C--------ccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhHHHHHH---hcC-----Cc
Q psy6346 343 Q--------KLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNSLRDRV---LSG-----RF 406 (1238)
Q Consensus 343 ~--------~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~eeL~ekI---l~g-----~~ 406 (1238)
. .....+||+.|||||++.+..+ +.++|||||||++|||++|..||.+.........+ ... ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 2 2345679999999999998887 89999999999999999999999876543332222 111 11
Q ss_pred cCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHHhccccccc
Q psy6346 407 RIPYFMSTECESLIRKMLVREPTKRYCIE---QIKRHRWMAEE 446 (1238)
Q Consensus 407 ~~P~~iS~eLkDLIrkML~kDPskRPTae---EILeHPWFke~ 446 (1238)
.++..+++++.+||.+||..||.+||+++ ++|+|+|.+..
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 23456899999999999999999999987 55788876554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-40 Score=359.34 Aligned_cols=245 Identities=17% Similarity=0.190 Sum_probs=206.3
Q ss_pred CcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCC-CCeeEEEEEeeeCCEEEEE
Q psy6346 189 GQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDH-PHIIKLFQVMETKSMIYIV 267 (1238)
Q Consensus 189 GqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~H-PNIVrL~dvfed~d~lyLV 267 (1238)
|..|+..+.||.|+||.||+|++..+|+.||||+++.... ...+.+|+++++.|.| +||+.+++++......|+|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 4568899999999999999999999999999999876542 2356789999999965 8999999999999999999
Q ss_pred EeecCCCccchhhhcc-cccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccC-----CCcEEEEecCCcccccC
Q psy6346 268 SEYANQGEIFDYIARY-GRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDS-----NLDIKLADFGFSNYYVP 341 (1238)
Q Consensus 268 MEy~~GGSL~d~Lkk~-~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~-----nG~VKLiDFGLS~~~~~ 341 (1238)
|||| +++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 68999888765 46999999999999999999999999999999999999964 57899999999987543
Q ss_pred C--------CccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChh---HHHHHHhcCC-----
Q psy6346 342 G--------QKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLN---SLRDRVLSGR----- 405 (1238)
Q Consensus 342 s--------~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~e---eL~ekIl~g~----- 405 (1238)
. ......+||+.|||||++.+..+ +.++|||||||++|||++|..||.+.... ....++....
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 2 12345679999999999998877 89999999999999999999999865432 2233333221
Q ss_pred ccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy6346 406 FRIPYFMSTECESLIRKMLVREPTKRYCIEQIKR 439 (1238)
Q Consensus 406 ~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILe 439 (1238)
..++..+++++.+++..|+..+|++||+++.+.+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1234568899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=361.89 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=191.6
Q ss_pred cEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHH--HHHHHHhCCCCCeeEEEEEeeeCC----E
Q psy6346 190 QTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYR--EVEIMKQLDHPHIIKLFQVMETKS----M 263 (1238)
Q Consensus 190 qVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~r--EIeILkkL~HPNIVrL~dvfed~d----~ 263 (1238)
+.|...+.||.|+||.||+|+. +|..||||+++... .+.+.+ |+..+..++|||||++++++.+.+ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 3466778999999999999975 68999999986532 233444 455556789999999999997543 6
Q ss_pred EEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhc--------cceeeccCCcccccccCCCcEEEEecCC
Q psy6346 264 IYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHN--------RRVVHRDLKAENLLMDSNLDIKLADFGF 335 (1238)
Q Consensus 264 lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHS--------kGIIHRDLKPeNILLd~nG~VKLiDFGL 335 (1238)
+|+|||||++|+|.+++.+ ..+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 8999999999999999976 468899999999999999999996 5999999999999999999999999999
Q ss_pred cccccCCC-----ccccccCCCCCCCcccccCCcc-----CCCccceehhhHHHHHHhhCCCCCCCC-------------
Q psy6346 336 SNYYVPGQ-----KLATWCGSPPYAAPEVFEGKKY-----CGPEIDIWSLGVVLYVLVCGALPFDGS------------- 392 (1238)
Q Consensus 336 S~~~~~s~-----~l~t~~GTp~YmAPEVL~gk~y-----~S~KSDIWSLGVILYELLTGrlPF~g~------------- 392 (1238)
+....... .....+||+.|+|||++.+... ++.++|||||||+||||++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98764432 2345689999999999876531 367899999999999999998877431
Q ss_pred --ChhHHHHHHhcCCc--cCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 393 --TLNSLRDRVLSGRF--RIPYF-----MSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 393 --d~eeL~ekIl~g~~--~~P~~-----iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
....+...+..... .+|.. ....+.+|+.+||..||++|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22333444443332 22222 22458899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.5e-40 Score=357.33 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=196.3
Q ss_pred EEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-----------CCCeeEEEEEeee
Q psy6346 192 IRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-----------HPHIIKLFQVMET 260 (1238)
Q Consensus 192 YkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-----------HPNIVrL~dvfed 260 (1238)
|...+.||.|+||+||+|++..+|+.||||++++. ....+.+.+|+.+|+.+. |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 88899999999999999999999999999999864 334467789999998874 5889999998854
Q ss_pred --CCEEEEEEeecCCCccchhh---hcccccchhHHHHHHHHHHHHHhHhhc-cceeeccCCcccccccCCCc------E
Q psy6346 261 --KSMIYIVSEYANQGEIFDYI---ARYGRMNENAARRKFWQILSAVEYCHN-RRVVHRDLKAENLLMDSNLD------I 328 (1238)
Q Consensus 261 --~d~lyLVMEy~~GGSL~d~L---kk~~~Lsesea~kI~~QILsALeYLHS-kGIIHRDLKPeNILLd~nG~------V 328 (1238)
....+++|+++..+...... .....+++..++.+++||+.||.|||+ .||+||||||+||||+.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 45677777777655433322 234578999999999999999999997 89999999999999986653 9
Q ss_pred EEEecCCcccccCCCccccccCCCCCCCcccccCCccCCCccceehhhHHHHHHhhCCCCCCCCChhH------HHHH--
Q psy6346 329 KLADFGFSNYYVPGQKLATWCGSPPYAAPEVFEGKKYCGPEIDIWSLGVVLYVLVCGALPFDGSTLNS------LRDR-- 400 (1238)
Q Consensus 329 KLiDFGLS~~~~~s~~l~t~~GTp~YmAPEVL~gk~y~S~KSDIWSLGVILYELLTGrlPF~g~d~ee------L~ek-- 400 (1238)
+|+|||.+.... ......+||+.|+|||++.+..+ +.++||||+||++++|++|+.||....... ....
T Consensus 172 kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 172 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEeecccccccc--cccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 999999987543 33456789999999999998887 899999999999999999999997543210 0000
Q ss_pred -Hhc---------------------------------------CCccCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy6346 401 -VLS---------------------------------------GRFRIPYFMSTECESLIRKMLVREPTKRYCIEQIKRH 440 (1238)
Q Consensus 401 -Il~---------------------------------------g~~~~P~~iS~eLkDLIrkML~kDPskRPTaeEILeH 440 (1238)
+.. ....++...++++.+||.+||.+||.+|||++|+|+|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0011112246789999999999999999999999999
Q ss_pred cccccc
Q psy6346 441 RWMAEE 446 (1238)
Q Consensus 441 PWFke~ 446 (1238)
|||++.
T Consensus 329 p~f~~~ 334 (362)
T d1q8ya_ 329 PWLKDT 334 (362)
T ss_dssp GGGTTC
T ss_pred cccCCC
Confidence 999964
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.4e-21 Score=194.74 Aligned_cols=134 Identities=17% Similarity=0.161 Sum_probs=107.0
Q ss_pred EEEEEecCCCCccccCceEccCCcEEEEEEeccCCCC----------------hHhHHHHHHHHHHHHhCCCCCeeEEEE
Q psy6346 193 RKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLD----------------PVNLQKVYREVEIMKQLDHPHIIKLFQ 256 (1238)
Q Consensus 193 karekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld----------------~e~ikrf~rEIeILkkL~HPNIVrL~d 256 (1238)
.....||.|+||.||+|.+ .+|+.||||+++..... ......+.+|+.+|.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4568999999999999976 47899999997643211 111244567899999999999998887
Q ss_pred EeeeCCEEEEEEeecCCCccchhhhcccccchhHHHHHHHHHHHHHhHhhccceeeccCCcccccccCCCcEEEEecCCc
Q psy6346 257 VMETKSMIYIVSEYANQGEIFDYIARYGRMNENAARRKFWQILSAVEYCHNRRVVHRDLKAENLLMDSNLDIKLADFGFS 336 (1238)
Q Consensus 257 vfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~kI~~QILsALeYLHSkGIIHRDLKPeNILLd~nG~VKLiDFGLS 336 (1238)
+.. .++||||+.+..+. .++...+..++.||+.+|.|||++||+||||||+|||+++++ ++|+|||++
T Consensus 82 ~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a 149 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149 (191)
T ss_dssp EET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred ecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence 643 27999999876543 345667788999999999999999999999999999998654 899999998
Q ss_pred ccc
Q psy6346 337 NYY 339 (1238)
Q Consensus 337 ~~~ 339 (1238)
...
T Consensus 150 ~~~ 152 (191)
T d1zara2 150 VEV 152 (191)
T ss_dssp EET
T ss_pred ccC
Confidence 754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.04 E-value=1.8e-06 Score=91.39 Aligned_cols=42 Identities=31% Similarity=0.319 Sum_probs=36.2
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEeec
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILSI 54 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~~ 54 (1238)
...+++|+|+++||+|+||+||+|++..||+.||||++....
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~ 47 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN 47 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh
Confidence 457899999999999999999999999999999999985443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.97 E-value=8.4e-06 Score=82.66 Aligned_cols=118 Identities=15% Similarity=0.141 Sum_probs=75.8
Q ss_pred CCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCC-CCCeeEEEEEeeeCCEEEEEEeecCCCccchhhhcccccchhHHH
Q psy6346 214 HTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLD-HPHIIKLFQVMETKSMIYIVSEYANQGEIFDYIARYGRMNENAAR 292 (1238)
Q Consensus 214 tG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~-HPNIVrL~dvfed~d~lyLVMEy~~GGSL~d~Lkk~~~Lsesea~ 292 (1238)
++..+.||+....... ....+.+|+.+|..|. +--+.+++.+...++..|+||++++|..+.+..... ....
T Consensus 36 ~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~ 108 (263)
T d1j7la_ 36 ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-----QSPE 108 (263)
T ss_dssp SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-----SCHH
T ss_pred CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-----ccHH
Confidence 4566788887654211 2235678999888773 334677888888899999999999987765432110 0011
Q ss_pred HHHHHHHHHHhHhh-----------------------------------------------------------ccceeec
Q psy6346 293 RKFWQILSAVEYCH-----------------------------------------------------------NRRVVHR 313 (1238)
Q Consensus 293 kI~~QILsALeYLH-----------------------------------------------------------SkGIIHR 313 (1238)
.++.++...|..|| ...++|+
T Consensus 109 ~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~Hg 188 (263)
T d1j7la_ 109 KIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHG 188 (263)
T ss_dssp HHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECS
T ss_pred HHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEe
Confidence 11111111111111 1248999
Q ss_pred cCCcccccccCCCcEEEEecCCccc
Q psy6346 314 DLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 314 DLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
|+.|.|||+++++.+.|+||+.+..
T Consensus 189 D~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 189 DLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCTTSEEEETTEEEEECCCTTCEE
T ss_pred eccCcceeecCCceEEEeechhccc
Confidence 9999999999877677999998764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.90 E-value=3.7e-06 Score=87.17 Aligned_cols=37 Identities=27% Similarity=0.293 Sum_probs=34.5
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEee
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILS 53 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~ 53 (1238)
+.|++++.||+|+||+||+|+++.||+.||||++...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~ 38 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD 38 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESS
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehh
Confidence 5799999999999999999999999999999998544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.88 E-value=4.4e-06 Score=88.12 Aligned_cols=35 Identities=26% Similarity=0.349 Sum_probs=33.7
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+++|++++.||+|+||+||+|+++.||+.||||++
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i 35 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 35 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEE
Confidence 47899999999999999999999999999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.88 E-value=5.1e-06 Score=87.49 Aligned_cols=36 Identities=31% Similarity=0.472 Sum_probs=34.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+++|++++.||+|+||+||+|+++.||+.||||++
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i 38 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV 38 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEE
Confidence 578999999999999999999999999999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=4.3e-06 Score=89.98 Aligned_cols=36 Identities=22% Similarity=0.289 Sum_probs=34.3
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
|++|+|++.||+|+||+||+|+++.||+.||||++.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~ 36 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK 36 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEc
Confidence 578999999999999999999999999999999983
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=6.8e-06 Score=85.88 Aligned_cols=35 Identities=17% Similarity=0.188 Sum_probs=33.3
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
-+.|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i 37 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 37 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEE
Confidence 35799999999999999999999999999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.82 E-value=7.4e-06 Score=85.89 Aligned_cols=36 Identities=19% Similarity=0.202 Sum_probs=34.2
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.++|++++.||+|+||+||+|+++.||+.||||++
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i 37 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL 37 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 357899999999999999999999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.81 E-value=6.8e-06 Score=86.24 Aligned_cols=36 Identities=33% Similarity=0.499 Sum_probs=33.3
Q ss_pred ccc-ceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVG-FYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig-~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
++| .|+|++.||+|+||+||+|++..||+.||||++
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~ 40 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE 40 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEE
Confidence 444 599999999999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.80 E-value=7.9e-06 Score=87.21 Aligned_cols=34 Identities=29% Similarity=0.421 Sum_probs=32.7
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
|.|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi 46 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV 46 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEE
Confidence 4599999999999999999999999999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.79 E-value=9.1e-06 Score=88.51 Aligned_cols=38 Identities=21% Similarity=0.370 Sum_probs=35.8
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+++|++++.||+|+||+||+|+++.||+.||||++
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i 74 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEE
Confidence 45678999999999999999999999999999999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=97.79 E-value=8.1e-06 Score=86.76 Aligned_cols=36 Identities=19% Similarity=0.237 Sum_probs=34.2
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..++|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i 68 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 68 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEE
Confidence 567899999999999999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.79 E-value=8.4e-06 Score=88.55 Aligned_cols=36 Identities=25% Similarity=0.324 Sum_probs=34.7
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+++|+++++||+|+||+||+|+++.||+.||||++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i 38 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL 38 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEE
Confidence 578999999999999999999999999999999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.78 E-value=8e-06 Score=89.38 Aligned_cols=36 Identities=25% Similarity=0.373 Sum_probs=34.3
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+++|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i 37 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 37 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 367899999999999999999999999999999998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.78 E-value=9.1e-06 Score=85.05 Aligned_cols=38 Identities=29% Similarity=0.409 Sum_probs=35.5
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..+++|+|++.||+|+||+||+|+++.||+.||||++.
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~ 40 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 40 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEc
Confidence 35789999999999999999999999999999999983
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.78 E-value=8.9e-06 Score=85.67 Aligned_cols=34 Identities=35% Similarity=0.551 Sum_probs=32.6
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.|++++.||+|+||+||+|+++.||+.||||++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i 43 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFI 43 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 4599999999999999999999999999999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.78 E-value=8.3e-06 Score=87.52 Aligned_cols=36 Identities=28% Similarity=0.355 Sum_probs=34.4
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+.+|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i 37 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL 37 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEE
Confidence 467899999999999999999999999999999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=97.78 E-value=9e-06 Score=84.69 Aligned_cols=34 Identities=24% Similarity=0.350 Sum_probs=32.6
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i 40 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL 40 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEE
Confidence 4599999999999999999999999999999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=1.1e-05 Score=85.47 Aligned_cols=36 Identities=28% Similarity=0.383 Sum_probs=33.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.-++|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i 41 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL 41 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEE
Confidence 346799999999999999999999999999999998
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.72 E-value=5.9e-05 Score=75.89 Aligned_cols=68 Identities=7% Similarity=0.017 Sum_probs=47.2
Q ss_pred cccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCC--CeeEEEEEeeeCCEEEEEEeecCCCccch
Q psy6346 205 CNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHP--HIIKLFQVMETKSMIYIVSEYANQGEIFD 278 (1238)
Q Consensus 205 tVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HP--NIVrL~dvfed~d~lyLVMEy~~GGSL~d 278 (1238)
.||+.. ...+..+.+|+...... ..+.+|+..|+.|... .+.+++.+..+.+..++||++++|.++.+
T Consensus 26 ~v~r~~-~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 26 AVFRLS-AQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp EEEEEE-CTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred eEEEEE-eCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 345432 34566788898765432 2466788888877332 35678888888889999999999877654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.72 E-value=1.1e-05 Score=85.14 Aligned_cols=34 Identities=24% Similarity=0.436 Sum_probs=32.5
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
++|+|++.||+|+||+||+|++..||+.||||++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~ 38 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE 38 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 5799999999999999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=97.71 E-value=1.5e-05 Score=86.90 Aligned_cols=38 Identities=26% Similarity=0.316 Sum_probs=35.2
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
....+.|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i 62 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI 62 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 34567899999999999999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.71 E-value=2.1e-05 Score=82.33 Aligned_cols=42 Identities=19% Similarity=0.102 Sum_probs=35.4
Q ss_pred ccccceeEEeeeeeecceEEEEEEEccC-CCEEEEEEeEeecc
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARHRIT-KTEVGALCSILSIS 55 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h~~T-g~~vAI~~~i~~~~ 55 (1238)
...++|+|++.||+|+||+||+|++..| ++.||||++.....
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~ 46 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG 46 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc
Confidence 3457899999999999999999999876 67799999855433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.70 E-value=1.3e-05 Score=86.09 Aligned_cols=36 Identities=22% Similarity=0.273 Sum_probs=34.2
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
-.++|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i 38 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV 38 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEE
Confidence 457899999999999999999999999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=97.68 E-value=1.4e-05 Score=87.01 Aligned_cols=38 Identities=29% Similarity=0.428 Sum_probs=35.4
Q ss_pred CccccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 13 PIRVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 13 ~~~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
...+++|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i 59 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 59 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEE
Confidence 34578899999999999999999999999999999988
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.66 E-value=1.2e-05 Score=87.02 Aligned_cols=35 Identities=20% Similarity=0.161 Sum_probs=31.4
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
.+|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~ 51 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS 51 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEC
Confidence 57999999999999999999999999999999984
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=97.65 E-value=2e-05 Score=82.13 Aligned_cols=37 Identities=22% Similarity=0.206 Sum_probs=32.9
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEee
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSILS 53 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~~ 53 (1238)
+++|++++.||+|+||+||+|++. +|+.||||++...
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~ 37 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE 37 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCS
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehh
Confidence 367999999999999999999996 8999999998443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.63 E-value=1.9e-05 Score=85.19 Aligned_cols=33 Identities=27% Similarity=0.256 Sum_probs=32.1
Q ss_pred ceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 18 FYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 18 ~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.|++++.||+|+||+||+|++..||+.||||++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i 53 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV 53 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEE
Confidence 599999999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.63 E-value=9.6e-06 Score=86.55 Aligned_cols=34 Identities=21% Similarity=0.138 Sum_probs=32.6
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.|++++.||+|+||+||+|+++.||+.||||++
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i 51 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 51 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEEC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 4699999999999999999999999999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.59 E-value=2.8e-05 Score=82.35 Aligned_cols=36 Identities=25% Similarity=0.339 Sum_probs=33.8
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+-+.|+|++.||+|+||+||+|+++.||+.||||++
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i 45 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 45 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEE
Confidence 446799999999999999999999999999999997
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.58 E-value=2e-05 Score=84.22 Aligned_cols=38 Identities=18% Similarity=0.136 Sum_probs=34.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
..++|++++.||+|+||+||+|+++.||+.||||++..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~ 41 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 41 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEEC
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEECh
Confidence 35689999999999999999999999999999999843
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.58 E-value=1.6e-05 Score=85.21 Aligned_cols=34 Identities=21% Similarity=0.199 Sum_probs=26.8
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..|++++.||+|+||+||+|+++.||+.||||++
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i 51 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL 51 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEEC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEE
Confidence 5699999999999999999999999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.58 E-value=3.1e-05 Score=83.65 Aligned_cols=40 Identities=15% Similarity=0.115 Sum_probs=35.4
Q ss_pred CCCccccceeEE-eeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 11 KAPIRVGFYDIE-RTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 11 ~~~~~ig~Y~i~-~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+....+++|+|+ ++||+|+||+||+|+++.||+.||||++
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i 45 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML 45 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE
T ss_pred CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEE
Confidence 334568999987 5799999999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=97.57 E-value=2.7e-05 Score=82.04 Aligned_cols=35 Identities=23% Similarity=0.269 Sum_probs=33.5
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.++|++++.||+|+||+||+|+++.||+.||||++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i 36 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKII 36 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEE
Confidence 46899999999999999999999999999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.55 E-value=1.9e-05 Score=84.40 Aligned_cols=34 Identities=32% Similarity=0.564 Sum_probs=32.6
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
+.|++++.||+|+||+||+|+++.||+.||||++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i 42 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI 42 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEE
Confidence 4599999999999999999999999999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.53 E-value=3.8e-05 Score=82.41 Aligned_cols=37 Identities=16% Similarity=0.281 Sum_probs=33.7
Q ss_pred ccccceeEEeeeeeecceEEEEEEE---ccCCCEEEEEEe
Q psy6346 14 IRVGFYDIERTIGKGNFAVVKLARH---RITKTEVGALCS 50 (1238)
Q Consensus 14 ~~ig~Y~i~~tLGkGsFgkVklA~h---~~Tg~~vAI~~~ 50 (1238)
..+++|++++.||+|+||+||+|++ ..||+.||||++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i 60 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEE
Confidence 4578899999999999999999998 458999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.50 E-value=3.1e-05 Score=82.79 Aligned_cols=35 Identities=26% Similarity=0.295 Sum_probs=32.9
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
..|++++.||+|+||+||+|+++.||+.||||++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~ 49 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 49 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEc
Confidence 45999999999999999999999999999999983
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.49 E-value=2.6e-05 Score=83.84 Aligned_cols=34 Identities=24% Similarity=0.237 Sum_probs=29.4
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..|++++.||+|+||+||+|++..||+.||||++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i 41 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI 41 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEE
Confidence 3499999999999999999999999999999997
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.48 E-value=9e-05 Score=81.47 Aligned_cols=78 Identities=15% Similarity=0.077 Sum_probs=46.6
Q ss_pred EecCCCCccccCceEccCCcEEEEEEeccCC-C----ChHhHHHHHHHHHHHHhCC-C--CCeeEEEEEeeeCCEEEEEE
Q psy6346 197 KCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQ-L----DPVNLQKVYREVEIMKQLD-H--PHIIKLFQVMETKSMIYIVS 268 (1238)
Q Consensus 197 kIGsGsfGtVYKav~lktG~kVAIKVLkks~-l----d~e~ikrf~rEIeILkkL~-H--PNIVrL~dvfed~d~lyLVM 268 (1238)
.+|.|....||++....+++.|.||.-.... . .+....+...|+++|+.+. + ..+++++.+. .+..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEEE
Confidence 4667777777776665667889999643210 0 1123356678998888772 2 3455666553 44567899
Q ss_pred eecCCCcc
Q psy6346 269 EYANQGEI 276 (1238)
Q Consensus 269 Ey~~GGSL 276 (1238)
|++.+..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred eccCCccc
Confidence 99987544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.46 E-value=2.4e-05 Score=83.29 Aligned_cols=35 Identities=26% Similarity=0.120 Sum_probs=33.1
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
-++|++++.||+|+||+||+|+++.||+.||||++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~ 53 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM 53 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEE
Confidence 34799999999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.31 E-value=3.6e-05 Score=81.20 Aligned_cols=35 Identities=11% Similarity=0.081 Sum_probs=32.9
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
-++|++++.||+|+||+||+|++..||+.||||++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i 50 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 50 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEE
Confidence 35799999999999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.23 E-value=9.2e-05 Score=77.55 Aligned_cols=32 Identities=28% Similarity=0.253 Sum_probs=29.0
Q ss_pred eEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 20 DIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 20 ~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
+.++.||+|+||+||+|+++.||+.||||++.
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~ 32 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIK 32 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEe
Confidence 35789999999999999999999999999883
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.21 E-value=8.7e-05 Score=78.90 Aligned_cols=34 Identities=15% Similarity=0.136 Sum_probs=26.5
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+|++++.||+|+||+||+|++..||+.+|+||.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~va 42 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA 42 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEE
Confidence 5699999999999999999999999987666554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.20 E-value=0.00014 Score=76.01 Aligned_cols=33 Identities=24% Similarity=0.225 Sum_probs=30.8
Q ss_pred eeEEeeeeeecceEEEEEEEccCCCEEEEEEeE
Q psy6346 19 YDIERTIGKGNFAVVKLARHRITKTEVGALCSI 51 (1238)
Q Consensus 19 Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i 51 (1238)
|++.+.||+|+||+||+|+++.||+.||||++.
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~ 43 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 43 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEc
Confidence 588899999999999999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=97.12 E-value=0.00016 Score=71.00 Aligned_cols=33 Identities=15% Similarity=0.055 Sum_probs=29.3
Q ss_pred eeEEeeeeeecceEEEEEEEccCCCEEEEEEeEe
Q psy6346 19 YDIERTIGKGNFAVVKLARHRITKTEVGALCSIL 52 (1238)
Q Consensus 19 Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~i~ 52 (1238)
|-|++.||+|+||+||+|++. +|+.||||+++.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~ 34 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKV 34 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEec
Confidence 568999999999999999985 799999998743
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.08 E-value=0.00021 Score=74.43 Aligned_cols=34 Identities=18% Similarity=0.209 Sum_probs=30.7
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
-..|++++.||+|+||+||+|++. +++.||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~ 45 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL 45 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEE
Confidence 367999999999999999999986 6889999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.04 E-value=0.00015 Score=75.80 Aligned_cols=34 Identities=21% Similarity=0.169 Sum_probs=30.1
Q ss_pred cceeEEeeeeeecceEEEEEEEcc-----CCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRI-----TKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~-----Tg~~vAI~~~ 50 (1238)
++|++++.||+|+||+||+|++.. |++.||||++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l 51 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 51 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEE
Confidence 679999999999999999999754 5578999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.95 E-value=0.00023 Score=74.96 Aligned_cols=36 Identities=28% Similarity=0.182 Sum_probs=31.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
+-++|++++.||+|+||+||+|+++ .+++.||||++
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i 51 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML 51 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEE
Confidence 3567999999999999999999975 46789999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.91 E-value=0.00036 Score=73.80 Aligned_cols=36 Identities=25% Similarity=0.261 Sum_probs=30.9
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..++|++++.||+|+||+||+|+++.||..+||++.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK 43 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK 43 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEE
Confidence 456899999999999999999999999987655444
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.90 E-value=0.00025 Score=73.31 Aligned_cols=33 Identities=24% Similarity=0.321 Sum_probs=29.8
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+|++++.||+|+||+||+|++. +++.||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i 37 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI 37 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEE
Confidence 36999999999999999999986 5788999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.88 E-value=0.00021 Score=74.19 Aligned_cols=33 Identities=24% Similarity=0.366 Sum_probs=30.4
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.+|++++.||+|+||+||+|+++ ++..||||.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l 36 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI 36 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEE
Confidence 47999999999999999999985 7889999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.86 E-value=0.00024 Score=75.18 Aligned_cols=35 Identities=20% Similarity=0.267 Sum_probs=31.3
Q ss_pred ccceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
.++|++++.||+|+||+||+|++. .+++.||||.+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~ 58 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 58 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEE
Confidence 478999999999999999999986 35789999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.81 E-value=0.00033 Score=73.83 Aligned_cols=34 Identities=24% Similarity=0.215 Sum_probs=30.9
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
.++|+|++.||+|+||+||+|++..| +.||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l 49 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTL 49 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEE
Confidence 47899999999999999999999876 56999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.76 E-value=0.00047 Score=71.69 Aligned_cols=34 Identities=29% Similarity=0.426 Sum_probs=30.6
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..++|++++.||+|+||.||+|++ +|+.||||++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i 38 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI 38 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEE
Confidence 346799999999999999999998 4889999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.71 E-value=0.00048 Score=71.27 Aligned_cols=34 Identities=21% Similarity=0.230 Sum_probs=28.5
Q ss_pred cceeEEeeeeeecceEEEEEEEccCC---CEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITK---TEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg---~~vAI~~~ 50 (1238)
++|+|++.||+|+||+||+|++..++ ..||||.+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~ 43 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC 43 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEEC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEe
Confidence 57999999999999999999998664 45777765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.69 E-value=0.00056 Score=72.24 Aligned_cols=36 Identities=22% Similarity=0.289 Sum_probs=29.3
Q ss_pred cccceeEEeeeeeecceEEEEEEEccCCC---EEEEEEe
Q psy6346 15 RVGFYDIERTIGKGNFAVVKLARHRITKT---EVGALCS 50 (1238)
Q Consensus 15 ~ig~Y~i~~tLGkGsFgkVklA~h~~Tg~---~vAI~~~ 50 (1238)
..+.|++++.||+|+||+||+|+++.+|+ .||||++
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~ 62 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEEC
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEE
Confidence 45789999999999999999999998876 5788776
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.66 E-value=0.00073 Score=71.94 Aligned_cols=34 Identities=18% Similarity=0.174 Sum_probs=30.3
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCC-----EEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKT-----EVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~-----~vAI~~~ 50 (1238)
++|++++.||+|+||+||+|++..+++ .||||.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~ 75 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 75 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEe
Confidence 579999999999999999999987765 6888877
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.62 E-value=0.00068 Score=71.66 Aligned_cols=35 Identities=20% Similarity=0.148 Sum_probs=31.2
Q ss_pred ccceeEEeeeeeecceEEEEEEEc-----cCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHR-----ITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~-----~Tg~~vAI~~~ 50 (1238)
.++|++++.||+|+||+||+|++. .+++.||||.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i 61 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEE
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEE
Confidence 367999999999999999999863 67889999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.55 E-value=0.00079 Score=70.21 Aligned_cols=34 Identities=18% Similarity=0.213 Sum_probs=28.9
Q ss_pred cceeEEeeeeeecceEEEEEEEccCC----CEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITK----TEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg----~~vAI~~~ 50 (1238)
..|++++.||+|+||+||+|+++.++ ..||||++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~ 44 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL 44 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEE
Confidence 35999999999999999999998876 47999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.52 E-value=0.00081 Score=71.01 Aligned_cols=32 Identities=25% Similarity=0.275 Sum_probs=29.3
Q ss_pred cceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
..|.+.+.||+|+||.||+|++ +|+.||||++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~ 34 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF 34 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEE
Confidence 3689999999999999999986 6999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.51 E-value=0.0005 Score=72.28 Aligned_cols=35 Identities=23% Similarity=0.214 Sum_probs=25.6
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCC-------CEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITK-------TEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg-------~~vAI~~~ 50 (1238)
.+.|+|++.||+|+||+||+|++..|+ ..||||++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~ 53 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 53 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEE
Confidence 478999999999999999999998776 47999887
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.48 E-value=0.005 Score=66.81 Aligned_cols=89 Identities=13% Similarity=0.149 Sum_probs=54.1
Q ss_pred cCCceeEEeeccCCCCCcEEEEEEEecCCCCccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCe-
Q psy6346 173 IDGRRLRLDTLHAEKNGQTIRKREKCGVKSRSCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHI- 251 (1238)
Q Consensus 173 idgRy~~i~~LgsGkfGqVYkarekIGsGsfGtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNI- 251 (1238)
++...+.+..|..|-...+|.+...-+ .. ........|.+++.-... . .-...+|..+++.+.-.++
T Consensus 40 ~~~~~l~v~~l~GGltN~~y~v~~~~~--~~------~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~ 107 (395)
T d1nw1a_ 40 VPLEHLRISRIKGGMSNMLFLCRLSEV--YP------PIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLG 107 (395)
T ss_dssp CCGGGEEEEEECCCTTEEEEEEEECTT--SC------CSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSS
T ss_pred CCccceEEEEcCCccccceEEEEeCCC--Cc------cccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCC
Confidence 344556777777777677776533211 11 012345668888875322 1 2245589999998843344
Q ss_pred eEEEEEeeeCCEEEEEEeecCCCccc
Q psy6346 252 IKLFQVMETKSMIYIVSEYANQGEIF 277 (1238)
Q Consensus 252 VrL~dvfed~d~lyLVMEy~~GGSL~ 277 (1238)
.++++++.+ .+||||++|..|.
T Consensus 108 Pkll~~~~~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 108 PKLYGIFSG----GRLEEYIPSRPLS 129 (395)
T ss_dssp SCEEEEETT----EEEECCCCEEECC
T ss_pred CeEEEEcCC----ceEEEEeccccCC
Confidence 578877754 6899999886554
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.20 E-value=0.00082 Score=70.26 Aligned_cols=32 Identities=22% Similarity=0.339 Sum_probs=28.2
Q ss_pred ccceeEEeeeeeecceEEEEEEEccCCCEEEEEEe
Q psy6346 16 VGFYDIERTIGKGNFAVVKLARHRITKTEVGALCS 50 (1238)
Q Consensus 16 ig~Y~i~~tLGkGsFgkVklA~h~~Tg~~vAI~~~ 50 (1238)
-++|++++.||+|+||+||+|++. ..||||++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~ 38 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKML 38 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEE
Confidence 467999999999999999999864 35999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.11 E-value=0.00098 Score=69.45 Aligned_cols=34 Identities=21% Similarity=0.354 Sum_probs=23.9
Q ss_pred cceeEEeeeeeecceEEEEEEEc-cCCC--EEEEEEe
Q psy6346 17 GFYDIERTIGKGNFAVVKLARHR-ITKT--EVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~tLGkGsFgkVklA~h~-~Tg~--~vAI~~~ 50 (1238)
++|++++.||+|+||+||+|++. .+++ .||||++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l 44 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL 44 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEE
Confidence 56999999999999999999875 4444 6789876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.01 E-value=0.0026 Score=66.74 Aligned_cols=34 Identities=24% Similarity=0.295 Sum_probs=27.8
Q ss_pred cceeEEee-eeeecceEEEEEEEccC--CCEEEEEEe
Q psy6346 17 GFYDIERT-IGKGNFAVVKLARHRIT--KTEVGALCS 50 (1238)
Q Consensus 17 g~Y~i~~t-LGkGsFgkVklA~h~~T--g~~vAI~~~ 50 (1238)
++|.+.+. ||+|+||+||+|+++.+ +..||||++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l 44 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL 44 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEE
Confidence 46888885 99999999999988754 557999987
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.77 E-value=0.018 Score=60.80 Aligned_cols=129 Identities=10% Similarity=0.062 Sum_probs=73.9
Q ss_pred ccccCceEccCCcEEEEEEeccCCCChHhHHHHHHHHHHHHhCCCCCe--eEEE-----EEeeeCCEEEEEEeecCCCcc
Q psy6346 204 SCNRPPVLLRHTVNVAIKIIDKSQLDPVNLQKVYREVEIMKQLDHPHI--IKLF-----QVMETKSMIYIVSEYANQGEI 276 (1238)
Q Consensus 204 GtVYKav~lktG~kVAIKVLkks~ld~e~ikrf~rEIeILkkL~HPNI--VrL~-----dvfed~d~lyLVMEy~~GGSL 276 (1238)
..||++. ..+|..|++|+.+....+ .+.+..|+..|..|...+| +..+ ..+...+..+.+++++.|..+
T Consensus 36 N~vy~v~-~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQ-DEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEEC-CTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEE-cCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 4555543 367888999998765433 3457788888887732222 1111 123456788999999987544
Q ss_pred chh----hhc--------------c-----cc-------------------cchhH---HHHHHHHHHHHHhHhh----c
Q psy6346 277 FDY----IAR--------------Y-----GR-------------------MNENA---ARRKFWQILSAVEYCH----N 307 (1238)
Q Consensus 277 ~d~----Lkk--------------~-----~~-------------------Lsese---a~kI~~QILsALeYLH----S 307 (1238)
... +.. . .. ++... ....+..++..+.-+- .
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 311 100 0 00 11111 1222233333332221 2
Q ss_pred cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.++||+|+++.|||++++ ..|+||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 479999999999999743 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.76 E-value=0.014 Score=60.53 Aligned_cols=31 Identities=29% Similarity=0.347 Sum_probs=27.8
Q ss_pred cceeeccCCcccccccCCCcEEEEecCCccc
Q psy6346 308 RRVVHRDLKAENLLMDSNLDIKLADFGFSNY 338 (1238)
Q Consensus 308 kGIIHRDLKPeNILLd~nG~VKLiDFGLS~~ 338 (1238)
.|+||+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4899999999999999888789999998763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.31 E-value=0.0044 Score=64.49 Aligned_cols=28 Identities=25% Similarity=0.328 Sum_probs=24.5
Q ss_pred eeeeeecceEEEEEEEc--cCCCEEEEEEe
Q psy6346 23 RTIGKGNFAVVKLARHR--ITKTEVGALCS 50 (1238)
Q Consensus 23 ~tLGkGsFgkVklA~h~--~Tg~~vAI~~~ 50 (1238)
|.||+|+||+||+|++. .+++.||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~ 42 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL 42 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEE
Confidence 57999999999999875 46789999988
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.95 E-value=0.0097 Score=62.91 Aligned_cols=32 Identities=16% Similarity=0.203 Sum_probs=25.3
Q ss_pred eeEEeeeeeecceEEEEEEEccCC---CEEEEEEe
Q psy6346 19 YDIERTIGKGNFAVVKLARHRITK---TEVGALCS 50 (1238)
Q Consensus 19 Y~i~~tLGkGsFgkVklA~h~~Tg---~~vAI~~~ 50 (1238)
+++.+.||+|+||+||+|++..++ ..||||.+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~ 63 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEE
Confidence 445789999999999999997754 36899877
|